Citrus Sinensis ID: 015781
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | 2.2.26 [Sep-21-2011] | |||||||
| Q06548 | 410 | Protein kinase APK1A, chl | yes | no | 0.897 | 0.875 | 0.692 | 1e-147 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.957 | 0.929 | 0.651 | 1e-146 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.892 | 0.917 | 0.674 | 1e-145 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.885 | 0.896 | 0.661 | 1e-140 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.857 | 0.881 | 0.623 | 1e-130 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.832 | 0.675 | 0.635 | 1e-129 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.832 | 0.781 | 0.630 | 1e-127 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.825 | 0.673 | 0.641 | 1e-126 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.805 | 0.755 | 0.623 | 1e-123 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.822 | 0.802 | 0.597 | 1e-114 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 521 bits (1342), Expect = e-147, Method: Compositional matrix adjust.
Identities = 250/361 (69%), Positives = 291/361 (80%), Gaps = 2/361 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + +GA++K KD G+ GS + SV PRTEGEIL N+KSFSF
Sbjct: 1 MGICLSAQVKAE-SSGASTKYDAKD-IGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSF 58
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK+ATRNFRPDSVLGEGGFGCVFKGWIDE + +RPGTG+VIAVK+LNQ+ QGH E
Sbjct: 59 AELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQE 118
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WL E+ +LGQ H +LVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR Y QPLSW +R
Sbjct: 119 WLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLR 178
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+KVALGAAKGLA+LHS + +VIYRDFKTSNILLD YNAKLSDFGLAKDGP G +SHVST
Sbjct: 179 LKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVST 238
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
RVMGT+GYAAPEY+ATGHLT KSDVYSFGVVLLE+LSGRR +DKNRPS E NL+EWAKPY
Sbjct: 239 RVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPY 298
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
L +KR+IF+V+D R++ QYS+ A K A L+++CL+ E K RP M EVV LE IQ N
Sbjct: 299 LVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQSLNA 358
Query: 361 A 361
A
Sbjct: 359 A 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1330), Expect = e-146, Method: Compositional matrix adjust.
Identities = 250/384 (65%), Positives = 297/384 (77%), Gaps = 1/384 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + P GA+ K + N + GS S S+ PRTEGEIL N+KSF+F
Sbjct: 1 MGICLSAQIKAVSP-GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTF 59
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK ATRNFRPDSVLGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH E
Sbjct: 60 AELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQE 119
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WL E+ +LGQ HPNLVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR SY QPLSWT+R
Sbjct: 120 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 179
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+KVALGAAKGLA+LH+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVST
Sbjct: 180 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 239
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
R+MGTYGYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRR +DKNRP E L+EWA+P
Sbjct: 240 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPL 299
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
L +KR++F+V+D R++ QYS+ A K A LA++CL+ E K RP M+EVV LE IQ N+
Sbjct: 300 LANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNE 359
Query: 361 AGVSRDESLQNSDRSTYKRKGLNE 384
AG + +Q R +N+
Sbjct: 360 AGGRNIDMVQRRMRRRSDSVAINQ 383
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 245/363 (67%), Positives = 298/363 (82%), Gaps = 6/363 (1%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG + GSS+ +S S +PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDG--SKGSST--ASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFRR ++ QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWN 176
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SHV
Sbjct: 177 TRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHV 236
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGT GYAAPEY+ATGHL+ KSDVYSFGVVLLE+LSGRR IDKN+P EHNL++WA+
Sbjct: 237 STRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWAR 296
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL +KRR+ +VMD R++GQYSL ALK AVLA+ C+S + K RPTM+E+VK +E++
Sbjct: 297 PYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
Query: 359 NDA 361
+A
Sbjct: 357 KEA 359
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-140, Method: Compositional matrix adjust.
Identities = 236/357 (66%), Positives = 288/357 (80%), Gaps = 3/357 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G S S S+V+ +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGLSLS-SRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFRR +Y +PL W +R
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VST
Sbjct: 178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
RVMGTYGYAAPEYM++GHL A+SDVYSFGV+LLE+LSG+R +D NRP++E NL++WA+PY
Sbjct: 238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARPY 297
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357
L SKR++ ++D R++ QY A++ A +A++CLS EPK RPTMD+VV+AL+Q+QD
Sbjct: 298 LTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-130, Method: Compositional matrix adjust.
Identities = 222/356 (62%), Positives = 275/356 (77%), Gaps = 13/356 (3%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
+TEGEIL + +KSFSFN LK ATRNFR DSV+GEGGFGCVF+GW+DE T P + +G+
Sbjct: 35 KTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGL 94
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
VIAVKRLN + QGH EWLTEI +LGQL HPNLVKLIGYCLED+ RLLVYEFM KGSLEN
Sbjct: 95 VIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLEN 154
Query: 164 HLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
HLF + +PLSW +R+KVAL AAKGLA+LHSD KVIYRD K SNILLD ++NAKLS
Sbjct: 155 HLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLS 214
Query: 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282
DFGLA+DGP G QS+VSTRVMGT+GYAAPEY++TGHL A+SDVYSFGVVLLE+L GR+ +
Sbjct: 215 DFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQAL 274
Query: 283 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342
D NRP++E NL++WA+PYL S+R++ ++D R+ QY A++ A +A++CLS EPK R
Sbjct: 275 DHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSR 334
Query: 343 PTMDEVVKALEQIQDTNDAGVSRDE----------SLQNSDRSTYKRKGLNENGQG 388
PTMD+VV+AL Q+QD+ + D L+ D+ Y+R GLN+ G
Sbjct: 335 PTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVGLKTEDK--YQRNGLNKKTVG 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1184), Expect = e-129, Method: Compositional matrix adjust.
Identities = 214/337 (63%), Positives = 266/337 (78%), Gaps = 4/337 (1%)
Query: 29 TSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGW 88
++ ++S S S P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGW
Sbjct: 101 STTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGW 160
Query: 89 IDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148
I+E+ AP +PGTG+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD
Sbjct: 161 IEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQ 220
Query: 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFK 207
RLLVYEFMP+GSLENHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFK
Sbjct: 221 RLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFK 277
Query: 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYS 267
TSNILLD +YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYS
Sbjct: 278 TSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 337
Query: 268 FGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKT 327
FGVVLLEML+GRR +DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K
Sbjct: 338 FGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKV 397
Query: 328 AVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 364
LA +CLS +PK RP M +VV+AL+ + D S
Sbjct: 398 TQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASS 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 212/336 (63%), Positives = 266/336 (79%), Gaps = 3/336 (0%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRTEGEIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+
Sbjct: 55 TPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGS 114
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+V+AVK+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSL
Sbjct: 115 GIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSL 174
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+KL
Sbjct: 175 ENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKL 232
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAK GPTG ++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRR
Sbjct: 233 SDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRA 292
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
+DK++ E +L++WA PYL KR++F++MD R+ GQY A A LA++CL+ + K
Sbjct: 293 VDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKL 352
Query: 342 RPTMDEVVKALEQIQDTNDA-GVSRDESLQNSDRST 376
RP M EV+ L+Q++ T GV ++ +S R +
Sbjct: 353 RPKMSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGS 388
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1160), Expect = e-126, Method: Compositional matrix adjust.
Identities = 215/335 (64%), Positives = 265/335 (79%), Gaps = 5/335 (1%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
+ T+ +S+ SS+S P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFK
Sbjct: 94 SSTTTTSNAESSLST-PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFK 152
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
GW++E+ AP +PGTG+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+ED
Sbjct: 153 GWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIED 212
Query: 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRD 205
D RLLVYEFMP+GSLENHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRD
Sbjct: 213 DQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRD 269
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDV 265
FKTSNILLD YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDV
Sbjct: 270 FKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV 329
Query: 266 YSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAAL 325
YSFGVVLLEML+GRR +DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A
Sbjct: 330 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQ 389
Query: 326 KTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
K LA +CLS + K RP M EVV+ L+ + D
Sbjct: 390 KVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 202/324 (62%), Positives = 256/324 (79%), Gaps = 2/324 (0%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
RTEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+
Sbjct: 60 RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
V+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 164 HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223
HLFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLSD
Sbjct: 180 HLFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSD 237
Query: 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 283
FGLAK GPTG +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRR +D
Sbjct: 238 FGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMD 297
Query: 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 343
+ E++L++WA PYL KR++F++MD ++ GQY A A LA++CL+ + K RP
Sbjct: 298 NSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRP 357
Query: 344 TMDEVVKALEQIQDTNDAGVSRDE 367
M EV+ LEQ++ G +
Sbjct: 358 KMSEVLVTLEQLESVAKPGTKHTQ 381
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/340 (59%), Positives = 253/340 (74%), Gaps = 11/340 (3%)
Query: 22 SRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGF 81
SR + + S+ R S P + +++ F+ L+T T++FRPD +LGEGGF
Sbjct: 27 SRSVSDLSDPSTPRFRDDSRTPISYAQVI------PFTLFELETITKSFRPDYILGEGGF 80
Query: 82 GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIG 141
G V+KG+ID++ + + +AVK LN+E LQGH EWLTE+ LGQL HPNLVKLIG
Sbjct: 81 GTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIG 137
Query: 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 201
YC EDDHRLLVYEFM +GSLENHLFR+ + PLSW+ RM +ALGAAKGLA+LH+ + V
Sbjct: 138 YCCEDDHRLLVYEFMLRGSLENHLFRKTT--APLSWSRRMMIALGAAKGLAFLHNAERPV 195
Query: 202 IYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA 261
IYRDFKTSNILLD +Y AKLSDFGLAK GP G ++HVSTRVMGTYGYAAPEY+ TGHLTA
Sbjct: 196 IYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTA 255
Query: 262 KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL 321
+SDVYSFGVVLLEML+GR+ +DK RPS+E NL++WA+P L KR++ Q++D R+E QYS+
Sbjct: 256 RSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSV 315
Query: 322 GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361
AA K LA CLS PK RP M +VV+ LE +Q T DA
Sbjct: 316 RAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| 255584865 | 410 | Protein kinase APK1B, chloroplast precur | 0.985 | 0.960 | 0.734 | 1e-171 | |
| 224112765 | 415 | predicted protein [Populus trichocarpa] | 0.99 | 0.954 | 0.747 | 1e-168 | |
| 356501055 | 392 | PREDICTED: protein kinase APK1A, chlorop | 0.927 | 0.946 | 0.764 | 1e-167 | |
| 255637885 | 392 | unknown [Glycine max] | 0.927 | 0.946 | 0.761 | 1e-166 | |
| 356501057 | 390 | PREDICTED: protein kinase APK1A, chlorop | 0.922 | 0.946 | 0.759 | 1e-166 | |
| 356551743 | 399 | PREDICTED: protein kinase APK1A, chlorop | 0.912 | 0.914 | 0.757 | 1e-163 | |
| 449450018 | 401 | PREDICTED: protein kinase APK1A, chlorop | 0.96 | 0.957 | 0.707 | 1e-163 | |
| 357492229 | 418 | Serine/threonine protein kinase [Medicag | 0.99 | 0.947 | 0.696 | 1e-161 | |
| 224106475 | 391 | predicted protein [Populus trichocarpa] | 0.957 | 0.979 | 0.696 | 1e-160 | |
| 224098423 | 368 | predicted protein [Populus trichocarpa] | 0.81 | 0.880 | 0.827 | 1e-160 |
| >gi|255584865|ref|XP_002533148.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223527043|gb|EEF29229.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 299/407 (73%), Positives = 338/407 (83%), Gaps = 13/407 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MGSCFS + +SPL +GA+ + K G+ SGSSS V S PRTEGEIL SN+KSF
Sbjct: 1 MGSCFSVRIKAESPLHHGADPRNRSKGGHDVSGSSSAVPST---PRTEGEILQSSNLKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
SFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG+VIAVKRLNQE QGH
Sbjct: 58 SFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGIVIAVKRLNQEGFQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY+QPLSW
Sbjct: 118 QEWLAEINYLGQLDHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYVQPLSWN 177
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+R+++AL AAKGLA+LHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+SHV
Sbjct: 178 LRIQIALDAAKGLAFLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSKSHV 237
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLEM+SGRR IDKNRPSRE NL+EWA+
Sbjct: 238 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEMISGRRAIDKNRPSREQNLVEWAR 297
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL +KR+IFQVMDAR+EGQYSL ALK A LA++C+S EP+FRP M+EVVKALEQ+ ++
Sbjct: 298 PYLGNKRKIFQVMDARVEGQYSLKDALKVANLAVQCISPEPRFRPKMEEVVKALEQLLES 357
Query: 359 ND---AGVSRDESLQNSDRST-----YKRKGLNENGQGKASVHHRPS 397
ND + SR ESL+ +R++ Y RK E GKA+ + RPS
Sbjct: 358 NDNEGSRGSRHESLRKVNRNSNNGPRYHRKSTAETCDGKAASYPRPS 404
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112765|ref|XP_002316286.1| predicted protein [Populus trichocarpa] gi|222865326|gb|EEF02457.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1542), Expect = e-168, Method: Compositional matrix adjust.
Identities = 305/408 (74%), Positives = 339/408 (83%), Gaps = 12/408 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MGSCFSA + +SP NG N+K + K GN SGSSS+VSS +V PRT+GEIL SN+K
Sbjct: 1 MGSCFSARIKAESPSRNGGNTKYAGKGGNDKSGSSSKVSSSTVPSTPRTQGEILQSSNLK 60
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SFSF+ LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG VIAVKRLNQES Q
Sbjct: 61 SFSFSELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGTVIAVKRLNQESSQ 120
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY QPLS
Sbjct: 121 GHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYFQPLS 180
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W +RMKVAL AAKGL YLHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+S
Sbjct: 181 WNLRMKVALDAAKGLEYLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSKS 240
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
HVSTR+MGTYGYAAPEYMATGHLTA+SDVYSFGVVLLEMLSGRR IDKNRPS+EHNL+EW
Sbjct: 241 HVSTRIMGTYGYAAPEYMATGHLTARSDVYSFGVVLLEMLSGRRAIDKNRPSKEHNLVEW 300
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
A+PYL SKRRIFQVMDARI+GQYS ALK A LAI+CLS EPK+RP M+ VVKALEQ+
Sbjct: 301 ARPYLSSKRRIFQVMDARIQGQYSSSDALKAANLAIQCLSTEPKYRPNMEAVVKALEQLH 360
Query: 357 DTND---AGVSRDESLQNSDRST-----YKRKGLNENGQGKASVHHRP 396
++ND + SR E+ + +RS+ Y RK + E GK + + P
Sbjct: 361 NSNDNDGSKGSRGENPRRVNRSSSNGPKYHRKNVKEVSNGKPASYAGP 408
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501055|ref|XP_003519344.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 289/378 (76%), Positives = 319/378 (84%), Gaps = 7/378 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 179
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 180 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 239
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIEWAK
Sbjct: 240 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIEWAK 299
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD+
Sbjct: 300 PYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQDS 359
Query: 359 ND----AGVSRDESLQNS 372
+D G SRD++ + S
Sbjct: 360 DDRVGGVGSSRDQTTRRS 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255637885|gb|ACU19261.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 288/378 (76%), Positives = 318/378 (84%), Gaps = 7/378 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 179
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 180 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 239
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++ G+R +D NRPS EHNLIEWAK
Sbjct: 240 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMFGKRALDSNRPSGEHNLIEWAK 299
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD+
Sbjct: 300 PYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQDS 359
Query: 359 ND----AGVSRDESLQNS 372
+D G SRD++ + S
Sbjct: 360 DDRVGGVGSSRDQTTRRS 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501057|ref|XP_003519345.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 287/378 (75%), Positives = 316/378 (83%), Gaps = 9/378 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG C +DG + S+ SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGNYHSCKEEDGLSSKASTP---SVPPTPRTEGEILKSSNMKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 58 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 118 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 177
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 178 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 237
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIEWAK
Sbjct: 238 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIEWAK 297
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL SKRRIFQVMDARIEGQY L A+K A LAI+CLS EP+FRP MDEVV+ALE++QD+
Sbjct: 298 PYLSSKRRIFQVMDARIEGQYMLREAMKVATLAIQCLSVEPRFRPKMDEVVRALEELQDS 357
Query: 359 ND----AGVSRDESLQNS 372
+D G SRD++ + S
Sbjct: 358 DDRVGGVGSSRDQTTRRS 375
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551743|ref|XP_003544233.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1495), Expect = e-163, Method: Compositional matrix adjust.
Identities = 285/376 (75%), Positives = 317/376 (84%), Gaps = 11/376 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVS--VVPRTEGEILLGSNIK 56
MG C SA + +SP NG +SK K+ +G S S+VS+ S PRTEGEIL SN+K
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLS---SKVSTPSDPPTPRTEGEILKSSNMK 57
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SF+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQ
Sbjct: 58 SFNFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQ 117
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWLTEI +LGQL HPNLVKLIGYCLEDD RLLVYEF+ KGSL+NHLFRRASY QPLS
Sbjct: 118 GHSEWLTEINYLGQLRHPNLVKLIGYCLEDDQRLLVYEFLTKGSLDNHLFRRASYFQPLS 177
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W RMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +S
Sbjct: 178 WNFRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKS 237
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
HVSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLIEW
Sbjct: 238 HVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDSNRPSGEHNLIEW 297
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
AKPYL +KRRIFQVMDARIEGQY+L ++K A LAI+CLS EP+FRP MDEVV+ALE++Q
Sbjct: 298 AKPYLSNKRRIFQVMDARIEGQYTLRESMKVANLAIQCLSVEPRFRPKMDEVVRALEELQ 357
Query: 357 DTND----AGVSRDES 368
D+ D G SRD++
Sbjct: 358 DSEDRAGGVGSSRDQT 373
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450018|ref|XP_004142761.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] gi|449527906|ref|XP_004170949.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1494), Expect = e-163, Method: Compositional matrix adjust.
Identities = 283/400 (70%), Positives = 332/400 (83%), Gaps = 16/400 (4%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MGSC SA + +SPL NG +S+ +R DGN S+S+ SSVS PRTEGEIL SN+K
Sbjct: 1 MGSCLSARIKAESPLHNGLSSRYAR-DGNDKGNSTSK-SSVSTPRTPRTEGEILQSSNLK 58
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
+FS+N LK ATRNFRPDSVLGEGGFG VFKGWIDE ++A +PGTG+VIAVKRLNQE Q
Sbjct: 59 NFSYNELKAATRNFRPDSVLGEGGFGSVFKGWIDEQSFAVTKPGTGLVIAVKRLNQEGFQ 118
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWLTEI +LGQL+HPNLV+LIG+CLED+HRLLVYEFMP+GSLENHLFRR+S+ QPLS
Sbjct: 119 GHREWLTEIDYLGQLHHPNLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRSSHFQPLS 178
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W++R+KVALGAAKGLA+LHSD+AKVIYRDFK+SNILLD +YNAKLSDFGLAKDGPTG +S
Sbjct: 179 WSLRLKVALGAAKGLAFLHSDEAKVIYRDFKSSNILLDSDYNAKLSDFGLAKDGPTGDRS 238
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
+VSTRVMGT+GYAAPEYM TGHLTAKSDVYSFGVVLLE+LSGRR IDKNRPS EHNL+EW
Sbjct: 239 YVSTRVMGTFGYAAPEYMITGHLTAKSDVYSFGVVLLEILSGRRAIDKNRPSGEHNLVEW 298
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
AKPYL SKRR+ Q++DARIEGQYS G ALK A LAI+C+S EPK RP M+ VVKALEQ+Q
Sbjct: 299 AKPYLTSKRRVLQMLDARIEGQYSTGGALKAAKLAIQCISTEPKLRPNMNAVVKALEQLQ 358
Query: 357 DTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 396
D+++ SR + LN + QG S +++P
Sbjct: 359 DSSETSGSRGT----------LSEPLNTSSQGSGSTNNKP 388
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492229|ref|XP_003616403.1| Serine/threonine protein kinase [Medicago truncatula] gi|355517738|gb|AES99361.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1481), Expect = e-161, Method: Compositional matrix adjust.
Identities = 285/409 (69%), Positives = 330/409 (80%), Gaps = 13/409 (3%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSG-SSSRVSSVSV---VPRTEGEILLGSN 54
MG C SA + +SP NG++SK R G SG SS +VS+ PRTEGEIL SN
Sbjct: 1 MGCCLSARIKAESPPRNGSSSK-DRSRETGLSGRSSGKVSTAPTAPPTPRTEGEILKSSN 59
Query: 55 IKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES 114
+KSF+F+ LKTATRNFRPDSV+GEGGFG VFKGWIDE+T P RPGTG+VIAVKRLNQE
Sbjct: 60 MKSFTFSELKTATRNFRPDSVVGEGGFGAVFKGWIDENTLVPVRPGTGVVIAVKRLNQEG 119
Query: 115 LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP 174
LQGH EWLTEI +LGQL+HPNLVKLIGYC ED+HRLLVYEF+ KGSL+NHLFRRASY QP
Sbjct: 120 LQGHSEWLTEINYLGQLHHPNLVKLIGYCFEDEHRLLVYEFLTKGSLDNHLFRRASYFQP 179
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
LSW+IRMKVAL AAKGLAYLHSD+AKVIYRDFKTSNILLD NYNAKLSDFGLAKDGP G
Sbjct: 180 LSWSIRMKVALDAAKGLAYLHSDEAKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPAGD 239
Query: 235 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
SHVSTRVMGTYGYAAPEYMATGHLT KSDVYSFGVVLLE++SG+R +D NRPS EHNLI
Sbjct: 240 NSHVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEIMSGKRALDNNRPSGEHNLI 299
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
EWAKPYL SKRR+FQVMDARIEGQY++ A+K A LA++CLS EP+FRP MDE+V+ LE+
Sbjct: 300 EWAKPYLNSKRRVFQVMDARIEGQYTVRQAMKVADLAVRCLSVEPRFRPKMDEIVRVLEE 359
Query: 355 IQDTN-----DAGVSRDESLQNSDRSTYKRKGLNENGQG-KASVHHRPS 397
+Q ++ G SRD++++ S + ++ N G + +RPS
Sbjct: 360 LQSSSVDTAGGVGSSRDQNIKRSVHDIKRSVHVSRNSNGPRQHRSNRPS 408
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106475|ref|XP_002314178.1| predicted protein [Populus trichocarpa] gi|222850586|gb|EEE88133.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1470), Expect = e-160, Method: Compositional matrix adjust.
Identities = 278/399 (69%), Positives = 323/399 (80%), Gaps = 16/399 (4%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIKSF 58
MG C SA+ A S CS T G+SS+VSS+SV PR+EGEIL SN+KSF
Sbjct: 1 MGICLSAQIK------AESSCS------TVGTSSKVSSLSVPPTPRSEGEILQSSNLKSF 48
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
SF+ LK ATRNFRPDSVLGEGGFG VFKGWIDE T++ A+PGTGMVIAVKRLNQ+ QGH
Sbjct: 49 SFSDLKMATRNFRPDSVLGEGGFGSVFKGWIDEQTFSAAKPGTGMVIAVKRLNQDGFQGH 108
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL E+ +LGQLY+P+LVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR SY QPLSW
Sbjct: 109 KEWLAEVNYLGQLYNPHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWN 168
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+RMKV+LGAAKGLA+LHS + KVIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHV
Sbjct: 169 LRMKVSLGAAKGLAFLHSAETKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKSHV 228
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGTYGYAAPEY+ATGHLTAKSDVYSFGVVLLEMLSGRR +DKNRPS EHNL+EWAK
Sbjct: 229 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 288
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL +KR+IF+++D+R+EGQYS+ A K + LA++CLS E KFRPTMDEVV ALEQ+QD+
Sbjct: 289 PYLANKRKIFRILDSRLEGQYSMDVAYKVSTLALRCLSIETKFRPTMDEVVTALEQLQDS 348
Query: 359 NDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRPS 397
+ G + + N R +R + G G + + RPS
Sbjct: 349 KETGTANGH-VGNKPR-IRRRSANDATGGGSIAAYPRPS 385
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098423|ref|XP_002311169.1| predicted protein [Populus trichocarpa] gi|222850989|gb|EEE88536.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1470), Expect = e-160, Method: Compositional matrix adjust.
Identities = 268/324 (82%), Positives = 292/324 (90%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRT+GEIL SN+KSFSFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGT
Sbjct: 29 TPRTQGEILQSSNLKSFSFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGT 88
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+VIAVKRL+QES QGH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL
Sbjct: 89 GIVIAVKRLSQESFQGHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 148
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRRASY QPLSW +RMKVALGAA+GLAYLHSDKAKVIYRDFK SNILLD +Y AKL
Sbjct: 149 ENHLFRRASYFQPLSWNLRMKVALGAAEGLAYLHSDKAKVIYRDFKASNILLDSSYGAKL 208
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAKDGPTGS+SHVSTRVMGT+GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR
Sbjct: 209 SDFGLAKDGPTGSKSHVSTRVMGTHGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRA 268
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
IDKNRPS+E L+EWA+PYL SKRRIFQVMDARI+GQYS ALK A LAI+CLS EP++
Sbjct: 269 IDKNRPSKEQYLVEWARPYLSSKRRIFQVMDARIQGQYSSSDALKAANLAIQCLSAEPRY 328
Query: 342 RPTMDEVVKALEQIQDTNDAGVSR 365
RP M+EVVKALEQ+ ++N+ SR
Sbjct: 329 RPNMEEVVKALEQLHNSNNNDGSR 352
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 400 | ||||||
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.922 | 0.872 | 0.650 | 1.2e-129 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.892 | 0.917 | 0.661 | 2.5e-129 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.935 | 0.946 | 0.621 | 4.8e-126 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.875 | 0.709 | 0.611 | 1.3e-116 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.935 | 0.877 | 0.579 | 3.4e-116 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.875 | 0.714 | 0.611 | 1.7e-114 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.912 | 0.856 | 0.569 | 4.1e-113 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.87 | 0.768 | 0.6 | 1.8e-112 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.835 | 0.810 | 0.608 | 6.8e-111 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.782 | 0.808 | 0.615 | 3.4e-109 |
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
Identities = 240/369 (65%), Positives = 284/369 (76%)
Query: 16 GANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
GA+ K + N + PRTEGEIL N+KSF+F LK ATRNFRPDSV
Sbjct: 26 GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSV 85
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH EWL E+ +LGQ HPN
Sbjct: 86 LGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPN 145
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR SY QPLSWT+R+KVALGAAKGLA+LH
Sbjct: 146 LVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLH 205
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVSTR+MGTYGYAAPEY+A
Sbjct: 206 NAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLA 265
Query: 256 TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARI 315
TGHLT KSDVYS+GVVLLE+LSGRR +DKNRP E L+EWA+P L +KR++F+V+D R+
Sbjct: 266 TGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRL 325
Query: 316 EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRS 375
+ QYS+ A K A LA++CL+ E K RP M+EVV LE IQ N+AG + +Q R
Sbjct: 326 QDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRR 385
Query: 376 TYKRKGLNE 384
+N+
Sbjct: 386 RSDSVAINQ 394
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1269 (451.8 bits), Expect = 2.5e-129, P = 2.5e-129
Identities = 240/363 (66%), Positives = 290/363 (79%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG+ PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDGS----KGSSTASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFRR ++ QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWN 176
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SHV
Sbjct: 177 TRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHV 236
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
STRVMGT GYAAPEY+ATGHL+ KSDVYSFGVVLLE+LSGRR IDKN+P EHNL++WA+
Sbjct: 237 STRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWAR 296
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
PYL +KRR+ +VMD R++GQYSL ALK AVLA+ C+S + K RPTM+E+VK +E++
Sbjct: 297 PYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
Query: 359 NDA 361
+A
Sbjct: 357 KEA 359
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-126, P = 4.8e-126
Identities = 235/378 (62%), Positives = 293/378 (77%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G + +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGL-SLSSRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFRR +Y +PL W +R
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VST
Sbjct: 178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
RVMGTYGYAAPEYM++GHL A+SDVYSFGV+LLE+LSG+R +D NRP++E NL++WA+PY
Sbjct: 238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDWARPY 297
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
L SKR++ ++D R++ QY A++ A +A++CLS EPK RPTMD+VV+AL+Q+QD N
Sbjct: 298 LTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQD-NL 356
Query: 361 AGVSRDESLQNSDRSTYK 378
S+ ++++ + +K
Sbjct: 357 GKPSQTNPVKDTKKLGFK 374
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
Identities = 217/355 (61%), Positives = 267/355 (75%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 115 PVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 174
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 175 LTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 234
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD +YNAKL
Sbjct: 235 NHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKL 291
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR
Sbjct: 292 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 351
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
+DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K LA +CLS +PK
Sbjct: 352 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKI 411
Query: 342 RPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 396
RP M +VV+AL+ + D S Q K G G + H+P
Sbjct: 412 RPKMSDVVEALKPLPHLKDMA-SSSYYFQTMQAERLKNGSGRSQGFGSRNGQHQP 465
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
Identities = 226/390 (57%), Positives = 284/390 (72%)
Query: 1 MGSCF--SAETDS----PLPNGAN--SKCSRKDGNGTXXXXXXXXXXXX-----XPRTEG 47
MG+C SA+ DS P N A+ S+ S K T PRTEG
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 48 EILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
EIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+G+V+AV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 108 KRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR 167
K+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 168 RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
R + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+KLSDFGLA
Sbjct: 181 RGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287
K GPTG ++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRR +DK++
Sbjct: 239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKV 298
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
E +L++WA PYL KR++F++MD R+ GQY A A LA++CL+ + K RP M E
Sbjct: 299 GMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSE 358
Query: 348 VVKALEQIQDTNDA-GVSRDESLQNSDRST 376
V+ L+Q++ T GV ++ +S R +
Sbjct: 359 VLAKLDQLESTKPGTGVGNRQAQIDSPRGS 388
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 217/355 (61%), Positives = 267/355 (75%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFKGW++E+ AP +PGTG
Sbjct: 109 PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 168
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 169 LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 228
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD YNAKL
Sbjct: 229 NHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR
Sbjct: 286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
+DKNRP+ EHNL+EWA+P+L KRR ++++D R+EG +S+ A K LA +CLS + K
Sbjct: 346 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKI 405
Query: 342 RPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 396
RP M EVV+ L+ + D S Q K + +G+G S + +P
Sbjct: 406 RPKMSEVVEVLKPLPHLKDMA-SASYYFQTMQAERLKAGSGSGSGRGFGSRNGQP 459
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1116 (397.9 bits), Expect = 4.1e-113, P = 4.1e-113
Identities = 218/383 (56%), Positives = 275/383 (71%)
Query: 1 MGSCF--SAETD----SPLPNGANS------KCSRKDGNGTXXXXXXXXXXXXXP----R 44
MG+C SA+ D SP N A+S K SR G P R
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 45 TEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV 104
TEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+V
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 165 LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
LFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLSDF
Sbjct: 181 LFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDF 238
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284
GLAK GPTG +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRR +D
Sbjct: 239 GLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDN 298
Query: 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 344
+ E++L++WA PYL KR++F++MD ++ GQY A A LA++CL+ + K RP
Sbjct: 299 SNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPK 358
Query: 345 MDEVVKALEQIQDTNDAGVSRDE 367
M EV+ LEQ++ G +
Sbjct: 359 MSEVLVTLEQLESVAKPGTKHTQ 381
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
Identities = 213/355 (60%), Positives = 262/355 (73%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P GE+ S ++ F FN LK ATRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 76 PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 135
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HP+LVKL+GYC+E+D RLLVYEFMP+GSLE
Sbjct: 136 LTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLE 195
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR PL W++RMK+ALGAAKGLA+LH + K VIYRDFKTSNILLD YNAKL
Sbjct: 196 NHLFRRTL---PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 252
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAKD P +SHVSTRVMGTYGYAAPEY+ TGHLT KSDVYSFGVVLLE+L+GRR
Sbjct: 253 SDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRS 312
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
+DK+RP+ E NL+EW +P+L K+R ++++D R+EG YS+ A K +A +CL+ + K
Sbjct: 313 VDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKA 372
Query: 342 RPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQGKASVHHRP 396
RP M EVV+AL+ + + D S S Q + G+ G G S + P
Sbjct: 373 RPKMSEVVEALKPLPNLKDFA-SSSSSFQTMQ--PVAKNGVRTQGGGFVSRNGPP 424
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1095 (390.5 bits), Expect = 6.8e-111, P = 6.8e-111
Identities = 207/340 (60%), Positives = 265/340 (77%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNFRPDSV+GEGGFG V+KGWIDE T +P++PG+G
Sbjct: 56 PRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSG 115
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH-RLLVYEFMPKGSL 161
MV+AVK+L +E QGH +WL E+ LG+L+H NLVKLIGYC + DH RLLVYE+MPKGSL
Sbjct: 116 MVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSL 175
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRR + +P+ W R+KVA+GAA+GLA+LH +A+VIYRDFK SNILLD +NAKL
Sbjct: 176 ENHLFRRGA--EPIPWRTRIKVAIGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKL 231
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
SDFGLAK GPTG ++HVST+VMGT GYAAPEY+ATG +TAKSDVYSFGVVLLE+LSGR
Sbjct: 232 SDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLT 291
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
+DK + E NL++WA PYL KR++F++MD ++ GQY A TA A++CL+ EPK
Sbjct: 292 VDKTKVGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKL 351
Query: 342 RPTMDEVVKALEQIQDTNDAG-VSRDESLQNSDRSTYKRK 380
RP M +V+ LE+++ T +G +S S S++ K
Sbjct: 352 RPKMSDVLSTLEELEMTLKSGSISNSVMKLTSSSSSFTAK 391
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 3.4e-109, P = 3.4e-109
Identities = 195/317 (61%), Positives = 259/317 (81%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNF+P+S++GEGGFGCV+KGWI E + +P++PG+G
Sbjct: 57 PRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSG 116
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
MV+AVK+L E QGH EWLTE+ +LG+L+H NLVKLIGYCLE + RLLVYE+MPKGSLE
Sbjct: 117 MVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLE 176
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
NHLFRR + +P+ W RMKVA AA+GL++LH +AKVIYRDFK SNILLD+++NAKLS
Sbjct: 177 NHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKLS 232
Query: 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282
DFGLAK GPTG ++HV+T+V+GT GYAAPEY+ATG LT+KSDVYSFGVVLLE+LSGR +
Sbjct: 233 DFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTL 292
Query: 283 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342
DK++ E NL++WA PYL +R++F++MD ++ GQY A A +A++CL+ EPK R
Sbjct: 293 DKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLR 352
Query: 343 PTMDEVVKALEQIQDTN 359
P M +V+ L+Q++ ++
Sbjct: 353 PDMADVLSTLQQLETSS 369
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q06548 | APK1A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6925 | 0.8975 | 0.8756 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 400 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-35 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-55
Identities = 82/223 (36%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQLYHP 134
LGEGGFG V+ + TG +A+K + +E LE L EI+ L +L HP
Sbjct: 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKL G +++H LV E+ GSL++ L LS +++ L +GL YL
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYL 108
Query: 195 HSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE- 252
HS +I+RD K NILLD N KL+DFGL+K S + ++GT Y APE
Sbjct: 109 HS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEV 164
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK-------NRPS 288
+ G+ + KSD++S GV+L E+ + +I K RPS
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPS 207
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 96/286 (33%), Positives = 138/286 (48%), Gaps = 35/286 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+ LG G FG V+K GTG ++AVK L + S + EI+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L +L HPN+V+LI + DH LV E+ G L ++L R PLS K+AL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQI 107
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+GL YLHS +I+RD K NILLD N K++DFGLAK S S ++T V GT
Sbjct: 108 LRGLEYLHS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPW 163
Query: 248 YAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
Y APE + G K DV+S GV+L E+L+G+ + L +
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQL 210
Query: 307 IFQVMDARIEGQYSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVK 350
I +++ +E ++ L KCL+ +P RPT +E+++
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-52
Identities = 91/282 (32%), Positives = 140/282 (49%), Gaps = 29/282 (10%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG T G + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+VKL+G C E++ ++V E+MP G L ++L R + + LS + + AL A+G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGM 116
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YL S I+RD N L+ N K+SDFGL++D + + AP
Sbjct: 117 EYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAP 173
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310
E + G T+KSDV+SFGV+L E+ + G P + E YL+ R+ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGE------EPYPGMSNAE-VLEYLKKGYRLPKP 226
Query: 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
+ E L ++C + +P+ RPT E+V+ L
Sbjct: 227 PNCPPE----------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 89/285 (31%), Positives = 137/285 (48%), Gaps = 36/285 (12%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+VKL+G C E++ +V E+M G L ++L + + S + + AL A+G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL---SLSDLLSFALQIARGM 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGY 248
YL S I+RD N L+ N K+SDFGL++D R G +
Sbjct: 116 EYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRW 169
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
APE + G T+KSDV+SFGV+L E+ + G +P + E YL++ R+
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE------QPYPGMSNEE-VLEYLKNGYRL 222
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
Q + E L ++C + +P+ RPT E+V+ L
Sbjct: 223 PQPPNCPPE----------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 85/299 (28%), Positives = 132/299 (44%), Gaps = 67/299 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V+KG T GT +AVK L + S + E+L E + +L H
Sbjct: 6 KLGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+L+G C + + +V E+MP G L + L + + L+ +++AL AKG+ Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEY 117
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST------RVMGTYG 247
L S ++RD N L+ N K+SDFGL++D + M
Sbjct: 118 LES--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSG--------------RRVIDKNRPSREHNL 293
APE + G T+KSDV+SFGV+L E+ + + D R R N
Sbjct: 172 --APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPEN- 228
Query: 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
++++M ++C + +P+ RPT E+V+ L
Sbjct: 229 ---------CPDELYELM--------------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-49
Identities = 83/306 (27%), Positives = 131/306 (42%), Gaps = 72/306 (23%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQLY 132
LGEG FG V+KG + G +AVK L S + ++L E + + +L
Sbjct: 2 KLGEGAFGEVYKGKLKGK-------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRRASYIQPLSWTIRMKVALGA 187
HPN+V+L+G C E++ LV E+M G L ++L + LS + A+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP------TGSQSHVSTR 241
AKG+ YL S K ++RD N L+ + K+SDFGL++D + + R
Sbjct: 115 AKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG--------------RRVIDKNRP 287
M APE + G T+KSDV+SFGV+L E+ + + R
Sbjct: 173 WM------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+ E+ ++++M + C +P+ RPT E
Sbjct: 227 PKP----EYCPD------ELYELM--------------------LSCWQLDPEDRPTFSE 256
Query: 348 VVKALE 353
+V+ LE
Sbjct: 257 LVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-47
Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 47/289 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ LGEG FG V+ TG ++A+K + ++ ++ E L EIK L
Sbjct: 1 YEILEKLGEGSFGKVYLAR---------DKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY----IQPLSWTIRMKVA 184
+L HPN+V+L ++D LV E+ G L + L +R + I
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI----- 106
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L YLHS +++RD K NILLD + + KL+DFGLA+ ++T V G
Sbjct: 107 ---LSALEYLHS--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-G 158
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI-DKNRPSREHNLIEWAKPYLQS 303
T Y APE + D++S GV+L E+L+G+ ++ I KP
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 218
Query: 304 KRRIF--QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ D L K L +P+ R T +E ++
Sbjct: 219 PEWDISPEAKD-----------------LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
F +G+GGFG V+K TG +A+K + ES + + + EI+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
+ HPN+VK G L+ D +V EF GSL++ L S Q L+ + V K
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLK 109
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
GL YLH +I+RD K +NILL + KL DFGL+ + ++GT +
Sbjct: 110 GLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWM 164
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + K+D++S G+ +E+ G+
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWL-TEIKHLGQLY 132
+LG G FG V+ +D+ T G ++AVK + + LE L EI+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 133 HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGAA 188
HPN+V+ G E + + E++ GSL + L F + +T ++
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------L 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GLAYLHS +++RD K +NIL+D + KL+DFG AK + V GT +
Sbjct: 112 EGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
APE + +D++S G ++EM +G+
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 34/293 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LGEG FG V Y P TG +AVK LN + H ++ EI+ L L H
Sbjct: 12 LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 135 NLVKLIGYCLEDDHR---LLVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAA 188
N+VK G C E L+ E++P GSL ++L R + + + L ++ ++
Sbjct: 67 NIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI------C 119
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST--RVMGTY 246
KG+ YL S + I+RD NIL++ K+SDFGLAK P + +
Sbjct: 120 KGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLIEWAKPYLQSKR 305
Y APE + T ++ SDV+SFGV L E+ + D ++ P E + Q +
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIA---QGQM 230
Query: 306 RIFQVMDARIEGQ-YSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVKALEQI 355
+ ++++ EG+ + V L C EP+ RP+ +++ ++++
Sbjct: 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 18/292 (6%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R + VLGEG FG V + Y PA GTG ++AVK L +E Q + W EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL-----YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH N+VK G C E L+ E++P GSL ++L + L+ + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFA 113
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH-VSTRVM 243
+G+AYLHS I+RD N+LLD + K+ DFGLAK P G + + V
Sbjct: 114 QQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
+ A E + + SDV+SFGV L E+L+ K P ++ + K +
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
R+ ++++ + + +L C E KFRPT ++ L+++
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQL 131
+ +G+G FG V G Y G +AVK L + + Q +L E + L
Sbjct: 12 ATIGKGEFGDVMLG-----DYR------GQKVAVKCLKDDSTAAQ---AFLAEASVMTTL 57
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPNLV+L+G L+ + +V E+M KGSL ++L R ++ ++ AL +G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGM 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YL ++RD N+L+ + AK+SDFGLAK+ SQ S ++ + AP
Sbjct: 116 EYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWTAP 168
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
E + + KSDV+SFG++L E+ S RV
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
++G G FG V+KG ++ T G +A+K+++ E + + + EI L L
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN+VK IG D ++ E+ GSL + + + + L + + L +GLA
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGLA 113
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLH + VI+RD K +NIL + KL+DFG+A S V+GT + APE
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPE 169
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ + SD++S G ++E+L+G
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 2e-29
Identities = 83/292 (28%), Positives = 125/292 (42%), Gaps = 28/292 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++R LGEG FG V+ D A V+A K ++ L EI+ L
Sbjct: 1 SYRILRKLGEGSFGEVYLA-RDRKLVA------LKVLAKKLESKSKEVERF--LREIQIL 51
Query: 129 GQLYHP-NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L HP N+VKL + ++ LV E++ GSLE L ++ PLS + + +
Sbjct: 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQI 110
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFGLAK----DGPTGSQSHVSTRV 242
L YLHS +I+RD K NILLD + KL DFGLAK G T S + +
Sbjct: 111 LSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 243 MGTYGYAAPEY---MATGHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIEWAK 298
+GT GY APE ++ + ++ SD++S G+ L E+L+G + S ++
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ LK K L+ +PK R + +
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIK 126
+ +G+G FG V+ G + +K L+ S + + L E+K
Sbjct: 1 KYEIIKQIGKGSFGKVYLV---RRKS------DGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS------WTIR 180
L +L HPN++K E +V E+ G L + ++ +P W ++
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ L YLHS K +++RD K NI L N KL DFG++K + + T
Sbjct: 112 L------CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 241 RVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
V GT Y +PE Y KSD++S G VL E+ + + + NL+
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE------NLL 209
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
E A L+ + I QYS + L+ V L +P+ RP++ ++
Sbjct: 210 ELALKILKGQYP-------PIPSQYS--SELRNLVS--SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 4e-27
Identities = 74/213 (34%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 76 LGEGGFGCVF----KGWIDEHTYAPARPGTGM-VIAVKRLNQESLQGHLEWLTEIKHLGQ 130
LG+G FG V K YA M V+ K++ + H LTE L +
Sbjct: 1 LGKGSFGKVLLVRKKD--TGKLYA-------MKVLKKKKIIKRKEVEHT--LTERNILSR 49
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGA 187
+ HP +VKL Y + + +L LV E+ P G L +HL + + + + + + +AL
Sbjct: 50 INHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE- 107
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
YLHS +IYRD K NILLD + + KL+DFGLAK+ + +T GT
Sbjct: 108 -----YLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC-GTPE 158
Query: 248 YAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + G+ A D +S GV+L EML+G+
Sbjct: 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
F + LG G FG V++G W + + +A+K L + L ++ E++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L H +L+ L C + ++ E M KGSL L + P++ I M A A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM--ACQVA 114
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+AYL I+RD NIL+ + K++DFGLA+ ++ Y +
Sbjct: 115 EGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKW 170
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
APE + G + KSDV+SFG++L EM +
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 66/228 (28%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLY 132
VLG G FG V+KG WI P + +A+K L +E+ + + E L E + +
Sbjct: 14 VLGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAK 189
HP++V+L+G CL L+ + MP G L +++ I L+W +++ AK
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G++YL ++ ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE-HNLIE 295
A E + T KSDV+S+GV + E+++ G + + P+ E +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 81/297 (27%), Positives = 129/297 (43%), Gaps = 56/297 (18%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G + P + + +A+K L S + L++LTE +GQ
Sbjct: 9 EKVIGGGEFGEVCRGRLKL----PGKKE--IDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+++L G + +++ E+M GSL+ L + + + G A G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGM 119
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG---- 247
YL S+ V +RD NIL++ N K+SDFGL S TY
Sbjct: 120 KYL-SEMNYV-HRDLAARNILVNSNLVCKVSDFGL---------SRRLEDSEATYTTKGG 168
Query: 248 -----YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 301
+ APE +A T+ SDV+SFG+V+ E++S G R PY
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER------------------PYW 210
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALEQ 354
+ V+ A +E Y L + L + C + RPT ++V L++
Sbjct: 211 DMSNQ--DVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V+KG P + +A+K L + + E+ E + + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMK 182
N+V L+G C ++ +++E++ G L L R + + L + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A+ A G+ YL S ++RD N L+ K+SDFGL++D + V ++
Sbjct: 129 IAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ + PE + G T +SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 46/286 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
+G+G FG V+KG + +AVK ++L E + L Q HP
Sbjct: 3 IGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKLIG C++ +V E +P GSL L ++ + L+ ++++L AA G+ YL
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYL 109
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
S I+RD N L+ N K+SDFG++++ G + + APE +
Sbjct: 110 ESKNC--IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 255 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDK---NRPSREHNLIEWAKPYLQSKRRIFQVM 311
G T++SDV+S+G++L E S N+ +RE
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE--------------------- 206
Query: 312 DARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALE 353
RIE Y + A L ++C + +P+ RP+ E+ L+
Sbjct: 207 --RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 38/217 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR----LNQESLQGHLEWLT-EIKHLGQ 130
LG G FG V++G + G AVK + ++ Q ++ L EI L +
Sbjct: 8 LGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAA 188
L HPN+V+ +G E+D+ + E +P GSL L + S+ +P+ IR+ + L
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQIL--- 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM----- 243
GL YLH ++RD K +NIL+D N KL+DFG+AK V
Sbjct: 113 LGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFK 162
Query: 244 GTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
G+ + APE G +D++S G +LEM +G+
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 57/306 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
+G+G FG VF+ P P T ++AVK L +E S ++ E + + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ------------------PLS 176
N+VKL+G C L++E+M G L L R+ Q PLS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-----DGP 231
T ++ +A A G+AYL S++ K ++RD T N L+ N K++DFGL++ D
Sbjct: 129 CTEQLCIAKQVAAGMAYL-SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 232 TGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290
S++ + R M PE + T +SDV+++GVVL E+ S
Sbjct: 187 KASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS------------- 227
Query: 291 HNLIEWAKPY--LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+PY + + I+ V D + L+ L C S P RP+ +
Sbjct: 228 ----YGMQPYYGMAHEEVIYYVRDGNVLSCPD-NCPLELYNLMRLCWSKLPSDRPSFASI 282
Query: 349 VKALEQ 354
+ L++
Sbjct: 283 NRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG G V+K TG +A+K RL +++ + + EI +
Sbjct: 25 EKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDC 72
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSL----ENHLFR----RASYIQPLSWTIRMKV 183
HPN+V L D +V E+M GSL + R + +Y+ +
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CRE 124
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L +GL YLHS VI+RD K+ NILL + + KL+DFG A S V+
Sbjct: 125 VL---QGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VV 177
Query: 244 GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSG 278
GT + APE + K D++S G++ +EM G
Sbjct: 178 GTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 91/292 (31%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG G FG V KG Y + G + +AVK L QE G E+L E + QL HP
Sbjct: 3 LGHGNFGSVVKGV-----YLM-KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV-ALGAAKGLAY 193
+V+LIG C + +LV E P G L +L +R +K A A G+AY
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG-----Y 248
L S ++RD N+LL + AK+SDFG+++ GS + +T T G +
Sbjct: 111 LES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKW 164
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
APE + G ++KSDV+S+GV L E S G AKPY + K
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPYGEMKGA- 205
Query: 308 FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+V+ A +E L + + + C P+ RPT E+ +
Sbjct: 206 -EVI-AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 87/286 (30%), Positives = 139/286 (48%), Gaps = 49/286 (17%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
++GEG FG V +G E+T G +AVK + + + Q LE E + +L+
Sbjct: 12 EIIGEGEFGAVLQG---EYT--------GQKVAVKNIKCDVTAQAFLE---ETAVMTKLH 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H NLV+L+G L + +V E M KG+L N L R + + ++ +L A+G+
Sbjct: 58 HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGME 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YL S K +++RD NIL+ + AK+SDFGLA+ G G ++++ + APE
Sbjct: 115 YLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPE 167
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312
+ ++KSDV+S+GV+L E+ S R PY K + +V +
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGR-----------------APY--PKMSLKEVKE 208
Query: 313 ARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
+E Y + G VL C EPK RP+ ++ + LE+
Sbjct: 209 C-VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
LG+G FG V +G W G + +AVK L + L + ++L E + L H
Sbjct: 3 LGDGSFGVVRRGEWS-----TSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGL 191
NL++L G L ++V E P GSL + L + A +S +++A G+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGM 110
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST---RVMGTYGY 248
YL S + I+RD NILL + K+ DFGL + P +V +V + +
Sbjct: 111 RYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
APE + T + SDV+ FGV L EM +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 46/283 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN---QESLQGHLEWLTEIKHLGQ 130
VLG+G G V+K + P TG + A+K+++ E + L L E+K L
Sbjct: 7 KVLGQGSSGVVYKV-----RHKP----TGKIYALKKIHVDGDEEFRKQL--LRELKTLRS 55
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
P +VK G + + +V E+M GSL + L + + + +A K
Sbjct: 56 CESPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILK 110
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
GL YLH+ + +I+RD K SN+L++ K++DFG++K +T V GT Y
Sbjct: 111 GLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYM 167
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR-RIF 308
+PE + + +D++S G+ LLE G+ P+L + F
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKF------------------PFLPPGQPSFF 209
Query: 309 QVMDARIEG-QYSLGAALKTAVLA---IKCLSNEPKFRPTMDE 347
++M A +G SL A + CL +PK RP+ E
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYH 133
LGEG FG VF G Y ++AVK L + + ++ E + L H
Sbjct: 12 ELGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRA----SYIQPLSWTIRMKV 183
N+VK G C E D ++V+E+M G L L S + L+ + +++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A+ A G+ YL S ++RD T N L+ + K+ DFG+++D T V M
Sbjct: 128 AVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ PE + T +SDV+SFGVVL E+ +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLY 132
V+G+G FGCV+ G ID G + AVK LN+ L+ ++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 133 HPNLVKLIGYCLEDDHR-LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG--AAK 189
HPN++ L+G CL + L+V +M G L N F R+ P T++ + G AK
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP---TVKDLIGFGLQVAK 109
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRVMGT 245
G+ YL S K ++RD N +LD ++ K++DFGLA+D +H ++
Sbjct: 110 GMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--P 165
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
+ A E + T T KSDV+SFGV+L E+++ R P + + + YL R
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA----PPYPDVDSFDITV-YLLQGR 219
Query: 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
R+ Q +Y + + + C +P+ RPT E+V +EQI
Sbjct: 220 RLLQ-------PEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIK 126
LG G G V K RP TG ++AVK + E +Q + L E+
Sbjct: 3 LEYLGELGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQI--LRELD 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L + P +V G + + E+M GSL+ L + I K+A+
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVA 108
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM--- 243
KGL YLH K K+I+RD K SNIL++ KL DFG VS +++
Sbjct: 109 VLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSL 155
Query: 244 -----GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + + KSD++S G+ L+E+ +GR
Sbjct: 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 84/297 (28%), Positives = 144/297 (48%), Gaps = 36/297 (12%)
Query: 76 LGEGGFG----CVFKGWID-EHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLG 129
LGEG FG C +G + AP G +++AVK L + + ++L EIK +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--------FRRASYIQPLSWTIRM 181
+L +PN+++L+G C+ DD ++ E+M G L L F A+ I +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A+ A G+ YL S ++RD T N L+ +Y K++DFG++++ +G + R
Sbjct: 133 YMAVQIASGMKYLAS--LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR---EHNLIEWAK 298
+ + A E + G T SDV++FGV L EM + + K +P + +IE
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENTG 246
Query: 299 PYLQSK-RRIFQVMDARIEGQYSL--GAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
+ +++ R+I+ Q L K L ++C S + K RPT +++ L
Sbjct: 247 EFFRNQGRQIYL-------SQTPLCPSPVFK---LMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 87/313 (27%), Positives = 147/313 (46%), Gaps = 37/313 (11%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ES 114
KS + N + ++ + ++V+ G G +KG GM VK +N S
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQFVVKEINDVNS 728
Query: 115 LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP 174
+ +EI +G+L HPN+VKLIG C + L++E++ +L L +
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RN 776
Query: 175 LSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
LSW R K+A+G AK L +LH V+ + I++D L L T
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
Query: 234 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293
++ +S+ Y APE T +T KSD+Y FG++L+E+L+G+ D ++
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SI 888
Query: 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGA--ALKTAVLAIKCLSNEPKFRPTMDEVVKA 351
+EWA+ Y S + +D I G S+ ++ LA+ C + +P RP ++V+K
Sbjct: 889 VEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947
Query: 352 LEQIQDTNDAGVS 364
LE ++ + V+
Sbjct: 948 LESASRSSSSCVT 960
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 42/274 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+G+G FG VFK R V A+K+++ + E + E + L +L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS----WTIRMKVALGAAK 189
+++ L+ +V E+ G L H + +PL W +++ LG
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG--- 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
LA+LHS K +++RD K+ N+ LD N K+ D G+AK ++ + ++GT Y
Sbjct: 114 -LAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYL 168
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
+PE KSDV++ GVVL E +G+ D N + LI +I +
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKIIR 215
Query: 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 343
+ + YS L A L +CL+ + + RP
Sbjct: 216 GVFPPVSQMYS--QQL--AQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 74/260 (28%), Positives = 121/260 (46%), Gaps = 31/260 (11%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+A+KR++ E Q ++ L E++ + Q HPN+VK + D LV ++ G
Sbjct: 25 NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84
Query: 160 SLEN---HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
SL + + R + + T+ +K L KGL YLHS+ I+RD K NILL +
Sbjct: 85 SLLDIMKSSYPRGGLDEAIIATV-LKEVL---KGLEYLHSNGQ--IHRDIKAGNILLGED 138
Query: 217 YNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVV 271
+ K++DFG LA G V +GT + APE M H K+D++SFG+
Sbjct: 139 GSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGIT 196
Query: 272 LLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 330
+E+ +G K P + ++ P L++ +YS + + +
Sbjct: 197 AIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY---------KKYS--KSFRKMI- 244
Query: 331 AIKCLSNEPKFRPTMDEVVK 350
CL +P RPT +E++K
Sbjct: 245 -SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 90/304 (29%), Positives = 140/304 (46%), Gaps = 38/304 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R+ + LG+G FG V + Y P + TG V+AVK+L Q S HL + EI+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKL-QHSTAEHLRDFEREIE 57
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFR---RASYIQPL--SWTI 179
L L H N+VK G C R LV E++P GSL ++L + R + + L + I
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
KG+ YL S + ++RD T NIL++ K+ DFGL K P + +
Sbjct: 118 --------CKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK- 166
Query: 240 TRVMG---TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLIE 295
R G + Y APE + + SDV+SFGVVL E+ + DK+ P E +
Sbjct: 167 VREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAE--FMR 220
Query: 296 WAKPYLQSKRRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
Q + ++ +++ G + + +C +N+P RP+ E+ +
Sbjct: 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
Query: 353 EQIQ 356
E I+
Sbjct: 281 EAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 70/223 (31%), Positives = 104/223 (46%), Gaps = 13/223 (5%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + +AVK L + S Q ++L E + + H
Sbjct: 13 ALGHGAFGEVYEG---LYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQPLSWTIR--MKVALGAAKG 190
N+V+LIG E R ++ E M G L++ L R +P S T++ + A AKG
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
YL I+RD N LL AK++DFG+A+D S R M
Sbjct: 129 CKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290
+ PE G T+K+DV+SFGV+L E+ S + R ++E
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 43/236 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLT 123
+F+ ++GEG F V E T A+K +L +E ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYV--KI 50
Query: 124 EIKHLGQL-YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E + L +L HP ++KL Y +D+ L V E+ P G L ++ + S + R
Sbjct: 51 EKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRF 106
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP---------- 231
A L YLHS +I+RD K NILLD + + K++DFG AK
Sbjct: 107 YAAE-ILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 232 ----TGSQSHVSTR----VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
SQ + R +GT Y +PE + SD+++ G ++ +ML+G+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGLA--KGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYIQPLSWTIRMKVALGAA 188
++V+L+G L+V E M KG L+++L R + P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-------GPTGSQSHVSTR 241
G+AYL + K ++RD N ++ + K+ DFG+ +D G + + R
Sbjct: 130 DGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 186
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
M APE + G T KSDV+SFGVVL EM +
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-24
Identities = 88/315 (27%), Positives = 138/315 (43%), Gaps = 57/315 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N LGEG FG V K R G V AVK L + + L + L+E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATA---FRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNL 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL---------------FRRASYI 172
L Q+ HP+++KL G C +D LL+ E+ GSL + L R +SY+
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 173 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ L+ + A ++G+ YL + K+++RD N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 228 KD------GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRR 280
+D S+ + + M A E + T +SDV+SFGV+L E+++ G
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 340
P R NL L++ R+ + + E Y+ L + C EP
Sbjct: 229 PYPGIAPERLFNL-------LKTGYRMERPENCS-EEMYN---------LMLTCWKQEPD 271
Query: 341 FRPTMDEVVKALEQI 355
RPT ++ K LE++
Sbjct: 272 KRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LTEIKHLGQ 130
+GEG +G V+K TG ++A+K++ L+ E L EIK L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKI---KLRFESEGIPKTALREIKLLKE 54
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L HPN++KL+ LV+EFM L L + L ++ +G
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQR--GLPESLIKSYLYQLLQG 110
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVMGTYG 247
LA+ HS +++RD K N+L++ KL+DFGLA+ P +H V TR
Sbjct: 111 LAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----W 163
Query: 248 YAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + + D++S G + E+LS R
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE----SLQGHLEWL-T 123
N+R +LG+G FG V Y TG +AVK++ + + + L
Sbjct: 3 NWRRGKLLGQGAFGRV---------YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIRMK 182
EI+ L L H +V+ G CL DD L ++ E+MP GS+++ L +Y L+ T+ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAY-GALTETVTRK 108
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR- 241
+G+ YLHS+ +++RD K +NIL D N KL DFG +K T S +
Sbjct: 109 YTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
V GT + +PE ++ K+DV+S G ++EML+
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 71/220 (32%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 76 LGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+G G FG V+ +D TG ++AVK R+ + E E+K L L
Sbjct: 8 IGGGTFGKVYTAVNLD----------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPNLVK G + + + E+ G+LE L I + L +GLA
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQL--LEGLA 113
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY---A 249
YLHS +++RD K +NI LD N KL DFG A + +T MG
Sbjct: 114 YLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAG 165
Query: 250 APEYMA---------TGHLTAKSDVYSFGVVLLEMLSGRR 280
P YMA GH A +D++S G V+LEM +G+R
Sbjct: 166 TPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 79/297 (26%), Positives = 128/297 (43%), Gaps = 46/297 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-----EWLTEIKHLG 129
+LGEG FG V +G + G+ + +AVK + L H E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLS------QDDGSQLKVAVKTMK---LDIHTYSEIEEFLSEAACMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRM-- 181
HPN++KLIG C E +++ FM G L + L P ++
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS---QSHV 238
K + A G+ YL + I+RD N +L + ++DFGL+K +G Q +
Sbjct: 117 KFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
+ + + A E +A T+KSDV++FGV + E+ + R H + +
Sbjct: 175 AKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD--- 226
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
YL+ R+ Q D ++ Y L C +PK RPT ++ + LE I
Sbjct: 227 -YLRHGNRLKQPEDC-LDELYD---------LMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWL-TEIKHL 128
VLG+G +G V+ G + G +IAVK++ N + + E L E+ L
Sbjct: 7 VLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L H N+V+ +G CL+D+ + EF+P GS+ + L R +P + K
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP----VFCKYTKQIL 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRVMG 244
G+AYLH++ V++RD K +N++L N KL DFG A+ G G+ S++ + G
Sbjct: 113 DGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
T + APE + KSD++S G + EM +G+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 75/302 (24%), Positives = 126/302 (41%), Gaps = 53/302 (17%)
Query: 76 LGEGGFGCV-------FKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTE 124
LGEG FG V + + ++ +++AVK L + + + ++L E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLKE 69
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSW 177
+K L +L PN+ +L+G C D ++ E+M G L L + A + LS+
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + +A A G+ YL S ++RD T N L+ NY K++DFG++++ +
Sbjct: 130 STLLYMATQIASGMRYLES--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 296
V R + A E + G T KSDV++FGV L E+L+ R
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE---------------- 231
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGA----ALKTAV------LAIKCLSNEPKFRPTMD 346
+PY QV++ G L ++C + + RPT
Sbjct: 232 -QPY--EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288
Query: 347 EV 348
E+
Sbjct: 289 EI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYH 133
+LG+G FG VFKG + + T +AVK ++ Q +++L+E + L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+VKLIG C + +V E +P G + L ++ L +K AL AA G+AY
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAY 108
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ N K+SDFG+++ G S + + + APE
Sbjct: 109 LESKNC--IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEA 165
Query: 254 MATGHLTAKSDVYSFGVVLLEMLS 277
+ G +++SDV+S+G++L E S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 72/254 (28%), Positives = 122/254 (48%), Gaps = 47/254 (18%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V+ G W+++ +A+K + +E +++ E + + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L G C E LV+EFM G L ++L +R S + + L +G+AY
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAY 115
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-------DGPTGSQSHVSTRVMGTY 246
L S + VI+RD N L+ N K+SDFG+ + TG++ V
Sbjct: 116 LES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------- 166
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--------HNLIEWAK 298
+++PE + ++KSDV+SFGV++ E+ S + +NR + E L K
Sbjct: 167 -WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY---K 222
Query: 299 PYLQSKRRIFQVMD 312
P L S+ ++++M
Sbjct: 223 PRLASQ-SVYELMQ 235
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-23
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWL--------TE 124
++G+G +G V+ TG ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
I+ L L H N+V+ +G+ +++ + E++P GS+ + L + + L +V
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
+GLAYLHS +++RD K N+L+D + K+SDFG++K + + + G
Sbjct: 119 ----EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 245 TYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRR 280
+ + APE + + +AK D++S G V+LEM +GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQ 130
S LGEG G V K + TGM+ A+K + + LQ + L E++
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQI--LRELEINKS 55
Query: 131 LYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRASYIQPLSWTIRM------K 182
P +VK G L++ + E+ GSL+ + Y + R+ K
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD------SIYKKVKKRGGRIGEKVLGK 109
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A KGL+YLHS K+I+RD K SNILL KL DFG++ G + S T
Sbjct: 110 IAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVN-SLAGTFT 164
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + + SDV+S G+ LLE+ R
Sbjct: 165 -GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 74/206 (35%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYHP 134
LGEG FG V + Y P TG +AVK L ES H+ L EI+ L LYH
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 135 NLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
N+VK G C ED L+ EF+P GSL+ +L R + I + ++K A+ KG+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI---NLKQQLKYAVQICKGMD 123
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAP 251
YL S + ++RD N+L++ + K+ DFGL K T + + V + + AP
Sbjct: 124 YLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS 277
E + SDV+SFGV L E+L+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 87/276 (31%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ K G L+D ++ E++ GS + L PL T + KGL YL
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
HS+K I+RD K +N+LL + KL+DFG+A G +GT + APE +
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 255 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR 314
+K+D++S G+ +E+ G + P + LI P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PT 220
Query: 315 IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+EG YS LK V A CL+ EP FRPT E++K
Sbjct: 221 LEGNYS--KPLKEFVEA--CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLEWLT--EIKHLGQ 130
V+GEG +G V K R TG ++A+K+ + ++ E+K L Q
Sbjct: 7 GVVGEGAYGVVLK----------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ 56
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-----ASYIQPLSWTIRMKVAL 185
L H N+V L LV+E++ + LE L ++ W +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQL------ 109
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ +AY HS +I+RD K NIL+ + KL DFG A+ S ++ V T
Sbjct: 110 --LQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 246 YGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 279
Y APE + K DV++ G ++ E+L G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 79/301 (26%), Positives = 137/301 (45%), Gaps = 43/301 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPA-------RPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LGEG FG V + P R G +++AVK L + + ++L E+K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR---------------ASYI 172
L +L PN+++L+G C+++D ++ E+M G L L A +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
+S++ + VAL A G+ YL S ++RD T N L+ N K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-- 290
G + R + + A E + G T SDV++FGV L E+L + K +P E
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGELT 246
Query: 291 -HNLIEWAKPYLQ-SKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+IE A + + R+++ +G Y L ++C S + + RP+ +
Sbjct: 247 DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE---------LMLQCWSRDCRERPSFSD 297
Query: 348 V 348
+
Sbjct: 298 I 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYH 133
+GEG G VFK E TG +A+K++ L+G + L EIK L H
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P +VKL+ +LV E+MP L L +PL KG+AY
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAY 114
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ-SH-VSTRVMGTYGYA 249
+H +++RD K +N+L+ + K++DFGLA+ SH V+TR Y
Sbjct: 115 MH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYR 167
Query: 250 APEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + D+++ G + E+L+G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 5e-22
Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 36/270 (13%)
Query: 94 YAPARPGTGMVIAVKRL----NQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147
Y TG ++AVK++ N S Q + EI+ + +L HP++++++G ED
Sbjct: 17 YQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76
Query: 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207
H L E+M GS+ + L S + + +GL+YLH + ++I+RD K
Sbjct: 77 HFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVK 130
Query: 208 TSNILLD-LNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAK 262
+N+L+D +++DFG LA G TG+ +++GT + APE +
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKG-TGA-GEFQGQLLGTIAFMAPEVLRGEQYGRS 188
Query: 263 SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLG 322
DV+S G V++EM + + + + S L IF++ A S+
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------------IFKIASA--TTAPSIP 233
Query: 323 AALKTAV--LAIKCLSNEPKFRPTMDEVVK 350
L + + ++CL +P+ RP E++K
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + T +AVK L ++ +L E + + +L H
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L C E++ +V E+M KGSL + L L + M A A+G+AYL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYLE 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMGT---YGYA 249
S I+RD NIL+ N K++DFGLA +D + R G +
Sbjct: 121 S--RNYIHRDLAARNILVGENLVCKIADFGLARLIED------DEYTAR-EGAKFPIKWT 171
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
APE G T KSDV+SFG++L E+++ RV
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 9e-22
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 40/223 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLE 120
+ LGEG +G V+K D+ T G ++A+K RL+ E +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIPSTALR---- 47
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L +L HPN+VKL+ + LV+E+ L+ +L +R + P I+
Sbjct: 48 ---EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN--LIK 101
Query: 181 --MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
M L +GLAY HS ++++RD K NIL++ + KL+DFGLA+ G
Sbjct: 102 SIMYQLL---RGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR--AFGIPLRT 154
Query: 239 STRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
T + T Y APE + + + TA D++S G + EM++G+
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------L 122
+F V+G+G FG V I + T + A+K +N+ Q +E L
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKRD------TKKMFAMKYMNK---QKCVEKGSVRNVL 48
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E + L +L HP LV L Y +D+ + LV + + G L HL ++ + + ++
Sbjct: 49 NERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKF 104
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L YLHS +I+RD K NILLD + ++DF +A + + T
Sbjct: 105 WIC-EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TS 158
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
GT GY APE + + D +S GV E L G+R
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 69/213 (32%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMV-IAVKRLNQESL-QGHLEWLTEIKHLGQLY 132
LG G FG V++G D PG+G + +AVK L + + Q E+L E +
Sbjct: 3 LGSGAFGEVYEGTATDI-----LGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQP-LSWTIRMKVALGAAK 189
HPN+VKL+G CL ++ + ++ E M G L ++L R + P L+ + + L AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 190 GLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
G YL ++ I+RD N L+ D + K+ DFGLA+D +
Sbjct: 118 GCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ APE + G T +SDV+SFGV++ E+L+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 29/207 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G +G V++G ++ + +AVK L +++++ E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L+G C + ++ EFM G+L ++L R Q ++ + + +A + + YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL- 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-------DGPTGSQSHVSTRVMGTYGY 248
+K I+RD N L+ N+ K++DFGL++ G++ + +
Sbjct: 121 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------W 171
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEM 275
APE +A + KSDV++FGV+L E+
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 76 LGEGGFG----CVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKH 127
LGEG FG C +G ++D+ +++AVK L +++ + ++L EIK
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------LSWTIR 180
+ +L PN+++L+ C+ D ++ E+M G L L R +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ +A A G+ YL S ++RD T N L+ NY K++DFG++++ +G +
Sbjct: 133 IFMATQIASGMKYLSS--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
R + + + E + G T SDV++FGV L E+L+
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 32/283 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ P VLG+G FG E T Y + +V L + S + + L EI
Sbjct: 1 HYIPIRVLGKGAFG--------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVI 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L L HPN++ + ++D+ L+ E+ G+L + + R+ + + + +
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
A ++Y+H KA +++RD KT NI L KL DFG++K GS+ ++ V+GT
Sbjct: 113 A--VSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPY 166
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
Y +PE KSD+++ G VL E+L+ +R D P NL+ +I
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV----------KI 213
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
Q + YS + L + V + L +P+ RPT DEV+
Sbjct: 214 VQGNYTPVVSVYS--SELISLVHS--LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHLG 129
+GEG +G V+K TG ++A+K++ E + + + EIK L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 130 QLYHPNLVKLIGYCLEDDHR--LLVYEFMP---KGSLENHLFR-RASYIQPLSWTIRMKV 183
+L HPN+V+L +V+E+M G L++ + S I+ MK
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY-----MKQ 108
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L +GL YLHS +++RD K SNIL++ + KL+DFGLA+ T S T +
Sbjct: 109 LL---EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRV 162
Query: 244 GTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
T Y PE + AT + D++S G +L E+ G+
Sbjct: 163 ITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 65/293 (22%)
Query: 76 LGEGGFGCV----FKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL 131
LG G FG V ++G ID +A+K + + ++ +++ E K + +L
Sbjct: 12 LGSGQFGVVHLGKWRGKID--------------VAIKMIREGAMSED-DFIEEAKVMMKL 56
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPNLV+L G C + +V E+M G L N+L R W + M + +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDM--CSDVCEAM 113
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVMGT-- 245
YL S I+RD N L+ + K+SDFGLA+ D T SQ GT
Sbjct: 114 EYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKF 163
Query: 246 -YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-----HNLIEWAKP 299
+A PE ++KSDV+SFGV++ E+ S ++ + + E +P
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP 223
Query: 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
L ++ +M C +P+ RP +++ L
Sbjct: 224 KLAPT-EVYTIMY--------------------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 86/276 (31%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG V+KG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ + G L+ ++ E++ GS + L PL T + KGL YL
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
HS++ I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE +
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPEVI 173
Query: 255 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR 314
K+D++S G+ +E+ G P R LI P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PT 220
Query: 315 IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+EGQYS K V A CL+ +P+FRPT E++K
Sbjct: 221 LEGQYS--KPFKEFVEA--CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 39/292 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV-KRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V +G +++ M IA+ R E ++L+E + + HP
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFDHP 60
Query: 135 NLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA- 187
N+++LIG CL+ +++ FM G L + L P +M V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 188 -AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVM 243
A G+ YL S I+RD N +L+ N N ++DFGL+K +G Q ++ +
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
+ A E +A T KSDV+SFGV + E+ + + P E++ I YL+
Sbjct: 179 ---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEI---YDYLRQ 229
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
R+ Q D ++G YSL + C PK RP+ + + LE+
Sbjct: 230 GNRLKQPPDC-LDGLYSLMS---------SCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F LG G FG V + H G+G A+K L++ + +E L E
Sbjct: 1 DDFEFIKTLGTGSFGRVM---LVRHK------GSGKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L + HP LV L G +DD L LV E++P G L +HL + + +P++ +V
Sbjct: 52 KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L L YLHS ++YRD K N+LLD + K++DFG AK V R
Sbjct: 111 VLA----LEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTY 156
Query: 244 ---GTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSG 278
GT Y APE + + G+ A D ++ G+++ EML+G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L +G L E K L ++
Sbjct: 1 LGKGGFGEV---------CACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 133 HPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+V L Y E D LV M G L+ H++ P + I + GL
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI--ICGL 108
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
+LH + +++YRD K N+LLD + N ++SD GLA + G + GT GY AP
Sbjct: 109 EHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAP 163
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSGR 279
E + D ++ G L EM++GR
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 68/282 (24%), Positives = 125/282 (44%), Gaps = 34/282 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ LG+G +G V+K R A+K ++ S+ + + + EI+
Sbjct: 1 DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L + HPN++ L+ + +V E+ P G L + +R + + ++ +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+GL LH K +++RD K++NILL N K+ D G++K + +++ +GT
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTP 165
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
Y APE + KSD++S G +L EM + P E A+ + +
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF-------APPFE------ARSMQDLRYK 212
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+ + I YS L+ + + L +PK RP D++
Sbjct: 213 VQRGKYPPIPPIYS--QDLQNFIRS--MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 32/294 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ESLQGHLEWLTEI 125
N + + LG G FG VF G ++ VK L + E+LQ E+ E+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKG----IEEEGGETLVLVKALQKTKDENLQ--SEFRREL 59
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-----QPLSWTIR 180
+L H N+V+L+G C E + ++ E+ G L+ L S PLS +
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ + A G+ +L A+ ++RD N L+ K+S L+KD S+ +
Sbjct: 120 VALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLR 176
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
+ + APE + + KSDV+SFGV++ E+ + + E
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNR 230
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
LQ+ + V + Y L +C + PK RP+ E+V AL +
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---------RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 82/294 (27%), Positives = 134/294 (45%), Gaps = 49/294 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIK 126
+ + +G+G FG V G ++ G +AVK + N + Q +L E
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATAQA---FLAEAS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L R + L +K +L
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 109
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ + YL ++ ++RD N+L+ + AK+SDFGL K+ + +Q V T
Sbjct: 110 DVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWT 166
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
APE + + KSDV+SFG++L E+ S RV PY R
Sbjct: 167 ----APEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PY---PR 202
Query: 306 RIFQVMDARIEGQYSLGA--ALKTAVLAI--KCLSNEPKFRPTMDEVVKALEQI 355
+ + R+E Y + A V + +C + RP+ ++ + LE I
Sbjct: 203 IPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 47/290 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-------LQGHLEWL 122
++ ++G G +G V++G TG V+A+K +N ++ +Q + L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
++++ Q PN+ K G RL ++ E+ GS+ + +A I ++ +
Sbjct: 54 SQLRQ-SQP--PNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVII 107
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L A L Y+H K VI+RD K +NIL+ N KL DFG+A S S ST
Sbjct: 108 REVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTF 161
Query: 242 VMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
V GT + APE + G K+D++S G+ + EM +G R LI +KP
Sbjct: 162 V-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP- 219
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
R+E L+ V A CL EPK R + +E++K
Sbjct: 220 ------------PRLEDN-GYSKLLREFVAA--CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-20
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 67 TRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE- 124
R +LG G FG V KG WI P + +A+K + S + + +T+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRM 181
+ +G L H +V+L+G C +L V + P GSL +H+ + + P L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
AKG+ YL ++ ++++R+ NILL + +++DFG+A + + +
Sbjct: 119 ------AKGMYYL--EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ A E + G T +SDV+S+GV + EM+S
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA----SYI----QP------LSWTIRM 181
+VK G C + D ++V+E+M G L F RA + I QP L + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A A G+ YL S ++RD T N L+ N K+ DFG+++D + V
Sbjct: 127 HIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
M + PE + T +SDV+SFGV+L E+ +
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 7e-20
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEI---KHLGQL 131
LGEG FG V K E T +AVK L ++ + L + ++E+ K +G+
Sbjct: 20 LGEGAFGQVVKA---EAVGLDNPNET-STVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYI------QPLSWTI 179
H N++ L+G C ++ +V E+ G+L + L R AS + L+
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ A A+G+ +L S K I+RD N+L+ ++ K++DFGLA+D +
Sbjct: 134 LVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
T + APE + T +SDV+SFGV+L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-20
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF + H P + M++AVK L + S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR------------RASYIQPLSWTIRMKV 183
+V+ G C E L+V+E+M G L N R L+ + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A A G+ YL S ++RD T N L+ K+ DFG+++D + V R M
Sbjct: 128 ASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ PE + T +SD++SFGVVL E+ +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V GT + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVL---------LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L +L D V E++ G L H+ R + +P + ++ LG
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYA 249
L +LH +IYRD K N+LLD + K++DFG+ K+G G V+T GT Y
Sbjct: 109 LQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYI 163
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE ++ D ++ GV+L EML+G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 86/276 (31%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ K G L+ ++ E++ GS + L RA +K L KGL YL
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
HS+K I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE +
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPEVI 173
Query: 255 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR 314
+K+D++S G+ +E+ G P R LI P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PT 220
Query: 315 IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ G++S K + A CL+ +P FRPT E++K
Sbjct: 221 LTGEFS--KPFKEFIDA--CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKH 127
F LGEG +G V+K + TG V+A+K + +E LQ E + EI
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE----------TGQVVAIKVVPVEEDLQ---EIIKEISI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L Q P +VK G ++ +V E+ GS+ + + + + + L+ +
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITN--KTLTEEEIAAILYQT 108
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
KGL YLHS+ K I+RD K NILL+ AKL+DFG++ T + + +T V+GT
Sbjct: 109 LKGLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQ-LTDTMAKRNT-VIGTPF 164
Query: 248 YAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
+ APE G+ K+D++S G+ +EM G+
Sbjct: 165 WMAPEVIQEIGY-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 77/236 (32%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+AVK+++ Q + +W + E+K L QL
Sbjct: 29 IGHGSFGAV---------YFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L++ LV E+ GS + L + +PL + GA +GLA
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 135
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL+DFG A S+S + +GT + APE
Sbjct: 136 YLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPE 187
Query: 253 Y---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQS 303
M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNDSPTLQS 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 41/289 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG VF+G + P R + I + Q ++L+E +GQ H
Sbjct: 12 VIGAGEFGEVFRGILK----MPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHH 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+++L G + +++ E+M G+L+ +L ++ G A G+ YL
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL 123
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAP 251
++RD NIL++ N K+SDFGL++ D P G+ + ++ + AP
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAP 179
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310
E +A T+ SDV+SFG+V+ E++S G R PY +V
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER------------------PYWDMSNH--EV 219
Query: 311 MDARIEGQYSLGAALK--TAV--LAIKCLSNEPKFRPTMDEVVKALEQI 355
M A +G + L A + +AV L ++C + RP ++V L+++
Sbjct: 220 MKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 42/220 (19%)
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQ 130
LG+G FG V+ + TG ++A+K++ + S + + L E+K L +
Sbjct: 5 KQLGDGTFGSVYLARNKE----------TGELVAIKKMKKKFYSWEECMN-LREVKSLRK 53
Query: 131 L-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF-----RRASYIQPLSWTIRMKVA 184
L HPN+VKL E+D V+E+M E +L+ R+ IR +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSES--VIR-SII 105
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ----SHVST 240
+GLA++H K +RD K N+L+ K++DFGLA++ S+ +VST
Sbjct: 106 YQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRSRPPYTDYVST 161
Query: 241 RVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
R Y APE + + ++ D+++ G ++ E+ + R
Sbjct: 162 R-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 71/263 (26%), Positives = 127/263 (48%), Gaps = 44/263 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--------NQESLQGHLEWLT-E 124
+++G G FG V+ G +G ++AVK++ +++ + L+ L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
I L +L H N+V+ +G L+ DH + E++P GS+ L ++ + L +R V
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVR 113
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR--- 241
KGL YLH+ +I+RD K +NIL+D K+SDFG++K S S +
Sbjct: 114 -QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 242 -VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------------RVIDKNRP 287
+ G+ + APE + T K+D++S G +++EML+G+ ++ + P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230
Query: 288 SREHNLIEWAKPYLQSKRRIFQV 310
N+ A +L + F++
Sbjct: 231 EIPSNISSEAIDFL---EKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ V+G G FG V + R ++ +K++ E + L E +
Sbjct: 1 KYEKIRVVGRGAFGIV---------HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQ 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP----LSWTIRMK 182
L L HPN+++ LED ++V E+ P G+L ++ +R + + L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQSHVSTR 241
+AL H +++RD KT NILLD + K+ DFG++K S+S T
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
V+GT Y +PE KSD+++ G VL E+ S +R + NL P L
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANL-----PAL 209
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349
K I A I +YS L+ +L++ L+ +P RP + +++
Sbjct: 210 VLK--IMSGTFAPISDRYS--PDLRQLILSM--LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 76/297 (25%), Positives = 123/297 (41%), Gaps = 65/297 (21%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG V+K ID+ T V+A+K ++ E + +E + EI+ L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
Q P + K G L+ ++ E+ GS L + L T +
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKP----GKLDETYIAFILREVL 108
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR---VMGT 245
GL YLH + I+RD K +NILL + KL+DFG++ G + ++ +GT
Sbjct: 109 LGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR------------RVIDKNRPSREHNL 293
+ APE + K+D++S G+ +E+ G +I KN P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------ 215
Query: 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
P L+ ++S K V CL+ +PK RP+ E++K
Sbjct: 216 -----PSLE-------------GNKFS--KPFKDFVSL--CLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 23/207 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL---NQESLQGHLEWLTEIKHLGQLY 132
LG G G V K +H P TG V+A K + + S++ + L E++ + +
Sbjct: 13 LGAGNGGSVSKV---KH-----IP-TGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECR 61
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
P +V G L +++ + EFM GSL+ ++++ P+ I K+A+ +GL
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG---PIPVEILGKIAVAVVEGLT 117
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YL+ + ++++RD K SNIL++ KL DFG++ + + ++ +GT Y +PE
Sbjct: 118 YLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE----LINSIADTFVGTSTYMSPE 172
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ G T KSDV+S G+ ++E+ G+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG+ A K + ES + +++ EI L + HPN
Sbjct: 13 LGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-----RASYIQPLSWTIRMKVALGAAKG 190
+V L ++ ++ EF G+L++ + I+ + + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L +LHS K VI+RD K NILL L+ + KL+DFG++ + Q + +GT + A
Sbjct: 116 LNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 251 PEYMATGHLT-----AKSDVYSFGVVLLEMLSGR 279
PE +A K+D++S G+ L+E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G P + +A+K L + + ++L+E +GQ
Sbjct: 9 EEVIGAGEFGEVCRG----RLKLPGKREI--FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++ L G + +++ EFM G+L++ L + + ++ G A G+
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGM 119
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG---TYGY 248
YL + ++RD NIL++ N K+SDFGL++ + T +G +
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
APE +A T+ SDV+S+G+V+ E++S G R PY +
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWDMSNQ- 218
Query: 308 FQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALEQI 355
V++A IE Y L + L + C + RP ++V L+++
Sbjct: 219 -DVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQG---HLEWLT 123
+ LGEG + V+K D+ T G ++A+K +L + + L
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE-----NHLFRRASYIQPLSWT 178
EIK L +L HPN++ L+ + LV+EFM LE + + I+ S+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK--SYM 108
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ +GL YLHS+ +++RD K +N+L+ + KL+DFGLA+ GS +
Sbjct: 109 LMT------LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRK 158
Query: 239 STRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
T + T Y APE H D++S G + E+L
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y +++AVK L S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHL---------FRRASYIQPLSWTIRMKVALG 186
+VK G C+E D ++V+E+M G L L + L+ + + +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
A G+ YL S ++RD T N L+ N K+ DFG+++D + V M
Sbjct: 129 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ PE + T +SDV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LGE FG ++KG H Y P +V A+K L + Q E+ E + +L+HP
Sbjct: 13 LGECAFGKIYKG----HLYLPGMDHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-------------QPLSWTIRM 181
N+V L+G ++ +++E++ +G L L R+ + L +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A+ A G+ YL S +++D NIL+ + K+SD GL+++ + V +
Sbjct: 128 HIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ + PE + G ++ SD++SFGVVL E+ S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V++G + T +AVK L ++ ++L E + + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
L++L C ++ +V E M GSL +L A L I M A A G+AYL
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYLE 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTYGYAAPEYM 254
+ I+RD N+L+ N K++DFGLA+ ++ + + APE
Sbjct: 121 AQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAA 176
Query: 255 ATGHLTAKSDVYSFGVVLLEMLS-GR 279
+ KSDV+SFG++L E+++ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 49/287 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLT-EIKHLGQLY 132
+G+G FG V K R G ++ K ++ ++ + L E+ L +L
Sbjct: 7 TIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 133 HPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRA----SYI-QPLSWTIRMKVAL 185
HPN+V+ ++ ++ L V E+ G L L ++ YI + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 186 GAAKGLAYLH---SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
L H V++RD K +NI LD N N KL DFGLAK S T V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYV 171
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302
GT Y +PE + KSD++S G ++ E+ + P A+ LQ
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------PPFT-------ARNQLQ 217
Query: 303 SKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPTMDE 347
+I + RI +YS L +K L+ +P RP+ +E
Sbjct: 218 LASKIKEGKFRRIPYRYSSELNEVIK------SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 20/221 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K LN+ + + ++E++ E + + H
Sbjct: 14 VLGSGAFGTVYKG-----IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P+LV+L+G CL +L V + MP G L +++ I L+W +++ AKG
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKG 121
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ YL ++ ++++RD N+L+ + K++DFGLA+ + + + + A
Sbjct: 122 MMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 290
E + T +SDV+S+GV + E+++ G + D P+RE
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 32/220 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + + + H ++ E++ L +L +
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------------LSWTI 179
HPN++ L+G C + L E+ P G+L + L R++ ++ LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 126 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 240 TRVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ MG + A E + T SDV+S+GV+L E++S
Sbjct: 180 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G+ + HT +A+K L Q S+ +L E + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGHTK----------VAIKSLKQGSMSPE-AFLAEANLMKQLQHPR 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L ++ ++ E+M GSL + L ++ I M A A+G+A++
Sbjct: 63 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDM--AAQIAEGMAFI- 118
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMGTYGYAAPE 252
++ I+RD + +NIL+ K++DFGLA +D ++ + T APE
Sbjct: 119 -ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APE 173
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
+ G T KSDV+SFG++L E+++ R+
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 51/290 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------------QESLQGHLEWL 122
LG G FGCV+K + ++A+K +N +S+ + +
Sbjct: 8 LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF----RRASYIQPLSWT 178
T IK QL HPN+V+ LE+D +V + + L H ++ + + W
Sbjct: 60 TIIKE--QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
I +++ L L YLH +K ++++RD +NI+L + ++DFGLAK +S +
Sbjct: 118 IFVQMVLA----LRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL 170
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
T V+GT Y+ PE + K+DV++FG +L +M + P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLAT 223
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+++ V + EG YS + CL+ + + RP + +V
Sbjct: 224 KIVEA------VYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLY 132
S +GEG +G V + T G+ +A+K+++ Q L EIK L +
Sbjct: 11 SYIGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 133 HPNLVK----LIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS---------WT 178
H N++ + E + + +V E M E L++ Q LS
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYK-LIKTQHLSNDHIQYFLYQI 115
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-DGPTGSQSH 237
+R GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+ P +
Sbjct: 116 LR---------GLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 279
T + T Y APE M K+ D++S G +L EMLS R
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-18
Identities = 84/303 (27%), Positives = 138/303 (45%), Gaps = 57/303 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQGHLE-----WL 122
+ + V+G G FG V G + PG + +A+K L G+ E +L
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLK-------LPGKREIPVAIKTLKA----GYTEKQRRDFL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+E +GQ HPN++ L G + ++V E+M GSL+ L + +T+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQL 108
Query: 183 VAL--GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSH 237
V + G A G+ YL SD V +RD NIL++ N K+SDFGL++ D P + +
Sbjct: 109 VGMLRGIASGMKYL-SDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 296
++ + APE +A T+ SDV+S+G+V+ E++S G R
Sbjct: 167 RGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER---------------- 208
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKAL 352
PY + + V+ A EG Y L A + L + C + RP +++V L
Sbjct: 209 --PYWEMSNQ--DVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
Query: 353 EQI 355
+++
Sbjct: 264 DKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 32/222 (14%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+GEG FG V + I + G M A+K L + S H ++ E++ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 132 -YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------------LSW 177
+HPN++ L+G C + + E+ P G+L + L R++ ++ L+
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++ A A G+ YL S+K + I+RD N+L+ N +K++DFGL++ G + +
Sbjct: 119 QQLLQFASDVATGMQYL-SEK-QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVY 172
Query: 238 VSTRVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
V + MG + A E + T KSDV+SFGV+L E++S
Sbjct: 173 VK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 55/288 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V G + +A+K +N+ ++ +++ E K + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQ----------IKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPK 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L G C + +V EFM G L N+L +R + + + + +G+ YL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYL- 116
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAPE 252
++ I+RD N L+ K+SDFG+ + D S S V ++ PE
Sbjct: 117 -ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPE 171
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRP-------SREHNLIEWAKPYLQSK 304
++KSDV+SFGV++ E+ + G+ +K SR L +P L S
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---RPKLASM 228
Query: 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
+++VM C +P+ RPT E+++A+
Sbjct: 229 -TVYEVM--------------------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ Y ++ M +AVK L +E+L L+ ++ H
Sbjct: 42 TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS---H 94
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
LG H N+V L+G C L++ E+ G L N L R+ L+ + +
Sbjct: 95 LGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQV 150
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
AKG+A+L S I+RD N+LL K+ DFGLA+D S V
Sbjct: 151 AKGMAFLASKNC--IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ APE + T +SDV+S+G++L E+ S
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 41/238 (17%)
Query: 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWL 122
+ R++ LGEG FG V+K + TG V+A+K++ + + + L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITAL 55
Query: 123 TEIKHLGQLYHPNLVKLIGYCLE--DDH---RLLVYEFMP------KGSLENHLFRRASY 171
EIK L +L HPN+V LI +E D R VY P G LEN +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---- 111
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--- 228
+ M L +G+ YLH + +++RD K +NIL+D K++DFGLA+
Sbjct: 112 LTESQIKCYMLQLL---EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 229 ------DGPTGSQSHVSTRVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
G G + T ++ T Y PE + T D++ G V EM + R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 51/266 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIA---VKRLNQES-LQGHLEWLTEIKHLGQL 131
+G G FG V G GM A VK L + L +L E++ +L
Sbjct: 3 IGNGWFGKVLLGEAH----------RGMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT-IRMKVALGAAKG 190
HPN+++ +G C+E LLV EF P G L+N+L + ++ + ++A A G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQSHVSTRVMG 244
L +LH +A I+ D N L + + K+ D+GLA + T V R
Sbjct: 113 LLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167
Query: 245 TYGYAAPEYMATGH-------LTAKSDVYSFGVVLLEM----------LSGRRVIDKNRP 287
+ APE + T KS+++S GV + E+ LS +V+ +
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQV 222
Query: 288 SREHNLIEWAKPYLQSK--RRIFQVM 311
RE + I+ KP L K R ++VM
Sbjct: 223 VREQD-IKLPKPQLDLKYSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L+ G L E + L ++
Sbjct: 1 LGKGGFGEVC---------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 133 HPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
P +V L Y E H LV M G L+ H++ + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
+LHS ++YRD K N+LLD N +LSD GLA + G T+ GT GY AP
Sbjct: 109 LHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAP 163
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSGR 279
E + + D ++ G + EM++GR
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 63/234 (26%), Positives = 98/234 (41%), Gaps = 55/234 (23%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
+ +G G +G V +D+ T G +A+K+++ + L L EIK
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 128 LGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
L L H N++ L+ + + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHK----------VIKSP 97
Query: 183 VALGAA----------KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---- 228
L +GL YLHS A VI+RD K SNIL++ N + K+ DFGLA+
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 229 DGPTGSQ--SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 279
D +V TR Y APE + + T D++S G + E+L+ +
Sbjct: 156 DEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 68 RNFRPDSV------LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
R+ P+ V LG+G FG V+K E TG + A K + +S + ++
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDY 56
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ EI+ L HP +VKL+G D ++ EF P G+++ + + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L A L YLHS K+I+RD K N+LL L+ + KL+DFG++ Q S
Sbjct: 117 RQMLEA---LQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-- 169
Query: 242 VMGTYGYAAPEY-----MATGHLTAKSDVYSFGVVLLEM 275
+GT + APE M K+D++S G+ L+EM
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 41/225 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K RL+ E+ + EI
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFM-----------PKGSLENHLFRRASYIQPL 175
L +L HPN+VKL+ ++ LV+EF+ P + L + SY+ L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQL 109
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
+GLA+ HS + V++RD K N+L++ KL+DFGLA+ G
Sbjct: 110 ------------LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVP 153
Query: 236 SHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
T + T Y APE + + + D++S G + EM++ R
Sbjct: 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 76/291 (26%), Positives = 134/291 (46%), Gaps = 59/291 (20%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V G W ++ +A+K + + S+ E++ E K + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMKLSHE 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
LV+L G C + +V E+M G L N+L QP +++ +G+AYL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYL 116
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVMGT---YG 247
S + I+RD N L+D K+SDFGL++ D T S +G+
Sbjct: 117 ESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS--------VGSKFPVR 166
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK--NRPSREH--NLIEWAKPYLQ 302
++ PE + ++KSDV++FGV++ E+ S G+ ++ N + E + +P+L
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226
Query: 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
S+ +++ +M YS C + + RPT +++ ++E
Sbjct: 227 SE-KVYAIM-------YS-------------CWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 75/302 (24%), Positives = 112/302 (37%), Gaps = 58/302 (19%)
Query: 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQ 130
+GEG FG V++G Y + + +AVK + E +L E + Q
Sbjct: 10 LGRCIGEGQFGDVYQG-----VYM-SPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP++VKLIG ++ +V E P G L ++L + S + +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLSTA 119
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
LAYL S + ++RD N+L+ KL DFGL++ S S + + A
Sbjct: 120 LAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMA 176
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS----------GRRVIDK----NRPSREHNLIEW 296
PE + T+ SDV+ FGV + E+L VI + R N
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN---- 232
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
P L YS L KC + +P RP E+ L I
Sbjct: 233 CPPTL-----------------YS---------LMTKCWAYDPSKRPRFTELKAQLSDIL 266
Query: 357 DT 358
Sbjct: 267 QE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 70/214 (32%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V G AVK L ++++ E KH
Sbjct: 2 VIGKGSFGKVLLA---------KHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV-A 184
L + HP LV L Y + +L V +++ G L HL R S+ +P R + A
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYA 102
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
A L YLHS +IYRD K NILLD + L+DFGL K+G S++ ++ G
Sbjct: 103 AEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCG 158
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
T Y APE + D + G VL EML G
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 67/226 (29%), Positives = 95/226 (42%), Gaps = 63/226 (27%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH-------L 128
+G+GG+G VF A + TG ++A+KR+ + L L E++H L
Sbjct: 9 VGQGGYGQVF--------LAKKK-DTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMP----------KGSLENHLFRRASYIQPLSW 177
LVKL+ Y +DD L L E++P G L R Y+
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYM----- 107
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
M A+ A L Y+H RD K N L+D + + KL+DFGL+K T + S
Sbjct: 108 -AEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSG 278
V +P+YMA L K D +S G +L E L G
Sbjct: 159 V----------GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 70/215 (32%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKH 127
FR +VLG G FG V + E+ TG + A+K L + + +E L K
Sbjct: 1 FRCLAVLGRGHFGKVL---LAEYK------KTGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 128 L----GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ HP LV L +DH V E+ G L H+ + +P + V
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACV 110
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
LG L YLH +K ++YRD K N+LLD K++DFGL K+G G ST
Sbjct: 111 VLG----LQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FC 162
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT + APE + T D + GV++ EML G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
+F LG G G V K H +G+++A K + HLE
Sbjct: 2 DFEKLGELGAGNGGVVTKV---LHRP------SGLIMARKLI-------HLEIKPAIRNQ 45
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
+ E+K L + P +V G D + E M GSL+ L ++A I I
Sbjct: 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPE---NIL 101
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS- 239
K+++ +GL YL +K K+++RD K SNIL++ KL DFG++ Q S
Sbjct: 102 GKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSM 154
Query: 240 -TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+GT Y +PE + H T +SD++S G+ L+EM GR
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E++ L QL
Sbjct: 23 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGS----LENHLFRRASYIQPLSWTIRMKVALGAA 188
HPN ++ G L + LV E+ GS LE H +PL + GA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK-------KPLQEVEIAAICHGAL 125
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GLAYLHS + I+RD K NILL KL+DFG A S + +GT +
Sbjct: 126 QGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYW 177
Query: 249 AAPEY---MATGHLTAKSDVYSFGVVLLEM 275
APE M G K DV+S G+ +E+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 7e-17
Identities = 89/311 (28%), Positives = 136/311 (43%), Gaps = 69/311 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E+K L ++
Sbjct: 33 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L + LV E+ GS + L + +PL + GA +GLA
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 139
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL+DFG A S + + +GT + APE
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPE 191
Query: 253 Y---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQSKR-- 305
M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPTLQSNEWS 250
Query: 306 ---RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL---------- 352
R F +D+ CL P+ RPT +E++K +
Sbjct: 251 DYFRNF--VDS--------------------CLQKIPQDRPTSEELLKHMFVLRERPETV 288
Query: 353 --EQIQDTNDA 361
+ IQ T DA
Sbjct: 289 LIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 65/260 (25%), Positives = 118/260 (45%), Gaps = 44/260 (16%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + HPN+V++ L D +V EF+ G+
Sbjct: 43 TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 161 LENHLFRRASYIQPLSWTIRMK------VALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
L + + RM V L K L++LH+ VI+RD K+ +ILL
Sbjct: 103 LTD-----------IVTHTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT 149
Query: 215 LNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGV 270
+ KLSDFG ++K+ P ++GT + APE ++ + D++S G+
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 271 VLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 330
+++EM+ G P + +P LQ+ +RI + +++ + + L++
Sbjct: 204 MVIEMVDG-------EPPY------FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS--F 248
Query: 331 AIKCLSNEPKFRPTMDEVVK 350
+ L +P R T E++
Sbjct: 249 LDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLYH 133
+G G FG VF G + +AVK +E+L L+ +L E + L Q H
Sbjct: 3 IGRGNFGEVFSGRLR---------ADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSH 52
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+LIG C + +V E + G L L +++ AA G+ Y
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEY 109
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 110 LESKHC--IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 254 MATGHLTAKSDVYSFGVVLLEMLS 277
+ G +++SDV+SFG++L E S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------------FRRASYIQPLSWTIR 180
HPN++ L+G C + L E+ P G+L + L S LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167
Query: 241 RVMGTYG--YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ MG + A E + T SDV+S+GV+L E++S
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 42/295 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY 132
+LG+G FG V + + G+ +AVK L + E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYI--QP--LSWTIRMK 182
HPN++KLIG L + +++ FM G L H F S I +P L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVR 117
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ A G+ YL S I+RD N +L+ N ++DFGL+K +G
Sbjct: 118 FMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK--PY 300
+ A E +A T SDV++FGV + E+++ R + +E ++ Y
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEIYNY 227
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
L R+ Q D +E Y L +C S EPK RP+ + LE I
Sbjct: 228 LIKGNRLKQPPDC-LEDVYE---------LMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G P T +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ--------PLSWTIRMKVALG 186
++V+L+G + L++ E M +G L+++L ++ L I+M A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM--AGE 127
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
A G+AYL+++K ++RD N ++ ++ K+ DFG+ +D + +
Sbjct: 128 IADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+ +PE + G T SDV+SFGVVL E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG++ A K ++ +S + +++ EI L HPN
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+VKL+ +++ ++ EF G+++ + +PL+ V + L YLH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
+K +I+RD K NIL L+ + KL+DFG++ Q S +GT + APE +
Sbjct: 121 ENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 176
Query: 256 TGH-----LTAKSDVYSFGVVLLEM 275
K+DV+S G+ L+EM
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY 132
VLG+G FG VF P G + A+K L + +L+ + E L ++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA-AKG 190
HP +VKL Y + + +L L+ +F+ G L L + + + +K L A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAELALA 110
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L +LHS +IYRD K NILLD + KL+DFGL+K+ + S GT Y A
Sbjct: 111 LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166
Query: 251 PEYM-ATGHLTAKSDVYSFGVVLLEMLSG 278
PE + GH T +D +SFGV++ EML+G
Sbjct: 167 PEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 20/195 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLE---WLTEIKHLGQLYHPNLVKLI--GYCLEDDHRLLVYEF 155
TG +A+K L ++ + + + E +LYHPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-- 213
+P +L L A P T R+ L LA H +++RD K NI++
Sbjct: 61 VPGRTLREVL--AADGALPAGETGRL--MLQVLDALACAH--NQGIVHRDLKPQNIMVSQ 114
Query: 214 -DLNYNAKLSDFGLAKDGP-----TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYS 267
+ +AK+ DFG+ P + +T V+GT Y APE + +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 268 FGVVLLEMLSGRRVI 282
+G++ LE L+G+RV+
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
F+ VLG G FG V+KG WI P + +A+K L + S + + E L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVA 184
+ + +P++ +L+G CL +L + + MP G L +++ I L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
AKG+ YL ++ ++++RD N+L+ + K++DFGLAK + + +
Sbjct: 119 ---AKGMNYL--EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ A E + T +SDV+S+GV + E+++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 45/287 (15%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPAR---PGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G FG V+ ++HT + PG+ V A +L E +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--------------FLAEANVMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
L H LVKL + + ++ EFM KGSL + L QPL I + A+
Sbjct: 57 TLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AE 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--G 247
G+A++ ++ I+RD + +NIL+ + K++DFGLA+ + + R +
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIK 168
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QSKRR 306
+ APE + G T KSDV+SFG++L+E+++ R+ PY S
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-----------------PYPGMSNPE 211
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
+ + ++ + + ++C N P+ RPT + + L+
Sbjct: 212 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 70/246 (28%), Positives = 96/246 (39%), Gaps = 57/246 (23%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGH-LEWLTEI 125
+F V+G G FG V+ TG V A+K L + + + E
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT----IR 180
L P +VKL Y +D+ L LV E+MP G L N L R+ + P
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAE 109
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS---- 236
+ +AL + L ++H RD K NIL+D + + KL+DFGL K
Sbjct: 110 LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 237 ------------------HVSTRVM-----GTYGYAAPE-YMATGHLTAKSDVYSFGVVL 272
H RV GT Y APE T + + D +S GV+L
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVIL 220
Query: 273 LEMLSG 278
EML G
Sbjct: 221 YEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R + LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW----------NGTTRV-AIKTLKPGTMSPE-AFLQEAQV 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ +L H LV+L + ++ +V E+M KGSL + F + + L + +A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQI 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY- 246
A G+AY+ ++ ++RD + +NIL+ N K++DFGLA+ + + R +
Sbjct: 112 ASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFP 166
Query: 247 -GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
+ APE G T KSDV+SFG++L E+ + RV PY
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVN 209
Query: 306 RIFQVMDARIEGQYSLGAALKTAV----LAIKCLSNEPKFRPTMDEVVKALE 353
R +V+D ++E Y + + L +C EP+ RPT + + LE
Sbjct: 210 R--EVLD-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 17/174 (9%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
Q P + KL D+ LV E++ G + L + + P W +
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGL-PEDWA--KQYIAEVVL 108
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ LH +I+RD K N+L+D + KL+DFGL+++G + + +GT Y
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYL 160
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-----EHNLIEWAK 298
APE + SD +S G V+ E L G P I W +
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 33/288 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G + T +AVK +N+ SL+ +E+L E +
Sbjct: 14 LGQGSFGMVYEGNARD--IIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQP--LSWTIRMKVALGA--A 188
++V+L+G + L+V E M G L+++L R + P T++ + + A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+AYL++ K ++RD N ++ ++ K+ DFG+ +D + + +
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKRR 306
APE + G T SD++SFGVVL E+ S L E +PY L +++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAE--QPYQGLSNEQV 230
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
+ VMD Q T ++ + C PK RPT E+V L+
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 71/286 (24%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + S + + E L E + +
Sbjct: 14 VLGSGAFGTVYKG-----IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P + +L+G CL +L V + MP G L +++ I L+W +++ AKG
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
++YL ++ ++++RD N+L+ + K++DFGLA+ + + + A
Sbjct: 122 MSYL--EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
E + T +SDV+S+GV + E+++ G + D P+RE L+ R+ Q
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE------IPDLLEKGERLPQ 232
Query: 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
I+ ++ +KC + + RP E+V ++
Sbjct: 233 PPICTID----------VYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+LG G G V+K + T ++AVK + + +++ + ++E++ L +
Sbjct: 8 ILGHGNGGTVYKAY---------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P ++ G ++ + EFM GSL+ ++R+ + + ++A+ KGL Y
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S K+++RD K SN+L++ KL DFG++ T + ++ +GT Y APE
Sbjct: 111 LWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPER 164
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGR 279
++ SDV+S G+ +E+ GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FGCV KG Y + + I V + E E + E + + QL +P
Sbjct: 3 LGSGNFGCVKKG-----VYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPY 56
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAAKGLAY 193
+V++IG C E + +LV E G L L + I +S + + +V++G + Y
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMG----MKY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAAP 251
L + ++RD N+LL + AK+SDFGL+K S+ R G + + AP
Sbjct: 111 L--EGKNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAP 167
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS 277
E + +++SDV+S+G+ + E S
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 19/233 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + HPN
Sbjct: 27 IGQGASGTV---------YTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + + V + L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
S++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 256 TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 307
K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 73/213 (34%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V R G AVK L ++ + E KH
Sbjct: 2 VIGKGSFGKVL---------LAKRKLDGKCYAVKVLQKKIVLNR----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L + HP LV L Y + +L V +F+ G L HL R S+ +P + R A
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAA- 103
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
A L YLHS ++YRD K NILLD + L+DFGL K+G +QS +T GT
Sbjct: 104 EIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGT 159
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
Y APE + D + G VL EML G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 76 LGEGGFGCVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHL 128
LGEG FG V ID+ +P + +AVK L ++ + L L +K +
Sbjct: 23 LGEGCFGQVVMAEALGIDKD-----KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA------SYI------QPLS 176
G+ H N++ L+G C +D ++ E+ KG+L +L R SY + ++
Sbjct: 78 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ + A+G+ YL S K I+RD N+L+ N K++DFGLA+D
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKC--IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+T + APE + T +SDV+SFGV++ E+ +
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 6 MVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
P + + C + RL V E++ G L H+ + + +P + ++A+G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG--- 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGY 248
L +LHS +IYRD K N++LD + K++DFG+ K+ G +TR GT Y
Sbjct: 114 -LFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDY 167
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE +A D ++FGV+L EML+G+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 69 NFRPDSVLGEGGFG--CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ +G G FG + + I EH YA VI RL QE H+ E +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI---RLKQEQ---HVH--NEKR 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L ++ HP +++L + E D R L + E++P G L ++L + S + + A
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF----SNSTGLFYA 107
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR--- 241
L YLHS +++YRD K NILLD + KL+DFG AK + R
Sbjct: 108 SEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTWT 157
Query: 242 VMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSG 278
+ GT Y APE + GH A D ++ G+++ EML G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G VFK +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P +V G D + E M GSL+ + ++A I I KV++
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE---QILGKVSI 110
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
KGL YL +K K+++RD K SNIL++ KL DFG++ ++ +GT
Sbjct: 111 AVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGT 165
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+LN++ L +G+ + E + L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF----RRASYIQPLSWTIRMKVALGA 187
H + + Y + L LV M G L H++ + +P + ++ G
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG- 109
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMG 244
L +LH + ++IYRD K N+LLD + N ++SD GLA KDG + ++ + G
Sbjct: 110 ---LEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----G 159
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
T G+ APE + D ++ GV L EM++ R
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G V+KG TG ++A+K++ ES + + + EI L +L H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPL---SWTIRMKVALGAA 188
PN+V L +++ L++EF+ L+ +L + Y+ S+ ++
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------L 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+ + HS +V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 112 QGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 249 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + + + D++S G + EM + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 69/211 (32%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA--A 188
HP L L Y + RL V E+ G L HL R + + R + GA
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF-YGAEIV 105
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L YLHS V+YRD K N++LD + + K++DFGL K+G + + GT Y
Sbjct: 106 SALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 161
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + D + GVV+ EM+ GR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 56/224 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G VFK E TG ++A+K+ +++ L EI+ L QL H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 134 PNLVKLI-------------GYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTI 179
PNLV LI YC DH +L E P+G + HL ++ + Q L
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKKIIW-QTL---- 110
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQS- 236
+ + + H K I+RD K NIL+ KL DFG A+ GP +
Sbjct: 111 ---------QAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKS--DVYSFGVVLLEMLSG 278
+V+TR Y APE + G DV++ G V E+L+G
Sbjct: 160 YVATR-----WYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
+F VLG+G FG V R GT + A+K L ++ + +E + E
Sbjct: 1 DFNFLMVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L P + + C + RL V E++ G L H+ + + +P + +++
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM- 243
+G L +LH + +IYRD K N++LD + K++DFG+ K+ V+TR
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFC 162
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 283
GT Y APE +A D +++GV+L EML+G+ D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + +T +AVK L ++ +L E + + +L H
Sbjct: 14 LGNGQFGEVWMGTWNGNTK----------VAVKTLKPGTMSPE-SFLEEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L + ++ +V E+M KGSL + L L + M A A G+AY+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI- 118
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAAPEY 253
++ I+RD +++NIL+ K++DFGLA+ + + R + + APE
Sbjct: 119 -ERMNYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEA 174
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QSKRRIFQVMD 312
G T KSDV+SFG++L E+++ RV PY + R + + ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMNNREVLEQVE 217
Query: 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
+ L ++C +P+ RPT + + LE
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLGQ 130
LG GGFG V A+K + + Q H+ +E + L +
Sbjct: 1 LGVGGFGRVELV-----KVKS----KNRTFALKCVKKRHIVETGQQEHI--FSEKEILEE 49
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP +VKL + + ++ E+ G L L R + +T R +A
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD---EYTARFYIA-CVVLA 105
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLH+ +IYRD K N+LLD N KL DFG AK +G ++ GT Y A
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160
Query: 251 PEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
PE + G+ + D +S G++L E+L+GR
Sbjct: 161 PEIILNKGYDFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 47/208 (22%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT--EIKHLGQLYHPNLVKL----------IGYCLE--- 145
TG +A+K++ + L T E+K L L H N++ L I + E
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204
D HRLL LE +IQ + I +GL Y+HS A V++R
Sbjct: 94 TDLHRLL-----TSRPLEKQ------FIQYFLYQI--------LRGLKYVHS--AGVVHR 132
Query: 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKS 263
D K SNIL++ N + K+ DFGLA+ +VSTR Y APE M T +
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEV 187
Query: 264 DVYSFGVVLLEMLSGRRVIDKNRPSREH 291
D++S G + EML G+ + P ++H
Sbjct: 188 DIWSAGCIFAEMLEGKPLF----PGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LG G FG V KG + +AVK L ++ L E L E + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKK-------SEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P +V++IG C E + +LV E G L L + + + +V++G + Y
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAAP 251
L ++ ++RD N+LL + AK+SDFGL+K +++ + G + + AP
Sbjct: 111 L--EETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAP 167
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS 277
E M ++KSDV+SFGV++ E S
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 77/229 (33%), Positives = 109/229 (47%), Gaps = 58/229 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT--EIKHL 128
LG+G +G V+K ID T V+A+K++ N Q T EI L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKIFDAFRNATDAQ-----RTFREIMFL 60
Query: 129 GQLY-HPNLVKLIG-YCLEDDHRL-LVYEFMP--------KGSLEN-HLFRRASYI--QP 174
+L HPN+VKL+ E+D + LV+E+M LE+ H +R YI Q
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KR--YIMYQL 116
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGP 231
L K L Y+HS VI+RD K SNILL+ + KL+DFGLA+ +
Sbjct: 117 L-------------KALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 232 TGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
++ V T + T Y APE + + T D++S G +L EML G+
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 87/306 (28%), Positives = 132/306 (43%), Gaps = 59/306 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y V+A+K+++ Q + +W + E++ L +L
Sbjct: 23 IGHGSFGAV---------YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L + LV E+ GS + L + +PL V GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL DFG A S + +GT + APE
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPE 181
Query: 253 Y---MATGHLTAKSDVYSFGVVLLEMLSGRR--VIDKNRPSREHNLIEWAKPYLQSKRRI 307
M G K DV+S G+ +E L+ R+ + + N S +++ + P LQS
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPALQSG--- 237
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK------------ALEQI 355
+S + V + CL P+ RPT + ++K ++ I
Sbjct: 238 ----------HWS--EYFRNFVDS--CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
Query: 356 QDTNDA 361
Q T DA
Sbjct: 284 QRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLT-- 123
N+R +LG+G FG V+ + +D TG +A K++ + ES + E
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 124 -EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTI 179
EI+ L L H +V+ G CL D + L ++ E+MP GS+++ L + L+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESV 107
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 108 TRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 240 TR-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
R V GT + +PE ++ K+DV+S G ++EML+ +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V YA T + IA+K + + + EI L H
Sbjct: 15 VLGKGTYGIV---------YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAAKGLA 192
N+V+ +G E+ + E +P GSL L + ++ TI K L +GL
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLK 122
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLH + ++++RD K N+L++ Y+ K+SDFG +K + + GT Y A
Sbjct: 123 YLHDN--QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMA 177
Query: 251 PEYMATGH--LTAKSDVYSFGVVLLEMLSGR 279
PE + G A +D++S G ++EM +G+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT 123
N+R +LG G FG V Y TG +AVK++ +QE+ +
Sbjct: 3 NWRLGKLLGRGAFGEV---------YLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIR 180
EI+ L L H +V+ G CL D + +L ++ E+MP GS+++ L + L+ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVT 108
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 109 RRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 241 R-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ V GT + +PE ++ K+DV+S ++EML+
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLE---WLT 123
N+R +LG+G FG V Y TG +AVK++ + ES + E
Sbjct: 3 NWRLGKLLGQGAFGRV---------YLCYDADTGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIR 180
EI+ L L H +V+ G CL D + L ++ E MP GS+++ L SY L+ +
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQL---KSY-GALTENVT 108
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 109 RKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 241 R-VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ V GT + +PE ++ K+D++S G ++EML+ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 72/229 (31%), Positives = 111/229 (48%), Gaps = 37/229 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKH 127
VLG+GG+G VF+ TG + A+K L + ++ H + E
Sbjct: 2 KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L + HP +V LI Y + +L L+ E++ G L HL R +++ + +++L
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG-PTGSQSHVSTRVMGT 245
L +LH + +IYRD K NILLD + KL+DFGL K+ G+ +H GT
Sbjct: 113 ----LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGT 163
Query: 246 YGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG---------RRVIDK 284
Y APE M +GH A D +S G ++ +ML+G ++ IDK
Sbjct: 164 IEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 52/224 (23%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPG-TGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V++ AR +G ++A+K R++ E + L EI L L
Sbjct: 15 IGEGTYGIVYR----------ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR 64
Query: 133 HPNLVKL---------------IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
HPN+V+L + YC +D LL + MP P S
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP---------------TPFSE 107
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + L +GL YLH + +I+RD K SN+LL K++DFGLA+ G +
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAK 163
Query: 238 VSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
T + T Y APE + T + TA D+++ G +L E+L+ +
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--H 133
LGEG FG V + + + +RP + +AVK L + L L L +L H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRM 181
N++ L+G C ++ ++ E+ KG+L L R + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
A A+G+ YL S + I+RD N+L+ + K++DFGLA+ ++
Sbjct: 138 SCAYQVARGMEYLESRRC--IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ APE + T +SDV+SFG+++ E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 40/282 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G+ + T +AVK L S+Q LE E + L H
Sbjct: 14 LGAGQFGEVWMGYYNNSTK----------VAVKTLKPGTMSVQAFLE---EANLMKTLQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L +++ ++ E+M KGSL + L L I + A+G+AY
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAY 118
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY--GYAAP 251
+ ++ I+RD + +N+L+ + K++DFGLA+ + + R + + AP
Sbjct: 119 I--ERKNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAP 173
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311
E + G T KSDV+SFG++L E+++ ++ P ++ + A LQ R+ ++
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKI---PYPGMSNSDVMSA---LQRGYRMPRME 227
Query: 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
+ E L +KT C + + RPT D + L+
Sbjct: 228 NCPDE----LYDIMKT------CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 41/289 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R D LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTW----------NGTTKV-AIKTLKPGTMMPE-AFLQEAQI 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ +L H LV L + ++ +V EFM KGSL + L L + M +
Sbjct: 55 MKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI-- 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY- 246
A G+AY+ ++ I+RD + +NIL+ N K++DFGLA+ + + R +
Sbjct: 112 ADGMAYI--ERMNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFP 166
Query: 247 -GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL-QSK 304
+ APE G T KSDV+SFG++L E+++ RV PY
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMVN 209
Query: 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
R + + ++ G L C +P RPT + + LE
Sbjct: 210 REVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 73/247 (29%), Positives = 110/247 (44%), Gaps = 49/247 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFR--RASYIQPLSWTIRMKV 183
+ + + V + Y E D LV M G L+ H++ A + + +
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-------RA 104
Query: 184 ALGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
AA+ GL LH ++ ++YRD K NILLD + + ++SD GLA P G +
Sbjct: 105 VFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKG 160
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
RV GT GY APE + T D ++ G +L EM++G+ P+
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ------------------SPF 201
Query: 301 LQSKRRI 307
Q K++I
Sbjct: 202 QQRKKKI 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 5e-15
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G VF TG +A+K++N + + EI + +L +PN
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE-----CLQALEFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
+++ VI+RD K+ N+LL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 133 ANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 256 TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 307
K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 5e-15
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + +PN
Sbjct: 27 IGQGASGTV---------YTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALDFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
S++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE +
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 256 TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRIFQVM 311
K D++S G++ +EM+ G P R LI P LQ+ R+ V
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 80/322 (24%), Positives = 126/322 (39%), Gaps = 85/322 (26%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQG 117
L T F V+GEG +G V+K + T G ++A+K ++ +E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEEEEIKE 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL------LVYEFMPKGSL---------- 161
L + HPN+ G ++ + LV E GS+
Sbjct: 52 EYNIL---RKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 162 -----ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
E + +YI +R +GLAYLH +K VI+RD K NILL N
Sbjct: 107 GKRLKEEWI----AYI------LR-----ETLRGLAYLHENK--VIHRDIKGQNILLTKN 149
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTR--VMGTYGYAAPEYMA-----TGHLTAKSDVYSFG 269
KL DFG++ S + R +GT + APE +A A+SDV+S G
Sbjct: 150 AEVKLVDFGVSAQ----LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 270 VVLLEMLSGRRVIDKNRPSREHNLIEWAK-PYLQSKRRIFQVMDARIEGQYSLGAALKTA 328
+ +E+ G+ + P R I P L+S + + I
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFIS------------ 253
Query: 329 VLAIKCLSNEPKFRPTMDEVVK 350
+CL + RP M+E+++
Sbjct: 254 ----ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 64/194 (32%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 101 TGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
TG + A+K + + + + LTE L Q P +VKL Y + L LV E
Sbjct: 17 TGDIYAIKVIKKADMIRKNQVDQV--LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVME 73
Query: 155 FMPKGSLENHLFRRASYIQPL-SWTIRMKVALGA--AKGLAYLHSDKAKVIYRDFKTSNI 211
++P G L AS ++ + S + A L YLHS+ +I+RD K NI
Sbjct: 74 YLPGGDL-------ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNI 124
Query: 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVS------TRVMGTYGYAAPEYM-ATGHLTAKSD 264
L+D N + KL+DFGL+K G Q +++ R++GT Y APE + GH + D
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVD 183
Query: 265 VYSFGVVLLEMLSG 278
+S G +L E L G
Sbjct: 184 WWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P +AVK L ++ + L L +K +G+
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 82
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA------SY------IQPLSWTI 179
H N++ L+G C +D ++ E+ KG+L +L R Y + LS+
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D H+
Sbjct: 142 LVSCAYQVARGMEYLASKKC--IHRDLAARNVLVTEDNVMKIADFGLARD-----IHHID 194
Query: 240 TRVMGTYG-----YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
T G + APE + T +SDV+SFGV+L E+ +
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 24/190 (12%)
Query: 101 TGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHRLLVYE 154
TG V+AVK++ N+E + L L + H P +VK GY + D + E
Sbjct: 39 TGHVMAVKQMRRTGNKEENKRILMDLDVV----LKSHDCPYIVKCYGYFITDSDVFICME 94
Query: 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
M + + L +R P+ I K+ + K L YL +K VI+RD K SNILLD
Sbjct: 95 LM--STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYL-KEKHGVIHRDVKPSNILLD 149
Query: 215 LNYNAKLSDFGLAKDGP-TGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFG 269
+ N KL DFG++ G S++ TR G Y APE + ++DV+S G
Sbjct: 150 ASGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205
Query: 270 VVLLEMLSGR 279
+ L+E+ +G+
Sbjct: 206 ISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR------LNQESLQGHLE 120
NF+ + +G+G F V+K G V+A+K+ ++ ++ Q +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQ---D 48
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE---NHLFRRASYI-QPLS 176
L EI L QL HPN++K + +E++ +V E G L H ++ I +
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W +++ L ++HS ++++RD K +N+ + KL D GL + S++
Sbjct: 109 WKYFVQL----CSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKT 160
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+ ++GT Y +PE + KSD++S G +L EM
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 27/175 (15%)
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVS 239
K+A+ K L YLHS K VI+RD K SN+L++ N KL DFG+ +G S
Sbjct: 107 KIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAK 160
Query: 240 TRVMGTYGYAAPEY----MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295
T G Y APE + KSDV+S G+ ++E+ +GR D
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS----------- 209
Query: 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
W P+ Q K+ + + ++S KCL K RP E+++
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVN----KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LGE FG V+KG H + A +A+K L ++ +G L E+ E +L H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA---------------SYIQPLSWT 178
PN+V L+G ++ +++ + L L R+ S ++P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ + A G+ +L S V+++D T N+L+ N K+SD GL ++ +
Sbjct: 127 --VHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ + +PE + G + SD++S+GVVL E+ S
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLG-Q 130
VLG+G FG V GT V A+K L ++ + + +TE + L
Sbjct: 2 VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 131 LYHPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP L L C + RL V E++ G L + R + +P S +V L
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--- 108
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L +LH + VIYRD K NILLD + KL+DFG+ K+G +T GT Y
Sbjct: 109 -LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + D ++ GV++ EM++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQL 131
+L EG FG +F G IDE +PG + VK + + +Q L L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGL 65
Query: 132 YHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGA- 187
H N++ ++ C+ED + ++Y +M G+L+ L R P + + + V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 188 -AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPT-----GSQSHVST 240
A G++YLH K VI++D N ++D K++D L++D P G +
Sbjct: 126 IACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ M A E + ++ SDV+SFGV+L E+++
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLY 132
++GEG +G V K E TG ++A+K+ + ++ + EI+ L QL
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H NLV LI LV+EF+ L++ Y L + K +G+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+ HS +I+RD K NIL+ + KL DFG A+ + V T + T Y APE
Sbjct: 115 FCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPE 170
Query: 253 YMATGHLTAKS-DVYSFGVVLLEMLSG 278
+ ++ D+++ G ++ EML+G
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V + E +G + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 133 --HPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP L +L C + RL V EF+ G L H+ + + + + ++
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----S 107
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L +LH +IYRD K N+LLD + KL+DFG+ K+G ++ ++ GT Y
Sbjct: 108 ALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSG 278
APE + D ++ GV+L EML G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQL 131
+G G FG V K +G ++AVKR+ +++ + L L +
Sbjct: 12 IGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP--LSWTIRMKVALGAAK 189
P +VK G + + E M SL+ ++ + + I K+A+ K
Sbjct: 63 --PYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYG 247
L YL + K+I+RD K SNILLD N N KL DFG++ G S TR G
Sbjct: 119 ALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172
Query: 248 YAAPEYMATGHLTA---KSDVYSFGVVLLEMLSGR 279
Y APE + +SDV+S G+ L E+ +G+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
+LG+G FG VF + GT A+K L ++ + +E K + L
Sbjct: 2 MLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 133 --HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP L L YC ++ V E++ G L H+ + P + ++ G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L +LHS ++YRD K NILLD + + K++DFG+ K+ G + GT Y
Sbjct: 109 --LQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G V+K D T IA+K RL QE + EI L ++ H
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRASYIQPLSWTIRMKVALGA 187
N+V+L + LV+E++ L+ H+ + I+ + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI-------- 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+G+AY HS + V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 112 LRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 247 GYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + + H + D++S G + EM++ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K RL E + EI L +L
Sbjct: 7 IGEGTYGVVYK----------ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+V+L+ + +++L LV+EF+ L+ + +S + L + +G+
Sbjct: 57 HPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
AY HS + V++RD K N+L+D KL+DFGLA+ G T + T Y AP
Sbjct: 113 AYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAP 168
Query: 252 E-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
E + + + D++S G + EM++ R
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E +TE + L
Sbjct: 2 LLGKGTFGKVI--LVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS V+YRD K N++LD + + K++DFGL K+G + + + GT Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
PE + D + GVV+ EM+ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G V K +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P +V G D + E M GSL+ + + A I I KV++
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPE---EILGKVSI 110
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+GLAYL +K ++++RD K SNIL++ KL DFG++ ++ +GT
Sbjct: 111 AVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGT 165
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282
Y +PE + H + +SD++S G+ L+E+ GR I
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V +G A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E++ G L HL R + + + ++
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS K++YRD K N++LD + + K++DFGL K+G T + + + GT Y A
Sbjct: 108 LDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLA 163
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
PE + D + GVV+ EM+ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P + +AVK L ++ L L +K +G+
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK- 76
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYI-----------QPLSWTI 179
H N++ L+G C +D ++ E+ KG+L +L RR + + L++
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D +
Sbjct: 136 LVSCAYQVARGMEYLASQKC--IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
T + APE + T +SDV+SFGV+L E+ +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG +G V+K D+ T G ++A+K RL+ E + + EIK L QL
Sbjct: 13 GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 132 YHPNLVKLIGYCLEDDHRL----------LVYEFMPK---GSLENHLFR-RASYIQPLSW 177
H N+V L + L LV+E+M G LE+ L +I+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-- 121
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
MK L +GL Y H K ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 122 ---MKQLL---EGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 238 VSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 286
+ +V+ T Y PE + DV+S G +L E+ + + + N+
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 69/212 (32%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLG 129
V+G+G FG V R G AVK L ++++ Q H+ + L
Sbjct: 2 VIGKGSFGKVLLA---------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LK 51
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP LV L Y + +L V +++ G L HL R +++P + +VA
Sbjct: 52 NLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA---- 106
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTY 246
+ YLHS +IYRD K NILLD + L+DFGL K+G P + S GT
Sbjct: 107 SAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS----TFCGTP 160
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
Y APE + D + G VL EML G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
VLG+G FG V + G G AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK- 189
+P L L +H V EF+ G L H IQ + AA+
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFH-------IQDKGRFDLYRATFYAAEI 105
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
GL +LHS +IYRD K N++LD + + K++DFG+ K+ G ++ GT
Sbjct: 106 VCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPD 161
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + T D +SFGV+L EML G+
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ S +G G +G V A TG +A+K+L++ +S E++
Sbjct: 17 YQNLSPVGSGAYGQVCS--------AFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 128 LGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRA----SYIQPLSW 177
L + H N++ L+ LV M G+ N++ + +IQ L +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
I +GL Y+HS A +I+RD K SNI ++ + K+ DFGLA+ +
Sbjct: 126 QI--------LRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175
Query: 238 VSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR 279
V+TR Y APE M H D++S G ++ E+L+G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 32/254 (12%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + +H N+V + L D +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + + ++ V L + L+YLH+ VI+RD K+ +ILL + K
Sbjct: 106 LTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIK 158
Query: 221 LSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
LSDFG ++K+ P ++GT + APE ++ + D++S G++++EM+
Sbjct: 159 LSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 277 SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 336
G P + +P LQ+ RRI + R++ + + + L+ L + L
Sbjct: 213 DG-------EPPY------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-GFLDLM-LV 257
Query: 337 NEPKFRPTMDEVVK 350
EP R T E+++
Sbjct: 258 REPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E +
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L ++ +V L Y E D LV M G L+ H++ + +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL LH ++ ++YRD K NILLD + ++SD GLA + P G + RV
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT GY APE + T D + G ++ EM+ G+
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G +G V+K D T G ++A+K + E EI L + H
Sbjct: 9 QRIGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGL 191
PN+V G L D +V E+ GSL++ + R PLS V KGL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGL 114
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
AYLH I+RD K +NILL + + KL+DFG++ T + + + + GT + AP
Sbjct: 115 AYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-LTATIAKRKSFI-GTPYWMAP 170
Query: 252 EYMA---TGHLTAKSDVYSFGVVLLEM 275
E A G K D+++ G+ +E+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLTEIKHL 128
VLG+G FG V A + GT A+K L ++ + LE + E + L
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV---LEDDDVECTMVERRVL 49
Query: 129 GQLY-HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ HP L L +C +H V E++ G L H IQ +
Sbjct: 50 ALAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH-------IQSSGRFDEARARF 100
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL +LH +IYRD K N+LLD + + K++DFG+ K+ G ++
Sbjct: 101 YAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTF 156
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + D +SFGV+L EML G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 8e-14
Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 21/234 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A++++N + + EI + + +PN
Sbjct: 28 IGQGASGTV---------YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLH 133
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-AKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
S++ VI+RD K+ NILL ++ + KL+DFG A+ P S+ + ++GT + APE +
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 188
Query: 255 ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AKPYLQSKRRI 307
K D++S G++ +EM+ G P R LI P LQ+ ++
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 44/221 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG VFK H T ++A+K+ + E + L EIK L L H
Sbjct: 20 IGQGTFGEVFKA---RHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 134 PNLVKLIGYC-----LEDDHR---LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
N+V LI C + ++ LV+EF E+ L S +K L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKN-------VKFTL 118
Query: 186 GAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ 235
K GL Y+H +K +++RD K +NIL+ + KL+DFGLA+ S+
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 236 SHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEM 275
+ T + T Y PE + D++ G ++ EM
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 76/295 (25%), Positives = 119/295 (40%), Gaps = 39/295 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGH-LEWLTEI 125
+ + + +GEG +G VFK A G +A+KR+ Q +G L + E+
Sbjct: 1 QQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 52
Query: 126 ---KHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
+HL HPN+V+L C + LV+E + + L +L + P
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 111
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
M L +GL +LHS + V++RD K NIL+ + KL+DFGLA+ S
Sbjct: 112 IKDMMFQL--LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 164
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297
T V+ T Y APE + D++S G + EM + + +
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---------- 214
Query: 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
+ +I V+ E + AL K KF +DE+ K L
Sbjct: 215 ---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 68/249 (27%), Positives = 118/249 (47%), Gaps = 27/249 (10%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLL-VYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V E+
Sbjct: 19 TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEY 77
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
+ G L H+ R+ + + +++L L YLH + +IYRD K N+LLD
Sbjct: 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH--ERGIIYRDLKLDNVLLDS 131
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+ KL+D+G+ K+G + ++ GT Y APE + D ++ GV++ EM
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 276 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL--GAALKTAVLAIK 333
++GR D S P ++ +FQV+ +E Q + ++K A +
Sbjct: 190 MAGRSPFDIVGSSD--------NPDQNTEDYLFQVI---LEKQIRIPRSLSVKAASVLKS 238
Query: 334 CLSNEPKFR 342
L+ +PK R
Sbjct: 239 FLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 53/293 (18%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F ++KG + PG + + +K L + L + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+LVKL G C+ D++ ++V E++ G L+ L R L W ++ VA A L YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYN----AKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
K+++ + NIL+ LN KLSD G+ S+ R+
Sbjct: 118 EDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 248 YAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
+ APE + G LT +D +SFG LLE+ S + L +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS------------------NGEEPLSTLS 211
Query: 306 RIFQVMDARIEGQYSLGAALKT------AVLAIKCLSNEPKFRPTMDEVVKAL 352
+ E Y L A L +C + +P RP+ +++ L
Sbjct: 212 S------SEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
NFR + +G G F V++ + + +A+K++ L + + + E
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV----------PVALKKVQIFDLMDAKARADCIKE 52
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMK 182
I L QL HPN++K +ED+ +V E G L + F++ + P +
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V L +A L ++HS +V++RD K +N+ + KL D GL + S++ + +
Sbjct: 113 VQLCSA--LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSL 166
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+GT Y +PE + KSD++S G +L EM
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS+K V+YRD K N++LD + + K++DFGL K+G + + GT Y A
Sbjct: 108 LDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
PE + D + GVV+ EM+ GR
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 90/333 (27%), Positives = 138/333 (41%), Gaps = 60/333 (18%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ V+G+G +G V ID HT G +A+K++N E + L EIK
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
L L HP++V++ L R +V+E M S + + + + P +
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGS--QS 236
L + L Y+H+ A V +RD K NIL + + K+ DFGLA+ D PT
Sbjct: 111 QLL---RALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 237 HVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
+V+TR Y APE + T D++S G + E+L+G+ + + +LI
Sbjct: 166 YVATR-----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
Query: 295 -----------------EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSN 337
E A+ YL S R+ Q A L + L+
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRK----KQPVPFSQKFPNADPLALRLLERLLAF 276
Query: 338 EPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQ 370
+PK RPT +E AL A V R+ S Q
Sbjct: 277 DPKDRPTAEE---ALADPYFKGLAKVEREPSAQ 306
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 7 VLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
P + + C + RL V E++ G L + + + +P + ++A+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVM-GT 245
L +LHS +IYRD K N++LD + K++DFG+ K DG V+T+ GT
Sbjct: 114 LFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCGT 164
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE +A D ++FGV+L EML+G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 38/107 (35%), Positives = 60/107 (56%), Gaps = 4/107 (3%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GL YLHS A +++RD K N+L++ N K+ DFGLA+ H++ V+ Y Y
Sbjct: 114 RGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 249 AAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
APE M + H T+ D++S G + E+L R + P ++ +LI
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIK 126
++P +G G +G V +G +A+K++ + L E+K
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL-----------ENHLFRRASYIQPL 175
L H N++ + D P G+ E+ L QPL
Sbjct: 57 ILRHFKHDNII-----AIRD-------ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPL 104
Query: 176 SWTIRMKVALGAA-KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
+ ++ L +GL Y+HS A VI+RD K SN+L++ + ++ DFG+A+ +
Sbjct: 105 T-EEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 235 QSH--VSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRR 280
H T + T Y APE + + T D++S G + EML GRR
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 78 EGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQES-LQGH-LEWLTEIKHLGQLYHP 134
EG +G V++ AR TG ++A+K+L E +G + L EI L +L HP
Sbjct: 15 EGTYGVVYR----------ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 135 NLVKL----IGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIRMKVALGA 187
N+V + +G L D +V E++ K +E + ++Q + M L
Sbjct: 65 NIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCL-MLQLL-- 116
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+A+LH + +++RD KTSN+LL+ K+ DFGLA+ GS T+++ T
Sbjct: 117 -SGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 248 YAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + + D++S G + E+L+ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL----QGHLEWLTEIKHLGQ 130
LG G FG V I +H GTG A+K L +E L H+ E L +
Sbjct: 26 LGTGSFGRV---RIAKHK------GTGEYYAIKCLKKREILKMKQVQHV--AQEKSILME 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L HP +V ++ +++ + EF+ G L HL + + ++ ++ L
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA---- 130
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLHS +IYRD K N+LLD + K++DFG AK P + + + GT Y A
Sbjct: 131 FEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLA 183
Query: 251 PEYMAT-GHLTAKSDVYSFGVVLLEMLSG 278
PE + + GH A D ++ GV+L E ++G
Sbjct: 184 PEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ + + V + Y E D LV M G L+ H++ + +
Sbjct: 52 RILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-----PGFDEQRAIF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL L + +++YRD K NILLD + ++SD GLA P G V RV
Sbjct: 107 YAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV 162
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 286
GT GY APE + T D + G ++ EM+ G+ K +
Sbjct: 163 -GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A KRL ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ + + V + Y E D LV M G L+ H++ + +
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-----PGFEEERALF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL LH + +YRD K NILLD + ++SD GLA P G + RV
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT GY APE + T D + G ++ EM+ G+
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
+ +LG G FG + +G + P++ + +A+ L S + +L E LGQ
Sbjct: 10 ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V+L G + ++V E+M G+L++ L + L M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGM 120
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG-LAKDGPTGSQSHVSTRVMGTYGYAA 250
YL + +++ +L++ + K+S F L +D + +S + + AA
Sbjct: 121 KYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW--AA 176
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRR 280
PE + H ++ SDV+SFG+V+ E++S G R
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRL-LVYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V EF
Sbjct: 19 TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEF 77
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
+ G L H+ R+ + + +++L L +LH +IYRD K N+LLD
Sbjct: 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHE--RGIIYRDLKLDNVLLDA 131
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+ KL+D+G+ K+G ST GT Y APE + D ++ GV++ EM
Sbjct: 132 EGHIKLTDYGMCKEG-IRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 276 LSGRRVID 283
++GR D
Sbjct: 190 MAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 76/319 (23%), Positives = 125/319 (39%), Gaps = 79/319 (24%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----HLEWLTEIKHLGQL 131
+G+GG G V+ Y P +A+K++ +E L +L E K L
Sbjct: 10 IGKGGMGEVYLA------YDPV---CSRRVALKKI-REDLSENPLLKKRFLREAKIAADL 59
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRRASYIQPLSWTIRMKVALGA-- 187
HP +V + C + D VY MP +G L + + LS + K ++GA
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 188 ------AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD------------ 229
+ Y+HS V++RD K NILL L + D+G A
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 230 -GPTGSQSHVST---RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-------- 277
T +++GT Y APE + + +D+Y+ GV+L +ML+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 278 -GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 336
GR++ ++ IE A PY + + Q+ A+K L+
Sbjct: 235 KGRKISYRDVILSP---IEVA-PYREIPPFLSQI--------------------AMKALA 270
Query: 337 NEPKFR-PTMDEVVKALEQ 354
+P R ++ E+ + LE
Sbjct: 271 VDPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRL----NQESLQ-GHLEWLT 123
+ P + +G G +G V+K AR P +G +A+K + N++ L + +
Sbjct: 2 YEPVAEIGVGAYGTVYK----------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA 51
Query: 124 EIKHLGQLYHPNLVKLIGYC--LEDDHRL---LVYEFMPKGSLENHLFRRASYIQPLSWT 178
+K L HPN+V+L+ C D LV+E + + L +L + P T
Sbjct: 52 LLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-T 109
Query: 179 IR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I+ M+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+ S
Sbjct: 110 IKDLMRQFL---RGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQ 161
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
T V+ T Y APE + D++S G + EM
Sbjct: 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YHPN--LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ + + Y +L + + M G L HL + + + ++ LG
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG-- 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 110 --LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 249 AAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291
APE + G + +D +S G +L ++L G + P R+H
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG------HSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 31/168 (18%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
EI+ L + HPN+VK + ++ EFM GSLE ++ ++ I
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI---- 177
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
G+AYLH + +++RD K SN+L++ N K++DFG+ S + + M
Sbjct: 178 ----LSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV---------SRILAQTM 222
Query: 244 -------GTYGYAAPEYMATGHLTAK-----SDVYSFGVVLLEMLSGR 279
GT Y +PE + T D++S GV +LE GR
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 57/225 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLN-QESLQG-HLEWLTEI---KHLG 129
+GEG +G V+K AR TG +A+K++ S +G L L EI K L
Sbjct: 7 IGEGAYGTVYK----------ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE 56
Query: 130 QLYHPNLVKLIGYCL--EDDHRL---LVYEFMPKGSLENHLFRRASYIQPL------SWT 178
HPN+V+L+ C D L LV+E + + L A+Y+ T
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDL---ATYLSKCPKPGLPPET 108
Query: 179 IR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I+ M+ L +G+ +LHS ++++RD K NIL+ + K++DFGLA+ S
Sbjct: 109 IKDLMRQLL---RGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFE 160
Query: 237 HVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEM 275
T V+ T Y APE Y D++S G + E+
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
NF+ + +G G F V++ +D A + V+ + + + EI
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--------VQIFEMMDAKARQDCVKEID 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVA 184
L QL HPN++K + +ED+ +V E G L + F++ + P + V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L +A + ++HS +V++RD K +N+ + KL D GL + S++ + ++G
Sbjct: 115 LCSA--VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
T Y +PE + KSD++S G +L EM
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 69 NFRPDSVLGEGGFGCVF--KGWID-EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ +GEG FG ++ K D EH T M + K +++ E+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EV 50
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI----QPLSWTIRM 181
L ++ HPN+V E+ +V E+ G L + R+ + Q LSW +++
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 240
+ GL ++H D+ K+++RD K+ NI L N AKL DFG+A+ ++
Sbjct: 111 SL------GLKHIH-DR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285
+GT Y +PE K+D++S G VL E+ + + + N
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF G + A+K L + ++ H
Sbjct: 1 NFELLRVLGTGAYGKVFL------VRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT--R 52
Query: 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
TE + L + P LV L Y + D +L L+ +++ G L HL++R + +
Sbjct: 53 TERQVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----E 106
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
++V + LA H + +IYRD K NILLD + L+DFGL+K+ + +
Sbjct: 107 VRVYIAEIV-LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 241 RVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSG 278
GT Y APE + GH A D +S GV+ E+L+G
Sbjct: 166 -FCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 47/264 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V G ++ Y PA+ + VK L S+Q +++L E + L H
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGAAKGLA 192
NL++ +G C E LLV EF P G L+ +L R+A + P T++ ++A A GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQSHVSTRVMGTY 246
+LH K I+ D N LL + K+ D+GL+ + T Q V R
Sbjct: 115 HLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----- 167
Query: 247 GYAAPEYMATGH-------LTAKSDVYSFGVVLLEM----------LSGRRVIDKNRPSR 289
+ APE + H T +S+V+S GV + E+ LS +V+ R
Sbjct: 168 -WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVR 224
Query: 290 EHNLIEWAKPYLQ--SKRRIFQVM 311
E L + KP L+ R ++VM
Sbjct: 225 EQQL-KLPKPRLKLPLSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 50/240 (20%)
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
L+ +F V+G G FG V + H + V A+K L++ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHK------SSKQVYAMKLLSKFEMIKR 84
Query: 119 LE----WLTEIKHLGQLYHPN---LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRAS 170
+ W E + + + H N +V+L Y +DD L +V E+MP G L N + ++
Sbjct: 85 SDSAFFW--EERDI--MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM---SN 136
Query: 171 YIQPLSW----TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG- 225
Y P W T + +AL A + ++H RD K N+LLD + + KL+DFG
Sbjct: 137 YDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGT 188
Query: 226 ---LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSG 278
+ +G T V GT Y +PE + + G+ + D +S GV L EML G
Sbjct: 189 CMKMDANG----MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKH 127
NF+ LGEG + V+KG TG ++A+K ++ ++ +G + EI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRA---SYIQPLSWTIRM 181
+ +L H N+V+L ++ +LV+E+M K ++ H R A + ++ ++ +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVS 239
KG+A+ H ++ V++RD K N+L++ KL+DFGLA+ P + S
Sbjct: 110 ------LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFS 158
Query: 240 TRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 279
V+ T Y AP+ + + S D++S G ++ EM++GR
Sbjct: 159 NEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 119 LEWLTEIKHLGQL--YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPL 175
++W+ KH+ + +P LV L C + RL LV E++ G L H+ R+ +
Sbjct: 39 IDWVQTEKHVFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH 97
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
+ ++ + L +LH + +IYRD K N+LLD + + KL+D+G+ K+G G
Sbjct: 98 ARFYAAEICIA----LNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG-LGPG 150
Query: 236 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295
ST GT Y APE + D ++ GV++ EM++GR D I
Sbjct: 151 DTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------II 199
Query: 296 WAKPYLQSKRRIFQVM 311
P + ++ +FQV+
Sbjct: 200 TDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 26/226 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YH---PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
P +V + D + + M G L HL + + + ++ LG
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG-- 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 110 --LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 249 AAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293
APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G ++AVK+++ Q E+ + H N+V++ L D +V EF+ G+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + + ++ V L K L+ LH+ VI+RD K+ +ILL + K
Sbjct: 104 LTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVK 156
Query: 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR- 279
LSDFG S ++GT + APE ++ + D++S G++++EM+ G
Sbjct: 157 LSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 280 -----------RVIDKNRPSREHNL 293
++I N P + NL
Sbjct: 215 PYFNEPPLKAMKMIRDNLPPKLKNL 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 75 VLGEGGFGCVF--KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
V+G+G FG V + +E YA V+ K + ++ + H+ + L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK------VLQKKAILKKKEEKHIMSERNVL-LKNVK 54
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HP LV L + + +L V +++ G L HL R +++P + ++A L
Sbjct: 55 HPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SAL 109
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTYGYA 249
YLHS ++YRD K NILLD + L+DFGL K+ G+ S GT Y
Sbjct: 110 GYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS----TFCGTPEYL 163
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSG 278
APE + D + G VL EML G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ P +G G +G V E T +A+K++ ++ L E
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWT 178
IK L L H N++ + + HR +VYE M + H R+S Q LS
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSDD 108
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ--- 235
+GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+
Sbjct: 109 HCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT 166
Query: 236 SHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRR 280
+V TR Y APE + T DV+S G + E+L GR+
Sbjct: 167 EYVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G VFK E T ++A+KR+ + + L EI L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA----LGAA 188
N+V+L L D +L LV+E+ + L + Y + I ++
Sbjct: 59 KNIVRLYD-VLHSDKKLTLVFEY-----CDQDLKK---YFDSCNGDIDPEIVKSFMFQLL 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTY 246
KGLA+ HS V++RD K N+L++ N KL+DFGLA+ P S V+ T
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA---EVV-TL 163
Query: 247 GYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRR 280
Y P+ + A + T+ D++S G + E+ + R
Sbjct: 164 WYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYH 133
G G +G V+K G A+K+ + Q EI L +L H
Sbjct: 9 GRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 134 PNLVKLIGYCLEDDHRL--LVYEFMPKGSLE---NHLFRRASYIQP-----LSWTIRMKV 183
N+V L+ LE + L++++ + H + I P L W I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---- 117
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSH 237
G+ YLHS+ V++RD K +NIL+ K+ D GLA+ + P +
Sbjct: 118 ----LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 238 VSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLS 277
+ V+ T Y APE + H T D+++ G + E+L+
Sbjct: 172 LD-PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 69 NFRPDSVLGEGGFGCVF-KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL----T 123
NF VLG G +G VF + H +G + A+K L + ++ + T
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD-------SGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 124 E---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTI 179
E ++H+ Q P LV L Y + D +L L+ +++ G L HL +R + +
Sbjct: 54 ERQVLEHIRQ--SPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ----- 105
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+++ G LA H K +IYRD K NILLD N + L+DFGL+K+ + +
Sbjct: 106 EVQIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERA 163
Query: 240 TRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSG 278
GT Y AP+ + GH A D +S GV++ E+L+G
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW 121
K +F LG G FG V + P +A+KR + + Q ++
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPP--------VAIKRFEKSKIIKQKQVDH 77
Query: 122 L-TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
+ +E K L + HP V L G ++ + LV EF+ G L R + +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
++ L YL S ++YRD K N+LLD + K++DFG AK T + +
Sbjct: 138 AQIVLI----FEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---- 187
Query: 241 RVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287
+ GT Y APE + GH A +D ++ G+ + E+L G N P
Sbjct: 188 -LCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF TG + A+K L + +L H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 123 TE---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
TE ++H+ Q P LV L Y + + +L L+ +++ G + HL++R ++ +
Sbjct: 53 TERNVLEHVRQ--SPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---E 106
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+R LA H K ++YRD K NILLD + L+DFGL+K+ + +
Sbjct: 107 VRF---YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 239 STRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSG 278
+ GT Y APE + GH A D +S G+++ E+L+G
Sbjct: 164 YS-FCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L D LV+E++ K L+ ++ + + + I + L +GLAY
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE-Y 253
H + KV++RD K N+L++ KL+DFGLA+ ++++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
+ + + + D++ G + EM SGR + + E +LI
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 17/182 (9%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G +AVK ++ Q E+ + H N+V++ L + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + S + I V + L YLHS VI+RD K+ +ILL L+ K
Sbjct: 105 LTDIV----SQTRLNEEQI-ATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVK 157
Query: 221 LSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
LSDFG ++KD P ++GT + APE ++ + D++S G++++EM+
Sbjct: 158 LSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 277 SG 278
G
Sbjct: 212 DG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V+ D+ A R I V LN E++Q + E + L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYI----QPLSWTIRMKVALGAA 188
+VK LE D ++ E+ L+ L + Q W I++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+ Y+H + ++++RD K NI L N K+ DFG+++ GS ++T GT Y
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGS-CDLATTFTGTPYY 171
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEM 275
+PE + +KSD++S G +L EM
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLTEIKHLGQ 130
LG+G +G V A +A+K++ + + L L ++H
Sbjct: 8 LGQGAYGIVCSA-----RNAETSEEET--VAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ-PLSWTIRMKVALGAAK 189
H N+ CL D + F N L+ ++ L IR L A
Sbjct: 61 --HKNIT-----CLYDMDIVFPGNF-------NELYLYEELMEADLHQIIRSGQPLTDAH 106
Query: 190 ----------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQS 236
GL Y+HS A V++RD K N+L++ + K+ DFGLA+ + P +
Sbjct: 107 FQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGRRVIDKNRPSREH-NLI 294
+ T + T Y APE M + K+ DV+S G +L E+L GR+ + K + + N I
Sbjct: 165 FM-TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 70/250 (28%), Positives = 109/250 (43%), Gaps = 41/250 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
V+G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 23 VVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH-- 71
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
H N+ G ++ DD LV EF GS+ + + W +
Sbjct: 72 ---HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYI 126
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVSTR 241
+GLA+LH+ K VI+RD K N+LL N KL DFG++ D G ++
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----T 180
Query: 242 VMGTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
+GT + APE +A +SD++S G+ +EM G + P R LI
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 297 -AKPYLQSKR 305
P L+SK+
Sbjct: 241 NPPPKLKSKK 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 69/250 (27%), Positives = 109/250 (43%), Gaps = 41/250 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
++G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 13 LVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-- 61
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
H N+ G ++ DD LV EF GS+ + + W +
Sbjct: 62 ---HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYI 116
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVSTR 241
+GL++LH + KVI+RD K N+LL N KL DFG++ D G ++
Sbjct: 117 CREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----T 170
Query: 242 VMGTYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
+GT + APE +A KSD++S G+ +EM G + P R LI
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 297 -AKPYLQSKR 305
P L+SK+
Sbjct: 231 NPAPRLKSKK 240
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
LA H +I+RD K++NILL N KL DFG +K V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310
PE + K+D++S GV+L E+L+ +R D + +V
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEEV 253
Query: 311 MDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPT 344
M + G+Y S+ ++ V A+ LS++PK RP+
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTAL--LSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 52/284 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LG+G +G V+K RP TG+ +A+K + E + + + E+ L + P
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+V G + + E+M GSL+ L+ + + + ++ KGL +L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
++ +I+RD K +N+L++ N KL DFG++ + + ++ +G Y APE +
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERI 173
Query: 255 ATGHLTA------KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-LQSKRRI 307
+G +SDV+S G+ +LEM GR PY ++ I
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRY------------------PYPPETYANI 215
Query: 308 FQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPT 344
F + A ++G YS A A KCL+ P RPT
Sbjct: 216 FAQLSAIVDGDPPTLPSGYSDDAQDFVA----KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 40/241 (16%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTI 179
EIK+L ++ N++K+ G+ ++ L L+ E+ +G L L + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKT 123
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
++ +A+ KGL L+ Y++ + + L+ NY K+ GL K + +V+
Sbjct: 124 KLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 240 TRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297
V Y + + + T K D+YS GVVL E+ +G ++ +N ++E
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-KIPFENLTTKE------- 229
Query: 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL----AIKCLSNEPKFRPTMDEVVKALE 353
+ D I SL L + C S++ RP + E++ L
Sbjct: 230 ------------IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
Query: 354 Q 354
Sbjct: 278 L 278
|
Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+GEG FG K + + G VI +++ S + E E+ L + HPN
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI----QPLSWTIRMKVALGAAKGL 191
+V+ E+ + +V ++ G L + + + Q L W +++ +AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H K+++RD K+ NI L + KL DFG+A+ S ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLS 277
E KSD+++ G VL EM +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 53/180 (29%), Positives = 73/180 (40%), Gaps = 24/180 (13%)
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L + H ++ LI +R V MPK + LF PL
Sbjct: 135 REIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQA 187
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ + + LAYLH +I+RD KT NI LD NA L DFG A +
Sbjct: 188 ITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA------CKLDAHP 239
Query: 241 RVMGTYGYA------APEYMATGHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNL 293
YG++ +PE +A AK+D++S G+VL EM + K S L
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 19/221 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ L+ +L + + + I M L +GL+Y
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYC 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE-Y 253
H K K+++RD K N+L++ KL+DFGLA+ ++++ + V T Y P+
Sbjct: 120 H--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
+ + + D++ G +L EM +GR + + E +LI
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW----TIRMKVALGAAK 189
P +V+L +D + +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
+ +H RD K N+LLD + + KL+DFG T V GT Y
Sbjct: 160 SMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210
Query: 250 APEYMAT----GHLTAKSDVYSFGVVLLEMLSG 278
+PE + + G+ + D +S GV L EML G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 53/247 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTE 124
++F+ +LG+G G VF + GTG + A+K L+++ + + LTE
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L L HP L L + + LV ++ P G L L +R QP + +VA
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR----QPGK-CLSEEVA 105
Query: 185 -LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------------ 228
AA+ L YLH ++YRD K NILL + + LSDF L+K
Sbjct: 106 RFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 229 --DGPTGSQSH----------VSTRVM---GTYGYAAPEYMA-TGHLTAKSDVYSFGVVL 272
G S + S R GT Y APE ++ GH + D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 273 LEMLSGR 279
EML G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K ++ ++ +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + V+E+M L ++ + + P + + M L +GLAY+
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYI 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE-Y 253
H +++RD K N+L+ KL+DFGLA+ SQ++ S V T Y P+
Sbjct: 120 H--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGR 279
+ ++ D++ G + +EML G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 54/160 (33%), Positives = 72/160 (45%), Gaps = 14/160 (8%)
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WT 178
L E L Q+ P +V L + + +L LV F+ G L +HL R + + +T
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ AL LH K VIYRD K NILLD + L DFGL K
Sbjct: 100 AELLCAL------ENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDK 149
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
+ GT Y APE + T D ++ GV+L EML+G
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 55/199 (27%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GL YLH+ ++I+RD KT NI ++ + D G A+ P + + + + GT
Sbjct: 168 EGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVET 222
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS---------REH-------- 291
APE +A +K+D++S G+VL EML+ I ++ PS H
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 292 -----------------NLIEWA----KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 330
IE+A +PY + FQ ++ I+G++ L
Sbjct: 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPC--FQRVNLPIDGEF----------L 330
Query: 331 AIKCLSNEPKFRPTMDEVV 349
K L+ + RP+ +E++
Sbjct: 331 VHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 46/152 (30%), Positives = 68/152 (44%), Gaps = 14/152 (9%)
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP----LSWTIRMKV 183
L ++ HPN+V D H +V E+ G L + + + P L W ++M
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-- 109
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L H + +V++RD K+ NI L N KL DFG A+ T ++ T V
Sbjct: 110 ------CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV- 161
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
GT Y PE KSD++S G +L E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQL-Y 132
+GEG F V K + TG A+K + + +SL+ L EI+ L +L
Sbjct: 7 IGEGTFSEVLKA---QSRK------TGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSP 56
Query: 133 HPNLVKLIGYCLEDDH-RL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HPN+++LI + RL LV+E M +L + R + M L K
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL---KS 112
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L ++H + + +RD K NIL+ + KL+DFG + T + T Y A
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIK-DDILKLADFGSCR---GIYSKPPYTEYISTRWYRA 166
Query: 251 PEYMAT-GHLTAKSDVYSFGVVLLEMLS 277
PE + T G+ K D+++ G V E+LS
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 34/204 (16%)
Query: 101 TGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYHPNLVKLI-----GYCLED-DHRLLV 152
TG+ +AVK+L++ +S+ E++ L + H N++ L+ LE+ + LV
Sbjct: 41 TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 153 YEFMPKGSLENHLFR----RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 208
M G+ N++ + ++Q L + I +GL Y+HS A +I+RD K
Sbjct: 101 THLM--GADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIHS--ADIIHRDLKP 148
Query: 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYS 267
SN+ ++ + K+ DFGLA+ +V+TR Y APE M H D++S
Sbjct: 149 SNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWS 203
Query: 268 FGVVLLEMLSGRRVIDKNRPSREH 291
G ++ E+L+GR + P +H
Sbjct: 204 VGCIMAELLTGRTLF----PGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGH-LEWLTEIKHLGQL 131
LGEG + V+KG + T G ++A+K RL E +G + E L L
Sbjct: 12 KLGEGSYATVYKG-RSKLT--------GQLVALKEIRLEHE--EGAPFTAIREASLLKDL 60
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V L LV+E++ L+ ++ + + + + L +GL
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGL 116
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSHVSTRVMGTYGYA 249
AY H + +V++RD K N+L+ KL+DFGL AK P+ + S+ V+ T Y
Sbjct: 117 AYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLWYR 170
Query: 250 APE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
P+ + + + D++ G + EM +GR
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 50/250 (20%)
Query: 61 NGLKTATRNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-- 117
N + + + + LGEG +G V K D T G ++A+K++ +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDV 51
Query: 118 ------------HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLE 162
H L E+K + ++ H N++ L+ +E D LV + M K ++
Sbjct: 52 TKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD 111
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
+ S ++ + I GL LH K ++RD +NI ++ K++
Sbjct: 112 RKIRLTESQVKCILLQI--------LNGLNVLH--KWYFMHRDLSPANIFINSKGICKIA 161
Query: 223 DFGLAK-------DGPTGSQSHVSTRVMGTYG-----YAAPE-YMATGHLTAKSDVYSFG 269
DFGLA+ + R T Y APE M D++S G
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
Query: 270 VVLLEMLSGR 279
+ E+L+G+
Sbjct: 222 CIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 28/191 (14%)
Query: 101 TGMVIAVKRLNQESLQGHL---EWLTEIKHLGQLYHPNLVKLIGY-----CLEDDHRL-L 151
TG +A+K+L + Q L E++ L + H N++ L+ L+ H L
Sbjct: 39 TGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97
Query: 152 VYEFMPK--GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209
V FM G L H IQ L + + KGL Y+H+ A +I+RD K
Sbjct: 98 VMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--------LKGLKYIHA--AGIIHRDLKPG 147
Query: 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSF 268
N+ ++ + K+ DFGLA+ + +V TR Y APE + H T D++S
Sbjct: 148 NLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSV 202
Query: 269 GVVLLEMLSGR 279
G ++ EML+G+
Sbjct: 203 GCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 30/158 (18%)
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSW----TIRMKVALGAA 188
P +V+L Y +DD L +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAI 158
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMG 244
+ ++H RD K N+LLD + + KL+DFG + K+G + V G
Sbjct: 159 HSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----G 205
Query: 245 TYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSG 278
T Y +PE + + G+ + D +S GV L EML G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 49/183 (26%), Positives = 74/183 (40%), Gaps = 20/183 (10%)
Query: 99 PGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158
T +K L + S E LT I H PN+V L Y + +D LV +
Sbjct: 15 TRTQQTFILKGLRKSSEYSR-ERLTIIPHC----VPNMVCLHKYIVSEDSVFLVLQHAEG 69
Query: 159 GSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
G L +H+ + + + W M VAL A LH + ++ RD +NILLD
Sbjct: 70 GKLWSHISKFLNIPEECVKRWAAEMVVALDA------LH--REGIVCRDLNPNNILLDDR 121
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
+ +L+ F + + Y APE T D +S G +L E+L
Sbjct: 122 GHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 277 SGR 279
+G+
Sbjct: 177 TGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 65/278 (23%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
G + K D S ++ + E ++ ++I ++ ++++
Sbjct: 21 NKGGSGKFEMNDKKLDEEERSHNNNAG--EDEDEEKMIDNDIN-------RSPNKSYKLG 71
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
+++G G FG V++ ID T +A+K++ Q+ + E L + L
Sbjct: 72 NIIGNGSFGVVYEAICID----------TSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 133 HPNLVKLIGY----CLEDDHRLL----VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
H N++ L Y C + + + + V EF+P+ ++ ++ A L + +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKD--GPTGSQSHVSTR 241
+ LAY+HS + +RD K N+L+D N + KL DFG AK+ S S++ +R
Sbjct: 177 YQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 242 VMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSG 278
Y APE M + T D++S G ++ EM+ G
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 8/183 (4%)
Query: 124 EIKHLGQLYHPNLVKLI-GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
E + L QL HPN+V + ED +V F G L + L + + P + +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V + A L YLH + +++RD KT N+ L K+ D G+A+ +Q +++ +
Sbjct: 109 VQIAMA--LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTL 162
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID-KNRPSREHNLIEWAKPYL 301
+GT Y +PE + KSDV++ G + EM + + + K+ S + +IE P +
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM 222
Query: 302 QSK 304
Sbjct: 223 PKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
LA H K ++YRD K NILLD + L DFGL+K + + + GT Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164
Query: 251 PEYM--ATGHLTAKSDVYSFGVVLLEMLSG 278
PE + G+ T D +S GV++ EM G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + A+K + E + EI + H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+V G L D + EF GSL++ H+ PLS + V+ +GL Y
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV------TGPLSESQIAYVSRETLQGLYY 121
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
LHS K K ++RD K +NILL N + KL+DFG++ S +GT + APE
Sbjct: 122 LHS-KGK-MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV 177
Query: 254 MAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310
A G D+++ G+ +E+ + + P R L K Q +
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNFQPPK----- 230
Query: 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ +++ S +K A L+ PK RPT +++++
Sbjct: 231 LKDKMKWSNSFHHFVKMA------LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 133 HPNLVKLIGYCLEDDHRL-----LVYEFMPKGS---LENHLFRRASYIQPLSWTIRMKVA 184
HPN+VK G + D + LV E GS L L Q L + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG---QRLDEAMISYIL 134
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
GA GL +LH+++ +I+RD K +NILL KL DFG++ T ++ +T V G
Sbjct: 135 YGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSV-G 190
Query: 245 TYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSG 278
T + APE +A A+ DV+S G+ +E+ G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ K L+ +L + I + + + L +GL Y
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYC 120
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE-Y 253
H + KV++RD K N+L++ KL+DFGLA+ ++++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGR 279
+ + + + D++ G + EM +GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ RP LG G G VF +D +AVK++ Q L EIK
Sbjct: 8 MDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 128 LGQLYHPNLVKLI------GYCLEDDHRLL--------VYEFMPKGSLENHLFRRASYIQ 173
+ +L H N+VK+ G L +D L V E+M E L
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL-ANVLEQG 109
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAK--DG 230
PLS +GL Y+HS A V++RD K +N+ ++ + K+ DFGLA+ D
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 231 PTGSQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ ++S ++ + Y +P ++ + T D+++ G + EML+G+
Sbjct: 168 HYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 70/261 (26%), Positives = 110/261 (42%), Gaps = 78/261 (29%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ----ESLQ-GHLEWLT 123
+F V+G G FG V + + TG + A+K+L + E Q H+
Sbjct: 2 DFESIKVIGRGAFGEV--RLVQKKD-------TGHIYAMKKLRKSEMLEKEQVAHVR--A 50
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRAS--------YIQP 174
E L + +P +VKL Y +D++ L L+ E++P G + L ++ + YI
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI-- 107
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-------- 226
+ TI +A+ + L Y+H RD K N+LLD + KLSDFGL
Sbjct: 108 -AETI---LAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155
Query: 227 --------AKDGPTGSQSHVST---------------RVM-----GTYGYAAPE-YMATG 257
+ P+ +S R + GT Y APE ++ TG
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 258 HLTAKSDVYSFGVVLLEMLSG 278
+ + D +S GV++ EML G
Sbjct: 216 Y-NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD- 229
Y +PL+ + + A+G+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 230 --GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-------GRR 280
P + R+ + APE + T +SDV+SFGV+L E+ S G +
Sbjct: 224 YKDPDYVRKG-DARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
Query: 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 340
ID+ R P + I+ +M + C N P+
Sbjct: 281 -IDEEFCRRLKEGTRMRAPE-YATPEIYSIM--------------------LDCWHNNPE 318
Query: 341 FRPTMDEVVKALEQIQDTN 359
RPT E+V+ L + N
Sbjct: 319 DRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 34/274 (12%)
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L L H G + H + K DD LL+ E+ G L + +R P
Sbjct: 116 LHCLAACDHFGIVKHFDDFK------SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY 169
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ L +HS K+++RD K++NI L KL DFG +K V
Sbjct: 170 EVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
++ GT Y APE + K+D++S GV+L E+L+ R
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR------------------ 269
Query: 299 PYLQSKRRIFQVMDARIEGQYS---LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LE 353
P+ +R ++M + G+Y + L LS P RPT +++ L+
Sbjct: 270 PFKGPSQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
Query: 354 QIQDTNDAGVSRDESLQNSDRSTYKRKGLNENGQ 387
+ + V E++ DR R+ L E+G+
Sbjct: 328 YVANLFQDIVRHSETISPHDREEILRQ-LQESGE 360
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
GL Y+HS A +I+RD K N+ ++ + K+ DFGLA+ +V TR Y
Sbjct: 128 CGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180
Query: 249 AAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 279
APE + H D++S G ++ EML+G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEI 125
+N P +G G +G V + D +AVK+L++ +SL E+
Sbjct: 18 QNLTP---VGSGAYGSVCSAY-DTRLRQK--------VAVKKLSRPFQSLIHARRTYREL 65
Query: 126 KHLGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHL-FRRAS--YIQPLSW 177
+ L + H N++ L+ +E+ + + + + L N + ++ S ++Q L +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ +GL Y+HS A +I+RD K SN+ ++ + ++ DFGLA+ +
Sbjct: 126 QL--------LRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY 175
Query: 238 VSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 279
V+TR Y APE M H D++S G ++ E+L G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 55/320 (17%)
Query: 101 TGMVIAVKRLNQESL--QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLEDDHRL-LVYEFM 156
TG + A+K + + L Q + + E + L P + +L Y +D L LV E+
Sbjct: 25 TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQ 83
Query: 157 PKGSLENHLFRRASYIQPLS------WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210
P G L + L R Y + + +A+ + + Y+H RD K N
Sbjct: 84 PGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMGYVH--------RDIKPEN 132
Query: 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKS------ 263
+L+D + KL+DFG A + V S +GT Y APE + T + K
Sbjct: 133 VLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190
Query: 264 DVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY-SLG 322
D +S GV+ EM+ GR P E + + +R + D ++ + L
Sbjct: 191 DWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244
Query: 323 AALKTAV---LAIKCLSNEPKF--------RPTMDEVVKALEQIQDTNDAGVSRDESLQN 371
+L L + L P F R ++ V L+ DT++ DE +N
Sbjct: 245 QSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNF----DEPEKN 300
Query: 372 SDRSTYK-RKGLNENG-QGK 389
S R + L NG GK
Sbjct: 301 STRRSQSSTTQLKPNGFSGK 320
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 50/169 (29%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
A+G+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 184 ARGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKR 305
+ APE + T +SDV+SFGV+L E+ S A PY +Q
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS-----------------LGASPYPGVQINE 284
Query: 306 RIFQVMD--ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
Q + R+ + + +LA C +PK RPT +V+ L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLA--CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 71/298 (23%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 8 ETDSPLPNGANSKCSRKDGNGTSGS-SSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTA 66
E P N + +G S +S + P G + L L
Sbjct: 91 ELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLA-- 148
Query: 67 TRNFRPDSVLGEGGFG----CVFKGWIDE-------HTYAPARPGTGMVIAVKRLNQESL 115
+FR L G FG C + +E ++ +P +IA +
Sbjct: 149 --HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 116 QGHLEWLTEIKHLGQLYHPNLVKL--------IGYCLEDDHRLLVYEFMPKGSLENHLFR 167
LE EI LG+L H N++K+ Y + + +Y FM + +
Sbjct: 207 AIQLE--NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK--- 261
Query: 168 RASYIQPLSWTIR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225
+PL R MK L A + Y+H K +I+RD K NI L+ + L DFG
Sbjct: 262 ----DRPLLKQTRAIMKQLLCA---VEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 226 LAKDGPTGSQSHVSTRVMGTYGYA------APEYMATGHLTAKSDVYSFGVVLLEMLS 277
A R YG+ +PE +A +D++S G++LL+MLS
Sbjct: 313 TA-------MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + AVK + E EI + + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+V G L + + E+ GSL++ H+ PLS V +GLAY
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHV------TGPLSELQIAYVCRETLQGLAY 121
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
LHS K K ++RD K +NILL N + KL+DFG+A S +GT + APE
Sbjct: 122 LHS-KGK-MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEV 177
Query: 254 MA---TGHLTAKSDVYSFGVVLLEM 275
A G D+++ G+ +E+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLY 132
V+GEG +G V K E T ++A+K+ ++E+ + L E+K L L
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEF-----------MPKGSLENHLFRRASYIQPLSWTIRM 181
N+V+L LV+E+ MP G + SYI L
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV---RSYIYQL------ 109
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
K + + H K +++RD K N+L+ N KL DFG A++ GS ++ T
Sbjct: 110 ------IKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TE 160
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ T Y +PE + D++S G +L E+ G+
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
AKG+++L S I+RD NILL K+ DFGLA+D S V
Sbjct: 224 AKGMSFLASKNC--IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 38/197 (19%)
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRRASYIQPLSWTIRMKVAL 185
L HPN+++ +G C+E LLV+E+ G L+++L RR S + L ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG-SQSHVST--RV 242
A G+ ++H K ++ D N L + K+ D+G+ GP+ + ++ T
Sbjct: 107 EIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDK 161
Query: 243 MGTYGYAAPEYMATGH---LTAK----SDVYSFGVVLLEM----------LSGRRVIDKN 285
+ APE + H +TA+ S+V++ GV L E+ LS R V++
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
Query: 286 RPSREHNLIEWAKPYLQ 302
++ L KP L+
Sbjct: 222 IKDQQVKLF---KPQLE 235
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 130 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302
APE + D++S G ++ EM+ G + P +H + +W K Q
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLF----PGTDH-IDQWNKIIEQ 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 54/178 (30%), Positives = 73/178 (41%), Gaps = 29/178 (16%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
AKG+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 189 AKGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK--- 304
+ APE + T +SDV+SFGV+L E+ S A PY K
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASPYPGVKIDE 289
Query: 305 ---RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359
RR+ + R Y+ +T + C EP RPT E+V+ L + N
Sbjct: 290 EFCRRLKEGTRMRAP-DYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 2/105 (1%)
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
PL ++ + A+G+ +L S I+RD N+LL AK+ DFGLA+D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC--IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
S V + APE + T +SDV+S+G++L E+ S
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 137 VKLIGYCLEDDHRL-LVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLA 192
+ + Y +D++ L LV ++ G L L + R + M +A+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGY 248
Y+H RD K NIL+D+N + +L+DFG L +DG QS V+ +GT Y
Sbjct: 123 YVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVA---VGTPDY 169
Query: 249 AAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
+PE + G + D +S GV + EML G P +L+E +
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNH 223
Query: 304 KRRIFQ 309
K R FQ
Sbjct: 224 KER-FQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
APE + D++S G ++ EM+ G + P +H + +W K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLF----PGTDH-IDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 52/170 (30%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 133 HPNLVKLIG-YCLED----DHRLLVYEFMPKGS---LENHLFRRASYIQPLSWTIRMKVA 184
HPN+VK G Y +D D LV E GS L +R ++ + A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L GL +LH +K I+RD K +NILL KL DFG++ S +G
Sbjct: 134 L---MGLQHLHVNKT--IHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVG 186
Query: 245 TYGYAAPEYMATGH-----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289
T + APE +A A+ DV+S G+ +E+ G + P R
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 51/202 (25%), Positives = 78/202 (38%), Gaps = 43/202 (21%)
Query: 101 TGMVIAVKRLNQES--------LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-L 151
T ++AVK++N +S LQ EI QL HPN++ D L +
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQ------EIITSRQLQHPNILP-YVTSFIVDSELYV 76
Query: 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211
V M GS E+ L + + + L + L Y+HS I+R K S+I
Sbjct: 77 VSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHI 132
Query: 212 LLDLNYNAKLSDF----GLAKDG---------PTGSQSHVSTRVMGTYGYAAPEYMATGH 258
LL + LS + K G P S ++ + +PE +
Sbjct: 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--------WLSPEVLQQNL 184
Query: 259 L--TAKSDVYSFGVVLLEMLSG 278
KSD+YS G+ E+ +G
Sbjct: 185 QGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T + + T + T Y
Sbjct: 135 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSG 278
APE + D++S G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 22/107 (20%)
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQS 236
M +A+ + L Y+H RD K N+LLD N + +L+DFG L DG QS
Sbjct: 111 MVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QS 160
Query: 237 HVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSG 278
+V+ +GT Y +PE + G + D +S GV + EML G
Sbjct: 161 NVA---VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K + + +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ L ++ + + P + + + L +GL+Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYI 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE-Y 253
H + +++RD K N+L+ KL+DFGLA+ SH + + T Y P+
Sbjct: 120 H--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSG 278
+ + + D++ G + +EM+ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 76 LGEGGFGCVFKGWIDE-HTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F +FKG E Y + +K L++ + + QL H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHK---TEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+LV G C+ D ++V E++ GSL+ +L + + I +SW +++VA A L +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISW--KLEVAKQLAWALHFL 116
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT--YGYAAPE 252
DK + + + N+LL + K + K G V + + + PE
Sbjct: 117 E-DK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 253 YMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311
+ +L+ +D +SFG L E+ SG ++P L S++++ Q
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA----------LDSQKKL-QFY 218
Query: 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
+ R Q + A L +C+ EP FRP+ +++ L
Sbjct: 219 EDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLS------GRRVIDK 284
APE + D++S G ++ EM+ GR ID+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 61/248 (24%)
Query: 101 TGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
T + A+K L + + H++ +I L + + +VKL Y +D L V +
Sbjct: 25 TNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKLY-YSFQDKDNLYFVMD 81
Query: 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAAKGLAYLHSDKAKVIYRDFKTSNILL 213
++P G + + L R + + L+ R +A L A + +H K I+RD K NIL+
Sbjct: 82 YIPGGDMMSLLIRLGIFEEDLA---RFYIAELTCA--IESVH--KMGFIHRDIKPDNILI 134
Query: 214 DLNYNAKLSDFGLA-------------------KDG--PTGSQSHVSTRVM--------- 243
D + + KL+DFGL +D P+ S + +
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 244 -----------GTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-E 290
GT Y APE + TG+ T D +S GV+L EML G+ + P+ +
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQ 253
Query: 291 HNLIEWAK 298
+I W
Sbjct: 254 LKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 41/255 (16%)
Query: 76 LGEGGFGCVFKG----WIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ 130
+G G +G V+K D+ YA + GTG+ ++ R EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 131 LYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYI--QPLSWTIRMKVAL- 185
L HPN++ L L R L++++ F RAS +P+ M +L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 186 -GAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAK--DGPTGSQSHV 238
G+ YLH++ V++RD K +NIL+ K++D G A+ + P + +
Sbjct: 115 YQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 239 STRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297
V+ T+ Y APE + H T D+++ G + E+L+ + R+ + I+ +
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH----CRQED-IKTS 226
Query: 298 KPYLQSK-RRIFQVM 311
PY + RIF VM
Sbjct: 227 NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K+ E + + L EI L L
Sbjct: 9 IGEGTYGKVYK----------ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS 58
Query: 133 H-PNLVKLIG--YCLEDDHRL---LVYEFMPKGSLENHLFR-RASYIQPLSWTIRMKVAL 185
+V+L+ + E + + LV+E++ L+ + +PL
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDG--PTGSQSHVSTRV 242
KG+A+ H K V++RD K N+L+D K++D GL + P S +H
Sbjct: 118 QLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----E 171
Query: 243 MGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG 278
+ T Y APE + + H + D++S G + EM
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLAYLHSD 197
Y +D++ L LV ++ G L L + R + M +A+ + L Y+H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 198 KAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
RD K N+LLD+N + +L+DFG + +DG QS V+ +GT Y +PE
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVA---VGTPDYISPEI 174
Query: 254 M-----ATGHLTAKSDVYSFGVVLLEMLSG 278
+ G + D +S GV + EML G
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 45/233 (19%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
Q+ H ++V L G C+ D ++V EF+ G L+ + R++ L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLAS 116
Query: 190 GLAYLHSDKAKVIYRDFKTSNILL-----DLNYNA--KLSDFGLAKDGPTG--SQSHVST 240
L+YL DK +++ + T NILL D KLSD G+ P S+
Sbjct: 117 ALSYLE-DK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECVE 170
Query: 241 RVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299
R+ + APE + + +L+ +D +SFG L E+ + P ++ L E
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDKTLAE---- 217
Query: 300 YLQSKRRIFQVMDARIEGQYSLGA--ALKTAVLAIKCLSNEPKFRPTMDEVVK 350
K R + EGQ L + A L C++ +P RP +++
Sbjct: 218 ----KERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 63/271 (23%), Positives = 96/271 (35%), Gaps = 89/271 (32%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F V+G+G FG V + TG + A+K L + +E+
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLK----------SEMFKK 42
Query: 129 GQLYH-------------PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP 174
QL H P +V L Y +D L L+ EF+P G L L + ++ +
Sbjct: 43 DQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED 101
Query: 175 LS--WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL------ 226
++ + +A+ A L ++H RD K NIL+D + KLSDFGL
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 227 ---------------AKDGPTGSQSHV-------------------STRVM-----GTYG 247
K+ S + R+M GT
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
Y APE + D +S G ++ E L G
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
A+G+ +L S ++RD N+LL K+ DFGLA+D S
Sbjct: 247 ARGMEFLASKNC--VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS------GRRVIDKNRPSREHNLIEWAKPYL 301
+ APE + T SDV+S+G++L E+ S ++D ++ + AKP
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD- 363
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT---MDEVVKAL 352
+ + ++ +M +KC ++EP+ RP+ + ++V++L
Sbjct: 364 HATQEVYDIM--------------------VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 47/180 (26%)
Query: 136 LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLA 192
+VK+ Y +D L L+ EF+P G + L ++ + + + + +A+ A L
Sbjct: 63 VVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----------------LAKDGPTG--- 233
++H RD K N+LLD + KLSDFG L + P+
Sbjct: 122 FIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 234 --------------SQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSG 278
++ ++ +GT Y APE +M TG+ D +S GV++ EML G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 57/192 (29%)
Query: 136 LVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLA 192
+VKL Y +D D+ V +++P G + + L R + + L+ + + +A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL---------AKDGPTGS--------- 234
++H RD K NIL+DL+ + KL+DFGL +K GS
Sbjct: 122 FIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 235 ---------------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYS 267
Q ++ ++GT Y APE + T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 268 FGVVLLEMLSGR 279
GV+L EML G+
Sbjct: 234 VGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 62/252 (24%), Positives = 100/252 (39%), Gaps = 63/252 (25%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLT 123
+F V+G G FG V + TG V A+K L + + GH+
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER 52
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIR 180
+I L + +VK+ Y +D L L+ EF+P G + L ++ + + + +
Sbjct: 53 DI--LVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS---- 236
+A+ + L ++H RD K N+LLD + KLSDFGL ++
Sbjct: 110 TVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 237 -----------------------------HVSTRVMGTYGYAAPE-YMATGHLTAKSDVY 266
++ +GT Y APE +M TG+ D +
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWW 220
Query: 267 SFGVVLLEMLSG 278
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
TE L + HP++++L G + L+ +P+ + + + A + + ++
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
++ + + YLH ++ +I+RD K NI ++ + L DFG A P ++
Sbjct: 189 RSV--LRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT APE +A D++S G+VL EM +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG-------------PTGSQSH 237
L YLH+ +++RD K N+L+ + KL+DFGL+K G ++
Sbjct: 114 LEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
+ +V GT Y APE + D ++ G++L E L G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK--GSLENHLFRRASYIQPLSWTIRM 181
E + L +L HP ++ L+ + LV +PK L +L R PL
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR---PLGLAQVT 263
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
VA + Y+H + +I+RD KT N+L++ + L DFG A +
Sbjct: 264 AVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLE 274
+ GT APE +A T D++S G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 95 APARPGTGMVIAVKRLNQES--------LQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145
A +P TG + V+R+N E+ LQG L H+ +L+ HPN+V +
Sbjct: 19 ARYKP-TGEYVTVRRINLEACTNEMVTFLQGEL-------HVSKLFNHPNIVPYRATFIA 70
Query: 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
D+ +V FM GS ++ + ++ +S + G K L Y+H ++R
Sbjct: 71 DNELWVVTSFMAYGSAKDLIC--THFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRS 126
Query: 206 FKTSNILLDLNYNAKLS----DFGLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMATG 257
K S+IL+ ++ LS + + G H S +V+ + +PE +
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP---WLSPEVLQQN 183
Query: 258 --HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290
AKSD+YS G+ E+ +G V K+ P+ +
Sbjct: 184 LQGYDAKSDIYSVGITACELANG-HVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 29/182 (15%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E+ + +L H N+V+ I L ++ L + EF G L ++ + + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 182 KVALGAAKGLAYLHSDK-----AKVIYRDFKTSNILLDL-------------NYN----A 219
+ LAY H+ K +V++RD K NI L N N A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLS 277
K+ DFGL+K+ S +H +GT Y +PE + T KSD+++ G ++ E+ S
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 278 GR 279
G+
Sbjct: 239 GK 240
|
Length = 1021 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 101 TGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPK 158
TG ++ V+ + E+ + HL+ L L + HPN++ ++ FM
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218
GS N L + + + +S + + GA +GL YLH + I+R+ K S+IL+ +
Sbjct: 84 GS-ANSLLK-TYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGL 139
Query: 219 AKLSD----FGLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMA---TGHLTAKSDVYS 267
LS + L ++G + ST V+ + +PE + G+ KSD+YS
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIYS 195
Query: 268 FGVVLLEMLSGR 279
G+ E+ +GR
Sbjct: 196 VGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 53/241 (21%)
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ Q+ H +L + G C+ ++V EF+ G L+ L + + P++W ++ VA
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAW--KITVAQQL 126
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNA----KLSDFGLAKDGPTGSQSHVST 240
A L+YL DK +++ + NILL L KLSD G++ S+
Sbjct: 127 ASALSYLE-DK-NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL--SREERVE 182
Query: 241 RVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEM-------LSGRRVIDKNR-PSREH 291
R+ + APE + G L+ +D +SFG LLE+ L R +K R ++H
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH 238
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351
L E + L A L +CL+ EP RP+ +++
Sbjct: 239 RLPEPSCKEL--------------------------ATLISQCLTYEPTQRPSFRTILRD 272
Query: 352 L 352
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
A G+ +L S ++RD N+L+ K+ DFGLA+D S
Sbjct: 249 ANGMEFLASKNC--VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ APE + T SDV+SFG++L E+ +
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 56/186 (30%)
Query: 142 YCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLAYLHSDK 198
Y +D D+ V +++P G + + L R + + L+ + + A+ + + ++H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--- 124
Query: 199 AKVIYRDFKTSNILLDLNYNAKLSDFGL---------AKDGPTGS--------------- 234
RD K NIL+D + + KL+DFGL +K +G
Sbjct: 125 -----RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 235 ---------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLL 273
Q ++ ++GT Y APE + T D +S GV+L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 274 EMLSGR 279
EML G+
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ + + + +AVK L +E+L L+ L+ H
Sbjct: 45 TLGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS---H 97
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
LGQ H N+V L+G C L++ E+ G L N L ++A
Sbjct: 98 LGQ--HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.001
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 43/162 (26%)
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK--- 189
+PN +KL +L+ +++ G L + ++ + L A+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--------------LLKKEGKLSEAEVKK 113
Query: 190 -------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAKDGPTGSQSH 237
L LH K +I+ D K N+L Y+ L D+GL K G+ S
Sbjct: 114 IIRQLVEALNDLH--KHNIIHNDIKLENVL----YDRAKDRIYLCDYGLCK--IIGTPSC 165
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSG 278
GT Y +PE + GH S D ++ GV+ E+L+G
Sbjct: 166 YD----GTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 7/103 (6%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQL-Y 132
LG G FG V ++ Y + M +AVK L + E L +E+K L L
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQP 174
H N+V L+G C L++ E+ G L N L R R S+I P
Sbjct: 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICP 140
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 17/108 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
+LG G FG V +G Y +R M +AVK L +++L L+ +T H
Sbjct: 44 ILGSGAFGKVVEG----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMT---H 96
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQP 174
LG H N+V L+G C + ++ E+ G L N+L + R +++
Sbjct: 97 LGP--HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.4 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.22 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.96 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.54 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.49 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.45 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.31 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.18 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.0 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.86 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.81 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=392.19 Aligned_cols=252 Identities=30% Similarity=0.424 Sum_probs=217.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+|...++||+|+|+.||.+.. ..+|..||+|++.+..+ .....+.+|+++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~---------~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARD---------LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEE---------cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 5799999999999999999954 34799999999988544 33567889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+++|||+|+|..++|..+++++ .++++..++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEeccc
Confidence 999999999999999999999865 57999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+|....... ....+.+|||.|.|||++.....+..+||||+||++|.||+|++||+...-......++
T Consensus 163 GLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--------- 231 (592)
T KOG0575|consen 163 GLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--------- 231 (592)
T ss_pred ceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH---------
Confidence 9999866432 24567899999999999999999999999999999999999999997653211111110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+...|...+.+..+||.++|+.||.+|||+.+||.|=-.
T Consensus 232 ---------~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 232 ---------LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ---------hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 11223445667888999999999999999999999997544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=377.75 Aligned_cols=256 Identities=28% Similarity=0.374 Sum_probs=211.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-------HHHHHHHHHHHccCCCCccc
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLV 137 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv 137 (400)
...+.|.+.+.||+|+||.|-+|+ ...||+.||+|++++..... ...+.+|+++|++|+|||||
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~---------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV 239 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAY---------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIV 239 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEE---------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEE
Confidence 345678999999999999999994 44589999999998764422 22356899999999999999
Q ss_pred ceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-
Q 015781 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN- 216 (400)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~- 216 (400)
+++++|++.+..||||||++||+|.+.+...+ .+.+....-+++||+.||.|||+.| |+||||||+|||+..+
T Consensus 240 ~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 240 RIKDFFEVPDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDA 313 (475)
T ss_pred EEeeeeecCCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCC
Confidence 99999999999999999999999999998875 4777788899999999999999999 9999999999999765
Q ss_pred --CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCC---CCccchhhHHHHHHHHHhCCCccCCCCCCc-c
Q 015781 217 --YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL---TAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-E 290 (400)
Q Consensus 217 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~ 290 (400)
..+||+|||+|+..... ..+.++||||.|.|||++.+..+ ..++|||||||++|-+++|.+||....... .
T Consensus 314 e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 78999999999986533 35778999999999999976643 347899999999999999999998765432 1
Q ss_pred chhHHhhhHHHhhhhhhhhhccccc--cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARI--EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...+ ...+. .+..-...+++..+||.+||..||++|||+.|+|+|-|.
T Consensus 391 ~eQI----------------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 391 KEQI----------------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHHH----------------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 1111 11110 011123567889999999999999999999999998775
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=363.12 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=213.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+++..++||+|..|+||++ .|+.|++.+|+|.+..... ....++.+|+++++..+||+||.+++.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 35677789999999999999 6667899999999955432 3456789999999999999999999999999
Q ss_pred C-eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 147 D-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 147 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
. ..+|+||||++|+|.+++... ..+++..+..++.+|+.||.|||. ++ |+||||||+|||++..|.|||+||
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccc
Confidence 8 599999999999999999876 358999999999999999999996 66 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|.+...... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||....+... . |..
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~---~~~------ 289 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-D---IFE------ 289 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-C---HHH------
Confidence 999865443 45678999999999999999999999999999999999999999976522110 0 100
Q ss_pred hhhhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
-+..+.+. ..+.++.. ++.++..++..||++||.+|||++++++|=+-
T Consensus 290 -Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 290 -LLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred -HHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 01111221 12334444 88899999999999999999999999998544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-51 Score=364.14 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+|.+.+.||.|+||+||+| ++..++..||||.+....+ ...+.+..|+.+|+.++|||||.+++++.+
T Consensus 10 ~~y~~~~~iG~GsfavVykg---------~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKG---------RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred ccceehhhccCcceEEEEEe---------EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 57899999999999999999 4555789999999988743 334557889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC------Cce
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------YNA 219 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~------~~~ 219 (400)
++++|+|||||.||+|.+||..++ .+++..+..++.||+.||++||+++ ||||||||.||||+.+ -.+
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999999999885 5899999999999999999999999 9999999999999764 568
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||+|||+|+....+. ...+.+|++.|||||++..+.|+.|+|+||+|+++|++++|+.||....+.+....++
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~---- 227 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK---- 227 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh----
Confidence 999999999876543 4667899999999999999999999999999999999999999998766543322221
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
....+ ....+...+..+.+|+...|+.+|..|-+..+.+.+
T Consensus 228 ---k~~~~--------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 228 ---KGNEI--------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ---ccccc--------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 11111 112222333344456666666666666666555543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-52 Score=352.93 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=211.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceee-EEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG-YCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~-~~~ 144 (400)
.+|++.++||.|+||.||++ .+..+|..+|.|.+.-... .....+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 46899999999999999999 5556899999999875443 23456889999999999999999998 454
Q ss_pred eCCe-eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCCeeeccCCCCCEEEcCCCceEE
Q 015781 145 EDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--KAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 145 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
++.. ++||||+|.+|+|...|+......+.+++..+|+++.|++.||.++|+. +..|+||||||.||+++.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 4444 8999999999999999998777778899999999999999999999993 334999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||+++..... .......+|||.||+||.+....|+++|||||+||++|||+.-++||.+..-....
T Consensus 170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~---------- 237 (375)
T KOG0591|consen 170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC---------- 237 (375)
T ss_pred ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH----------
Confidence 999999976532 23456689999999999999999999999999999999999999999876311111
Q ss_pred hhhhhhhhhccccccCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYS-LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..+...--...+ ..++.++..||.-|+.+||+.||+.-.++..+.
T Consensus 238 -------~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 238 -------KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 111111111223 567889999999999999999998555544443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=367.43 Aligned_cols=290 Identities=55% Similarity=0.963 Sum_probs=250.6
Q ss_pred CcccccHhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC
Q 015781 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133 (400)
Q Consensus 54 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h 133 (400)
....|++.++..++++|.-..+||+|+||.||+|.+.+ |..||||.+.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56779999999999999999999999999999998764 47899998877553314569999999999999
Q ss_pred CcccceeeEEEeCC-eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCCE
Q 015781 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSNI 211 (400)
Q Consensus 134 pniv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~dlkp~Ni 211 (400)
||+++++|||.+.+ ..+||+||+.+|+|.+++...... +++|..+++|+.++|.||+|||... ++|+|||||+.||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999998 599999999999999999876542 8999999999999999999999853 3699999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeec-ccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV-MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
|+|+++..||+|||+++..+.. .. ..... .||.+|++||.+..+..+.++||||||+++.||+||+.+.+...+...
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred eECCCCCEEccCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 9999999999999999765431 11 11122 799999999999889999999999999999999999999887776666
Q ss_pred chhHHhhhHHHhhhhhhhhhcccccc-CCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIE-GQYSL-GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+..|..+.+.+. .+..++|+.+. ..+.. .....+..+..+|++.+|.+||++.+|++.|+.+...
T Consensus 287 ~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 67889987777666 78889999877 55554 5677789999999999999999999999999766544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=368.41 Aligned_cols=255 Identities=27% Similarity=0.371 Sum_probs=214.7
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccC-CCCcccce
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKL 139 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~hpniv~~ 139 (400)
+....+|.+++.||+|+|++|++| +.+.+++.+|||++.+..+-. ...+..|-..|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 445578999999999999999999 455589999999998765432 22355777888888 79999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
+..|.|+..+|+|+||+++|+|.++|.+.+ .+++.-...++.+|+.||+|||++| ||||||||+|||++.++++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcE
Confidence 999999999999999999999999999986 4899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCc-----------ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCC
Q 015781 220 KLSDFGLAKDGPTGSQS-----------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 288 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 288 (400)
+|+|||.|+........ .....++||..|.+||+|.....++.+|||+||||+|+|+.|.+||.+..+.
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99999999865442211 1124589999999999999999999999999999999999999999876542
Q ss_pred ccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ..+++ +.-.++...++...+|++++|..||.+|+|+.+|.+|
T Consensus 294 liF----------------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 LIF----------------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH----------------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 11111 2334555666888999999999999999999999886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=348.03 Aligned_cols=266 Identities=26% Similarity=0.360 Sum_probs=213.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+.|+...++|+|+||+||++ +++.||+.||||++...... ..+-.++|+++|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 45788889999999999999 66679999999998654332 22336799999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
...+++|+|||+. ++.+-+.... ..++...+.++++|++.|+.|+|+++ ++||||||+||||+.+|.+||||||
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccch
Confidence 9999999999955 6666666554 56899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh-HHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK-PYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~ 303 (400)
+|+.... .....+..+.|.+|+|||++.+ ..|...+||||+||++.||++|.+.|.+..+.+....+.... ..+..
T Consensus 147 FAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 147 FARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred hhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 9997653 2224566788999999999987 689999999999999999999999999998877665553221 11111
Q ss_pred hhhhh-------hhcccc------ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRIF-------QVMDAR------IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~~-------~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...++ .+.-+. ++..+ +..+.-+.+|++.||+.||.+|++..+++.|
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 000000 11111 2345578899999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=355.81 Aligned_cols=251 Identities=29% Similarity=0.389 Sum_probs=210.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.++||+|+||+||.++ +..|++.+|+|++++..... .....+|..+|..++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vr---------k~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVR---------KKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEE---------EcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3689999999999999999984 44589999999998876543 34577899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
++.+.+|+|+||+.||.|.-.|++.+ .+++..+..++..|+.||.|||++| |+||||||+|||++.+|+++|+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEec
Confidence 99999999999999999999998775 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++...... ....+++||+.|||||++.+..|+.++|.||||+++|+|++|.+||.+.+.......+
T Consensus 169 FgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------- 237 (357)
T KOG0598|consen 169 FGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------- 237 (357)
T ss_pred cccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH---------
Confidence 99998643322 2345689999999999999999999999999999999999999999876532211111
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC----CHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP----TMDEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~eil~~ 351 (400)
...+ ....+...+.+..++++++|+.||++|. .+.+|-+|
T Consensus 238 -------~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 238 -------LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -------hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1111 1223334567888999999999999995 55555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=361.86 Aligned_cols=266 Identities=33% Similarity=0.542 Sum_probs=219.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcE-EEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+.+.+.||.|+||+||+|.|.. .. ||+|++....... ...|.+|+.+|.+++|||||++++++.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g-----------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRG-----------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCC-----------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34555669999999999998874 44 9999998754333 4479999999999999999999999998
Q ss_pred CC-eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEEee
Q 015781 146 DD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (400)
Q Consensus 146 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~D 223 (400)
.. .+++||||+++|+|.+++... ....+++..++.++.||+.||.|||++++ |||||||++|||++.++ ++||+|
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECC
Confidence 87 799999999999999999874 12579999999999999999999999875 89999999999999997 999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhc--cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||+++...... ...+...||+.|||||++. ...|+.++||||||+++|||+||..||....+..
T Consensus 188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------------ 253 (362)
T KOG0192|consen 188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------------ 253 (362)
T ss_pred Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------------
Confidence 99998654322 2233468999999999999 5689999999999999999999999998765411
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCCCCc
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRD 366 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~ 366 (400)
....+.....+...+..++..+..|+.+||+.||..||++.+|+..|+.+........+..
T Consensus 254 ----~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~ 314 (362)
T KOG0192|consen 254 ----VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED 314 (362)
T ss_pred ----HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence 1112222333444455578889999999999999999999999999999877666544443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=359.56 Aligned_cols=267 Identities=26% Similarity=0.354 Sum_probs=218.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHH--HHHHHHHHccCC-CCcccceeeE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLY-HPNLVKLIGY 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-hpniv~~~~~ 142 (400)
.-++|.+++.||.|+||.||+| +.+.+|..||||.++..... .++ -++|+..|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 4468999999999999999999 55568999999999875432 333 458999999998 9999999999
Q ss_pred EEeCC-eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 143 CLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 143 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
+.+.+ .+|+||||| ..+|+.+|+.+. .++++..++.|+.||+.||+|+|.+| +.|||+||+|||+..+..+||
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEe
Confidence 99988 999999999 679999999884 78999999999999999999999999 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhh-ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
+|||+|+....... .+..+.|.+|+|||++ ....|+.+.||||+|||++|+++-++.|.+..+.+....+.....-
T Consensus 152 aDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 152 ADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred cccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 99999997655432 3556889999999987 5678999999999999999999999999999887776665321110
Q ss_pred -----HhhhhhhhhhccccccC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 -----LQSKRRIFQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 -----~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.....+...+.-.+.. .+-...+.++.+++.+||.-||.+|||+.++|++
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 01111122222221111 1112378899999999999999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=326.41 Aligned_cols=268 Identities=28% Similarity=0.348 Sum_probs=216.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+|...+.||+|.||.||+|+.. .||+.||||.+......+ ....++|++.|+.++|+||+.++++|.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~---------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT---------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec---------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 46888899999999999999544 489999999998775442 3457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+.+.+|+||+ ..+|...|+... ..+....+..++.+++.||+|||.+. |+||||||.|+||+.+|.+||+|||
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeeccc
Confidence 99999999999 569999998766 57899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH----------
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI---------- 294 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~---------- 294 (400)
+++........ ....+.|.+|+|||++.| ..|+...||||.|||+.||+-|.+.|.+..+.+....+
T Consensus 147 LAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 147 LARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred chhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 99986654432 333478999999998865 57999999999999999999999999998876665554
Q ss_pred HhhhH-HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 295 EWAKP-YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 295 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
+|..- .+.+-..+.......... +-...+.+..+|+..||..||.+|+|+.++|++=.
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 12110 011111111111111111 22345667799999999999999999999999743
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=356.76 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=218.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
...|.....||+|+.|.||.| ....+++.||+|++........+-+++|+.+|+..+|+|||++++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 356888889999999999999 45557889999999987766666788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+|+||||++||+|.|.+.... +++.++..|+.+++.||+|||.+| |+|||||.+|||++.+|.+||+|||+
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeee
Confidence 99999999999999999997653 899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
|........ ...+.+|||+|||||+.....|+++.||||||++++||+-|.+||-...+.....++.
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa----------- 482 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------- 482 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-----------
Confidence 987655432 5677899999999999999999999999999999999999999998766544333321
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ...+-..+...+..+.+|+.+||+.|+.+|||+.|+|+|
T Consensus 483 --~n--g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 --TN--GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --hc--CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 111222345667889999999999999999999999997
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=341.38 Aligned_cols=265 Identities=24% Similarity=0.338 Sum_probs=213.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH-HHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..+.|++.++||.|..++||+|+.. .++.+||||+++.+..... ..+.+|+..++.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~---------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCI---------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeec---------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 3468999999999999999999654 3679999999998876554 67889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
.+..+|+||.||.+|++.++++..-. ..+++..+..|++++++||.|||.+| .+|||||+.||||+.+|.|||+||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999999999987543 56999999999999999999999999 999999999999999999999999
Q ss_pred cCCccCCCCC-Cccee-eecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 225 GLAKDGPTGS-QSHVS-TRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 225 g~~~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|.+....... ..... .+++||++|||||++.. ..|+.|+||||||+++.||.+|..||....+...........+
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p- 249 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP- 249 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC-
Confidence 9876433322 22222 56799999999999754 4799999999999999999999999988776433221110000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.......+...-....+..+..++..||+.||.+|||+.++|++
T Consensus 250 -------p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 -------PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -------CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000000111112334477889999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=351.73 Aligned_cols=256 Identities=27% Similarity=0.349 Sum_probs=211.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccCC-CCcccce
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLY-HPNLVKL 139 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~-hpniv~~ 139 (400)
...+|.+.+.||+|+||+|++| .+..++..||+|++..... .....+.+|+.+++.+. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a---------~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLA---------KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEe---------eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 3468999999999999999999 4455789999998877522 12334668999999998 9999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-Cc
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YN 218 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~ 218 (400)
++++.....+|+||||+.||+|.+++... .++.+..+..++.||+.|++|||++| |+||||||+|||++.+ +.
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGN 159 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCC
Confidence 99999999999999999999999999884 46888999999999999999999998 9999999999999999 99
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCC-CC-CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||||+++|.|++|..||...........
T Consensus 160 ~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--- 234 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--- 234 (370)
T ss_pred EEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---
Confidence 9999999998764 2223466789999999999999877 85 789999999999999999999987432111110
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHH-HHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGA-ALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
+... .-.++... +.++..|+.+||..||.+|+|+.+|+.+=|.-.
T Consensus 235 -------------i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 235 -------------IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1111 11223333 778999999999999999999999997666554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=359.80 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=216.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.-|++++.||.|+-|.|-+| +|..||+..|||++..... .....+.+|+-+|+.+.|||+++++++++
T Consensus 12 GpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 45899999999999999998 7788999999999987632 12345789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+..++|+|.||++||.|.+++..++ ++++....+++.||+.|+.|+|..+ |+||||||+|+|++..+.+||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeecc
Confidence 9999999999999999999999885 6899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|+|.....+. ...+-||+|.|.|||++.+..| ..++||||+|||+|.|+||+.||++.+..
T Consensus 157 GMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--------------- 218 (786)
T KOG0588|consen 157 GMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--------------- 218 (786)
T ss_pred ceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---------------
Confidence 9998654443 4566799999999999999988 57899999999999999999999854321
Q ss_pred hhhhhhhcccccc--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.++.+-.. -.+|...+.++.+||.+||..||.+|.|++||++|-+-.
T Consensus 219 -----~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 219 -----VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred -----HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 11111111 233456778899999999999999999999999997654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=327.27 Aligned_cols=237 Identities=28% Similarity=0.377 Sum_probs=206.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||.|+||.|.+++ ++.+|..+|+|++....... .+...+|-.+|+.+.||+++++++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr---------~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVR---------EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEE---------EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 679999999999999999984 44579999999998876543 344668999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+++||||||++||.|..++.+.+ .+++..++.++.||+.||+|||+++ |++|||||+|||+|.+|++||+||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999998764 6899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+|+.... ...+.||||.|+|||++....|+.++|.||||+++|||+.|.+||...++.....
T Consensus 189 GFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------------ 251 (355)
T KOG0616|consen 189 GFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------------ 251 (355)
T ss_pred cceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH------------
Confidence 99987543 3567899999999999999999999999999999999999999998776522111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 342 (400)
.+... .-.+|...+..+.+|+.++|+.|-.+|
T Consensus 252 ----KI~~~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 ----KILEG--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----HHHhC--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11111 123456677889999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=342.87 Aligned_cols=262 Identities=30% Similarity=0.442 Sum_probs=211.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|...+.||+|+||.||++... .+|...|||............+.+|+.+|.+++|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~---------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK---------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEec---------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 45788899999999999999554 358899999987764334556889999999999999999999754444
Q ss_pred --eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEeec
Q 015781 148 --HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (400)
Q Consensus 148 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~Df 224 (400)
.++++|||+.+|+|.+++...+. .+++..+..+..||+.||+|||++| ++|+||||+|||++. ++.+||+||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccC
Confidence 68999999999999999988763 5899999999999999999999998 999999999999999 799999999
Q ss_pred cCCccCCC-CCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCC-CCCccchhHHhhhHHH
Q 015781 225 GLAKDGPT-GSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKN-RPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~ 301 (400)
|++..... ...........||+.|||||++.++ ....++|||||||++.||+||.+||... ...
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------------- 229 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------------- 229 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-------------
Confidence 99986543 1122223457899999999999853 3345999999999999999999999763 110
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+..+......+.++...+.+..+++.+|+..||++|||+.++|+|....+...
T Consensus 230 ---~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 230 ---EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 0011111112233556667889999999999999999999999999977655444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=351.10 Aligned_cols=248 Identities=28% Similarity=0.375 Sum_probs=213.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|.+.+.||+|+||.||+| +++.+.+.||+|.+.+... ++...+.+|+++++.++||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47889999999999999999 7778999999999977543 345568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
..++|+|+||+.| +|..++...+ .++++.+..++.+++.||.|||+++ |+|||+||.|||++.++++|++|||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhh
Confidence 9999999999966 9999998875 5899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+|+.... .....+...|||.|||||+..++.|+..+|+|||||++|||++|++||-.. ...+-.+
T Consensus 146 ~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------------si~~Lv~ 210 (808)
T KOG0597|consen 146 LARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------------SITQLVK 210 (808)
T ss_pred hhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------------HHHHHHH
Confidence 9997554 344567789999999999999999999999999999999999999999432 2111111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+ ... ...++...+..+..+++.+|..||..|.|+.+++.|
T Consensus 211 ~I---~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 211 SI---LKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HH---hcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11 111 123345778889999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=348.40 Aligned_cols=269 Identities=25% Similarity=0.319 Sum_probs=212.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..+.|+.++.||+|+||.||+| ++..+|+.||+|.+..+... ...-..+|+.+|++|+||||+++.+..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 3456888899999999999999 45558999999999876633 234466899999999999999999998
Q ss_pred EeC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 144 LED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 144 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.+. ..+|||+|||+ -+|.-++.... -.+++.++..++.||+.||+|||..| |+|||||..|||||.+|.+||
T Consensus 186 t~~~~~siYlVFeYMd-hDL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMD-HDLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EecCCceEEEEEeccc-chhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEe
Confidence 876 68999999995 58888886543 46899999999999999999999999 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKP 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~ 299 (400)
+|||+|+.+...... ..+..+.|.+|+|||++.+. .|+.+.|+||+|||+.||++|++.|++..+.....+|- ....
T Consensus 260 aDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred ccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 999999976554433 35667889999999998775 79999999999999999999999999988766555441 1110
Q ss_pred HHhhhhhhhhhc-----c------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVM-----D------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~-----~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...+.+....+. . ..+... -...+....+|+..||..||.+|.|+.++|..
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000111100111 0 001111 11235567789999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=348.67 Aligned_cols=259 Identities=31% Similarity=0.455 Sum_probs=215.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.+++.+.||+|.||.||+|.++.. ..||+|.+..... ..+.|.+|+++|++|+|+|||++++++..++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 3456678999999999999999863 3589998876543 4557889999999999999999999999988
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+||||||++.|+|.++|..... ..+...+.+.++.||++|++||.+++ +|||||...||||+++..+||+|||++
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999999987332 56889999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+.... +.........-...|.|||.+....++.+|||||||++||||+| |+.|+.+....+
T Consensus 351 r~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------- 412 (468)
T KOG0197|consen 351 RLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------- 412 (468)
T ss_pred cccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------
Confidence 94333 22222222233567999999999999999999999999999998 778887654321
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+.++...+-..|..++..++++++.||+.+|++|||+..+...|+.+....
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 12223333344456678999999999999999999999999999999886543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=342.63 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=209.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
...++|.++++||+|+||.||+| +.+.||.++|+|++++..+.. ...++.|-.+|...++|.||+++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 34578999999999999999999 455689999999999876543 344678889999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.|.+.+++||||||++||++..+|...+ .+++..+.+++.+++.||+.||++| ++||||||+|+|||..|++||
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEee
Confidence 9999999999999999999999998874 6999999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCC----------------------CCCcc----e-------------------eeecccccCcccchhhcc
Q 015781 222 SDFGLAKDGPT----------------------GSQSH----V-------------------STRVMGTYGYAAPEYMAT 256 (400)
Q Consensus 222 ~Dfg~~~~~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~ 256 (400)
+|||++.-... ..... . ....+|||.|+|||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 99999852111 00000 0 012589999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh-HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcc
Q 015781 257 GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 335 (400)
Q Consensus 257 ~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 335 (400)
..|+...|.||||||+||||.|.+||....+...... +.|.. . +........+.+..+||.+||
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----------~----l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----------T----LKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------h----ccCCCcCcccHHHHHHHHHHh
Confidence 9999999999999999999999999998876433222 12211 1 111112234478899999999
Q ss_pred cCCCCCCC---CHHHHHHH
Q 015781 336 SNEPKFRP---TMDEVVKA 351 (400)
Q Consensus 336 ~~dP~~Rp---s~~eil~~ 351 (400)
. ||++|. .+.||.+|
T Consensus 428 ~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred c-CHHHhcCcccHHHHhcC
Confidence 9 999996 58888776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=347.67 Aligned_cols=270 Identities=28% Similarity=0.406 Sum_probs=209.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 46799999999999999999975321 1233567899999875432 2345688999999999 8999999999887
Q ss_pred eC-CeeEEEEeecCCCCHHHHHhhhcCC----------------------------------------------------
Q 015781 145 ED-DHRLLVYEFMPKGSLENHLFRRASY---------------------------------------------------- 171 (400)
Q Consensus 145 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 171 (400)
.. ..+++||||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999999753211
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccc
Q 015781 172 ------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245 (400)
Q Consensus 172 ------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 245 (400)
..++++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 235788899999999999999999988 999999999999999999999999999764332222122234456
Q ss_pred cCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHH
Q 015781 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAA 324 (400)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
..|+|||++.+..++.++|||||||++|+|++ |..||........ .. . ..... .....+...+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~---~-~~~~~----------~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC---Q-RLKDG----------TRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH---H-HHhcC----------CCCCCCCCCC
Confidence 78999999988899999999999999999997 9999976432110 00 0 00000 0111223345
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 325 LKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 325 ~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 6788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=343.95 Aligned_cols=250 Identities=28% Similarity=0.378 Sum_probs=216.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..|+..++||+|+||.||+|.+ ..+++.||+|++..+...+ .+.+.+|+.+|.+++++||.++++.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d---------~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAID---------NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeee---------ccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 4577789999999999999954 4579999999999876654 45677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..++++||||.||++.+++.... .+.+..+..++.+++.||.|||.++ .+|||||+.||++..+|.+||+|||.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecce
Confidence 99999999999999999997653 4588888899999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ...+++||+.|||||++.+..|+.++||||||++.+||++|.+|+.+..+.+...++.
T Consensus 158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp----------- 224 (467)
T KOG0201|consen 158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP----------- 224 (467)
T ss_pred eeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-----------
Confidence 987654332 3477899999999999998899999999999999999999999999988866554442
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+...+.+...++..+.+++..||+.||+.|||+.++|+|
T Consensus 225 ------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 ------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 122233344667788999999999999999999999986
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=314.87 Aligned_cols=268 Identities=26% Similarity=0.336 Sum_probs=220.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
...++|++.+.||+|||+-||++ ++..++..+|+|++.....++.+...+|++..++++|||+++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 34578999999999999999998 667789999999998888777888999999999999999999998765
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.+ ...|++++|+..|+|.+.+......+..+++.++++|+.+|++||++||...++++||||||.||++.+.+.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 43 3489999999999999999988777778999999999999999999999998889999999999999999999
Q ss_pred EEeeccCCccCCCCCCcce-------eeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 220 KLSDFGLAKDGPTGSQSHV-------STRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
+|.|||.++...-...... ......|..|+|||++. +...+.++|||||||++|.|+.|..||+..-.
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-- 246 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-- 246 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--
Confidence 9999999986543221111 12245789999999984 45678999999999999999999999964321
Q ss_pred cchhHHhhhHHHhhhhhhh-hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 290 EHNLIEWAKPYLQSKRRIF-QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
....+. .+.+......-...+++.+.+++++||+.||.+||++.+++.++..+.
T Consensus 247 -------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 112222222223347889999999999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=345.70 Aligned_cols=270 Identities=23% Similarity=0.381 Sum_probs=219.3
Q ss_pred ccHhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCc
Q 015781 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPN 135 (400)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpn 135 (400)
.+..++....+.+.+.+.||+|+||+||+|+|+. .||||+++..... ..+.|.+|+..+++-+|-|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3445566677788899999999999999999875 3999999876553 3567999999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 136 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
|+-++|++..... .||+.+|+|.+|+.++.... ..++....+.|+.||+.|+.|||.++ |+|||||..|||+.+
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHE 523 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEcc
Confidence 9999999998876 99999999999999997765 46889999999999999999999999 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
++.|||+|||++................|...|||||+++- ..|++.+|||||||++|||+||..||.......-..
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif 603 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF 603 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence 99999999999986555444334455678899999999853 478999999999999999999999998433211111
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.+. + .....+. ......++.++.+|+..||..++++||.+.+||..|+.+...
T Consensus 604 mVG--r-----G~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVG--R-----GYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Eec--c-----cccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000 0 0000000 112235677888999999999999999999999998888764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=351.58 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=209.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCccccee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLI 140 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~ 140 (400)
...++|++.++||+|+||+|+++.. +.+++.+|||++++..+- +.+....|-+++... +||.+++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~---------k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~ 435 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAEL---------KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF 435 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEE---------cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence 4457899999999999999999954 457899999999987653 334456677777666 599999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
..|...+++|+||||+.||++..++.. ..+++..+..++..|+.||.|||++| ||+||||.+|||+|.+|++|
T Consensus 436 ~~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 436 SCFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred cccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEE
Confidence 999999999999999999995433322 45899999999999999999999999 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||+++..... .....+++|||.|+|||++.+..|+.++|.|||||+||||+.|..||.+.+.....+.+
T Consensus 509 iADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------ 580 (694)
T KOG0694|consen 509 IADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------ 580 (694)
T ss_pred ecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------
Confidence 9999999875422 22577899999999999999999999999999999999999999999987653322222
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~ 351 (400)
+. .+..+|...+.+...|++++|..||++|.- +.+|.+|
T Consensus 581 ----------~~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 581 ----------VN--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred ----------hc--CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 11 134567778889999999999999999974 4555553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=334.21 Aligned_cols=267 Identities=27% Similarity=0.323 Sum_probs=213.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--------------hhHHHHHHHHHHHc
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------------QGHLEWLTEIKHLG 129 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~ 129 (400)
....++|++.+.||+|.||.|-+|+.. .+++.||+|++.+... ...+.+.+|+.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~---------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE---------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec---------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 345578999999999999999999654 4689999999976432 12346789999999
Q ss_pred cCCCCcccceeeEEEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 015781 130 QLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQP-LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (400)
Q Consensus 130 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 206 (400)
++.|||||+++++..+ .+.+|||+|||..|.+...=. ..+ +++.++++++.+++.||+|||.+| |+||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDI 236 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDI 236 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence 9999999999999975 478999999999888754221 134 899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCceEEeeccCCccCCCCCCc---ceeeecccccCcccchhhccCC----CCCccchhhHHHHHHHHHhCC
Q 015781 207 KTSNILLDLNYNAKLSDFGLAKDGPTGSQS---HVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGR 279 (400)
Q Consensus 207 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~ 279 (400)
||.|+||+.+|++||+|||.+.....+... ......+|||.|+|||+..++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999998865333211 1123368999999999987633 356889999999999999999
Q ss_pred CccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 280 RVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.||-+....... ..+++..+.-.........+.+||++||++||+.|.++.+|..|.|..+.-.
T Consensus 317 ~PF~~~~~~~l~----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 317 LPFFDDFELELF----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CCcccchHHHHH----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 999765432211 1233333433334456788999999999999999999999999999887755
Q ss_pred CCC
Q 015781 360 DAG 362 (400)
Q Consensus 360 ~~~ 362 (400)
.+.
T Consensus 381 ~~~ 383 (576)
T KOG0585|consen 381 SPQ 383 (576)
T ss_pred CCc
Confidence 553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=325.74 Aligned_cols=273 Identities=24% Similarity=0.300 Sum_probs=217.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...+.|+....|++|+||.||+| +++.|++.||+|+++-+.... ..-.++|+.+|.+++|||||.+.++
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEV 143 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEV 143 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence 34467899999999999999999 566689999999987654321 2345799999999999999999998
Q ss_pred EEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 143 CLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 143 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+.- -+.+|||||||+ -+|..+|.... +++...++..++.|++.||+|||.+. |+|||||++|+|++..|.+|
T Consensus 144 VvG~~~d~iy~VMe~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 144 VVGSNMDKIYIVMEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred EeccccceeeeeHHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEE
Confidence 864 367999999995 59999998776 78999999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH----
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE---- 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~---- 295 (400)
|+|||+|+.+.... ...+..+.|.+|+|||++.+ ..|+...|+||+|||+.||+++++.|.+....+..+.+-
T Consensus 218 iaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 218 IADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred ecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 99999999876542 34566788999999999876 469999999999999999999999999988766655541
Q ss_pred ------hhhHHHhh---hhhhhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 296 ------WAKPYLQS---KRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 296 ------~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
|.....-. ...+.......++..+... .++.-++|+..+|..||.+|.|+.+.|+|=+.
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 11100000 0111111112222222222 55778899999999999999999999998543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=329.65 Aligned_cols=285 Identities=27% Similarity=0.349 Sum_probs=224.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecc--ccchhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.....|...+.||+|+||.|+.|.. ..+|..||+|.+.. .......+..+|+++|+.++|+||+.++++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~---------~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKD---------KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred eccceecccccccCcceeeEEEEEE---------cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence 3446677789999999999999954 44789999999873 333455678899999999999999999999
Q ss_pred EEe-----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 143 CLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 143 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
+.. -..+|+|+|+| +.+|...|+.. +.++...+..+++||+.||+|+|+.+ |+||||||.|++++.+.
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADC 162 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCC
Confidence 865 35789999999 77999998775 35899999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhh-ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.+||+|||+|+..........++..+.|.+|+|||++ ....|+.+.||||+|||+.||++|++.|.+.+......++..
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9999999999976543334445677889999999976 456899999999999999999999999999887665555422
Q ss_pred hhHH--------Hhhhhh---hh---hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcCC
Q 015781 297 AKPY--------LQSKRR---IF---QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTND 360 (400)
Q Consensus 297 ~~~~--------~~~~~~---~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~ 360 (400)
.... +..... +. ......+...++ .......+|+.+||..||.+|+|++|+|+| |..+.+..+
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 1110 000000 00 000111111112 456788899999999999999999999997 888888888
Q ss_pred CCCCCc
Q 015781 361 AGVSRD 366 (400)
Q Consensus 361 ~~~~~~ 366 (400)
++.+..
T Consensus 322 EP~~~~ 327 (359)
T KOG0660|consen 322 EPVCQP 327 (359)
T ss_pred CCCCCC
Confidence 875543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.02 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=216.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH---HHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..+|++.+.||+|.||.|-+|+. ...|+.||||.+.++...+. ..+.+|+++|..|+||||+.++++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e---------~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYE---------HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhh---------ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 46899999999999999999844 34799999999998776554 3577899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
+..+...|||||..+|.|+||+.+++ .+++.....++.||+.|+.|+|.++ ++|||||.+|||+|.++.+||+|
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeec
Confidence 99999999999999999999999885 5899999999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||++-.+.... ...++||++.|.+||++.+..| .+..|-||||+++|.|+.|..||++.+....
T Consensus 197 FGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l------------ 261 (668)
T KOG0611|consen 197 FGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL------------ 261 (668)
T ss_pred cchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH------------
Confidence 99998765433 4567899999999999998888 6799999999999999999999988653111
Q ss_pred hhhhhhhhccccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCCCC
Q 015781 303 SKRRIFQVMDARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 365 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 365 (400)
+.....+.+ .+..+....-||.+||..||++|.|+.+|..|-|- ...+..++..
T Consensus 262 --------vrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv-Nwgy~~~V~~ 316 (668)
T KOG0611|consen 262 --------VRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWV-NWGYNMPVIQ 316 (668)
T ss_pred --------HHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee-eccccccccc
Confidence 111111111 11223455669999999999999999999998663 3333333333
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.87 Aligned_cols=258 Identities=28% Similarity=0.335 Sum_probs=217.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH---HHHHHHHHHHccCCCCcccceee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
...+.|++.+.||.|.-|+||++.... ++..+|+|++.+..+... .++..|-++|+.++||.+..++.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 344678889999999999999996654 568999999998766543 34567899999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.|+.+...|+|||||+||+|..++++... .-+++..+..++..++.||+|||..| ||+|||||+||||-++|+|-|
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEe
Confidence 99999999999999999999999988765 67999999999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCC---------------------------------CCC---------------------cceeeecccccC
Q 015781 222 SDFGLAKDGPT---------------------------------GSQ---------------------SHVSTRVMGTYG 247 (400)
Q Consensus 222 ~Dfg~~~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~ 247 (400)
+||.++..... ... ......++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998753211 000 001123689999
Q ss_pred cccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHH
Q 015781 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKT 327 (400)
Q Consensus 248 y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 327 (400)
|+|||++.+...+.++|.|+||+++|||+.|..||.+... ...+..++.+.+.-......+..+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHH
Confidence 9999999999999999999999999999999999988653 333445555555444445778899
Q ss_pred HHHHHhcccCCCCCCCC----HHHHHHH
Q 015781 328 AVLAIKCLSNEPKFRPT----MDEVVKA 351 (400)
Q Consensus 328 ~~li~~~l~~dP~~Rps----~~eil~~ 351 (400)
.+||+++|.+||.+|.- +.||.+|
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999998 8888775
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.51 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=217.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+|...+++|+|+||.++++ +++..+..+++|.+....... .....+|+.+++++.|||||.+.+.|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57899999999999999987 666678899999998776433 3357799999999999999999999999
Q ss_pred CCe-eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++. ++|||+||+||+|.+.|.+... .-++++.++.++.||+.|+.|||+++ |+|||||+.|||++.++.|+|+||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecch
Confidence 888 9999999999999999988763 56899999999999999999999888 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++...... ....+..||+.|++||++.+.+|+.++|||||||++|||++-+++|...+-......+
T Consensus 151 GlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---------- 218 (426)
T KOG0589|consen 151 GLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---------- 218 (426)
T ss_pred hhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH----------
Confidence 9999866543 2456689999999999999999999999999999999999999999876532111111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
....-...+..++.++..+++.||..+|..||++.++|.+
T Consensus 219 -------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 -------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111234567788899999999999999999999999986
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.16 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=217.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeE-EEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGY-CLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~-~~~ 145 (400)
.++++.++|.+|||+.||+|.... .|..+|+|++-.........+.+|+++|++|. |+|||.+++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 568889999999999999996654 35889999998877677778899999999997 9999999993 221
Q ss_pred ------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 146 ------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 146 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.-.++|+||||.||.|.|+|..+.. ..|++..+++|++|++.|+++||...++|+|||||-+||||..+|..
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 1356889999999999999998765 44999999999999999999999999999999999999999999999
Q ss_pred EEeeccCCccCCCCCCcc-e------eeecccccCcccchhh---ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 220 KLSDFGLAKDGPTGSQSH-V------STRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
||||||.++......... . .-...-|+.|+|||++ .+..++.|+|||||||+||-|+....||+....
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999997433222110 0 0113458999999987 577889999999999999999999999975422
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..+++....-.....++..+.+||..||+.||.+||++-+++.++.++.......
T Consensus 264 ------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 264 ------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 2334444443444678999999999999999999999999999999886654443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=306.13 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=217.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|.+.+.||+|-||.||+|+. +.++..||+|++.+.+.. ...++.+|+++-..|+||||++++++|.
T Consensus 22 ~dfeigr~LgkgkFG~vYlare---------kks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLARE---------KKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhccccccccCCccccEeEeee---------ccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 6799999999999999999954 447889999999887653 2456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+....|+++||..+|+|...+..... ..+++...+.++.|++.||.|+|.++ ++||||||+|+|++..+.+||+||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999999986544 56899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|.+...+. ....+.+||..|++||+..+..++..+|+|++|++.||++.|.+||........
T Consensus 169 GwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------------- 230 (281)
T KOG0580|consen 169 GWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------------- 230 (281)
T ss_pred CceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--------------
Confidence 99976542 246778999999999999999999999999999999999999999976542111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..++.. ..-.++...+....++|.+||..+|.+|.+..+++.|-+-.
T Consensus 231 --YkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 231 --YKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred --HHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 111111 12344567788899999999999999999999999987653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.20 Aligned_cols=276 Identities=26% Similarity=0.422 Sum_probs=209.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcC-------CCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYA-------PARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~ 138 (400)
.++|++.+.||+|+||.||+|.+...... ..+..++..||+|++...... ....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 35799999999999999999987542100 012345668999998765332 3456889999999999999999
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS---------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 203 (400)
+++++.+.+..++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ |+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 99999999999999999999999999865321 1134678889999999999999999988 999
Q ss_pred ccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh--CCCc
Q 015781 204 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRV 281 (400)
Q Consensus 204 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~p 281 (400)
|||||+||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976543332222333456788999999988889999999999999999987 5567
Q ss_pred cCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
|....... .+.......... ........+..++..+.+|+.+||+.||.+|||+.+|.+.|+.
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 76543211 111111111000 0000111122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.57 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=220.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH--HHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..-|.+.+.||+|.|.+|-+| +|..||..||||++.+..+... ..+.+|++.|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 356889999999999999988 7778999999999998776543 45889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE-cCCCceEEee
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSD 223 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill-~~~~~~kl~D 223 (400)
....+|+|+|+-++|+|+|||-++. ..+.+....+++.||+.||.|+|+.. +|||||||+|+.+ ..-|-|||.|
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999998877 57999999999999999999999987 9999999999876 5568899999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCC-CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||++-.+.++. ...+.+|+..|.|||++.+..|+ ++.||||||+|+|.|++|++||+...+....
T Consensus 163 FGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------- 228 (864)
T KOG4717|consen 163 FGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------- 228 (864)
T ss_pred ccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-----------
Confidence 99998776655 35678999999999999999886 6899999999999999999999876543222
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..+++ +....|...+.++.+||..||..||++|.|+++|..+-|
T Consensus 229 -----TmImD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 229 -----TMIMD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred -----hhhhc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 22233 344667888999999999999999999999999998644
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.94 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=204.7
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
|+..+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.+++.++|+||+++++++.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 777899999999999999554 36889999998754332 223567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999988865432 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----------- 214 (285)
T cd05631 149 AVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----------- 214 (285)
T ss_pred cEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-----------
Confidence 97643322 1234578999999999999999999999999999999999999998654321111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
... ......++...+..+.+|+.+||+.||.+||+ +.++++|-+
T Consensus 215 --~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 215 --RRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred --HHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 000 00111233345678889999999999999997 889998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.08 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+++.+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 36889999999999999999554 3688999999875432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++...|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEec
Confidence 999999999999999999999765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------------ 208 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------------ 208 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 998764322 223578999999999998889999999999999999999999997653211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~~ 354 (400)
.+... ...++...+..+.+|+++||+.||.+||+ +.++++|-+.
T Consensus 209 ----~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 209 ----KILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred ----HHHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 00000 01223334567889999999999999995 9999988554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.25 Aligned_cols=267 Identities=27% Similarity=0.355 Sum_probs=208.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 35799999999999999999975321 2344678899999875432 2345678899999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------------------------------------------------
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------------------------------------------------ 170 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 170 (400)
+.+..++||||+++|+|.+++.....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCC
Q 015781 171 -----------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (400)
Q Consensus 171 -----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 233 (400)
...++++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 0125788899999999999999999988 999999999999999999999999999765433
Q ss_pred CCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 234 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+ +.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~--------------~~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM--------------IK 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH--------------HH
Confidence 22112222345667999999999999999999999999999998 888986543211 11110 01
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.......+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0001111222356788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=336.00 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 36899999999999999999654 3688999999976532 23345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999999765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--------- 211 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--------- 211 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---------
Confidence 99975433 2234578999999999998899999999999999999999999997654322111110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
..................+.++.+++.+||..+|.+||++.++++|-
T Consensus 212 -~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 212 -YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00000110000001123467888999999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.18 Aligned_cols=267 Identities=24% Similarity=0.344 Sum_probs=208.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||++... .++..+|+|++..... .....+.+|++++++++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 67999999999999999999544 4688999999876532 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCc
Confidence 9999999999999999999765 3588999999999999999999974 5 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh--
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS-- 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-- 303 (400)
++...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ......
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~ 223 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEE 223 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--cccccccc
Confidence 98754322 1233568999999999998899999999999999999999999996543211100000 000000
Q ss_pred --------------------------hh---hhhh-hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 --------------------------KR---RIFQ-VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 --------------------------~~---~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. .+.. +.............+.++.+|+.+||+.||++|||+.++++|-+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00 0000 00000111112235678999999999999999999999999876
Q ss_pred hc
Q 015781 354 QI 355 (400)
Q Consensus 354 ~~ 355 (400)
.-
T Consensus 304 ~~ 305 (331)
T cd06649 304 IK 305 (331)
T ss_pred Hh
Confidence 53
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=334.79 Aligned_cols=243 Identities=29% Similarity=0.387 Sum_probs=199.0
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
++||+|+||.||+|... .+|..+|+|++..... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREK---------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 46999999999999543 4688999999876432 22345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
+||||+.+++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 72 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 999999999999998765 35899999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----------------~ 207 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------I 207 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH----------------H
Confidence 2211 123346799999999999999999999999999999999999999975432110000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
... ...++...+.++.+++.+||+.||++|| ++.++++|
T Consensus 208 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 208 LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 000 1122334567888999999999999999 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=337.59 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=208.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... ....++..||+|.+...... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 35799999999999999999976431 12335678999999764322 344578899999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------------------------------------------------
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------------------------------------------------ 170 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 170 (400)
+.+..++||||+.+|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcce
Q 015781 171 ------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (400)
Q Consensus 171 ------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 238 (400)
...++++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1135788899999999999999999988 99999999999999999999999999976543322212
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccC
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEG 317 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (400)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..........
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~----------------~~~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF----------------YKMVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH----------------HHHHHcccCc
Confidence 222345668999999988899999999999999999997 99999764321110 0001111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 318 QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 318 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..+...+.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.61 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=207.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
..|.+.+.||+|+||.||+|.... ..+..||+|.+..........+.+|+.+++.++||||+++++++..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~--------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGS--------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcC--------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 348999999999999999995432 126778899876655444556778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|+||||+++++|.+++........++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 999999999999999988764433457899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+..............+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~------------ 281 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ------------ 281 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH------------
Confidence 86543322223345679999999999998899999999999999999999999997543211 000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...... ....+...+..+.+++.+||+.||++||++.+++.+
T Consensus 282 -~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 -QVLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -HHHhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000000 011223455678999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=335.77 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK---------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 57899999999999999999654 3688999999875432 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999765 35788999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.....
T Consensus 163 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------------ 225 (329)
T PTZ00263 163 GFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------------ 225 (329)
T ss_pred cCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------------
Confidence 999765332 223578999999999999899999999999999999999999997643211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
.+.... ..++...+..+.+|+.+||+.||.+||+ +.+++.|-+
T Consensus 226 ----~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 226 ----KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred ----HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 011111 1122234567889999999999999996 799988743
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=310.59 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=214.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+.|.+.++||+|.|+.||++ .+..||+.+|+|+++.... .+.+++.+|+.+-+.|+||||+++.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 367899999999999999987 6677899999999877644 34667889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---CCCceEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKL 221 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl 221 (400)
+....|||+|++.|++|..-|..+. -.++..+-.++.||+.+|.|+|.++ |||||+||+|+++. ...-+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceee
Confidence 9999999999999999988777663 4688889999999999999999999 99999999999994 3456999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||++.....+ .....+.|||.|||||++....|+..+|||+.|+++|-|+.|.+||.+.+..+...-+.
T Consensus 155 ~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~------ 225 (355)
T KOG0033|consen 155 ADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK------ 225 (355)
T ss_pred cccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh------
Confidence 999999987632 24566899999999999999999999999999999999999999997744321111110
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
... . ......=...+++..+|+.+||..||.+|.|+.|.|+|-|....+..
T Consensus 226 ~g~------y--d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~ 276 (355)
T KOG0033|consen 226 AGA------Y--DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV 276 (355)
T ss_pred ccc------c--CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence 000 0 01111112456678899999999999999999999998776654443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=348.73 Aligned_cols=273 Identities=29% Similarity=0.432 Sum_probs=227.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..+.++.+.||+|+||.||+|..... .-......||||.++..... ...+|.+|++++..|+|||||+++|+|.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 35567789999999999999976531 22345678999999887665 56789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC------C----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS------Y----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~------~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
++.++||+|||..|+|.++|..+.. . ..+++..+.+.|+.|||.|++||-++. +|||||-..|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGE 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceecc
Confidence 9999999999999999999975332 1 234899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 294 (400)
+..|||+|||+++..-..+.........-..+|||||.+..+.|+++|||||+||++||+++ |..||.+.........+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999999998777666655555566789999999999999999999999999999998 88888776543222222
Q ss_pred HhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
....+ -..+..++.+++.|+..||+.+|++||+++||-..|+.........
T Consensus 719 ----------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 719 ----------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred ----------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 11222 3446678899999999999999999999999999999876655443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.36 Aligned_cols=268 Identities=23% Similarity=0.263 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 36899999999999999999654 3688999999875432 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..|+||||++++.+..+.... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence 99999999999887665544322 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh---
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ--- 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--- 302 (400)
++......... ......|++.|+|||++.+..++.++|||||||++|+|++|++||......+....+........
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 146 FARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred Ccccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 99865432211 12335689999999999888899999999999999999999999987543222211111000000
Q ss_pred -----hhhhhhhhcccc------ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 -----SKRRIFQVMDAR------IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 -----~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
............ .........+..+.+|+++||+.||++|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0001112245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.40 Aligned_cols=243 Identities=30% Similarity=0.499 Sum_probs=206.5
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
.+-||.|+.|.||+|++++ +.||||+++.-. ..+++.|++|+||||+.+.++|.....++||
T Consensus 129 LeWlGSGaQGAVF~Grl~n-----------etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN-----------ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeeccC-----------ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 4569999999999998864 569999765321 2678999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
||||..|.|+..|+.. .++.......|..+|+.|+.|||.++ |||||||.-||||+.+..|||+|||-++....
T Consensus 191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999876 57889999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ....++||..|||||++.+...+.++|||||||+||||+||..||.+-+. ..|.| -+-.
T Consensus 265 ~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw------------GVGs 325 (904)
T KOG4721|consen 265 KS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW------------GVGS 325 (904)
T ss_pred hh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEE------------eccC
Confidence 32 23458999999999999999999999999999999999999999975432 11112 2222
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+.-..+..+++.+.-|++.||+..|.+|||+.+|+.||+.+..+
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 3333445667888999999999999999999999999999876543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=321.20 Aligned_cols=265 Identities=27% Similarity=0.446 Sum_probs=212.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|..... ....+...+++|.+...... ....+.+|+..++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4689999999999999999976542 11234578999998754432 344678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
...+++|||+++++|.+++...... ...+++..++.++.||+.||+|||+++ ++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 9999999999999999999764221 135788999999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchh
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 293 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 293 (400)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--- 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--- 235 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 999999999999876433332222334456788999999988899999999999999999998 9999976543211
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ..+........+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 236 ~--------------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 I--------------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H--------------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 11111111223445678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=318.50 Aligned_cols=259 Identities=22% Similarity=0.363 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. ....+..+|+|.+...... ....+.+|+..+++++||||+++++++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 568999999999999999997652 2235778999998765332 234678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 36889999999999999999999988 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~--------- 220 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA--------- 220 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---------
Confidence 7653221111 1112334678999999998999999999999999999775 9999976543211 100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+........+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 221 -----~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 -----VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000011122334566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.43 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||.|+||.||+|... .++..||+|++...... ....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 57999999999999999999543 36889999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999999996 59998886543 35788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh-------
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK------- 298 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~------- 298 (400)
+........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 875432221 1233567899999998865 568999999999999999999999997755432221111000
Q ss_pred -HHHhhhhhhhhhccccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 299 -PYLQSKRRIFQVMDARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 299 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.......+.....+.... ......+.++.+|+.+||+.||.+|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000000000 0011235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=320.89 Aligned_cols=269 Identities=27% Similarity=0.407 Sum_probs=213.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|.+.+.||+|+||.||++..... ....++..+|+|.+..........+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 5789999999999999999975431 123456789999987655445567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRA---------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.+++||||+.+++|.+++.... .....+++..++.++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence 9999999999999999997543 12235899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 297 (400)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i--- 235 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI--- 235 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999875433222111223345778999999988899999999999999999998 89998655431110000
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
... . ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 236 ----~~~---------~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 ----TQG---------R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ----HcC---------C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 0 00111224457899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=316.17 Aligned_cols=269 Identities=25% Similarity=0.291 Sum_probs=207.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCc-ccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPN-LVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpn-iv~~~~~~~ 144 (400)
..|...+.||+|+||+||+|+. ..+|+.||+|.+...... ......+|+.+|+.++|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~---------~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARS---------KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEE---------ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 4567778899999999999954 457899999999876542 3345679999999999999 999999998
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
..+ .+++||||+ ..+|..++.........++...+..++.||+.||+|||+++ |+||||||.||+|+.+|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCc
Confidence 877 889999999 67999999876532235777899999999999999999999 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||+|+....... ..+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+....+-..
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 99999999986543222 24556889999999999876 7999999999999999999999999988764433322000
Q ss_pred hHHHhhhhhhhhhc---cc--ccc-----CCCCH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 298 KPYLQSKRRIFQVM---DA--RIE-----GQYSL---GAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 298 ~~~~~~~~~~~~~~---~~--~~~-----~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. .......+.... +- ... ..+.. .......+++.+||+.+|.+|.|++.++.|
T Consensus 237 l-GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 L-GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred c-CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 000000110000 00 000 00001 112477889999999999999999999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=328.94 Aligned_cols=270 Identities=27% Similarity=0.379 Sum_probs=209.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||.||+|..... ....+++.||+|++...... ....+..|+.++.++ +|+||+++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 346899999999999999999965321 23346789999998754322 234577899999999 899999999987
Q ss_pred Ee-CCeeEEEEeecCCCCHHHHHhhhcCC---------------------------------------------------
Q 015781 144 LE-DDHRLLVYEFMPKGSLENHLFRRASY--------------------------------------------------- 171 (400)
Q Consensus 144 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------- 171 (400)
.. +..++++|||+++++|.+++......
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46788999999999999998643210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccc
Q 015781 172 ------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245 (400)
Q Consensus 172 ------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 245 (400)
..++++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++................++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 136899999999999999999999988 999999999999999999999999999865433222222334556
Q ss_pred cCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHH
Q 015781 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAA 324 (400)
Q Consensus 246 ~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (400)
..|+|||++.+..++.++|||||||++|+|++ |..||.+...... .. ... ........+...+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~----------~~~~~~~~~~~~~ 302 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRL----------KEGTRMRAPEYAT 302 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHH----------hccCCCCCCccCC
Confidence 78999999999999999999999999999998 9999976432211 00 000 0000111122345
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 325 LKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 325 ~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.++.+++.+||+.+|++||++.+++++|+.+..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=330.64 Aligned_cols=254 Identities=25% Similarity=0.312 Sum_probs=198.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|+..+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.+++.++|+||+++++++.++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 46778899999999999999554 36889999998654322 235678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+++||||+.+++|.+. ....+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999998642 23567788899999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+........ ......||..|+|||++.. ...+.++|||||||++|+|++|+.||..............
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----- 287 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----- 287 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-----
Confidence 876432211 1233578999999998743 2345689999999999999999999974332211111100
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.........+...+.++.+|+.+||+.||++|||+.++++|-+-..
T Consensus 288 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 288 ---------ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ---------HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 0000111223345678899999999999999999999999855443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.33 Aligned_cols=246 Identities=20% Similarity=0.334 Sum_probs=199.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEEEe----C
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE----D 146 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~----~ 146 (400)
..||+|++|.||+|.+. |..||+|.+....... ...+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 57999999999999763 6789999987654322 3457799999999999999999999877 3
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
...++||||+.+|+|.+++... ..+++...+.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccc
Confidence 5789999999999999999765 3578899999999999999999984 6 8899999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ..
T Consensus 169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~-------- 232 (283)
T PHA02988 169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD-------- 232 (283)
T ss_pred hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH--------
Confidence 987543221 23467899999999976 6899999999999999999999999976532111 00
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.+.........+...+..+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus 233 -----~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 -----LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -----HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111111122333456789999999999999999999999999998764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=329.41 Aligned_cols=256 Identities=27% Similarity=0.308 Sum_probs=216.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCC-CCcccceee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLY-HPNLVKLIG 141 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~~~~ 141 (400)
....|.+.+.||.|.||.||++ .++.+|..+|+|.+.+..... ...+.+|+.+|+++. ||||+.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3467999999999999999999 555579999999998876643 357889999999998 999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC----CC
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----NY 217 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~----~~ 217 (400)
+|++.+.+++|||+|.||.|.+.+... .+++..+..++.|++.+++|||+.| |+||||||+|+|+.. ++
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCC
Confidence 999999999999999999999999876 2899999999999999999999988 999999999999953 35
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.++++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.........+...
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~ 253 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG 253 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC
Confidence 799999999998665 33567789999999999999899999999999999999999999999876643222211100
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+-......-...+..+.+++.+||..||.+|+|+.++|+|-|-
T Consensus 254 --------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 254 --------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred --------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 0011222223557788899999999999999999999999763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.01 Aligned_cols=264 Identities=27% Similarity=0.413 Sum_probs=209.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|.+.+.||+|+||.||+|..... ....++..+|+|.+...... ....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 5688899999999999999976431 12345688999998765443 345788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
...++||||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 999999999999999999976431 2245788999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 295 (400)
+.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE 235 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH
Confidence 9999999999875432222112223345788999999999999999999999999999998 9999865433211 10
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.. ........+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 236 ~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CI--------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH--------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 0011111223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=318.83 Aligned_cols=268 Identities=27% Similarity=0.417 Sum_probs=214.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||.||+|..... ....++..+++|.+..........+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4688899999999999999975431 223456779999987766555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 99999999999999999976431 1234789999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 294 (400)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~ 235 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI 235 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 99999999999976443322222233456788999999988899999999999999999999 999986644311 11
Q ss_pred HhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.. + ........+...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 236 ~~-------------~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 EC-------------I-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HH-------------H-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00 0 00001111223456788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.06 Aligned_cols=269 Identities=27% Similarity=0.366 Sum_probs=205.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||++... .++..+|+|++..... .....+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 368999999999999999999543 4688999998876532 233568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeC
Confidence 99999999999999999999764 3578999999999999999999974 5 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH------hhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE------WAK 298 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~------~~~ 298 (400)
|++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. +..
T Consensus 149 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 149 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred Ccchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 998754322 1223568999999999998889999999999999999999999997543211110000 000
Q ss_pred ------------------HHHhhhhhhhhhcc---ccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 299 ------------------PYLQSKRRIFQVMD---ARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 299 ------------------~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+............. ....... ....+.++.+|+.+||+.||++|||+.+++.|-..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 00000000000000 0000001 11245678899999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=344.50 Aligned_cols=258 Identities=24% Similarity=0.282 Sum_probs=207.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||+||+|... .++..||+|++..... .....+.+|+..+..++|+||+++.+.+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV---------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 3468999999999999999999543 3688999999876543 2334577899999999999999998876
Q ss_pred EeCC--------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 144 LEDD--------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 144 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
...+ .+++||||+.+|+|.+++........++++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCS 178 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeC
Confidence 5432 368999999999999999876544567999999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------ 252 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------ 252 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------
Confidence 99999999999976543322223345679999999999999899999999999999999999999997543211
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ..... .....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 253 ~~~----------~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMH----------KTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH----------HHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 00000 0112233456788999999999999999999999876
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=317.17 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=208.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC-
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD- 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~- 147 (400)
.|...+++|.|+||.||.|...+ +++.||||....+.... -+|+++|+.++|||||++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 57778999999999999997765 47899999987665322 27999999999999999998886431
Q ss_pred ----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceEEe
Q 015781 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLS 222 (400)
Q Consensus 148 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~ 222 (400)
++.+||||+ ..+|.+++.......+.++...+.-+..||++||.|||++| |+||||||.|+|+|.+ |.+||+
T Consensus 92 ~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEec
Confidence 456899999 56999999876555577889999999999999999999988 9999999999999876 899999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|||.|+....+... .....|..|+|||++.+ ..|+.+.||||.||++.||+-|++.|.+....+....+......
T Consensus 169 DFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~- 244 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT- 244 (364)
T ss_pred cCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC-
Confidence 99999976655533 34567999999998866 57999999999999999999999999997765544333211100
Q ss_pred hhhhhh------------hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhc
Q 015781 302 QSKRRI------------FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDT 358 (400)
Q Consensus 302 ~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~ 358 (400)
.....+ .++.......-+....+.++.+|+.++|..+|.+|.++.+++.| +..+++.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000111 11111111111334557789999999999999999999999986 4444444
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=328.47 Aligned_cols=244 Identities=28% Similarity=0.384 Sum_probs=198.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
+.||+|+||.||++... .++..||+|++..... .....+.+|+.+++.++||||+++++++.+++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREK---------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 46899999999999543 4688999999976432 22345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 999999999999888664 35899999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----------------~ 207 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------I 207 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------------h
Confidence 2211 122345799999999999988999999999999999999999999975432111000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
.. ....++...+.++.+++.+||+.||.+|| ++.++++|-
T Consensus 208 ~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 208 LM--EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred cc--CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 00 01122334566788999999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=328.21 Aligned_cols=244 Identities=29% Similarity=0.383 Sum_probs=198.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
+.||+|+||.||++... .+|..||+|++..... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 46999999999999543 4688999999876432 22335668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
+||||+++++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 72 FVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 999999999999888765 35899999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----------------~ 207 (323)
T cd05595 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------------I 207 (323)
T ss_pred cCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----------------H
Confidence 22111 22345789999999999988999999999999999999999999976432111000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
... ...++...+..+.+++.+||+.||.+|| ++.++++|-
T Consensus 208 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 208 LME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred hcC--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 000 1122334566788999999999999998 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.97 Aligned_cols=266 Identities=23% Similarity=0.396 Sum_probs=207.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|.+... ....++..+|+|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 346799999999999999999976531 2233567899999865332 33456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
++...++||||+.+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 999999999999999999998753321 134678889999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 297 (400)
++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999875433222111222345778999999988889999999999999999999 788886543211 11000
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... .....+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 235 -------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -------------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -------------HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 0011122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=323.72 Aligned_cols=268 Identities=22% Similarity=0.277 Sum_probs=200.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 367999999999999999999554 36889999998754322 23456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+...++||||+ .++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCC
Confidence 99999999999 568888886543 45788999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh-
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS- 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 303 (400)
++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+... ...........
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 224 (303)
T cd07869 149 LARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTP 224 (303)
T ss_pred cceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCC
Confidence 9875332211 1233568899999999865 4588899999999999999999999986533111 00000000000
Q ss_pred -hhhh------hhhccccccCCC---------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 -KRRI------FQVMDARIEGQY---------SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 -~~~~------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...+ ............ ....+..+.+|+.+||+.||++|||+.++++|=+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0000 000000000000 0012346778999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.37 Aligned_cols=270 Identities=24% Similarity=0.338 Sum_probs=210.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCC-CCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLY-HPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|..... .+..++..||+|++...... ....+.+|+.+++++. ||||++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 3457899999999999999999976421 23334668999999754332 3456889999999996 9999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcC----------------------------------------------------
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRAS---------------------------------------------------- 170 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------- 170 (400)
+.+.+..|+|||||++|+|.+++.....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 9999999999999999999999865321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCC
Q 015781 171 ----------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210 (400)
Q Consensus 171 ----------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 210 (400)
....+++..+..++.||+.||+|||+.+ ++|+||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 0134788889999999999999999988 9999999999
Q ss_pred EEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCc
Q 015781 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSR 289 (400)
Q Consensus 211 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 289 (400)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999876433222212233456788999999988889999999999999999997 999986542211
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.. . ...........+...+..+.+++.+||+.||++|||+.+|.+.|+.+.
T Consensus 348 ~~--~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 TF--Y--------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH--H--------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00 0 000000111123345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=301.34 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=209.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hh----HHHHHHHHHHHccC-CCCc
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QG----HLEWLTEIKHLGQL-YHPN 135 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~e~~~l~~l-~hpn 135 (400)
..-..|...+.||.|..++|-++ .++.+|..+|+|++..... .. .++-.+|+.+|+++ -||+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY 84 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc
Confidence 44567889999999999999887 6667899999999865322 11 22345799999998 5999
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 136 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
|+++.++|+.+..+++|+|.|+.|.|.|++.... .++++....|+.|++.|++|||..+ ||||||||+|||+++
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILldd 158 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDD 158 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecc
Confidence 9999999999999999999999999999998774 5899999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
+.+++|+|||+++....+.. ....+|||+|+|||.+.. ..|+...|+||+|+|+|.|+.|.+||
T Consensus 159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF------- 228 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF------- 228 (411)
T ss_pred ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch-------
Confidence 99999999999998877653 566899999999998853 46888999999999999999999999
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
|-+..+--- ..++.....-.- =...+....+||.+||+.||.+|.|++|+|.|-..
T Consensus 229 ------wHRkQmlML---R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 229 ------WHRKQMLML---RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred ------hHHHHHHHH---HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 333221111 111111111111 12456778899999999999999999999998554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=329.33 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|.+... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 5799999999999999999965431 246899999865432 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecC
Confidence 999999999999999999999765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.....
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------------ 238 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------------ 238 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------------
Confidence 999764321 234578999999999998889999999999999999999999997654311100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
.+.... ..++...+..+.+++++||+.||.+|+ +++++++|-
T Consensus 239 ----~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 239 ----KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ----HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 011110 112333456788999999999999995 899999874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=321.92 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=207.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+... ....+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 5699999999999999999976531 122345699999875432 3345688899999999999999999998765
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..++++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccc
Confidence 5789999999999999997654 35788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------------- 220 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------- 220 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---------------
Confidence 986543332211222334678999999999999999999999999999997 9999975432110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
............+..++..+..++.+||..+|.+||++.+++..|..+....
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 221 --SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0011111111112234567889999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=312.10 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|.+.. ...+...+|+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKL------PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEcc------CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 568999999999999999997753 1123568999998765432 344678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccch
Confidence 99999999999999999997654 36899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~-------- 221 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV-------- 221 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH--------
Confidence 987642222111222344678999999998899999999999999999998 999986543211 00000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
........+...+..+.+++.+||+.+|++||++.+++++|+++
T Consensus 222 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 ------EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00001111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=333.48 Aligned_cols=255 Identities=24% Similarity=0.270 Sum_probs=199.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|++.+.||+|+||+||+|... .++..+|+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV---------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 5888999999999999999543 46889999999764322 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCc
Confidence 99999999999999999998765 35889999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCC---------------------------------------------cceeeecccccCcccchhhccCCCC
Q 015781 226 LAKDGPTGSQ---------------------------------------------SHVSTRVMGTYGYAAPEYMATGHLT 260 (400)
Q Consensus 226 ~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 260 (400)
++........ .......+||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 8753211000 0001235799999999999988999
Q ss_pred CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhc--ccCC
Q 015781 261 AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKC--LSNE 338 (400)
Q Consensus 261 ~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~--l~~d 338 (400)
.++|||||||++|+|++|..||....+......+ ... ............+.++.+|+.+| +..+
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i-------------~~~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV-------------INW-ENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH-------------Hcc-ccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999999999999999765432111000 000 00011111123456778888884 4556
Q ss_pred CCCCCCHHHHHHHH
Q 015781 339 PKFRPTMDEVVKAL 352 (400)
Q Consensus 339 P~~Rps~~eil~~L 352 (400)
|..||++.+++.|-
T Consensus 293 ~~~R~~~~~~l~hp 306 (381)
T cd05626 293 RLGRNGADDIKAHP 306 (381)
T ss_pred ccCCCCHHHHhcCc
Confidence 66699999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=324.69 Aligned_cols=241 Identities=27% Similarity=0.340 Sum_probs=196.2
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 799999999999544 3688999999875432 2334577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 72 LAFINGGELFHHLQRE----GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 9999999999999764 35889999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ...
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~----------~~~ 207 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRK----------ILQ 207 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHH----------HHc
Confidence 21 12334679999999999999999999999999999999999999997543210 1010 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRP---TMDEVVKA 351 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~eil~~ 351 (400)
. ...++...+..+.+++.+||+.||.+|| ++.+++.|
T Consensus 208 ~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 208 E--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred C--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 1122334567788999999999999997 46788776
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=332.86 Aligned_cols=256 Identities=27% Similarity=0.312 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 36889999999999999999554 3688999999876432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999999999999765 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCC---------------------------CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh
Q 015781 225 GLAKDGPTGS---------------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277 (400)
Q Consensus 225 g~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 277 (400)
|++....... .........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9997644322 0011234578999999999999999999999999999999999
Q ss_pred CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHH
Q 015781 278 GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKALE 353 (400)
Q Consensus 278 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~eil~~L~ 353 (400)
|..||........... .. ... ..+........+..+.+++.+||. ||.+||+ +.++++|-+
T Consensus 226 g~~Pf~~~~~~~~~~~------i~-------~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 226 GFPPFYSDTLQETYNK------II-------NWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCCCCCCHHHHHHH------Hh-------ccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 9999976542111000 00 000 001111111246788899999997 9999999 999999843
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.74 Aligned_cols=264 Identities=19% Similarity=0.223 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||+|... .+++.||+|.... ..+.+|+.+++.++||||+++++++..+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~---------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDN---------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEEC---------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 57999999999999999999554 4688999997542 24568999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++|||++ +++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 157 ~~~lv~e~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 157 FTCLILPRY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred eeEEEEecC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 999999999 57898888664 35789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc----hhHHhhhHHH--
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH----NLIEWAKPYL-- 301 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~----~~~~~~~~~~-- 301 (400)
....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.......
T Consensus 230 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 7532211 11223457999999999999889999999999999999999999887543321100 0000000000
Q ss_pred -------hhhhhhhhhc-------cccccCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 302 -------QSKRRIFQVM-------DARIEGQ----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 302 -------~~~~~~~~~~-------~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.....+.... ....... .....+.++.+|+.+||+.||.+|||+.|+|++=+.
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0000000000 0000000 011345678899999999999999999999987553
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.13 Aligned_cols=255 Identities=23% Similarity=0.272 Sum_probs=197.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|.. ..++..||+|++...... ....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQK---------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3688999999999999999954 446889999999764321 2345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+...+|+||||++||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeec
Confidence 999999999999999999999765 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc---------------------------------ceeeecccccCcccchhhccCCCCCccchhhHHHH
Q 015781 225 GLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVV 271 (400)
Q Consensus 225 g~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~i 271 (400)
|+++........ ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998753321100 00123579999999999999999999999999999
Q ss_pred HHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhccc--CCCCCCCCHHHHH
Q 015781 272 LLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS--NEPKFRPTMDEVV 349 (400)
Q Consensus 272 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dP~~Rps~~eil 349 (400)
+|+|++|..||....+......+ .... ..+........+..+.+++.+|+. .++..||++.+|+
T Consensus 226 l~ell~G~~Pf~~~~~~~~~~~i-------------~~~~-~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~ 291 (363)
T cd05628 226 MYEMLIGYPPFCSETPQETYKKV-------------MNWK-ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIK 291 (363)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHH-------------HcCc-CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence 99999999999765432111100 0000 000000011235567778887654 2334568999999
Q ss_pred HH
Q 015781 350 KA 351 (400)
Q Consensus 350 ~~ 351 (400)
+|
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=315.57 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=207.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. .+..++..+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 468888999999999999997632 2334578899999875432 2335677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS-------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
...|+||||+.+++|.+++..... ....+++..+..++.||+.||+|||+++ ++|+||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 999999999999999999864321 1234788899999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccch
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 292 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 292 (400)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--- 234 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--- 234 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986543332222333445678999999988889999999999999999998 999986543211
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+. .........+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus 235 ~~~~--------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEM--------------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH--------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1110 00000111222345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.11 Aligned_cols=258 Identities=25% Similarity=0.318 Sum_probs=203.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
+|++.+.||+|+||.||++... ....++..+|+|++..... .....+..|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 4788999999999999998653 2334689999999875322 2234567899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++..++||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999998765 35889999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. .
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~---- 221 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--R---- 221 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--H----
Confidence 9998764332211 22345799999999999765 47889999999999999999999997543322111110 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
.+.. .....+...+..+.+++.+||+.||++|| ++.++++|-+
T Consensus 222 ------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 222 ------RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred ------HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 0000 11122334566788999999999999999 7889998743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=333.66 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 36899999999999999999544 4688999999975432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeec
Confidence 999999999999999999998765 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcc------------------------------------eeeecccccCcccchhhccCCCCCccchhhH
Q 015781 225 GLAKDGPTGSQSH------------------------------------VSTRVMGTYGYAAPEYMATGHLTAKSDVYSF 268 (400)
Q Consensus 225 g~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwsl 268 (400)
|++.......... .....+||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9986532211000 0112469999999999998899999999999
Q ss_pred HHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC---H
Q 015781 269 GVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT---M 345 (400)
Q Consensus 269 G~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~ 345 (400)
||++|+|++|..||....+......+ .... ..+........+..+.++|.+||. +|.+|++ +
T Consensus 226 G~il~el~~G~~Pf~~~~~~~~~~~i------~~~~--------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQETYRKI------INWK--------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHHHHHHH------HcCC--------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 99999999999999765432111000 0000 000001111345678889999996 9999997 9
Q ss_pred HHHHHHH
Q 015781 346 DEVVKAL 352 (400)
Q Consensus 346 ~eil~~L 352 (400)
.++++|-
T Consensus 291 ~~ll~h~ 297 (364)
T cd05599 291 NEIKSHP 297 (364)
T ss_pred HHHhcCC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=332.17 Aligned_cols=267 Identities=23% Similarity=0.278 Sum_probs=209.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-C-----Ccccceee
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H-----PNLVKLIG 141 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~~~~ 141 (400)
.+|.+.++||+|+||.|.+|++. +|++.||||+++.... -..+...|+.+|..|+ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~---------~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDH---------KTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEec---------CCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 37788999999999999999655 4799999999986543 3345567888888886 3 48999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC--Cce
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNA 219 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~--~~~ 219 (400)
+|...+++|||+|.+ ..+|+++++...- .+++...+..++.||+.||.+||..+ |||+||||+||||... ..|
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence 999999999999999 7799999987653 67999999999999999999999988 9999999999999543 469
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh-
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK- 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~- 298 (400)
||+|||.++...... .....+..|+|||++.+..|+.+.||||||||++||++|.+.|.+..+.+....+....
T Consensus 331 KVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred eEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 999999999754432 25677889999999999999999999999999999999999999988766544431100
Q ss_pred --------------HHHhhhhhhhh-----------------------hccc-------cccCCCCHHHHHHHHHHHHhc
Q 015781 299 --------------PYLQSKRRIFQ-----------------------VMDA-------RIEGQYSLGAALKTAVLAIKC 334 (400)
Q Consensus 299 --------------~~~~~~~~~~~-----------------------~~~~-------~~~~~~~~~~~~~l~~li~~~ 334 (400)
.++........ ..+. .+...........+.+++++|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 00111000000 0000 000111224456789999999
Q ss_pred ccCCCCCCCCHHHHHHHHHh
Q 015781 335 LSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 335 l~~dP~~Rps~~eil~~L~~ 354 (400)
|..||.+|+|..++|+|-+-
T Consensus 486 L~~dP~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFL 505 (586)
T ss_pred hccCchhcCCHHHHhcCccc
Confidence 99999999999999998544
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=315.75 Aligned_cols=266 Identities=27% Similarity=0.379 Sum_probs=208.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478899999999999999976431 1222346789998875543 23456788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRAS--------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 207 (400)
..+++|||+.+++|.+++..... ...++++..++.++.|++.||+|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 99999999999999999865321 1235789999999999999999999988 9999999
Q ss_pred CCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCC
Q 015781 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNR 286 (400)
Q Consensus 208 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~ 286 (400)
|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875433222111222345678999999988889999999999999999998 999997654
Q ss_pred CCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 287 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
+.... ...........+...+..+.+++.+||+.+|++||++.++++.|+++-.
T Consensus 235 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLF-----------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH-----------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 32111 1111111122233455688899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=311.65 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=207.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .....+.+|+..++.++||||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 458888999999999999996643 57889999987543 33456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999976432 45889999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~------------ 215 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y------------ 215 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H------------
Confidence 765432211 1112234567999999988899999999999999999998 9999875432111 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
...........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 --ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00111111222334567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.98 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=196.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHcc---CCCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQ---LYHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~---l~hpniv~~~~~ 142 (400)
++|++.+.||+|+||.||+|.... .++..||+|.+...... ....+.+|+.+++. ++||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 479999999999999999996532 23678999988654322 12334556655554 479999999998
Q ss_pred EE-----eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 143 CL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 143 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
+. ....+++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG 147 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCC
Confidence 85 3456899999995 699999876432 45889999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 148 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 148 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred CEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 99999999997643321 233457899999999998889999999999999999999999999876543222111100
Q ss_pred hHHHhhhhhhhh-------hcccccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 298 KPYLQSKRRIFQ-------VMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 298 ~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ......+.. ....... .......+..+.+++.+||+.||++|||+.++++|
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 225 IG-LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hC-CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 000000000 0000000 00111245677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.91 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=199.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAID---------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEE---------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 588899999999999999954 3468899999987532 23344678999999999999999999988543
Q ss_pred -----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 147 -----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
..+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEE
Confidence 3579999999 57899988754 35899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCC-cceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 222 SDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|||+++....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.........+....
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 99999975432211 112234578999999999865 678999999999999999999999997654322111110000
Q ss_pred --------HHHh--hhhhhhhhccccccCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 299 --------PYLQ--SKRRIFQVMDARIEGQY---SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 299 --------~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... ........+........ -...+..+.+++.+||+.||++|||+.++++|=+
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 0000 00000000000000000 0123456789999999999999999999999744
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=312.80 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=209.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 3568999999999999999996542 677999999877655566788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999976432 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... .....++..|++||.+....++.++||||||+++|+|++ |+.||........ ...
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~--------- 216 (261)
T cd05148 151 ARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQ--------- 216 (261)
T ss_pred hhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH---------
Confidence 9765432211 123345678999999988889999999999999999998 8999976542111 110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 217 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 -----ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001111122344567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.72 Aligned_cols=255 Identities=23% Similarity=0.250 Sum_probs=199.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+|++.+.||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRK---------VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEE---------CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 689999999999999999954 34689999999875432 123456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999999765 35788999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCC-----------------------------------------CcceeeecccccCcccchhhccCCCCCccc
Q 015781 226 LAKDGPTGS-----------------------------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSD 264 (400)
Q Consensus 226 ~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD 264 (400)
++....... ........+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 975321000 000012357999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-
Q 015781 265 VYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP- 343 (400)
Q Consensus 265 iwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp- 343 (400)
||||||++|+|++|+.||....+......+. . . ............+..+.+++.+|+ .+|.+|+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~---~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVI-------N---W----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHh-------c---c----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 9999999999999999997654321111000 0 0 000000111234556778888876 5999999
Q ss_pred --CHHHHHHHHH
Q 015781 344 --TMDEVVKALE 353 (400)
Q Consensus 344 --s~~eil~~L~ 353 (400)
++.++++|-+
T Consensus 292 ~~t~~ell~h~~ 303 (376)
T cd05598 292 KNGADEIKAHPF 303 (376)
T ss_pred CCCHHHHhCCCC
Confidence 9999999833
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.88 Aligned_cols=247 Identities=27% Similarity=0.355 Sum_probs=199.2
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||.||++.... ...++..||+|++..... .....+.+|+.+++.++||||+++++++.+++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 679999999999996532 234688999999875432 2233467899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|.+++... ..+.+..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9999999999999998765 35788899999999999999999988 99999999999999999999999999874
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ . ..
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~----------~~ 211 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------I----------DK 211 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------H----------HH
Confidence 322211 22345789999999999888899999999999999999999999976542110 0 01
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
+... ....+...+..+.+++.+||+.||++|| ++.++++|-
T Consensus 212 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 212 ILKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 1111 1122334456788999999999999999 899998864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=327.65 Aligned_cols=244 Identities=30% Similarity=0.379 Sum_probs=197.5
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
+.||+|+||.||++.. ..++..+|+|++..... .....+..|+++++.++||||+++++++.+++..|
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 4699999999999954 34688999999976432 22345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
+||||+.+++|..++... ..+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++..
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999999999999888764 358999999999999999999997 67 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------------- 208 (325)
T cd05594 146 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------- 208 (325)
T ss_pred cCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---------------
Confidence 322111 223457999999999999889999999999999999999999999764321111000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
... ...++...+.++.+++.+||+.||++|+ ++.++++|-
T Consensus 209 -~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 209 -LME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -hcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 000 1112333456788999999999999996 999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.41 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||+||+|.+... .......+++|.+...... ...++..|+..++.++||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 5788999999999999999977431 1112335888887644322 2346777888999999999999999876 4
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++++||+.+++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcc
Confidence 56789999999999999997654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..+...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~- 227 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKG- 227 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCC-
Confidence 976543322222233456778999999988899999999999999999998 9999976543211111 0000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.....+..++..+..++.+||..||.+|||+.++++.|..+....
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 ---------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 000111123456788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=313.34 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=208.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||++..... ....++..+++|.+..........+.+|+++++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 5788899999999999999965421 233457789999987665555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
..+++|||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCC
Confidence 99999999999999999976431 1134788999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 295 (400)
+.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI- 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH-
Confidence 9999999999875433222111222345678999999988899999999999999999998 89998654321111000
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 238 ----------------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ----------------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----------------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0001111222345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.82 Aligned_cols=256 Identities=23% Similarity=0.264 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||++... .+++.||+|++..... .....+.+|+++++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK---------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 36889999999999999999543 4688999999865432 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999998764 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc---------------------------------------------ceeeecccccCcccchhhccCCC
Q 015781 225 GLAKDGPTGSQS---------------------------------------------HVSTRVMGTYGYAAPEYMATGHL 259 (400)
Q Consensus 225 g~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 259 (400)
|+++........ ......+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632110000 00012468999999999998899
Q ss_pred CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCC
Q 015781 260 TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEP 339 (400)
Q Consensus 260 ~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 339 (400)
+.++|||||||++|+|++|..||...........+ . ... ..+........+.++.+|+.+||. +|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-------~~~-~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI------I-------NWR-ETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH------H-------ccC-CccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 99999999999999999999999765431111000 0 000 000000111245678899999997 67
Q ss_pred CCC---CCHHHHHHHHH
Q 015781 340 KFR---PTMDEVVKALE 353 (400)
Q Consensus 340 ~~R---ps~~eil~~L~ 353 (400)
.+| +++.+++.|-+
T Consensus 291 ~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 291 ENRLGRGGAHEIKSHPF 307 (377)
T ss_pred hhcCCCCCHHHHhcCCC
Confidence 665 69999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=328.03 Aligned_cols=254 Identities=23% Similarity=0.252 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|.+.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK---------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 36889999999999999999544 4688999999976533 22345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccC
Confidence 9999999999999999999997753 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc------cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|++......... ......||+.|+|||++. ...++.++|||||||++|+|++|..||......... .
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~ 219 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------N 219 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------H
Confidence 999765432221 223357899999999986 456789999999999999999999999764421110 0
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... ...+........+..+.+|+.+||+ +|.+|||+.+++.|
T Consensus 220 ~i~~~--------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 220 NIMNF--------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHcC--------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00000 0000111112345678899999998 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=310.50 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=209.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 57899999999999999999654 3578999998764322 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754433356889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..+...
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~----- 219 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK----- 219 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH-----
Confidence 99876433221 1223468889999999988889999999999999999999999986432210 001000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
+.............+..+.+++.+||+.+|.+||++.++++.++.++
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 -----IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000111112345677899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.70 Aligned_cols=254 Identities=23% Similarity=0.257 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..+|++.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 467999999999999999999543 4688999999865322 2233467899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999999998653 4788899999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccC----CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------- 256 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------- 256 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH--------
Confidence 999876432211 112345799999999998653 4789999999999999999999999765431110
Q ss_pred HHhhhhhhhhhccccccCCCC--HHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~ 353 (400)
..+........++ ...+..+.+|+.+||+.+|.+ |+|+.++++|-+
T Consensus 257 --------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 257 --------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred --------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0111111011111 234678889999999999988 999999999853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=324.23 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=196.6
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHH---HHccCCCCcccceeeEE
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK---HLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~hpniv~~~~~~ 143 (400)
|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|.. .++.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 677899999999999999654 3688999999875432 12234445544 45677899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..|+||||+.+++|..++.. ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999888754 35899999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~----------- 211 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----------- 211 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 99987532211 12334678999999999999999999999999999999999999997654211100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
.+... ....+...+..+.+++.+||+.||.+|| ++.+++++-
T Consensus 212 -----~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 212 -----SIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred -----HHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 00000 1122334566788999999999999999 688888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.80 Aligned_cols=255 Identities=35% Similarity=0.553 Sum_probs=198.5
Q ss_pred CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 72 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
+.+.||.|.||.||+|.+.. .....+..|+||.+..... .....+.+|++.+++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999998873 3444678999999965433 23667899999999999999999999999888899
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||++.||+++.++.+||+|||++...
T Consensus 78 lv~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 99999999999999988722 56899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
.................|+|||.+.+..++.++||||||+++|||++ |..||....... ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~-------------~ 217 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE-------------K 217 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH-------------H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc-------------c
Confidence 33222222333456778999999988889999999999999999999 678886543211 000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
+ ........+..++..+..++.+||+.||++|||+.++++.|
T Consensus 218 ~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 L-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp H-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 11111122334567788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=308.45 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=197.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|.+. .++..+|+|.+..... .....+.+|+++++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEe---------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46999999999999654 3578899998765432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999986543 35889999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
............+..|+|||.+.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-----------------~~~ 209 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-----------------EAI 209 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-----------------HHH
Confidence 211111111123456999999988889999999999999999998 88888654321100 001
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 210 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111111223344668889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.54 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=210.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||++..... ........+|+|.+..... .....+.+|+.+++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 35789999999999999999976532 1123457899999876432 2334578899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
.++..+++|||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ |+|+||||+||+
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil 164 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVL 164 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEE
Confidence 9999999999999999999997532 12356899999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999986544322212222334678999999988899999999999999999997 99998754321111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
. ..........+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 245 ~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K-----------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 01111111223344667889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.28 Aligned_cols=253 Identities=24% Similarity=0.274 Sum_probs=198.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|++.+.||+|+||+||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV---------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 5888999999999999999543 4688999999876432 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECC
Confidence 99999999999999999998765 35789999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCC---------------------------------------------CcceeeecccccCcccchhhccCCCC
Q 015781 226 LAKDGPTGS---------------------------------------------QSHVSTRVMGTYGYAAPEYMATGHLT 260 (400)
Q Consensus 226 ~~~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 260 (400)
++....... ........+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 975321000 00001234789999999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCC
Q 015781 261 AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPK 340 (400)
Q Consensus 261 ~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 340 (400)
.++|||||||++|+|++|+.||....+......+ . .. ............+..+.+++.+|+ .+|.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV------I-------NW-QTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH------H-------cc-CCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 9999999999999999999999765432111000 0 00 000111111234567778888876 5999
Q ss_pred CCCC---HHHHHHH
Q 015781 341 FRPT---MDEVVKA 351 (400)
Q Consensus 341 ~Rps---~~eil~~ 351 (400)
+|++ +.++++|
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9987 9998886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.10 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=205.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCC-CCccccee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLI 140 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~ 140 (400)
....+.|++.+.||.||.+.||++...+ ...+|+|.+.... .....-+.+|+..|.+|+ |.+||+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 3455789999999999999999985432 3456666554332 234456899999999995 89999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+|-..++++||||||- ..+|..+|.+... . ++.-.++.++.||+.|+.++|++| |||.||||.|+|+- .|.+|
T Consensus 427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~--~-~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 427 DYEVTDGYLYMVMECG-DIDLNKILKKKKS--I-DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eeeccCceEEEEeecc-cccHHHHHHhccC--C-CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEE
Confidence 9999999999999986 7799999988764 2 333388999999999999999999 99999999999986 57999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCC-----------CCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-----------LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
|+|||+|...............+||+.||+||.+.... .+.++||||||||||+|+.|+.||....
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--- 576 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--- 576 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---
Confidence 99999999888877777788899999999999985432 4578999999999999999999996421
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHH-HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAA-LKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.....+..+.++.-+.+++.--. .++.++++.||+.||++|||+.++|+|
T Consensus 577 ------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 ------------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11223344555544444443222 238999999999999999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=336.62 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=194.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC------CCCcccc
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL------YHPNLVK 138 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~ 138 (400)
...++|++.+.||+|+||+||+|... .++..||||++..... ....+..|+.+++.+ .|+++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDR---------KRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEc---------CCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 34578999999999999999999553 3678999999864321 122334455555554 3556888
Q ss_pred eeeEEEeC-CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCC
Q 015781 139 LIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 139 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~ 216 (400)
+++++..+ .++|+|||++ +++|.+++.+. .++++..+..++.||+.||+|||+ .+ |+||||||+|||++.+
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETS 268 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecC
Confidence 98888754 5789999998 78899888765 358999999999999999999997 47 9999999999999866
Q ss_pred C----------------ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCC
Q 015781 217 Y----------------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 217 ~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~ 280 (400)
+ .+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 5 499999998764322 1234679999999999999999999999999999999999999
Q ss_pred ccCCCCCCccchhHHhh---------hH--------HHhhhhhhhhhcccc-----cc--CCCCHHHHHHHHHHHHhccc
Q 015781 281 VIDKNRPSREHNLIEWA---------KP--------YLQSKRRIFQVMDAR-----IE--GQYSLGAALKTAVLAIKCLS 336 (400)
Q Consensus 281 pf~~~~~~~~~~~~~~~---------~~--------~~~~~~~~~~~~~~~-----~~--~~~~~~~~~~l~~li~~~l~ 336 (400)
||...........+... .. +......+....+.. .. ..........+.+||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 99876543222222110 00 000000000000000 00 00001124567799999999
Q ss_pred CCCCCCCCHHHHHHHHHhc
Q 015781 337 NEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 337 ~dP~~Rps~~eil~~L~~~ 355 (400)
.||++|||+.|+|+|=+..
T Consensus 424 ~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred cChhhCCCHHHHhcCcccc
Confidence 9999999999999975543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.57 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=199.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
...+|++.+.||+|+||.||+|... .++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 3467999999999999999999543 368899999885432 123479999999999999999987743
Q ss_pred C--------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 146 D--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 146 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
. ..+++||||++ ++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCC
Confidence 2 25679999995 5888887654434467899999999999999999999988 99999999999998665
Q ss_pred -ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 218 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
.+||+|||+++....... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 699999999986543221 223578999999999865 468999999999999999999999998765432211111
Q ss_pred hhh--HHHhhhh---------hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 296 WAK--PYLQSKR---------RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 296 ~~~--~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
... +...... .+.......+...++...+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 000 0000000 000000011111122234568899999999999999999999998744
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.44 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=198.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCC-cccceeeEEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHP-NLVKLIGYCL 144 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hp-niv~~~~~~~ 144 (400)
+|++.+.||+|+||.||+|... .+++.||+|++..... .....+..|..++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 4888999999999999999554 3678999999876432 2334567888899888765 5888999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeec
Confidence 999999999999999999998765 35789999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------------ 211 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------------ 211 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99874322111 2334678999999999999899999999999999999999999997653211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
.+.. ....++...+..+.+++.+||+.||.+|++. .++++|
T Consensus 212 ----~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 212 ----SIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----HHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0001 0112233456678899999999999999976 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=309.97 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3578999999999999999996542 45799998875432 345788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999976532 45788899999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..+ ...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~-- 219 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----LQR-- 219 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----HHc--
Confidence 9865432211 1122345678999999988889999999999999999998 9999975432111 100 000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 220 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 --------GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 001111123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.36 Aligned_cols=273 Identities=32% Similarity=0.463 Sum_probs=207.2
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC--
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED-- 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-- 146 (400)
|++.+.||+|+||+||++.... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4889999999999999876542 3445688999999876533 2345678899999999999999999987653
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+.+++|.+++... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccc
Confidence 4689999999999999998653 4899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .....+..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~ 231 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-TVV 231 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-chh
Confidence 886543322111 122345667999999988889999999999999999999999986543211 11110000000 000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.+............+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111112223345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=314.44 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=198.9
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||+|+||+||++... .+++.+|+|.+...... ....+..|+.+++.++||||+++.+++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMR---------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEc---------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 699999999999543 46889999998754332 224567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999888654333356899999999999999999999988 99999999999999999999999999875443
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||............ ......
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~~ 215 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------KQRILN 215 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHhhcc
Confidence 221 123357899999999999999999999999999999999999999764322111000 000111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
. ....+...+..+.+++.+||+.||++|| ++.++++|-
T Consensus 216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 216 D--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred c--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 1 1122334567888999999999999999 778888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=322.63 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=195.5
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||+||+|... .++..||+|++..... .....+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 46999999999999554 3688999999875432 2234566788888766 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 9999999999999988765 35889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~----------------~ 207 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE----------------A 207 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH----------------H
Confidence 32211 12334678999999999998899999999999999999999999997654211100 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~eil~~ 351 (400)
+... ....+...+..+.+++.+||+.||.+||++ ++++.|
T Consensus 208 i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 208 ILND--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HhcC--CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0000 111223356678899999999999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=321.56 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=197.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||.||+|... .++..||+|++...... ....+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 46999999999999554 36889999999764322 233467888888888 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999999999999888654 35899999999999999999999988 99999999999999999999999999874
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc--cchhHHhhhHHHhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR--EHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 307 (400)
..... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... ......+....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------- 216 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------- 216 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-------
Confidence 22111 12334678999999999999999999999999999999999999996432211 11111111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT------MDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~eil~~ 351 (400)
+.... ...+...+..+.+++.+||+.||.+||+ +.++++|
T Consensus 217 --~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 217 --ILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111 1123344567889999999999999997 6788876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=316.31 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=204.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|++.++||+|+||.||++... .++..||+|++...... ....+.+|+.+++.++||||+++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4788899999999999999543 36889999998754332 22346789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----------- 213 (285)
T cd05605 148 LAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----------- 213 (285)
T ss_pred CceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-----------
Confidence 9876433221 22347899999999998889999999999999999999999999764432111000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
...+. .....++...+..+.+|+.+||+.||.+|| ++.++++|-
T Consensus 214 --~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 214 --ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred --HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 00000 011122334567788999999999999999 888998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=328.58 Aligned_cols=255 Identities=23% Similarity=0.261 Sum_probs=201.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
..++|++.+.||+|+||.||++... .++..+|+|++..... .....+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3468999999999999999999544 4688999999865322 223346789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998653 4788999999999999999999988 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccC----CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 185 DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------- 256 (370)
T cd05621 185 DFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------- 256 (370)
T ss_pred ecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-------
Confidence 9999986533221 122346799999999998654 3788999999999999999999999765321110
Q ss_pred HHHhhhhhhhhhcccc--ccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHH
Q 015781 299 PYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 353 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~ 353 (400)
..+.... +........+..+.+++.+||..++.+ |+++.++++|-+
T Consensus 257 ---------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 257 ---------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ---------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 1111111 111111234667888999999866544 899999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.10 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=204.5
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.+.||+|+||.||+|.... ...++..+|+|.+..... .....+.+|+..++.++||||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5778999999999999997643 223467899999876433 23356788999999999999999999886654
Q ss_pred e------eEEEEeecCCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 148 H------RLLVYEFMPKGSLENHLFRRAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 148 ~------~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
. .+++|||+++++|..++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeE
Confidence 4 7999999999999999865431 2246899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 298 (400)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~- 228 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL- 228 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence 9999999886543322211222334678999999988889999999999999999999 889986543211 11110
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
........+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 229 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 -------------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011122334567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=313.67 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=207.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+... .....+..||+|.+...... ....+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3577889999999999999976432 12234678999999755432 234577899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
+..++++||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 99999999999999999986321 11235788899999999999999999988 99999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchh
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 293 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 293 (400)
.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 235 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999886543332222333456788999999988889999999999999999998 888886543211 0
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
. ..+........+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus 236 ~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I--------------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H--------------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 0000111112234566778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=321.16 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=192.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHcc-CCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||.||+|... .++..||+|++..... .....+..|..++.. .+||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999999654 3688999999876432 122334556666654 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 72 ~lv~e~~~gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 9999999999999998765 35889999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~----------------~ 207 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD----------------S 207 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence 43222 12334678999999999998899999999999999999999999997654211000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~ 351 (400)
+.. ....++...+.++.+++.+||+.||.+||++. ++++|
T Consensus 208 i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 208 ILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 000 01122334566788999999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=312.55 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|..... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 35789999999999999999977532 1134568899999875532 334567889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
....++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 99999999999999999999754321 124788899999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---- 234 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV---- 234 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH----
Confidence 9999999875443322222233456788999999988889999999999999999998 99998654432111100
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 -------------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000011223334678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.72 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=209.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|.+.+.||+|+||.||+|.+... .+..++..+|+|.+..... .....+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 35799999999999999999975321 2344677899999875432 2345678899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
..+..++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999975432 34899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~-------- 255 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK-------- 255 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH--------
Confidence 99876543322112223445778999999988889999999999999999998 99998754321100 00
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 256 ------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 ------LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000011111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=322.30 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=196.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||.||+|... .++..||+|++..... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 46999999999999544 4688999999876432 2233466788888765 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 9999999999999988765 35889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~----------------~ 207 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE----------------S 207 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH----------------H
Confidence 322211 2334578999999999998899999999999999999999999997654211100 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-------TMDEVVKAL 352 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~eil~~L 352 (400)
+... ....+...+.++.+++.+||+.||++|| ++.++++|-
T Consensus 208 i~~~--~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 208 ILHD--DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 0000 0112223456788999999999999999 889998873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.79 Aligned_cols=272 Identities=25% Similarity=0.361 Sum_probs=210.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|.+.+.||+|+||.||+|...... .....++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999764311 0122345679999997643 23345677899999999 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+++..|+||||+.+++|.+++...... ...+++..++.++.||+.||+|||+++ ++|+||||+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheE
Confidence 999999999999999999999764321 134788999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.++|+|||.+................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.........
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999999875533221111122234568999999988889999999999999999998 88888654321100
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
...........+...+..+.+|+.+||..+|.+|||+.++++.|+.+....
T Consensus 253 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 -----------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -----------------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 000111111223345668889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.96 Aligned_cols=269 Identities=24% Similarity=0.256 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|.+.+.||+|+||.||++.... ..++..||+|.+.... ...+|+.++++++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 4579999999999999999986532 2357889999886532 345799999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++|||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999 57888888433 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh--
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK-- 304 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 304 (400)
+................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..........
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 976544333222334679999999999998899999999999999999999999997765432211111000000000
Q ss_pred -------hhhh---hhccccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 -------RRIF---QVMDARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 -------~~~~---~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+. ..........+. ...+.++.++|.+||..||++|||+.++|.+=+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0000 000000000000 1234577889999999999999999999998544
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=306.83 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=210.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+|..+|+|.+..... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 57999999999999999999654 3688999998864322 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998764443456899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ......
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~------ 218 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK------ 218 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh------
Confidence 99875433221 122346888999999998888999999999999999999999998654311 000000
Q ss_pred hhhhhhccccccCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 305 RRIFQVMDARIEGQYS-LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
. .........+ ...+..+.+++.+||..+|++|||+.+|++.|+.++
T Consensus 219 ----~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 ----K-IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----h-hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0000011112 245668889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=320.70 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=193.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHcc-CCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||.||+|... .+|..||+|++..... .....+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 46999999999999554 4688999999876432 223345667777765 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 9999999999999998764 35789999999999999999999988 99999999999999999999999999874
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~------------- 207 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFES------------- 207 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH-------------
Confidence 32221 12344678999999999999999999999999999999999999997543211 0000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~ 351 (400)
+.. ....++...+.++.+++.+||+.||.+||++. ++++|
T Consensus 208 ~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 208 IRV--DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHh--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 000 01122233456788999999999999999985 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.26 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 458888999999999999997643 4579999876543 23456788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999999999987543 35789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+ . ..
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~----~~-- 217 (256)
T cd05114 148 RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---S----RG-- 217 (256)
T ss_pred cccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----CC--
Confidence 754322211 1112234568999999988889999999999999999999 89999765421111100 0 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 218 --------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 --------FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00011222345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.73 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=195.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||.||+|... .+++.+|+|++..... .....+..|+.++.++ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 46999999999999554 3688999999976432 2233466788887766 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 9999999999999888654 35899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc--cchhHHhhhHHHhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR--EHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 307 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......+....
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------- 216 (329)
T cd05618 146 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------- 216 (329)
T ss_pred ccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-------
Confidence 322111 2234678999999999999999999999999999999999999996422111 11111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT------MDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~eil~~ 351 (400)
+... ...++...+..+.+++.+||+.||++||+ +.++++|
T Consensus 217 --i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 217 --ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111 11233445667889999999999999998 4688776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.10 Aligned_cols=255 Identities=28% Similarity=0.387 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-----hHHHHHHHHHHHccCCCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
+.|.+.+.||+|++|.||+|... .++..+|+|.+...... ....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV---------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEc---------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 46899999999999999999543 36889999988654321 22457789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999998765 35789999999999999999999988 9999999999999999999999
Q ss_pred eccCCccCCCCCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 223 DFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~------- 216 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I------- 216 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H-------
Confidence 9999875432211111 1234578899999999988899999999999999999999999965432110 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
............+...+..+.+++.+||..+|.+|||+.+++++.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 217 ------FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred ------HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 0111111122334456678889999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.20 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=205.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|.+.+.||+|+||.||+|.+... ....++..|++|.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 5689999999999999999976531 11225778999988754332 334688899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---ceE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAK 220 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~k 220 (400)
+..++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++.++ .++
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 999999999999999999976532 1235899999999999999999999988 99999999999998654 599
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~------- 232 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME------- 232 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------
Confidence 999999986532221111122233567999999988899999999999999999997 999997654321111
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..........+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 233 ----------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ----------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01111111223344567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.96 Aligned_cols=277 Identities=27% Similarity=0.387 Sum_probs=206.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe--
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-- 145 (400)
.+|++.+.||+|+||.||++.... ....++..||+|.+..........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478899999999999999997542 3445688999999877655556678899999999999999999998653
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
...+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCc
Confidence 356899999999999999997543 35889999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++........... .....++..|+|||.+.+..++.++|||||||++|+|++|..++......- ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIV 232 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccch
Confidence 9986543322111 111223456999999988889999999999999999999887654322100 00000000000000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..+...+........+...+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111111111112234456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.14 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=205.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 356899999999999999999653 246799999876542 345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcce
Confidence 99999999999999999997654 246899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||..........
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------------- 215 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ------------- 215 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------------
Confidence 8865422111 1111222457999999988899999999999999999999 999997643211100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 216 ----QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0000001112234457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=324.54 Aligned_cols=265 Identities=29% Similarity=0.440 Sum_probs=214.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc---chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+-.+.+.||+|+||.||+|.+... .......||+|...... .....++.+|.+++++++||||++++|+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4455668999999999999988642 11112238999988532 345667999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
....+++|||+|.||+|.++|.+.. ..++..+...++.+.+.||+|||+++ ++||||-..|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999998876 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceee-ecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 225 GLAKDGPTGSQSHVST-RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|+++.... ..... ...-...|+|||.+....|++++|||||||++||+++ |..||.+.......
T Consensus 307 GLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~----------- 372 (474)
T KOG0194|consen 307 GLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK----------- 372 (474)
T ss_pred ccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-----------
Confidence 99886531 11111 1134578999999999999999999999999999999 78899876532111
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
..+.........+...+..+..++.+||..+|++|||+.++.+.|+.+......
T Consensus 373 -----~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 373 -----AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111122223344456677888899999999999999999999999998766554
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.38 Aligned_cols=269 Identities=23% Similarity=0.353 Sum_probs=209.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCC-CCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-hpniv~~~~~~ 143 (400)
..++|.+.+.||+|+||.||+|.+... .+..++..||+|++....... ...+.+|+.+|.++. ||||+++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 345688899999999999999987642 233456789999997653322 346788999999997 99999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcC-----------------------------------------------------
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRAS----------------------------------------------------- 170 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 170 (400)
...+..++||||+.+|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCC
Q 015781 171 -----------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (400)
Q Consensus 171 -----------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~ 209 (400)
....+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 1124677788999999999999999988 999999999
Q ss_pred CEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCC
Q 015781 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPS 288 (400)
Q Consensus 210 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~ 288 (400)
||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999875432221111223456788999999988889999999999999999998 88898654321
Q ss_pred ccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
... ...+........+...+.++.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 349 ~~~----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQF----------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 100 0000011111123334678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=321.22 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=198.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
+|++.+.||+|+||.||+|... .++..+|+|++...... ....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 4788999999999999999544 36889999998764321 223455677777766 5899999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccC
Confidence 999999999999999999998765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 146 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~------------ 211 (323)
T cd05616 146 GMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------------ 211 (323)
T ss_pred CCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99875322111 2234578999999999999999999999999999999999999997654211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
.+... ...++...+.++.+++.+||+.||.+|++. .++++|
T Consensus 212 ----~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 212 ----SIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----HHHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01111 112233456788899999999999999985 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=318.49 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=193.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHcc-CCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||.||+|... .++..||+|++..... ........|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 46999999999999554 3688999999876432 222345567777765 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999999999999998764 35788999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~------- 209 (316)
T cd05619 146 NMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----R------- 209 (316)
T ss_pred CCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----H-------
Confidence 322211 2334578999999999998899999999999999999999999997643211 11000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~ 351 (400)
. ....++...+.++.+++.+||+.||++||++. +++.|
T Consensus 210 ~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 210 M----DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred h----CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 0 01112233456788999999999999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=310.68 Aligned_cols=276 Identities=27% Similarity=0.393 Sum_probs=211.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcC-------CCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYA-------PARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~ 138 (400)
..+|++.+.||+|+||.||+|........ ..+...+..+|+|.+...... ....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35799999999999999999976532110 133345678999998765432 3456788999999999999999
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS-------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
+++++..++..+++||++.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence 99999999999999999999999999976541 1236899999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh--CCCccCCCCCCc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSR 289 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf~~~~~~~ 289 (400)
+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876543332222334456778999999988889999999999999999998 677775443211
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+....... ...........+...+.++.+++.+||+.||.+|||+.+|++.|++
T Consensus 242 ---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 ---VIENAGHFF-------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHhcc-------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111000 0001111111222345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=318.11 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=195.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
....+|++.+.||+|+||.||+|... .++..||+|+..... ...|+.++++++||||+++++++.
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKP---------GQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEEC---------CCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEE
Confidence 33457999999999999999999654 357889999854332 246899999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+....++|||++ .++|.+++.... .++++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 128 ~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 128 SGAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred eCCeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecC
Confidence 999999999999 568888886543 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH---
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL--- 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--- 301 (400)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|+++..++....+.............+
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 202 GAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred ccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 9987432211 1234568999999999998899999999999999999998665543332222111110000000
Q ss_pred -hh----hhhh---------hhhccccccC-----CC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 302 -QS----KRRI---------FQVMDARIEG-----QY----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 302 -~~----~~~~---------~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ...+ .......... .+ ....+..+..||.+||+.||.+|||+.|+|+|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0000 0000000000 00 01223456679999999999999999999987
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=313.16 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=211.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
..+|.+.+.||+|+||.||+|...... ......+..+|+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 467899999999999999999753210 01223466899999875432 3345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
.....|+||||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 99999999999999999999976432 1235788899999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999986543322222223345678999999988889999999999999999998 78888654321110
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.. +........+..++..+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus 250 ~~-----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KL-----------------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HH-----------------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 00 0000111122345678889999999999999999999999999886653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=306.73 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=209.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+|++.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 46888999999999999999543 3578999998765332 23346788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..+++|||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998764433356899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~------ 218 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK------ 218 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhh------
Confidence 99876433221 1223568899999999988889999999999999999999999996543210 00000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
...............+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 ----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000111112345678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.11 Aligned_cols=246 Identities=28% Similarity=0.362 Sum_probs=198.0
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 151 (400)
+.||+|+||.||++... ....+|..+|+|++...... ....+..|+.++++++||||+++++++.+++..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999998643 23346899999999764332 23456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999998664 35899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 232 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
.... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... .+.
T Consensus 150 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----------------~i~ 211 (318)
T cd05582 150 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----------------MIL 211 (318)
T ss_pred CCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----------------HHH
Confidence 3211 2334678999999999988889999999999999999999999997643211000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 351 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~ 351 (400)
.. ....+...+..+.+++.+||+.||.+||+ +.+++.+
T Consensus 212 ~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 212 KA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 00 11223344667889999999999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=307.95 Aligned_cols=264 Identities=22% Similarity=0.362 Sum_probs=205.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||+||+|.+... .......||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 5789999999999999999976532 1112345899998754332 34567889999999999999999999875
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...+++|||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCc
Confidence 45789999999999999987643 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---------- 222 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PD---------- 222 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----------
Confidence 986543222111122234678999999988899999999999999999998 8999865432110 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+........+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 223 ----LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01111111112334567889999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=310.99 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=206.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 346899999999999999999976532 1122356899998865432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
+.+..++||||+.+++|.+++..... ....+....+..++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 99999999999999999999975431 1234567788999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 297 (400)
++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||....... ....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~- 233 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF- 233 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999875433222111222345678999999988889999999999999999998 788886543211 0000
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ... .....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 234 ---~---------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 ---V---------MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---H---------HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0 000 00111223356889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=318.76 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=196.0
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||+||+|... .++..||+|++..... .....+..|..+++.+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999999554 3678999999976432 2234466788888777 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|..++... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 9999999999999988765 35899999999999999999999988 99999999999999999999999999865
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ . . .
T Consensus 146 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~---~----------~ 207 (318)
T cd05570 146 GILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---F---Q----------S 207 (318)
T ss_pred cCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---H---H----------H
Confidence 322111 12335689999999999999999999999999999999999999975432110 0 0 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
+... ....+...+..+.+|+.+||+.||.+|||+ .+++++
T Consensus 208 i~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 208 ILED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHcC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0000 111223456678899999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.77 Aligned_cols=256 Identities=27% Similarity=0.331 Sum_probs=203.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||+|+||.||+|... .++..+|+|++..........+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 357999999999999999999553 36789999998765444455677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999998654 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+........ ......++..|+|||.+. ...++.++|+|||||++|+|++|..||....+......+ .
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~ 222 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------S 222 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------e
Confidence 976532211 122346888999999874 345788999999999999999999998654322111000 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.. ....... ......+..+.+++.+||+.+|++|||+.+++++|
T Consensus 223 ~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 KS---NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cC---CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0000000 11123456788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=305.97 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=201.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468889999999999999996543 34599998875443 3456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||.||+++.++.+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999987643 35899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------------ 214 (256)
T cd05113 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------------ 214 (256)
T ss_pred eecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------------
Confidence 754332211 1112234567999999988889999999999999999998 99998654421110000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. ......+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 215 ----~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 ----SQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----hc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 0001112223578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=309.42 Aligned_cols=275 Identities=25% Similarity=0.406 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCc------C-CCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccce
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY------A-PARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKL 139 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~-~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~ 139 (400)
++|++.+.||+|+||.||++....... . .....++..+|+|++..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999986543110 0 01223456799999876532 234568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASY-------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
++++.+++..++||||+.+++|.+++...... ...+++..++.++.||+.||+|||+++ ++|+||||+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence 99999999999999999999999999764321 123678899999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh--CCCccCCCCCCcc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSRE 290 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf~~~~~~~~ 290 (400)
++.++.++|+|||++................++..|++||...++.++.++|+|||||++|+|++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999876433222112222344678999999888889999999999999999998 7788865433211
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+.......... ........+..++..+.+|+.+||+.||++||++.+|++.|++
T Consensus 243 ---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 ---IENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11100000000 0000111122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=309.38 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=196.0
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||+|+||.||++... .+|..+|+|.+...... ....+..|++++++++||||+++++++.++...++|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 799999999999544 36899999998654322 223455799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.|++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred EecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 999999999988865432 45889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .... ....
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~----------~~~~ 212 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKR----------RTLE 212 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHH----------Hhhc
Confidence 22 1233568999999999988889999999999999999999999997543211110 0000 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.... ......+.++.+|+.+||+.||++||+++|+++.+..
T Consensus 213 ~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 213 DEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred cccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 0000 0112346678999999999999999999776654444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=323.38 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=197.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
...|.+.+.||+|+||.||+|... .+++.||+|.... ..+.+|+++|++++|+||+++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~---------~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP---------DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC---------CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 457999999999999999999543 4678999996432 2346899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++|||++ .++|.+++.... .++++..++.++.||+.||.|||+++ |+||||||+||||+.++.++|+|||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999999999 578988886543 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc--------chhHHhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--------HNLIEWAK 298 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~--------~~~~~~~~ 298 (400)
++...............||+.|+|||++.+..++.++|||||||++|||++|..|+........ ...+.+..
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 9765332222223345799999999999999999999999999999999998866433221110 01111100
Q ss_pred HHHhh-----hhhhhhhc----cccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 299 PYLQS-----KRRIFQVM----DARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 299 ~~~~~-----~~~~~~~~----~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
..... ...+.... ......... ...+..+.+||.+||+.||.+|||+.|+|+|=
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 00000 00000000 000000000 12345688899999999999999999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=325.12 Aligned_cols=258 Identities=23% Similarity=0.251 Sum_probs=202.4
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCccccee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
....++|++.+.||+|+||.||+|... .+++.+|+|++..... .....+.+|..+++.++||||++++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 344578999999999999999999544 4788999999865322 2233467899999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+++.++..+|+||||+++++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+|
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998653 4788899999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccC----CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
|+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 183 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----- 256 (371)
T cd05622 183 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----- 256 (371)
T ss_pred EEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-----
Confidence 999999976533221 122346799999999998654 3789999999999999999999999765421100
Q ss_pred hhHHHhhhhhhhhhcccc--ccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHh
Q 015781 297 AKPYLQSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 354 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~~ 354 (400)
..+.... +........+..+.+++.+||..++.+ |+++.++++|.+.
T Consensus 257 -----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 257 -----------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred -----------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 0111100 111112245667888999999844443 7899999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=317.42 Aligned_cols=270 Identities=28% Similarity=0.378 Sum_probs=206.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... ....+++.||+|++...... ....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 35799999999999999999975421 23446889999999764322 334577899999999 6899999999876
Q ss_pred e-CCeeEEEEeecCCCCHHHHHhhhcC-----------------------------------------------------
Q 015781 145 E-DDHRLLVYEFMPKGSLENHLFRRAS----------------------------------------------------- 170 (400)
Q Consensus 145 ~-~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 170 (400)
. +...++||||+++|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 4567899999999999999865321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceee
Q 015781 171 ----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240 (400)
Q Consensus 171 ----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 240 (400)
....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 0124678888999999999999999988 9999999999999999999999999987643322211122
Q ss_pred ecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCC
Q 015781 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY 319 (400)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (400)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ..... ......
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~----------~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKE----------GTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhc----------cCCCCC
Confidence 2345677999999988899999999999999999997 9999865432110 00 00000 001111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 320 SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 320 ~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
+...+..+.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 122345788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=308.05 Aligned_cols=267 Identities=23% Similarity=0.351 Sum_probs=209.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.++||+|+||.||+|.+.. ....++..|++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~-----~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILID-----EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEec-----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4679999999999999999997654 1223468899998875432 234557889999999999999999998765
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASY----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+...++++||+.+++|.+++...... ...+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEE
Confidence 57789999999999999999764322 146899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++...............++..|+|||++.+..++.++|||||||++|++++ |+.||....+.. ...+..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~- 233 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK- 233 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH-
Confidence 999999976543322211222345678999999988889999999999999999999 999997643311 111100
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
. .........++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 234 ---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 ---D----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---c----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00111122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.53 Aligned_cols=268 Identities=24% Similarity=0.317 Sum_probs=201.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|... .++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP---------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC---------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 4788999999999999999543 368899999986532 23345678999999999999999999999877
Q ss_pred C-----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 147 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
+ ..|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEe
Confidence 6 7899999995 6888877543 46899999999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH-
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP- 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~- 299 (400)
+|||++........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+......+.....
T Consensus 145 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~ 223 (372)
T cd07853 145 CDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223 (372)
T ss_pred ccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999975433221 122334678999999998764 578999999999999999999999987654332222111000
Q ss_pred -----HHhhhhhhhh-hccccccC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 300 -----YLQSKRRIFQ-VMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 300 -----~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.......... +....... ......+.++.+|+.+||+.||.+|||+.++++|-+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000000000 00000000 111223567889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.20 Aligned_cols=243 Identities=28% Similarity=0.361 Sum_probs=192.2
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHH-HHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||+||+|... .+|+.||+|++...... ....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 46999999999999554 46889999998754322 2223444444 56788999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 9999999999999998764 35889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~----------~ 207 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YD----------N 207 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HH----------H
Confidence 32221 123345789999999999998999999999999999999999999976432110 00 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH----HHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD----EVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----eil~~ 351 (400)
+.... ...+...+..+.+++.+||+.||.+||++. +++++
T Consensus 208 i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 208 ILNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11111 112223466788999999999999999884 66654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.18 Aligned_cols=251 Identities=29% Similarity=0.363 Sum_probs=216.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+-|.+.+.||+|+||.||+| .|+.+|.++|+|.+..+. +..++..|+.++++.+.|++|++|+.|....
T Consensus 33 EVFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 34777889999999999998 667789999999987654 6678899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|+|||||..|++.+++..+. +++.+..+..++...+.||+|||... -+|||||..|||++.+|+.||+|||.+
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhcccc
Confidence 9999999999999999998776 68999999999999999999999987 899999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
-..... .....+..||+.|||||++..-.|+.++||||||++..||.-|++||.+..+......+.-
T Consensus 177 GQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----------- 243 (502)
T KOG0574|consen 177 GQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----------- 243 (502)
T ss_pred chhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-----------
Confidence 765432 2245668999999999999999999999999999999999999999998877554433310
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+...-..+...+.++.+++++||-.+|++|.|+.++++|
T Consensus 244 ----~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 244 ----KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ----CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111122344567888999999999999999999999987
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=302.99 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=198.0
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
.||+|+||.||+|.+.. ..++..+|+|++..... .....+.+|+.+++.++||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 58999999999997642 23578899999875432 23456788999999999999999999876 4567899
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++... ..+++..++.++.|++.||+|||+++ ++|+||||.||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999999999999754 35889999999999999999999988 99999999999999999999999999976543
Q ss_pred CCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 233 GSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 233 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... ......++..|+|||.+....++.++|+|||||++|+|++ |..||........ .. .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~--------------~ 210 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ--------------M 210 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------H
Confidence 32111 1112234578999999988889999999999999999998 9999976432111 11 1
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+........+...+.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus 211 i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 211 IESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111111223334567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=309.99 Aligned_cols=275 Identities=28% Similarity=0.434 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCc-----CCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceee
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY-----APARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
++|++.+.||+|+||.||++....... ..........||+|.+...... ....+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987643110 0011223456899998765322 3346889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRAS--------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+||++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence 99999999999999999999999865321 1124688899999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh--CCCccCCCCCCccc
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--GRRVIDKNRPSREH 291 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t--g~~pf~~~~~~~~~ 291 (400)
+.++.+||+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ +..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 9999999999999876443322222223345678999999988889999999999999999998 567776543211
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+........ ..........+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 241 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 -VIENTGEFFR-------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHhhh-------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111110000 000111111122345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.83 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=197.4
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||.||+|... .++..+|+|++...... ....+.+|..++.++ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 46999999999999554 36889999999865332 233467888888887 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 9999999999999888754 35899999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............+....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------- 214 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------- 214 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---------
Confidence 32211 1233467999999999999999999999999999999999999999754332222211111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~eil~~ 351 (400)
.... ....+...+..+.+++.+||+.||.+|+++ .++++|
T Consensus 215 ~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 215 ILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 0111 112233445678899999999999999984 577776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.41 Aligned_cols=258 Identities=21% Similarity=0.231 Sum_probs=198.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||++... .++..||+|++..... .....+.+|..++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 46899999999999999999544 4688999999875322 22344778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999997643 45889999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|++......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... ..
T Consensus 147 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~ 219 (331)
T cd05597 147 GSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GK 219 (331)
T ss_pred CceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HH
Confidence 998754332211 1223468999999999863 45788999999999999999999999754321110 00
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~ 353 (400)
.... ..... +. ......+..+.+++.+||..++++ |+++.++++|-+
T Consensus 220 i~~~-~~~~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 220 IMNH-KEHFQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHcC-CCccc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0000 00000 00 011124667888999888654443 789999999843
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=303.58 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=205.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|.+.+.||+|+||.||+|.... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999996543 57899999986543 23445688899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEccccc
Confidence 999999999999999999976532 56899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......+++.|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----------- 211 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL----------- 211 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----------
Confidence 876543221 2233568899999999998889999999999999999999999997554211 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 212 --~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 --KIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0000 01112222456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=312.08 Aligned_cols=272 Identities=25% Similarity=0.381 Sum_probs=209.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
..+|.+.+.||+|+||.||+|...... .........+|+|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357899999999999999999653211 01223466799998875432 2345678899999999 6999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+...+++||||+.+++|.+++..... ....+++..+..++.||+.||.|||++| ++|+||||+||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 99999999999999999999976431 1235888999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986543222111122234567999999988889999999999999999999 88898654321111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.. .. .......+..++..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 247 ~~-------~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 247 KL-------LR----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HH-------HH----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 10 00 00111223344567889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=308.46 Aligned_cols=276 Identities=30% Similarity=0.401 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+.|++.+.||+|+||.||++.+.. ....++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 457889999999999999997643 345578899999987553 23345688999999999999999999998775
Q ss_pred --CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCC
Confidence 56899999999999999986543 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++......... .......++..|+|||.+.+..++.++|||||||++|+|+++..|+........ .......... .
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~~~~-~ 231 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTHGQM-T 231 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhcccccccc-c
Confidence 998865432221 112234567789999999888899999999999999999998766432211000 0000000000 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
................+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000011111112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=311.15 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=206.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+.+++.+.||||+++++.+.++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV---------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC---------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 368999999999999999999543 36789999998876655566788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...|+||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECcccc
Confidence 9999999999999999998642 4788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... .+ .
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~----~----- 229 (296)
T cd06654 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LI----A----- 229 (296)
T ss_pred chhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HH----h-----
Confidence 875433221 1233468899999999988889999999999999999999999997654311100 00 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.........+...+..+.+++.+||..+|++|||+.+++.+-+
T Consensus 230 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 230 ----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 0000011112345567889999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=325.89 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36888999999999999999544 4688999999875432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||++|++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999765 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc---------------------------------ceeeecccccCcccchhhccCCCCCccchhhHHHH
Q 015781 225 GLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVV 271 (400)
Q Consensus 225 g~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~i 271 (400)
|++......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 998743221100 00123579999999999999999999999999999
Q ss_pred HHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHH
Q 015781 272 LLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP---TMDEV 348 (400)
Q Consensus 272 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ei 348 (400)
+|+|++|..||....+......+ . .. ...+........+..+.+|+.+|+ .||.+|+ ++.++
T Consensus 226 lyel~tG~~Pf~~~~~~~~~~~i------~-------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 226 MYEMLIGYPPFCSETPQETYRKV------M-------NW-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred eeecccCCCCCCCCCHHHHHHHH------H-------cC-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 99999999999765432111100 0 00 000000011124567788888876 4999998 47888
Q ss_pred HHH
Q 015781 349 VKA 351 (400)
Q Consensus 349 l~~ 351 (400)
++|
T Consensus 291 ~~h 293 (360)
T cd05627 291 KSH 293 (360)
T ss_pred hcC
Confidence 887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=303.69 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=202.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 3579999999999999999996542 45699999876543 34568899999999999999999998854
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCcee
Confidence 568999999999999999876432 45889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~--------- 215 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ--------- 215 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---------
Confidence 9764332211 1122335567999999988889999999999999999999 899996543211 1100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.........+...+..+.+|+.+||..+|.+|||+.++++.|+.+
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 216 -----VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred -----HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011111122334566789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=304.47 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=202.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+|++.+.||+|+||.||++.. ..++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQH---------VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEE---------cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 478889999999999999954 3468899999986543 233456778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|++|||+++++|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcc
Confidence 99999999999999998865432 45789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~--------- 210 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------IL--------- 210 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HH---------
Confidence 75433221 22345688999999999888899999999999999999999999975432110 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ......+...+..+.+++.+||+.||++|||+.+++..
T Consensus 211 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 -KVCQ-GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhc-CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 00111233445678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=304.55 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 467999999999999999999643 367899999876543 3457889999999999999999999875 4
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcc
Confidence 578999999999999999865432 46889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~---------- 214 (260)
T cd05067 149 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ---------- 214 (260)
T ss_pred eeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH----------
Confidence 8765422211 1122345678999999988889999999999999999999 9999975432111 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+........+...+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 215 ----NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0011111112233456799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.65 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=198.7
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC-
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 146 (400)
|.+.+.||+|+||.||+|.+... .....+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 35678999999999999976431 122468999886542 23345678899999999999999999987432
Q ss_pred -----CeeEEEEeecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 147 -----DHRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
...+++|||+.+++|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCE
Confidence 24689999999999999885322 12245899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|+|||++................+++.|++||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---- 224 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY---- 224 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----
Confidence 9999999986543322111122345678999999988899999999999999999999 889997543211 00
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
....... ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 225 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 DYLRQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011100 0011223456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=303.88 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 45889999999999999999653 245799999865432 3346778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999999999997654 35899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....+......
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------- 213 (256)
T cd05059 148 RYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES------------- 213 (256)
T ss_pred eeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-------------
Confidence 754322111 1111223457999999988899999999999999999999 8999975433211000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 ----VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000011122233567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=312.18 Aligned_cols=269 Identities=27% Similarity=0.360 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||++.. ..++..+|+|.+...... ....+.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLH---------RPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEE---------cCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3688999999999999999954 346888999998754322 234578899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+.+++||||+++++|.+++... .++++..+..++.|++.||.|||+ ++ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCC
Confidence 9999999999999999999765 458899999999999999999997 46 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh-
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK- 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 304 (400)
++...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......................
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 146 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred Cccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 98754322 1233578899999999988889999999999999999999999996543221111110000000000
Q ss_pred ---------------hhhhhhccc---cccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 ---------------RRIFQVMDA---RIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ---------------~~~~~~~~~---~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.......+. ...... ....+.++.+++.+||..+|++|||+.+++++.+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000 000011 112456789999999999999999999999997764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=309.21 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
++|++.++||+|+||.||+|..... +....+++|.+.... ......+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 5789999999999999999976431 122347888876432 23345678899999999 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++||||||+||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence 9999999999999999999965321 1135889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccch
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 292 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 292 (400)
+.++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999986422111 0111123457999999988889999999999999999997 999997654211100
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..........+...+..+.+|+.+||+.+|.+|||+.++++.|+.+.......
T Consensus 230 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 230 -----------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred -----------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 00011111122335567889999999999999999999999999887665443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=314.43 Aligned_cols=253 Identities=20% Similarity=0.236 Sum_probs=198.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||++... .++..+|+|++..... .....+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 36889999999999999999654 3678999999865322 12234678899999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997643 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|++........ .......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... .
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~- 218 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------G- 218 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------H-
Confidence 99875432211 1223357999999999985 346889999999999999999999999764321111 0
Q ss_pred HHhhhhhhhhhccccccC---CCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~ 351 (400)
.+....... ......+..+.+|+.+||..++++ |+++.++++|
T Consensus 219 ---------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 ---------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001100000 111234667888999988665544 6899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.16 Aligned_cols=254 Identities=33% Similarity=0.508 Sum_probs=201.6
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHH--HHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.+.||+|+||+||++.. ..+++.+|+|++......... ...+|+..++.++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKN---------KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEE---------TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEE---------CCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 66788999999999999954 446889999999887654332 2346999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++|||++.+++|.+++... ..+++..++.++.||+.||++||+++ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence 999999999999999999844 45899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
.... ..........++..|+|||++. +..++.++||||||+++|+|++|..||...........+.... ..
T Consensus 146 ~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~~--- 217 (260)
T PF00069_consen 146 VKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---KR--- 217 (260)
T ss_dssp EEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---HT---
T ss_pred cccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---cc---
Confidence 7531 1122344567899999999998 7889999999999999999999999998652111111111000 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. ..... .........+.+++.+||+.||++|||+.+++++
T Consensus 218 --~-~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 218 --P-LPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --H-HHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --c-ccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 0000112688999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=314.82 Aligned_cols=257 Identities=21% Similarity=0.237 Sum_probs=198.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||++... .++..+|+|++..... .....+.+|..++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 46899999999999999999544 3688999999875322 12334677889999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+.||+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999997643 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|++........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i----- 220 (331)
T cd05624 147 GSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI----- 220 (331)
T ss_pred cceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH-----
Confidence 99875433221 11233579999999999865 46788999999999999999999999754321110000
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKAL 352 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L 352 (400)
...... ... .......+..+.+++.+||..++++ |+++.++++|-
T Consensus 221 -~~~~~~------~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 221 -MNHEER------FQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred -HcCCCc------ccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000000 000 0011124567888999999876654 46899999873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.77 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=203.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|+..+.||+|+||.||++... .+++.+|+|.+....... ...+.+|+.++++++|++|+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 3677889999999999999554 368899999987543222 2346789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999998865432 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---------- 214 (285)
T cd05630 148 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---------- 214 (285)
T ss_pred ceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH----------
Confidence 9875432221 123468999999999998899999999999999999999999997643211111000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
.... ......+...+..+.+|+.+||+.||.+||| +.++++|-+
T Consensus 215 ---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 215 ---RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ---hhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0000 0011122334567889999999999999999 899998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=308.43 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=203.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+.|++.+.||.|+||.||+|... .++..+++|.+..........+.+|+.+++.++||||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC---------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 367999999999999999999544 36889999999876655566788899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|..++.... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999988876543 45899999999999999999999988 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+....... .......+++.|+|||++. ...++.++|+|||||++|+|++|..||....+... ... ..
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----~~ 228 (292)
T cd06644 157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----IA 228 (292)
T ss_pred ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH----Hh
Confidence 86532211 1123456788999999884 34578899999999999999999999965432110 000 00
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 229 -------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 -------KSE--PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------cCC--CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 00111123345678899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=319.04 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||++... .+|..+|+|++.... ......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDT---------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEc---------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence 34578999999999999999999543 468899999986542 2234567789999999999999999999
Q ss_pred EEeCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 143 CLEDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 143 ~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+.... .+|+||||+. ++|...+. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~ 159 (359)
T cd07876 89 FTPQKSLEEFQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 159 (359)
T ss_pred eccCCCccccceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC
Confidence 86443 5799999995 46666653 23788899999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH--
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-- 294 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-- 294 (400)
+.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+
T Consensus 160 ~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 160 CTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999997543221 223357899999999999999999999999999999999999999866432111000
Q ss_pred -------HhhhHHHhhhhhhhhhccccc------------------cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 015781 295 -------EWAKPYLQSKRRIFQVMDARI------------------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349 (400)
Q Consensus 295 -------~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 349 (400)
.+...... .......... ........+..+.+|+.+||+.||++|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 237 QLGTPSAEFMNRLQP---TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred hcCCCcHHHHHHHHH---HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 00000000 0000000000 0000112345688999999999999999999999
Q ss_pred HHHHh
Q 015781 350 KALEQ 354 (400)
Q Consensus 350 ~~L~~ 354 (400)
+|-+-
T Consensus 314 ~hp~~ 318 (359)
T cd07876 314 RHPYI 318 (359)
T ss_pred cCchh
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=316.89 Aligned_cols=241 Identities=27% Similarity=0.324 Sum_probs=189.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHH-HHHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI-KHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||+||+|... .++..+|+|++...... ....+..|. .+++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHK---------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 46999999999999554 36789999998754321 122334443 456788999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|.+++... ..+.+..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999998764 34788889999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~ 207 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------N 207 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------H
Confidence 32211 123346799999999999999999999999999999999999999976432111 00 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 349 (400)
+.... .......+..+.+++.+||+.||.+||++.+.+
T Consensus 208 i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 208 ILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHhCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 00110 112224466788999999999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=312.67 Aligned_cols=270 Identities=24% Similarity=0.304 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 57999999999999999999543 36788999998754332 233567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcccc
Confidence 99999999996 58888876553 35788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH------
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP------ 299 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------ 299 (400)
+........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 875432221 1223467899999998865 4688999999999999999999999987654322222111000
Q ss_pred --HHhhhhhhhhhccccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 300 --YLQSKRRIFQVMDARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 300 --~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.................. ......+.++.+++.+||+.||.+|||+.++++|-+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 000000000000000000 0111345678899999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.17 Aligned_cols=255 Identities=32% Similarity=0.482 Sum_probs=206.5
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|..... ..++..+++|.+....... ...+.+|+..++.++|+||+++++++.+....++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4699999999999977531 1347889999998765433 56788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 153 YEFMPKGSLENHLFRRASY-----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
|||+++++|.+++...... ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875211 256899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
................++..|+|||.+....++.++|||||||++|+|++ |..||....... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~---------- 219 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEY---------- 219 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----------
Confidence 87654332222334567889999999988889999999999999999999 699997653211 1100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.........+...+..+.+++.+||+.+|.+|||+.+++++|+
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 ----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0001111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.51 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+... .......+|+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 5788999999999999999976531 1222447999988766432 34567889999999999999999999887
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcc
Confidence 78899999999999999987654 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+................++..|+|||.+....++.++|+|||||++|+|++ |..||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------------- 221 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------------- 221 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH--------------
Confidence 986543322211112223567999999988889999999999999999998 99999765431111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+........+...+..+.+++.+||..+|.+||++.++++.|+.+...
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 ---DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00111111112223446788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.52 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=213.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+-|.++..||.|+||.||+| +++.++...|.|+|........+.++-|+++|...+||+|+++++.|..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA---------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKA---------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhh---------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 45788889999999999999 445577888999998877777778889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.++|+.|||.||-+..+|..-+ .++.+.++..+++|++.||.|||+++ |+|||||..|||++.+|.++|+|||.+
T Consensus 103 kLwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeeccccc
Confidence 9999999999999999998766 68999999999999999999999999 999999999999999999999999988
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
.... ........+.|||+|||||+.. ..+|+.++||||||+++.+|..+.+|.....+......+.-..+
T Consensus 178 AKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP--- 252 (1187)
T KOG0579|consen 178 AKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--- 252 (1187)
T ss_pred ccch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC---
Confidence 6432 2233466789999999999864 46899999999999999999999999877665443332221110
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..+ .-|...+..+.+++++||..||..||++.++++|-+
T Consensus 253 -----PTL-------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 253 -----PTL-------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred -----Ccc-------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 000 113345667889999999999999999999998743
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.16 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||+|.+.. ...+|+|.+..... ....+.+|+.+++.++||||+++++++.+ +
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-C
Confidence 569999999999999999996543 23599999876443 34567889999999999999999998754 5
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCce
Confidence 68999999999999999976432 35788999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||...+..++.++|||||||++|+|++ |..||...........
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~------------- 215 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------- 215 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-------------
Confidence 765432211 1122345678999999988889999999999999999999 8888865432111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 216 ---~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 216 ---V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---H-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 00001112334566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.04 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+... ...+..||+|.+.... ......+..|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4588899999999999999976531 1124579999987643 23345788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999999999987653 35789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeee-cc--cccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 227 AKDGPTGSQSHVSTR-VM--GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
+.............. .. .+..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---- 225 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---- 225 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----
Confidence 875433221111111 11 2357999999998899999999999999999886 999986543211 111100
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.......+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 226 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ----------QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011111233456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.78 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=197.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCC-CCcccceeeEEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~~~~~~~ 144 (400)
+|++.+.||+|+||.||+|... .++..||+|++..... .....+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 4677899999999999999543 4688999999876432 22334667888888775 577888999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecc
Confidence 999999999999999999998765 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~--------- 211 (323)
T cd05615 146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQ--------- 211 (323)
T ss_pred ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---------
Confidence 99875322211 22345689999999999988999999999999999999999999976542111 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
.+... ...++...+..+.+++.+||+.+|.+|++. .++++|
T Consensus 212 ----~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 212 ----SIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----HHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 01111 112233445678899999999999999974 566655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.83 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||.|+||.||+|... |..+|+|.+..... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 357899999999999999998543 57799999987654 456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999999999976542 36899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+........ ....+..|+|||.+....++.++||||||+++|+|++ |..||........ .
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----------- 209 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----------- 209 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H-----------
Confidence 986532211 2234567999999988889999999999999999997 9999865432110 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
...........+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 ---PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00001111122234467888999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.28 Aligned_cols=253 Identities=32% Similarity=0.466 Sum_probs=199.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|.+.. ...++..+|+|.+...... ....+.+|+.+++.+.||||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 469999999999997643 2224578999998866543 3456889999999999999999999876 4568999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999999999997653 5789999999999999999999988 99999999999999999999999999886533
Q ss_pred CCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 233 GSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 233 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...+.. .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~------- 213 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----S------- 213 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----c-------
Confidence 222110 111223467999999988899999999999999999998 999997543211 111100 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
......+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 214 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 ---GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0011122334567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.59 Aligned_cols=264 Identities=28% Similarity=0.404 Sum_probs=205.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|..... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred HhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 5799999999999999999975421 1223577899999876533 2345688899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 208 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp 208 (400)
...++||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|+||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 999999999999999999975321 1134788899999999999999999988 99999999
Q ss_pred CCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCC
Q 015781 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRP 287 (400)
Q Consensus 209 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~ 287 (400)
+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875433222111222344667999999988899999999999999999997 8888864432
Q ss_pred CccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.. ... ...+... ...+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 239 ~~---~~~-------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EE---VIY-------------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH---HHH-------------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 000 0000000 01122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=310.06 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|.+... +....+++|.+..... .....+.+|+.++.++ +||||+++++++.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccC-------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 5788999999999999999976431 1223567877664322 2344677899999999 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
++.+|+||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++||||||+||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence 9999999999999999999975432 1135789999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccch
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 292 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 292 (400)
+.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||........
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 232 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-- 232 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--
Confidence 999999999999986422111 1111234567999999988889999999999999999998 9999965432111
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
... .........+...+..+.+|+.+||+.+|++||++.+++..|+.+.....
T Consensus 233 -~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 -YEK--------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -HHH--------------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000 00000111122345678899999999999999999999999998755543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=306.64 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=203.3
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCee
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+++++.++||||+++++++..++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK---------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC---------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 678899999999999999554 36788999998766555566788899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++||||+++++|..++.... .++++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999998876533 46899999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
..... .......++..|+|||++. +..++.++|||||||++|+|++|.+||....+.... ...
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~-------- 220 (282)
T cd06643 153 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKI-------- 220 (282)
T ss_pred ccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHH--------
Confidence 43221 1123356889999999883 345788999999999999999999999754321110 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... .......+...+..+.+++.+||+.||.+||++.+++++-+.
T Consensus 221 ---~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 221 ---AKS--EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred ---hhc--CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 000 000111122345688999999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=311.16 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=210.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
.+|++.+.||+|+||.||+|...... ......+..+|+|.+..... .....+.+|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 57999999999999999999764311 01122345799998875432 2345688999999999 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
++..+++|||+.+++|.+++..... ....+++..++.++.||+.||.|||.++ ++||||||+||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill 167 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLV 167 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE
Confidence 9999999999999999999976431 1234788899999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccch
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHN 292 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~ 292 (400)
+.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999876433221111222334567999999998899999999999999999998 888886543211100
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
.+........+...+..+.+++.+||+.+|.+|||+.+++++|+.+.....
T Consensus 248 -----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 -----------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -----------------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 000111112223445678899999999999999999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.79 Aligned_cols=255 Identities=29% Similarity=0.362 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||.|+||.||+|... .++..+++|.+..........+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI---------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec---------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 57899999999999999999543 357789999998765555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|++|||+.+++|.+++.... .++++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccc
Confidence 9999999999999999987653 35889999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccC---CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
....... .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||....+....... ..
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--------~~ 218 (262)
T cd06613 149 AQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--------SK 218 (262)
T ss_pred hhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------Hh
Confidence 7543321 112335678899999998776 7899999999999999999999999764431111000 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+ ...........+..+.+++.+||..+|.+|||+.+++.+
T Consensus 219 ~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 SNF-----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccC-----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000111233456788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.69 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=197.7
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 153 (400)
.||+|+||.||+|.+.. ...+..+|+|++...... ....+.+|+.++++++||||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 38999999999997642 124567999998765432 2346889999999999999999999876 45789999
Q ss_pred eecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCC
Q 015781 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (400)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 233 (400)
||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 74 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999987543 46899999999999999999999988 999999999999999999999999998754332
Q ss_pred CCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 234 SQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 234 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~ 211 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----------------SFI 211 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----------------HHH
Confidence 21111 111223568999999988889999999999999999996 99999765321110 011
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
........+...+.++.+++.+||..+|++||++.+|++.|+.+
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11111223344567888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=306.57 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.++||+|+||.||+|... .++..+|+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL---------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 36888899999999999999543 4688999999875432 2345688899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 72 NRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred CEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 999999999999999654 23678889999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch-hHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-LIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 305 (400)
+...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... .....
T Consensus 142 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 209 (279)
T cd06619 142 STQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-------- 209 (279)
T ss_pred ceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH--------
Confidence 8754322 1233578999999999988889999999999999999999999997543221110 00000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
....+...........+..+.+++.+||+.+|.+||++.+++++-+.
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 210 --QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred --HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 00000111111112345578899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.24 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|+..+.||+|+||.||+|..... ......+++|.+..... .....+..|+++++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMP------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 4678889999999999999976421 11245799999876532 3345688899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 35889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCccee-eecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSHVS-TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+............ .....+..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~--------- 221 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK--------- 221 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---------
Confidence 8755432211111 11223457999999988889999999999999999997 999996543211 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 222 -----~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 -----AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000011111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.40 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=207.1
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEe
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 154 (400)
+||+|.||+||-|++ ..|...+|||-+.........-+.+|+..-+.|+|.|||+++|.+.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD---------~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARD---------MDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecc---------ccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 699999999999954 44788999999987665555667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-CCCceEEeeccCCccCC
Q 015781 155 FMPKGSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 155 ~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 231 (400)
-++||+|.+++...- .|+ .+..+-.+.+||++||.|||.+. |||||||-+|+||+ -.|.+||+|||-+++..
T Consensus 653 qVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred cCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999999997654 356 88899999999999999999998 99999999999994 57899999999998754
Q ss_pred CCCCcceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 232 TGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
. ......++.||..|||||++..+ .|..++|||||||++.||.||++||-..... ...+++
T Consensus 728 g--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFk 790 (1226)
T KOG4279|consen 728 G--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFK 790 (1226)
T ss_pred c--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhh
Confidence 3 23356778999999999999754 6899999999999999999999999654321 111222
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
+---..-+.+|...+.+...+|.+|+.+||.+||+++++|.
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 22223345677888999999999999999999999999987
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=310.08 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=194.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHcc---CCCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQ---LYHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~---l~hpniv~~~~~~ 143 (400)
+|++.+.||+|+||+||+|... .+++.+|+|.+...... ....+.+|+.+++. ++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP---------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC---------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 4888999999999999999543 46889999998754321 12234456655554 4799999999988
Q ss_pred Ee-----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 144 LE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 144 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.. ....++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCC
Confidence 64 346899999996 589888876432 45899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
++|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|.+||...........+....
T Consensus 147 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 223 (288)
T cd07863 147 VKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223 (288)
T ss_pred EEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh
Confidence 9999999987643221 1233467899999999988899999999999999999999999997654322111110000
Q ss_pred HHHhhhhhhhhhc---cccc-------cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 299 PYLQSKRRIFQVM---DARI-------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 299 ~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. ......+.... .... ........+..+.+++.+||+.||++|||+.+++.|
T Consensus 224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 224 G-LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred C-CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000000 0000 001112345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=315.91 Aligned_cols=239 Identities=29% Similarity=0.363 Sum_probs=189.4
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHH-HHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||+||+|... .+|..+|+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK---------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999999543 4688999999875432 12234445544 56778999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|..++... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999999999999888654 46899999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... . .
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~----------~ 207 (325)
T cd05604 146 GIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------D----------N 207 (325)
T ss_pred CCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------H----------H
Confidence 322211 233457899999999999999999999999999999999999999764321100 0 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 347 (400)
..... .......+..+.+++.+||+.+|.+||++.+
T Consensus 208 ~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 208 ILHKP--LVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHcCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11111 0112234567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.06 Aligned_cols=243 Identities=28% Similarity=0.365 Sum_probs=191.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHH-HHHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI-KHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
++||+|+||.||+|... .++..+|+|++...... ....+..|. .+++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 46999999999999554 36889999998754322 222344454 467888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999888654 35788999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~----------~ 207 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYD----------N 207 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHH----------H
Confidence 32221 12334578999999999998899999999999999999999999997643210 000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH----HHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD----EVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----eil~~ 351 (400)
+.... ...+...+..+.+++.+||+.||.+||++. +++++
T Consensus 208 i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 208 ILHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HhcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 11111 122334456788999999999999999764 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.32 Aligned_cols=256 Identities=29% Similarity=0.425 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 4679999999999999999996542 46699999876543 345688999999999999999999999998
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECcccc
Confidence 999999999999999999976542 45899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||........ ...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~--------- 216 (261)
T cd05034 150 ARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ--------- 216 (261)
T ss_pred ceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---------
Confidence 8765432111 1112234568999999998889999999999999999998 9999965432111 100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ........+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 217 ----~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 217 ----V-ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ----H-HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 0 00011111223356788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.91 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. ....+..+|+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKL------PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEec------CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578899999999999999997642 1123457999998754322 345678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999999999997654 35789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+........... .....++..|++||.+.+..++.++|+|||||++|++++ |..||........ .... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~- 224 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EE- 224 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hC-
Confidence 986543221111 111233567999999988889999999999999999886 9999865432111 1100 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
......+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 225 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 ---------GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001111233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.48 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=200.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE-eC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-ED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~ 146 (400)
.+|++.+.||+|+||.||++... +..+|+|.+.... ....+.+|+.++++++|+|++++++++. ++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 57899999999999999998543 5678999886543 2446789999999999999999998754 55
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcc
Confidence 678999999999999999976543 35789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~--------- 211 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR--------- 211 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---------
Confidence 87543221 12334567999999988889999999999999999997 99998643211 11100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 212 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 -----VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001111122334566888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=309.28 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=206.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||+|+||.||+|... .++..||+|.+..........+.+|+.+++.++||||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDI---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEEC---------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 368999999999999999999543 36889999999766555556678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999998643 4788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+......+.
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~----------- 228 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------- 228 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-----------
Confidence 875433221 1233568889999999988889999999999999999999999997654321111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 229 ----TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011123345667889999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=305.09 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=201.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 57888899999999999999543 468899999987665444556778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceee
Confidence 999999999999999998765 35899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
....... .......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+........ .
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--------~ 223 (267)
T cd06645 154 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--------K 223 (267)
T ss_pred eEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--------c
Confidence 7543221 1123457899999999874 4568899999999999999999999986544321110000 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ....... .....+..+.+++.+||+.+|++|||+.+++++
T Consensus 224 ~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 SN---FQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cC---CCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 0000000 011234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=318.59 Aligned_cols=268 Identities=21% Similarity=0.258 Sum_probs=199.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|.. ..++..+|+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 84 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEe---------cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence 3457899999999999999999954 34688899999875432 233467789999999999999999998
Q ss_pred EEeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 143 CLED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 143 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+... ...|+||||++ ++|.+.+.. .+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~ 155 (355)
T cd07874 85 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 155 (355)
T ss_pred eeccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC
Confidence 8643 35799999995 467666642 3788899999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+............
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 156 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999997643321 22345789999999999998999999999999999999999999976543221110000
Q ss_pred ----------------hhHHHhhhhhhh-----hhcccc---ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 297 ----------------AKPYLQSKRRIF-----QVMDAR---IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 297 ----------------~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
...+........ ...... .........+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000000 000000 00011112345778999999999999999999999984
Q ss_pred H
Q 015781 353 E 353 (400)
Q Consensus 353 ~ 353 (400)
+
T Consensus 313 ~ 313 (355)
T cd07874 313 Y 313 (355)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=306.63 Aligned_cols=256 Identities=28% Similarity=0.377 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||.|+||.||+|.+. .++..+|+|.+..........+..|++++++++||||+++++++.++.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK---------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc---------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 56999999999999999999654 357899999997665555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+++++|.+++.... .++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccc
Confidence 9999999999999999987654 46899999999999999999999988 999999999999999999999999988
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
........ ......+++.|++||.+. ...++.++|+|||||++|+|++|..||......... ..
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~------- 219 (280)
T cd06611 151 AKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK------- 219 (280)
T ss_pred hhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH-------
Confidence 75432211 223456889999999874 345778999999999999999999999765321110 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+..... .....+...+..+.+++.+||+.+|.+||++.+++++-+-
T Consensus 220 ----~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 220 ----ILKSEP--PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred ----HhcCCC--CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 000000 0001122345678899999999999999999999998553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=298.38 Aligned_cols=253 Identities=28% Similarity=0.403 Sum_probs=201.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|++|.||+|.+.. .......+|+|.+..... .....+.+|+.++++++||||+++++++.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999997753 122345799999988766 455678899999999999999999999988 889999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999999999977542 46899999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 233 GSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 233 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
.... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... ..
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----------~~- 215 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI----------DK- 215 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----------Hh-
Confidence 2211 11123456788999999988889999999999999999998 9999965432111 1000 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 216 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 --EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00011112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.02 Aligned_cols=276 Identities=27% Similarity=0.355 Sum_probs=210.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
++|++.+.||+|+||.||+|.+.. .+..++..+|+|++...... ....+.+|+..++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 568888999999999999997654 23456889999999866543 45678899999999999999999999887
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccc
Confidence 567899999999999999997654 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|.+.......... ......++..|++||.+.+..++.++||||||+++|+|++|..||.............. . ....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~-~~~~ 231 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-Q-GQMI 231 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc-c-cccc
Confidence 9998654322111 11123445679999999888899999999999999999999999865322110000000 0 0000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
...+...+........+..++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0001111111111122234457788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=319.10 Aligned_cols=267 Identities=21% Similarity=0.250 Sum_probs=199.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||.||+|... .++..+|+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC---------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 3478999999999999999999543 367889999987542 22345677899999999999999999987
Q ss_pred EeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 144 LED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 144 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
... ..+|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 163 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCC
Confidence 543 35799999995 577777642 3788899999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh-
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW- 296 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~- 296 (400)
.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 164 ~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 164 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997643321 22345789999999999999999999999999999999999999987654222111100
Q ss_pred --------hh-------HHHhhhhhh-----hhhccc---cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 297 --------AK-------PYLQSKRRI-----FQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 297 --------~~-------~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. .+....... ...... .............+.+|+.+||+.||.+|||+.++|+|-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 000000000 000000 0000011123457789999999999999999999999844
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.85 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=202.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---------HHHHHHHHHHHccCCCCcccce
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---------HLEWLTEIKHLGQLYHPNLVKL 139 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~hpniv~~ 139 (400)
+|.+.+.||+|+||.||+|... .++..+|+|.+....... ...+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4788899999999999999543 357889999886543221 2357789999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
++++.+.+..++||||+++++|.+++... .++++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGI 145 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCE
Confidence 99999999999999999999999999765 35788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCC----cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 220 KLSDFGLAKDGPTGSQ----SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
+|+|||.+........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----- 220 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----- 220 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----
Confidence 9999999876542111 1112234678899999999888899999999999999999999999975432100
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+..... ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus 221 -----------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 -----------IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----------HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000000 11122334456788899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=315.79 Aligned_cols=243 Identities=25% Similarity=0.285 Sum_probs=188.3
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccC---CCCcccceeeEEEeCCee
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~ 149 (400)
||+|+||+||+|... .++..||+|++....... ......|..++..+ .||||+++++++.+.+.+
T Consensus 1 lG~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKK---------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 799999999999543 468899999987543221 22344555665544 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 9999999999999988764 35899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------------- 209 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------------- 209 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH--------------
Confidence 322211 23345799999999998654 5899999999999999999999999764321110000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC----CHHHHHHHH
Q 015781 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP----TMDEVVKAL 352 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~eil~~L 352 (400)
..... .......+..+.+++.+||+.||.+|| ++.++++|-
T Consensus 210 --~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 210 --AFGKV-RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred --HcCCC-CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 00000 000112456788999999999999998 678888763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.07 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||.|+||.||+|.. ..+++.|++|.+..........+.+|+.+++.++||||+++++++.+.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAID---------VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEE---------cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 4699999999999999999954 3368899999987665555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+.+++|..++... .+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999988643 4789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+......+ ..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------~~---- 229 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------AT---- 229 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hh----
Confidence 75433221 122346888999999998888999999999999999999999999765432111000 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........+...+..+.+++.+||..||.+|||+.+++.+=+
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 230 ----NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred ----cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000001112234567888999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=341.46 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=200.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
....+|++.+.||+|+||+||+|... .++..+|+|++..... .....+..|+.+++.|+||||++++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34468999999999999999999543 4688999999875433 234568889999999999999999998
Q ss_pred EEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCeeeccCCCCCEEEcC
Q 015781 143 CLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-----AKVIYRDFKTSNILLDL 215 (400)
Q Consensus 143 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~ivH~dlkp~Nill~~ 215 (400)
|.+ ...+||||||+.+++|.++|.........+++..++.|+.||+.||.|||+.+ .+|+|+||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 45789999999999999999765433357999999999999999999999843 24999999999999964
Q ss_pred -----------------CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHH
Q 015781 216 -----------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEML 276 (400)
Q Consensus 216 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~ 276 (400)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2348999999997653322 2234578999999999854 45889999999999999999
Q ss_pred hCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 277 SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 277 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+|..||....... .++ . .+.... .......+..+.+||.+||+.+|.+||++.++|.+
T Consensus 238 TGk~PF~~~~~~~--qli---~-----------~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 238 SGKTPFHKANNFS--QLI---S-----------ELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HCCCCCCcCCcHH--HHH---H-----------HHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999997543211 000 0 000000 00011235678899999999999999999999965
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.54 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=198.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
++.+.+..||.|+.|+|++++.. .+|..+|||.+..... ....+++..+.++.+. ++|.||+++++|..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 34566788999999999999654 4789999999987643 3445677788777665 48999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..+++.||.| ..-+..++..-. .++++..+-++...++.||.||..+ ++|+|||+||+|||+|+.|.+||+|||
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeeccc
Confidence 99999999998 445555555543 6899999999999999999999766 469999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++-+..... ..+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+....-+. .
T Consensus 238 IsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----l----- 304 (391)
T KOG0983|consen 238 ISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----L----- 304 (391)
T ss_pred ccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----H-----
Confidence 997654432 345568999999999985 347899999999999999999999999876432111 0
Q ss_pred hhhhhhhhccccccCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+++.. .+.+ ....+..+.+++..||+.|+.+||...++|+|
T Consensus 305 -----tkvln~e-PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 305 -----TKVLNEE-PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----HHHHhcC-CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 0111100 0111 12267889999999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=298.93 Aligned_cols=254 Identities=29% Similarity=0.395 Sum_probs=201.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++|||++++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 568999999999999999996543 34589998765432 3456788999999999999999998875 45
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..+++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccc
Confidence 68999999999999999976432 45789999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+... ..+
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~---------- 215 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ---------- 215 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----------
Confidence 764332211 1122345678999999988889999999999999999999 8999976432110 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.........+...+..+.+++.+||+.||.+||+++++++.|+.+
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 216 ----VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ----HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000111122234567889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.33 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=207.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|..... ........+++|.+...... ....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 5788999999999999999987542 22345678999988765433 345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASY-----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
+..++||||+++++|.+++...... ..++++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 9999999999999999999765421 125899999999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~----- 229 (275)
T cd05046 159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN----- 229 (275)
T ss_pred cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH-----
Confidence 99999864322211 11223356778999999988888999999999999999998 7888865432111 10
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...........+...+..+.+++.+||+.+|.+|||+.+++..|+
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 --------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001111111122345568889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.30 Aligned_cols=265 Identities=22% Similarity=0.308 Sum_probs=205.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~---------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP---------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC---------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 57999999999999999999543 3688999999875432 22346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS-------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
+++..|+||||++|++|.+++..... ....++...++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCC
Confidence 99999999999999999999864211 1134567788999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCC----------------cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc
Q 015781 218 NAKLSDFGLAKDGPTGSQ----------------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 281 (400)
.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|+||..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999975421110 0011235799999999999999999999999999999999999999
Q ss_pred cCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhchhc
Q 015781 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDT 358 (400)
Q Consensus 282 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~eil~~L~~~~~~ 358 (400)
|......... +. ...............+..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 231 F~~~~~~ki~----~~-----------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKIS----YR-----------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhh----hh-----------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9763321110 00 00000000000123455678899999999999996 677788888876543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.51 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=198.5
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|.+. . +..|++|.+...... ....+.+|++++++++||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe---------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 46999999999999543 2 678999998765443 455788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++.... ..+++..++.++.+++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999999999986643 35789999999999999999999988 99999999999999999999999999876442
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
............+..|+|||.+.+..++.++|+|||||++|+|++ |..||........... .
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----------------~ 208 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----------------I 208 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----------------H
Confidence 221111111233567999999988889999999999999999999 8888866543211110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000111122344668899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.39 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=200.9
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
|+..+.||+|+||+||+|.+. .+++.+|+|.+...... ....+.+|+.+++.++|+||+.+.+.+.++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 667789999999999999554 36889999998764332 223467899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCc
Confidence 999999999999999988865432 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----------- 214 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----------- 214 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 87543221 1223468999999999988899999999999999999999999997643211100000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~ 351 (400)
..... ....++...+..+.+|+.+||+.||++||+ +.+++.+
T Consensus 215 -~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 -RRVLE--TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -Hhhhc--cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 011122334567789999999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=300.99 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|.+.+.||+|+||.||+|.+... ......+++|...... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 5688999999999999999976431 1234578999887654 3345568899999999999999999998875
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCce
Confidence 45789999999999999997643 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||.+....++.++||||||+++|+|++ |..||...........+
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----------- 221 (270)
T cd05056 154 SRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----------- 221 (270)
T ss_pred eeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence 8754332211 1112234567999999988889999999999999999986 99999765422111100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
........+...+..+.+++.+||..+|.+|||+.++++.|+.+..+.
T Consensus 222 ------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 222 ------ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000011122344568889999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=308.35 Aligned_cols=267 Identities=26% Similarity=0.412 Sum_probs=220.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH-HHHHHHHHHHccCCCCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
-......+++.||+|.||.|.++.... +..||+|.++....... .+|..|+++|.+|+||||++++++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 344678899999999999999996653 67899999988765544 6799999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..++.+++||||++.|+|..++.++... .+.......|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecC
Confidence 9999999999999999999999987531 1355667779999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHH--hCCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML--SGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~--tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||+++..-.++........+-..+|||+|.+..++++.++|+|+||+++||++ +...||....+.. ..
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------vv 750 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------VV 750 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------HH
Confidence 99999877777777777777889999999999999999999999999999975 4678886544321 11
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+...+..-.....-...|.-++.++++++.+||..+-.+|||++++..+|.+.
T Consensus 751 en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122222221112222233556788999999999999999999999999998764
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=298.75 Aligned_cols=251 Identities=29% Similarity=0.385 Sum_probs=205.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+.. ++..+++|.+..... ...+.+|+++++.++||||+++++++.++.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578999999999999999996543 578899999876532 567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999999986543 46899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------- 211 (256)
T cd06612 147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------- 211 (256)
T ss_pred hhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------
Confidence 86543321 223345788999999998889999999999999999999999999764432111000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ........+...+..+.+++.+||+.||++|||+.+++++
T Consensus 212 ~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 212 PN--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cc--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00 0000111123445678999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.34 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=201.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
.|++.+.||+|++|.||++... .+++.+|+|.+..... .....+.+|+.++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4888999999999999999543 3578899999865432 233457789999999999999999988764
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..+|++|||+++++|.+++..... .++++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEeccc
Confidence 4568999999999999999976432 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++....... .......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+... ...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~------- 212 (257)
T cd08223 148 IARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVY------- 212 (257)
T ss_pred ceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHH-------
Confidence 987543221 12334568899999999998899999999999999999999999997543110 000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... .....+...+..+.+++.+||+.||++||++.+++++
T Consensus 213 ---~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 ---RIIEG-KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---HHHhc-CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0112233456788999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.95 Aligned_cols=254 Identities=28% Similarity=0.361 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
+...|++.+.||+|+||.||+|... .++..+|+|.+.... .....+..|+.+++++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 4467889999999999999999654 367899999987543 3345677899999888 6999999999987
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.. ...|+||||+.+++|.+++..... ..+++..++.++.|++.||+|||+++ |+|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAE 149 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCC
Confidence 53 468999999999999999876432 46889999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
++|+|||++....... .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+......
T Consensus 150 ~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 150 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227 (272)
T ss_pred EEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 9999999987543221 1233457889999999985 34578899999999999999999999965432111000
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..............+..+.+|+.+||..+|.+|||+.+++++
T Consensus 228 ----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ----------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ----------------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000111112345678899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.70 Aligned_cols=268 Identities=23% Similarity=0.279 Sum_probs=199.3
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
....++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDT---------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEEC---------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence 345678999999999999999999543 3688999999875432 22345678999999999999999998
Q ss_pred EEEeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 142 YCLED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 142 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
++... ...|++|+++ +++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~ 153 (343)
T cd07878 82 VFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNE 153 (343)
T ss_pred hhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECC
Confidence 87543 4578999998 8899888753 35899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+
T Consensus 154 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 154 DCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999864332 233568999999999876 56899999999999999999999999765432111110
Q ss_pred H-hhhH----HHhh--hhhhhhhccccccCCC-------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 295 E-WAKP----YLQS--KRRIFQVMDARIEGQY-------SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 295 ~-~~~~----~~~~--~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
. .... .... ......... .+.... .......+.+|+.+||+.||.+|||+.++++|=+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 0000 0000 000000000 000000 00123457789999999999999999999998544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=336.55 Aligned_cols=270 Identities=30% Similarity=0.417 Sum_probs=218.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
...++.+.||+|.||.||.|...... .......||+|.+.... .+...+|++|..+|+.++||||++++|++.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 45567789999999999999876532 11114568999887653 34566799999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
...+|++|||.||+|..+|.+... ....+.....+.++.||+.|+.||++++ .|||||...|+|++....+||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999987521 1246899999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||+|+.....+.......-.-...|||||.+..+.++.++|||||||++||++| |..||...+..+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--------- 916 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--------- 916 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---------
Confidence 999995544443333322233468999999999999999999999999999999 8889987654221110
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
++... +-..+..+++.+++++..||+.+|++||++..|++.+..+.+...
T Consensus 917 -------~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 917 -------VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -------HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11111 223466788999999999999999999999999999888755543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=300.50 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=200.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|...... .....+..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36899999999999765321 1122346899998765432 3345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-----ceEEeec
Q 015781 153 YEFMPKGSLENHLFRRASY---IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-----NAKLSDF 224 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-----~~kl~Df 224 (400)
|||+++++|.+++...... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999754321 134788999999999999999999988 99999999999999877 8999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~------- 225 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH------- 225 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH-------
Confidence 99875433322222223355788999999998899999999999999999998 999996543211 1100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.........+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 -------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00111112233456788899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=305.78 Aligned_cols=264 Identities=23% Similarity=0.395 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|+..+.||+|+||.||+|.+... .......+|+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 5688899999999999999976531 1112346899988765432 233577899999999999999999998754
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccc
Confidence 4679999999999999987653 35789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...... . ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~- 227 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P----DLLEKG- 227 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHCC-
Confidence 986543222211222345678999999988899999999999999999997 8999865432111 0 011110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.....+...+..+..++.+||..+|++||++.++++.|+.+....
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 ---------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 001111223457889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.08 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 57999999999999999999543 36789999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999999996 68988887643 45789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...... ....
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~ 227 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT-PTEE 227 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CChh
Confidence 875432221 1223456889999998865 45788999999999999999999999765432111111000000 0000
Q ss_pred hhhhhcc---------cccc----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 306 RIFQVMD---------ARIE----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 306 ~~~~~~~---------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+...+. +... .......+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0000000 0000 00112235578899999999999999999999996443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=297.59 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=205.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.++||.|+||.||.+... .++..+++|.+..... .....+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5888999999999999998543 4688899998865432 3345678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..+++|||+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcc
Confidence 999999999999999999976532 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......... .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~-------- 211 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------V-------- 211 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------H--------
Confidence 876533221 223456899999999998888999999999999999999999999654321100 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
....... ...+...+.++.+++.+||+.+|.+||++.++++++
T Consensus 212 --~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 --KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0000001 111234566788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.04 Aligned_cols=267 Identities=21% Similarity=0.292 Sum_probs=190.5
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe--CCeeE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRL 150 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~ 150 (400)
.+.||+|+||+||+|.... ..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 3579999999999997532 23577899999875432 2356789999999999999999998854 45689
Q ss_pred EEEeecCCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE----cCCCceEE
Q 015781 151 LVYEFMPKGSLENHLFRRAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKL 221 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl 221 (400)
++|||+ +++|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999999 5688888764321 1235899999999999999999999988 9999999999999 45678999
Q ss_pred eeccCCccCCCCCC-cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc------hh
Q 015781 222 SDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH------NL 293 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~------~~ 293 (400)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ..
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999976533221 111234578999999999876 45899999999999999999999999765432110 00
Q ss_pred HHhhhHHHh--hhhhhh---------hhc---cccccC---------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 294 IEWAKPYLQ--SKRRIF---------QVM---DARIEG---------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 294 ~~~~~~~~~--~~~~~~---------~~~---~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
......... ....+. ... ...... .........+.+|+.+||+.||.+|||+.|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000000 000 000000 000112345788999999999999999999997
Q ss_pred H
Q 015781 351 A 351 (400)
Q Consensus 351 ~ 351 (400)
|
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=301.76 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=205.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||.|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 36888999999999999999654 368899999987654 23345678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...|+|+||+.+++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998653 6899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||....+......
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~------------- 209 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL------------- 209 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------
Confidence 97654332 122345678899999999888899999999999999999999999975442111000
Q ss_pred hhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 307 IFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
............ .+..+.+++.+||..+|++|||+.+++++-+-
T Consensus 210 ----~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 210 ----IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred ----hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 000011111112 56678899999999999999999999997443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=293.90 Aligned_cols=250 Identities=29% Similarity=0.384 Sum_probs=210.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHH---HHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
-++|...++||+|.||.|.++ +.+.+|+.+|+|+++++......+ -+.|-++|+..+||.+..+...|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 367888999999999999998 566689999999999876544433 35688999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..++.+|+||||..||.|.-++.+. ..+++.....+-..|+.||.|||+.+ ||.||||.+|+++|.+|++||.|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeee
Confidence 9999999999999999999888775 45888999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++.... ....+.+++|||.|+|||++....|..+.|.|.+|+++|||++|+.||...+......++...
T Consensus 312 FGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------ 383 (516)
T KOG0690|consen 312 FGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------ 383 (516)
T ss_pred cccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------
Confidence 999986432 233467799999999999999999999999999999999999999999876654443333211
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
+-.+|...+.+...|+..+|..||.+|. .++||.+|
T Consensus 384 ------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 ------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1234445566778899999999999994 46666654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=294.46 Aligned_cols=247 Identities=31% Similarity=0.468 Sum_probs=196.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
++||+|+||.||+|... .+..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 46899999999999543 3678999998765432 234578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++.... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999999999986543 35789999999999999999999988 99999999999999999999999999875332
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
.... ......++..|+|||++.+..++.++||||||+++|++++ |..||.......... ..
T Consensus 146 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~~---------- 207 (250)
T cd05085 146 GIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------QV---------- 207 (250)
T ss_pred cccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HH----------
Confidence 2111 1112234567999999988889999999999999999998 999997543211100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 000111222334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.48 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=194.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEE-eCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-EDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~l 151 (400)
+.||+|+||.||+|.+.. .......+|+|.+.... ......+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999997643 12345789999885432 233456788999999999999999999765 4566899
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
||||+.+++|.+++.... ..+.+..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999997643 24577788899999999999999988 9999999999999999999999999987543
Q ss_pred CCCCcc--eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhC-CCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 232 TGSQSH--VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 232 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
...... ......++..|+|||.+.+..++.++|||||||++|+|++| .+||...... ..... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~----~------- 215 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY----L------- 215 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H-------
Confidence 221110 11123456789999999888899999999999999999995 5666543211 11100 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.. ......+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 216 --~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 --LQ-GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --hc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 0001112223567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=307.03 Aligned_cols=255 Identities=28% Similarity=0.361 Sum_probs=204.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..+|+|.+...... ....+..|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc---------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 36888999999999999999543 36889999999765433 3345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+....|+||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeec
Confidence 99999999999999999999875432 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc---------------------------ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh
Q 015781 225 GLAKDGPTGSQS---------------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277 (400)
Q Consensus 225 g~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 277 (400)
|++......... .......|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754221110 01113467889999999988889999999999999999999
Q ss_pred CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHHH
Q 015781 278 GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT----MDEVVKA 351 (400)
Q Consensus 278 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~eil~~ 351 (400)
|..||........ +................+..+.+++.+||+.||++||| +.+++.+
T Consensus 228 g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 228 GTTPFKGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999976543111 01111111111111225678999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=296.85 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.+.. +..+++|.+.... .....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4679999999999999999996542 4569999887543 234567889999999999999999999887
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcc
Confidence 778999999999999999976432 45788899999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......++..|+|||++....++.++|+|||||++|++++ |..||........ ..+.
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~-------- 216 (260)
T cd05073 149 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL-------- 216 (260)
T ss_pred eeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH--------
Confidence 8754332211 1222345677999999988889999999999999999999 9999975432111 1000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
............+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 ------ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ------hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00001111233456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=298.42 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=204.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc------hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
+|+..+.||+|+||.||+|.. ..++..+|+|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 478889999999999999954 34688999999875431 123567889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEE
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKL 221 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl 221 (400)
+.+.+..++||||+.+++|.+++... .++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999999764 36889999999999999999999988 99999999999998776 5999
Q ss_pred eeccCCccCCCCCC--cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 222 SDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
+|||.+........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----- 220 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----- 220 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-----
Confidence 99999876543211 11122346788999999998888999999999999999999999999654322111111
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
............+...+..+.+++.+||..+|.+||++.+++++
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 --------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01111111233445567788999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.91 Aligned_cols=246 Identities=30% Similarity=0.391 Sum_probs=204.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|.=.+.||.|+||.||.|++ ..+..+||||.+.-... ..+..++.|+..|+++.|||+|.+.+.|..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd---------~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeec---------cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 355567899999999999954 44789999999876543 345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+...|+||||| -|+-.|++.-.. +|+-+..+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeecccc
Confidence 99999999999 679999988776 68999999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
.+....+ ...++|||+|||||++. .+.|+-++||||||++..||.-.++|+...+-.+.
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------------ 233 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------ 233 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------------
Confidence 9986544 34579999999999984 46899999999999999999999999755432111
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
-..+.+.-.+.+ -....+..+..++..||++-|.+|||..++|+|
T Consensus 234 -LYHIAQNesPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 234 -LYHIAQNESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -HHHHHhcCCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111111111 134567788899999999999999999999886
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=298.34 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=193.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|.+.. ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 368999999999997642 22467899998876542 2334678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 153 YEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
|||+++++|.+++..... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999975432 1234577788899999999999999988 9999999999999999999999999987543
Q ss_pred CCCCcceeeecccccCcccchhhccC-------CCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 232 TGSQSHVSTRVMGTYGYAAPEYMATG-------HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
............++..|+|||++.+. .++.++||||||+++|+|++ |..||....+... ..+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~----- 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTV----- 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHh-----
Confidence 32221122234577889999998532 35789999999999999996 9999976433211 00000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........ ........+..+.+++.+|| .+|++|||+.+|+..|.
T Consensus 224 ~~~~~~~~----~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLP----KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCC----CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000111 11112234456778999998 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=297.35 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=204.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
+|++.+.||.|+||.||++.. ..++..+|+|.+..... .....+..|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRR---------KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeee---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 478889999999999999954 34688999999875433 234467789999999999999999997753
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCeeeccCCCCCEEEcCCCce
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH-----SDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
+...+++|||+++++|.+++........++++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNV 149 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCE
Confidence 45689999999999999999775444467899999999999999999999 777 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
+|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ...+
T Consensus 150 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---- 220 (265)
T cd08217 150 KLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS---- 220 (265)
T ss_pred EEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH----
Confidence 9999999986544321 123356899999999998888999999999999999999999999765311 1110
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 221 ----------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ----------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011111123344566788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=302.72 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=199.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|++|.||+|... .++..||+|.+...... ....+.+|+.+++.++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 4788899999999999999654 36789999998754322 234677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+|+||||+. ++|.+++..... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 689888865332 246899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH-Hhhh----HH
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWAK----PY 300 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~----~~ 300 (400)
+....... .......+++.|+|||.+.+. .++.++|||||||++|+|+||++||............ .... ..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543221 112234568899999988653 5788999999999999999999999765432111000 0000 00
Q ss_pred Hhhh---hhhhhhccc---cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 LQSK---RRIFQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 ~~~~---~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ......... ..........+.++.+++.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 000000000 00000111245677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.10 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=191.7
Q ss_pred ccccCCCceEEEEEecCCC---------------cCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccce
Q 015781 75 VLGEGGFGCVFKGWIDEHT---------------YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKL 139 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~---------------~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~ 139 (400)
.||+|+||.||+|.+.... ....+......|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999763211 1112333456799999876554445567889999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC--
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 217 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-- 217 (400)
++++.++...++||||+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886543 35789999999999999999999988 99999999999997543
Q ss_pred -----ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHH-hCCCccCCCCCCcc
Q 015781 218 -----NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSRE 290 (400)
Q Consensus 218 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~~ 290 (400)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643221 12356788999998865 56899999999999999984 79999876543211
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
... .... ...+......+.+++.+||+.+|++|||+.++++.|
T Consensus 231 ~~~-------~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERF-------YEKK------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-------HHhc------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 100 0000 011111234688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=304.10 Aligned_cols=260 Identities=27% Similarity=0.295 Sum_probs=201.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
...++|++.+.||+|+||.||+|... .++..+|+|++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 45578999999999999999999553 3678899998765332 234567899999998 699999999987
Q ss_pred E-----eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 144 L-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 144 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
. .++..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCC
Confidence 4 446789999999999999988654333356889999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
++|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||....+.....
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~- 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF- 239 (286)
T ss_pred EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence 99999999875433211 1223468899999998753 457889999999999999999999997543311100
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. ..... ......+...+..+.+++.+||+.||++|||+.+++++..
T Consensus 240 -~-----------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 240 -K-----------IPRNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred -h-----------ccccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0 00000 0000111223457889999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=302.97 Aligned_cols=259 Identities=28% Similarity=0.361 Sum_probs=201.9
Q ss_pred hHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccce
Q 015781 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKL 139 (400)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~ 139 (400)
.+.......|++.+.||.|+||.||+|... .++..+|+|++.... .....+..|+.+++++ +|+||+++
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~ 78 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY 78 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence 334455678999999999999999999654 367899999986653 2334577888888888 69999999
Q ss_pred eeEEEe------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 140 IGYCLE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 140 ~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
++++.. ....|++|||+.+++|.+++..... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili 154 (282)
T cd06636 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL 154 (282)
T ss_pred eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence 998853 4678999999999999999976543 45788999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCC
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 288 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 288 (400)
+.++.++|+|||++........ ......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+.
T Consensus 155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 9999999999999875432111 123356889999999875 346788999999999999999999999654321
Q ss_pred ccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.....+ .............+..+.+++.+||+.||.+||++.+++++
T Consensus 233 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 233 RALFLI----------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhhhH----------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111100 00000111112345688999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.15 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=195.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~l 151 (400)
++||+|+||.||+|.+... +....+++|.+..... .....+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 4689999999999976431 1123578888875332 2345678899999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 152 VYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeE
Confidence 9999999999999976431 1134789999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----- 223 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 223 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-----
Confidence 999999986322111 1111223567999999988889999999999999999997 9999965432111000
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.........+...+..+.+++.+||..+|.+|||+.+++..|+.+.
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000111122234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.10 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=197.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.+|++.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV---------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc---------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 46899999999999999999543 4688999998865322 123457789999999999999999998
Q ss_pred EEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 143 CLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 143 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+.+ ....+++|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEE
Confidence 875 36788999999999999999764 34788999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCC-cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||........
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--------- 217 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--------- 217 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---------
Confidence 999999875432111 1111234578899999999888899999999999999999999999975422100
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+............+......+..++ +||..+|++||+++++++|
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 218 -------IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -------HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0011111112233444556677777 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.23 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=203.2
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
+++.+.||.|+||.||++..... ...++..+|+|.+...... ....+..|+..++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 45778999999999999976541 1134588999999766543 45678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.+++|||+++++|.+++..... ..+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999999999976542 22899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
......... .....++..|+|||.+.+..++.++||||||+++|+|++ |.+||....... ....
T Consensus 152 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----------- 216 (258)
T smart00219 152 DLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY----------- 216 (258)
T ss_pred ecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------
Confidence 654432211 112236788999999988889999999999999999998 788886532211 0100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.........+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 ---LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000011112233567889999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=296.82 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=192.7
Q ss_pred CccccCCCceEEEEEecCCCcCC---CCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAP---ARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
+.||+|+||.||+|.+....... ........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864321000 112345578999887655444556788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc-------eEEee
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-------AKLSD 223 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-------~kl~D 223 (400)
+||||+.+++|..++.... .++++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998886543 46899999999999999999999988 999999999999986654 89999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHH-hCCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......... ..
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~- 221 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RF- 221 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HH-
Confidence 998865432 12245788899999886 467899999999999999997 588887654321100 00
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..... ........++.+|+.+||+.||.+||++.+|+++|+
T Consensus 222 ---------~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 ---------YEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---------HhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 011122457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=297.82 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=200.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc------hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
+|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4888999999999999999543 477899998865321 122457789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+.+..++||||+++++|.+++... .++++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEec
Confidence 99999999999999999999999765 35789999999999999999999988 9999999999999999999999
Q ss_pred eccCCccCCCCC----CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 223 DFGLAKDGPTGS----QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 223 Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|||++....... .........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----- 219 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY----- 219 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-----
Confidence 999987542211 11112235688999999999888899999999999999999999999975432111000
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... .......+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 220 --~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 220 --IGAH--------RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --hhhc--------cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 001112233456778999999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=308.56 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=195.9
Q ss_pred CCCccccC--CCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 72 PDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 72 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.++||+| +|++||++. ...+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLAR---------YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEe---------ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 678999984 445799999999976532 22345667999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+++.||+.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999999999999976432 45889999999999999999999988 999999999999999999999999865
Q ss_pred ccCCCCCCc-----ceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 228 KDGPTGSQS-----HVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 228 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 226 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGT 226 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCC
Confidence 432211100 01112346778999999975 46899999999999999999999999754321100 0000000
Q ss_pred Hh---h-----hhhh-------------hh--h-------ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 301 LQ---S-----KRRI-------------FQ--V-------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 301 ~~---~-----~~~~-------------~~--~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
.. . ...+ .. . .............+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 0000 00 0 0000000112234567889999999999999999999998
Q ss_pred HHH
Q 015781 351 ALE 353 (400)
Q Consensus 351 ~L~ 353 (400)
+-+
T Consensus 307 ~p~ 309 (327)
T cd08227 307 HSF 309 (327)
T ss_pred Chh
Confidence 744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.56 Aligned_cols=253 Identities=28% Similarity=0.375 Sum_probs=206.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..|+..+.||.|+||.||+|.+. .++..+|+|.+..... .....+.+|+.+++.+.||||+++++.+.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 45778899999999999999554 3578999999875432 3345678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++.. .++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEccccc
Confidence 999999999999999998864 35788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------------- 211 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------------- 211 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------
Confidence 875433221 1223467889999999988889999999999999999999999997544321110
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..............+..+.+++.+||+.+|++||++.+++.+-...
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 212 ---LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred ---hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 0011111233445677889999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=301.77 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=207.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||++... .++..+|+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 56888999999999999999554 3578899998865432 3345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
..+++||||+++++|.+++... .++++..+..++.+++.+|.|||+ ++ ++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCC
Confidence 9999999999999999988764 358999999999999999999997 46 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc-----hhHHhhhHH
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-----NLIEWAKPY 300 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-----~~~~~~~~~ 300 (400)
++....... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......... ....+..
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 223 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-- 223 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH--
Confidence 886532211 22356899999999998889999999999999999999999999865432111 0111110
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
...............+..+.+|+.+||+.||.+|||+.+++++..-++.
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 224 --------QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --------HHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1111000111112255678899999999999999999999998766543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=295.94 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 468888999999999999996542 45799998875433 3456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++.... ..+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999987543 35789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~-------~--- 213 (256)
T cd05112 148 RFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE-------T--- 213 (256)
T ss_pred eecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH-------H---
Confidence 754322111 1112334578999999988889999999999999999998 999996543211 010 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
+........+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 214 ----INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000001011112356788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=296.80 Aligned_cols=261 Identities=27% Similarity=0.405 Sum_probs=201.4
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.++||+|+||.||+|.+.. ...++..+|+|++..... .....+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6678899999999999997642 334688999999876432 23456788999999999999999999886532
Q ss_pred ------eeEEEEeecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 148 ------HRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
..++++||+.+++|.+++.... .....++...++.++.||+.||+|||+++ |+|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCE
Confidence 2478899999999998875432 11234788999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||....... ...+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~- 228 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL- 228 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH-
Confidence 9999999886543322212223345678999999988889999999999999999999 888886543211 11100
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.... ....+...+..+.+++.+||+.+|++|||+.+++..|+.+
T Consensus 229 ---~~~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 ---IKGN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---HcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0011223456888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.24 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.+.....||+|+||.||+|... .++..+++|.+..........+.+|+.+++.++|+||+++++++..++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDL---------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEec---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 34445568999999999999543 357889999987766556667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEeec
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~Df 224 (400)
..++||||+.+++|.+++.... .++ ++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecc
Confidence 9999999999999999997643 234 78888999999999999999988 999999999999976 678999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|.+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ..+..
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~---- 224 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV---- 224 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh----
Confidence 99875432211 12234578999999998654 378899999999999999999999965332110 00000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.........+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 --------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011122334456778899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=301.11 Aligned_cols=250 Identities=28% Similarity=0.384 Sum_probs=202.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.|+..+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 4667788999999999999654 3578899999875432 23346788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+++++|.+++.. .++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999998854 35789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------- 211 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------------- 211 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---------------
Confidence 75433211 1223467889999999988889999999999999999999999986543211100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..............+..+.+++.+||+.+|.+||++.+++++-+
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 212 --LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred --hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 00011111223345667889999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.71 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.+|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 46889999999999999999544 3688999998754321 123457789999999999999999998
Q ss_pred EEeC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 143 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+.+. ..++++|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEE
Confidence 8763 56889999999999999987653 4788899999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||++......... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------- 217 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--------- 217 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---------
Confidence 9999998754321111 112234688899999999888899999999999999999999999965421100
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.............+...+..+.+++.+||. +|++||++.+++++
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 -------IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 001111111223344566778889999995 99999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=300.48 Aligned_cols=258 Identities=27% Similarity=0.319 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHH-HccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|.. ..+|..||+|.+..... .....+..|+.. ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRH---------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEE---------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 3688899999999999999954 34689999999876532 223445556654 566789999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++..|++|||++ ++|.+++.........+++..++.++.||+.||+|||++ + ++|+||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeec
Confidence 999999999995 689888876443346789999999999999999999987 6 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... ..
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~------- 216 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQ------- 216 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HH-------
Confidence 9987543211 1223467889999998864 456889999999999999999999996432110 00
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+................+.++.+++.+||..+|.+||++.+++++-+..
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 265 (283)
T cd06617 217 ------LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265 (283)
T ss_pred ------HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence 0000110000011123466788999999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.26 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=200.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch----------hHHHHHHHHHHHccCCCCcccc
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------GHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~hpniv~ 138 (400)
+|.+.+.||.|+||.||+|.. ..++..+|+|.+...... ....+..|+.+++.++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALN---------VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEee---------cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 578889999999999999954 346889999987642111 1234678999999999999999
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
+++++...+..++||||+.+++|.+++... .++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGI 146 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCe
Confidence 999999999999999999999999998765 35888999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCC--CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
++|+|||++................++..|+|||.+.... ++.++|+||||+++|+|++|..||....... ..
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~ 221 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM 221 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH
Confidence 9999999987543322111223356788999999987654 7899999999999999999999996432210 00
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... . ...............+..+.+++.+||+.+|.+|||+.++++|
T Consensus 222 -~~~~--~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 -FKLG--N----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -HHhh--c----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 0 0000111111223456788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.47 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=192.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 153 (400)
+.||.|+||.||+|....... ........+++|.+..........+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997643110 001234568888886655444557788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--------eEEeecc
Q 015781 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--------AKLSDFG 225 (400)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg 225 (400)
||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999997654 35789999999999999999999988 999999999999987665 6999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCC-CccCCCCCCccchhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+....
T Consensus 154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~------------ 215 (258)
T cd05078 154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL------------ 215 (258)
T ss_pred cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH------------
Confidence 8865432 123467889999999976 45799999999999999999994 565443221100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..... ....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 216 -----~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 -----QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 11223334467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.32 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||++.+. .++..+|+|.+..... .....+.+|+.++++++||||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR---------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 36889999999999999999554 3688999998875422 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..|+||||+++++|..++.... ....+++..+..++.||+.||.|||. .+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999999998886532 12468999999999999999999996 46 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccC------CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
++...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~------ 218 (286)
T cd06622 149 VSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ------ 218 (286)
T ss_pred CcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH------
Confidence 98754322 12234578899999998543 357899999999999999999999965432111000
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+...... .....+...+..+.+++.+||+.+|++||++.+++.+-+..
T Consensus 219 -------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 219 -------LSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred -------HHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 0011111 11223344677889999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=295.76 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=203.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||++... .+++.+|+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 5888999999999999998543 3578999999875432 2344678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999999999999876432 35789999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~-------- 211 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VL-------- 211 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HH--------
Confidence 875433221 12234578899999999888899999999999999999999999865322100 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... .....+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 212 --~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 --KIIRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHhcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00000 0111233456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.61 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=190.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|..... .....+++|.+...... ....+.+|+..++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3689999999999965321 23567899987654322 234578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 153 YEFMPKGSLENHLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
|||+.+++|.+++...... ....++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999999765432 223467888999999999999999988 9999999999999999999999999986533
Q ss_pred CCCCcceeeecccccCcccchhhcc-------CCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 232 TGSQSHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
............++..|+|||++.. ..++.++|||||||++|+|++ |..||....+... ... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~---~~~- 224 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQ---VVR- 224 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHH---Hhh-
Confidence 2221111222345678999998743 356889999999999999999 7888865432110 000 000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.....+ .........+..+..++..|| .||++|||+++|++.|
T Consensus 225 -~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 225 -EQDIKL----PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -ccCccC----CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 000001 111222344566677888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=298.50 Aligned_cols=256 Identities=28% Similarity=0.360 Sum_probs=202.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|... .++..+++|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 3478999999999999999999553 3578899999876543 345678999999998 7999999999997
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
+.. .+++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCe
Confidence 644 589999999999999998765433357899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
++|+|||++....... .......++..|+|||++.. ..++.++|||||||++|+|++|..||..........
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 228 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF- 228 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH-
Confidence 9999999987543221 12233568899999998753 346789999999999999999999996543211100
Q ss_pred HHhhhHHHhhhhhhhhhccccc-cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+..... ....+...+..+.+++.+||..||++|||+.+++++
T Consensus 229 ---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 ---------------KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---------------HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000000 111122356688899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.28 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=201.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
+|+..+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL---------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEc---------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 4778899999999999999654 3578899998865432 2345678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.++..++++|||+++++|.+++... .++++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999998764 35789999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCC-CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||++....... ......++..|++||.+.... ++.++|+|||||++|+|++|..||....+.... .
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~-------- 212 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--F-------- 212 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--H--------
Confidence 99987643322 123456889999999987766 899999999999999999999999754321100 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...........+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 213 ------KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ------HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000000112233456778899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.70 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||++.... +++.+|+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368899999999999999996543 578999999875432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++...|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999999998765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~--------- 208 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---YE--------- 208 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---------
Confidence 998765432 2334688999999999888889999999999999999999999975442100 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
..... ...++...+..+.+++.+||..||.+|+ +++++++|-
T Consensus 209 ----~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 209 ----KILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ----HHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 00000 1122233467888999999999999999 888888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=301.40 Aligned_cols=267 Identities=25% Similarity=0.318 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 36889999999999999999654 3688999998865432 123456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+++++|..++... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccc
Confidence 99999999999988887776543 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~ 303 (400)
++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+. ........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9986543321 1223457889999999865 457899999999999999999999998665432211110 00000000
Q ss_pred hhhh-------hhhccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRI-------FQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~-------~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... .....+...... ....+..+.+|+.+||+.+|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 000000000000 01235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.54 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=190.9
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 153 (400)
.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 599999999999865321 1245677887765432 33457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCC
Q 015781 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (400)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 233 (400)
||+++++|.+++.........++...++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999875433345677888999999999999999988 999999999999999999999999987643221
Q ss_pred CCcceeeecccccCcccchhhcc-------CCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 234 SQSHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
..........++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.. .. ......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~-- 224 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VL---NHVIKD-- 224 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHhh--
Confidence 11112234567889999998743 245789999999999999997 566775443211 01 000000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
......+ .......+..+.+++..|| .+|++||++.+|++.|.
T Consensus 225 ~~~~~~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 QQVKLFK----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccccCC----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0011111 1222234567788999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=301.51 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=202.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|.+. .+|..+|+|++..... .....+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR---------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC---------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5888999999999999999654 3588999999876542 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9999999999 999999987654 56899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh-
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK- 304 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~- 304 (400)
+........ .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||....+......+ .......
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~ 221 (286)
T cd07832 146 ARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV---FRTLGTPN 221 (286)
T ss_pred cccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH---HHHcCCCC
Confidence 886543321 112335688999999988654 4689999999999999999998888665432111110 0000000
Q ss_pred -------hhhhhhcccccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 305 -------RRIFQVMDARIE-------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 305 -------~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
..+......... .......+..+.+++.+||+.+|.+|||+++++.|-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000 000112357889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.77 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=202.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.+++.++||||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 4888999999999999999654 3688999999876532 2345678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg 225 (400)
+..++||||+++++|.+++..... ..+++..++.++.|++.+|+|||+++ ++|+||+|+||+++.+ +.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999999999999976542 45899999999999999999999988 9999999999999865 457999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~---~--------- 212 (256)
T cd08220 148 ISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL---K--------- 212 (256)
T ss_pred CceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH---H---------
Confidence 9986543221 223567889999999988888999999999999999999999997654311100 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... .....+...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 213 ----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 ----IMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----HHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 0111223356678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=294.21 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=201.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----------hhHHHHHHHHHHHcc-CCCCccc
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------QGHLEWLTEIKHLGQ-LYHPNLV 137 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~-l~hpniv 137 (400)
.|++.+.||+|+||.||+|.... .++..+|+|.+..... .....+.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999997643 1467899998754321 123346678887765 7999999
Q ss_pred ceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCC
Q 015781 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~ 216 (400)
++++++.+++..++||||+++++|.+++.........+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~ 150 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED 150 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC
Confidence 99999999999999999999999999986543333568999999999999999999996 56 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~----- 222 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA----- 222 (269)
T ss_pred CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-----
Confidence 999999999997654332 233456889999999998888999999999999999999999999654321100
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. ...............+..+.+++.+||+.||++||++.++..+++
T Consensus 223 -~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 -T----------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -H----------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 000000011111134567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.18 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=189.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe--CCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~l 151 (400)
..||+|+||.||+|.... ..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~-------~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecC-------CCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 579999999999997542 23567899999875432 3356789999999999999999998853 567899
Q ss_pred EEeecCCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE----cCCCceEEe
Q 015781 152 VYEFMPKGSLENHLFRRAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLS 222 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~kl~ 222 (400)
||||+. ++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999995 588888753211 1235889999999999999999999988 9999999999999 566789999
Q ss_pred eccCCccCCCCCCc-ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch-------h
Q 015781 223 DFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-------L 293 (400)
Q Consensus 223 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~-------~ 293 (400)
|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|+||.+||.......... .
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99999865432211 11234578999999999876 458999999999999999999999997554321100 0
Q ss_pred HHhhhHHH-hhhhhhh---------hhccc---c------c---cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYL-QSKRRIF---------QVMDA---R------I---EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~-~~~~~~~---------~~~~~---~------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
........ .....+. ..... . + ...........+.+|+.+||+.||.+|||+.|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 0000000 00000 0 0 000011224567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.21 Aligned_cols=247 Identities=33% Similarity=0.507 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5689999999999999998742 46779999986543 335678899999999999999999998765
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccc
Confidence 47999999999999999976542 45789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
....... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........
T Consensus 148 ~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~------------- 209 (254)
T cd05083 148 RVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC------------- 209 (254)
T ss_pred eeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------------
Confidence 7543221 11234567999999988889999999999999999997 9999976543111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 210 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 ----VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00111111223456778899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=301.24 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=196.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|... .+|..+|+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4788899999999999999554 36889999998654321 224567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999995 58888876543 45899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh--h
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ--S 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~ 303 (400)
+........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ .......... .
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~ 221 (284)
T cd07839 146 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPT 221 (284)
T ss_pred hhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCC
Confidence 875433221 12234578899999998664 478999999999999999999988643222110 0000000000 0
Q ss_pred hh---hhhhhcccccc---------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 304 KR---RIFQVMDARIE---------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 304 ~~---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.. .+....+.... .......+..+.+++.+||+.||.+|||+.++++|-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 00 00000000000 011123456788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=296.06 Aligned_cols=263 Identities=27% Similarity=0.325 Sum_probs=204.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC-
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 146 (400)
+|+..+.||.|++|.||+|... .++..+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLK---------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEEC---------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 5778899999999999999654 3688999999875433 2345688999999999999999999988653
Q ss_pred -CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+.+|+||||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecc
Confidence 4789999999999999988654433456899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCC--ccchhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS--REHNLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~ 303 (400)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+...
T Consensus 151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 222 (287)
T cd06621 151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---- 222 (287)
T ss_pred ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----
Confidence 987543221 12345788999999998889999999999999999999999999765331 11111111110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
. ....+.. . .......+..+.+++.+||..+|.+|||+.|++++-+-
T Consensus 223 ~-~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 223 M-PNPELKD-E--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred C-Cchhhcc-C--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 0 0000000 0 01012345678899999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=301.62 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
.|.....||+|+||.||++... .++..+|+|.+..........+.+|+..++.++||||+++++.+..++.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 3444567999999999998543 3678999999876554555668899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.|+||||+++++|.+++.. ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999999998754 24788999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+...... +.
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~ 231 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IR 231 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HH
Confidence 5432221 12335688999999999888899999999999999999999999975433111000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
........ .....+..+.+++.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 112345578889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=295.90 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=204.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+|++.+.||.|+||.||++... .+++.+++|.+..... .....+.+|+++++.++||||+++++++..+.
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 5788899999999999999654 3688999999876543 33456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..+++|||+.+++|.+++.... .++++..++.++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997653 468999999999999999999999 88 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ......
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~-------- 214 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQ-------- 214 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHH--------
Confidence 86543211 11256888999999998889999999999999999999999999754321111 111100
Q ss_pred hhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...... ....+.. .+..+.++|.+||..||++|||+.+++.+=+
T Consensus 215 --~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 215 --YIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred --HHhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 011110 1112222 5677899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.13 Aligned_cols=258 Identities=26% Similarity=0.300 Sum_probs=199.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
...++|.+.+.||+|+||.||+|... .++..+|+|.+..... ....+.+|+.+++++ +|||++++++++
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34578999999999999999999553 3688999999865432 234567888899888 799999999998
Q ss_pred EeC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 144 LED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 144 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
... ...++||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCC
Confidence 753 3689999999999999998754333356899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-----CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||....+....
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 99999999876433221 12234678899999988543 3688999999999999999999999764331111
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+ ...... ....+......+.+++.+||+.+|++||++.++++|
T Consensus 243 ~~~-----------~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKI-----------PRNPPP--TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHH-----------hcCCCC--CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 000000 001122334568899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.92 Aligned_cols=267 Identities=24% Similarity=0.327 Sum_probs=197.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|++|.||+|... .++..||+|.+...... ....+.+|+++++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 57899999999999999999643 35788999998754322 223466899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999996 59999887654 36889999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............+.........
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 875332111 1122346788999999865 4588999999999999999999999975542111000000000000000
Q ss_pred hhhhhc--------------cccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVM--------------DARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~--------------~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+.... ...+.... .......+.+++.+||+.+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 00000000 01112677899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=309.89 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=216.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
...|.+.+.||+|.|+.|.+| .+..|+..||+|++.+..... ...+.+|+++|..++|||||+++.+.+
T Consensus 55 vg~y~i~~tig~g~f~~V~La---------~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLA---------RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEee---------EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 357899999999999999999 556689999999998876543 345789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
....+|+||||+.+|.+.+++.+.+. +.+..+..++.|++.|++|||+++ |||||||++|||++.+..+||+||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeecc
Confidence 99999999999999999999998863 566888899999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++..+..+. ...+.+|++.|.|||++.+..| .+++|+|++|+++|.|+.|..||++..-..
T Consensus 200 gfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------- 262 (596)
T KOG0586|consen 200 GFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------- 262 (596)
T ss_pred ccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------------
Confidence 9998776433 4567899999999999988877 579999999999999999999998754321
Q ss_pred hhhhhhhcccccc--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 304 KRRIFQVMDARIE--GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 304 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
+-.+.+. ...+...+.++.+||.++|-.+|.+|+++.++.++-|.-..
T Consensus 263 ------Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 263 ------LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ------ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 1111111 23345567788899999999999999999999998776433
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=318.33 Aligned_cols=285 Identities=21% Similarity=0.291 Sum_probs=192.3
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCC------CCCCCCcE----EEEEEeccccchhHHHHHHHHHHHccCCCC
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAP------ARPGTGMV----IAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~------~~~~~~~~----vavK~~~~~~~~~~~~~~~e~~~l~~l~hp 134 (400)
....+|++.+.||+|+||+||++.+....... .....+.. ++.|.+... ......+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCC
Confidence 34578999999999999999998764321000 00000111 111221111 12234577899999999999
Q ss_pred cccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 135 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
||+++++++.+.+..|+|++++ +++|.+++..... .........+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 9999999999999999999999 5688877754321 1122345677889999999999999988 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc-cCCCCCCccch
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHN 292 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p-f~~~~~~~~~~ 292 (400)
+.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|+|++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999976543221 122346799999999999999999999999999999999998754 43322111111
Q ss_pred hHHhhhH-------HHhhhhhhhhhcccc-cc---CCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKP-------YLQSKRRIFQVMDAR-IE---GQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~-------~~~~~~~~~~~~~~~-~~---~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+.+.... +......+...+... .. ... ....+..+.+++.+||+.||++|||+.|+|.|-+.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 1110000 000000011111000 00 000 00123456778999999999999999999987543
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=292.44 Aligned_cols=259 Identities=28% Similarity=0.374 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||.|+||+||+|.... ++..+++|++..... .....+.+|+..++.++|+||+++++.+.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 468999999999999999996543 578899999876443 2445688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++|||++++++|.+++..... ...+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999976421 135899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcc--eeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+.......... ......++..|++||.+... .++.++|+|||||++|+|++|..||............ . ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~----~~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--L----QN 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH--h----cC
Confidence 87654432221 22335688999999998766 7899999999999999999999999765432111100 0 00
Q ss_pred hhhhhhhccccccCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQY-SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
......... ....+..+.+++.+||+.||++|||+.++++|
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000010000 12446778899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.47 Aligned_cols=267 Identities=27% Similarity=0.337 Sum_probs=201.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+++++.++|+||+++++++.++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK---------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK 72 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC---------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence 6889999999999999999554 3678999998875432 2235678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||++++.+..++... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999999999876666555432 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH-Hhh-
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-LQS- 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~- 303 (400)
+......... ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...........+...... ...
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 147 ARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8865443321 22335678899999999877 8899999999999999999999999765432211111100000 000
Q ss_pred ------hhh-----hhhhcc-ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 ------KRR-----IFQVMD-ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ------~~~-----~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ...... ......++...+.++.+++++||..+|++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000 000011222346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=292.21 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=207.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+|++.+.||+|++|.||+|... .++..+++|++..... .....+.+|+..+..++|+||+++++++....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHK---------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEc---------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 5888999999999999999544 4688999999877654 33557889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..++||||+++++|.+++... .++++..++.++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999999765 468999999999999999999999 88 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............+
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------- 214 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---------- 214 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----------
Confidence 8865432221 1234678899999999888899999999999999999999999976643111111111
Q ss_pred hhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+. .......+.. .+..+.+++.+||..+|++|||+.+++++
T Consensus 215 ---~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ---IC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---Hh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 1111122223 56789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=298.54 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||.||++... .++..+++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 67999999999999999999543 357789999987655555567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+|+||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999999998653 4688899999999999999999988 999999999999999999999999988
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......+++.|++||.+....++.++|+||||+++|+|++|..||....+......+.
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------ 228 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------ 228 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------------
Confidence 75433221 1233468889999999988889999999999999999999999997654322111000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.........+...+..+.+++.+||..+|++||++.+++.|-..
T Consensus 229 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 229 ---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred ---cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 00000011122345678899999999999999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.51 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=196.9
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc----chhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++..+||+|+|-+||+|.+.. +|..||--.+.... .....++..|+.+|+.|+||||++++++|.+
T Consensus 42 ~k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred eehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 4667899999999999996643 57777644333222 1234678899999999999999999999987
Q ss_pred CCe--eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEe
Q 015781 146 DDH--RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLS 222 (400)
Q Consensus 146 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~ 222 (400)
... ..+|+|++..|+|..|+++.+ .++.+.+..|+.||++||.|||++.++|+|||||.+||||+. .|.|||+
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 655 778999999999999999885 488999999999999999999999999999999999999975 5899999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|+|+|+...... .....|||.|||||+.. ..|+..+||||||++++||+|+.+||......
T Consensus 189 DLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------------- 249 (632)
T KOG0584|consen 189 DLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------------- 249 (632)
T ss_pred chhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--------------
Confidence 999998754432 23378999999999996 89999999999999999999999999754321
Q ss_pred hhhhhhhhccccccCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.++..+-..+..|. -...++.+||.+||.. ..+|||+.|+|++
T Consensus 250 -----AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 250 -----AQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----HHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111111111111 1245788899999999 9999999999985
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=299.79 Aligned_cols=266 Identities=25% Similarity=0.311 Sum_probs=200.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-----hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
+|++.+.||+|+||.||+|... .++..||+|.+...... ....+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK---------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC---------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 4788899999999999999654 35789999998765432 233466899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEcc
Confidence 9999999999999 899999987643 36899999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhHH-
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPY- 300 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~- 300 (400)
||++........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||....+......+. .....
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 146 FGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred ceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 999976543221 1223356788999998854 467899999999999999999988887654422111110 00000
Q ss_pred ---HhhhhhhhhhccccccC-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 ---LQSKRRIFQVMDARIEG-----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
................. ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000000 0112346788899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=291.06 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=192.4
Q ss_pred CccccCCCceEEEEEecCCC-cCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
+.||+|+||.||+|.+.... +..........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876421 00111223356888887655433 5678899999999999999999999888 778999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-------ceEEeecc
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-------NAKLSDFG 225 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg 225 (400)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999998754 26889999999999999999999988 99999999999999887 79999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.......... .+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------FYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH------HHh-
Confidence 9876433 1223567789999999776 78999999999999999999 577776543211100 000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. ...+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 221 ~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011111267889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.79 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=201.2
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCee
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
|.....||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 444567999999999999543 35789999998765444455678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|..++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999999999987754 34789999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......+ . .
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-------~------~ 231 (297)
T cd06659 167 ISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------R------D 231 (297)
T ss_pred cccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------h------c
Confidence 432211 123356889999999998888999999999999999999999999754321111000 0 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.... ........+..+.+++.+||+.+|.+||++.+++++-...
T Consensus 232 ~~~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 232 SPPP--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred cCCC--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 0000 0011123355688899999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.49 Aligned_cols=252 Identities=24% Similarity=0.296 Sum_probs=197.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+|++.+.||+|+||.||++.. ..++..|++|.+..... .....+.+|+.+++.++||||+++++.+..
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRH---------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET 72 (305)
T ss_pred CceEeeEeecCCCeeEEEEEE---------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence 688899999999999999954 34688999999876532 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..++||||++|++|.+++... .++++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCC
Confidence 99999999999999999999765 35889999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCC-------------cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 226 LAKDGPTGSQ-------------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 226 ~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-- 224 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-- 224 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 8863211100 0011124578899999999888899999999999999999999999975432110
Q ss_pred hHHhhhHHHhhhhhhhhhcccccc-CCCCHHHHHHHHHHHHhcccCCCCCCCCH---HHHHHH
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 351 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~eil~~ 351 (400)
.. ........ .......+.++.+++.+||+.+|++||+. .+++++
T Consensus 225 ----~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 ----FG----------QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----HH----------HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00000000 01112346678899999999999999985 555555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=282.88 Aligned_cols=268 Identities=24% Similarity=0.247 Sum_probs=210.8
Q ss_pred HHhcCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 65 TATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
.++++|++. ++||-|-.|.|..+ .++.||+.+|+|++... ....+|++.--.. .|||||.++++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidV 123 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDV 123 (400)
T ss_pred cchhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehh
Confidence 455677764 58999999999887 55668999999998643 3455777655443 69999999999
Q ss_pred EEe----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---C
Q 015781 143 CLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---L 215 (400)
Q Consensus 143 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~ 215 (400)
|+. ...+.+|||.++||.|...++.++. .++++..+..|+.||..|+.|||+.+ |.||||||+|+|.+ .
T Consensus 124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSP 199 (400)
T ss_pred hhhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCC
Confidence 864 3577899999999999999999876 78999999999999999999999988 99999999999995 4
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|..+||+|||+|+..... ....+.+-||.|.|||++....|+...|+||+||++|-|++|.+||-...-.- ..
T Consensus 200 na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-is--- 272 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-IS--- 272 (400)
T ss_pred CcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CC---
Confidence 567999999999875432 23456788999999999999999999999999999999999999996543210 00
Q ss_pred hhhHHHhhhhhhhhhccccccCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCCCCcc
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDE 367 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~ 367 (400)
+.+ ..++.... ..++ ...++...++|+.+|..+|.+|.|+.++++|-|--+..-.+..+...
T Consensus 273 ---pgM-----k~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 273 ---PGM-----KRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred ---hhH-----HhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 000 00111110 0111 25678888999999999999999999999998877666666655533
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.74 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=204.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|++++++++||||+++++.+.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 4788899999999999999544 3688999999976432 234568889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+.+++|.+++... .++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecc
Confidence 99999999999999999998765 36889999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------- 211 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----------- 211 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----------
Confidence 988654332 123356788999999998888999999999999999999999999866532111100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM--DEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~eil~~ 351 (400)
..... .....+...+..+.+++.+||+.||.+||++ ++++++
T Consensus 212 ---~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 212 ---AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred ---HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 00000 1122334456788999999999999999999 776653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=290.64 Aligned_cols=252 Identities=30% Similarity=0.423 Sum_probs=201.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||+|... .++..+++|.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL---------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC---------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5888999999999999999554 35789999998766543 456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++|+||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998764 34788999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcce--eeecccccCcccchhhccCC---CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 227 AKDGPTGSQSHV--STRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 227 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+........... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... +.....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~ 218 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH 218 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH
Confidence 886543322111 11346788999999997665 889999999999999999999999754311 111000
Q ss_pred hhhhhhhhhccccccCCCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ......+ ...+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 219 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 VGA---------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred Hhc---------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0011111 1236677899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=299.76 Aligned_cols=273 Identities=22% Similarity=0.261 Sum_probs=199.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc---chhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+|++.+.||+|+||.||+|..... .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999965421 258899999998743 2223456789999999999999999999998
Q ss_pred C--CeeEEEEeecCCCCHHHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC----CCc
Q 015781 146 D--DHRLLVYEFMPKGSLENHLFRRASYI-QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----NYN 218 (400)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~----~~~ 218 (400)
. ..+++||||++ ++|.+++....... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccce
Confidence 8 88999999995 57777775443322 36899999999999999999999988 999999999999999 899
Q ss_pred eEEeeccCCccCCCCCC-cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh---
Q 015781 219 AKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL--- 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~--- 293 (400)
+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999886543222 111223467889999998865 4578999999999999999999999986654331000
Q ss_pred ---HHhhhHHHh-----------hhhhhhhhccccccCCCC---------H--HHHHHHHHHHHhcccCCCCCCCCHHHH
Q 015781 294 ---IEWAKPYLQ-----------SKRRIFQVMDARIEGQYS---------L--GAALKTAVLAIKCLSNEPKFRPTMDEV 348 (400)
Q Consensus 294 ---~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~dP~~Rps~~ei 348 (400)
.......+. .........+.......+ . ..+..+.+++.+||+.||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000000000 000000000000000001 0 234578899999999999999999999
Q ss_pred HHH
Q 015781 349 VKA 351 (400)
Q Consensus 349 l~~ 351 (400)
++|
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.22 Aligned_cols=267 Identities=25% Similarity=0.355 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|.+.. +++.+|+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999996543 5789999987654322 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+...|+||||+++++|..+.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeee
Confidence 99999999999998888776543 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~~~ 303 (400)
++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+. +.......
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 146 FARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 9876433221 1233467889999999865 457889999999999999999999997554321111110 00000000
Q ss_pred hhhhh-------hhcccccc-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRIF-------QVMDARIE-----GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~~-------~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... ........ .......+..+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 00000000 00112346778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=290.70 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=206.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|+||.||++.. ..++..+++|.+..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKR---------LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEE---------CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 478889999999999999954 34688999999876432 2344677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999998775444467899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.........
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--------------- 210 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--------------- 210 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------
Confidence 9765443 122345788999999998888999999999999999999999999765421100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...........+...+.++.+++.+||+.+|++|||+.+++++
T Consensus 211 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 --YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001111122334567789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=292.59 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=201.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
-|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 4778899999999999999554 3578999999865433 23346778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+||||+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccc
Confidence 99999999999999998864 35789999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+... ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~-------- 212 (277)
T cd06641 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFL-------- 212 (277)
T ss_pred eecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHH--------
Confidence 75433211 12234678899999999888889999999999999999999999965432110 000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.............+..+.+++.+||+.+|.+||++.+++++-
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 213 ---IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred ---HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 000111122334566788999999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.68 Aligned_cols=249 Identities=31% Similarity=0.429 Sum_probs=205.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
+|.+.+.||+|++|.||++.... ++..+++|++..........+.+|+..++.++|+||+++++++..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788999999999999996543 578899999987665456678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++++||+++++|.+++.... ..+++..+..++.|++.+|.+||..+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999999999987653 46899999999999999999999988 9999999999999999999999999988
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............ .
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~----- 210 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------A----- 210 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------H-----
Confidence 6554321 23456889999999998888999999999999999999999999764321111000 0
Q ss_pred hhccccccCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 309 QVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 309 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. ...... ....+..+.+++.+||+.||++|||+.+++++
T Consensus 211 ---~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 211 ---T-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---h-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000111 11125678899999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.54 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=207.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||.|+||.||++.+. .++..+++|.+..... .....+.+|+++++.++|||++++.+.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK---------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc---------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4788899999999999999654 3578999999876543 3455678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++.........+++..++.++.+++.||.+||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999876433367899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------------- 213 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL-------------- 213 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH--------------
Confidence 87654432 12333568899999999988889999999999999999999999996543211000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ......+...+..+.+++.+||..+|++|||+.+++++
T Consensus 214 --~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 214 --KILK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --HHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01112233456788899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=287.86 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=207.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|+..+.||+|++|.||+|... .++..+++|++..... .....+.+|+.++++++||||+++++.+.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4778899999999999999554 3688999999876653 3355688999999999999999999999988
Q ss_pred --CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
..++++|||+.+++|.+++.... .+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccc
Confidence 89999999999999999997653 6899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|.+................++..|+|||.+....++.++||||||+++|+|++|..||...... ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---------- 212 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAA---------- 212 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHH----------
Confidence 9988655433211123456888999999998888999999999999999999999999765410 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.............+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 213 --~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 213 --LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111111223344457789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=295.62 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=203.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|...+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++|||++++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4778889999999999999654 3578999999865432 223467889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+...++||||+. ++|.+++.... .++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCC
Confidence 999999999996 58888776543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++..... .....++..|+|||.+. .+.++.++|||||||++|+|++|..||.........
T Consensus 171 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~----------- 233 (317)
T cd06635 171 SASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------- 233 (317)
T ss_pred CccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-----------
Confidence 8865432 12346788999999873 456889999999999999999999998654221100
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..+.............+..+.+++.+||+.+|.+||++.++++++..+.......
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 234 -----YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred -----HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 0000001111112234567889999999999999999999999988876555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=296.22 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=198.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||.|+||.||+|... .++..+|+|.+...... ....+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 4788899999999999999553 36889999988754322 234678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999995 689888865432 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh-HHhhhHH----
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPY---- 300 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~~~~~~---- 300 (400)
+........ ......++..|+|||.+.+. .++.++|||||||++|+|+||..||........... ..+....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 147 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224 (284)
T ss_pred hhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 875432211 12233568899999988654 468899999999999999999999976543211100 0000000
Q ss_pred -------HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 -------LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
......+......... ......+..+.++|.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000000 0011234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=296.84 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||.|+||.||+|.+. .++..+++|.+....... ...+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 57899999999999999999654 367889999987543321 2345689999999999999999999887
Q ss_pred C--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 146 D--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
. ...|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEee
Confidence 7 89999999996 59999887654 36899999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-------
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE------- 295 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~------- 295 (400)
||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+.
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 150 FGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred cCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 999886544321 12234578899999988654 46889999999999999999999997654322111110
Q ss_pred ---hhhH--HHh-hhhhhhhhccccccCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 296 ---WAKP--YLQ-SKRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 296 ---~~~~--~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
|... ... ............+...++.. .+..+.+++.+||+.+|++|||+.|++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 00000000001111122222 46778899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=296.33 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=197.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..+|++.+.||+|+||.||+|... .++..+|+|.+....... ...+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR---------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc---------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 367999999999999999999554 357889999987543222 2356789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..|+||||+. ++|.+++.... ..+.+..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccc
Confidence 999999999995 68877775443 35778888999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+........|........
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 149 LARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred cccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 9875332211 1223457889999999865 357889999999999999999999997654321111011100000000
Q ss_pred h------hh----hhhccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 R------RI----FQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~------~~----~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. .+ ............ ....+..+.+++.+||..||.+|||+.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00 000000000000 01124577889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=294.16 Aligned_cols=252 Identities=28% Similarity=0.373 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc---------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 56899999999999999999554 3578999998864432 22345788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+. ++|.+++.... .++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeec
Confidence 9999999999995 67877775443 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||...........+
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------- 226 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 226 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-------
Confidence 998754322 2346788999999874 356889999999999999999999998654321110000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.............+..+.+++.+||+.+|++||++.+++.+.+...
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 227 ---------AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ---------hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000001112235667899999999999999999999999866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=307.29 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=212.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++.++.++||+|.||.|++|.|+. -.++-..||||.+...... ....|++|+.+|.+|+|+|++++|+++.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~------psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQ------PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccC------CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 345667899999999999999974 2334567999999887665 55679999999999999999999999987
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
....||||++..|+|.+.|.+. ....+.......++.||+.|+.||.+++ +|||||...|+++.....|||+|||+
T Consensus 183 qp~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccc
Confidence 6778999999999999999872 3367888999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceee-ecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSHVST-RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
.+....++....+. .......|+|||.+....++.++|+|++||+||||++ |..||.+.....
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------- 323 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------- 323 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------------
Confidence 99876665544332 2344568999999999999999999999999999998 778998765321
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
+.+.++..-.-.-+..+++.++++++.||..+|.+|||+..|.+
T Consensus 324 --IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 324 --ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 22223332233345678999999999999999999999999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=291.13 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=200.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCC---CCcccceeeEEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY---HPNLVKLIGYCL 144 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~---hpniv~~~~~~~ 144 (400)
.|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.+. |||++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 4778899999999999999653 3678999999875432 23445778888888886 999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++...++||||+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccC
Confidence 999999999999999999988543 5889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++........ ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--------- 214 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI--------- 214 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---------
Confidence 99876544321 2233568899999998865 45789999999999999999999999765432111000
Q ss_pred hhhhhhhccccccCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSL-GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... .....+. ..+..+.+++.+||+.||++||++.+++.+-+.
T Consensus 215 ----~~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 215 ----PKS----KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ----ccC----CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 000 0011111 145678899999999999999999999986443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.03 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=200.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
.|...+.||+|++|.||++... .++..+++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK---------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 3555679999999999999543 3578899998876544445567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++++||+.+++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccch
Confidence 9999999999999999876 24788999999999999999999988 9999999999999999999999999886
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....+.... .. +.
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~-------~~ 228 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KR-------IR 228 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HH-------HH
Confidence 5432211 123356889999999998888999999999999999999999999654321110 00 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
....... ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 229 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 229 DNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred hcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0000000 1112245678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=287.53 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-----chhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.+|++.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA---------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc---------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 46899999999999999999543 468899999875321 1233467789999999999999999999
Q ss_pred EEeC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 143 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+.+. ..++++|||+++++|.+++.... ++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEE
Confidence 8764 46889999999999999987543 4788999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||++......... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------- 216 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------- 216 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----------
Confidence 9999999754321110 11123568899999999988889999999999999999999999996542210
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+............+...+..+.+++.+||+ +|..||++.+++.|
T Consensus 217 ------~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 217 ------AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111111112233455677889999999999 57999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=303.13 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=200.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDT---------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEEC---------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeee
Confidence 34578999999999999999999543 468899999986532 2334467789999999999999999998
Q ss_pred EEeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 143 CLED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 143 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+... ...|+||||+. ++|.+.+... ++...+..++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~ 154 (353)
T cd07850 84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD 154 (353)
T ss_pred eccCCCccccCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC
Confidence 8643 35799999994 5888877532 788899999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH--
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-- 294 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-- 294 (400)
+.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 155 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 155 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999999998643322 123346788999999999999999999999999999999999999765432111100
Q ss_pred -------HhhhH-------HHhhh-----hhhhhhccccc----cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 295 -------EWAKP-------YLQSK-----RRIFQVMDARI----EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 295 -------~~~~~-------~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+... +.... ..+........ ........+..+.+++.+||+.||++|||+.++|.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000 00000000000 000011345678899999999999999999999997
Q ss_pred HH
Q 015781 352 LE 353 (400)
Q Consensus 352 L~ 353 (400)
=+
T Consensus 312 ~~ 313 (353)
T cd07850 312 PY 313 (353)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.70 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=199.3
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||.|+||.||+|... .++..+|+|++...... ....+.+|+.+++.++||||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVK---------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 699999999999654 36889999998764432 234688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 72 MEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9999999999999765 34889999999999999999999988 99999999999999999999999999986544
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ......++..|++||.+.+..++.++|+||||+++|+|++|..||....... .... .....
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~----------~~~~~ 208 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY----------NDILK 208 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH----------HHHhc
Confidence 32 1233467889999999988889999999999999999999999997654211 0000 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
.......+...+..+.+++.+||+.+|++||+ ++|++++-+
T Consensus 209 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 209 GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 11122233334678999999999999999999 888888543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.57 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=194.5
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCC-CCcccceeeEEEeC-
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLED- 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~- 146 (400)
|++.+.||+|+||.||+|... .++..+|+|.+..... .......+|+..+.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 677889999999999999543 3678899999875422 22233457888888885 99999999999987
Q ss_pred -CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. +.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecc
Confidence 88999999996 58888876543 46899999999999999999999988 999999999999999 999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++........ .....++..|+|||.+. +..++.++|||||||++|+|++|..||...+..+. +.+........
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~ 218 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTP 218 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCC
Confidence 9976533221 12345788999999764 45578899999999999999999999977554221 11111100000
Q ss_pred -hhhhhhccc--cccC-----------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 -RRIFQVMDA--RIEG-----------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 -~~~~~~~~~--~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+...... .... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0000 0012346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.81 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=206.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
....|++.+.||+|+||.||+|.... ++..+++|++..... ....+.+|+..++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 34568888999999999999996542 578899999876543 45567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..|+|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999999998764 36899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+.....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------------- 226 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------------- 226 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 8865432211 1233457889999999988889999999999999999999999997543311100
Q ss_pred hhhhhcccccc-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 306 RIFQVMDARIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 306 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........ .......+..+.+++.+||+.+|.+|||+.+++.+-..
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 227 ---LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred ---HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 00000000 01112245678899999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.24 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=190.7
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHH---HHHccCCCCcccceeeEEEeCCe
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI---KHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
+||+|+||.||++... .++..+|+|.+...... ....+.+|. .++....||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999999553 36889999988654321 112233343 33444579999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++||||+.+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 99999999999999988765 35899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
...... .....|+..|+|||.+. +..++.++|||||||++|+|++|..||.............
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------ 209 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------ 209 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH------------
Confidence 543221 12346899999999986 4568999999999999999999999997654321111000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHh
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~~ 354 (400)
. ........+...+.++.+++.+||+.||.+|| |++++++|-..
T Consensus 210 --~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 210 --M-TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred --H-hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 0 00111223445667889999999999999999 69999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.79 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=201.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||.|+||.||+|... .+|..+|+|.+..... .....+.+|+.+++.++|+||+++++.+.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK---------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc---------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4788899999999999999654 3578899999876432 2344677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc-eEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg 225 (400)
...++|+||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++. ++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999999999999976543 35789999999999999999999988 999999999999988864 6999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
.+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... +....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~----- 214 (257)
T cd08225 148 IARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKI----- 214 (257)
T ss_pred cchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH-----
Confidence 9876543221 1223468889999999988889999999999999999999999996543211 11100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ........+..+.+++.+||+.+|++|||+.+++++
T Consensus 215 -----~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 -----CQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----hccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000 011222345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.63 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=196.0
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||+|+||+||+|... .+|..+|+|.+...... ....+..|+.+++.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 699999999999544 36889999998754322 233456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999999976543 46899999999999999999999988 99999999999999999999999998875432
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. ...
T Consensus 148 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~- 211 (277)
T cd05577 148 GK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR------------RTL- 211 (277)
T ss_pred CC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh------------ccc-
Confidence 11 12234578899999999888899999999999999999999999976543211111100 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
......+...+..+.+++.+||+.||.+|| ++.+++.|-
T Consensus 212 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 212 -EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred -cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 011122334467888999999999999999 777787753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=283.57 Aligned_cols=276 Identities=22% Similarity=0.285 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..|++...||+|+||.||+|.-.+ .+..-...+|+|.+..+... ......+|+..++.++|||++.+..+|..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~-----~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKN-----TNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeecc-----CCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 568999999999999999995433 11112347899998776332 23356799999999999999999999887
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC----Cce
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNA 219 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~----~~~ 219 (400)
+..+++++||.+ -+|..+|.-+.. ....++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|
T Consensus 99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 788999999995 589888865432 2356899999999999999999999998 9999999999999877 899
Q ss_pred EEeeccCCccCCCCCCcc-eeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccch-hH--
Q 015781 220 KLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN-LI-- 294 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~-~~-- 294 (400)
||+|||+++.....-... .....+.|.+|+|||++.+. .|+.+.||||+|||+.||+|-.+.|.+........ ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999999765433222 23446789999999998764 79999999999999999999999997765432211 00
Q ss_pred ----------------HhhhHHHhhhhhhhhhcc-ccccCCCCH----------HHHHHHHHHHHhcccCCCCCCCCHHH
Q 015781 295 ----------------EWAKPYLQSKRRIFQVMD-ARIEGQYSL----------GAALKTAVLAIKCLSNEPKFRPTMDE 347 (400)
Q Consensus 295 ----------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~l~~li~~~l~~dP~~Rps~~e 347 (400)
.|.. +.+--+....+. .+.....+. ..+...++|+.+||+.||.+|.|+.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~--lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPD--LKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred HHHHHHHHHcCCCccccchh--hhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 0100 000000000000 000000010 01223678999999999999999999
Q ss_pred HHHHHH
Q 015781 348 VVKALE 353 (400)
Q Consensus 348 il~~L~ 353 (400)
.+++.=
T Consensus 334 Aleh~y 339 (438)
T KOG0666|consen 334 ALEHPY 339 (438)
T ss_pred Hhcccc
Confidence 999753
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.73 Aligned_cols=271 Identities=26% Similarity=0.319 Sum_probs=200.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..+|++.+.||+|+||.||+|... .+|..||+|.+....... ...+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 467999999999999999999654 368899999986543221 234568999999999999999999987
Q ss_pred eC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 145 ED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 145 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+. +..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEC
Confidence 55 56899999995 58988887543 46899999999999999999999988 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-hHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA-KPY 300 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~~~ 300 (400)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....+......+... ...
T Consensus 151 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 151 DFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred ccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999986543221 1222345788999999865 56789999999999999999999999765442221111100 000
Q ss_pred Hhhh----h-----hhhhhccccccC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 301 LQSK----R-----RIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 301 ~~~~----~-----~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.... . ............ ......+..+.++|.+||+.||++|||+.+++.|-+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0000 0 000000000000 0001135677889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.75 Aligned_cols=270 Identities=21% Similarity=0.245 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCC-CCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|.+. .++..||+|.+...... ....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36889999999999999999654 36889999988654322 2346778999999995 699999999988
Q ss_pred eCCe-----eEEEEeecCCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CC
Q 015781 145 EDDH-----RLLVYEFMPKGSLENHLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NY 217 (400)
Q Consensus 145 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~ 217 (400)
..+. .|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCC
Confidence 7665 8999999975 898888654332 356899999999999999999999988 999999999999998 88
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH-H
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-E 295 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~ 295 (400)
.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....+......+ .
T Consensus 149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999875432211 1122356888999998865 45789999999999999999999999765432211100 0
Q ss_pred hhhH----HHhhhhhhhhhc-----cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 296 WAKP----YLQSKRRIFQVM-----DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 296 ~~~~----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ............ ............+..+.++|.+||..||.+||++.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000000000 0000000112346678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.38 Aligned_cols=258 Identities=26% Similarity=0.339 Sum_probs=196.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCC-CCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~ 146 (400)
+|...+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4666789999999999999543 4688999999876433 23446778999999986 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 147 DHRLLVYEFMPKGSLENHLFRR-ASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
...+++|||+. ++|.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeec
Confidence 99999999984 5666544321 11125689999999999999999999974 6 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccC---CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++....... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||..... ......
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~--- 221 (288)
T cd06616 153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT--- 221 (288)
T ss_pred chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh---
Confidence 9987543221 12234678899999998765 689999999999999999999999975431 000000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.........+........+..+.+|+.+||+.+|.+|||+.+|+++-+
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 222 ----QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred ----hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000000011111222345678899999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.10 Aligned_cols=278 Identities=26% Similarity=0.338 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|.+.+.||+|+||+||+|.. ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKN---------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEe---------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 35799999999999999999954 3478999999987532 223345678999999999999999999876
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.. ...|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCE
Confidence 44 3579999999 57898888654 35899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA- 297 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~- 297 (400)
+|+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 148 kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 148 KICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred EECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999998654322 12233467889999998864 46899999999999999999999999765321111100000
Q ss_pred h-------HHHhhhhhhhhhcc---cccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcCCCC
Q 015781 298 K-------PYLQSKRRIFQVMD---ARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAG 362 (400)
Q Consensus 298 ~-------~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~~~ 362 (400)
. ..... ........ .... .......+..+.+++.+||+.+|.+|||+.++++| ++.+......+
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~ 304 (337)
T cd07858 226 GSPSEEDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP 304 (337)
T ss_pred CCCChHHhhhcCc-hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCc
Confidence 0 00000 00000000 0000 00112346778899999999999999999999998 66665554443
Q ss_pred C
Q 015781 363 V 363 (400)
Q Consensus 363 ~ 363 (400)
.
T Consensus 305 ~ 305 (337)
T cd07858 305 V 305 (337)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.62 Aligned_cols=270 Identities=25% Similarity=0.326 Sum_probs=196.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 357999999999999999999543 36889999988654322 2234568999999999999999999887
Q ss_pred eCC--------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 145 EDD--------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 145 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
... ..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~ 155 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD 155 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC
Confidence 653 4599999995 58888876543 35899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCc--ceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 217 YNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
+.++|+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+......
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999754332211 112234578889999988654 478899999999999999999999976654322222
Q ss_pred HHhhhHHH-----hhhhhhh--h---hcc---ccccCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYL-----QSKRRIF--Q---VMD---ARIEGQ-YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~-----~~~~~~~--~---~~~---~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+....... .....+. . ... ...... .....+..+.+|+.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11110000 0000000 0 000 000000 001123466789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=301.69 Aligned_cols=271 Identities=29% Similarity=0.351 Sum_probs=199.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .+|..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 368999999999999999999543 4688999999864322 234457789999999999999999988765
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
. ...|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEE
Confidence 4 35799999995 588877754 35899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCc-ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|+|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...... ...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~ 223 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LIL 223 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence 9999998754332211 11223568899999998754 568899999999999999999999997643211100 000
Q ss_pred HHHh--hhhhhhhhcccc---------ccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchh
Q 015781 299 PYLQ--SKRRIFQVMDAR---------IEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 357 (400)
Q Consensus 299 ~~~~--~~~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~ 357 (400)
.... ....+..+.... .... .....+..+.+++.+||+.+|++|||+.+++++ ++.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 000000000000 0000 011235678899999999999999999999998 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=283.71 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=204.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||+|++|.||++... .++..+++|.+..... .....+.+|++++++++|||++++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL---------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc---------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4788899999999999999544 3578899999987654 3455788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...+++|||+++++|.+++... ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999999999999998765 36899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+......... .....++..|+|||.+.+..++.++|+|+||+++|+|++|..||....... ..+..
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~-------- 211 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRI-------- 211 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHH--------
Confidence 9865443321 233567889999999988788999999999999999999999996543210 00000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. .......+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 212 ----~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 212 ----V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ----h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0 011112233446788899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=299.41 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=218.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
....+.++||+|.||.||.|.+... .++...-||||..+.+. ..+.+.|+.|.-++++++||||++++|++.+.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 3455678899999999999988752 24445679999888743 34567899999999999999999999999875
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..|||||+++-|.|..|++.+. ..++......++.||..||+|||+.+ .|||||...|||+....-+||+|||+
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 6899999999999999999876 46888999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++.......... +...-..-|||||.+.-..++.++|||.||+++||++. |..||.+-...+....+
T Consensus 538 SR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----------- 605 (974)
T KOG4257|consen 538 SRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----------- 605 (974)
T ss_pred hhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----------
Confidence 997766554432 23334668999999999999999999999999999765 99999875543332222
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
+..-+...|..++..++.|+.+||..+|.+||.+.+|...|..+..+.
T Consensus 606 ------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 606 ------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 122233456788889999999999999999999999999998876643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.07 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=204.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC--CCc----ccc
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--HPN----LVK 138 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hpn----iv~ 138 (400)
....+|.+...+|+|.||.|..++++. ++..||||+++... .-.+...-|+++|+++. .|+ ++.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 346899999999999999999997654 47899999987543 23445667899999983 232 777
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--- 215 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~--- 215 (400)
+.++|...++.+||+|.+ |-++.++|..+.. .+++...+..+..|++.++++||+.+ ++|.||||+|||+..
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEY 230 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccce
Confidence 888899999999999998 7799999987654 78999999999999999999999998 999999999999832
Q ss_pred -----------------CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhC
Q 015781 216 -----------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278 (400)
Q Consensus 216 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg 278 (400)
+..|+|+|||.|+..... ....+.|..|+|||++.+-.|+..+||||+||||+||+||
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 335899999999864432 2456789999999999999999999999999999999999
Q ss_pred CCccCCCCCCccchhHHhh--------------hHHHhhhhhhhhhccccc----------------cCCCCHHHHHHHH
Q 015781 279 RRVIDKNRPSREHNLIEWA--------------KPYLQSKRRIFQVMDARI----------------EGQYSLGAALKTA 328 (400)
Q Consensus 279 ~~pf~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~ 328 (400)
...|+..+...-....+.. ..++... .+ ++.+... -.........+++
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9999887633221111110 0000000 00 0000000 0011235677899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHH
Q 015781 329 VLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 329 ~li~~~l~~dP~~Rps~~eil~~L 352 (400)
+|+++||..||.+|+|+.|+|.|-
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCH
Confidence 999999999999999999999873
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.78 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=198.2
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.+.||.|++|.||+|... .+|..||+|++...... ....+.+|+.+++.++||||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK---------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEc---------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 677889999999999999654 36889999998755322 2345778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|++|||+ +++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 999999999 5699998876542 35899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh-HHhhhHHHhh--
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IEWAKPYLQS-- 303 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~-- 303 (400)
........ ......++..|+|||++.+. .++.++|+||||+++|+|++|..||....+...... ..+.......
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 147 RAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred cccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 75432211 11223568899999987654 578899999999999999999999976543221110 0000000000
Q ss_pred --hhhhhhhcc------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 --KRRIFQVMD------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 --~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...+..... ...........+..+.+++.+||+.+|.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 000001112334678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=289.42 Aligned_cols=268 Identities=24% Similarity=0.329 Sum_probs=200.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+|++.+.||.|++|.||+|... .+|..+|+|.+...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 4788899999999999999553 36889999998765432 2345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+. ++|.+++..... ..++++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999996 589888866442 246899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH-Hhh-hHHHhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWA-KPYLQSK 304 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~-~~~~~~~ 304 (400)
........ ......++..|++||.+.+ ..++.++|||||||++|+|++|..||...........+ ... .+....-
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 75432211 1223456889999998865 45788999999999999999999999765432211110 000 0000000
Q ss_pred hhhh---hhccc------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIF---QVMDA------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~---~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+. ..... ..........+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00000 00001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=284.41 Aligned_cols=249 Identities=22% Similarity=0.239 Sum_probs=193.4
Q ss_pred HHHHhcCCCCCCcc--ccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc-CCCCcccce
Q 015781 63 LKTATRNFRPDSVL--GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ-LYHPNLVKL 139 (400)
Q Consensus 63 ~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~ 139 (400)
.....+.|.+.+.+ |+|+||.||++.. ..++..+|+|.+........ |+..... .+||||+++
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~ 74 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKH---------KPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKL 74 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEE---------cCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEE
Confidence 33445677777776 9999999999954 34688999999875432221 1211211 269999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-c
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-N 218 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~ 218 (400)
++.+...+.+|+||||+++++|.+++.... ++++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++ .
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 75 YYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCe
Confidence 999999999999999999999999997653 6899999999999999999999988 99999999999999988 9
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
++|+|||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||....... .....+..
T Consensus 149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~ 221 (267)
T PHA03390 149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK 221 (267)
T ss_pred EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH
Confidence 999999988754321 22457899999999988889999999999999999999999997543221 11111111
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKA 351 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~eil~~ 351 (400)
.... ........+..+.+++.+||+.+|.+||+ ++++++|
T Consensus 222 -----------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 222 -----------RQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -----------hhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0000 11122246678899999999999999995 6999875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.79 Aligned_cols=254 Identities=30% Similarity=0.404 Sum_probs=207.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.-+|+-...||.|.||.||.| .+..+|...|+|-+..... .....+.+|+.+|..++|||+|+++++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 456778889999999999999 5556899999997765332 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..+|.||||++|+|.+++.... -.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++||
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecc
Confidence 9999999999999999999997764 3677777888999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCC--cceeeecccccCcccchhhccC---CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 225 GLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 225 g~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|.|........ ........||+.|||||++.+. .-..+.|||||||++.||+||+.||...+. .|..-
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIM 1451 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIM 1451 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHH
Confidence 99986544321 1122347899999999999654 356789999999999999999999976543 23332
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.- ...-.+.+|...+.+-.++|.+||+.||++|+++.+++++
T Consensus 1452 y~V---------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHV---------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHH---------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222 2222344556688889999999999999999999999886
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.29 Aligned_cols=273 Identities=22% Similarity=0.306 Sum_probs=201.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDT---------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 368999999999999999999543 4688999999876432 23445678999999999999999998875
Q ss_pred e----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 145 E----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 145 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
. ....++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEE
Confidence 3 357899999994 6898888654 35899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCC--cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 221 LSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH
Confidence 999999875432221 111234578899999998865 46889999999999999999999999765432111111000
Q ss_pred hH-----HHh--hhhhhhhhccc-cccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 298 KP-----YLQ--SKRRIFQVMDA-RIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 298 ~~-----~~~--~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.. ... ....+...... ...... ....+..+.+++++||+.+|.+|||+.+++.+-+.-
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 00 000 00000000000 000001 123467889999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.99 Aligned_cols=275 Identities=28% Similarity=0.384 Sum_probs=208.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.|...+.||+|+||.||+| +++.+|+.||||.++... ....+.+.+|+++|++++|||||+++++-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred ceeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 3566789999999999999 566799999999998753 344567789999999999999999998866543
Q ss_pred ------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE--cCCCc-
Q 015781 148 ------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYN- 218 (400)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill--~~~~~- 218 (400)
...+|||||.||+|...+.+..+ ...+++..++.++.++..||.|||.+| |+||||||.||++ ..+|+
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCce
Confidence 56899999999999999986543 256999999999999999999999998 9999999999998 33343
Q ss_pred -eEEeeccCCccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 219 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 219 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.||+|||.|+....+. ....++||..|++||++. ++.|+..+|.|||||++|+++||..||-.........-+.|
T Consensus 162 IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred EEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 6999999999876554 567789999999999998 58899999999999999999999999966554432222222
Q ss_pred hhHHHhhhhhhhhhcccc----c--------cCCCCHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHHhchhcC
Q 015781 297 AKPYLQSKRRIFQVMDAR----I--------EGQYSLGAALKTAVLAIKCLSNEPKFRP--TMDEVVKALEQIQDTN 359 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~----~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rp--s~~eil~~L~~~~~~~ 359 (400)
....- ++....-..... . ...........+-.++..+|..+|.+|. ...+....+..|....
T Consensus 239 ~~~tk-kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 239 HIITK-KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhhcc-CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 21111 111100000000 0 1112233444555677789999999999 7777777776665443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=294.88 Aligned_cols=268 Identities=19% Similarity=0.244 Sum_probs=195.1
Q ss_pred CccccC--CCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
..||+| +||+||++.. ..+|..||+|++...... ....+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARH---------TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEE---------cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 456766 8999999954 446899999998764322 234677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++++||+.+..
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999999999877542 45899999999999999999999988 99999999999999999999999986542
Q ss_pred CCCCCCc-----ceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh-HH------
Q 015781 230 GPTGSQS-----HVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-IE------ 295 (400)
Q Consensus 230 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~~------ 295 (400)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||........... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 2111100 001112345679999998763 478999999999999999999999976532111000 00
Q ss_pred hh-------hHHHhhh---------------hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 296 WA-------KPYLQSK---------------RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 296 ~~-------~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
+. ....... ..........+........+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 0000000 0000001111112223456778899999999999999999999998755
Q ss_pred h
Q 015781 354 Q 354 (400)
Q Consensus 354 ~ 354 (400)
.
T Consensus 311 ~ 311 (328)
T cd08226 311 F 311 (328)
T ss_pred H
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.41 Aligned_cols=263 Identities=18% Similarity=0.182 Sum_probs=188.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH-----------HHHHHHHHHHccCCCCc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-----------LEWLTEIKHLGQLYHPN 135 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~hpn 135 (400)
.++|++.++||+|+||+||+|.+... ...+..+|+|+......... .....++..+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 36899999999999999999976431 11145677776543322110 11234455667789999
Q ss_pred ccceeeEEEeCC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 136 LVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 136 iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
|+++++.+.... ..+++++++ ..++.+++... ...++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Ni 157 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENI 157 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 999998765443 447888887 45777776543 23578889999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCC
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 286 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~ 286 (400)
|++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999764322111 11123469999999999999999999999999999999999999998763
Q ss_pred CCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 287 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
........ .. ...+..+...... ....+..+.+++..||+.+|++||++.++++.|
T Consensus 238 ~~~~~~~~--~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHA--AK-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHH--hH-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 22111000 00 0000111111110 112356788999999999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=286.61 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=190.4
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHH---HHHHccCCCCcccceeeEEEeCCe
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTE---IKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e---~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
+||+|+||.||+|... .+++.||+|.+....... ...+..| +..++...||+|+++.+++.+.+.
T Consensus 1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999543 468899999987643221 1122333 344555689999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++||||+.|++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 99999999999999988654 36899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
...... .....|+..|+|||.+.++ .++.++||||+||++|+|++|..||.............
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 209 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------ 209 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH------------
Confidence 543221 2234689999999998754 68999999999999999999999997653321111000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
. ........+...+..+.+++.+||..+|.+|| ++.+++++-+
T Consensus 210 --~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 210 --M-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred --H-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 0 00011122333467899999999999999999 9999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=290.31 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=197.1
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
...||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++++++..++..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEc---------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 467999999999999554 36889999998655444455688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+++++|.+++... .+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999999987542 4788999999999999999999988 99999999999999999999999998875432
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ .....
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------------~~~~~ 233 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP 233 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhhCC
Confidence 211 122346788999999998888899999999999999999999999754332111100 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+. .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0000 112235567889999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=291.46 Aligned_cols=268 Identities=24% Similarity=0.299 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|++|+||+|... .+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR---------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec---------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 46889999999999999999543 3688999998865432 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~Df 224 (400)
+...|+||||++ ++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccc
Confidence 999999999995 588888765432 34678889999999999999999988 999999999999985 567999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH-Hhh-hHH-
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI-EWA-KPY- 300 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~~-~~~- 300 (400)
|++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+||.+||....+......+ ... .+.
T Consensus 148 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 148 GLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225 (294)
T ss_pred ccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99975432211 1223456889999998865 45789999999999999999999999765432211110 000 000
Q ss_pred --Hhhhhhhhhhccc------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 --LQSKRRIFQVMDA------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 --~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.....+...... ..........+..+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 00000112345678899999999999999999999986
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=285.67 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=194.3
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||.|+||.||++... .++..+++|.+..... .....+.+|++++++++||||+++++.+..+...|++
T Consensus 1 lg~g~~~~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKK---------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999654 3688999999876544 2345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++.... .+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 72 MEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99999999999997653 5899999999999999999999988 99999999999999999999999999875433
Q ss_pred CCC------cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 233 GSQ------SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 233 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
... ........++..|++||.+....++.++|+||||+++|+|++|..||....+... ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~----------- 211 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQ----------- 211 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HH-----------
Confidence 211 1122335678899999999888899999999999999999999999975542110 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH---HHHHHH
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 351 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~eil~~ 351 (400)
...............+..+.+++.+||+.+|.+|||+ .+++++
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 212 --NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --HHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000001100011136778899999999999999999 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.54 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=208.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.+.|+.-++||+|+||.||-+... .||+.+|.|.+.+..... ....++|-.+|.+++.+.||.+--.|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvr---------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVR---------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEe---------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 456888999999999999988544 489999999887765432 33467899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
+..+.+++||..|.||+|.-+|...+. ..+++..+..++.+|+.||++||..+ ||+|||||+|||+|+.|+++|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeec
Confidence 999999999999999999999988765 56999999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+|+|.....+.. ....+||.+|||||++.++.|+...|.|||||+||+|+.|+.||........ |
T Consensus 331 LGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~------- 395 (591)
T KOG0986|consen 331 LGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----R------- 395 (591)
T ss_pred cceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----H-------
Confidence 999998766543 3345899999999999999999999999999999999999999975432211 1
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 346 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 346 (400)
..+.+.. ......++...+++..+|...+|+.||.+|.-..
T Consensus 396 -eEvdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 -EEVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -HHHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 0111111 1122356677888999999999999999996443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=297.31 Aligned_cols=274 Identities=28% Similarity=0.323 Sum_probs=201.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccC-CCCcccceee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
...++|++.+.||+|+||.||+|.+. .++..+|+|.+.... ......+.+|+.+++++ +||||+++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~ 74 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence 34578999999999999999999654 357889999885432 22334567899999999 9999999999
Q ss_pred EEEeC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 142 YCLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 142 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
++... ...|+||||+. ++|.+++... .+++..++.++.||+.||+|||+++ |+|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 75 VIKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred eeccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcE
Confidence 88643 46899999996 5998888653 4788899999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCc---ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 220 KLSDFGLAKDGPTGSQS---HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
+|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999998765433211 12234568999999998754 457889999999999999999999997654322111110
Q ss_pred hhhHHHh--hh-----hhhhhhcccccc------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhc
Q 015781 296 WAKPYLQ--SK-----RRIFQVMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQI 355 (400)
Q Consensus 296 ~~~~~~~--~~-----~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~ 355 (400)
....... .. ......++.... .......+..+.+++.+||+.||.+|||+.+++++ +..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000 00 000000000000 00111246788999999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=297.69 Aligned_cols=279 Identities=28% Similarity=0.360 Sum_probs=207.9
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+|++.+.||.|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK---------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC---------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 5888999999999999999543 358899999987643 23345688899999999999999999998877
Q ss_pred C-----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 147 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
. ..|+||||+. ++|.+++... .++++..++.++.||+.||++||++| ++|+||||.||+++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 5 7899999996 5888888654 36899999999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCCCCCc-ceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+.....
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 224 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence 999999865443210 112334678899999999877 789999999999999999999999976653211111100000
Q ss_pred H-----Hh--hhhhhhhhcc---cc---ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcCCCCC
Q 015781 300 Y-----LQ--SKRRIFQVMD---AR---IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAGV 363 (400)
Q Consensus 300 ~-----~~--~~~~~~~~~~---~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~~~~ 363 (400)
. .. .......... .. .........+..+.+++.+||+.+|.+|||+.+++.+ ++.++.......
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 0 00 0000000000 00 0000112246678899999999999999999999997 666655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.52 Aligned_cols=247 Identities=29% Similarity=0.387 Sum_probs=195.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.|...+.||+|+||+||+|... .++..+++|.+..... .....+.+|+.+++.++|||++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNS---------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 3677788999999999999543 3688999999865432 223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....|+||||+. ++|.+++.... .++++..++.++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecC
Confidence 999999999995 68888776543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...........+.
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------- 233 (313)
T cd06633 167 SASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------- 233 (313)
T ss_pred CCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------
Confidence 8864322 22356888999999984 4568889999999999999999999987654311111000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
............+..+.+++.+||+.+|.+||++.+++.+-
T Consensus 234 ---------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 234 ---------QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred ---------hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000111122345688899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=285.84 Aligned_cols=262 Identities=26% Similarity=0.319 Sum_probs=201.0
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.+.||.|++|.||+|.. ..++..+++|.+...... ....+.+|+.++++++|+||+++++++.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARD---------KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEc---------CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 56778999999999999954 346889999998765433 3456778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+. ++|.+++.... .++++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeee
Confidence 9999999996 48888887643 46899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh--h
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS--K 304 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~ 304 (400)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+. ..... .
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~ 220 (283)
T cd05118 146 RSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDP 220 (283)
T ss_pred EecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCch
Confidence 76544321 12234578889999998776 78999999999999999999999997655322111110 00000 0
Q ss_pred hhhhhhcc-----------cc--ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMD-----------AR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~-----------~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+..... .. .........+.++.+++.+||+.||.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 00 0001122457789999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=288.57 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCC-CCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~~~~~~ 143 (400)
++|.+.+.||+|+||.||+|.... ++..+++|++..... .....+.+|+.+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 368899999999999999996543 688999999876432 22345778999999998 99999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++..++|||++.+++|.+++.... .+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecC
Confidence 99999999999999999999997653 6899999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCc------------------ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCC
Q 015781 224 FGLAKDGPTGSQS------------------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285 (400)
Q Consensus 224 fg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 285 (400)
||++......... .......++..|+|||.+....++.++|+||||+++++|++|..||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998754332210 1223356788999999998888999999999999999999999999765
Q ss_pred CCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHHH
Q 015781 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM----DEVVKA 351 (400)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~eil~~ 351 (400)
..... . .... ......+...+..+.+++.+||+.+|.+|||+ .++++|
T Consensus 226 ~~~~~---~-------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 226 NEYLT---F-------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred cHHHH---H-------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 42100 0 0000 11222333446778899999999999999999 888875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.98 Aligned_cols=253 Identities=27% Similarity=0.368 Sum_probs=199.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..|...+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc---------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 44777889999999999999654 3578899998864322 22345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
.....++||||+. ++|.+++.... .++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999995 68888775443 46889999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++...... ....++..|+|||.+. ...++.++|||||||++|+|++|..||........ ..
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~--- 224 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY--- 224 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HH---
Confidence 998754321 2346788999999874 35678899999999999999999999865321100 00
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
...............+..+.+++.+||+.+|.+||++.+++++.+....
T Consensus 225 -------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 225 -------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000000111122456678899999999999999999999999776653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=282.12 Aligned_cols=243 Identities=24% Similarity=0.281 Sum_probs=188.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHH-HccCCCCcccceeeEEEeCCee
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKH-LGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~-l~~l~hpniv~~~~~~~~~~~~ 149 (400)
+.||+|+||.||+|... .+++.+|+|.+....... ...+..|..+ ....+|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKR---------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEec---------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 56899999999999543 367899999987643221 1223444443 4455899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+||||+++++|.+++... .++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 9999999999999999765 35889999999999999999999988 99999999999999999999999998875
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
... .....++..|++||.+.+..++.++||||||+++|+|++|..||........ . ......
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~------ 208 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---F---DNILSR------ 208 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHhc------
Confidence 332 2234678899999999888889999999999999999999999975432110 0 000000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH---HHHHHH
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 351 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~eil~~ 351 (400)
...........++..+.+++.+||+.+|++||++ .++++|
T Consensus 209 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 209 --RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred --ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0001111122356788999999999999999966 566655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.61 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=186.0
Q ss_pred CCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHH
Q 015781 101 TGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178 (400)
Q Consensus 101 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 178 (400)
++..+|+|++.... ......+.+|+.+++.++||||+++++++.+++..+++|||+.+++|.+++..... ..+++.
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~ 101 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPEL 101 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc--cCCCHH
Confidence 68899999987652 23445688999999999999999999999999999999999999999999986533 458899
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCC-----cceeeecccccCcccchh
Q 015781 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEY 253 (400)
Q Consensus 179 ~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~ 253 (400)
.+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+........ ........++..|+|||+
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 99999999999999999988 99999999999999999999999998864432111 111223456788999999
Q ss_pred hcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH----------Hhhhhhhh--------hhccc
Q 015781 254 MAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY----------LQSKRRIF--------QVMDA 313 (400)
Q Consensus 254 ~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~--------~~~~~ 313 (400)
+.. ..++.++|+|||||++|+|++|..||........ ..+..... ........ .....
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD 257 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccccccchhh
Confidence 865 3588999999999999999999999976543211 00000000 00000000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 314 RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 314 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..........+..+.+++.+||+.||++|||+.+++++-.
T Consensus 258 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 258 SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 1111223455678899999999999999999999999755
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.64 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccc---c--chhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---S--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
+|.+.+.||+|+||.||++.+.. ++..+++|++... . ......+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58889999999999999996543 2334445544332 1 12233566789999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+....++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999998764444467899999999999999999999988 999999999999975 5699999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~----- 215 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVL----- 215 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH-----
Confidence 999876433221 223356788999999998888999999999999999999999999643211 0000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 216 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 -----RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0000 11122344566788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=287.30 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=198.7
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeC-
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 146 (400)
|++.+.||.|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++|||++++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK---------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 667889999999999999654 357899999998653 22334577899999999999999999999988
Q ss_pred -CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
...++||||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEcccc
Confidence 89999999996 58888886543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...... ...
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~-~~~ 223 (287)
T cd07840 146 LARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-PTD 223 (287)
T ss_pred ceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-Cch
Confidence 99865443211 1223456788999997764 45789999999999999999999999765532211111000000 000
Q ss_pred hhhhhh--------------ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQV--------------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+... ....+...+...++..+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00000001111136688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=274.32 Aligned_cols=268 Identities=23% Similarity=0.345 Sum_probs=206.9
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEeCCeeEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 151 (400)
.++||+|+|+.|-.+ +...+|..+|||++.+.......++.+|++++.+.+ |+||+.++++|+++...|+
T Consensus 83 ~e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 83 SELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 368999999999887 666789999999999887677788999999999885 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc---eEEeeccCCc
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLSDFGLAK 228 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~ 228 (400)
|||-+.||+|...|.++. .+++..+..+..+|+.||.+||.+| |.||||||+|||-..... +||+||.+..
T Consensus 154 VfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999999885 5899999999999999999999999 999999999999966554 8999998876
Q ss_pred cCCCCC-----CcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 229 DGPTGS-----QSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 229 ~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
-..... ......+.+|+..|||||+.. ...|+.+.|.||||+|+|-|++|.+||.+.-..+= .|.+
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdr 303 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDR 303 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccC
Confidence 432211 112234578999999999763 23689999999999999999999999987543110 0111
Q ss_pred HHH--hhhhhhhhhccccccCC--CC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcCCCC
Q 015781 299 PYL--QSKRRIFQVMDARIEGQ--YS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAG 362 (400)
Q Consensus 299 ~~~--~~~~~~~~~~~~~~~~~--~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~~~ 362 (400)
... .-.+.+ +....++. +| ...+.+..+++..+|..|+..|.++..++.| +..+..+.+-+
T Consensus 304 Ge~Cr~CQ~~L---FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp 374 (463)
T KOG0607|consen 304 GEVCRVCQNKL---FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP 374 (463)
T ss_pred CCccHHHHHHH---HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence 000 000011 11111111 12 2457778889999999999999999999995 44444443333
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=318.15 Aligned_cols=275 Identities=23% Similarity=0.252 Sum_probs=216.6
Q ss_pred HhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcc
Q 015781 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNL 136 (400)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpni 136 (400)
...++....+|.++++||+|+||.|.++ +++.|+++||.|++++... .+..-|..|-.+|..-+.+=|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi 137 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI 137 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence 3445566789999999999999999998 5566899999999988433 233447778888887788889
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+.+...|.++.++|+||||++||+|..+|.+.. ++++..+.+++..|+.||.-||+.| +|||||||+|||||..
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~ 211 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS 211 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc
Confidence 999999999999999999999999999998764 6899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhc----c-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----T-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
|++||+|||.|-...... .-.....+|||.|.+||++. + +.|+...|.||+||++|||+.|..||....-
T Consensus 212 GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl---- 286 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL---- 286 (1317)
T ss_pred CcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----
Confidence 999999999987655322 22345579999999999984 2 5789999999999999999999999954321
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCC--HHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHHH-------hchhcC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKFRPT---MDEVVKALE-------QIQDTN 359 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~eil~~L~-------~~~~~~ 359 (400)
... ...+++..-.-.+| ...+....+||.+.+. +|+.|.. +.++-.|-- .|++..
T Consensus 287 ---------veT---Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~ 353 (1317)
T KOG0612|consen 287 ---------VET---YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESV 353 (1317)
T ss_pred ---------HHH---HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcC
Confidence 111 11222222122223 3467888889987764 8889987 999988742 344555
Q ss_pred CCCCCCcc
Q 015781 360 DAGVSRDE 367 (400)
Q Consensus 360 ~~~~~~~~ 367 (400)
.+-+|..+
T Consensus 354 pP~vPevs 361 (1317)
T KOG0612|consen 354 PPVVPEVS 361 (1317)
T ss_pred CCCCCcCC
Confidence 55555433
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.72 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=195.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|.+. .++..+|+|.+..... .....+..|+.++.++ .||||+++++++.+
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFK---------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred chheeeeEeeccCCeEEEEEEEC---------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 67899999999999999999654 3578999999875432 2334566677666666 49999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
....|++|||+ +++|.+++.... .++++..+..++.||+.||+|||+ ++ ++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 86 DSDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred CCeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECcc
Confidence 99999999998 558888776643 468999999999999999999997 46 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCC----CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ... .
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~---~-- 229 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVL---T-- 229 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHH---H--
Confidence 99875432221 12235778899999986543 7889999999999999999999996532210 000 0
Q ss_pred Hhhhhhhhhhcccc-ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 301 LQSKRRIFQVMDAR-IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 301 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...... .........+..+.+|+.+||+.||.+||++.+++.+-+.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 230 --------KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred --------HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 000000 0001111345678999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=294.12 Aligned_cols=249 Identities=25% Similarity=0.292 Sum_probs=202.3
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 150 (400)
.++||.|.||+||-| ++.++|+.||||++.+.... ....+.+|+.+|+++.||.||.+...|+..+.+|
T Consensus 569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 589999999999998 77789999999999876543 3456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCceEEeeccCC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLA 227 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 227 (400)
+|||-+.|.-|.-++.... ..+++.....++.||+.||.|||-++ |+|+||||+|||+.. -.++||+|||+|
T Consensus 640 VVMEKl~GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhhcchHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccce
Confidence 9999995544444444333 46899999999999999999999998 999999999999954 357999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+...... .....+|||.|+|||++.+..|+..-|+||.|+|+|.-+.|..||....+.. ..+++..-
T Consensus 715 RiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaF- 781 (888)
T KOG4236|consen 715 RIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAF- 781 (888)
T ss_pred eecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhcccc-
Confidence 9876543 4566899999999999999999999999999999999999999997654311 11111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+..+.. =.+.+....+||..+|+..-.+|-|+...+.|.|.
T Consensus 782 --MyPp~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 782 --MYPPNP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred --ccCCCc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 000111 12456678899999999999999999999887553
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.76 Aligned_cols=268 Identities=24% Similarity=0.288 Sum_probs=198.5
Q ss_pred cCCC-CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--------------HHHHHHHHHHHccCC
Q 015781 68 RNFR-PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--------------HLEWLTEIKHLGQLY 132 (400)
Q Consensus 68 ~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~ 132 (400)
++|. +.+.||.|+||+||+|... .++..||+|.+....... ...+.+|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4565 4578999999999999643 368899999886543221 124678999999999
Q ss_pred CCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 133 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
||||+++++++..++..++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nil 151 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIF 151 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeE
Confidence 9999999999999999999999995 6999988654 35889999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCC------------cceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCC
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQ------------SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 279 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~ 279 (400)
++.++.++|+|||++........ ........++..|+|||.+.+. .++.++|+|||||++|+|++|.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999875431110 0111223567889999998654 4689999999999999999999
Q ss_pred CccCCCCCCccchhHHhhhHHHhhh--hhhhhhc--------ccccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 015781 280 RVIDKNRPSREHNLIEWAKPYLQSK--RRIFQVM--------DARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMD 346 (400)
Q Consensus 280 ~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--------~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 346 (400)
.||....+......+. ...... ..+.... ..... .......+..+.+++.+||+.+|.+|||+.
T Consensus 232 ~p~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 232 PLFPGENEIDQLGRIF---ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCHHHHHHHHH---HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 9998765432111110 000000 0000000 00000 000112356788999999999999999999
Q ss_pred HHHHHHHh
Q 015781 347 EVVKALEQ 354 (400)
Q Consensus 347 eil~~L~~ 354 (400)
+++.+-+.
T Consensus 309 ~~l~~~~~ 316 (335)
T PTZ00024 309 EALKHEYF 316 (335)
T ss_pred HHhcCccc
Confidence 99997655
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=282.98 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=199.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
.|++.+.||+|+||.||+|.... ...+|..||+|++..... .....+.+|+.+++++ +|+||+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47888999999999999996532 234688999999875432 2234567899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..+...|+||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999999765 35789999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||++........ .......|+..|+|||.+... .++.++||||||+++|+|++|..||.......... ....
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~--- 222 (290)
T cd05613 149 FGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EISR--- 222 (290)
T ss_pred Cccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HHHH---
Confidence 999876433221 112235688999999998653 46789999999999999999999996433211111 0000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
.... ....++...+..+.+++.+||+.||.+|| ++.+++.+
T Consensus 223 -------~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -------RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01122334556788999999999999997 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=314.61 Aligned_cols=255 Identities=29% Similarity=0.396 Sum_probs=193.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
+-..+|+..++||+||||.||++ +++-.|+.||||+|.... ......+.+|+..|.+|+|||||+++..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 44567888999999999999999 556689999999998764 23345688999999999999999987543
Q ss_pred Ee------------------------------------------------------------------------------
Q 015781 144 LE------------------------------------------------------------------------------ 145 (400)
Q Consensus 144 ~~------------------------------------------------------------------------------ 145 (400)
.+
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 21
Q ss_pred ---------------------------------C--------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 015781 146 ---------------------------------D--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184 (400)
Q Consensus 146 ---------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 184 (400)
+ ..+||-||||+..+|.+++.+..-. -.....|.++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLF 703 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLF 703 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHH
Confidence 0 1357889999887777777654311 1467889999
Q ss_pred HHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC----------------CCCCcceeeecccccCc
Q 015781 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP----------------TGSQSHVSTRVMGTYGY 248 (400)
Q Consensus 185 ~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y 248 (400)
.+|++||.|+|+.| ||||||||.|||+++++.|||+|||+++... .+......+..+||..|
T Consensus 704 reIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 704 REILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 99999999999988 9999999999999999999999999998621 01111134567899999
Q ss_pred ccchhhccC---CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcccccc--CCCCHHH
Q 015781 249 AAPEYMATG---HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLGA 323 (400)
Q Consensus 249 ~aPE~~~~~---~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 323 (400)
+|||++.+. .|+.|+||||||++++||+. ||....+ ....+..+.+..+. ..+....
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~~ 843 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDPE 843 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCccccccc
Confidence 999999765 49999999999999999986 4543211 11111111111111 2233445
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 324 ALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 324 ~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
......+|.+||+.||.+|||+.|+|+.
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 5667789999999999999999999974
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=283.91 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=194.5
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccC---CCCcccceeeEEE
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGYCL 144 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~hpniv~~~~~~~ 144 (400)
|++.+.||+|+||.||+|.... ++..+|+|.+...... ....+.+|+.+++++ +||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 6678899999999999996542 5789999998754322 123455666655544 6999999999998
Q ss_pred eCCe-----eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 EDDH-----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
+.+. .+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCE
Confidence 8776 999999996 589988876432 35899999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hh-
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WA- 297 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~- 297 (400)
+|+|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+. ..
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07838 147 KIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223 (287)
T ss_pred EEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcC
Confidence 9999999876533221 122357888999999998889999999999999999999999997654322111110 00
Q ss_pred --------hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 298 --------KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 298 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
................. ........+..+.+++.+||+.||.+||++.+++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHhcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000000000000 011112345778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.89 Aligned_cols=269 Identities=26% Similarity=0.294 Sum_probs=198.1
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK---------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC---------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 34578999999999999999999654 3578899999875432 223456789999999999999999998
Q ss_pred EEeCC----------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 143 CLEDD----------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 143 ~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+.+.. .+++||||+++ +|..++.... ..+++..++.++.||+.||+|||+.+ |+|+||+|+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nil 148 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNIL 148 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 87654 78999999965 7777776542 46899999999999999999999988 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.........
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred ECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999998765432211 1122345778999998864 35788999999999999999999999765432211
Q ss_pred hhHHhhhHHHhhhhhhhhhcc--------------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 292 NLIEWAKPYLQSKRRIFQVMD--------------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+..... ......+..+.. ...... ....+..+.+++.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 228 ELISRLCG-SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHhC-CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110000 000000000000 000000 11235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=294.42 Aligned_cols=268 Identities=24% Similarity=0.289 Sum_probs=196.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||.|+||.||+|... .++..||+|.+..........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~---------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS---------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC---------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 368999999999999999999554 36889999998776555556788999999999999999999776543
Q ss_pred --------------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 147 --------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 147 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nil 146 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVF 146 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEE
Confidence 35799999995 589888754 24789999999999999999999988 999999999999
Q ss_pred Ec-CCCceEEeeccCCccCCCCCCc-ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 213 LD-LNYNAKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 213 l~-~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
++ .++.++|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 4567899999998754322111 11122357889999998754 567889999999999999999999997665422
Q ss_pred cchhHHhhhHHHh--hhh----hhhhhcc-ccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 290 EHNLIEWAKPYLQ--SKR----RIFQVMD-ARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 290 ~~~~~~~~~~~~~--~~~----~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
....+....+... ... .+..... ...... .....+.++.+++.+||+.||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 2111111000000 000 0000000 000000 011245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.37 Aligned_cols=265 Identities=30% Similarity=0.516 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
...|...++||+|+||.||+|... .++..||+|.+....... ..|+..+++++||||+++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcC
Confidence 456788889999999999999653 357899999986543211 2468889999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..|+||||+++|+|.+++. .+++..+..++.||+.||+|||.. ..+|+||||||+||+++.++..++. ||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999984 378899999999999999999943 1339999999999999998887775 55
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
....... .....+++.|+|||++.+..++.++|||||||++|||+||+.||..... ......+|....... .
T Consensus 828 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~ 899 (968)
T PLN00113 828 LPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-C 899 (968)
T ss_pred ccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-c
Confidence 5433211 1123678999999999999999999999999999999999999954322 233444555432221 2
Q ss_pred hhhhhccccccC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 306 RIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 306 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
....+.++.+.. ........++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 233334443322 2334556678899999999999999999999999998865443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.47 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=195.7
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 147 (400)
.+-...||.|+||+|++- .++.+|+..|||++..... .+..+++.|.+...+- ++||||+++|.+..++
T Consensus 66 Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred HHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 344568999999999986 6778999999999988765 4456688888765554 7999999999998889
Q ss_pred eeEEEEeecCCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 148 HRLLVYEFMPKGSLENHLFRR-ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..||.||+| ..+|..+.+.. .-....+++..+-.|....+.||.||-.. ..|+|||+||+|||++..|.+||+|||+
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccc
Confidence 999999999 66776654321 11124689999999999999999999765 4599999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+-..... ...+...|...|||||.+.. ..|+.+||+||||+++||+.||..|+.+++. .+.+
T Consensus 215 cGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------vfeq-- 278 (361)
T KOG1006|consen 215 CGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------VFEQ-- 278 (361)
T ss_pred hHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------HHHH--
Confidence 8754322 22344678899999999853 3599999999999999999999999987532 1111
Q ss_pred hhhhhhccc---ccc-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDA---RIE-GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~---~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.+++.. .+. ..-....+..+..+|..||.+|...||...+++++
T Consensus 279 --l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 --LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111111 111 11123467788999999999999999999998874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=294.89 Aligned_cols=246 Identities=25% Similarity=0.287 Sum_probs=202.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
....|.+...+|.|+|+.|-.+ .+..+++..++|++....... .+|+.++... +||||+++.+++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~~----~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADDN----QDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeee---------eccccccchhheecccccccc----ccccchhhhhcCCCcceeecceec
Confidence 3567889999999999999887 455578899999998762221 2455444343 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE-cCCCceEEee
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSD 223 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill-~~~~~~kl~D 223 (400)
++.+.|+|||++.|+-|.+.+.... .....+..|+.+|+.|+.|||.+| ++||||||+|||+ +..++++|+|
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEE
Confidence 9999999999999999988886653 333677789999999999999988 9999999999999 6899999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||.++..... ..+.+-|..|.|||++....|+.++|+||||+++|+|++|+.||.....+
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------------- 519 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------------- 519 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------
Confidence 9999876543 23346688999999999999999999999999999999999999876543
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.++......+.+....+....+|+.+||+.||.+||++.+++.|-+..
T Consensus 520 ----~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 520 ----IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred ----HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 112222233344467788999999999999999999999999998873
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=306.11 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=217.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
....+.++||.|.||.||+|+++. ..+....||||.++..... ....|+.|..+|-+++||||+++.+++...
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~------pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKL------PGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccC------CCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 455778999999999999998863 2234678999999876543 456799999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..+.||+|||++|+|+.+|..+.+ .+...++.-.++.|+.|++||-+.+ +|||||...|||++.+..+|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999988874 4888889999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeccc--ccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQSHVSTRVMG--TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++...+.... ..++..| ..+|.|||.+..+.++.++||||+|+++||.++ |..||-+....+..+.
T Consensus 778 SRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka---------- 846 (996)
T KOG0196|consen 778 SRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA---------- 846 (996)
T ss_pred eeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH----------
Confidence 9976544322 1222222 468999999999999999999999999999765 8889865443222211
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
++...+-..|..++..|.+|+++||++|..+||.+.+|+.+|.++..+
T Consensus 847 -------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 -------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 122223344677889999999999999999999999999999998544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=281.41 Aligned_cols=265 Identities=26% Similarity=0.376 Sum_probs=197.7
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCC-CCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~ 147 (400)
|++.+.||+|+||+||+|.... ++..+++|.+..... .......+|+..+++++ ||||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6778899999999999996543 578899999865432 12233457899999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+ +++|.+++..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 8899998876542 46899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhHH----H
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKPY----L 301 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~~----~ 301 (400)
........ .....++..|+|||++. +..++.++|+||||+++++|++|++||......+....+. +.... .
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 75433221 12345788999999874 4567899999999999999999999997664422211110 00000 0
Q ss_pred hhhhhhhhhcccccc-------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 302 QSKRRIFQVMDARIE-------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.....+......... .......+..+.+++.+||+.+|++|||+++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000000 00011124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.86 Aligned_cols=264 Identities=28% Similarity=0.369 Sum_probs=199.8
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
|++.+.||+|+||.||+|. ...++..+|+|.+.... ......+..|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKAR---------DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEee---------ecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5667889999999999994 44468899999988653 223456778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+. ++|.+++.... ..+++..++.++.|++.||++||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999996 59999998753 35899999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-hhhH----HH
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-WAKP----YL 301 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~~~~----~~ 301 (400)
........ ......++..|+|||.+.+. .++.++|||||||++|+|++|.+||...........+. .... ..
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence 76543221 12234567889999998766 78999999999999999999999997654322111110 0000 00
Q ss_pred hh-------hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 302 QS-------KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 302 ~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. ............. ......+..+.+++.+||..+|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HhhcccccccccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0000000000000 0011225678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=291.75 Aligned_cols=271 Identities=23% Similarity=0.312 Sum_probs=199.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
...+|.+.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 83 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDK---------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF 83 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeC---------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhee
Confidence 3578999999999999999999543 3688999999875422 1234577899999999999999999998
Q ss_pred EeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 144 LED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 144 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
... ..+++||||+. .+|..++. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~ 154 (342)
T cd07879 84 TSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDC 154 (342)
T ss_pred cccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCC
Confidence 754 34689999995 47766542 35789999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 155 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 155 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754321 123457889999999866 4688999999999999999999999986543221111111
Q ss_pred hhH--------HHhhh--hhhhhhccccccCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcC
Q 015781 297 AKP--------YLQSK--RRIFQVMDARIEGQY---SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTN 359 (400)
Q Consensus 297 ~~~--------~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~ 359 (400)
... ..... ............... ....+..+.+++.+||+.||.+||++.+++.| ++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 000 00000 000000000000000 01234568899999999999999999999987 77776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.24 Aligned_cols=270 Identities=27% Similarity=0.325 Sum_probs=194.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .++..+|+|.+....... ...+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI---------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 468999999999999999999544 367889999886543222 235678999999999999999998875
Q ss_pred eC--------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 145 ED--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 145 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+. ..+++||||+. ++|...+.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~ 151 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 43 35699999995 57777665432 46899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCc---------ceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCC
Q 015781 217 YNAKLSDFGLAKDGPTGSQS---------HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNR 286 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~ 286 (400)
+.++|+|||++......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+..
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999998754332211 011234568889999987653 57899999999999999999999997655
Q ss_pred CCccchhHHhhhH-H----HhhhhhhhhhccccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 287 PSREHNLIEWAKP-Y----LQSKRRIFQVMDARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 287 ~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.......+..... . ......+............+ ......+.+++.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 4322111100000 0 00000000000000000000 1123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=281.91 Aligned_cols=259 Identities=25% Similarity=0.329 Sum_probs=199.0
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
+|++.+.||+|+||.||++.... ...++..+|+|.+..... .....+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 37788999999999999986532 233578899999875422 2234567899999999 599999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..+...++||||+.+++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999999998654 35889999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCC--CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||++........ .......|+..|++||.+.+.. ++.++|+||||+++|+|++|..||......... ......
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~-- 223 (288)
T cd05583 149 FGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRR-- 223 (288)
T ss_pred Cccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHH--
Confidence 999875433221 1122346789999999987654 788999999999999999999999643321110 000000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... .....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 224 --------~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 --------ILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------HHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 0112233355678899999999999999997766655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=288.71 Aligned_cols=269 Identities=24% Similarity=0.272 Sum_probs=193.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
+|++.+.||+|+||.||++..... ..+..+|+|.+..... .....+.+|+.+++++ +||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999965431 1277899998865321 2234577899999998 59999999987543
Q ss_pred C----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 146 D----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 146 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
. ...|++||++ +++|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|
T Consensus 74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 74 FPGNFNELYLYEELM-EADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccccCCcEEEEEecc-cCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEe
Confidence 2 4578899998 56898888654 46899999999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCCCCCc--ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-
Q 015781 222 SDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA- 297 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~- 297 (400)
+|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+...
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 999999754332211 11233568999999998765 46899999999999999999999999765432111100000
Q ss_pred --------hHHHh-hhhhhhhhccccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 298 --------KPYLQ-SKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 298 --------~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... ............... ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 000000000000000 0011135678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=290.64 Aligned_cols=272 Identities=25% Similarity=0.318 Sum_probs=201.5
Q ss_pred HhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCccc
Q 015781 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLV 137 (400)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv 137 (400)
...+....++|.+.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv 79 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence 3445667789999999999999999999543 3688999999875422 2234577899999999999999
Q ss_pred ceeeEEEeC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 138 KLIGYCLED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 138 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
++++++... ...|++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.+ ++|+||||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 151 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNL 151 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHE
Confidence 999988643 3468888887 8899888754 24789999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999998754321 223467889999998866 5688999999999999999999999976543221
Q ss_pred chhHHhhhH----H----Hhh--hhhhhhhccccccCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 291 HNLIEWAKP----Y----LQS--KRRIFQVMDARIEGQY---SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 291 ~~~~~~~~~----~----~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...+..... . ... .......+.......+ ....+..+.+++.+||+.||.+||++.+++.+=+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 111100000 0 000 0000000000000000 0123557889999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=287.69 Aligned_cols=264 Identities=26% Similarity=0.315 Sum_probs=198.0
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++.++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQ---------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEEC---------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 35578999999999999999999544 4688999998765322 223467789999999999999999998
Q ss_pred EEe-CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 143 CLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 143 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
+.. ....+++|||+ +++|..++.. .++++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.++|
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEe
Confidence 865 56789999999 6789888754 34788888999999999999999988 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-h---
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-W--- 296 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~--- 296 (400)
+|||.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+. .
T Consensus 150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 224 (328)
T cd07856 150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224 (328)
T ss_pred CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754321 123457888999998765 568999999999999999999999997654321111100 0
Q ss_pred -----hhHHHhhhhhhhhhccccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 -----AKPYLQSKRRIFQVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 -----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... ......-..........+ ...+..+.+++.+||+.+|++|||+.+++.+
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000000000011111 1235688899999999999999999999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=288.69 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=197.1
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
....++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDR---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEEC---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence 345678999999999999999999544 3688999999865322 22345778999999999999999999
Q ss_pred EEEeCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 142 YCLEDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 142 ~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
++..+. ..++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+|+||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~ 153 (343)
T cd07880 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNE 153 (343)
T ss_pred eecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence 987553 458999999 7899888754 35899999999999999999999988 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 154 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 154 DCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred CCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998764322 123457889999999865 45889999999999999999999999765431110000
Q ss_pred -H--------hhhHHH-hhhhhhhhhcccccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 295 -E--------WAKPYL-QSKRRIFQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 295 -~--------~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. +..... .........+..... .......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 000000000000000 00111234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.51 Aligned_cols=257 Identities=28% Similarity=0.360 Sum_probs=212.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
......|++.++||.|.+|.||++ ++.++++..|+|++..... ..+++..|.++|+.+ .|||++.++++
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344567999999999999999999 5666888999999876653 344677888999887 69999999999
Q ss_pred EEe-----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 143 CLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 143 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
|.. ++.+|||||||.||+..|+++.-. +..+.|..+..|++.++.|+.+||.+. ++|||||-.|||++.++
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENA 160 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccC
Confidence 863 578999999999999999998766 478999999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
.|||+|||.+...... .....+..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+.+..+.....
T Consensus 161 ~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred cEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 9999999999875443 234567899999999999854 357789999999999999999999998877754433
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
++. .++...-.-+..-+.++.++|..||.+|..+||+..++|+|
T Consensus 239 ~Ip---------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 LIP---------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cCC---------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 321 11111112234567788899999999999999999998875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=290.15 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=217.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.....+......||-|.||.||.|+|+.. ...||||.++.+. ...++|+.|..+|+.++|||+|+++++|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 33444556678899999999999998753 4569999987655 4467899999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..+..+|||+|||..|+|.+||.+... ..++...+++++.||..|++||..++ .|||||...|+|+.++..||++|
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeec
Confidence 999999999999999999999987653 56788888999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||+++.+...... ......-.+-|.|||.+....++.++|||+||++|||+.| |-.||.+.+.
T Consensus 409 FGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------------- 472 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------- 472 (1157)
T ss_pred cchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------
Confidence 9999976543321 1222223567999999999999999999999999999988 6678876432
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.....++.+..+..-+..++..+++|+..||+-+|.+||++.|+-+.+|.+-.
T Consensus 473 --SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 473 --SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11233444555556677889999999999999999999999999999987643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.25 Aligned_cols=255 Identities=23% Similarity=0.269 Sum_probs=215.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..+++.+..||-|+||.|-++..+.. ...+|+|++++....+ .+.+..|-.+|...+.|.||++|-.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 34667788899999999999866542 2358999888765543 34567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.++.++||+||-|-||.|...+.+++. ++......++..+++|++|||.++ |++|||||+|++++.+|.+||.|
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEee
Confidence 999999999999999999999998864 788889999999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+|+....+. .+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++....+++.-....
T Consensus 564 FGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--- 637 (732)
T KOG0614|consen 564 FGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--- 637 (732)
T ss_pred hhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---
Confidence 99999876654 467899999999999999999999999999999999999999999998886655544322211
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~~~ 355 (400)
..+|........+|++++...+|.+|.- +.+|-+|-|..
T Consensus 638 -------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 638 -------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred -------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 1233445567778999999999999975 88999887753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.53 Aligned_cols=241 Identities=31% Similarity=0.391 Sum_probs=195.4
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
||.|+||.||++... .++..+++|.+...... ....+..|+.++++++||||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKK---------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 699999999999553 35789999998765432 334677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 72 LEYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999999999997653 5899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. .......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .... ....
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~-------------~~~~ 207 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE-------------KILK 207 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH-------------HHhc
Confidence 21 1223456788999999998888899999999999999999999999655321 0000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH---HHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM---DEVVKA 351 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~eil~~ 351 (400)
.....+...+..+.+++++||..||++||++ .+++++
T Consensus 208 --~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 208 --DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1112333346788899999999999999999 666554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.20 Aligned_cols=266 Identities=26% Similarity=0.320 Sum_probs=198.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++.++
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDT---------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEEC---------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence 34578999999999999999999654 3678999999865322 233456789999999999999999988
Q ss_pred EEeCCe------eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 143 CLEDDH------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 143 ~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+...+. .++|+||+ +++|.+++.. .++++..++.++.||+.||+|||+.+ ++|+||+|+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~ 154 (343)
T cd07851 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED 154 (343)
T ss_pred hhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC
Confidence 876554 89999999 7799998864 35899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH-
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI- 294 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~- 294 (400)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 155 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 155 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999865332 223467889999998865 36789999999999999999999999765432111100
Q ss_pred Hhh--------hHHH-hhhhhhhhhccccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 295 EWA--------KPYL-QSKRRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 295 ~~~--------~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
... .... .....+........... .....+..+.+++.+||+.+|++|||+.+|+.|-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 000 0000 00000000000000000 0012367889999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.78 Aligned_cols=242 Identities=28% Similarity=0.404 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHH---HHHHHHHHccC-CCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
.+|.+..+||+|+||.|.+| .++++.+.+|||+++++....... -..|-++|... +-|.++.+...|
T Consensus 349 tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred cccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 57888999999999999998 677899999999998865432211 23455666655 467899999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..-+.+|+||||+.||+|--.|++.+. +.+..+..++..|+-||-+||++| |++||||.+||+++.+|++||+|
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeee
Confidence 999999999999999999999988764 566678889999999999999999 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++....... ...+++|||.|+|||++..+.|+..+|.||+|+++|||+.|++||++.+.....
T Consensus 494 FGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------------ 559 (683)
T KOG0696|consen 494 FGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------------ 559 (683)
T ss_pred cccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------
Confidence 999986444332 356689999999999999999999999999999999999999999987642211
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 344 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 344 (400)
..+++. .-.++-..+.+...+.+..|...|.+|.-
T Consensus 560 ----~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 ----QAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----HHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 122222 23456677888899999999999999953
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=247.30 Aligned_cols=266 Identities=24% Similarity=0.292 Sum_probs=202.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.|.-.+.||+|.||+||+| ++..+++.||+|..+.+... -....++|+.+|+.++|.||++++++...+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 3555678999999999999 55568999999998765432 245678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..+-+|+||| ..+|..+...-. ..++.+.+..++.|++.||.++|+++ +.||||||.|++|+.+|.+||+|||+
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccch
Confidence 9999999999 568888876554 45889999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh-h
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ-S 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~-~ 303 (400)
++.+.-... .....+.|.+|++|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+-.+....+-|...... +
T Consensus 148 arafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred hhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 986544321 23345679999999998765 58999999999999999986 6666887765444433322211100 0
Q ss_pred -hhhhhhhccccccCCCC---------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 -KRRIFQVMDARIEGQYS---------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 -~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
--.+..+.+-..-+.++ +.....-.++++++|.-+|..|.++++.+++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00111111111111111 1233445678889999999999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.78 Aligned_cols=146 Identities=26% Similarity=0.334 Sum_probs=129.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|.... ++..||+|++...... ....+..|+.+++.++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 579999999999999999996543 6889999998764322 2345778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
..+.+||||||+.+++|.+++... ..+++..++.++.||+.||+|||.++ |+||||||+||||+.++.++|+||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeC
Confidence 999999999999999999999764 35788999999999999999999988 999999999999999999999999
Q ss_pred cCCc
Q 015781 225 GLAK 228 (400)
Q Consensus 225 g~~~ 228 (400)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=273.23 Aligned_cols=275 Identities=25% Similarity=0.361 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc--CCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~~ 145 (400)
...++.++||+|.||.||+|.++ ++.||||++.... ...+.+|-++++. ++|+||++++++-.-
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 45667789999999999999765 4779999997543 4456666655544 589999999988765
Q ss_pred CC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeeeccCCCCCEEEc
Q 015781 146 DD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILLD 214 (400)
Q Consensus 146 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------~~~ivH~dlkp~Nill~ 214 (400)
.. .++||++|.+.|+|.+||+.+. ++|.....++..|+.||+|||.. +++|+|||||..||||.
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK 350 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK 350 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence 54 8999999999999999998864 89999999999999999999965 36799999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCC-CC-----CccchhhHHHHHHHHHhCCCccCCCCCC
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LT-----AKSDVYSFGVVLLEMLSGRRVIDKNRPS 288 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDiwslG~il~~l~tg~~pf~~~~~~ 288 (400)
.|++..|+|||+|..+..+.........+||.+|||||++.+.. +. .+.||||+|.++|||++....+......
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 99999999999998877665555555689999999999997642 22 3689999999999999976555321111
Q ss_pred ccchhHHhhhHHHhhhhhhhh-hccccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 289 REHNLIEWAKPYLQSKRRIFQ-VMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
......+........-..+.. ++.++.++.++ .....-+.+.+..||..|++-|.|+.=+.+.+..+.-...-
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111100000000011111 11222222222 23456788899999999999999999999999888655543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=293.18 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=214.2
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
.+..++||.|+||+||+|.|-. +...-..+||+|++..... +...++++|+.+|.+++|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 3446789999999999998864 4444567899999876543 45678999999999999999999999998765
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
+-||++|+++|.|.|++..+. .++..+..+.|..||++|+.|||.++ +|||||-..|+|+....++||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 789999999999999998876 57889999999999999999999988 9999999999999999999999999999
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
...............-.+-|||-|.+....|+.++|||||||++|||+| |..|+.+....+ +
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------------I 909 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------------I 909 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------------h
Confidence 7666544433333344567999999999999999999999999999998 888987764322 2
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..++....+-.-+..++.+++.++.+||..|+..||+++++...+.++
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 222222222334567788999999999999999999999999988775
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=268.92 Aligned_cols=226 Identities=21% Similarity=0.227 Sum_probs=179.2
Q ss_pred CCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEeecCC
Q 015781 79 GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (400)
Q Consensus 79 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 158 (400)
|.||.||++.. ..+++.+|+|.+.... ....|...+....||||+++++++.+.+..++||||+++
T Consensus 4 g~~~~v~~~~~---------~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMD---------TRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEE---------ccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 89999999954 4478899999987643 222444455556799999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcce
Q 015781 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (400)
Q Consensus 159 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 238 (400)
++|.+++.... ++++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+......
T Consensus 70 ~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 70 GKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred CCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 99999987653 4899999999999999999999988 999999999999999999999999987654322
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCC
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQ 318 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .. .....
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~----~~~~~ 196 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NT----HTTLN 196 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------cc----ccccC
Confidence 122345678999999988889999999999999999999998875321100 00 00011
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 319 YSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 319 ~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
.+...+..+.+++.+||+.||++||++ .++++|
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 223345678899999999999999996 555543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=270.76 Aligned_cols=271 Identities=27% Similarity=0.361 Sum_probs=205.6
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc--CCCCccccee
Q 015781 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLI 140 (400)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~ 140 (400)
..+..++.++.+.||+|.||.||+|.|+ |+.||||++.... ...+.+|.++++. |+|+||+.++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhh
Confidence 3577788999999999999999999987 6779999997654 3456677777765 4899999999
Q ss_pred eEEEeC----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCC
Q 015781 141 GYCLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSN 210 (400)
Q Consensus 141 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~dlkp~N 210 (400)
+.-..+ .++|||++|.+.|+|+|||.+. .++...+++++..++.||++||.. ++.|.|||||..|
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 876543 4789999999999999999874 489999999999999999999954 4679999999999
Q ss_pred EEEcCCCceEEeeccCCccCCCCCC--cceeeecccccCcccchhhccCC----C--CCccchhhHHHHHHHHHhC----
Q 015781 211 ILLDLNYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGH----L--TAKSDVYSFGVVLLEMLSG---- 278 (400)
Q Consensus 211 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDiwslG~il~~l~tg---- 278 (400)
||+..++...|+|+|+|........ .......+||.+|||||++.... + -..+||||||.++||++-.
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 9999999999999999976544321 12234578999999999995431 1 1368999999999999752
Q ss_pred ------CCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 279 ------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 279 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
++||.+.-+.+.-. .+ +.+..-+.++.....+..........+.+|++.||..||.-|.|+-.|.+.|
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~-ee-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSF-EE-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CEehhhcCCcccCCCCCCCH-HH-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 46775544332211 00 0000001111111122233456677888899999999999999999999999
Q ss_pred Hhchhc
Q 015781 353 EQIQDT 358 (400)
Q Consensus 353 ~~~~~~ 358 (400)
.++.+.
T Consensus 501 ~~l~~~ 506 (513)
T KOG2052|consen 501 AKLSNS 506 (513)
T ss_pred HHHhcC
Confidence 988653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=260.94 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=199.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCcccceee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
...+|.+.++||+|+|+.|.++ ..+.|.+.+|+|+++++-.. +...+..|-.+..+. +||.+|-+..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 4578999999999999999988 55568899999998875332 222334455555444 6999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.|..+..+++|.||++||+|.-.+++.. .+++..+..+...|..||.|||+.| |+.||||.+|+|++..|++||
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikl 392 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKL 392 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceee
Confidence 9999999999999999999988887763 5899999999999999999999999 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCC-CccchhHHhhhHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP-SREHNLIEWAKPY 300 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~ 300 (400)
.|+|+++..-.. .....+++|||.|.|||++.+..|.+..|.|+||++++||+.|+.||+--.- ..+.+...+.
T Consensus 393 tdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl--- 467 (593)
T KOG0695|consen 393 TDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL--- 467 (593)
T ss_pred cccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH---
Confidence 999999864332 2346779999999999999999999999999999999999999999963221 1111111111
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 344 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 344 (400)
+.-++.+++ ..+...+.....+++..|++||.+|.-
T Consensus 468 ------fqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 468 ------FQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------HHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 112233322 234455666778899999999999953
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.91 Aligned_cols=276 Identities=26% Similarity=0.328 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..|.-...||+|.||.||+| ....+|+.||+|+.--++. .-....++|+++|..|+|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 45666778999999999999 4555788899987544322 223456799999999999999999987753
Q ss_pred --------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 146 --------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
...+|+||++|+ .+|.-++.... ..++...+.+++.+++.||.|+|... |+|||+|++|+||+.+|
T Consensus 88 k~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCE-HDLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDG 161 (376)
T ss_pred ccCCcccccceeeeeHHHhh-hhHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCc
Confidence 245899999995 58888887654 46889999999999999999999988 99999999999999999
Q ss_pred ceEEeeccCCccCCCCC--CcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 218 NAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
.+||+|||+++.+.... .....+..+.|.+|++||.+.+ ..|++..|||+.||++.+|+|+.+.++++.......++
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 99999999997543222 1122345677999999998865 57999999999999999999999999988765544443
Q ss_pred HhhhH-----HHhhhhh--hhhhc--cccc--------cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 295 EWAKP-----YLQSKRR--IFQVM--DARI--------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 295 ~~~~~-----~~~~~~~--~~~~~--~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
...-. .+..-.. +.+-+ .+.. +...+....++..+|+.++|..||.+|+.+.+++.|.....+
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 21100 0000000 00000 0000 001122234577889999999999999999999999877654
Q ss_pred c
Q 015781 358 T 358 (400)
Q Consensus 358 ~ 358 (400)
.
T Consensus 322 p 322 (376)
T KOG0669|consen 322 P 322 (376)
T ss_pred C
Confidence 3
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=272.81 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=205.9
Q ss_pred hHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-------HHHHHHHHHHHccCCC
Q 015781 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYH 133 (400)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h 133 (400)
++-.+..++|-+..+||+|+|+.||+|++-. ..+.||+|+-....... .....+|.++-+.|+|
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDH 526 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDH 526 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCc
Confidence 3344556788889999999999999996532 46789999876543221 1235689999999999
Q ss_pred CcccceeeEEE-eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 134 PNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 134 pniv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
|.||+++++|. +.+.+|-|+|||+|.+|.-|++.+. .++++.+..|+.||+.||.||....++|+|-||||.|||
T Consensus 527 pRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNIL 602 (775)
T KOG1151|consen 527 PRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNIL 602 (775)
T ss_pred ceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEE
Confidence 99999999986 5577889999999999999999875 589999999999999999999999999999999999999
Q ss_pred Ec---CCCceEEeeccCCccCCCCCCc-----ceeeecccccCcccchhhcc----CCCCCccchhhHHHHHHHHHhCCC
Q 015781 213 LD---LNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMAT----GHLTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 213 l~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~sDiwslG~il~~l~tg~~ 280 (400)
+. ..|.+||.|||+++........ .......||.+|++||.+.- ...+.++||||+|||+|..+.|+.
T Consensus 603 Lv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 603 LVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred EecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 94 4578999999999876554332 23455789999999998843 356889999999999999999999
Q ss_pred ccCCCCCCccchhHHhhhHHHhhhhhhhhhcccc-ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDAR-IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
||....... ++.+. . .++... ..-...+..+.+...+|.+||+.--++|....++..+
T Consensus 683 PFGhnqsQQ--dILqe-------N----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 683 PFGHNQSQQ--DILQE-------N----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CCCCchhHH--HHHhh-------h----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 997654211 11111 0 111111 1111224566788889999999999999988887653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=262.35 Aligned_cols=268 Identities=20% Similarity=0.291 Sum_probs=198.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-----C---Ccccce
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----H---PNLVKL 139 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pniv~~ 139 (400)
.+|.+.+.||.|.|++||+|++.. ..+.||+|+.+.... -.+..+.|+++|++++ | .+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999998765 468899999876643 2345678999998873 3 369999
Q ss_pred eeEEEe----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 140 IGYCLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 140 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
++.|.. +.+++||+|++ |.+|..+|..... +.++...+.+|++||+.||.|||.. .+|+|.||||+|||+..
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCS 223 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeec
Confidence 999974 56899999999 8899999988765 6688999999999999999999987 67999999999999821
Q ss_pred C-----------C-------------------------------------------------------------------
Q 015781 216 N-----------Y------------------------------------------------------------------- 217 (400)
Q Consensus 216 ~-----------~------------------------------------------------------------------- 217 (400)
+ +
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 1 0
Q ss_pred --------------------------------------------------------------------------------
Q 015781 218 -------------------------------------------------------------------------------- 217 (400)
Q Consensus 218 -------------------------------------------------------------------------------- 217 (400)
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence
Q ss_pred --------ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 218 --------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 218 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
.+||+|||-|+.... ..+....|..|+|||++.+..|++.+||||++|++|||+||...|+...-..
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 022223332221110 1122356788999999999999999999999999999999999886443211
Q ss_pred ---cch-h---H--------------HhhhHHHhhhhhhhhhccccc---------cCCCCHHHHHHHHHHHHhcccCCC
Q 015781 290 ---EHN-L---I--------------EWAKPYLQSKRRIFQVMDARI---------EGQYSLGAALKTAVLAIKCLSNEP 339 (400)
Q Consensus 290 ---~~~-~---~--------------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP 339 (400)
+.+ + + ++.+.++.....+..+-.-+. ...++...+.++.+++.-||+.+|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 111 1 1 122333333333333222111 123566778899999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 015781 340 KFRPTMDEVVKALEQ 354 (400)
Q Consensus 340 ~~Rps~~eil~~L~~ 354 (400)
++|||+.++|+|-|.
T Consensus 539 eKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPWL 553 (590)
T ss_pred cccccHHHHhcCccc
Confidence 999999999998665
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=285.30 Aligned_cols=270 Identities=27% Similarity=0.407 Sum_probs=211.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
..++..+.+.||+|.||.|++|....... ........||||.+..... .+...+..|+.+|+.+ .|+||+.+++.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~--~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSK--ALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred chhhccccceeecccccceEeEEEeeccc--ccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 33455677799999999999998764211 0012367899999876543 3456688999999998 699999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhc---CC-------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRA---SY-------I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~-------~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
...+.+++|+||+..|+|.+++.... .. . ..+.....+.++.||+.|++||++.. ++||||-..||
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNV 449 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNV 449 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhE
Confidence 99999999999999999999998766 11 0 23889999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecc--cccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCC
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM--GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPS 288 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~ 288 (400)
|++.+..+||+|||+++........... .-. -...|||||.+....|+.++||||+|+++||+++ |..||.+....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 9999999999999999965444333211 111 2345999999999999999999999999999998 77888763211
Q ss_pred ccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
. .+. +.+....+...|..++.+++++++.||+.+|++||++.++.+.++...
T Consensus 529 ~--~l~--------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 E--ELL--------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred H--HHH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 111 112222223345566889999999999999999999999999998853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=254.42 Aligned_cols=238 Identities=32% Similarity=0.420 Sum_probs=192.6
Q ss_pred CCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEeecCC
Q 015781 80 GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (400)
Q Consensus 80 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 158 (400)
+||.||+|... .++..+++|++....... ...+.+|++.+++++|+||+++++.+......+++|||+.+
T Consensus 1 ~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDK---------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEEC---------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 58999999654 367899999998765544 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcce
Q 015781 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (400)
Q Consensus 159 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 238 (400)
++|.+++.... .++...++.++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 99999987643 3789999999999999999999988 9999999999999999999999999998654432 2
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCC
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQ 318 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....++..|++||.+.+..++.++|||+||+++|+|++|..||...... ..... .........
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~--------------~~~~~~~~~ 206 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK--------------KIGKPKPPF 206 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH--------------HHhccCCCC
Confidence 23456788999999998888999999999999999999999999653211 00010 000000000
Q ss_pred CCHH--HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 319 YSLG--AALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 319 ~~~~--~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... .+..+.+++.+||..+|++||++.+++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 0011 45688899999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.60 Aligned_cols=217 Identities=25% Similarity=0.327 Sum_probs=180.0
Q ss_pred HhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcc
Q 015781 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNL 136 (400)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpni 136 (400)
++.-+....-|..++.||-|+||.|.+++ ...|...+|.|.+.+...-. ...+..|-.+|...+.+=|
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~---------KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV 691 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVR---------KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV 691 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEe---------ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce
Confidence 33333444557778899999999999984 34467889999887765422 2235678899999999999
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
|+++..|.+.+.+|+||+|++||++-.+|.+.+ -+.+..+.+++..+.+|+++.|..| .|||||||+|||||.+
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD 765 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC
Confidence 999999999999999999999999999998875 4889999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCC---------CCCCc-------------------------------ceeeecccccCcccchhhcc
Q 015781 217 YNAKLSDFGLAKDGP---------TGSQS-------------------------------HVSTRVMGTYGYAAPEYMAT 256 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~ 256 (400)
|+|||.|||+|+-+. .++.. ......+||+.|+|||++..
T Consensus 766 GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r 845 (1034)
T KOG0608|consen 766 GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR 845 (1034)
T ss_pred CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc
Confidence 999999999997211 00000 00123689999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 257 GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 257 ~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
..|+...|.|+.|||||||+.|++||....+....
T Consensus 846 ~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 846 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred cCccccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999999999999888776443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=255.07 Aligned_cols=276 Identities=24% Similarity=0.335 Sum_probs=220.0
Q ss_pred cHhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCccc
Q 015781 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLV 137 (400)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv 137 (400)
+..++.....++++..++-+|.||.||.|.|.+.+ ...+.+.+.+|.++.... -....++.|...+..+.|||+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 44455556677999999999999999999887642 222344556665543321 2234578899999999999999
Q ss_pred ceeeEEEe-CCeeEEEEeecCCCCHHHHHhh----hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 138 KLIGYCLE-DDHRLLVYEFMPKGSLENHLFR----RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 138 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
.+.++..+ .+..++++.++.-|+|..++.. .....+.++..+...++.|++.|++|||+++ ++|.||...|++
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCv 428 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCV 428 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcce
Confidence 99998764 4678899999999999999973 2223456888888999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
|++..++||+|=.+++..-+.+.............||+||.+.+..|+.++|+||||+++|||+| |+.|+...+|....
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999998777666555555566778999999999999999999999999999998 88898876653322
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
. ++.++..+ .-|.+++++++.++.-||...|++||+++++...|.++..
T Consensus 509 ~-------ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 509 H-------YLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred H-------HHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2 22222222 2356788999999999999999999999999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=284.48 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=172.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeE---
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGY--- 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~--- 142 (400)
..++|.+.+.||+|+||.||+|.+... ....+..||+|.+...... .....+ .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~-----~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNK-----QSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCC-----ccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 346899999999999999999976541 1123789999987643221 111111 1222222233322221
Q ss_pred ---EEeCCeeEEEEeecCCCCHHHHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 015781 143 ---CLEDDHRLLVYEFMPKGSLENHLFRRASY----------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (400)
Q Consensus 143 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 203 (400)
...+..+++||||+.+++|.+++...... ........+..++.||+.||+|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 24566889999999999999998754210 001123456789999999999999988 999
Q ss_pred ccCCCCCEEEcC-CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC----------------------CCC
Q 015781 204 RDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----------------------HLT 260 (400)
Q Consensus 204 ~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 260 (400)
|||||+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 57899999999975433221 223456789999999966322 244
Q ss_pred CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh---hhccccccCC------CCHHHHHHHHHHH
Q 015781 261 AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF---QVMDARIEGQ------YSLGAALKTAVLA 331 (400)
Q Consensus 261 ~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~l~~li 331 (400)
.++|||||||++|||+++..++... ...+............ .......... ..........+|+
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 5679999999999999977654321 1111110000000011 1111100000 0001123455899
Q ss_pred HhcccCCCCCCCCHHHHHHHHH
Q 015781 332 IKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 332 ~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+||+.||++|||+.++|+|=+
T Consensus 431 ~~mL~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAHPY 452 (566)
T ss_pred HHHccCCcccCCCHHHHhCCcC
Confidence 9999999999999999999843
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=239.73 Aligned_cols=207 Identities=26% Similarity=0.344 Sum_probs=171.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
...++...+..||+|++|.|-+- ++..+|...|+|.+...-. +...+.++|+.+..+. .+|.+|++++.
T Consensus 43 V~ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cchhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 34455666788999999999765 5667899999999876432 3445677888877665 79999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+..+..+++.||.+ .-+|..+-.+.-..+..+++..+-+|+..++.||.|||++ ..++|||+||.||||+.+|++|+|
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEc
Confidence 99999999999999 6688887766555557899999999999999999999998 679999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhc----cCCCCCccchhhHHHHHHHHHhCCCccCCC
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 285 (400)
|||++-.....- ..+-..|...|+|||.+. +..|+.++||||||+++.||.+++.||+.+
T Consensus 192 DFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 192 DFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999987543321 122356888999999874 347999999999999999999999999764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=256.45 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccc--cchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+.+..+-||.|+||.||.+ .+..+|+.||+|.+... ++.....+.+|+++|..++|.|++..+++..-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 34566789999999999987 66678999999988653 33445678899999999999999999887653
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
. ..+|+++|++ ..+|..+|... ++++...+.-+++||+.||+|||+.+ |.||||||.|+|++.+..+|
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLK 196 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILK 196 (449)
T ss_pred CCchHHHHHHHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEE
Confidence 3 3467888988 56887777543 67899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++...... ...++..+.|.+|+|||++.+ ..|+.+.||||.|||+.||+..+..|+...+.....++.....
T Consensus 197 ICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 197 ICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred ecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 99999998654433 334555678999999999987 4799999999999999999999999998887766655532110
Q ss_pred --HHhh-----hhhhhhhccccccC-C------C--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 300 --YLQS-----KRRIFQVMDARIEG-Q------Y--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 300 --~~~~-----~~~~~~~~~~~~~~-~------~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... .+....++....+. . + +.....+...++..++.+||++|.+..+.+.++-
T Consensus 276 TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 276 TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0000 00001111111111 0 1 1233445667888999999999999999998753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=282.14 Aligned_cols=248 Identities=29% Similarity=0.423 Sum_probs=188.5
Q ss_pred CCCCCccccCCCce-EEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGC-VFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~ 147 (400)
|.-.+++|.|+-|+ ||+|... |+.||||.+-.+. ..-..+|+..|+.- +|||||++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 45567899999986 6999765 6789999886543 22456899999888 5999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---C--CceEEe
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---N--YNAKLS 222 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~--~~~kl~ 222 (400)
+.||+.|.| ..+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEec
Confidence 999999999 67999999874111111122456788999999999999988 999999999999965 2 468999
Q ss_pred eccCCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhC-CCccCCCCCCccchhHHhhhHH
Q 015781 223 DFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|||+++....+...- ......||.+|+|||++.....+.++|||||||++|+.++| .+||...-.- +.+ .
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------I 725 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------I 725 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------h
Confidence 999999876554322 24557899999999999988888899999999999999987 8999754210 000 0
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+.....+..+ . ... .+ +..+||.+|++++|..||++.+||.|
T Consensus 726 l~~~~~L~~L-----~-~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 726 LTGNYTLVHL-----E-PLP-DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hcCccceeee-----c-cCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111111110 0 001 11 77889999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=271.28 Aligned_cols=281 Identities=19% Similarity=0.210 Sum_probs=186.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCc-------CCCCCCCCcEEEEEEeccccchhHHH--------------HHHHH
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESLQGHLE--------------WLTEI 125 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~e~ 125 (400)
.++|++.++||+|+||+||+|.+..... .......++.||||.+.........+ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 5689999999999999999997532110 11223456789999987543222222 23456
Q ss_pred HHHccCCCCcc-----cceeeEEEe--------CCeeEEEEeecCCCCHHHHHhhhcC--------------------CC
Q 015781 126 KHLGQLYHPNL-----VKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRRAS--------------------YI 172 (400)
Q Consensus 126 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~ 172 (400)
.++.+++|.++ +++++++.. .+..++||||+.+++|.+++..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666665544 566666642 3568999999999999999864321 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccch
Q 015781 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252 (400)
Q Consensus 173 ~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 252 (400)
..+++..++.++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++......... ......+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 23467788999999999999999988 999999999999999999999999999754332211 111223478999999
Q ss_pred hhccCC--------------------C--CCccchhhHHHHHHHHHhCCC-ccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 253 YMATGH--------------------L--TAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 253 ~~~~~~--------------------~--~~~sDiwslG~il~~l~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
.+.... | ..+.||||+||++|+|++|.. ||......... ...+ ......+..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~----~~~~~~~r~ 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQY----DNDLNRWRM 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhc----cchHHHHHh
Confidence 875322 1 124699999999999999875 66532211100 0000 000000001
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHHHHhc
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEP---KFRPTMDEVVKALEQI 355 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~eil~~L~~~ 355 (400)
..............+....+|+.+||..+| .+|+|+.++|+|-+..
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 111111111123456788899999999866 6899999999986654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.49 Aligned_cols=271 Identities=21% Similarity=0.206 Sum_probs=206.4
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC------CCcc
Q 015781 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY------HPNL 136 (400)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------hpni 136 (400)
......+|.+....|+|-|++|.+|... .-|..||||+|...... +..=+.|+++|++|+ --|+
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~---------~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQ---------ARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeecccc---------CCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 3456678999999999999999999543 34679999999876543 233457999999995 2479
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
++++-.|...+++|||+|-+ ..+|.+++++.+.. -.+....+..++.|++.||..|-..| |+|.||||+|||+++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccC
Confidence 99999999999999999998 77999999987643 45788899999999999999999988 9999999999999865
Q ss_pred -CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 217 -YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
..+||||||.|......... ....+..|.|||++.|-.|+...|+||.||+||||+||+..|.+......+.+.-
T Consensus 573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 56899999999876554422 2345677999999999999999999999999999999999999876543332221
Q ss_pred hh-----hHHHhhhhhhhhhcccccc----------------------------------CCCC---HHHHHHHHHHHHh
Q 015781 296 WA-----KPYLQSKRRIFQVMDARIE----------------------------------GQYS---LGAALKTAVLAIK 333 (400)
Q Consensus 296 ~~-----~~~~~~~~~~~~~~~~~~~----------------------------------~~~~---~~~~~~l~~li~~ 333 (400)
.. ...+....-..+-++..+. ..++ ......+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 00 0001111111111111100 0122 2345667889999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 015781 334 CLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 334 ~l~~dP~~Rps~~eil~~ 351 (400)
||..||++|.|+.++|+|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=234.03 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=197.9
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~ 143 (400)
...++|++.+.+|+|-|+.||.| .+..+.+.++||+++... ...+.+|+.+|+.|. ||||++++++.
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 34578999999999999999998 444567889999997643 456789999999997 99999999999
Q ss_pred EeC--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceE
Q 015781 144 LED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 220 (400)
Q Consensus 144 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~k 220 (400)
.+. ....+|+||+.+.+...+. +.++...+..++.+++.||.|+|+.| |+|||+||.|++|+.. -.++
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred cCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceee
Confidence 865 4568999999887776654 34777889999999999999999988 9999999999999864 5699
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCC-CCccchhH----
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-PSREHNLI---- 294 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~-~~~~~~~~---- 294 (400)
|+|+|+|.+..++.... -.+.+..|.-||++. .+.|+..-|+|||||++..|+..+.||.... ..+..-.+
T Consensus 174 lIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 99999999877655432 245678899999885 4678999999999999999999998875433 32322221
Q ss_pred ------HhhhHHH-hhhhhhhhhcccccc--------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 295 ------EWAKPYL-QSKRRIFQVMDARIE--------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 295 ------~~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.+...+- .-...+..++..-.+ ..-..-.+.+..+|+.++|..|-.+|+|++|++.|-
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 1111110 000001111111000 001112357888999999999999999999999873
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=261.28 Aligned_cols=199 Identities=24% Similarity=0.316 Sum_probs=170.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH--------HHHHHHHHHHccCC---CC
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--------LEWLTEIKHLGQLY---HP 134 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~e~~~l~~l~---hp 134 (400)
...+|...+.+|+|+||.|++|..+ .+...|++|.+.++..-.. -.+-.|+.+|..++ |+
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K---------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~ 629 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHK---------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE 629 (772)
T ss_pred ccccceeeeeccccccceEEEeeec---------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence 3456999999999999999999544 4577899999987654211 12456899999997 99
Q ss_pred cccceeeEEEeCCeeEEEEeec-CCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 135 NLVKLIGYCLEDDHRLLVYEFM-PKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 135 niv~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
||++++++|++++++||+||-. +|-+|.++|..+. .+++....-|+.||+.|+++||+.| |||||||-+|+.+
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv 703 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV 703 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC--ceecccccccEEE
Confidence 9999999999999999999976 4568999998764 5899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccC
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVID 283 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~ 283 (400)
+.+|-+||+|||.+.....+. ...++||..|.|||++.+..| ...-|||+||+++|.++....||.
T Consensus 704 d~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999997655443 456789999999999998887 566899999999999999988874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=264.77 Aligned_cols=255 Identities=26% Similarity=0.322 Sum_probs=208.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|.+...+|.|+||.||++ +++.+++..|+|+++.+...+..-+.+|+.+++..+||||+.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 367999999999999999999 55568999999999988777777777899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+++.||||.||+|++.-.-. .++++.++..+++..+.||+|||+.| -+|||||-.||++++.|.+|++|||.
T Consensus 85 dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred cCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCc
Confidence 9999999999999999876544 57999999999999999999999988 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeecccccCcccchhh---ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+-..... ......+.||+.|||||+- ..+.|...+|||++|++..||---++|.....+.....+..
T Consensus 159 saqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-------- 228 (829)
T KOG0576|consen 159 SAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-------- 228 (829)
T ss_pred hhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--------
Confidence 8754332 2234568899999999976 45689999999999999999988888866555543332221
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
+..... ....-...-+..+.+|++.+|..+|++||++..+|.|
T Consensus 229 kS~~qp-----p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 229 KSGFQP-----PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCCCC-----CcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 000000 0011122345567789999999999999999887753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=239.49 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=196.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..+|.-.+.+|.|.- .|..|. +...++.||+|...... .....+..+|+..+..++|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~---------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAF---------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecc---------hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 356777888899887 666653 33467889999876542 123445678999999999999999999885
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
-. ...|+|||++ ..+|...+.. .++-..+..|+.|+++|++|||+.| |+||||||+||++..+..
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhh
Confidence 33 4579999999 6799888873 3677889999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh--
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-- 296 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-- 296 (400)
+||.|||+++..... -..+..+.|..|+|||++.+..|...+||||+||++.||++|+..|.+.+..+....+..
T Consensus 157 lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred eeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 999999999864332 245667889999999999888899999999999999999999999987765443322210
Q ss_pred --------------hhHHHhhh-----hhhhh-hccccccCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 --------------AKPYLQSK-----RRIFQ-VMDARIEGQ--YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 --------------~~~~~~~~-----~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+.+.... ..+.. ..|...... .+......+.+++.+||-.||++|.|++++|.|
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000 00000 001011111 111234567779999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=227.18 Aligned_cols=212 Identities=39% Similarity=0.575 Sum_probs=182.5
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEe
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 154 (400)
||+|++|.||++.... ++..+++|++...... ....+.+|+..++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999996542 5788999999876543 23568899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEeeccCCccCCCC
Q 015781 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTG 233 (400)
Q Consensus 155 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 233 (400)
++.+++|.+++.... ..++...++.++.+++.+|++||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 999899999987653 35789999999999999999999988 999999999999999 899999999999865443
Q ss_pred CCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcc
Q 015781 234 SQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312 (400)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (400)
.. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 21 12334578889999999777 888999999999999998
Q ss_pred ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 313 ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 313 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
..+.+++.+||+.+|.+||++.++++++
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3566799999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=229.13 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=191.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeE-EE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY-CL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~-~~ 144 (400)
.+.|.+.+.||+|.||.+-++ .|..+...+++|.+..... ...+|.+|...--.| .|.||+..+++ |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 457999999999999999998 6777899999999987653 456788888765555 58999998864 66
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc--CCCceEEe
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLS 222 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~ 222 (400)
..+.+++++||++.|+|..-+... .+.+.....++.|++.||.|||+++ +||||||.+||||- +...+||+
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEee
Confidence 778889999999999998877553 4788999999999999999999999 99999999999993 34579999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhcc---C--CCCCccchhhHHHHHHHHHhCCCccCCCCCC--ccchhHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---G--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS--REHNLIE 295 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~--~~~~~~~ 295 (400)
|||..+..... .....-+..|.+||+... + ...+.+|+|.||+++|.++||..||+..... ......+
T Consensus 166 DFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 166 DFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred ecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence 99998764332 122334667999997632 2 2367899999999999999999999854322 1122223
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHHHHhc
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR---PTMDEVVKALEQI 355 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~eil~~L~~~ 355 (400)
|...... .... .-...+..+..+.++-|..+|++| .+++...+.++.-
T Consensus 241 w~~rk~~-----------~~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 241 WLKRKNP-----------ALPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HhcccCc-----------cCch-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 3221111 0000 011345677889999999999999 6666666666553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=236.94 Aligned_cols=272 Identities=25% Similarity=0.297 Sum_probs=200.9
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceee
Q 015781 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
++...+.|..++.||+|+|++||++.+.. .......||+|.+...+ ....+.+|+++|..+ -+.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchh
Confidence 45566789999999999999999997653 13357899999987654 344678999999998 4899999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAK 220 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~k 220 (400)
.+..++...+||||++.....++.. .++...+..+++.++.||+++|.+| ||||||||.|++.+. .+.-.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCce
Confidence 9999999999999999999988874 3678889999999999999999999 999999999999964 56789
Q ss_pred EeeccCCccC-----------------CC--CC-----------------------CcceeeecccccCcccchhhc-cC
Q 015781 221 LSDFGLAKDG-----------------PT--GS-----------------------QSHVSTRVMGTYGYAAPEYMA-TG 257 (400)
Q Consensus 221 l~Dfg~~~~~-----------------~~--~~-----------------------~~~~~~~~~gt~~y~aPE~~~-~~ 257 (400)
|+|||++... .. +. .........||++|+|||++. ..
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 9999998710 00 00 000112357999999999885 45
Q ss_pred CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH---------------------HhhhHH----Hhhhhhhhhhc-
Q 015781 258 HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI---------------------EWAKPY----LQSKRRIFQVM- 311 (400)
Q Consensus 258 ~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~---------------------~~~~~~----~~~~~~~~~~~- 311 (400)
..++++||||.|+|+..++++..||-.....-..... .|.... ......+..+.
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 6789999999999999999999998655432211110 000000 00000000110
Q ss_pred c---c-----cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 312 D---A-----RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 312 ~---~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. + ..........+..+++|+.+||..||.+|.|+++.|+|
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 0 00011122345588999999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=222.37 Aligned_cols=200 Identities=35% Similarity=0.455 Sum_probs=172.0
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
|.+.+.||.|++|.||++.... ++..+++|.+...... ....+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5677899999999999996543 5788999999876554 55678889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++++|++.+++|.+++..... .+++..++.++.+++.+|.+||+++ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999876531 2789999999999999999999988 9999999999999999999999999988
Q ss_pred cCCCCCCcceeeecccccCcccchhh-ccCCCCCccchhhHHHHHHHHHhCCCccCC
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 284 (400)
....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 6544320 012335678889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=258.57 Aligned_cols=199 Identities=21% Similarity=0.240 Sum_probs=139.3
Q ss_pred CCC-CcccceeeEE-------EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 015781 131 LYH-PNLVKLIGYC-------LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (400)
Q Consensus 131 l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 202 (400)
++| .||.+++++| .+...++++||++ +++|.+++.... .++++..++.++.||+.||+|||++| |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 345 5777777776 2334667789987 779999997542 46899999999999999999999988 99
Q ss_pred eccCCCCCEEEcCCCce-------------------EEeeccCCccCCCCCC--------------cceeeecccccCcc
Q 015781 203 YRDFKTSNILLDLNYNA-------------------KLSDFGLAKDGPTGSQ--------------SHVSTRVMGTYGYA 249 (400)
Q Consensus 203 H~dlkp~Nill~~~~~~-------------------kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~ 249 (400)
||||||+||||+..+.+ |++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999655544 4555555442110000 00011245788999
Q ss_pred cchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHH
Q 015781 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV 329 (400)
Q Consensus 250 aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 329 (400)
|||++.+..|+.++|||||||++|||++|.+|+..... .+ .. ... ...... ..........
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~---~~-~~~-----~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM---SS-LRH-----RVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH---HH-HHH-----hhcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999888643211 00 00 000 000000 0111234567
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 330 LAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 330 li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
++.+||+.+|.+||++.+++++-+.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhchhh
Confidence 8889999999999999999987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=204.48 Aligned_cols=168 Identities=23% Similarity=0.210 Sum_probs=127.7
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcce
Q 015781 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (400)
Q Consensus 159 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 238 (400)
|+|.+++.... .++++..++.++.||+.||+|||+++ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997654 46999999999999999999999864 999999999999999 99987643321
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcccccc-C
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE-G 317 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 317 (400)
..|++.|+|||++.+..++.++|||||||++|+|++|..||......... ... ... ........ .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~---~~~------~~~~~~~~~~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEI---LLN------GMPADDPRDR 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHH---HHH------HhccCCcccc
Confidence 25889999999999999999999999999999999999999654321110 000 000 00000000 0
Q ss_pred CCCHHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 318 QYSLGAAL--KTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 318 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
........ .+.+++.+||+.+|.+||++.++++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11122333 68999999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=205.28 Aligned_cols=265 Identities=18% Similarity=0.222 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 146 (400)
-.|++.+.||+|+||.++.| ++.-+++.||||...... ..-++..|.+..+.| ..++|..++-+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecc---------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 46999999999999999999 666789999999876543 233566788777777 478999999888888
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-----CceEE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-----YNAKL 221 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-----~~~kl 221 (400)
-+-.||||++ |-+|.|+....+ ..++.+.+..++.||+.-++|+|.+. +|.|||||+|+||... ..|.+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEE
Confidence 8889999999 899999998776 67999999999999999999999998 9999999999999643 45899
Q ss_pred eeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 222 SDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+|||+|+...+.... .......||.+||+-....+.+.+.+.|+-|||=++++++-|..||++..-......-
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-- 248 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-- 248 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH--
Confidence 999999976554322 2234578999999999999999999999999999999999999999886532221111
Q ss_pred hhHHHhhhhhhhhhccccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 297 AKPYLQSKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..+-+....- .+-...+.++..-+.-.=..+-.+-|...-+...+..+.+..+..
T Consensus 249 -----------eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t 306 (449)
T KOG1165|consen 249 -----------EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET 306 (449)
T ss_pred -----------HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence 1111111000 011123444455444444557777788887777666665544443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-26 Score=213.65 Aligned_cols=265 Identities=22% Similarity=0.212 Sum_probs=198.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC----CcccceeeEE-
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH----PNLVKLIGYC- 143 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----pniv~~~~~~- 143 (400)
+|.+.+.||+|+||.||++..... ....+|+|............+..|..++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~--------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE--------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC--------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999966431 046789998876543333256677777777752 5899999988
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-----Cc
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-----YN 218 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-----~~ 218 (400)
..+.+.|+||+.+ |.+|.++..... ...++...++.|+.|++.+|++||+.| ++||||||.|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccce
Confidence 5778899999998 999999886665 367999999999999999999999988 9999999999999755 46
Q ss_pred eEEeeccCCccCC--CCCCc----c-e-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 219 AKLSDFGLAKDGP--TGSQS----H-V-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 219 ~kl~Dfg~~~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
+.|+|||+++... ..... . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|..||........
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 9999999998322 11110 0 1 1235699999999999999999999999999999999999999966553322
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
....... .............+..+..+...+-..+...+|....+...|+......
T Consensus 246 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKFEKD-------------PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHH-------------hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111100 0000000011223345555666666689999999999999988876665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=192.14 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=195.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC-CcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~ 144 (400)
...+|++++.||.|+||.+|+| .+..+|..||+|+..... ....+.-|.++.+.|++ ..|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3468999999999999999999 566689999999876543 23356678888888864 68888888889
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC---CceEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAKL 221 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~kl 221 (400)
+..+-.+||+++ |-+|.++..-.. ..++.+.++-++-|++.-++|+|.++ .+||||||+|+|..-+ ..+.|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence 999999999999 889999987554 46889999999999999999999998 9999999999999643 56899
Q ss_pred eeccCCccCCCCCC-----cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 222 SDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+|||+++...+... ........||..|.+-..+.+...+.+.|+-|+|.++.++.-|..||++..........+
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE- 234 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE- 234 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-
Confidence 99999986543221 122345789999999988888888999999999999999999999999875432221111
Q ss_pred hhHHHhhhhhhhhhccccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+.+....-. +-...+.++.-.+.-|=..--++-|...-+-+.+..+
T Consensus 235 ------------kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 235 ------------KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred ------------HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1111111100 0112344555566667666777777766655554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=207.96 Aligned_cols=177 Identities=20% Similarity=0.154 Sum_probs=132.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-----chhHHHHHHHHHHHccCCCCccccee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
...+|.+.+.||+|+||+||+|..... ++..+|+|++.... ......+.+|+++|++++|+|++..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 446899999999999999999965421 46778999875331 11244588999999999999998633
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-CCCCEEEcCCCce
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNYNA 219 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl-kp~Nill~~~~~~ 219 (400)
.. .+..|+||||++|++|.. +. +.. ...++.|++.+|.|||++| |+|||| ||+|||++.++.+
T Consensus 88 ~~---~~~~~LVmE~~~G~~L~~-~~-------~~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 88 LA---TGKDGLVRGWTEGVPLHL-AR-------PHG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EE---cCCcEEEEEccCCCCHHH-hC-------ccc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCE
Confidence 22 245799999999999963 21 111 1457889999999999988 999999 9999999999999
Q ss_pred EEeeccCCccCCCCCCcce------eeecccccCcccchhhccC------CCCCccchh
Q 015781 220 KLSDFGLAKDGPTGSQSHV------STRVMGTYGYAAPEYMATG------HLTAKSDVY 266 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~sDiw 266 (400)
+|+|||+++.......... .....+++.|+|||.+... ..+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999986544321111 1346788899999988532 233446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=228.94 Aligned_cols=260 Identities=22% Similarity=0.252 Sum_probs=187.0
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEe-ccccchhH-HHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~-~~~~~~~~-~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
....++|.|++|.|+.+..... ........+++| . ........ ..+..|+.+-..+.|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~----~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD----LKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCC----Cccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 5678899999997776643221 000111222222 1 11111111 125668888888999999988887777666
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.+-+||||++ +|..++... ..+....+..++.|++.|++|||..| |.|||||++|++++.+|.+||+|||.+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred chhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcce
Confidence 6666999998 999998765 24778888999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCCc--ceeeecccccCcccchhhccCCCCC-ccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 229 DGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTA-KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 229 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
........ ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+..... ....
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~ 541 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYS 541 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hccc
Confidence 65544433 4566789999999999999999976 589999999999999999999766544332100 0000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..... ..-...+....+.....++.+||+.||.+|.|+++|++-
T Consensus 542 ~~~~~--~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 542 DQRNI--FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccc--ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000 000011122345567779999999999999999999984
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-23 Score=192.07 Aligned_cols=261 Identities=30% Similarity=0.418 Sum_probs=196.1
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCC-cccceeeEEEe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHP-NLVKLIGYCLE 145 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hp-niv~~~~~~~~ 145 (400)
|.+.+.||.|+||.||++... ..+++|.+....... ...+.+|+..++.+.|+ +|+++.+.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999999543 568999887765432 55688899999999988 79999999987
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~Df 224 (400)
....+++++++.++++.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEecc
Confidence 77789999999999999776654311 25889999999999999999999988 99999999999999988 7999999
Q ss_pred cCCccCCCCCCcc----eeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc-cchhHHh
Q 015781 225 GLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR-EHNLIEW 296 (400)
Q Consensus 225 g~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~ 296 (400)
|.+.......... ......|+..|++||.+.+ ..+....|+|++|++++++++|..||....... .......
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9997544332221 2355789999999999987 578899999999999999999999976554310 0000000
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. ...... .................+.+++.+|+..+|..|.+..+....
T Consensus 227 ~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 I---LELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred H---HhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000000000002223567789999999999999999888775
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=183.43 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=194.1
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.+...|.+...|..|+|+|.. ..+++|++....... ...|..|.-.|+-+.||||+.+++.|....
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 4455678999999999998864 347778776654332 345778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe--ecc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS--DFG 225 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~--Dfg 225 (400)
++.++..|++-|+|+..+....+ -.++..+..+++.+|+.|++|||+..+-|.---|....++||++.+.+|. |--
T Consensus 261 nlv~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred CceEeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence 99999999999999999987654 34677888999999999999999987555556788999999998877663 332
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCC---CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL---TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++... ....-.|.|++||.+....- -.++|+|||++++|||.|...||....+..-...+
T Consensus 339 fsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------- 401 (448)
T KOG0195|consen 339 FSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------- 401 (448)
T ss_pred eeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------
Confidence 22211 11234788999999965443 24789999999999999999999887664322222
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
--..++...++..+.....|+.-|++.||.+||.+..|+-.||+++
T Consensus 402 --------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 --------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1123445567777888889999999999999999999999998874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=214.68 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=179.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc----chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.|...+.||.+.|=.|.+|..++ |. |++|++-+.. +....+.+.|++ ...+++||.+.+..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57788999999999999986543 43 8899876543 223334445555 55668999999988887
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
.+...|||-+|+ ..+|+|.+..+. -+...+.+.|+.|++.||..+|..| |+|||||.+||||+.-+.+.|+||
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcc
Confidence 777888998998 569999987653 3677788999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCC-----CCcceeeecccccCcccchhhccC-----------CCCCccchhhHHHHHHHHHh-CCCccCCCCC
Q 015781 225 GLAKDGPTG-----SQSHVSTRVMGTYGYAAPEYMATG-----------HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRP 287 (400)
Q Consensus 225 g~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDiwslG~il~~l~t-g~~pf~~~~~ 287 (400)
..-+..-.. +......+...-.+|.|||.+... ..+++.||||+||+++||++ |++||.-.+
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ- 243 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ- 243 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-
Confidence 876542221 222222333344689999987431 15678999999999999988 577785211
Q ss_pred CccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
+..+.... .......+.. + ....+..++..|++.||.+|.|+++.|+...
T Consensus 244 -----L~aYr~~~---~~~~e~~Le~-I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 -----LLAYRSGN---ADDPEQLLEK-I-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -----HHhHhccC---ccCHHHHHHh-C-------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111100 0001111111 1 1125678999999999999999999999743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=182.14 Aligned_cols=174 Identities=13% Similarity=0.066 Sum_probs=133.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHH---------HHHHHHHHccCCCC
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---------WLTEIKHLGQLYHP 134 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~hp 134 (400)
.....+|++.++||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.|+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 45678999999999999999998632 24469999997654333222 57899999999999
Q ss_pred cccceeeEEEeC--------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 015781 135 NLVKLIGYCLED--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (400)
Q Consensus 135 niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 206 (400)
+|..+.+++.+. ...+++|||++|.+|.++.. +++ ....+++.+|..||..| ++|+|+
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g--i~H~Di 161 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG--MVSGDP 161 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 999999886643 35789999999999987631 222 24568899999999998 999999
Q ss_pred CCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh
Q 015781 207 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277 (400)
Q Consensus 207 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 277 (400)
+|.||+++.++ ++|+|||........... ...+....|+.++|+|+||+++..+..
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999999988 999999987654221110 113345567789999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=208.34 Aligned_cols=257 Identities=18% Similarity=0.172 Sum_probs=185.5
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
......|.|.+.||+|+||+||.|.. .. |+.||+|+-........--..+-..+|+..--+.|.++...+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~---------~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATH---------SN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeec---------CC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHH
Confidence 44556788899999999999999943 22 899999998876643221111222233211235677777777
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-------CC
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-------LN 216 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-------~~ 216 (400)
...+.-++|+||.+-|+|.+++... ..+++..++.+..||+..|++||..+ |||+||||+|++|. ..
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcc
Confidence 7777789999999999999999843 56899999999999999999999988 99999999999993 24
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
..++|+|||.+.....-.........++|-.+-++|+..|..|++..|.|.|+.+++.|+.|++-=
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------- 903 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------- 903 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------
Confidence 569999999998655444444566678899999999999999999999999999999999997421
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
........+...+.+- ...+-+.+++..+|+.|=..=|.+.++...|+.+-...
T Consensus 904 ------~~~g~~~~~~~~~~Ry---~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 904 ------VKNGSSWMVKTNFPRY---WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ------hcCCcceeccccchhh---hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0000001111111111 11223444666777744444488888888887765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=183.83 Aligned_cols=235 Identities=21% Similarity=0.251 Sum_probs=150.2
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCC----------CCc
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY----------HPN 135 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~----------hpn 135 (400)
.+...+.||.|+|+.||.+.+ ..|++.+|+|++..... ...+++.+|.-....+. |-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d---------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTD---------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEE---------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 455667899999999999954 44899999998765442 23445556655554432 222
Q ss_pred ccceeeEEE---------eC---C-----eeEEEEeecCCCCHHHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 015781 136 LVKLIGYCL---------ED---D-----HRLLVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLAYLH 195 (400)
Q Consensus 136 iv~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~qi~~~l~~LH 195 (400)
++-.++... .. . ..+++|+-+ .++|.+++.. ......++.....+.+..|++..+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 333333322 11 1 236788877 6788888653 2221123445566778899999999999
Q ss_pred cCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC--------CCCCccchhh
Q 015781 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--------HLTAKSDVYS 267 (400)
Q Consensus 196 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDiws 267 (400)
..| ++|+||+|+|++++.+|.++|+||+........ ......+..|.+||..... .++.+.|.|+
T Consensus 163 ~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 SYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp HTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred hcc--eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 998 999999999999999999999999887654321 1113445789999977432 4788999999
Q ss_pred HHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 015781 268 FGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342 (400)
Q Consensus 268 lG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 342 (400)
||+++|.|+++..||....+...... .-.... ..++.+..||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999976543211110 011223 677889999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=173.28 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=106.9
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--h-------H-----------------HHHHHHHH
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--G-------H-----------------LEWLTEIK 126 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~ 126 (400)
...||+|+||.||+|.. . +|+.||+|++...... . . .....|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~---------~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATT---------A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEEC---------C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 46899999999999943 2 5899999998764221 0 0 11234889
Q ss_pred HHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecc
Q 015781 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVIYRD 205 (400)
Q Consensus 127 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~ivH~d 205 (400)
.+.++.++++.....+... ..+|||||++|+++...+... .+++...+..++.|++.+|.+| |+.| |+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR--LVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence 9999988877544433222 238999999888776553332 3578899999999999999999 6888 99999
Q ss_pred CCCCCEEEcCCCceEEeeccCCccC
Q 015781 206 FKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 206 lkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
|||+||+++ ++.++|+|||++...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=165.94 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=108.6
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---------------------h-----HHHHHHHHH
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------------------G-----HLEWLTEIK 126 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~ 126 (400)
.+.||+|+||.||+|.. . +|..||+|++...... . ...+..|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~---------~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHART---------G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEc---------C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 46899999999999943 2 5899999998765211 0 112346889
Q ss_pred HHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeecc
Q 015781 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRD 205 (400)
Q Consensus 127 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~d 205 (400)
.+.++.|+++.....+.... .||||||++|+++....... .+++......++.|++.++.+||. .| |+|||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrD 143 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGD 143 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCC
Confidence 99999999886555444332 48999999887554432222 246788899999999999999999 88 99999
Q ss_pred CCCCCEEEcCCCceEEeeccCCccCC
Q 015781 206 FKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 206 lkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
|||+||+++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 8899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=191.51 Aligned_cols=229 Identities=28% Similarity=0.350 Sum_probs=181.9
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH--HHHHHHHHHHccCC-CCcccceeeEEEeCCeeEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 151 (400)
++|+|.||.|+++.-- .....|..+|.|+......... .....|..++...+ ||.++++...++.+...++
T Consensus 1 vlg~g~~gkvfLvrk~------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHh------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 4799999999987422 3444677888888776543221 12335667777776 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
++++..||.|...+.... -+.+.....+...++.+++++|+.+ ++|||+|++||+++.+|++++.|||+.+..-
T Consensus 75 ~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhH
Confidence 999999999988776654 3677788888899999999999988 9999999999999999999999999998644
Q ss_pred CCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhc
Q 015781 232 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311 (400)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (400)
.... .+||..|||||++. ....++|-||||+++++|+||..||... .+..++
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il 200 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRIL 200 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHh
Confidence 3322 18999999999997 5678999999999999999999999750 011111
Q ss_pred cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 015781 312 DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 345 (400)
Q Consensus 312 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 345 (400)
. .+...+...+....+++..++..+|.+|.-.
T Consensus 201 ~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 K--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1234566778888889999999999999744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=160.33 Aligned_cols=188 Identities=17% Similarity=0.119 Sum_probs=137.4
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh----HHHHHHHHHHHccCC-CCcccceeeEEEe
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----HLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-hpniv~~~~~~~~ 145 (400)
-+...|+.|+||+||++.. .+..++.+.+.....-. ...+.+|+++|++|. |++|.+++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3567899999999997632 35677777665543311 124678999999995 5889999886
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC-CCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl-kp~Nill~~~~~~kl~Df 224 (400)
+..+++|||+.|.+|...+.. . ...++.|++.+|+++|.+| |+|||| ||+||+++.++.++|+||
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEEC
Confidence 346999999999998654311 1 1346788999999999998 999999 799999999999999999
Q ss_pred cCCccCCCCCCc----ce-------eeecccccCcccchhhcc-CCCC-CccchhhHHHHHHHHHhCCCccCCCC
Q 015781 225 GLAKDGPTGSQS----HV-------STRVMGTYGYAAPEYMAT-GHLT-AKSDVYSFGVVLLEMLSGRRVIDKNR 286 (400)
Q Consensus 225 g~~~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~-~~~~-~~sDiwslG~il~~l~tg~~pf~~~~ 286 (400)
|++......... .. ......++.|+.|+...- ...+ .+.+.++.|+-+|.++|+..|+-...
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 999865433211 00 011235777888875421 1223 56788999999999999998875543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=161.50 Aligned_cols=135 Identities=19% Similarity=0.185 Sum_probs=104.1
Q ss_pred CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-----CCCcccceeeEEEeC
Q 015781 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-----YHPNLVKLIGYCLED 146 (400)
Q Consensus 72 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~ 146 (400)
-.+.||+|+||.||. + +.++.. +||++..........+.+|+.+++.+ +||||++++++++++
T Consensus 6 ~~~~LG~G~~~~Vy~---h--------p~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA---H--------PEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE---C--------CCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 356899999999995 1 123444 69988765444556788999999999 579999999999987
Q ss_pred C---eeE-EEEee--cCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeeeccCCCCCEEEcC----
Q 015781 147 D---HRL-LVYEF--MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL-AYLHSDKAKVIYRDFKTSNILLDL---- 215 (400)
Q Consensus 147 ~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~ivH~dlkp~Nill~~---- 215 (400)
. .++ +|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+||+++.
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISES 144 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCC
Confidence 4 434 78999 4579999999653 24444 35577888777 9999998 999999999999964
Q ss_pred CCceEEeeccCC
Q 015781 216 NYNAKLSDFGLA 227 (400)
Q Consensus 216 ~~~~kl~Dfg~~ 227 (400)
++.++|+||+.+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 347999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=176.65 Aligned_cols=220 Identities=26% Similarity=0.388 Sum_probs=165.0
Q ss_pred HccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 015781 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (400)
Q Consensus 128 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 207 (400)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.... ..+++.....++.+|+.||+|||.--. ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeec
Confidence 467889999999999999999999999999999999998744 578999999999999999999998642 2899999
Q ss_pred CCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCC-------CCCccchhhHHHHHHHHHhCCC
Q 015781 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-------LTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 208 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDiwslG~il~~l~tg~~ 280 (400)
..|++++....+||.|||+.................-...|.|||++.+.. .+.+.||||+|++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987654311111111122345699999997641 4667999999999999999999
Q ss_pred ccCCCCCCcc-chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 281 VIDKNRPSRE-HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 281 pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
||........ ..++.+... .......+.+... ......+..++.+||..+|.+||++..+-..++.+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9986543322 222222111 0001111111100 133347888999999999999999999999998876543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=179.00 Aligned_cols=178 Identities=25% Similarity=0.346 Sum_probs=132.0
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
.++||.|++|...+|.++|..+.. ....+....+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhh
Confidence 367899999999999999975443 2456888899999999999999 67 99999999999999999999999999
Q ss_pred CccCCCCC----CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHH
Q 015781 227 AKDGPTGS----QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 227 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
........ .....+...||..||+||.+.+..|+.++||||||++++||+. =...|..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------------- 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------------- 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------
Confidence 98655443 2223556789999999999999999999999999999999988 2222211
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
...+..+.+..+.+.+. ..-..-+.|+.+++.+.|.+||++.+..-
T Consensus 466 --~~t~~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 466 --IATLTDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred --HHhhhhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHHHHhh
Confidence 11111111111110000 11123456899999999999996555443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=165.42 Aligned_cols=199 Identities=19% Similarity=0.227 Sum_probs=141.8
Q ss_pred CCCcccceeeEEEe---------------------------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 015781 132 YHPNLVKLIGYCLE---------------------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184 (400)
Q Consensus 132 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 184 (400)
.|||||+++.+|.+ ...+|+||..+ ..+|..++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887743 23579999988 569999986643 5667777889
Q ss_pred HHHHHHHHHhhcCCCCeeeccCCCCCEEEc--CC--CceEEeeccCCccCCCC----CCcceeeecccccCcccchhhcc
Q 015781 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LN--YNAKLSDFGLAKDGPTG----SQSHVSTRVMGTYGYAAPEYMAT 256 (400)
Q Consensus 185 ~qi~~~l~~LH~~~~~ivH~dlkp~Nill~--~~--~~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 256 (400)
.|+++|+.|||.+| |.|||+|.+|||+. +| ..++|+|||.+--.... ......-...|...-||||+...
T Consensus 348 aQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999999 99999999999993 33 45899999976432110 01111123457788999998853
Q ss_pred CC-----C-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHH
Q 015781 257 GH-----L-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 330 (400)
Q Consensus 257 ~~-----~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 330 (400)
.. . -.++|.|+.|.+.||+++...||.+....-. +. + . .....-+.++..++..+.++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~----r-------~----Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DT----R-------T----YQESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-ch----h-------h----hhhhhCCCCcccCChHHHHH
Confidence 21 1 2479999999999999999999976322110 00 0 0 11111223455667788889
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHh
Q 015781 331 AIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 331 i~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+..+|+.||.+|++..-....|.-
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHHH
Confidence 999999999999998776665544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=155.12 Aligned_cols=148 Identities=18% Similarity=0.156 Sum_probs=110.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------------------------hHHH
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------------GHLE 120 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~ 120 (400)
....-|.+.+.||+|+||.||+|.+ +..+|..||+|++...... ....
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 3344689999999999999999952 2336889999998754210 0112
Q ss_pred HHHHHHHHccCCCCc--ccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 015781 121 WLTEIKHLGQLYHPN--LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK 198 (400)
Q Consensus 121 ~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 198 (400)
+..|+..+.++.+.+ +.++++ .. ..++||||+.|.+|...+... .++....+..++.||+.+|++||.+|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeE---ec-CceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 457999999987532 333343 22 358999999998886654322 23556667899999999999999854
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
.++|+||||+||+++ ++.++|+|||.+...
T Consensus 169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 399999999999999 889999999988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=180.29 Aligned_cols=209 Identities=24% Similarity=0.324 Sum_probs=143.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|..+++|..|+||.||++ +|+.+.+.+|+| +++..+.- .+ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeee---------eccccccchhhc-ccccchhh----hc---cccccCCccee----------
Confidence 57889999999999999998 555578889994 44433210 01 22223334333
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
|+-..+++..+ +++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.
T Consensus 136 -----------gDc~tllk~~g----~lPvd--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIG----PLPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred -----------chhhhhcccCC----CCcch--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhh
Confidence 33333333222 23322 267899999987 999999999999999999999999998
Q ss_pred ccCCCCCCc------------c-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 228 KDGPTGSQS------------H-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 228 ~~~~~~~~~------------~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
+..-..... . .....+||+.|.|||++.-..|...+|.|++|+|+|+++-|..||.+..+......+
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 742111100 0 012358999999999999999999999999999999999999999988664332211
Q ss_pred HhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 015781 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 343 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 343 (400)
. .+...+.+- ......+..+++.++|+.+|..|-
T Consensus 271 i------sd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 I------SDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h------hhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 111111110 112345777899999999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=150.65 Aligned_cols=134 Identities=18% Similarity=0.248 Sum_probs=111.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+.||+|++|.||+|.+. |..+++|+....... ....+.+|+.++..+.|++|.....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999652 566889976543221 12346789999999999998888777777
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..+++|||++|++|.+++.... . ....++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECC
Confidence 788899999999999999886432 1 77889999999999999988 99999999999999 7899999999
Q ss_pred CCcc
Q 015781 226 LAKD 229 (400)
Q Consensus 226 ~~~~ 229 (400)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=148.69 Aligned_cols=130 Identities=19% Similarity=0.291 Sum_probs=104.7
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.||+|+||.||+|.+ .+..+++|........ ....+.+|+.++..+.|+++....-++.+.
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999964 2567889985542211 123466899999999988776666566667
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||++|++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCC
Confidence 77899999999999998875431 078899999999999988 99999999999999 88999999998
Q ss_pred Ccc
Q 015781 227 AKD 229 (400)
Q Consensus 227 ~~~ 229 (400)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=144.75 Aligned_cols=141 Identities=17% Similarity=0.086 Sum_probs=107.4
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch----------------------hHHHHH
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------------------GHLEWL 122 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~ 122 (400)
.....|.+.+.||+|+||.||++... +|..+|+|++...... ......
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQ 81 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHH
Confidence 33445888999999999999998542 5889999987653210 011245
Q ss_pred HHHHHHccCCCCc--ccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 015781 123 TEIKHLGQLYHPN--LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 200 (400)
Q Consensus 123 ~e~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ 200 (400)
.|+..+..+.|++ +..+++ ....++||||++|++|..+... .....++.+++.++.++|..+
T Consensus 82 ~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g-- 145 (198)
T cd05144 82 KEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG-- 145 (198)
T ss_pred HHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC--
Confidence 6888888887774 444433 2456899999999998765321 234678889999999999988
Q ss_pred eeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 201 VIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 201 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
++|+||+|+||+++.++.++|+|||++....
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=167.31 Aligned_cols=137 Identities=21% Similarity=0.243 Sum_probs=109.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEec-cc-c---c---hhHHHHHHHHHHHccCCCCcccc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QE-S---L---QGHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-~~-~---~---~~~~~~~~e~~~l~~l~hpniv~ 138 (400)
...|...+.||+|+||+||+|.+... .+++|+.. .. . . .....+.+|+++++.++|++++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 34567789999999999999876431 23333221 11 1 1 11245778999999999999998
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
...++.+....++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCc
Confidence 8877777778899999999999998874 24678899999999999988 9999999999999 6789
Q ss_pred eEEeeccCCcc
Q 015781 219 AKLSDFGLAKD 229 (400)
Q Consensus 219 ~kl~Dfg~~~~ 229 (400)
++|+|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-18 Score=172.88 Aligned_cols=263 Identities=24% Similarity=0.244 Sum_probs=192.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCC-CCcccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~ 145 (400)
.|.+.+.||+|+|+.|-+.... ..+...+|.|.+.... .........|..+-..+. |+|++++++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~--------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNS--------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhc--------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 4677778999999999776432 1235567777665543 112223345777777776 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCCCCCEEEcCCC-ceEEee
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nill~~~~-~~kl~D 223 (400)
.+..++++++..|+++.+-+..... ...+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred CcccccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCC
Confidence 9999999999999999888842211 24556667788999999999999 777 99999999999999999 999999
Q ss_pred ccCCccCCC-CCCcceeeeccc-ccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 224 FGLAKDGPT-GSQSHVSTRVMG-TYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 224 fg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
||++..... ..........+| ++.|.|||.+.+. ......|+||+|+++..+++|..|+......... ...|..
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~-- 245 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS-- 245 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc--
Confidence 999997766 444444556788 9999999999874 4567899999999999999999998765543211 111111
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.... ...............++.+++..+|..|.+.+++-..-+...
T Consensus 246 --~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 --NKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --cccc--------cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 001111233445667888999999999999999887655544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.6e-16 Score=148.97 Aligned_cols=254 Identities=24% Similarity=0.282 Sum_probs=185.6
Q ss_pred hcCCCCCCcccc--CCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccC-CCCcccceee
Q 015781 67 TRNFRPDSVLGE--GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 67 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
...|.+.+.+|. |.+|.||.+.+. +..++..+|+|.-.... ......-.+|+.....+ .|+|.++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~-------~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCT-------NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccCC-------cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 356788889999 999999998652 13467889998733321 12222334666666666 4999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeeeccCCCCCEEEcCC-
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----GLAYLHSDKAKVIYRDFKTSNILLDLN- 216 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~ivH~dlkp~Nill~~~- 216 (400)
.++..+..|+-+|+| +.+|..+..... ..++...++..+.+... ||.++|+.+ ++|.|+||.||++..+
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDW 259 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccccc
Confidence 999999999999999 678888776544 34778888888888888 999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcce---eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHV---STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
...+++|||+......+..... .....|...|++||++ ++-++..+|+|+||.++.+..++..++...--
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------ 332 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------ 332 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------
Confidence 8899999999987655542221 2233678889999988 45788999999999999999988766543200
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..|.. . ... .+..++-...+..+...+..|++.+|..|++++.+..+
T Consensus 333 ~~W~~----~----r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 SSWSQ----L----RQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred CCccc----c----ccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00211 0 000 01111222234455558889999999999999888763
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.6e-16 Score=136.65 Aligned_cols=134 Identities=23% Similarity=0.227 Sum_probs=101.1
Q ss_pred Cccc-cCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-------------hhHHHHHHHHHHHccCCCCcc--c
Q 015781 74 SVLG-EGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNL--V 137 (400)
Q Consensus 74 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpni--v 137 (400)
.+|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4577 7888888887442 56788888754221 122356789999999998875 6
Q ss_pred ceeeEEEeC-Ce---eEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 138 KLIGYCLED-DH---RLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 138 ~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
..+++.... .. .++|||+++| .+|.+++... +++.. .+.+|+.+|.+||++| |+|+||||.|||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NIL 174 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNIL 174 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEE
Confidence 677664432 22 2599999997 6898887542 34444 3568899999999998 999999999999
Q ss_pred EcCCCceEEeeccCCcc
Q 015781 213 LDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~ 229 (400)
++.++.++|+|||.+..
T Consensus 175 v~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 175 LDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EcCCCCEEEEECCCccc
Confidence 99999999999998875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-16 Score=133.64 Aligned_cols=136 Identities=20% Similarity=0.175 Sum_probs=94.2
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHH----------------------HHHHHHHH
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLE----------------------WLTEIKHL 128 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l 128 (400)
.+.||+|+||+||+|... ++..||+|++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 468999999999999532 47889999987543211 111 12345555
Q ss_pred ccCCCCc--ccceeeEEEeCCeeEEEEeecCCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeec
Q 015781 129 GQLYHPN--LVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYR 204 (400)
Q Consensus 129 ~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~ 204 (400)
..+.+.. +.++++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ ++|+
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~ 139 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG--LVHG 139 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC--cCcC
Confidence 5553332 3444432 24689999998854321 111111 01 5567889999999999999 88 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
||||+||+++ ++.++|+|||.+....
T Consensus 140 Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 140 DLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCChhhEEEE-CCcEEEEECccccccc
Confidence 9999999999 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=124.47 Aligned_cols=134 Identities=19% Similarity=0.095 Sum_probs=109.0
Q ss_pred CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC--CcccceeeEEEeCCee
Q 015781 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHR 149 (400)
Q Consensus 72 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~ 149 (400)
+.+.||.|.++.||++... +..+++|....... ...+..|+..++.+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 3567999999999999653 25689998866543 4467788889988876 5889999888887889
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
+++|||+.++.+..+ +......++.+++.+|++||... .+++|+|++|.||+++..+.++++|||.+.
T Consensus 69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999999988777543 44566778899999999999841 239999999999999998999999999886
Q ss_pred c
Q 015781 229 D 229 (400)
Q Consensus 229 ~ 229 (400)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-15 Score=133.90 Aligned_cols=209 Identities=24% Similarity=0.257 Sum_probs=144.9
Q ss_pred HHHHccCCCCcccceeeEEEeC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 015781 125 IKHLGQLYHPNLVKLIGYCLED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA 199 (400)
Q Consensus 125 ~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 199 (400)
+.-|-++.|.||+++..|+.+. ....+++||+..|+|..+|++.......+......+|+-||+.||.|||+..+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 4455566799999999988654 35789999999999999999877766778889999999999999999999999
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCC--cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 277 (400)
+|+|+++..+.|++..+|-+|+.--.-......... ........+-++|.+||.=...+.+.++|||++|+...+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999888888753211110000000 000112345678999996555566778999999999999988
Q ss_pred CCCccCC-CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 278 GRRVIDK-NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 278 g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
+..--.. .........+ ... .-.........++.+|++..|..||++++++-|.-.
T Consensus 278 lEiq~tnseS~~~~ee~i-------------a~~--------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI-------------ANV--------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred heeccCCCcceeehhhhh-------------hhh--------eeeccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 7643211 1110000000 000 000001122347779999999999999999887543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-13 Score=132.05 Aligned_cols=168 Identities=17% Similarity=0.198 Sum_probs=127.1
Q ss_pred CCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCC
Q 015781 97 ARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176 (400)
Q Consensus 97 ~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 176 (400)
..+.++..|.|..+............+.++.|+.++||||+++++.++.++..|+|+|.+ ..|..++++.+
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------- 102 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------- 102 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-------
Confidence 344467788888877665433345677899999999999999999999999999999987 47888886643
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc
Q 015781 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT 256 (400)
Q Consensus 177 ~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 256 (400)
...+...+.||+.||.+||.. ..++|++|....|+|+..|..||++|.++........ ......---.|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 567778899999999999855 3499999999999999999999999998865332221 0111111223556665432
Q ss_pred CCCCCccchhhHHHHHHHHHhC
Q 015781 257 GHLTAKSDVYSFGVVLLEMLSG 278 (400)
Q Consensus 257 ~~~~~~sDiwslG~il~~l~tg 278 (400)
.. -..|.|-|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-13 Score=131.67 Aligned_cols=141 Identities=19% Similarity=0.159 Sum_probs=95.4
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH----------------------------------
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---------------------------------- 118 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------- 118 (400)
.+.||.|++|.||+|++. +|+.||||+.........
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 357999999999999765 478999999865421100
Q ss_pred ------HHHHHHHHHHccC----CCCcccceeeEE-EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 015781 119 ------LEWLTEIKHLGQL----YHPNLVKLIGYC-LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187 (400)
Q Consensus 119 ------~~~~~e~~~l~~l----~hpniv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi 187 (400)
..+.+|...+.++ +|.+-+.+-.++ ...+..++||||++|++|.++...... ..+ ...++.++
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHH
Confidence 0123344444443 232223332232 223457899999999999887654321 122 23455555
Q ss_pred HH-HHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 188 AK-GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 188 ~~-~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
+. .+..+|..| ++|+|++|.||+++.++.++++|||++....
T Consensus 266 ~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 55 468889888 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-13 Score=133.35 Aligned_cols=146 Identities=15% Similarity=0.135 Sum_probs=93.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh------------------------------
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------------------ 117 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 117 (400)
..|.. +.||.|++|.||+|++++ +|+.||||++.......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45665 789999999999997653 58899999997542110
Q ss_pred ----HH------HHHHHHHHHccC----CCCcccceeeEEEe-CCeeEEEEeecCCCCHHHHH--hhhcCCCCCCCHHHH
Q 015781 118 ----HL------EWLTEIKHLGQL----YHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIR 180 (400)
Q Consensus 118 ----~~------~~~~e~~~l~~l----~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~ 180 (400)
.. .+.+|...+.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.++. ...+.....+.+..+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 00 123333333333 23333443333332 45568999999999998753 222110112333344
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC----ceEEeeccCCccCCC
Q 015781 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY----NAKLSDFGLAKDGPT 232 (400)
Q Consensus 181 ~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 232 (400)
..++.|+ ...| ++|+|++|.||+++.++ .++++|||++.....
T Consensus 270 ~~~~~Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444444 3456 99999999999999888 999999999976543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=110.19 Aligned_cols=129 Identities=19% Similarity=0.090 Sum_probs=93.0
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCccc-ceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv 152 (400)
+.|+.|.++.||++... +..+++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++|
T Consensus 4 ~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 56899999999998542 56799998765432 122456788888887655544 444433 3345899
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|||++|.++... . .....++.+++.+|+.||..+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 70 ~e~i~G~~l~~~----~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 70 TEFIEGSELLTE----D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEecCCCccccc----c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999999887542 0 0112356788999999998761 249999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-11 Score=103.87 Aligned_cols=144 Identities=11% Similarity=0.071 Sum_probs=97.9
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---------------------hh-HHH----HHHHHH
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------------------QG-HLE----WLTEIK 126 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------------~~-~~~----~~~e~~ 126 (400)
...||.|--+.||.|...... .....+..+|+|+...... .. ... ..+|+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 457999999999999543210 0011357899998754211 00 111 237888
Q ss_pred HHccCCC--CcccceeeEEEeCCeeEEEEeecCCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCee
Q 015781 127 HLGQLYH--PNLVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVI 202 (400)
Q Consensus 127 ~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~iv 202 (400)
.|+++.. -++.+++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |..| |+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lV 147 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN--LV 147 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 8888853 456666654 45689999996643321 2221 1244556677889999999998 8877 99
Q ss_pred eccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 203 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
|+||++.||++. ++.++|+|||.+....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=123.65 Aligned_cols=252 Identities=22% Similarity=0.199 Sum_probs=177.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHH--HHHHHHHHHccC-CCCcccceeeE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
...+|..+..||.|.|+.|+.... +..++..+++|........... .-..|+.+...+ .|.+++..+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~--------r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSK--------RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeee--------cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 345788889999999999998742 2235778888876554332222 223455555555 48889998888
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceEE
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKL 221 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl 221 (400)
+......|+-.|||+++++...+.-. +-+++..++.+..|++.++.++|+.. ++|+|++|+||++..+ +..++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhc
Confidence 88888888999999999887766322 34778888999999999999999988 9999999999999876 77899
Q ss_pred eeccCCccCCCCCCcceeeecccccCcc--cchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYA--APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
.|||......... ......-++. +++......+..+.|+++||..+.+.+++...-..... |
T Consensus 409 ~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--- 472 (524)
T KOG0601|consen 409 GDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--- 472 (524)
T ss_pred cccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c---
Confidence 9999886422211 1112233333 55555666788899999999999999998754322111 1
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
..+..... ...+ .....+..+.+.++..++..||++.++..+.+...+
T Consensus 473 --------~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 473 --------LTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred --------eeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 11111111 1111 222667778889999999999999999887776554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.8e-11 Score=110.34 Aligned_cols=163 Identities=18% Similarity=0.243 Sum_probs=124.2
Q ss_pred CCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE----eCCeeEEEEeecCC-CCHHHHHhhhcC-
Q 015781 97 ARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL----EDDHRLLVYEFMPK-GSLENHLFRRAS- 170 (400)
Q Consensus 97 ~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~~- 170 (400)
..+.+|..|++|+++.......-....-++.++++.|+|||++.++|. .+..+++|++|+++ .+|.++-.....
T Consensus 296 ~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~ 375 (655)
T KOG3741|consen 296 TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPF 375 (655)
T ss_pred eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcc
Confidence 455579999999996555444334446688999999999999998886 34578999999875 477776543221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceee
Q 015781 171 ----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240 (400)
Q Consensus 171 ----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 240 (400)
.....++..+|.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|...|+.........
T Consensus 376 t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----- 448 (655)
T KOG3741|consen 376 TKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----- 448 (655)
T ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCCC-----
Confidence 1234688999999999999999999988 88899999999999999999998887765433220
Q ss_pred ecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCC
Q 015781 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~ 280 (400)
|-+. --.+-|.=.||.+++.|.||..
T Consensus 449 -----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 449 -----------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred -----------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 1111 1235688999999999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=95.86 Aligned_cols=131 Identities=21% Similarity=0.278 Sum_probs=96.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEE-eccc----cchh---HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-LNQE----SLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~-~~~~----~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..+++|+-+.+|.+.+. |..+++|. +.+. .+.. ...-.+|++++.++.--.|.-.+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46789999999998553 33455553 2222 1111 1235678999988876666666666667
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+...|+|||++|..|.+++... ...++..+-.-+.-||..| |+|+||.++||++..++ +.++|||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECC
Confidence 77788999999999998888654 1345666667788899988 99999999999998665 9999999
Q ss_pred CCcc
Q 015781 226 LAKD 229 (400)
Q Consensus 226 ~~~~ 229 (400)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.2e-10 Score=93.14 Aligned_cols=143 Identities=18% Similarity=0.200 Sum_probs=104.9
Q ss_pred CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEE-e----ccccch---hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-L----NQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 72 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~-~----~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
...+|-+|+-+.|+++.+. |+..+||. + +.+.+. ...+..+|.+.|.++.--.|.-..=++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 4568899999999998664 56666663 2 222221 123467899999888766666666677
Q ss_pred EeCCeeEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---ce
Q 015781 144 LEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 219 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~ 219 (400)
.+...-.|+|||++| .++.+++..... .+........++.+|-..|.-||.++ |+|+||..+||++..++ .+
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCce
Confidence 777778899999966 488888876543 22333334778888889999999998 99999999999996544 35
Q ss_pred EEeeccCCcc
Q 015781 220 KLSDFGLAKD 229 (400)
Q Consensus 220 kl~Dfg~~~~ 229 (400)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-11 Score=124.63 Aligned_cols=248 Identities=21% Similarity=0.211 Sum_probs=167.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
+.+.+.+-+-.|.++.++.+ ....+|...+.|+...... ........+-.++-...+|-++...-.+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 45666777888999998876 3334454455554333211 01111222222222223466665554555
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
-....+++++|+.+++|...+...+ +.+.......+..+..++++||... +.|+|++|.|+++..+++.++.||
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcc
Confidence 5677899999999999998887654 3444455556666778999999976 899999999999999999999999
Q ss_pred cCCccCCCC--------C---------------------CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHH
Q 015781 225 GLAKDGPTG--------S---------------------QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275 (400)
Q Consensus 225 g~~~~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l 275 (400)
|........ . .........+|+.|.+||.+.+......+|.|++|+++++.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 844321110 0 00012235789999999999999999999999999999999
Q ss_pred HhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccc-cCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 015781 276 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 346 (400)
Q Consensus 276 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 346 (400)
++|.+||....+.... ..+..... ...-+...+....+++.+.+..+|.+|..+.
T Consensus 1029 l~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hcCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999876653221 11111111 1222345566777888899999999998776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-10 Score=99.99 Aligned_cols=141 Identities=22% Similarity=0.235 Sum_probs=101.9
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCC--CcccceeeEEEeC---C
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYH--PNLVKLIGYCLED---D 147 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~---~ 147 (400)
+.|+.|..+.||++... .|..+++|........ ....+..|+.+++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999998543 1567999987654321 23456789999988865 3457777776653 2
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------------ 197 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------ 197 (400)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 67899999999888664421 1355566666677777777777642
Q ss_pred ------------------------CCCeeeccCCCCCEEEcC--CCceEEeeccCCcc
Q 015781 198 ------------------------KAKVIYRDFKTSNILLDL--NYNAKLSDFGLAKD 229 (400)
Q Consensus 198 ------------------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~ 229 (400)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 133799999999999998 66789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-09 Score=97.13 Aligned_cols=265 Identities=15% Similarity=0.141 Sum_probs=162.6
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeE------E
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY------C 143 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~------~ 143 (400)
...+.||+|+-+.+|..-. -.-.+.|++.........+ .+..|... .||-+-.-+.+ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e------------~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE------------VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecch------------hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence 3456799999999996411 1225678877665433322 22233333 46644331111 0
Q ss_pred EeC-CeeEEEEeecCCCCH-HHHHhh--hcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 144 LED-DHRLLVYEFMPKGSL-ENHLFR--RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 144 ~~~-~~~~lv~e~~~~~~L-~~~l~~--~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
-+. ...-++|..+.|..- .++..- +........|...+.++..++.+.+.||.+| .+-+|+.++|+|+.+++.+
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceE
Confidence 112 225678888876533 222221 1112244789999999999999999999998 8899999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhC-CCccCCCCCCccc--
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREH-- 291 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~~-- 291 (400)
.|+|-..-... .........+|...|.+||.-. +..-+...|.|.||++|++|+.| ++||.+.......
T Consensus 157 ~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 157 VLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred EEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 99985433222 1222344568899999999753 34556789999999999999887 9999876432211
Q ss_pred --h-hHHhhhHHHhhhhhhhhhccccccCCCCHH-HHHHHHHHHHhcccC--CCCCCCCHHHHHHHHHhchhc
Q 015781 292 --N-LIEWAKPYLQSKRRIFQVMDARIEGQYSLG-AALKTAVLAIKCLSN--EPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 292 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~--dP~~Rps~~eil~~L~~~~~~ 358 (400)
. -|.- ..+....+. ...........+.. .+..+..|+.+|+.. ++.-|||++..+..|..+.+.
T Consensus 234 p~E~~Ia~-g~f~ya~~~--~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 234 PLETDIAH-GRFAYASDQ--RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cchhhhhc-ceeeechhc--cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0 0100 000011110 00011111122222 244566677788765 367899999999988877554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.7e-09 Score=95.19 Aligned_cols=124 Identities=16% Similarity=0.124 Sum_probs=89.8
Q ss_pred CcEEEEEEeccccch-----------hHHHHHHHHHHHccCCCCc--ccceeeEEEe-----CCeeEEEEeecCCC-CHH
Q 015781 102 GMVIAVKRLNQESLQ-----------GHLEWLTEIKHLGQLYHPN--LVKLIGYCLE-----DDHRLLVYEFMPKG-SLE 162 (400)
Q Consensus 102 ~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 162 (400)
|+.+.||........ ....+.+|+..+.++..-+ ...++.+.+. ...-++|||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 567889976443311 0113668888887774333 3344555543 23468999999876 899
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-------CCceEEeeccCCcc
Q 015781 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-------NYNAKLSDFGLAKD 229 (400)
Q Consensus 163 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~ 229 (400)
+++..... .+.+......++.+++..+..||..| |+|+|+++.|||++. +..+.|+||+.+..
T Consensus 125 ~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 98864322 34567778899999999999999998 999999999999975 46799999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-09 Score=91.33 Aligned_cols=98 Identities=23% Similarity=0.270 Sum_probs=63.4
Q ss_pred HHHHHHHHccCCCC--cccceeeEEEeCCeeEEEEeecC--CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-hh
Q 015781 121 WLTEIKHLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY-LH 195 (400)
Q Consensus 121 ~~~e~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH 195 (400)
..+|++.|.++..- ++.+++++. ..+|||||++ |..+..+.... +.......++.+++..+.. +|
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHH
Confidence 56799999999755 456666442 3479999998 65554433322 1123345566777775544 57
Q ss_pred cCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 196 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
..| |+|+||.+.||+++++ .+.|+|||.+....
T Consensus 125 ~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 KAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp CTT--EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred hcC--ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 877 9999999999999987 99999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.6e-09 Score=89.94 Aligned_cols=136 Identities=18% Similarity=0.122 Sum_probs=96.5
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----------------------hhHHHHHHHHH
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------------------QGHLEWLTEIK 126 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~ 126 (400)
-..+...||-|--+.||.|... .|..+|+|.-+.... .......+|++
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 3567789999999999999654 478899996433211 01123568999
Q ss_pred HHccCCCC--cccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 127 HLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 127 ~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
+|.+|.-. .+.+.+++ +...+|||+++|..|...- ++....-.++..|+.-+..+-..| |||+
T Consensus 162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G--iVHG 226 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG--IVHG 226 (304)
T ss_pred HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC--cccc
Confidence 99998643 67777654 4567999999997775432 123333444455555555555556 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCcc
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+++-||+++++|.+.++||-.+..
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CCchheEEEecCCCEEEEeCccccc
Confidence 9999999999999999999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-10 Score=110.12 Aligned_cols=151 Identities=24% Similarity=0.340 Sum_probs=104.9
Q ss_pred HHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcc-------eeeecccccCcccchhhccC
Q 015781 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH-------VSTRVMGTYGYAAPEYMATG 257 (400)
Q Consensus 185 ~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 257 (400)
.+++.|+.|+|.. +.+||++|.|++|.++.++.+||+.|+++.......... ..........|.|||.+.+.
T Consensus 106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3455899999987 779999999999999999999999999887544322111 11112345689999999888
Q ss_pred CCCCccchhhHHHHHHHHH-hCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhccc
Q 015781 258 HLTAKSDVYSFGVVLLEML-SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLS 336 (400)
Q Consensus 258 ~~~~~sDiwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 336 (400)
..+.++|+||||+++|.+. .|+..+........ + ......+......++...+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~---------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----Y---------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch-----h---------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999 55555544321110 0 0111111111122334567788888999999
Q ss_pred CCCCCCCCHHHHHH
Q 015781 337 NEPKFRPTMDEVVK 350 (400)
Q Consensus 337 ~dP~~Rps~~eil~ 350 (400)
.++..||++..++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999996665543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.8e-08 Score=83.42 Aligned_cols=105 Identities=22% Similarity=0.203 Sum_probs=81.6
Q ss_pred HHHHHHHHHHccCCC--CcccceeeEEEeC----CeeEEEEeecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 015781 119 LEWLTEIKHLGQLYH--PNLVKLIGYCLED----DHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191 (400)
Q Consensus 119 ~~~~~e~~~l~~l~h--pniv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l 191 (400)
....+|+..+..|.. =.+.+++++.+.. ...++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 346677777766643 2355566666543 2348999999874 79998876432 56667788999999999
Q ss_pred HHhhcCCCCeeeccCCCCCEEEcCCC---ceEEeeccCCcc
Q 015781 192 AYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAKD 229 (400)
Q Consensus 192 ~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~ 229 (400)
.-||.+| |+|+|+++.|||++.++ .+.++||+.++.
T Consensus 132 ~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999998887 899999997765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-07 Score=79.94 Aligned_cols=138 Identities=19% Similarity=0.147 Sum_probs=98.0
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc------chhHHHHHHHHHHHccCCCC--cccceeeEEE-e-
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES------LQGHLEWLTEIKHLGQLYHP--NLVKLIGYCL-E- 145 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~-~- 145 (400)
-|.||.+.|++.... |..+-+|....-- .-....|.+|+..|.+|..- .+.++. ++. .
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 466999999986543 2357777653110 12345688899888888532 244444 322 1
Q ss_pred ---CCeeEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--e
Q 015781 146 ---DDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--A 219 (400)
Q Consensus 146 ---~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--~ 219 (400)
.-.-+||+|-+.| .+|.+++..... .+.+......++.+++..|.-||..| +.|+|+.+.||+++.++. +
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeE
Confidence 1235799997743 588888765432 35677888899999999999999988 999999999999986667 9
Q ss_pred EEeeccCCcc
Q 015781 220 KLSDFGLAKD 229 (400)
Q Consensus 220 kl~Dfg~~~~ 229 (400)
.++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999976653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=92.05 Aligned_cols=142 Identities=17% Similarity=0.173 Sum_probs=90.9
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhH-----------------------------------
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH----------------------------------- 118 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------- 118 (400)
+-|+.++-|.||+|.++. |+.||||+.+..-....
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 568999999999998863 89999999866321100
Q ss_pred -----HHHHHHHHHHccCC-----CCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 015781 119 -----LEWLTEIKHLGQLY-----HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188 (400)
Q Consensus 119 -----~~~~~e~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~ 188 (400)
-.+.+|...+.++. .+++.=..=+++-.+...|+|||++|-.+.+...-.. ..++.+.+.....++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 01223333333331 2322221212233456689999999999988853332 2345444443333322
Q ss_pred HHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 189 ~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
+..+=..| ++|.|..|.||++..+|.+.+.|||+......
T Consensus 278 --~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 --LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33333346 99999999999999999999999999876544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.1e-07 Score=78.74 Aligned_cols=140 Identities=14% Similarity=0.128 Sum_probs=83.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc--ccceeeEEEeCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIGYCLEDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~~~~~l 151 (400)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+++.+..+.+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 46899999999984 13457888876533 2334678998888875433 4677888877888899
Q ss_pred EEeecCCCC-HHHHH--------------hh-----hcCCCCCCCHHHHH-HHHHH----------HHH-HHHHh--hcC
Q 015781 152 VYEFMPKGS-LENHL--------------FR-----RASYIQPLSWTIRM-KVALG----------AAK-GLAYL--HSD 197 (400)
Q Consensus 152 v~e~~~~~~-L~~~l--------------~~-----~~~~~~~~~~~~~~-~i~~q----------i~~-~l~~L--H~~ 197 (400)
|||+++|.+ +...+ .+ +.-........... .+..+ +.. ...+| +..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998864 21111 00 00000001101000 00000 000 01111 122
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 198 KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 198 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23478999999999999888 99999987763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.9e-07 Score=77.26 Aligned_cols=139 Identities=14% Similarity=0.082 Sum_probs=89.8
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHH---------HHHHHHHHccCC--
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---------WLTEIKHLGQLY-- 132 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~-- 132 (400)
.....+|.+.+++-......|.+-.. .|..+++|............ ..+++..+..+.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~ 95 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNE 95 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHc
Confidence 34556788888888888777776543 36789999876654322211 223333333332
Q ss_pred -CCcccceeeEEE-----eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 015781 133 -HPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (400)
Q Consensus 133 -hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 206 (400)
-..+..++.+.+ .....+++|||++|..|.++.. +++ .+...++.++.-||..| +.|+|.
T Consensus 96 g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G--~~HGD~ 161 (229)
T PF06176_consen 96 GFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG--FYHGDP 161 (229)
T ss_pred CccccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 222333332222 2244568999999988866432 222 23455667899999988 999999
Q ss_pred CCCCEEEcCCCceEEeeccCCc
Q 015781 207 KTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 207 kp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.|.|++++.+ .++++||+..+
T Consensus 162 hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 162 HPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcCcEEEECC-cEEEEECcccc
Confidence 9999999855 49999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.3e-06 Score=72.24 Aligned_cols=152 Identities=18% Similarity=0.153 Sum_probs=97.0
Q ss_pred ccHhHHHHHhcCCCCCCcc---ccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----------------
Q 015781 58 FSFNGLKTATRNFRPDSVL---GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----------------- 117 (400)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~l---g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------- 117 (400)
.++..+.....+..+..+. +.|--+.||+|.. ..+..+|+|++......-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 3444555566666666554 4566678999843 247889999986532210
Q ss_pred --H-----HHHHHHHHHHccCC--CCcccceeeEEEeCCeeEEEEeecCCCCH-HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 015781 118 --H-----LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLVYEFMPKGSL-ENHLFRRASYIQPLSWTIRMKVALGA 187 (400)
Q Consensus 118 --~-----~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~qi 187 (400)
. .....|+..|.++. +=.+.+.+.+.. ..|||||+....+ .-.|+. -++.......+..++
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~ 175 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDV 175 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHH
Confidence 0 11346777777774 334555554433 4699999954311 111111 122333566677778
Q ss_pred HHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 188 AKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 188 ~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
+..+.-|-. .+ +||+||+.-|||+. ++.+.|+|||.+....
T Consensus 176 v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 176 VEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECccccccC
Confidence 888887766 55 99999999999999 8899999999887543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.2e-06 Score=73.45 Aligned_cols=75 Identities=17% Similarity=0.114 Sum_probs=50.0
Q ss_pred cccCCC-ceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEeCCeeEEEE
Q 015781 76 LGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 76 lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 153 (400)
|..|.. ..||+.... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444444 788987321 3468888876543 224456777777763 334567777777666789999
Q ss_pred eecCCCCHHHH
Q 015781 154 EFMPKGSLENH 164 (400)
Q Consensus 154 e~~~~~~L~~~ 164 (400)
|+++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99999887644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.4e-08 Score=92.53 Aligned_cols=187 Identities=20% Similarity=0.128 Sum_probs=129.4
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc-ccceeeEEEeCCe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDH 148 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~ 148 (400)
+....-+++|+++.+++.+... .+....+.+... ....-++++|.+++||| .+..++-+..++.
T Consensus 244 s~~fh~fvK~altknpKkRpta----------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTA----------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCCh----------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3344568899999999863321 122224444332 34556889999999999 7777777777888
Q ss_pred eEEEEeecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 149 RLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 149 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+++|+++.++ +....+.... ..+..-+...+...-+.++++||+-- -+|+| ||+..+ +..+..||+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSE---IALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred cchhhhhhcCCccccccCChhh---Hhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCC
Confidence 99999999776 2222111110 12333344455555667899999853 58888 666654 67899999988
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCC
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 284 (400)
....... ......+++.++|||+.....+....|.|++|.-..++.-|.+|-..
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 7655433 34557899999999999999999999999999877788777766543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.1e-06 Score=67.29 Aligned_cols=130 Identities=16% Similarity=0.103 Sum_probs=88.0
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccc-eeeEEEeCCe
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVK-LIGYCLEDDH 148 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~~~~ 148 (400)
.+..+.|++|++|.||++.|. |..+|+|+-..+.. ...+..|.++|..+.--++.. ++.|-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678999999999999875 45799998776543 446778999888887666554 333332
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC-CCCEEEcCCCceEEeeccCC
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK-TSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfg~~ 227 (400)
-++.|||+.|..|.+..... +.+.+. .++..---|-..| |-|+.|. |..++|..++.+.|+||..|
T Consensus 87 ~~i~me~i~G~~L~~~~~~~-------~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG-------DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc-------cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccch
Confidence 24569999998987755321 223333 3444433444445 8888886 44455555569999999988
Q ss_pred cc
Q 015781 228 KD 229 (400)
Q Consensus 228 ~~ 229 (400)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 74
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.7e-06 Score=73.32 Aligned_cols=77 Identities=17% Similarity=0.180 Sum_probs=52.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCC--cccceeeEEE---eCCe
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIGYCL---EDDH 148 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~~~---~~~~ 148 (400)
+.|+.|..+.||+.... +..+++|..... .....+..|..+++.+... .+.+++.+.. ....
T Consensus 3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 46899999999998543 247999997665 3344566777777777432 3456665432 3345
Q ss_pred eEEEEeecCCCCHHH
Q 015781 149 RLLVYEFMPKGSLEN 163 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~ 163 (400)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 789999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=78.69 Aligned_cols=141 Identities=17% Similarity=0.124 Sum_probs=86.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh------------------------------------
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------------------------ 117 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 117 (400)
+.||..+.|.||+|+.++ |+.||||+.+..-...
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 579999999999998764 8899999976532100
Q ss_pred -HHHHHHHHHHHc----cCCCCcc---cceeeEEE-eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 015781 118 -HLEWLTEIKHLG----QLYHPNL---VKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188 (400)
Q Consensus 118 -~~~~~~e~~~l~----~l~hpni---v~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~ 188 (400)
+-.|.+|.+-.. .+.|-++ |.+=.++. -.....|+|||++|..+.|+-.-.. ..++...+...+.+..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAY 313 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHH
Confidence 001233332222 2234441 11222222 2345789999999998876643222 2345554444433332
Q ss_pred HHHHHhhcCCCCeeeccCCCCCEEEcC----CCceEEeeccCCccCC
Q 015781 189 KGLAYLHSDKAKVIYRDFKTSNILLDL----NYNAKLSDFGLAKDGP 231 (400)
Q Consensus 189 ~~l~~LH~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~ 231 (400)
++.+=..| .+|+|-.|.||++.. ++.+.+.|||+.....
T Consensus 314 --~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 314 --LEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22223335 999999999999983 6789999999987543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.7e-05 Score=64.41 Aligned_cols=128 Identities=18% Similarity=0.212 Sum_probs=87.6
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc----------------chhHHHHHHHHHHHccCC----
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----------------LQGHLEWLTEIKHLGQLY---- 132 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~---- 132 (400)
...||+|+.-.||.- + .....+||+..... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 457999999999962 2 13346788887665 112334455555444444
Q ss_pred --CCcccceeeEEEeCCeeEEEEeecC------CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 133 --HPNLVKLIGYCLEDDHRLLVYEFMP------KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 133 --hpniv~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
+.+|.+++|+.+++...-+|+|.+. ..+|.+++... .++. ...+.+.+ -..||-.++ |+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~---f~~~l~~~~--Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDE---FKRYLLDHH--IVIR 142 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHH---HHHHHHHcC--Ceec
Confidence 7889999999999999999999863 24788888543 2444 44444443 456666666 9999
Q ss_pred cCCCCCEEEcCC---C-ceEEee
Q 015781 205 DFKTSNILLDLN---Y-NAKLSD 223 (400)
Q Consensus 205 dlkp~Nill~~~---~-~~kl~D 223 (400)
||+|.||++... . .+.|+|
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEe
Confidence 999999999432 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.7e-05 Score=81.89 Aligned_cols=82 Identities=17% Similarity=0.206 Sum_probs=55.6
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCC-CCcc--cceeeEEEeC--
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLY-HPNL--VKLIGYCLED-- 146 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-hpni--v~~~~~~~~~-- 146 (400)
.+.++.|.+..+|+...... .....+++|+..... ......+.+|+++++.+. |+++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 45689999999998754321 111357777765432 223346778999999885 6664 7777777654
Q ss_pred -CeeEEEEeecCCCCH
Q 015781 147 -DHRLLVYEFMPKGSL 161 (400)
Q Consensus 147 -~~~~lv~e~~~~~~L 161 (400)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467899999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.4e-05 Score=69.65 Aligned_cols=30 Identities=20% Similarity=0.196 Sum_probs=25.3
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
.++|+|+.+.||+++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998765567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.7e-05 Score=63.68 Aligned_cols=99 Identities=26% Similarity=0.228 Sum_probs=76.5
Q ss_pred HHHHHHccCCC-CcccceeeEEEeCCeeEEEEeecCCCCHHHH---HhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 015781 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENH---LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK 198 (400)
Q Consensus 123 ~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 198 (400)
.|.-+++.+++ +++.+++|+|- .++|+||...+++... +... -..+|..+.+|+.+++..+++|+..-
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 57777878865 58999999984 3678999976665421 1111 13589999999999999999998732
Q ss_pred C-CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 199 A-KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 199 ~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
. .+.-.|++++|+-+++++++|++|...+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 1 166789999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.7e-05 Score=82.34 Aligned_cols=196 Identities=21% Similarity=0.209 Sum_probs=136.4
Q ss_pred HHHHHHHHccCCCCcccceeeEEEeCCee----EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 015781 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS 196 (400)
Q Consensus 121 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 196 (400)
..-|+..+.++.|+|++.++.|..+.... .+..++|...++...+.... .++....+.+..++++||.|+|.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 34577888889999999999887655332 23457888888888877653 57888889999999999999999
Q ss_pred CCCCeeeccCCCC---CEEEcCCCceEEe--eccCCccCCCCCCcceeeecccccCcccchhhccCCCCC--ccchhhHH
Q 015781 197 DKAKVIYRDFKTS---NILLDLNYNAKLS--DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA--KSDVYSFG 269 (400)
Q Consensus 197 ~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDiwslG 269 (400)
.. +.|.-|... +-..+..+.+.+. ||+.......... .........+.++|......+.. ..|+|.+|
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred hc--cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 76 666655555 4444566667766 8888876554332 22234456678888776665544 47999999
Q ss_pred HHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 015781 270 VVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349 (400)
Q Consensus 270 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 349 (400)
.....+..|..+-..... ...+++. .......+...+|+..+.++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999988754322110 0011111 1111455677789999999999999999
Q ss_pred HHH
Q 015781 350 KAL 352 (400)
Q Consensus 350 ~~L 352 (400)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00018 Score=61.28 Aligned_cols=125 Identities=30% Similarity=0.392 Sum_probs=85.4
Q ss_pred cCCCCCCccccCCC-ceEEEEEecCCCcCCCCCCCCcEEEEEEecc---ccc-------h-----------hHHHHHHHH
Q 015781 68 RNFRPDSVLGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ESL-------Q-----------GHLEWLTEI 125 (400)
Q Consensus 68 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~-------~-----------~~~~~~~e~ 125 (400)
.+++..+.||.|.- |.||++... |..+|+|++.. ... . ...-|..|-
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 67888999999999 999999765 67899999322 110 0 011256676
Q ss_pred HHHccCC---CCcc--cceeeEEEeC------------------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHH
Q 015781 126 KHLGQLY---HPNL--VKLIGYCLED------------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182 (400)
Q Consensus 126 ~~l~~l~---hpni--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 182 (400)
+...+|+ +.++ +++++|..-. ....||.||+.... .+. ..
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~ 168 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IR 168 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hh
Confidence 6666664 4556 8999987422 12357788775433 112 22
Q ss_pred HHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 183 i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
-+.+|..-|..+|..| |+-+|+++.|..= =+|+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~~-----G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLG--IVPRDVKPRNYRG-----GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCC--eeeccCccccccC-----CEEEecccC
Confidence 3456677788999988 9999999999862 389999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.9e-05 Score=66.60 Aligned_cols=138 Identities=17% Similarity=0.115 Sum_probs=74.4
Q ss_pred cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEEEe
Q 015781 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLVYE 154 (400)
Q Consensus 76 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e 154 (400)
+..|-...+|+... .+..+++|+.......-.....+|..+++.+...++ .+++... . -++|||
T Consensus 4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 55677788888742 255688887654322111124567778877754333 3333332 2 368999
Q ss_pred ecCCCCHHHH-------H-------hh---hcCCCCCCCHH-HHHHHHHHH---------HHHHHHhhcC------CCCe
Q 015781 155 FMPKGSLENH-------L-------FR---RASYIQPLSWT-IRMKVALGA---------AKGLAYLHSD------KAKV 201 (400)
Q Consensus 155 ~~~~~~L~~~-------l-------~~---~~~~~~~~~~~-~~~~i~~qi---------~~~l~~LH~~------~~~i 201 (400)
|++|..+... + .+ ......+++.. .+..+..++ ...+..+-.. ...+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9988765321 1 10 00011122221 111111111 1112222111 1348
Q ss_pred eeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 202 IYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 202 vH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
+|+|+.|.||++++++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0004 Score=64.06 Aligned_cols=77 Identities=12% Similarity=-0.023 Sum_probs=52.6
Q ss_pred CCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC---CcccceeeEEEe---
Q 015781 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH---PNLVKLIGYCLE--- 145 (400)
Q Consensus 72 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---pniv~~~~~~~~--- 145 (400)
-.+.||.|..+.||..... +..+.+|..+... ....+..|...|+.+.- -.+.++++++.+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-----------QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcC-----------CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 3457999999999986432 2246677754311 22366788888877742 357778877754
Q ss_pred CCeeEEEEeecCCCCH
Q 015781 146 DDHRLLVYEFMPKGSL 161 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L 161 (400)
.+..+||||+++|.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00036 Score=62.03 Aligned_cols=75 Identities=20% Similarity=0.181 Sum_probs=44.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv 152 (400)
+.|..|-...+|+..... ..+..+++|+....... .....+|+.+++.+...++ .+++.... -.+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 457778888999874321 02456889977643221 1223467777777743333 34443322 2479
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0013 Score=61.44 Aligned_cols=30 Identities=27% Similarity=0.307 Sum_probs=25.8
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++||+|+.+.||+++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 499999999999999766568999998764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0045 Score=59.04 Aligned_cols=76 Identities=20% Similarity=0.147 Sum_probs=48.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccc------c-chhHHHHHHHHHHHccCC---CCcccceeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE------S-LQGHLEWLTEIKHLGQLY---HPNLVKLIGYC 143 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---hpniv~~~~~~ 143 (400)
+.||.|.+..||++.... .++.++||.-... . .-.......|.+.|+.+. -..+.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 578999999999986542 1247999985421 0 112334556777776652 2356667665
Q ss_pred EeCCeeEEEEeecCCCC
Q 015781 144 LEDDHRLLVYEFMPKGS 160 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~ 160 (400)
+.+..++|||++++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 3455789999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0036 Score=57.66 Aligned_cols=143 Identities=17% Similarity=0.089 Sum_probs=79.1
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc--ccceee------EEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIG------YCL 144 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~------~~~ 144 (400)
.+.|..|....+|+.... +..+++|+.... ....+..|+.++..+.+.+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 345777877899987432 235888987652 2334556666666663222 344433 223
Q ss_pred eCCeeEEEEeecCCCCHHH----HHh----------hh-cCCCC------CCCHHHHH----------HHHHHHHHHHHH
Q 015781 145 EDDHRLLVYEFMPKGSLEN----HLF----------RR-ASYIQ------PLSWTIRM----------KVALGAAKGLAY 193 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~----~l~----------~~-~~~~~------~~~~~~~~----------~i~~qi~~~l~~ 193 (400)
.++..++|+++++|..+.. .+. .. ..... ...+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999998876521 110 00 00000 00111000 001112233344
Q ss_pred hhc-----CCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 194 LHS-----DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 194 LH~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
+.. ....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 432 113499999999999999887778999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=1.8e-05 Score=83.99 Aligned_cols=158 Identities=15% Similarity=0.007 Sum_probs=116.6
Q ss_pred HHHHHHccCCCCcccceeeEEE--eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---
Q 015781 123 TEIKHLGQLYHPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--- 197 (400)
Q Consensus 123 ~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--- 197 (400)
.|..-++...|+++.....-.. +....|.+++|+.+|.+.+.|.+......+++..-+.....+.+....-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 4444555567888877665443 23456889999999999999987766555666555554444435555554433
Q ss_pred CCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh
Q 015781 198 KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277 (400)
Q Consensus 198 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 277 (400)
|...+|+++|+.|.+|..+..+++.++|+.+...+ .........+++.|+.|++...-.++.++|+|..|+.+|++..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 34578999999999999999999999999983222 1223445677888999998877788888999999999999998
Q ss_pred CCCcc
Q 015781 278 GRRVI 282 (400)
Q Consensus 278 g~~pf 282 (400)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00092 Score=61.87 Aligned_cols=80 Identities=20% Similarity=0.232 Sum_probs=46.6
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv~ 153 (400)
.|..|-...+|+....... .....+..+++|+..... .......+|..++..+...++ .+++.++. + .+|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 5 KISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4566666788887543211 122346789999976543 222344577777777643333 34454443 2 3689
Q ss_pred eecCCCCHH
Q 015781 154 EFMPKGSLE 162 (400)
Q Consensus 154 e~~~~~~L~ 162 (400)
||++|.++.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0039 Score=57.84 Aligned_cols=31 Identities=29% Similarity=0.281 Sum_probs=26.9
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3499999999999999888778999987753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00015 Score=65.68 Aligned_cols=135 Identities=16% Similarity=0.089 Sum_probs=90.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch----------------------hHHHHHHHHH
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------------------GHLEWLTEIK 126 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~ 126 (400)
-+.+.+.||-|--+.||.+-.. .|...++|+-...... ......+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3677889999999999998554 3677888864332110 0112346777
Q ss_pred HHccCC-C-CcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 127 HLGQLY-H-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 127 ~l~~l~-h-pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
.|+.|. | --+.+.++ .+..++|||++.|-.|...-. -.+... +...+..-|--|..+| +||+
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la~~G--lIHg 226 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLANHG--LIHG 226 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHHHcC--ceec
Confidence 777763 2 22444443 345689999999888865321 122233 3344445566777778 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCcc
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
|+.-=||++++++.++++||-.+..
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999976553
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0014 Score=60.54 Aligned_cols=141 Identities=16% Similarity=0.169 Sum_probs=90.1
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--h------------------------HHHHHHH
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--G------------------------HLEWLTE 124 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e 124 (400)
.+..+|..|--+.||.|.-. .|..+|||+++..-+. + ......|
T Consensus 147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE 216 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE 216 (520)
T ss_pred ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence 34567888999999998543 4777999998653220 0 0123568
Q ss_pred HHHHccCCCCcccceeeEEEeCCeeEEEEeecCCCCH-HHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 015781 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL-ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (400)
Q Consensus 125 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 203 (400)
++-|.++....|...--+... ...|||+|+....- .-.|+. -+++...+..+-.|++.-+.-|-+. +.+||
T Consensus 217 ~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVH 288 (520)
T KOG2270|consen 217 MRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQK-CRLVH 288 (520)
T ss_pred HHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHH-hceec
Confidence 888888876665433322222 24689999942211 111111 2355556666666777777666443 44999
Q ss_pred ccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 204 RDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 204 ~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
.||.--|+|+. +|.+.|+|.+.+...
T Consensus 289 ADLSEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 289 ADLSEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred cchhhhhheEE-CCEEEEEEccccccC
Confidence 99999999986 578999999877643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.00067 Score=65.12 Aligned_cols=168 Identities=26% Similarity=0.325 Sum_probs=93.9
Q ss_pred hHHHHHHHHHHHccCCCCcccceeeEEEeC-CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 015781 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195 (400)
Q Consensus 117 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 195 (400)
...+++....+++.+.|+|...++++.... ....+|||++ +.+|++++..+.. ... ++ +
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l-----~~~-------s~---~---- 84 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL-----KDE-------SL---L---- 84 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc-----chh-------hh---c----
Confidence 345677888999999999999999887643 4578899999 7899998876531 000 11 0
Q ss_pred cCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHH
Q 015781 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275 (400)
Q Consensus 196 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l 275 (400)
.++ +.|- |+ ++.+| -++... |-. ..+++|||++|.++.++
T Consensus 85 ~~~--~~~~-----~~-------~~~td-~~~t~~--------------------~~~-----~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 85 AHG--VLHL-----NI-------IYITD-HFLTKY--------------------PSP-----IGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccc--ccee-----hh-------hhccc-cccccC--------------------CCC-----CCcchhhhhHHHHHHHH
Confidence 112 3332 11 22223 111100 111 11499999999999999
Q ss_pred HhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 015781 276 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350 (400)
Q Consensus 276 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 350 (400)
.-|..-+...........+ ..+.-........ ..+......+.....++.++|+-..|..||...++.+
T Consensus 125 ~L~~~l~~~~~~s~~l~~i---~k~~~~d~~~~~~---a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEIL---LKYYTDDQELLST---AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHhhHHHHHHHHHHHHHHH---HHhccCchhHHHH---HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 9988665433221111110 1110000000000 0000122345566777889999999999986655443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0049 Score=58.12 Aligned_cols=145 Identities=16% Similarity=0.129 Sum_probs=77.8
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCccc-ceeeEEEeCCeeEEEE
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDHRLLVY 153 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~ 153 (400)
.|..|-.-.+|++.+... ....+..+++|+...... ......+|..+++.+..-++. ++++.+.. . .|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 455577778998754321 112346789998865432 112234677777777544443 44555432 2 589
Q ss_pred eecCCCCHHHH-------H----h---h-hc-C---CCCCCCHHHHHHHHHHH-----------------HHHHHH----
Q 015781 154 EFMPKGSLENH-------L----F---R-RA-S---YIQPLSWTIRMKVALGA-----------------AKGLAY---- 193 (400)
Q Consensus 154 e~~~~~~L~~~-------l----~---~-~~-~---~~~~~~~~~~~~i~~qi-----------------~~~l~~---- 193 (400)
+|+++.+|... + . + +. . ...+..+..+..++.++ ...+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987776421 1 0 0 00 0 00111122222222111 111111
Q ss_pred hhc--CCCCeeeccCCCCCEEEcC-CCceEEeeccCCcc
Q 015781 194 LHS--DKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKD 229 (400)
Q Consensus 194 LH~--~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 229 (400)
+.. ....++|+|+++.||++++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111 1124899999999999976 47899999987753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0069 Score=55.34 Aligned_cols=73 Identities=22% Similarity=0.223 Sum_probs=43.4
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC---CCCcccceeeEEEeCCee
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~ 149 (400)
.+.++.|....+|+.. .++..+.||+-... ....+..|..-|+.| .--.+.+++.+...++..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 3468889999999874 24678999987632 223455666666655 344677888888877778
Q ss_pred EEEEeecCCC
Q 015781 150 LLVYEFMPKG 159 (400)
Q Consensus 150 ~lv~e~~~~~ 159 (400)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.013 Score=54.12 Aligned_cols=33 Identities=21% Similarity=0.410 Sum_probs=29.2
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCccCCC
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 232 (400)
.++|+|+.+.|++|+.++-+=|+||+++....+
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 489999999999999988899999999986544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=53.02 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.3
Q ss_pred CeeeccCCCCCEEEcCCCc-eEEeeccCCcc
Q 015781 200 KVIYRDFKTSNILLDLNYN-AKLSDFGLAKD 229 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~ 229 (400)
.++|+|+.+.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.034 Score=51.58 Aligned_cols=30 Identities=17% Similarity=0.153 Sum_probs=27.6
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++||+|+.+.|++++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0082 Score=51.71 Aligned_cols=100 Identities=16% Similarity=0.145 Sum_probs=64.4
Q ss_pred EEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 015781 106 AVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184 (400)
Q Consensus 106 avK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 184 (400)
.+|++..-... ...-+..+..+++++. .|+++..= +.-.+-++.|+|-.-. ....-.|.
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----------------i~~~N~i~ 148 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----------------INFSNFIT 148 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----------------cchhHHHH
Confidence 34444433222 3334667888888764 47777621 3345668899983211 11111222
Q ss_pred HHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 185 ~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
.. +.+|.-+|+...+.+|+|..|+||+-|..|.+||.|=+.
T Consensus 149 ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred Hh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 22 367888896667799999999999999999999999653
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.014 Score=54.03 Aligned_cols=74 Identities=18% Similarity=0.131 Sum_probs=57.2
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
..+.|++|++. |++|.- + ....+.++..++.+.+..++-+..+ .+.-|||+...||+|+ +|.|.|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEee
Confidence 34667888886 656532 2 2245678888888888777777665 6789999999999999 9999999999
Q ss_pred CCccC
Q 015781 226 LAKDG 230 (400)
Q Consensus 226 ~~~~~ 230 (400)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99843
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.045 Score=50.78 Aligned_cols=29 Identities=24% Similarity=0.302 Sum_probs=25.2
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34999999999999987 678999998665
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.028 Score=52.71 Aligned_cols=29 Identities=17% Similarity=0.232 Sum_probs=25.3
Q ss_pred eeeccCCCCCEEEcC-CCceEEeeccCCcc
Q 015781 201 VIYRDFKTSNILLDL-NYNAKLSDFGLAKD 229 (400)
Q Consensus 201 ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 229 (400)
++|+|+.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999975 57899999988754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.048 Score=47.39 Aligned_cols=76 Identities=22% Similarity=0.256 Sum_probs=49.4
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC---CCCcccceeeEEEeCCee
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~hpniv~~~~~~~~~~~~ 149 (400)
.+.+..|..-..|..... ...+-+|.-.... ...|..|+.-|..| +--.+.+++.+-.+.++.
T Consensus 21 r~~v~gG~inea~~v~dg-----------~~~~FvK~n~~~~---~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s 86 (286)
T COG3001 21 REEVSGGDINEAWRLRDG-----------TDPFFVKCNQREQ---LSMFTAEADGLELLARSNTITVPKVIAVGASRDHS 86 (286)
T ss_pred ccccCCccccceeEeecC-----------CcceEEEecchhh---HHHHHHHHHHHHHHHhcCCccccceEEecCCCCee
Confidence 345555655566655332 3457788654432 23455665555444 445678888888899999
Q ss_pred EEEEeecCCCCHH
Q 015781 150 LLVYEFMPKGSLE 162 (400)
Q Consensus 150 ~lv~e~~~~~~L~ 162 (400)
|+||||++-+.+.
T Consensus 87 ylVle~L~~~~~d 99 (286)
T COG3001 87 YLVLEYLPTGPLD 99 (286)
T ss_pred EEEEeeccCCCCC
Confidence 9999999876665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.07 Score=50.07 Aligned_cols=31 Identities=19% Similarity=0.264 Sum_probs=25.3
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
..++|||+.+.||++++++ ++++|+..+...
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G 222 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYG 222 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccccC
Confidence 3489999999999997654 789999877643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.15 Score=48.87 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=45.0
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-------hhHHHHHHHHHHHccCC---CCcccceeeE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLY---HPNLVKLIGY 142 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---hpniv~~~~~ 142 (400)
.+.||.|....||+.... +..++||.-..... ....+...|...|+.+. ...+.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 456899999999997432 23588887552111 12223334455555442 2467778877
Q ss_pred EEeCCeeEEEEeecCC
Q 015781 143 CLEDDHRLLVYEFMPK 158 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~ 158 (400)
+.+ ..+++||++++
T Consensus 106 ded--~~vlvME~L~~ 119 (418)
T PLN02756 106 DRT--MALIGMRYLEP 119 (418)
T ss_pred CCC--CCEEEEeecCC
Confidence 763 45789999966
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.21 Score=47.70 Aligned_cols=81 Identities=10% Similarity=0.054 Sum_probs=43.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccc-eeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVK-LIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~~~~~~lv 152 (400)
+.|..|-...+|++...... ...-..+.|.+.+..... .....-.+|+.+++.+...++.+ +++.+. -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 34556777889988654311 000011224444432211 11112246788888886555554 444443 2589
Q ss_pred EeecCCCCHH
Q 015781 153 YEFMPKGSLE 162 (400)
Q Consensus 153 ~e~~~~~~L~ 162 (400)
.||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999888764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.14 Score=47.65 Aligned_cols=28 Identities=29% Similarity=0.444 Sum_probs=25.3
Q ss_pred eeeccCCCCCEEEcCCCc-eEEeeccCCc
Q 015781 201 VIYRDFKTSNILLDLNYN-AKLSDFGLAK 228 (400)
Q Consensus 201 ivH~dlkp~Nill~~~~~-~kl~Dfg~~~ 228 (400)
+||+|+.|.||+++.+.. +-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 8899998775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.056 Score=51.01 Aligned_cols=59 Identities=19% Similarity=0.168 Sum_probs=41.5
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeeccCCCCCEEEc
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~ivH~dlkp~Nill~ 214 (400)
..++-+|..|.++..+++... .++.....++.-.+.|+-.+ --.+ .+|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 356667888989999887654 34556666666556665433 2334 99999999999994
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.39 Score=52.02 Aligned_cols=31 Identities=42% Similarity=0.478 Sum_probs=26.0
Q ss_pred CCeeeccCCCCCEEEcCCC--ceE-EeeccCCcc
Q 015781 199 AKVIYRDFKTSNILLDLNY--NAK-LSDFGLAKD 229 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~~~~ 229 (400)
..+||+|+.+.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999998775 555 999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=1 Score=42.03 Aligned_cols=29 Identities=21% Similarity=0.226 Sum_probs=24.2
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
.++||+|+.+.||+++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3489999999999995 4 578999998764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.16 Score=48.37 Aligned_cols=32 Identities=25% Similarity=0.387 Sum_probs=26.4
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
..++||||.|.|||++++ .+|++|..++...+
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfyGP 258 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAFYGP 258 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccccCC
Confidence 348999999999999976 58999988776543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.055 Score=45.86 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.7
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
..+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 378999999999998877 99999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 400 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 513 bits (1324), Expect = 0.0
Identities = 108/325 (33%), Positives = 177/325 (54%), Gaps = 30/325 (9%)
Query: 46 EGEIL--LGSNIKSFSFNGLKTATRNFRP------DSVLGEGGFGCVFKGWIDEHTYAPA 97
E + L + SFSF LK T NF + +GEGGFG V+KG+++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 98 RPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153
+AVK+L + + + ++ EIK + + H NLV+L+G+ + D LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213
+MP GSL + L PLSW +R K+A GAA G+ +LH + I+RD K++NILL
Sbjct: 110 VYMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL 166
Query: 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLL 273
D + AK+SDFGLA+ +Q+ +++R++GT Y APE + G +T KSD+YSFGVVLL
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225
Query: 274 EMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIK 333
E+++G +D++R L++ + ++ I +D ++ + +A +
Sbjct: 226 EIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQ 282
Query: 334 CLSNEPKFRPTMDEVVKALEQIQDT 358
CL + RP + +V + L+++ +
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = 0.0
Identities = 121/333 (36%), Positives = 181/333 (54%), Gaps = 13/333 (3%)
Query: 31 GSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWID 90
GS ++ S+ L+ L+ AT NF ++G G FG V+KG +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 91 EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150
+ G +A+KR ES QG E+ TEI+ L HP+LV LIG+C E + +
Sbjct: 62 D----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210
L+Y++M G+L+ HL+ +SW R+++ +GAA+GL YLH+ +I+RD K+ N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSIN 169
Query: 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGV 270
ILLD N+ K++DFG++K G Q+H+ST V GT GY PEY G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 271 VLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVL 330
VL E+L R I ++ P NL EWA ++ Q++D + + + K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 331 AIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363
A+KCL+ + RP+M +V+ LE ++ +
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-151
Identities = 125/336 (37%), Positives = 189/336 (56%), Gaps = 21/336 (6%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
VP E + +K FS L+ A+ NF ++LG GGFG V+KG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 102 GMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
G ++AVKRL +E QG L++ TE++ + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNA 219
+ + L R PL W R ++ALG+A+GLAYLH K+I+RD K +NILLD + A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ DFGLAK +HV+T V GT G+ APEY++TG + K+DV+ +GV+LLE+++G+
Sbjct: 174 VVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 280 RVIDKNRPSREH--NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSN 337
R D R + + L++W K L ++++ ++D ++G Y + +A+ C +
Sbjct: 233 RAFDLARLANDDDVMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 338 EPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSD 373
P RP M EVV+ LE D R E Q +
Sbjct: 292 SPMERPKMSEVVRMLE-----GDGLAERWEEWQKEE 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 7e-88
Identities = 75/327 (22%), Positives = 122/327 (37%), Gaps = 43/327 (13%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
L + + V G FGCV+K + +AVK + Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ- 61
Query: 118 HLEWL--TEIKHLGQLYHPNLVKLIGYCLEDDH----RLLVYEFMPKGSLENHLFRRASY 171
W E+ L + H N+++ IG L+ F KGSL + L
Sbjct: 62 --SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTSNILLDLNYNAKLSD 223
+SW +A A+GLAYLH D K + +RD K+ N+LL N A ++D
Sbjct: 116 -NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-----TAKSDVYSFGVVLLEMLSG 278
FGLA G + + +GT Y APE + + D+Y+ G+VL E+ S
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 279 RRVIDKNRPSREHNLIE--WAKPYLQSKRRI--FQVMDARIEGQYSLGAALKT-AVLAIK 333
D E P L+ + + + + + A + +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 334 CLSNEPKFRPTMDEVVKALEQIQDTND 360
C ++ + R + V + + Q+Q +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-68
Identities = 61/338 (18%), Positives = 121/338 (35%), Gaps = 54/338 (15%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
+ + N + ++G G +G V+KG +D +AVK + + Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50
Query: 118 HLEWLTE--IKHLGQLYHPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRAS 170
++ E I + + H N+ + I LLV E+ P GSL +L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILLDLNYNAKLSD 223
W ++A +GLAYLH++ K + +RD + N+L+ + +SD
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 224 FGLAK------DGPTGSQSHVSTRVMGTYGYAAPEYM-------ATGHLTAKSDVYSFGV 270
FGL+ G + + + +GT Y APE + + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 271 VLLEMLSGRRVIDKNRPSREHNL----IEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAA 324
+ E+ + E+ + P + + + R + +
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 325 LKTAV--LAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
++ C + + R T + + ++ +
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-66
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 42/291 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
+G G FG V + W G +AVK L ++ E+L E+ + +L
Sbjct: 44 KIGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+V +G + + +V E++ +GSL L ++ + L R+ +A AKG+
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGM 150
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YLH+ +++R+ K+ N+L+D Y K+ DFGL++ + S S GT + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAP 208
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVM 311
E + KSDVYSFGV+L E+ + + +P+ QV+
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQ------------------QPW--GNLNPAQVV 248
Query: 312 DARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
A L + A + C +NEP RP+ ++ L + +
Sbjct: 249 AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 9e-66
Identities = 83/289 (28%), Positives = 135/289 (46%), Gaps = 48/289 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG V K + +A+K++ ES + ++ E++ L ++ HP
Sbjct: 15 VVGRGAFGVVCKA-----KW------RAKDVAIKQIESESERK--AFIVELRQLSRVNHP 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKL G CL + LV E+ GSL N L A + + M L ++G+AYL
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 195 HSDKAK-VIYRDFKTSNILLDLNYN-AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
HS + K +I+RD K N+LL K+ DFG A D T G+ + APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312
+ + K DV+S+G++L E+++ R KP+ + F++M
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRR------------------KPFDEIGGPAFRIMW 215
Query: 313 ARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
A G +L +++ L +C S +P RP+M+E+VK + +
Sbjct: 216 AVHNGTRPPLIKNLPKPIES--LMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 77/321 (23%), Positives = 128/321 (39%), Gaps = 49/321 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G FG K T+ TG V+ +K L + + +L E+K + L HP
Sbjct: 17 VLGKGCFGQAIKV-----THR----ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N++K IG +D + E++ G+L + S W+ R+ A A G+AYL
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------------DGPTGSQSHVSTRV 242
HS +I+RD + N L+ N N ++DFGLA+ V
Sbjct: 125 HS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302
+G + APE + K DV+SFG+VL E++ A P
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYL 226
Query: 303 SKRRIFQVMDARIEGQYSLGAALKT----AVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
+ F + + G + ++C +P+ RP+ ++ LE ++
Sbjct: 227 PRTMDFGL---NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 359 NDAGVSRDESLQNSDRSTYKR 379
+ L+ DR ++
Sbjct: 284 LAGHLPLGPQLEQLDRGFWET 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-64
Identities = 77/299 (25%), Positives = 132/299 (44%), Gaps = 55/299 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-------EWLTEIKH 127
+G+GGFG V KG V+A+K L +G E+ E+
Sbjct: 26 QIGKGGFGLVHKG-----RLV----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ L HPN+VKL G +V EF+P G L + L +A P+ W++++++ L
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLD-----LNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
A G+ Y+ + +++RD ++ NI L AK++DFGL++ H + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 243 MGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL--IEWAK 298
+G + + APE + T K+D YSF ++L +L+G P E++ I++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFIN 240
Query: 299 PYLQSKRR--IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ R I + R+ + C S +PK RP +VK L ++
Sbjct: 241 MIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-62
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 49/293 (16%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
L E G ++KG W G I VK L ++ E L
Sbjct: 17 KLNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 132 YHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HPN++ ++G C H L+ +MP GSL N L ++ + + +K AL A+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMAR 122
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+A+LH+ + + + ++++D + A++S + S S M +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWV 175
Query: 250 APEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
APE + +D++SF V+L E+++ P + + +E R
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR 229
Query: 307 --IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357
I + + + L C++ +P RP D +V LE++QD
Sbjct: 230 PTIPPGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-60
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 55/297 (18%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL----EWLTEIKHLG 129
++G GGFG V++ W G +AVK + + E K
Sbjct: 14 IIGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
L HPN++ L G CL++ + LV EF G L L + + I + A+ A+
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIAR 116
Query: 190 GLAYLHSDK-AKVIYRDFKTSNILLD--------LNYNAKLSDFGLAKDGPTGSQSHVST 240
G+ YLH + +I+RD K+SNIL+ N K++DFGLA++
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKM 172
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
G Y + APE + + SDV+S+GV+L E+L+G P R + + A
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGV 226
Query: 301 LQSKRR--IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+K I A L C + +P RP+ ++ L I
Sbjct: 227 AMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-59
Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 45/311 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--TEIKHLGQL 131
+G+G +G V+ G W E +AVK W TEI +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 132 YHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
H N++ I ++ L+ ++ GSL ++L L +K+A +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSS 143
Query: 188 AKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVS 239
GL +LH++ K + +RD K+ NIL+ N ++D GLA T
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 240 TRVMGTYGYAAPE----YMATGHLTA--KSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HN 292
+GT Y PE + H + +D+YSFG++L E+ + ++
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 293 LIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLSNEPKFRPTMDEVV 349
+ + P + R I + R ++S L+ L +C ++ P R T V
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 350 KALEQIQDTND 360
K L ++ ++ D
Sbjct: 324 KTLAKMSESQD 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 70/295 (23%), Positives = 129/295 (43%), Gaps = 53/295 (17%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G G FG V+KG W + +AVK LN + + E+ L +
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H N++ +GY +V ++ SL +HL + + +A A+G+
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMD 134
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLH+ +I+RD K++NI L + K+ DFGLA + S SH ++ G+ + APE
Sbjct: 135 YLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 253 ---YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--LQSKRRI 307
+ + +SDVY+FG+VL E+++G+ PY + ++ +I
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------PYSNINNRDQI 234
Query: 308 FQV------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
++ + + + +K L +CL + RP+ ++ +E++
Sbjct: 235 IEMVGRGSLSPDLSKVRSNCPKRMKR--LMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-58
Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 47/318 (14%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+T R+ +G+G +G V++G W E+ +AVK + + W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSSRDEK---SWF 48
Query: 123 --TEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLS 176
TE+ + L H N++ I + H L+ + GSL ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLD 103
Query: 177 WTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--K 228
+++ L A GLA+LH + K + +RD K+ NIL+ N ++D GLA
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282
T + +GT Y APE + + D+++FG+VL E+
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 283 DKNRPSRE--HNLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLSN 337
+ ++++ P + R++ V R I ++ L + A L +C
Sbjct: 224 GIVEDYKPPFYDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282
Query: 338 EPKFRPTMDEVVKALEQI 355
P R T + K L +I
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-58
Identities = 87/380 (22%), Positives = 147/380 (38%), Gaps = 69/380 (18%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEG-EILLGSNIKSFSFNGLKTATR 68
D P + + TSGS S + + V RT I+L +I
Sbjct: 6 DRPFISEGTTLKDLIYDMTTSGSGSGLPLL--VQRTIARTIVLQESI------------- 50
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE--I 125
G+G FG V++G W E +AVK + + W E I
Sbjct: 51 --------GKGRFGEVWRGKWRGEE------------VAVKIFSSREER---SWFREAEI 87
Query: 126 KHLGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
L H N++ I +D+ LV ++ GSL ++L R ++ +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMI 142
Query: 182 KVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTG 233
K+AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 234 SQSHVSTRVMGTYGYAAPE----YMATGHLTA--KSDVYSFGVVLLEMLSGRRVIDKNRP 287
+ +GT Y APE + H + ++D+Y+ G+V E+ + +
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 288 SR-EHNLIEWAKPYLQSKRRIFQVMDAR--IEGQYSLGAALKT-AVLAIKCLSNEPKFRP 343
+ + + + P ++ R++ R I ++ AL+ A + +C R
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 344 TMDEVVKALEQIQDTNDAGV 363
T + K L Q+ +
Sbjct: 323 TALRIKKTLSQLSQQEGIKM 342
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 58/304 (19%), Positives = 114/304 (37%), Gaps = 58/304 (19%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
++G+G FG V+ G W E +A++ ++ E + E+ Q
Sbjct: 40 LIGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V +G C+ H ++ +L + + L ++A KG+
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGM 143
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGY 248
YLH+ ++++D K+ N+ D N ++DFGL G + G +
Sbjct: 144 GYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 249 AAPEYM---------ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299
APE + + SDV++ G + E+ + P
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------------------WP 242
Query: 300 Y--LQSKRRIFQVMDA--RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ ++ I+Q+ Q +G + + + C + E + RPT +++ LE++
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD--ILLFCWAFEQEERPTFTKLMDMLEKL 300
Query: 356 QDTN 359
N
Sbjct: 301 PKRN 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 34/303 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + LG+G FG V Y P + TG V+AVK+L + + ++ EI+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L L H N+VK G C R L+ E++P GSL ++L + I ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-HIKLLQY--TS 121
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST----- 240
KG+ YL + + I+RD T NIL++ K+ DFGL K P +
Sbjct: 122 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 241 --RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
APE + + SDV+SFGVVL E+ + P E +
Sbjct: 180 PIFWY------APESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEFMRMIGND 231
Query: 299 PYLQSKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
Q +++ ++ L G + ++ +C +N RP+ ++ ++Q
Sbjct: 232 KQGQMIVF--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 355 IQD 357
I+D
Sbjct: 289 IRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-45
Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 34/297 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V Y P + TG V+AVK+L + + ++ EI+ L L H
Sbjct: 47 QQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 134 PNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
N+VK G C R L+ E++P GSL ++L + I ++ KG+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-HIKLLQY--TSQICKGM 158
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST-------RVMG 244
YL + + I+RD T NIL++ K+ DFGL K P + +
Sbjct: 159 EYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
APE + + SDV+SFGVVL E+ + P E + Q
Sbjct: 216 -----APESLTESKFSVASDVWSFGVVLYELFTYIE--KSKSPPAEFMRMIGNDKQGQMI 268
Query: 305 RRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357
+++ ++ L G + ++ +C +N RP+ ++ ++QI+D
Sbjct: 269 VF--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 86/313 (27%), Positives = 127/313 (40%), Gaps = 56/313 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P GTG ++AVK L ++ H W EI
Sbjct: 31 RYLKKIRDLGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH +++K G C + LV E++P GSL ++L R + + L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFA 140
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST---- 240
+G+AYLH+ I+RD N+LLD + K+ DFGLAK P G + +
Sbjct: 141 QQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 241 ---RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 296
APE + SDV+SFGV L E+L+ D ++ L
Sbjct: 199 SPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELI 248
Query: 297 AKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPT 344
Q ++ + G+ Y L C E FRPT
Sbjct: 249 GIAQGQMTVL--RLTELLERGERLPRPDKCPAEVYH---------LMKNCWETEASFRPT 297
Query: 345 MDEVVKALEQIQD 357
+ ++ L+ + +
Sbjct: 298 FENLIPILKTVHE 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 83/311 (26%), Positives = 126/311 (40%), Gaps = 54/311 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P TG +AVK L ES H+ + EI+
Sbjct: 21 RFLKRIRDLGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH N+VK G C ED L+ EF+P GSL+ +L + + I L ++ A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI-NLKQQLKY--A 132
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST---- 240
+ KG+ YL S + ++RD N+L++ + K+ DFGL K T + +
Sbjct: 133 VQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 241 ---RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 296
APE + SDV+SFGV L E+L+ + L
Sbjct: 191 SPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMI 240
Query: 297 AKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPT 344
+ Q ++++ EG+ Y L KC +P R +
Sbjct: 241 GPTHGQMTVT--RLVNTLKEGKRLPCPPNCPDEVYQ---------LMRKCWEFQPSNRTS 289
Query: 345 MDEVVKALEQI 355
+++ E +
Sbjct: 290 FQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 73/288 (25%), Positives = 113/288 (39%), Gaps = 41/288 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+G G FG VF G R +V AVK + ++L E + L Q H
Sbjct: 121 QIGRGNFGEVFSG--------RLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+LIG C + +V E + G L L +++ AA G+ Y
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEY 228
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 229 LES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 254 MATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMD 312
+ G +++SDV+SFG++L E S G PY Q +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGAS------------------PY--PNLSNQQTRE 326
Query: 313 ARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
+E L L +C + EP RP+ + + L+ I+
Sbjct: 327 -FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 59/313 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + S LG+G FG V Y P TG ++AVK+L ++ EI+
Sbjct: 23 RHLKYISQLGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMK 182
L L+ +VK G + LV E++P G L + L R + + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY----- 132
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST-- 240
+ KG+ YL S + ++RD NIL++ + K++DFGLAK P +V
Sbjct: 133 -SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 241 -----RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 294
APE ++ + +SDV+SFGVVL E+ + +
Sbjct: 190 GQSPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCD------KSCSPSAEF 237
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFR 342
+ + ++++ EGQ + L C + P+ R
Sbjct: 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE---------LMKLCWAPSPQDR 288
Query: 343 PTMDEVVKALEQI 355
P+ + L+ +
Sbjct: 289 PSFSALGPQLDML 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 61/312 (19%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+F +VLG+G FG V K + A+K++ + L+E+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---RNA------LDSRYYAIKKIRHTEEKLS-TILSEVM 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-------------LVYEFMPKGSLENHLFRRASYIQ 173
L L H +V+ LE + + + E+ G+L + + Q
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 174 P-LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---- 228
W + ++ L+Y+HS +I+RD K NI +D + N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 229 ---------DGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSG 278
GS ++++ + GT Y A E + TGH K D+YS G++ EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 279 RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNE 338
S + + + + + + + ++
Sbjct: 228 --------FSTGMERVN---ILKKLRSVSIE-FPPDFDDNKMKVEKK----IIRLLIDHD 271
Query: 339 PKFRPTMDEVVK 350
P RP ++
Sbjct: 272 PNKRPGARTLLN 283
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 60/304 (19%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G F +FKG + Y + +K L++ + + +L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+LV G C+ D +LV EF+ GSL+ +L ++ + W + + A A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEV--AKQLAAAMHF 128
Query: 194 LHSDKAKVIYRDFKTSNILLDL--------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
L + +I+ + NILL KLSD G++ V+
Sbjct: 129 L-EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 246 YGY------AAPEYMATG-HLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297
PE + +L +D +SFG L E+ S G
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD------------------ 216
Query: 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI--KCLSNEPKFRPTMDEVVKALEQI 355
KP + + + E ++ L A + + C+ EP RP+ +++ L +
Sbjct: 217 KPLSALDSQ--RKLQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 356 QDTN 359
+
Sbjct: 274 FTPD 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 60/298 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P++ +L+G CL L+ + MP G L +++ I L+W + AKG
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ YL ++++RD N+L+ + K++DFGLAK + + + + A
Sbjct: 130 MNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
E + T +SDV+S+GV + E+++ G + PY +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPAS--E 227
Query: 310 VMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ +G+ Y + KC + RP E++ ++
Sbjct: 228 ISSILEKGERLPQPPICTIDVYM---------IMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWL-TEI 125
R + D +G G F V+KG +D T + +A L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-LDT--------ETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 126 KHLGQLYHPNLVKLIGYCL---EDDHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ L L HPN+V+ + +++ E M G+L+ +L R + + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLR 132
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVST 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 188
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
V+GT + APE + DVY+FG+ +LEM +
Sbjct: 189 AVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 72/325 (22%), Positives = 136/325 (41%), Gaps = 69/325 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG+G FG V++G + +A+K +N+ S++ +E+L E + +
Sbjct: 32 ELGQGSFGMVYEG----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRASYIQPLSWTIRMKVALGA 187
++V+L+G + L++ E M +G L+++L + P S + +++A
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT------GSQSHVSTR 241
A G+AYL++ K ++RD N ++ ++ K+ DFG+ +D G + + R
Sbjct: 148 ADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS--------------GRRVIDKNRP 287
M +PE + G T SDV+SFGVVL E+ + R V++
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+ N +F++M C PK RP+ E
Sbjct: 260 DKPDN----------CPDMLFELM--------------------RMCWQYNPKMRPSFLE 289
Query: 348 VVKALEQIQDTNDAGVSRDESLQNS 372
++ ++++ + VS S +N
Sbjct: 290 IISSIKEEMEPGFREVSFYYSEENK 314
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 67/307 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V +G GT + +AVK + + S + E+L+E +
Sbjct: 41 ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 133 HPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVAL 185
HPN+++L+G C+E +++ FM G L +L P ++ +K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRV- 242
A G+ YL S++ ++RD N +L + ++DFGL+K +G + ++
Sbjct: 155 DIALGMEYL-SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 243 ---MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAK 298
+ A E +A T+KSDV++FGV + E+ + G P E
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYD 260
Query: 299 PYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
YL R ++++M C +P RPT +
Sbjct: 261 -YLLHGHRLKQPEDCLDELYEIM--------------------YSCWRTDPLDRPTFSVL 299
Query: 349 VKALEQI 355
LE++
Sbjct: 300 RLQLEKL 306
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 73/303 (24%), Positives = 124/303 (40%), Gaps = 41/303 (13%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W + +AVK L +++++ E+L E + ++ H
Sbjct: 227 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 275
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PNLV+L+G C + ++ EFM G+L ++L + M A + + Y
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSAMEY 333
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L I+R+ N L+ N+ K++DFGL++ TG + APE
Sbjct: 334 LEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPES 390
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 313
+A + KSDV++FGV+L E+ + PY QV +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLS--QVYEL 431
Query: 314 RIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESL 369
+ Y + G K L C P RP+ E+ +A E + + ++ L
Sbjct: 432 LEKD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
Query: 370 QNS 372
Sbjct: 491 GKR 493
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 58/299 (19%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+F+ ++G GGFG VFK G +KR+ + + E+K
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK---------HRIDGKTYVIKRVKYNNEKA----EREVKA 57
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL----------------LVYEFMPKGSLENHLFRRASY 171
L +L H N+V G D+ + EF KG+LE + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG- 116
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ L + +++ KG+ Y+HS K +I RD K SNI L K+ DFGL
Sbjct: 117 -EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT--- 170
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291
+ TR GT Y +PE +++ + D+Y+ G++L E+L
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------- 217
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
++ + + D I + KT + K LS +P+ RP E+++
Sbjct: 218 -----CDTAFETSKFFTDLRDGIISDIFD--KKEKTLLQ--KLLSKKPEDRPNTSEILR 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 75/318 (23%), Positives = 114/318 (35%), Gaps = 73/318 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG VF + M++AVK L + S ++ E + L L H
Sbjct: 48 ELGEGAFGKVFLA----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-----------ASYIQPLSWTIRMKV 183
++V+ G C E L+V+E+M G L L PL + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT------GSQSH 237
A A G+ YL ++RD T N L+ K+ DFG+++D + G ++
Sbjct: 164 ASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVIDK--- 284
+ R M PE + T +SDV+SFGVVL E+ LS ID
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 285 -NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 343
R ++ +M C EP+ R
Sbjct: 276 GRELERPRA----------CPPEVYAIM--------------------RGCWQREPQQRH 305
Query: 344 TMDEVVKALEQIQDTNDA 361
++ +V L+ +
Sbjct: 306 SIKDVHARLQALAQAPPV 323
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 49/293 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
++G G G V G V A+K L + + ++L+E +GQ H
Sbjct: 56 IIGSGDSGEVCYG-----RLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+++L G ++V E+M GSL+ L + + + G G+ Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRY 166
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG------ 247
L ++RD N+L+D N K+SDFGL++ + +T G
Sbjct: 167 LSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIR 219
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE +A ++ SDV+SFGVV+ E+L+ G R PY R
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER------------------PYWNMTNR 261
Query: 307 IFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ + +E Y L G L + C + RP ++V L+ +
Sbjct: 262 --DVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 51/293 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G FG V G W+++ +A+K + + ++ +++ E + + +L H
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-----------VAIKTIREGAMSEE-DFIEEAEVMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P LV+L G CLE LV EFM G L ++L R + + M L +G+AY
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAY 119
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
L A VI+RD N L+ N K+SDFG+ + T GT +A+
Sbjct: 120 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWAS 173
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE + ++KSDV+SFGV++ E+ S G+ PY R +
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI------------------PY--ENRSNSE 213
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
V++ I + L A+ + C P+ RP +++ L +I ++
Sbjct: 214 VVE-DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 83/302 (27%), Positives = 128/302 (42%), Gaps = 65/302 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 32 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ L+G CL + L+V +M G L N + R P + + L AKG+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDL-IGFGLQVAKGMK 142
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV----MG 244
YL S K ++RD N +LD + K++DFGLA+D + ++ M
Sbjct: 143 YLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303
A E + T T KSDV+SFGV+L E+++ G P + N + YL
Sbjct: 200 -----ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV-YLLQ 247
Query: 304 KRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
RR +++VM +KC + + RP+ E+V +
Sbjct: 248 GRRLLQPEYCPDPLYEVM--------------------LKCWHPKAEMRPSFSELVSRIS 287
Query: 354 QI 355
I
Sbjct: 288 AI 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 50/308 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+++ LGEGGF V E + G A+KR+ Q E E
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV---EGLH------DGHFYALKRILCHEQQDREEAQREADM 79
Query: 128 LGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLS-WTIRMK 182
HPN+++L+ YCL + L+ F +G+L N + R L+ I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LW 138
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ LG +GL +H+ +RD K +NILL L D G +
Sbjct: 139 LLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 243 M-------GTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289
+ T Y APE + ++DV+S G VL M+ G D
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 290 EH-NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+ L +Q++ I ++S +AL L ++ +P RP + +
Sbjct: 254 DSVALA------VQNQLSI------PQSPRHS--SALWQ--LLNSMMTVDPHQRPHIPLL 297
Query: 349 VKALEQIQ 356
+ LE +Q
Sbjct: 298 LSQLEALQ 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 55/290 (18%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG V G + G +AVK + ++ +L E + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRH 245
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
NLV+L+G +E+ L +V E+M KGSL ++L R + ++ +L + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAME 303
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YL ++RD N+L+ + AK+SDFGL K+ + + ++ + APE
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKL--PVKWTAPE 356
Query: 253 YMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI--FQ 309
+ + KSDV+SFG++L E+ S GR PY RI
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY----PRIPLKD 394
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ R+E Y + G + C + RPT ++ + LE I
Sbjct: 395 VVP-RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 70/331 (21%), Positives = 129/331 (38%), Gaps = 64/331 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P++ +L+G CL L+ + MP G L +++ I L+W + AKG
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ YL ++++RD N+L+ + K++DFGLAK + + + + A
Sbjct: 130 MNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
E + T +SDV+S+GV + E+++ G + PY +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPAS--E 227
Query: 310 VMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI-- 355
+ +G+ Y + +KC + RP E++ ++
Sbjct: 228 ISSILEKGERLPQPPICTIDVYM---------IMVKCWMIDADSRPKFRELIIEFSKMAR 278
Query: 356 --QDTNDAGVSRDESLQNSDRSTYKRKGLNE 384
Q L + S + R ++E
Sbjct: 279 DPQRYLVIQGDERMHLPSPTDSNFYRALMDE 309
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 49/314 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V+KG + + +A+K L + + +++L E +GQ H
Sbjct: 51 VIGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
N+++L G + +++ E+M G+L+ L R + + M G A G+ Y
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGM--LRGIAAGMKY 162
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG------ 247
L + ++RD NIL++ N K+SDFGL++ ++ +T G
Sbjct: 163 LAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIR 215
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE ++ T+ SDV+SFG+V+ E+++ G R PY +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNH 257
Query: 307 IFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ-IQDTNDA 361
+VM I + L L ++C E RP ++V L++ I+ +
Sbjct: 258 --EVMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314
Query: 362 GVSRDESLQNSDRS 375
D + S R
Sbjct: 315 KTLADFDPRVSIRL 328
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR----------- 180
HPN++ L+G C + L E+ P G+L + L R P
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP---TGSQSH 237
+ A A+G+ YL S K + I+RD NIL+ NY AK++DFGL++ +
Sbjct: 145 LHFAADVARGMDYL-SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS 277
+ R M A E + T SDV+S+GV+L E++S
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-36
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 43/286 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 238
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L E+ +V E+M KGSL + L L + M A A G+AY
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 295
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 296 VER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 352
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 313
G T KSDV+SFG++L E+ + RV PY R +V+D
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNR--EVLD- 392
Query: 314 RIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++E Y + L +C EP+ RPT + + LE
Sbjct: 393 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 60/298 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYH 133
VLG G FG V KG + P + + +K + +S Q + +G L H
Sbjct: 20 VLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
++V+L+G C LV +++P GSL +H+ + + P L+W + AKG
Sbjct: 75 AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKG 127
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ YL +++R+ N+LL +++DFG+A P + + + + A
Sbjct: 128 MYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
E + G T +SDV+S+GV + E+++ G PY + +
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAE------------------PYAGLRLA--E 225
Query: 310 VMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V D +G+ Y + +KC + RPT E+ ++
Sbjct: 226 VPDLLEKGERLAQPQICTIDVYM---------VMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 72/329 (21%), Positives = 130/329 (39%), Gaps = 69/329 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LG+G FG V + G+ + +AVK L + + E+L E + +
Sbjct: 30 MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
HP++ KL+G L + +++ FM G L L P + ++ ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRV 242
+ A G+ YL S I+RD N +L + ++DFGL++ +G + ++++
Sbjct: 144 VDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 243 ----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297
+ A E +A T SDV++FGV + E+++ G+ P E
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGIENAEIY 249
Query: 298 KPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
YL R ++ +M +C S +PK RP+
Sbjct: 250 N-YLIGGNRLKQPPECMEEVYDLM--------------------YQCWSADPKQRPSFTC 288
Query: 348 VVKALEQI-QDTNDAGVSRDESLQNSDRS 375
+ LE I + S+D N +R+
Sbjct: 289 LRMELENILGHLSVLSTSQDPLYINIERA 317
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 45/287 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ S LG G +G VFK G + AVKR + L E+
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 127 -HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ-PLSWTIRMKVA 184
H HP V+L E L E SL+ H + + W
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L LA+LHS +++ D K +NI L KL DFGL + G+ + G
Sbjct: 168 LA----LAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-G 218
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
Y APE + + +DV+S G+ +LE+ + P +
Sbjct: 219 DPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMEL-----PH-----------GGEGW 261
Query: 305 RRIFQ-VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+++ Q + S + L++ ++ L +PK R T + ++
Sbjct: 262 QQLRQGYLPPEFTAGLS--SELRSVLV--MMLEPDPKLRATAEALLA 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 53/309 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W +AVK L +++++ E+L E + ++ H
Sbjct: 20 KLGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PNLV+L+G C + ++ EFM G+L ++L R Q +S + + +A + + Y
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEY 126
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS-QSHVSTRV----MGTYGY 248
L I+RD N L+ N+ K++DFGL++ + +H +
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 179
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
APE +A + KSDV++FGV+L E+ + G PY
Sbjct: 180 -APESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLS- 219
Query: 308 FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363
QV + +E Y + G K L C P RP+ E+ +A E + +
Sbjct: 220 -QVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
Query: 364 SRDESLQNS 372
++ L
Sbjct: 278 EVEKELGKR 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 51/290 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +A+K + + S+ E++ E K + L H
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMNLSH 78
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L G C + ++ E+M G L N+L R + + M + + Y
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEM--CKDVCEAMEY 135
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
L S + ++RD N L++ K+SDFGL++ T +G+ ++
Sbjct: 136 LES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY----VLDDEYTSSVGSKFPVRWSP 189
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE + ++KSD+++FGV++ E+ S G+ PY + +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM------------------PY--ERFTNSE 229
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ I L A+ K + C + RPT ++ + +
Sbjct: 230 TAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 51/292 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +AVK + + S+ E+ E + + +L H
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-----------VAVKMIKEGSMSED-EFFQEAQTMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P LVK G C ++ +V E++ G L N+L ++P S + M +G+A+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEM--CYDVCEGMAF 119
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
L S + I+RD N L+D + K+SDFG+ + +GT ++A
Sbjct: 120 LES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSA 173
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE ++KSDV++FG+++ E+ S G+ PY +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM------------------PYDLYTNS--E 213
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357
V+ ++ + L A+ + C P+ RPT +++ ++E +++
Sbjct: 214 VVL-KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 22 DKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L +P +V++IG C + +LV E G L +L ++ ++ I + + G
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHV-KDKNIIEL--VHQVSMG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG------ 244
+ YL + ++RD N+LL + AK+SDFGL+K +++ + G
Sbjct: 130 MKYL-EES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKW 186
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303
APE + ++KSDV+SFGV++ E S G++ PY
Sbjct: 187 Y----APECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGM 224
Query: 304 KRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
K +V +E + G + L C + + + RP V L
Sbjct: 225 KGS--EVTA-MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 57/294 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G+G FG V G + +AVK + ++ +L E + QL H
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
NLV+L+G +E+ L +V E+M KGSL ++L R+ L +K +L + + Y
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV----MGTYGYA 249
L ++RD N+L+ + AK+SDFGL K+ + + ++
Sbjct: 133 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKLPVKWT------ 181
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308
APE + + KSDV+SFG++L E+ S GR PY + +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY--PRIPLK 221
Query: 309 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
V+ R+E Y + G + C + RP+ ++ + LE I+
Sbjct: 222 DVVP-RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 61/300 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 96 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ L+G CL + L+V +M G L N + R ++ + I L AKG+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGF--GLQVAKGMK 206
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG------TY 246
+L S K ++RD N +LD + K++DFGLA+D V +
Sbjct: 207 FLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305
A E + T T KSDV+SFGV+L E+++ G P + N + YL R
Sbjct: 264 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV-YLLQGR 313
Query: 306 R----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
R +++VM +KC + + RP+ E+V + I
Sbjct: 314 RLLQPEYCPDPLYEVM--------------------LKCWHPKAEMRPSFSELVSRISAI 353
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 80/302 (26%), Positives = 124/302 (41%), Gaps = 65/302 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G+G FG V+ G + + A+K L++ +Q +L E + L H
Sbjct: 28 VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ LIG L + ++ +M G L + R + I L A+G+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISF--GLQVARGME 138
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV----MG 244
YL K ++RD N +LD ++ K++DFGLA+D Q H R+
Sbjct: 139 YLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303
A E + T T KSDV+SFGV+L E+L+ G P R + + +L
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------PPYRHIDPFDLTH-FLAQ 243
Query: 304 KRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
RR ++QVM +C +P RPT +V +E
Sbjct: 244 GRRLPQPEYCPDSLYQVM--------------------QQCWEADPAVRPTFRVLVGEVE 283
Query: 354 QI 355
QI
Sbjct: 284 QI 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V G V A+K L + + ++L E +GQ H
Sbjct: 52 VVGAGEFGEVCSG-----RLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+++L G + ++V E+M GSL++ L + + + + + G A G+ Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
L SD ++RD NIL++ N K+SDFGL + ++ +TR G + +
Sbjct: 163 L-SDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTS 218
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE +A T+ SDV+S+G+VL E++S G R PY + +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER------------------PYWEMSNQ--D 258
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ A ++ Y L L + C + RP +++V L+++
Sbjct: 259 VIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 76/307 (24%), Positives = 127/307 (41%), Gaps = 67/307 (21%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---EWLTEIKHLGQ 130
LG+G FG V +G W A G + +AVK L + L +++ E+ +
Sbjct: 25 KLGDGSFGVVRRGEWD-------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L H NL++L G L +V E P GSL + L + + L R A+ A+G
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHF-LLGTLSRY--AVQVAEG 133
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YG 247
+ YL S + I+RD N+LL K+ DFGL + P +V +
Sbjct: 134 MGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE + T + SD + FGV L EM + G+ +P++
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGS 231
Query: 307 IFQVMDARIEGQ--------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
Q++ +I+ + Y+ + ++C +++P+ RPT + L
Sbjct: 232 --QILH-KIDKEGERLPRPEDCPQDIYN---------VMVQCWAHKPEDRPTFVALRDFL 279
Query: 353 EQIQDTN 359
+ Q T+
Sbjct: 280 LEAQPTD 286
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 78/361 (21%), Positives = 133/361 (36%), Gaps = 103/361 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V + +P +AVK L + + + + ++E+ K +G+
Sbjct: 76 PLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWT 178
H N++ L+G C +D ++ E+ KG+L +L R + + LS
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 192 DLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD--------- 240
Query: 239 STRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEM----------L 276
+ Y APE + T +SDV+SFGV+L E+ +
Sbjct: 241 ---IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 277 SGRRVIDKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALK 326
+ L+ R ++ +M
Sbjct: 298 PVEELFK----------------LLKEGHRMDKPSNCTNELYMMM--------------- 326
Query: 327 TAVLAIKCLSNEPKFRPTMDEVVKALEQI-QDTNDAGVSRDESLQNSDRSTYKRKGLNEN 385
C P RPT ++V+ L++I T++ + + D + L N
Sbjct: 327 -----RDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFN 381
Query: 386 G 386
G
Sbjct: 382 G 382
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 43/286 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 321
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L E+ +V E+M KGSL + L L + M A A G+AY
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 378
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 379 VER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 435
Query: 254 MATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 313
G T KSDV+SFG++L E+ + RV PY R +V+D
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNR--EVLD- 475
Query: 314 RIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++E Y + L +C EP+ RPT + + LE
Sbjct: 476 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 72/308 (23%), Positives = 121/308 (39%), Gaps = 82/308 (26%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V++G + + G + +AVK ++ +L ++++E + L
Sbjct: 19 ILGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HP++VKLIG E+ ++ E P G L ++L R + + +L K +A
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLY--SLQICKAMA 127
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY---- 248
YL S ++RD NIL+ KL DFGL+ R + Y
Sbjct: 128 YLES--INCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKAS 172
Query: 249 --------AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 299
+PE + T SDV+ F V + E+LS G++ P
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ------------------P 214
Query: 300 YLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+ + + V+ +G Y+ L +C +P RP E
Sbjct: 215 FFWLENK--DVIGVLEKGDRLPKPDLCPPVLYT---------LMTRCWDYDPSDRPRFTE 263
Query: 348 VVKALEQI 355
+V +L +
Sbjct: 264 LVCSLSDV 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 64/312 (20%), Positives = 120/312 (38%), Gaps = 50/312 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEI 125
NFR + +G G F V++ G+ +A+K++ L + EI
Sbjct: 33 NFRIEKKIGRGQFSEVYRAA---------CLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS----WTIRM 181
L QL HPN++K +ED+ +V E G L + + + W +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
++ L ++HS + V++RD K +N+ + KL D GL + + + +
Sbjct: 144 QLCSA----LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSL 196
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
V GT Y +PE + KSD++S G +L EM + + P+
Sbjct: 197 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS------------------PFY 237
Query: 302 QSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
K ++ + + Y L+ V C++ +P+ RP + V +++
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN--MCINPDPEKRPDVTYVYDVAKRM 295
Query: 356 QDTNDAGVSRDE 367
+ +
Sbjct: 296 HACTASSLEHHH 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 77/321 (23%), Positives = 118/321 (36%), Gaps = 86/321 (26%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 23 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRMKV 183
+VK G C + D ++V+E+M G L L L + + +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQSH 237
A A G+ YL S ++RD T N L+ N K+ DFG+++D G +
Sbjct: 139 ASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVIDKNRP 287
+ R M PE + T +SDV+SFGV+L E+ LS VI+
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE---- 246
Query: 288 SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAIKCLSN 337
+ R ++ VM + C
Sbjct: 247 ------------CITQGRVLERPRVCPKEVYDVM--------------------LGCWQR 274
Query: 338 EPKFRPTMDEVVKALEQIQDT 358
EP+ R + E+ K L +
Sbjct: 275 EPQQRLNIKEIYKILHALGKA 295
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 67/366 (18%), Positives = 134/366 (36%), Gaps = 50/366 (13%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPG 100
+ ++ F ++ + +GEG FG D Y
Sbjct: 3 HHHHHSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYV----- 53
Query: 101 TGM-VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+ I + R++ + + E E+ L + HPN+V+ E+ +V ++ G
Sbjct: 54 --IKEINISRMSSKERE---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 160 SLENHLFRRASYIQP----LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
L + + + L W +++ L ++H K +++RD K+ NI L
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHDRK--ILHRDIKSQNIFLTK 160
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM 275
+ +L DFG+A+ S ++ +GT Y +PE KSD+++ G VL E+
Sbjct: 161 DGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 276 LSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCL 335
+ + ++ L K I + YS L++ V +
Sbjct: 219 CTLK------HAFEAGSMKN-----LVLK--IISGSFPPVSLHYS--YDLRSLVS--QLF 261
Query: 336 SNEPKFRPTMDEVVKALEQIQDTNDAGVSRDESLQNSDRSTYKRKGLN-ENGQGKASVHH 394
P+ RP+++ +++ I + +S + T+ + G + AS +
Sbjct: 262 KRNPRDRPSVNSILE-KGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320
Query: 395 RPSERR 400
S
Sbjct: 321 SISVMP 326
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 51/290 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ + +AVK + S+ +L E + L H
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-----------VAVKTMKPGSMSVE-AFLAEANVMKTLQH 242
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LVKL ++ ++ EFM KGSL + L QPL I + A+G+A+
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAF 299
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
+ I+RD + +NIL+ + K++DFGLA+ + + T G + A
Sbjct: 300 IEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV----IEDNEYTAREGAKFPIKWTA 353
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE + G T KSDV+SFG++L+E+++ GR PY +
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------PY--PGMSNPE 393
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ A +E Y + + + ++C N P+ RPT + + L+
Sbjct: 394 VIRA-LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 54/305 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F P LG GGFG VF+ A+KR+ + + E + E+K
Sbjct: 6 DFEPIQCLGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 128 LGQLYHPNLVKLIGYCLEDD---------HRLLVY---EFMPKGSLENHLFRRASYIQPL 175
L +L HP +V+ LE + ++ +Y + K +L++ + R I+
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEER 115
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------- 228
++ + + L A+ + +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 229 ---DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285
T +GT Y +PE + + K D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225
Query: 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 345
S + + + F + Q V LS P RP
Sbjct: 226 PFSTQMERVRTLT---DVRNLKFP----PLFTQKY--PCEYVMVQ--DMLSPSPMERPEA 274
Query: 346 DEVVK 350
+++
Sbjct: 275 INIIE 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 51/290 (17%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G + +AVK L Q S+ +L E + QL H
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMSPD-AFLAEANLMKQLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L ++ ++ E+M GSL + L + ++ + M A A+G+A+
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM--AAQIAEGMAF 124
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGYAA 250
+ I+RD + +NIL+ + K++DFGLA+ + + T G + A
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTA 178
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
PE + G T KSDV+SFG++L E+++ GR PY +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRI------------------PY--PGMTNPE 218
Query: 310 VMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ +E Y + + L C P+ RPT D + LE
Sbjct: 219 VIQ-NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 67/320 (20%), Positives = 109/320 (34%), Gaps = 41/320 (12%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + L +L H N+VKL H++L+ EF P GSL L S L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEF 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 115 LIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170
Query: 237 HVSTRVMGTYGYAAPEYMATGHL--------TAKSDVYSFGVVLLEMLSGRR-VIDKNRP 287
+ GT Y P+ L A D++S GV +G P
Sbjct: 171 QFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 288 SREHNLIE----------WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSN 337
R ++ + I D + S G + + L
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 338 EPKFRPTMDEVVKALEQIQD 357
+ + D+ I
Sbjct: 290 DQEKCWGFDQFFAETSDILH 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 77/295 (26%), Positives = 121/295 (41%), Gaps = 51/295 (17%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q + E + E + + QL
Sbjct: 15 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + +LV E G L L + I P+S + + G+
Sbjct: 68 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAEL--LHQVSMGM 123
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG------T 245
YL +K ++RD N+LL + AK+SDFGL+K S+ + R G
Sbjct: 124 KYL-EEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWY 180
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304
APE + +++SDV+S+GV + E LS G++ PY + K
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKMK 218
Query: 305 RRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+VM IE + + L C + + RP V + +
Sbjct: 219 GP--EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 67/322 (20%), Positives = 109/322 (33%), Gaps = 41/322 (12%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + L +L H N+VKL H++L+ EF P GSL L S L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEF 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 115 LIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170
Query: 237 HVSTRVMGTYGYAAPEYMATGHL--------TAKSDVYSFGVVLLEMLSGRR-VIDKNRP 287
+ GT Y P+ L A D++S GV +G P
Sbjct: 171 QFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 288 SREHNLIE----------WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSN 337
R ++ + I D + S G + + L
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
Query: 338 EPKFRPTMDEVVKALEQIQDTN 359
+ + D+ I
Sbjct: 290 DQEKCWGFDQFFAETSDILHRG 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-34
Identities = 37/229 (16%), Positives = 74/229 (32%), Gaps = 18/229 (7%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+ ++ +LGEG F V++ +K +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA---TQGDLNDAK-NKQKFVLKVQKPANPWEFYIGT 115
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-QPLSWTIRM 181
++ L +K L + +LV E G+L N + + + + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-----------DLNYNAKLSDFGLAKDG 230
A+ + +H ++I+ D K N +L DL+ L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ + T T G+ E ++ + D + + ML G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 78/383 (20%), Positives = 137/383 (35%), Gaps = 98/383 (25%)
Query: 23 RKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTAT--------RNFRPDS 74
R+ SSS S+ +V T + +
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 88 PLGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWT 178
H N++ L+G C +D ++ E+ KG+L +L R + +++
Sbjct: 146 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QS 236
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D +
Sbjct: 204 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 237 HVSTRV----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVI 282
+ R+ M APE + T +SDV+SFGV++ E+ + +
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 283 DKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAI 332
L+ R ++ +M
Sbjct: 316 K----------------LLKEGHRMDKPANCTNELYMMM--------------------R 339
Query: 333 KCLSNEPKFRPTMDEVVKALEQI 355
C P RPT ++V+ L++I
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 73/323 (22%), Positives = 124/323 (38%), Gaps = 90/323 (27%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 42 PLGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR---------- 180
H N++ L+G C +D ++ E+ KG+L +L R S+ I
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 181 --MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QS 236
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D +
Sbjct: 158 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 237 HVSTRV----MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LSGRRVI 282
+ R+ M APE + T +SDV+SFGV++ E+ + +
Sbjct: 216 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 283 DKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAVLAI 332
L+ R ++ +M
Sbjct: 270 K----------------LLKEGHRMDKPANCTNELYMMM--------------------R 293
Query: 333 KCLSNEPKFRPTMDEVVKALEQI 355
C P RPT ++V+ L++I
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 81/326 (24%), Positives = 124/326 (38%), Gaps = 66/326 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + P P V AVK L + S Q L++L E + + H
Sbjct: 78 GLGHGAFGEVYEG---QVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR--MKVALGAAKG 190
N+V+ IG L+ R ++ E M G L++ L R QP S + + VA A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
YL + I+RD N LL AK+ DFG+A+D G
Sbjct: 194 CQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCA 246
Query: 248 Y-----AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 301
PE G T+K+D +SFGV+L E+ S G PY
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PY- 287
Query: 302 QSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349
+ +V++ G Y + +C ++P+ RP ++
Sbjct: 288 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---------IMTQCWQHQPEDRPNFAIIL 337
Query: 350 KALEQI-QDTNDAGVSRDESLQNSDR 374
+ +E QD + +
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVE 363
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 74/333 (22%), Positives = 115/333 (34%), Gaps = 56/333 (16%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
S S+++ + +LL +K + + +G G FG V +
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHR 76
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
D+ TG AVK++ E + E+ L P +V L G E
Sbjct: 77 M-KDK--------QTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREG 122
Query: 147 DHRLLVYEFMPKGSLENHLFRRASYIQ---PLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203
+ E + GSL I+ L + A +GL YLH+ ++++
Sbjct: 123 PWVNIFMELLEGGSL-------GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--RILH 173
Query: 204 RDFKTSNILLDLN-YNAKLSDFGLAK----DGPTGSQSHVSTRVMGTYGYAAPE-YMATG 257
D K N+LL + A L DFG A DG S + GT + APE M
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPEVVMGKP 232
Query: 258 HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA---R 314
AK D++S ++L ML+G P W + ++
Sbjct: 233 C-DAKVDIWSSCCMMLHMLNGC------HP--------WTQ--YFRGPLCLKIASEPPPI 275
Query: 315 IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
E S A+ + L EP R + E
Sbjct: 276 REIPPSCAPLTAQAIQ--EGLRKEPVHRASAME 306
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 74/315 (23%), Positives = 117/315 (37%), Gaps = 73/315 (23%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGE FG V+KG H + PA +A+K L + E+ E +L H
Sbjct: 16 ELGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRM 181
PN+V L+G +D +++ + G L L R + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG------PTGSQ 235
+ A G+ YL S V+++D T N+L+ N K+SD GL ++
Sbjct: 132 HLVAQIAAGMEYL-SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 236 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLI 294
S + R M APE + G + SD++S+GVVL E+ S G +
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-------------- 229
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFR 342
PY + V++ Q Y+ L I+C + P R
Sbjct: 230 ----PYCGYSNQ--DVVEMIRNRQVLPCPDDCPAWVYA---------LMIECWNEFPSRR 274
Query: 343 PTMDEVVKALEQIQD 357
P ++ L +
Sbjct: 275 PRFKDIHSRLRAWGN 289
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 71/313 (22%), Positives = 111/313 (35%), Gaps = 65/313 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+ LG GGFG V + H TG +A+K+ QE + E W EI+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQD------TGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 128 LGQLYHPNLVKLI------GYCLEDDHRLLVYEFMPKGSLENHLFRR-----------AS 170
+ +L HPN+V +D LL E+ G L +L + +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA---KLSDFGLA 227
+ + + L YLH + ++I+RD K NI+L K+ D G A
Sbjct: 126 LLSDI------------SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287
K+ G V GT Y APE + T D +SFG + E ++G RP
Sbjct: 172 KELDQGELCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------RP 222
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNE--------- 338
+ ++ K V+ + G + L T L+ +
Sbjct: 223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML 282
Query: 339 ---PKFRPTMDEV 348
+ R T +
Sbjct: 283 MWHQRQRGTDPQN 295
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 77/314 (24%), Positives = 120/314 (38%), Gaps = 71/314 (22%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
LG G FG V++G + +AVK L + S Q L++L E + +
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR--MKVALGAAK 189
H N+V+ IG L+ R ++ E M G L++ L R QP S + + VA A
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPT------GSQSHVST 240
G YL + I+RD N LL AK+ DFG+A+D G + +
Sbjct: 152 GCQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRR-------------VIDKNR 286
+ M PE G T+K+D +SFGV+L E+ S G V R
Sbjct: 210 KWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 287 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD 346
N ++++M +C ++P+ RP
Sbjct: 264 MDPPKNC----------PGPVYRIM--------------------TQCWQHQPEDRPNFA 293
Query: 347 EVVKALEQIQDTND 360
+++ +E D
Sbjct: 294 IILERIEYCTQDPD 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 78/307 (25%), Positives = 110/307 (35%), Gaps = 80/307 (26%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G Y V A+K S ++L E + Q H
Sbjct: 22 CIGEGQFGDVHQG-----IYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P++VKLIG E+ ++ E G L + L R + S I A + LAY
Sbjct: 76 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLAS-LILY--AYQLSTALAY 131
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY----- 248
L S + ++RD N+L+ N KL DFGL+ R M Y
Sbjct: 132 LES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASK 176
Query: 249 -------AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPY 300
APE + T+ SDV+ FGV + E+L G + P+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK------------------PF 218
Query: 301 LQSKRRIFQVMDARIEGQ------------YSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
K V+ G+ YS L KC + +P RP E+
Sbjct: 219 QGVKNN--DVIGRIENGERLPMPPNCPPTLYS---------LMTKCWAYDPSRRPRFTEL 267
Query: 349 VKALEQI 355
L I
Sbjct: 268 KAQLSTI 274
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V+ G + IA+K + + + EI L H
Sbjct: 29 VLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVALGAAKGLA 192
N+V+ +G E+ + E +P GSL L + ++ TI K L +GL
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLK 136
Query: 193 YLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YLH + ++++RD K N+L++ + K+SDFG +K G T GT Y AP
Sbjct: 137 YLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTET-FTGTLQYMAP 192
Query: 252 E---YMATGHLTAKSDVYSFGVVLLEMLSGRR 280
E G+ +D++S G ++EM +G+
Sbjct: 193 EIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 78/306 (25%), Positives = 127/306 (41%), Gaps = 43/306 (14%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q E + E + + QL
Sbjct: 341 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + +LV E G L L + I P+S + + G+
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAEL--LHQVSMGM 449
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA-- 249
YL +K ++R+ N+LL + AK+SDFGL+K S+ + R G +
Sbjct: 450 KYL-EEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWY 506
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308
APE + +++SDV+S+GV + E LS G++ PY + K
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKMKGP-- 546
Query: 309 QVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVS 364
+VM IE + + L C + + RP V + + + + V
Sbjct: 547 EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605
Query: 365 RDESLQ 370
+L+
Sbjct: 606 GGSALE 611
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 35/295 (11%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLE 120
+ + ++ +G G +G K R G ++ K L+ S+
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 121 WLTEIKHLGQLYHPNLVKLIG-YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++E+ L +L HPN+V+ + L +V E+ G L + + + Q L
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 179 IRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
++V L H V++RD K +N+ LD N KL DFGLA+
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDT 170
Query: 236 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295
S T V GT Y +PE M KSD++S G +L E+ + P + E
Sbjct: 171 SFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKE 223
Query: 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
L K I + RI +YS L + + L+ + RP+++E+++
Sbjct: 224 -----LAGK--IREGKFRRIPYRYS--DELNEIIT--RMLNLKDYHRPSVEEILE 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 46/229 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + + + + +AVK L ++E+ HLGQ
Sbjct: 53 TLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ----------PLSWTIR 180
H N+V L+G C L++ E+ G L N L R++ ++ S
Sbjct: 109 --HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ + A+G+A+L S I+RD N+LL + AK+ DFGLA+D
Sbjct: 167 LHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARD----------- 213
Query: 241 RVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS 277
+M Y APE + T +SDV+S+G++L E+ S
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 71/334 (21%), Positives = 122/334 (36%), Gaps = 95/334 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG VF+ ++AVK L +E S ++ E + + +
Sbjct: 54 DIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------------ASYIQ 173
PN+VKL+G C L++E+M G L L +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT- 232
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 233 -----GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEM----------LS 277
+ R M PE + T +SDV+++GVVL E+ ++
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 278 GRRVIDKNRPSREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKT 327
VI Y++ ++ +M
Sbjct: 282 HEEVIY----------------YVRDGNILACPENCPLELYNLM---------------- 309
Query: 328 AVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361
C S P RP+ + + L+++ + +
Sbjct: 310 ----RLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 60/314 (19%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
++ F + R + +G GG VF+ + A+K +N E
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 116 QGHL--EWLTEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
+ EI +L +L + ++L Y + D + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--- 121
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + R + + +H +++ D K +N L+ + KL DFG+A
Sbjct: 122 -KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177
Query: 232 TGSQSHVSTRVMGTYGYAAPE-----------YMATGHLTAKSDVYSFGVVLLEMLSGRR 280
+ S V +GT Y PE + ++ KSDV+S G +L M G+
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKC 334
P+ Q + A I+ + L+ + C
Sbjct: 238 ------------------PF-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD--VLKCC 276
Query: 335 LSNEPKFRPTMDEV 348
L +PK R ++ E+
Sbjct: 277 LKRDPKQRISIPEL 290
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 74/326 (22%), Positives = 114/326 (34%), Gaps = 95/326 (29%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + Y + M +AVK L L ++E+ +LG
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------ASYIQPLS 176
H N+V L+G C L++ E+ G L N L R+ L
Sbjct: 86 --HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARD------- 194
Query: 237 HVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 283
+ Y APE + T +SDV+S+G+ L E+ S G
Sbjct: 195 -----IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---- 245
Query: 284 KNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAV 329
P + + ++ R ++ +M
Sbjct: 246 --SPYPGMPVDSKFYK----MIKEGFRMLSPEHAPAEMYDIM------------------ 281
Query: 330 LAIKCLSNEPKFRPTMDEVVKALEQI 355
C +P RPT ++V+ +E+
Sbjct: 282 --KTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-32
Identities = 76/292 (26%), Positives = 115/292 (39%), Gaps = 50/292 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G + M +A+K S ++L E + Q H
Sbjct: 397 CIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P++VKLIG E+ ++ E G L + L + + L+ I A + LAY
Sbjct: 451 PHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILY--AYQLSTALAY 506
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP-----TGSQSHVSTRVMGTYGY 248
L S + ++RD N+L+ N KL DFGL++ S+ + + M
Sbjct: 507 LES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 559
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
APE + T+ SDV+ FGV + E+L G + P+ K
Sbjct: 560 -APESINFRRFTSASDVWMFGVCMWEILMHGVK------------------PFQGVKNN- 599
Query: 308 FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
V+ RIE L L KC + +P RP E+ L I
Sbjct: 600 -DVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 70/316 (22%), Positives = 118/316 (37%), Gaps = 62/316 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F P VLG G G + + +AVKR+ E E++ L
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMF------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ HPN+++ + + + E +L+ ++ ++ + +
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQT 127
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAK--DGPTGSQSHVST 240
GLA+LHS +++RD K NIL+ A +SDFGL K S S S
Sbjct: 128 TSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 241 RVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297
GT G+ APE + + T D++S G V ++S H
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS----------H------ 228
Query: 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDEV----- 348
P+ +S +R ++ L V+A K ++ +P+ RP+ V
Sbjct: 229 -PFGKSLQRQANILLGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 349 ----VKALEQIQDTND 360
K L+ QD +D
Sbjct: 287 FWSLEKQLQFFQDVSD 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 78/326 (23%), Positives = 117/326 (35%), Gaps = 96/326 (29%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLG 129
LG G FG V + + T +AVK L + + H ++E+ H+G
Sbjct: 34 PLGRGAFGQVIEADAFG-----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 130 QLYHPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLS 176
H N+V L+G C +++ EF G+L +L + Y L+
Sbjct: 89 H--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 147 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD------- 197
Query: 237 HVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 283
+ Y APE + T +SDV+SFGV+L E+ S G
Sbjct: 198 -----IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---- 248
Query: 284 KNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALKTAV 329
P + L+ R ++Q M
Sbjct: 249 --SPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTM------------------ 284
Query: 330 LAIKCLSNEPKFRPTMDEVVKALEQI 355
+ C EP RPT E+V+ L +
Sbjct: 285 --LDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 74/299 (24%), Positives = 117/299 (39%), Gaps = 64/299 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 63
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQ 173
EI L H ++V G+ ED+ + +V E + SL RR Y++
Sbjct: 64 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 123 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 234 SQSHVSTRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291
+ +V+ GT Y APE + + + + DV+S G ++ +L G+ P
Sbjct: 169 GERK---KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETS 218
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
L E Y RI + + I + A A L K L +P RPT++E++
Sbjct: 219 CLKET---Y----LRIKKN-EYSIPKHINPVA----ASLIQKMLQTDPTARPTINELLN 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 48/221 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHL 128
LG+G FG V+ AR + ++A+K L + L+ L E++
Sbjct: 16 PLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLR--REVEIQ 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQPLSWTI 179
L HPN+++L GY D R+ L+ E+ P G++ L + A+YI L
Sbjct: 64 SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL---- 118
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
A L+Y HS + VI+RD K N+LL K++DFG + P+ + +
Sbjct: 119 --------ANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---T 165
Query: 240 TRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR 279
+ GT Y PE M G + K D++S GV+ E L G+
Sbjct: 166 D-LCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 25/227 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYA--------PARPGTGMVIAVKRLNQESLQGHLE 120
++R L +G F + D YA + +++ +S +
Sbjct: 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTI 179
E++ + + + + G + + + ++YE+M S+ + + I
Sbjct: 92 --NELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 180 RMKVAL----GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
++V +Y+H++K + +RD K SNIL+D N KLSDFG ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-- 205
Query: 236 SHVSTRVMGTYGYAAPEYMATGHLT---AKSDVYSFGVVLLEMLSGR 279
+ GTY + PE + + AK D++S G+ L M
Sbjct: 206 -KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 50/222 (22%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVK-----RLNQESLQGHLEWLTEIKHL 128
LG+G FG V+ AR ++A+K +L +E ++ L EI+
Sbjct: 21 PLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQ 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQPLSWTI 179
L HPN++++ Y D R+ L+ EF P+G L L + A++++ L
Sbjct: 69 SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL---- 123
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
A L Y H K VI+RD K N+L+ K++DFG + P+
Sbjct: 124 --------ADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----R 168
Query: 240 TRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR 279
R M GT Y PE M G K D++ GV+ E L G
Sbjct: 169 RRTMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 74/299 (24%), Positives = 117/299 (39%), Gaps = 64/299 (21%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 89
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQ 173
EI L H ++V G+ ED+ + +V E + SL RR Y++
Sbjct: 90 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 149 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 234 SQSHVSTRVM-GTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291
+ +V+ GT Y APE + + + + DV+S G ++ +L G+ P
Sbjct: 195 GERK---KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETS 244
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
L E Y RI + + I + A A L K L +P RPT++E++
Sbjct: 245 CLKET---Y----LRIKKN-EYSIPKHINPVA----ASLIQKMLQTDPTARPTINELLN 291
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 79/328 (24%), Positives = 124/328 (37%), Gaps = 95/328 (28%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V K + R G V AVK L + S + L+E L Q+ H
Sbjct: 30 TLGEGEFGKVVKA---TAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------------ASYIQ 173
P+++KL G C +D LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
L+ + A ++G+ YL ++ K+++RD NIL+ K+SDFGL++D
Sbjct: 146 ALTMGDLISFAWQISQGMQYL-AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRD---- 199
Query: 234 SQSHVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEM------ 275
V Y A E + T +SDV+SFGV+L E+
Sbjct: 200 --------VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 276 ----LSGRRVIDK----NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKT 327
+ R+ + +R R N ++++M
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN----------CSEEMYRLM---------------- 285
Query: 328 AVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++C EP RP ++ K LE++
Sbjct: 286 ----LQCWKQEPDKRPVFADISKDLEKM 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 73/337 (21%), Positives = 122/337 (36%), Gaps = 101/337 (29%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
VLG G FG V Y ++ G + +AVK L ++ ++E+ LG
Sbjct: 52 VLGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------------------ASY 171
H N+V L+G C L++E+ G L N+L +
Sbjct: 108 --HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ L++ + A AKG+ +L ++RD N+L+ K+ DFGLA+D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARD-- 221
Query: 232 TGSQSHVSTRVMGTYGYA------------APEYMATGHLTAKSDVYSFGVVLLEMLS-G 278
+M Y APE + G T KSDV+S+G++L E+ S G
Sbjct: 222 ----------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 279 RRVIDKNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAA 324
P + N + +Q+ + I+ +M
Sbjct: 272 V------NPYPGIPVDANFYK----LIQNGFKMDQPFYATEEIYIIM------------- 308
Query: 325 LKTAVLAIKCLSNEPKFRPTMDEVVKALE-QIQDTND 360
C + + + RP+ + L Q+ D +
Sbjct: 309 -------QSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 63/359 (17%), Positives = 121/359 (33%), Gaps = 71/359 (19%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
+G + S + + + + + S + S G R +
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----RIYSIL 61
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-----LNQESLQGHLEWLTEIKHL 128
+G GG VF+ + A+K + ++L + EI +L
Sbjct: 62 KQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYL 108
Query: 129 GQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+L + ++L Y + D + +V E L + L ++ + + R
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKN 163
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ + +H +++ D K +N L+ + KL DFG+A + S V +G
Sbjct: 164 MLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 247 GYAAPE-----------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295
Y PE + ++ KSDV+S G +L M G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------------- 264
Query: 296 WAKPYLQSKRRIFQVMDARIEGQY------SLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
P+ Q + A I+ + L+ + CL +PK R ++ E+
Sbjct: 265 --TPF-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD--VLKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 60/295 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G GG VF+ + A+K +N E + EI +L +L
Sbjct: 16 QIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 133 HPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
+ ++L Y + D + +V E L + L ++ + + R +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ +H +++ D K +N L+ + KL DFG+A + S V +GT Y
Sbjct: 121 VHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 251 PE-----------YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299
PE + ++ KSDV+S G +L M G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------P 219
Query: 300 YLQSKRRIFQVMDARIEGQYS------LGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+ Q + A I+ + L+ + CL +PK R ++ E+
Sbjct: 220 F-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD--VLKCCLKRDPKQRISIPEL 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 61/308 (19%), Positives = 101/308 (32%), Gaps = 62/308 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTE 124
T F +G G FG VFK + G + A+KR + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV---------KRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L H ++V+ EDDH L+ E+ GSL + + + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-------------------YNAKLSDF 224
L +GL Y+HS +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--TGHLTAKSDVYSFGVVLLEMLSGRRVI 282
G S G + A E + HL K+D+++ + ++
Sbjct: 179 GHVT-----RISSPQVEE-GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE--- 228
Query: 283 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342
R + +W + I Q RI S + + +P+ R
Sbjct: 229 ---PLPRNGD--QWHE--------IRQGRLPRIPQVLS--QEFTELLK--VMIHPDPERR 271
Query: 343 PTMDEVVK 350
P+ +VK
Sbjct: 272 PSAMALVK 279
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 71/289 (24%), Positives = 120/289 (41%), Gaps = 59/289 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEW--LTEIKHLGQLY 132
LG+G F V++ E TG+ +A+K ++++++ + E+K QL
Sbjct: 19 LGKGSFAGVYRA---ESI------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR---------ASYIQPLSWTIRMK 182
HP++++L Y ED + + LV E G + +L R ++ +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------- 121
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ YLHS +++RD SN+LL N N K++DFGLA + H T +
Sbjct: 122 -----ITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 243 MGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
GT Y +PE +AT +SDV+S G + +L GR P +
Sbjct: 173 CGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKN---TL- 221
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
++ D + S+ A L + L P R ++ V+
Sbjct: 222 ---NKVVLA-DYEMPSFLSIEA----KDLIHQLLRRNPADRLSLSSVLD 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 33/317 (10%), Positives = 70/317 (22%), Gaps = 58/317 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
R + L G VF A+K + E
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVR---------DVERLEDFALKVFTMGAENSRSELERLHE 111
Query: 124 EIKHLGQLYHPNLVKLIGYC--------------------------LEDDHRLLVYEFMP 157
+L + + + LL+
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171
Query: 158 --KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
L + L + + + A L S +++ F N+ +
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMP 229
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLL 273
+ L D YA E++ T + + G+ +
Sbjct: 230 DGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284
Query: 274 EMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIK 333
+ P + + + R+ L +KT + +
Sbjct: 285 RVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG--R 335
Query: 334 CLSNEPKFRPTMDEVVK 350
L+ + + R E ++
Sbjct: 336 FLNFDRRRRLLPLEAME 352
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 71/321 (22%), Positives = 118/321 (36%), Gaps = 65/321 (20%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R VL EGGF V++ + +G A+KRL + + + E+
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA---QDVG------SGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 128 LGQL-YHPNLVKLIGYCLEDDHR-------LLVYEFMPKGSLENHLFRRASYIQPLS-WT 178
+ +L HPN+V+ L+ + KG L L + S PLS T
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDT 137
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQ 235
+ K+ + + ++H K +I+RD K N+LL KL DFG A P S
Sbjct: 138 VL-KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 236 SHVSTRVM-------GTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285
S ++ T Y PE + + K D+++ G +L + + +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSL------GAALKTAVLAIKCLSNEP 339
+K RI + G+YS+ + L L P
Sbjct: 257 -----------------AKLRI-------VNGKYSIPPHDTQYTVFHS--LIRAMLQVNP 290
Query: 340 KFRPTMDEVVKALEQIQDTND 360
+ R ++ EVV L++I +
Sbjct: 291 EERLSIAEVVHQLQEIAAARN 311
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 51/367 (13%), Positives = 110/367 (29%), Gaps = 72/367 (19%)
Query: 21 CSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGG 80
+R +S + S + + G + S G + R +VLG+
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP--RTLVRGTVLGQED 85
Query: 81 FGCVFKGWIDEHT---YA------PARPGTGMVIAVKR-----------LNQESLQGHLE 120
+ D+ T + RP + + +K NQ+ + HL
Sbjct: 86 PYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK-----GSLENHLFRRASYIQPL 175
++ + ++++ D L + P+ + L +S + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
R+++ L + LA LH +++ + +I+LD L+ F +
Sbjct: 204 VHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------R 255
Query: 236 SHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDK 284
+ G+ PE A +T D ++ G+V+ +
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD----- 310
Query: 285 NRPSREHNLIEWAKPYLQSKRRI-FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP 343
P + + ++ +S + I V L L + R
Sbjct: 311 -LPITKDAALGGSEWIFRSCKNIPQPVRA-----------------LLEGFLRYPKEDRL 352
Query: 344 TMDEVVK 350
+ ++
Sbjct: 353 LPLQAME 359
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKHL 128
F S LG G G VFK H +G+V+A K ++ E + E++ L
Sbjct: 35 FEKISELGAGNGGVVFKV---SHK------PSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ P +V G D + E M GSL+ L + I KV++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVI 141
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
KGL YL K+++RD K SNIL++ KL DFG++ S ++ V GT Y
Sbjct: 142 KGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRSY 196
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+PE + H + +SD++S G+ L+EM GR
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 91/294 (30%), Positives = 131/294 (44%), Gaps = 60/294 (20%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG VFKG ID T V+A+K ++ E + +E + EI L
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
Q P + K G L+D ++ E++ GS L PL T +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEP----GPLDETQIATILREIL 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
KGL YLHS+K I+RD K +N+LL + KL+DFG+A T +Q +T +GT +
Sbjct: 130 KGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNT-FVGTPFW 185
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHNLIEW 296
APE + +K+D++S G+ +E+ G +V I KN P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------- 236
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
P +EG YS LK V CL+ EP FRPT E++K
Sbjct: 237 --P--------------TLEGNYS--KPLKEFV--EACLNKEPSFRPTAKELLK 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 74/345 (21%), Positives = 125/345 (36%), Gaps = 83/345 (24%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N ++ + +LG G G V + ++ G +AVKR+ + L
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM 57
Query: 121 WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
EIK L + HPN+++ D + E +L++ + + + L
Sbjct: 58 ---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113
Query: 180 RMKVA---LGAAKGLAYLHSDKAKVIYRDFKTSNILLD-------------LNYNAKLSD 223
A G+A+LHS K+I+RD K NIL+ N +SD
Sbjct: 114 EYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 224 FGLAK---DGPTGSQSHVSTRVMGTYGYAAPE-------YMATGHLTAKSDVYSFGVVLL 273
FGL K G + +++++ GT G+ APE LT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 274 EMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI- 332
+LS + H P+ R ++ G +SL ++
Sbjct: 231 YILSKGK----------H-------PFGDKYSRESNII----RGIFSLDEMKCLHDRSLI 269
Query: 333 --------KCLSNEPKFRPTMDEV---------VKALEQIQDTND 360
+ + ++P RPT +V K LE + +D
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 60/301 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
V+G G V +A+KR+N E Q ++ L EI+ + Q +H
Sbjct: 22 VIGSGATAVVQAA-YCA--------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR-------MKVALG 186
PN+V + D LV + + GS+ + + + + S + ++ L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL- 131
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRV 242
+GL YLH + I+RD K NILL + + +++DFG LA G T V
Sbjct: 132 --EGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 243 MGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSR 289
GT + APE M K+D++SFG+ +E+ +G +V +N P
Sbjct: 188 -GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-- 244
Query: 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349
P L++ V D + +Y + + + CL +P+ RPT E++
Sbjct: 245 ---------PSLETG-----VQDKEMLKKYG--KSFRKMI--SLCLQKDPEKRPTAAELL 286
Query: 350 K 350
+
Sbjct: 287 R 287
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+R ++G GG G V++ E T R +A+K +++ L + T E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---EDTVRE-RI-----VALKLMSET-LSSDPVFRTRMQREA 85
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ G+L P++V + + D + + L L R+ PL+ + +
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVR 141
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
L H A +RD K NIL+ + A L DFG+A + + +GT
Sbjct: 142 QIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGT 198
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
Y APE + H T ++D+Y+ VL E L+G
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
++ LG GG V+ D + +A+K + + E L E+
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-DTIL--------NIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ QL H N+V +I EDD LV E++ +L ++ PLS +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTN 118
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
G+ + H ++++RD K NIL+D N K+ DFG+AK S + + V+GT
Sbjct: 119 QILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGT 175
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
Y +PE +D+YS G+VL EML G
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 46/249 (18%), Positives = 86/249 (34%), Gaps = 47/249 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHT---YA---PARPGTGMVIAVKRLNQESLQGHLE 120
R +VLG+ + D+ T + P A+K++ +E L+ L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLR--LR 133
Query: 121 WLTEIKHLGQ-------------LYHPNLVKLIGYCLEDDHRLLVYEF--MPK-----GS 160
L IK+ Q + P K+I L++ ++ F P+ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L +S + L R+++ L + LA LH +++ + +I+LD
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVF 251
Query: 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----------TGHLTAKSDVYSFGV 270
L+ F G+ S G+A PE A +T D ++ G+
Sbjct: 252 LTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 271 VLLEMLSGR 279
+ +
Sbjct: 306 AIYWIWCAD 314
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 20/216 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK-H 127
P LG G +G V K H +G ++AVKR+ Q L ++
Sbjct: 9 LEPIMELGRGAYGVVEKM---RHV------PSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ + P V G + + E M SL+ + Q + I K+A+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
K L +LHS K VI+RD K SN+L++ K+ DFG++ G
Sbjct: 119 VKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKP 174
Query: 248 YAAPE----YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + + KSD++S G+ ++E+ R
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 43/286 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ +D T G +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE 124
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS+ +VI+RD K+ NILL ++ + KL+DFG T QS ST V GT
Sbjct: 125 CLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTP 180
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK-- 304
+ APE + K D++S G++ +EM+ G P PYL
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPL 222
Query: 305 RRIFQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
R ++ + ++ L A + + +CL + + R + E
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLN--RCLEMDVEKRGSAKE 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 46/218 (21%), Positives = 78/218 (35%), Gaps = 32/218 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ + GG G ++ RP + +K L + E + L
Sbjct: 82 YEVKGCIAHGGLGWIYLA---LDRNVNGRP-----VVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-----LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
++ HP++V++ + D +V E++ SL+ + L +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAY 187
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRV 242
L L+YLHS ++Y D K NI+L KL D G G +
Sbjct: 188 LLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------L 237
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
GT G+ APE + T +D+Y+ G L +
Sbjct: 238 YGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 28/220 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
F VLG GGFG VF A TG + A K+LN++ L + + + E
Sbjct: 186 WFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
K L +++ +V L Y E L LV M G + H++ R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFY 294
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G L +LH +IYRD K N+LLD + N ++SD GLA + G
Sbjct: 295 TAQIVSG----LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TK 347
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT G+ APE + D ++ GV L EM++ R
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 43/286 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+GEG G V ++H+ G +AVK ++ Q E+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ H N+V++ L + ++ EF+ G+L + + + L+ V
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEA 149
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ LAYLH+ VI+RD K+ +ILL L+ KLSDFG + + V GT
Sbjct: 150 VLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLV-GTP 205
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK-- 304
+ APE ++ + D++S G++++EM+ G P PY
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDSPV 247
Query: 305 RRIFQVMDA---RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+ + ++ D+ +++ + + L+ + + L +P+ R T E
Sbjct: 248 QAMKRLRDSPPPKLKNSHKVSPVLRDFLE--RMLVRDPQERATAQE 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 68/220 (30%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
FR VLG+GGFG V A TG + A K+L ++ + + L E
Sbjct: 185 TFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
+ L ++ +V L Y E L LV M G L+ H++ P + R
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFY 291
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G L LH ++ ++YRD K NILLD + + ++SD GLA P G
Sbjct: 292 AAEICCG----LEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-- 343
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
RV GT GY APE + T D ++ G +L EM++G+
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 51/308 (16%), Positives = 94/308 (30%), Gaps = 50/308 (16%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLYHP 134
G V + TG + V+R+N E+ + +L E+ HP
Sbjct: 36 GFEDLMTVNLA---RYK------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V + D+ +V FM GS ++ + ++ ++ + G K L Y+
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFG-LAKDGPTGSQSHV----STRVMGTYGYA 249
H ++R K S+IL+ ++ LS G + V + +
Sbjct: 145 HHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 250 APEYMATGHL--TAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHNLIE 295
+PE + AKSD+YS G+ E+ +G ++ +
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----------------KCLSNEP 339
L + + +CL P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 340 KFRPTMDE 347
RP+
Sbjct: 323 DARPSAST 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G S + S S+ V +G + + + + + ++ V
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKV-TTVVATPGQGPDRPQEVSYTDTKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G FG V++ + + +G ++A+K++ Q+ E++ + +L H N
Sbjct: 62 IGNGSFGVVYQAKLCD---------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCN 108
Query: 136 LVKLIGYCLEDDHRL------LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAA 188
+V+L + + LV +++P+ ++ + Q L I +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMGT 245
+ LAY+HS + +RD K N+LLD + KL DFG AK G S++ +R
Sbjct: 167 RSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 246 YGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
Y Y APE + AT T+ DV+S G VL E+L G+
Sbjct: 221 Y-YRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 68/359 (18%), Positives = 116/359 (32%), Gaps = 115/359 (32%)
Query: 68 RNFRPDSVLGEGGFGCVFKGW--IDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTE 124
+F P +G GGFG VF+ +D+ Y A+KR+ + + E + E
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNY-----------AIKRIRLPNRELAREKVMRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS-------------- 170
+K L +L HP +V+ LE E + S
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 171 ----------------------YIQ------------------------PLSWTIRMKVA 184
YIQ + I +++A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----------GPTGS 234
+ +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 175 EA----VEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 235 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
T +GT Y +PE + + + K D++S G++L E+L
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY----------------- 271
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLA--IK-CLSNEPKFRPTMDEVVK 350
+ R+ + D R ++ L K ++ LS P RP ++++
Sbjct: 272 ----SFSTQMERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE- 124
+F ++G GGFG V+ + TG + A+K L+++ + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 125 --IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ + P +V + Y +L + + M G L HL + + + M
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DM 294
Query: 182 K-----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ + LG L ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 295 RFYAAEIILG----LEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKS-DVYSFGVVLLEMLSGR 279
V GT+GY APE + G S D +S G +L ++L G
Sbjct: 347 -PHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 70/299 (23%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG+G FG V+K ++ T G + A K + +S + +++ EI+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP +VKL+G D ++ EF P G+++ + + L+ V +
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLE 128
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-AKDGPTGSQSHVSTRVMGTYGY 248
L +LHS + +I+RD K N+L+ L + +L+DFG+ AK+ T + +GT +
Sbjct: 129 ALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYW 183
Query: 249 AAPEYMATGHLT-----AKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREH 291
APE + + K+D++S G+ L+EM RV I K+ P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---- 239
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
P L + ++S + + L P+ RP+ ++++
Sbjct: 240 -------PTLLTP------------SKWS--VEFRDFL--KIALDKNPETRPSAAQLLE 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 81/332 (24%), Positives = 132/332 (39%), Gaps = 71/332 (21%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEI 125
F LGEG +G V+K H TG ++A+K++ + LQ E + EI
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA---IHK------ETGQIVAIKQVPVESDLQ---EIIKEI 75
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ Q P++VK G ++ +V E+ GS+ + + R L+ +
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQ 132
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
KGL YLH + I+RD K NILL+ +AKL+DFG+A T + + +T + GT
Sbjct: 133 STLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ-LTDTMAKRNTVI-GT 188
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPSREHNL 293
+ APE + +D++S G+ +EM G+ R I N P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------ 242
Query: 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK--- 350
P + +S V +CL P+ R T ++++
Sbjct: 243 -----PTFRKPEL------------WS--DNFTDFVK--QCLVKSPEQRATATQLLQHPF 281
Query: 351 ---------ALEQIQDTNDAGVSRDESLQNSD 373
+ I + D + R ES Q +
Sbjct: 282 VRSAKGVSILRDLINEAMDVKLKRQESQQREE 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK- 126
+ + +G G +G V K H +G ++AVKR+ + + L ++
Sbjct: 23 DLKDLGEIGRGAYGSVNKM---VHK------PSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ P +V+ G + + E M + + + + + I K+ L
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG--SQSHVSTRVMG 244
K L +L + K+I+RD K SNILLD + N KL DFG++ G S TR G
Sbjct: 134 TVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAG 187
Query: 245 TYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
Y APE + +SDV+S G+ L E+ +GR
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 31/239 (12%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
N + + + F+ + + G+G FG V G TGM +A+K++ Q+
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQD 59
Query: 114 SLQGHLEWLTEIKHLGQLYHPNLVKLI------GYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ E L ++ L L+HPN+V+L G D L +V E++P +L
Sbjct: 60 PRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR 117
Query: 167 RRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDF 224
I +KV L + + LH V +RD K N+L++ + KL DF
Sbjct: 118 NYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 225 GLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
G AK +++ +R Y Y APE + H T D++S G + EM+ G
Sbjct: 177 GSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+ +LG GG V D +AVK L + L + E
Sbjct: 14 YELGEILGFGGMSEVHLAR-DLRD--------HRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
++ L HP +V + + +V E++ +L + + P++ +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAI 119
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST- 240
+V A + L + H + +I+RD K +NI++ K+ DFG+A+ S T
Sbjct: 120 EVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
V+GT Y +PE + A+SDVYS G VL E+L+G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 44/283 (15%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
+ ++G + G++ + + + + + K NF V
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----------LTEI 125
LG G +G VF + TG + A+K L + ++ + L I
Sbjct: 62 LGTGAYGKVFLV---RKI---SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
+ P LV L Y + + +L L+ +++ G L HL +R + + ++
Sbjct: 116 RQ-----SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIY 164
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ L L +LH +IYRD K NILLD N + L+DFGL+K+
Sbjct: 165 VGEIVLA----LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 240 TRVMGTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y AP+ +GH A D +S GV++ E+L+G
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 44/245 (17%)
Query: 52 GSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN 111
GS+ S + K F VLG+GG+G VF+ TG + A+K L
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQV---RKV---TGANTGKIFAMKVLK 54
Query: 112 QESL---QGHLEW-LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ + E L ++ HP +V LI Y + +L L+ E++ G L L
Sbjct: 55 KAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE 113
Query: 167 RRASYIQPLSWTIRMK-----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
R +++ +++ L +LH +IYRD K NI+L+ + KL
Sbjct: 114 REGIFMED-----TACFYLAEISMA----LGHLHQKG--IIYRDLKPENIMLNHQGHVKL 162
Query: 222 SDFGLAKDGPTGSQSHVSTRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLE 274
+DFGL K+ T GT EYMA +GH D +S G ++ +
Sbjct: 163 TDFGLCKESIHDGT---VTHTFCGT-----IEYMAPEILMRSGH-NRAVDWWSLGALMYD 213
Query: 275 MLSGR 279
ML+G
Sbjct: 214 MLTGA 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 83/364 (22%), Positives = 137/364 (37%), Gaps = 79/364 (21%)
Query: 26 GNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVF 85
G G+ + V + + ++ VLG+G FG V
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIF-----------------SDRYKGQRVLGKGSFGEVI 43
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLYHPNLVKLIGY 142
+ TG AVK +++ ++ + L E++ L QL HPN++KL +
Sbjct: 44 LC---KDK------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 143 CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 201
ED LV E G L + + R + + + I ++ L + Y+H K+
Sbjct: 95 F-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG---ITYMHK--NKI 147
Query: 202 IYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH 258
++RD K N+LL + N ++ DFGL+ S +GT Y APE + G
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE-VLHGT 203
Query: 259 LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-YLQSKRRIF-QVMDARIE 316
K DV+S GV+L +LSG P ++ I +V +
Sbjct: 204 YDEKCDVWSTGVILYILLSGCP------------------PFNGANEYDILKKVEKGKYT 245
Query: 317 ------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ--IQDTNDAGVSRDES 368
+ S A K + K L+ P R + + AL+ IQ +S D
Sbjct: 246 FELPQWKKVSESA--KDLIR--KMLTYVPSMRISARD---ALDHEWIQTYTKEQISVDVP 298
Query: 369 LQNS 372
++
Sbjct: 299 SLDN 302
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 78/302 (25%), Positives = 118/302 (39%), Gaps = 67/302 (22%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ D V+A+K+++ Q + +W +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIK 103
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E++ L +L HPN ++ G L + LV E+ + + + +PL V
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAV 159
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
GA +GLAYLHS +I+RD K NILL KL DFG A S + +
Sbjct: 160 THGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFV 211
Query: 244 GTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSGR---------RV---IDKNRPS 288
GT + APE M G K DV+S G+ +E+ + I +N
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES- 270
Query: 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
P LQ G +S + V CL P+ RPT + +
Sbjct: 271 ----------PALQ-------------SGHWS--EYFRNFVD--SCLQKIPQDRPTSEVL 303
Query: 349 VK 350
+K
Sbjct: 304 LK 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 42/226 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIK 126
F VLG+G FG VF + + + A+K L + +L+ + E
Sbjct: 25 QFELLKVLGQGSFGKVFLV---KKI---SGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK--- 182
L ++ HP +VKL Y + + +L L+ +F+ G L L + + + +K
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYL 132
Query: 183 --VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+AL L +LHS +IYRD K NILLD + KL+DFGL+K+ +
Sbjct: 133 AELALA----LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KA 183
Query: 241 RVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 279
GT EYMA GH T +D +SFGV++ EML+G
Sbjct: 184 YSFCGT-----VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 44/232 (18%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWL 122
K +F+ +LGEG F V AR T A+K L + H+
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKR----HIIKE 71
Query: 123 TEIKH-------LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP 174
++ + + +L HP VKL + +DD +L + G L ++ + S+ +
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 175 LSWTIRMKVA-LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ R A + +A L YLH +I+RD K NILL+ + + +++DFG AK
Sbjct: 131 CT---RFYTAEIVSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 234 SQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 279
S+ + +GT +Y++ + SD+++ G ++ ++++G
Sbjct: 184 SKQARANSFVGT-----AQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGL 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 63/259 (24%), Positives = 101/259 (38%), Gaps = 40/259 (15%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G+SGSS + + L + + + +G G G V+K
Sbjct: 1 GSSGSSGKQTGY-----------LTIGGQRYQAE-----INDLENLGEMGSGTCGQVWKM 44
Query: 88 WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIK-HLGQLYHPNLVKLIGYCLE 145
TG VIAVK++ + + + L ++ L P +V+ G +
Sbjct: 45 R---FR------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
+ + E M + + L +R P+ I K+ + K L YL VI+RD
Sbjct: 96 NTDVFIAMELMGTCAEK--LKKR--MQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRD 150
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-----T 260
K SNILLD KL DFG++ R G Y APE +
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGR---LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 261 AKSDVYSFGVVLLEMLSGR 279
++DV+S G+ L+E+ +G+
Sbjct: 208 IRADVWSLGISLVELATGQ 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
+G+G FG V I + T + A+K +N++ + + E++ + L
Sbjct: 22 AIGKGSFGKVC---IVQKN------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAAK 189
HP LV L Y +D+ + +V + + G L HL + + + T+++ + L A
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMA- 127
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L YL + + +I+RD K NILLD + + ++DF +A P + T + GT Y
Sbjct: 128 -LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYM 181
Query: 250 APEYMA----TGHLTAKSDVYSFGVVLLEMLSGRR 280
APE + G+ A D +S GV E+L GRR
Sbjct: 182 APEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRR 215
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLY 132
LG G +G V T + A+K + + S+ + + L E+ L L
Sbjct: 44 KLGSGAYGEVLLC---RDK------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++KL + ED LV E G L + + R + + + I +K L +
Sbjct: 95 HPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-IKQVLSG---V 149
Query: 192 AYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
YLH +++RD K N+LL + + K+ DFGL+ +GT Y
Sbjct: 150 TYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYY 204
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
APE + K DV+S GV+L +L+G
Sbjct: 205 IAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN------------QESLQGHLEWL 122
LG G +G V + A+K + ++++ E +
Sbjct: 43 KLGSGAYGEVLLC---KEK------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 123 -TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L L HPN++KL ED LV EF G L + R + + + I
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI- 151
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
MK L + YLH +++RD K NILL + N K+ DFGL+ S+ +
Sbjct: 152 MKQILSG---ICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDY 203
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
+GT Y APE + K DV+S GV++ +L G
Sbjct: 204 KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 75/319 (23%), Positives = 122/319 (38%), Gaps = 68/319 (21%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
+ L+ F ++G G +G V+KG T G + A+K ++
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG- 61
Query: 116 QGHLEWLTEIKHLGQL-YHPNLVKLIG-----YCLEDDHRL-LVYEFMPKGSLENHLFRR 168
E EI L + +H N+ G D +L LV EF GS+ + + +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--K 119
Query: 169 ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ L + +GL++LH K VI+RD K N+LL N KL DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-----AKSDVYSFGVVLLEMLSGR---- 279
+ +T +GT + APE +A KSD++S G+ +EM G
Sbjct: 178 Q-LDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
Query: 280 -----RV---IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLA 331
R I +N P L+SK ++S ++ +
Sbjct: 236 DMHPMRALFLIPRNPA-----------PRLKSK-------------KWS--KKFQSFIE- 268
Query: 332 IKCLSNEPKFRPTMDEVVK 350
CL RP ++++K
Sbjct: 269 -SCLVKNHSQRPATEQLMK 286
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESL--QGHLEW-LTE 124
F +LG+G FG V + TG A+K L +E + + + LTE
Sbjct: 149 EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L HP L L Y + RL V E+ G L HL R + + R +
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF 252
Query: 184 -ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
L YLHS+K V+YRD K N++LD + + K++DFGL K+G + +
Sbjct: 253 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 308
Query: 243 M-GTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 279
GT PEY+A L D + GVV+ EM+ GR
Sbjct: 309 FCGT-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 42/266 (15%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNG--LKTATRNFRPDSVLGEGGFGCVF 85
+ S++ ++ V + P + IK + +G + + V+G G FG VF
Sbjct: 2 SFTMSNAPLNGVKLNPLDDP----NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145
+ + E + V A+K++ Q+ E++ + + HPN+V L +
Sbjct: 58 QAKLVE---------SDEV-AIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYS 103
Query: 146 DDHRL------LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDK 198
+ + LV E++P+ ++ A Q + + +K+ + + LAY+HS
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHS-- 159
Query: 199 AKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTG--SQSHVSTRVMGTYGYAAPEYM- 254
+ +RD K N+LLD KL DFG AK G + S++ +R Y Y APE +
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIF 214
Query: 255 -ATGHLTAKSDVYSFGVVLLEMLSGR 279
AT + T D++S G V+ E++ G+
Sbjct: 215 GAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 40/222 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EIKHLGQ 130
+LGEG +G V + + T AVK L ++ L+ EI+ L +
Sbjct: 12 LLGEGSYGKVKEV---LDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 131 LYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L H N+++L + Y E +V E+ G E + + + + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--ML---DSV------PEKRFPVCQA 111
Query: 189 K--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
GL YLHS ++++D K N+LL K+S G+A+ +
Sbjct: 112 HGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 241 RVMGTYGYAAPEYMATGHLT---AKSDVYSFGVVLLEMLSGR 279
G+ + PE +A G T K D++S GV L + +G
Sbjct: 170 TSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+VK G+ E + + L E+ G L + + I M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPD-AQRFFHQL 114
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 248 YAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + DV+S G+VL ML+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG G F VF + TG + A+K + + EI L ++ H
Sbjct: 16 VLGSGAFSEVFLV---KQR------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L H LV + + G L + + R Y + + + ++ L A + YL
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSA---VKYL 122
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H +++RD K N+L + N ++DFGL+K G +ST GT GY AP
Sbjct: 123 HE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-GTPGYVAP 176
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSG 278
E +A + D +S GV+ +L G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 43/255 (16%)
Query: 48 EILLG-SNIKSFSFNGLKTATRNFRPDSV---------LGEGGFGCVFKGWIDEHTYAPA 97
EI L S K F F L ++ P ++ LG G G V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---FER---- 157
Query: 98 RPGTGMVIAVKRLNQESLQGHLEW--------LTEIKHLGQLYHPNLVKLIGYCLEDDHR 149
T +A++ +++ TEI+ L +L HP ++K+ + + +
Sbjct: 158 --KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209
+V E M G L + + + L A + YLH + +I+RD K
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQMLLA---VQYLHEN--GIIHRDLKPE 268
Query: 210 NILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE---YMATGHLTAKS 263
N+LL + + K++DFG +K G S + T GT Y APE + T
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAV 325
Query: 264 DVYSFGVVLLEMLSG 278
D +S GV+L LSG
Sbjct: 326 DCWSLGVILFICLSG 340
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEW----- 121
+ +GEG +G VFK + T G ++A+K +++
Sbjct: 4 KYEKIGKIGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESEDD-----PVIKKIA 49
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
L EI+ L QL HPNLV L+ LV+E+ ++ + L R +
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT 108
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSH-V 238
L + + + H I+RD K NIL+ + KL DFG A+ GP+ V
Sbjct: 109 WQTL---QAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 239 STRVMGTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 279
+TR Y +PE + + DV++ G V E+LSG
Sbjct: 164 ATR-----WYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 66/300 (22%), Positives = 108/300 (36%), Gaps = 57/300 (19%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
+ + N + + + +G + + K
Sbjct: 32 LNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE 91
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--- 122
+ + P V+G G V + H TG AVK + + + E L
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRC---VHR------ATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 123 -----TEIKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF--------- 166
E L Q+ HP+++ LI E + LV++ M KG E LF
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E--LFDYLTEKVAL 197
Query: 167 --RRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
+ I M+ L A +++LH+ +++RD K NILLD N +LSDF
Sbjct: 198 SEKETRSI--------MRSLLEA---VSFLHA--NNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 278
G + G + + GT GY APE + D+++ GV+L +L+G
Sbjct: 245 GFSCHLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 73/288 (25%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLY 132
+LG+G FG V K + T AVK +N+ S + + E++ L +L
Sbjct: 29 MLGKGSFGEVLKC---KDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++KL ED +V E G L + + +R + + + I +K +
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG---I 134
Query: 192 AYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
Y+H +++RD K NILL + + + K+ DFGL+ +GT Y
Sbjct: 135 TYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYY 189
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP-YLQSKRRI 307
APE + G K DV+S GV+L +LSG P Y +++ I
Sbjct: 190 IAPEVL-RGTYDEKCDVWSAGVILYILLSGTP------------------PFYGKNEYDI 230
Query: 308 FQ-VMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV 348
+ V + S A K + K L+ P R T +
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDA--KDLIR--KMLTFHPSLRITATQC 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 72/302 (23%), Positives = 115/302 (38%), Gaps = 56/302 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLGEG V + T AVK + ++ E++ L Q H
Sbjct: 20 VLGEGAHARVQTC---INL------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALG 186
N+++LI + E+D LV+E M GS+ +H+ +R AS + ++
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVAS 122
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKD-GPTGSQSHVSTRV 242
A L +LH+ + +RD K NIL + K+ DF L G S +ST
Sbjct: 123 A---LDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 243 M----GTYGYAAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293
+ G+ Y APE + A D++S GV+L +LSG P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCG 231
Query: 294 IEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKFRPTMD 346
+ ++ ++ I EG+Y + L K L + K R +
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 347 EV 348
+V
Sbjct: 292 QV 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+VK G+ E + + L E+ G L + + I M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPD-AQRFFHQL 114
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 248 YAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE DV+S G+VL ML+G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 66/223 (29%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG V R TG A+K L +E + + + +TE
Sbjct: 6 DFDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK- 182
+ L HP L L Y + RL V E+ G L HL R + + R +
Sbjct: 56 SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARF 109
Query: 183 ----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ L YLHS V+YRD K N++LD + + K++DFGL K+G +
Sbjct: 110 YGAEIVSA----LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--- 160
Query: 239 STRVM-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ + GT Y APE + D + GVV+ EM+ GR
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 71/330 (21%), Positives = 125/330 (37%), Gaps = 78/330 (23%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSLENHLFRRASY 171
+ + + H N++ L+ LE+ + +V E M + L++ R SY
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH---ERMSY 131
Query: 172 I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ Q L G+ +LHS A +I+RD K SNI++ + K+ DFGLA+
Sbjct: 132 LLYQML-------------CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 230 GPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------- 279
T +V TR Y APE + D++S G ++ EM+ G
Sbjct: 177 AGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
Query: 280 -----RVIDK-NRPSRE--HNLIEWAKPYLQS----KRRIFQVMDARIEGQYSLGAALKT 327
+VI++ P E L + Y+++ F+ + +
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK 291
Query: 328 AVLAI----KCLSNEPKFRPTMDEVVKALE 353
A A K L + R ++DE AL+
Sbjct: 292 ASQARDLLSKMLVIDASKRISVDE---ALQ 318
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 55/254 (21%), Positives = 91/254 (35%), Gaps = 62/254 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
+G+G +G V T + A+K ++ Q + + TE++ +
Sbjct: 33 AIGQGSYGVVRVAI---------ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG-- 186
+L+HPN+ +L ED+ + LV E G L + L +K +
Sbjct: 84 KLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 187 ---------------------------AAK-------GLAYLHSDKAKVIYRDFKTSNIL 212
+ L YLH+ + +RD K N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200
Query: 213 L--DLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAPE--YMATGHLTAKSDV 265
+ ++ KL DFGL+K G ++T+ GT + APE K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259
Query: 266 YSFGVVLLEMLSGR 279
+S GV+L +L G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 54/242 (22%), Positives = 86/242 (35%), Gaps = 60/242 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----- 121
+ + G +G V G+ +A+KR+ G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 122 ------LTEIKHLGQLYHPNLVKL----IGYCLEDDHRL-LVYEFM----------PKGS 160
L EI+ L +HPN++ L + + H+L LV E M +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
+ + Y L GL LH A V++RD NILL N +
Sbjct: 131 ISPQHIQYFMY-HIL-------------LGLHVLHE--AGVVHRDLHPGNILLADNNDIT 174
Query: 221 LSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLS 277
+ DF LA++ + +V+ R Y APE + T D++S G V+ EM +
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 278 GR 279
+
Sbjct: 230 RK 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHL 128
LG G FG V R G A+K L +E + H E L
Sbjct: 13 TLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVEHT--NDERLML 60
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK----- 182
+ HP ++++ +D ++ ++ +++ G L + L + + P K
Sbjct: 61 SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAE 114
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V L L YLHS +IYRD K NILLD N + K++DFG AK P T
Sbjct: 115 VCLA----LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYT 162
Query: 243 M-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 279
+ GT P+Y+A + + D +SFG+++ EML+G
Sbjct: 163 LCGT-----PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 37/262 (14%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G + ++ + S V + K + + F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML- 59
Query: 88 WIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIG 141
+ +G A+K L+++ + H L E + L + P LVKL
Sbjct: 60 ---------VKHKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLE- 107
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 200
+ +D+ L +V E++ G + +HL R + +P + ++ L YLHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS--LD 161
Query: 201 VIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYAAPE-YMATGH 258
+IYRD K N+L+D +++DFG AK T + GT APE ++ G+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSKGY 215
Query: 259 LTAKS-DVYSFGVVLLEMLSGR 279
K+ D ++ GV++ EM +G
Sbjct: 216 --NKAVDWWALGVLIYEMAAGY 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ ++GEG +G V K + TG ++A+K+ + + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDD---KMVKKIAMR 73
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
EIK L QL H NLV L+ C + LV+EF+ ++ + L + + +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSH-VST 240
+ G+ + HS +I+RD K NIL+ + KL DFG A+ P V+T
Sbjct: 133 II---NGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 241 RVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
R Y APE + DV++ G ++ EM G
Sbjct: 188 R-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K + A+K++ + + EI L +L HPN
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 136 LVKLIGYCLED-DHRL-LVYEFMP---KGSLENHLFRRASYIQ-PLSWTIRMKVALGAAK 189
++ L L D ++ L++++ ++ H +A+ L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSHVSTRVM 243
G+ YLH+ V++RD K +NIL+ K++D G A+ + P + + V+
Sbjct: 140 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 244 GTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
T+ Y APE + H T D+++ G + E+L+
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 59/288 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQL 131
+G+G F V H TG +A+K +++ L L E++ + L
Sbjct: 23 IGKGNFAKVKLA---RHIL------TGREVAIKIIDKTQLNPTSLQKLF--REVRIMKIL 71
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK-- 189
HPN+VKL + L+ E+ G + ++L RMK +K
Sbjct: 72 NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFR 121
Query: 190 ----GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ Y H + +++RD K N+LLD + N K++DFG + + G + G
Sbjct: 122 QIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GA 176
Query: 246 YGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
YAAPE + + + DV+S GV+L ++SG P NL E +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKEL-------R 223
Query: 305 RRIFQVMDARIEGQYSLGAALKTAV--LAIKCLSNEPKFRPTMDEVVK 350
R+ + G+Y + + T L + L P R T+++++K
Sbjct: 224 ERV-------LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--------QESLQGH 118
N+ P +LG G V + H T AVK ++ E +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---IHK------PTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 119 LEWL-TEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
E E+ L ++ HPN+++L + LV++ M KG L ++L + + + +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I M+ L + LH +++RD K NILLD + N KL+DFG + G +
Sbjct: 127 RKI-MRALLEV---ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 179
Query: 237 HVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 278
+ GT Y APE + D++S GV++ +L+G
Sbjct: 180 -LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 71/330 (21%), Positives = 124/330 (37%), Gaps = 78/330 (23%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSLENHLFRRASY 171
+ + + H N++ L+ LE+ + LV E M + L++ R SY
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSY 168
Query: 172 I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ Q L G+ +LHS A +I+RD K SNI++ + K+ DFGLA+
Sbjct: 169 LLYQML-------------CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 230 GPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------- 279
T +V TR Y APE + D++S G ++ EM+ +
Sbjct: 214 AGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 280 -----RVIDK-NRPSRE--HNLIEWAKPYLQS----KRRIFQVMDARIEGQYSLGAALKT 327
+VI++ P E L + Y+++ F +
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 328 AVLAI----KCLSNEPKFRPTMDEVVKALE 353
A A K L +P R ++D+ AL+
Sbjct: 329 ASQARDLLSKMLVIDPAKRISVDD---ALQ 355
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 53/218 (24%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQ 130
V+G G F V + TG V A+K +N+ + E + E L
Sbjct: 68 VIGRGAFSEVAV----------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAA 188
+ +L + +D++ L LV E+ G L L + I P R +A + A
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEMA-RFYLAEIVMA 174
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ +H ++RD K NILLD + +L+DFG V GT Y
Sbjct: 175 --IDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDY 229
Query: 249 AAPEYMATGHLTAKSDVY-------SFGVVLLEMLSGR 279
+PE + + Y + GV EM G+
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 52/232 (22%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ + + +G G +G V ID+ + G +A+K+L++ +S E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSL-ENHLFRRAS 170
+ L + H N++ L+ L + + LV FM E +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI----Q 129
Query: 171 YI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
Y+ Q L KGL Y+HS A V++RD K N+ ++ + K+ DFGLA+
Sbjct: 130 YLVYQML-------------KGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
+V TR + Y APE + + H D++S G ++ EML+G+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 49/223 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
V+G+G FG V AR + AVK L ++++ + + ++E L +
Sbjct: 45 VIGKGSFGKVLL----------ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 131 -LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-----V 183
+ HP LV L + + +L V +++ G L HL R +++P R + +
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEI 148
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A L YLHS ++YRD K NILLD + L+DFGL K+ + +T
Sbjct: 149 ASA----LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199
Query: 244 -GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 279
GT PEY+A + D + G VL EML G
Sbjct: 200 CGT-----PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 72/293 (24%), Positives = 111/293 (37%), Gaps = 57/293 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YH 133
LGEG F K H + AVK +++ + EI L H
Sbjct: 18 PLGEGSFSICRKC---VHK------KSNQAFAVKIISKRMEANTQK---EITALKLCEGH 65
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALG 186
PN+VKL + H LV E + G L + ++ ASYI M+ +
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVS 117
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A ++++H V++RD K N+L + N K+ DFG A+ P +Q + T
Sbjct: 118 A---VSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC- 170
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
T YAAPE + D++S GV+L MLSG+ P + +
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLT 217
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAV------LAIKCLSNEPKFRPTMDEVVK 350
++M +G +S V L L+ +P R M +
Sbjct: 218 CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 50/281 (17%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S+ D N S + G++S V + +
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------------- 51
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ F +S LG G V++ + GT A+K L + + + TEI
Sbjct: 52 -SDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKTVDKKIVR--TEI 99
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR----- 180
L +L HPN++KL LV E + G L + + + Y + R
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY------SERDAADA 153
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
+K L A +AYLH +++RD K N+L + K++DFGL+K Q
Sbjct: 154 VKQILEA---VAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVL 206
Query: 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
+ T GT GY APE + + D++S G++ +L G
Sbjct: 207 MKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G +G V GT + A K++ + ++ + EI+ + L HP
Sbjct: 16 TIGRGSWGEVKIA---VQ------KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+++L ++ LV E G L + + + + + I MK L A +AY
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYC 122
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H V +RD K N L + KL DFGLA G + +GT Y +P
Sbjct: 123 HK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSP 177
Query: 252 EYMATGHLTAKSDVYSFGVVLLEMLSG 278
+ + + + D +S GV++ +L G
Sbjct: 178 QVLEGLY-GPECDEWSAGVMMYVLLCG 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 24/230 (10%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
+ + T + +LG+G FG V K + T AVK +N+
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKC---KDR------ITQQEYAVKVINKA 58
Query: 114 SLQGHLE--WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
S + L E++ L +L HPN++KL + +V E G L + + +R +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 228
+ + I +K + Y+H +++RD K NILL + + + K+ DFGL+
Sbjct: 119 SEHDAARI-IKQVFSG---ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
++ + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 173 CFQQNTK--MKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 60/244 (24%), Positives = 89/244 (36%), Gaps = 31/244 (12%)
Query: 52 GSNIKSFSFNGLKTATRNFR----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
G + + F V+G+G F V + + TG AV
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRC---INR------ETGQQFAV 54
Query: 108 KRLNQESLQGHLEW-----LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
K ++ E L HP++V+L+ D +V+EFM L
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114
Query: 163 NHLFRRASYIQPLS---WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLN 216
+ +RA S + M+ L A L Y H +I+RD K +LL + +
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD--NNIIHRDVKPHCVLLASKENS 169
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
KL FG+A S RV GT + APE + DV+ GV+L +L
Sbjct: 170 APVKLGGFGVAIQLG-ESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227
Query: 277 SGRR 280
SG
Sbjct: 228 SGCL 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 54/261 (20%), Positives = 101/261 (38%), Gaps = 65/261 (24%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL+T+++ + LG G FG V + + E +G A+K++ Q+
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRYK---- 47
Query: 122 LTEIKHLGQLYHPNLVKLIGY-------------------------------------CL 144
E+ + L H N++KL+ Y
Sbjct: 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107
Query: 145 EDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKVI 202
+ L ++ E++P +L L + + + + + + + ++HS +
Sbjct: 108 SQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGIC 163
Query: 203 YRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG-H 258
+RD K N+L++ N KL DFG AK +++ +R + Y APE M
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATE 218
Query: 259 LTAKSDVYSFGVVLLEMLSGR 279
T D++S G V E++ G+
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ +L HPN+V+L E+ LV++ + G L + R Y + + ++
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQI 114
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 115 LES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 167
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT GY +PE + + D+++ GV+L +L G
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 29/216 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQ 130
V+G G FG V + V A+K LN+ + E + E L
Sbjct: 81 VIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAA 188
+ L Y +DD+ L LV ++ G L L + P R +A + A
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMA-RFYLAEMVIA 187
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ +H ++RD K NIL+D+N + +L+DFG S V GT Y
Sbjct: 188 --IDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 249 AAPEYMATGHLTAKS-----DVYSFGVVLLEMLSGR 279
+PE + D +S GV + EML G
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
LG G FG V E +G+ +K +N++ Q +E + EI+ L L H
Sbjct: 29 KLGSGAFGDVHLV---EER------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSL---------ENHLF--RRASYIQPLSWTIRM 181
PN++K+ ED H + +V E G L + + M
Sbjct: 80 PNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--------M 130
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHV 238
K + A LAY HS V+++D K NIL + K+ DFGLA+
Sbjct: 131 KQMMNA---LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEH 182
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
ST GT Y APE + +T K D++S GVV+ +L+G
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 33/224 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------- 121
+ LG G G V T +A+K +++
Sbjct: 11 EYIMSKTLGSGACGEVKLA---FER------KTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 122 -LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
TEI+ L +L HP ++K+ + + + +V E M G L + + +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY- 119
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
L A + YLH +I+RD K N+LL + + K++DFG +K G S
Sbjct: 120 FYQMLLA---VQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 238 VSTRVMGTYGYAAPE---YMATGHLTAKSDVYSFGVVLLEMLSG 278
+ T GT Y APE + T D +S GV+L LSG
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G EH TG +AVK ++ + G ++ EI++L
Sbjct: 19 LGVGTFGKVKIG---EHQ------LTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKL 67
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP+++KL Y + +V E++ G L +++ + R++
Sbjct: 68 FRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARR 115
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 116 LFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171
Query: 243 MGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGR 279
G+ YAAPE ++ + + D++S GV+L +L G
Sbjct: 172 -GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LG G + V+KG +++ T G+ +A+K + +S +G + EI + +L H
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIR--MKVALGAAK 189
N+V+L ++ LV+EFM K +++ L+ ++ L +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN-LVKYFQWQLL---Q 119
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTRVMGTYG 247
GLA+ H +K +++RD K N+L++ KL DFGLA P + S V+ T
Sbjct: 120 GLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 248 YAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
Y AP+ + + + T+ D++S G +L EM++G+
Sbjct: 174 YRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 63/283 (22%), Positives = 103/283 (36%), Gaps = 46/283 (16%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLG---SNIKSFSFNGLKTATRNFR- 71
G S + S++ ++ V L + F +
Sbjct: 28 GDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS 87
Query: 72 -----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+LG G FG V K E T TG+ +A K + ++ E EI
Sbjct: 88 FYTVSKTEILGGGRFGQVHKC---EET------ATGLKLAAKIIKTRGMKDKEEVKNEIS 138
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RRASYIQPLSW 177
+ QL H NL++L E + + LV E++ G L E++
Sbjct: 139 VMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF----- 192
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQ 235
MK G+ ++H +++ D K NIL K+ DFGLA+ +
Sbjct: 193 ---MKQICE---GIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 236 SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
V GT + APE + ++ +D++S GV+ +LSG
Sbjct: 245 LKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 38/215 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G + + H T M AVK +++ E + + GQ HP
Sbjct: 29 DIGVGSYSVCKRC---IHK------ATNMEFAVKIIDKSKRDPTEE-IEILLRYGQ--HP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALGA 187
N++ L + + +V E M G L + + R+ AS + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKT 128
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA---KLSDFGLAKDGPTGSQSHVSTRVM 243
+ YLH+ V++RD K SNIL D + N ++ DFG AK + + T
Sbjct: 129 ---VEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC- 181
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
T + APE + A D++S GV+L ML+G
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 71/302 (23%), Positives = 109/302 (36%), Gaps = 76/302 (25%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + H TG A+K L E+ H Q
Sbjct: 36 VLGLGVNGKVLEC---FHR------RTGQKCALKLLYDSPKAR-----QEVDHHWQASGG 81
Query: 134 PNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRR---------ASYIQPLSWTI 179
P++V ++ E+ H L++ E M G L + + R A+ I
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI------- 133
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 236
M+ A + +LHS + +RD K N+L + + KL+DFG AK+ +
Sbjct: 134 -MRDIGTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
+ T T Y APE + D++S GV++ +L G
Sbjct: 186 -LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP---------------- 227
Query: 297 AKP-YLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKFRPTMDEV 348
P Y + + I M RI GQY + V L L +P R T+ +
Sbjct: 228 --PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
Query: 349 VK 350
+
Sbjct: 286 MN 287
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F VLG+G FG V + GT + AVK L ++ + +E + E
Sbjct: 21 DFNFLMVLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L P L +L C + RL V E++ G L H+ + + +P + +
Sbjct: 71 KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A+G L +L S +IYRD K N++LD + K++DFG+ K+ +T+
Sbjct: 130 IAIG----LFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 180
Query: 243 M-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + D ++FGV+L EML+G+
Sbjct: 181 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F VLG+G FG V + GT + AVK L ++ + +E + E
Sbjct: 342 DFNFLMVLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L P L +L C + RL V E++ G L H+ + + +P + +
Sbjct: 392 KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A+G L +L S +IYRD K N++LD + K++DFG+ K+ +T+
Sbjct: 451 IAIG----LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 501
Query: 243 M-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + D ++FGV+L EML+G+
Sbjct: 502 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 539
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG VF A T A+K L ++ + +E + E
Sbjct: 18 DFILHKMLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 125 IKHLGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP L + + L V E++ G L H+ + R
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RAT 121
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ LG L +LHS ++YRD K NILLD + + K++DFG+ K+ G
Sbjct: 122 FYAAEIILG----LQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 173
Query: 238 VSTRVM-GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
T GT Y APE + D +SFGV+L EML G+
Sbjct: 174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKH 127
+ LGEG + V+KG T ++A+K + E +G + E+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSL 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L L H N+V L + LV+E++ K L+ +L + I + + + L
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-- 110
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTRVMGT 245
+GLAY H KV++RD K N+L++ KL+DFGLA K PT + + V+ T
Sbjct: 111 -RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-T 163
Query: 246 YGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
Y P+ + +T + T D++ G + EM +GR
Sbjct: 164 LWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ +L HPN+V+L E+ LV++ + G L + R Y + + ++
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQI 137
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 138 LES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 190
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT GY +PE + + D+++ GV+L +L G
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 45/219 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G A+K RL +E +++ EI
Sbjct: 10 IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIR-------EIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
L +L H N+VKL +LV+E + + L+ L ++ + T + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV--TAKSFLLQL 109
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRV 242
L G+AY H + V++RD K N+L++ K++DFGLA+ P +H +
Sbjct: 110 L---NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EI 161
Query: 243 MGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
+ T Y AP+ + + + T D++S G + EM++G
Sbjct: 162 V-TLWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP 134
LG G + VF+ + VK L + + EIK L L P
Sbjct: 44 LGRGKYSEVFEAINIT---------NNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS-WTIR--MKVALGAAKGL 191
N++ L + R F + N F++ Q L+ + IR M L K L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQ--LYQTLTDYDIRFYMYEIL---KAL 143
Query: 192 AYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGY 248
Y HS +++RD K N+++D + +L D+GLA+ G + V++R +
Sbjct: 144 DYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----F 196
Query: 249 AAPEYMATGHLTAKS-DVYSFGVVLLEMLSGRR 280
PE + + S D++S G +L M+ +
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
++ S +G G +G V + + TG+ +AVK+L++ +S+ E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++ L + H N++ L+ LE+ + + LV M L Q L+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADL-NNIVKCQKLT-D 131
Query: 179 IRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++ + +GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+ +
Sbjct: 132 DHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 238 VSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
V+TR Y APE M H D++S G ++ E+L+GR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 37/215 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG V K +N EI + QL+HP
Sbjct: 58 ELGSGAFGVVHRC---VEK------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RRASYIQPLSWTIRMKVAL 185
L+ L ED + + L+ EF+ G L E++ M+ A
Sbjct: 109 KLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY--------MRQAC 159
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVM 243
GL ++H +++ D K NI+ + + K+ DFGLA +
Sbjct: 160 E---GLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTT 211
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
T +AAPE + + +D+++ GV+ +LSG
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
NF VLG+G FG V AR TG + AVK L ++ + +E +TE
Sbjct: 24 NFEFIRVLGKGSFGKVML----------ARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP L +L C + RL V EF+ G L H+ + + + + +
Sbjct: 74 KRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ L +LH +IYRD K N+LLD + KL+DFG+ K+G +T
Sbjct: 133 IISA----LMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTAT 183
Query: 243 M-GTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
GT Y APE + D ++ GV+L EML G
Sbjct: 184 FCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 45/219 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G ++A+K RL+ E +++ EI
Sbjct: 29 VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EIS 71
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
L +L+HPN+V LI + LV+EFM K L+ L + +Q I+ +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS--QIKIYLYQL 128
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRV 242
L +G+A+ H + +++RD K N+L++ + KL+DFGLA+ P S +H V
Sbjct: 129 L---RGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EV 180
Query: 243 MGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
+ T Y AP+ + + + T+ D++S G + EM++G+
Sbjct: 181 V-TLWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 57/232 (24%), Positives = 87/232 (37%), Gaps = 50/232 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----- 123
+ S LG G FG V W + VK + +E + W+
Sbjct: 25 KYSTMSPLGSGAFGFV---WTAVDKE------KNKEVVVKFIKKEKVLED-CWIEDPKLG 74
Query: 124 ----EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGS-LENHLFRR-------AS 170
EI L ++ H N++K++ E+ LV E G L + R AS
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 171 YI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
YI Q +S + YL +I+RD K NI++ ++ KL DFG A
Sbjct: 134 YIFRQLVS-------------AVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
G + GT Y APE M + + +++S GV L ++
Sbjct: 179 YLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 32/222 (14%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWL-TE 124
T ++ LG+G F V + G A +N + L + L E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC---VKV------LAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR---- 180
+ L HPN+V+L E+ H L+++ + G L + R Y +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY------SEADASH 114
Query: 181 -MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 236
++ L A + + H V++R+ K N+LL KL+DFGLA + Q+
Sbjct: 115 CIQQILEA---VLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT GY +PE + D+++ GV+L +L G
Sbjct: 170 -WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 47/228 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F V+G G + V R T + A+K + +E + ++W TE
Sbjct: 10 DFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
Q HP LV L C + + RL V E++ G L H+ R+ + +
Sbjct: 60 KHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HAR 113
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++L L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 114 FYSAEISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 165
Query: 238 VSTRVM-GTYGYAAPEYMA----TGHLTAKS-DVYSFGVVLLEMLSGR 279
+T GT P Y+A G S D ++ GV++ EM++GR
Sbjct: 166 -TTSTFCGT-----PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 66/288 (22%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRN 69
D +P N G+G +++ + ++ F L+
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSS-----LGLQDFDL--LR----- 58
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEI 125
V+G G + V R T + A++ + +E + ++W TE
Sbjct: 59 -----VIGRGSYAKVLL----------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 126 KHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK- 182
Q HP LV L C + + RL V E++ G L H+ R+ + +
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARF 157
Query: 183 ----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
++L L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 158 YSAEISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 208
Query: 239 STRVM-GTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGR 279
+T GT P Y+A + D ++ GV++ EM++GR
Sbjct: 209 TTSTFCGT-----PNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 40/232 (17%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ +F+ S+LGEG +G V + T G ++A+K++ + L L EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 126 KHLGQLYHPNLVKLI----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
K L H N++ + E+ + + ++ E M + + + Q LS
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----QMLS-DDH 113
Query: 181 MKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA----KDGPT 232
++ L + + LH + VI+RD K SN+L++ N + K+ DFGLA +
Sbjct: 114 IQYFIYQTL---RAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 233 GSQSHVSTRVMGTY----GYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
S+ M + Y APE M + + DV+S G +L E+ R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 5e-20
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G VFK + T ++A+K RL+ + +L+ EI
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALR-------EIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+V+L D LV+EF + L+ + + P + L
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL- 111
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRVMG 244
KGL + HS V++RD K N+L++ N KL++FGLA+ P S V+
Sbjct: 112 --KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV- 163
Query: 245 TYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRR 280
T Y P+ + A + T+ D++S G + E+ + R
Sbjct: 164 TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 36/214 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHP 134
+G G FG T ++AVK + + + +++ EI + L HP
Sbjct: 28 IGSGNFGVARLM---RDK------LTKELVAVKYIERGAAIDENVQ--REIINHRSLRHP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+V+ L H ++ E+ G L + R
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLL 126
Query: 190 -GLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
G++Y HS ++ +RD K N LLD + K+ DFG +K SQ + V GT
Sbjct: 127 SGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181
Query: 247 GYAAPE-YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + + +DV+S GV L ML G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+R +G G +G V +D T G +A+K+L + +S E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++ L + H N++ L+ L+D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDL-GKLMKHEKLG-E 127
Query: 179 IRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
R++ + KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ + +
Sbjct: 128 DRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 238 VSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
V TR Y APE + T D++S G ++ EM++G+
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 61/252 (24%)
Query: 59 SFNGLK-TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
S N + LG GG G VF +D +A+K++ Q
Sbjct: 1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQS 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLI-------------GYCLEDDHRL-LVYEFMP------ 157
L EIK + +L H N+VK+ L + + + +V E+M
Sbjct: 52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 158 --KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD- 214
+G L R Y Q L +GL Y+HS A V++RD K +N+ ++
Sbjct: 112 LEQGPLLEEHARLFMY-QLL-------------RGLKYIHS--ANVLHRDLKPANLFINT 155
Query: 215 LNYNAKLSDFGLAK--DGPTGSQSH----VSTRVMGTYGYAAPEYM-ATGHLTAKSDVYS 267
+ K+ DFGLA+ D + H + T+ Y +P + + + T D+++
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWA 210
Query: 268 FGVVLLEMLSGR 279
G + EML+G+
Sbjct: 211 AGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 43/230 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ S +GEG +G V D + +A+K+++ E L EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISPFEHQTYCQRTLREI 76
Query: 126 KHLGQLYHPNLVKLIG----YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
K L + H N++ + +E + +V + M E L + Q LS
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL-YKLLKTQHLS-NDH 129
Query: 181 MKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ L +GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+
Sbjct: 130 ICYFLYQIL---RGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 237 ------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSGR 279
+V+TR Y APE M + T D++S G +L EMLS R
Sbjct: 185 TGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 48/223 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-------LTEIKHL 128
LGEG +G V+K ID T +A+KR+ E E + E+ L
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEH-----EEEGVPGTAIREVSLL 87
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIRMKVAL 185
+L H N+++L + L++E+ K ++ + I+ + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------ 141
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-----KLSDFGLAKD--GPTGSQSHV 238
G+ + HS + ++RD K N+LL ++ + K+ DFGLA+ P +H
Sbjct: 142 --INGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH- 196
Query: 239 STRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGR 279
++ T Y PE + + + T+ D++S + EML
Sbjct: 197 --EII-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 44/219 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G +H TG +AVK ++ + G + EI++L
Sbjct: 24 LGVGTFGKVKVG---KHE------LTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKL 72
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP+++KL Y + + +V E++ G L +++ + R+
Sbjct: 73 FRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRR 120
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 121 LFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176
Query: 243 MGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 279
G+ YAAPE + +G L + D++S GV+L +L G
Sbjct: 177 -GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 78/369 (21%), Positives = 122/369 (33%), Gaps = 76/369 (20%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S P+P A + + ++ + + G IK +
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
T VLG G G V + + T A+K L E+
Sbjct: 65 VT-----SQVLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REV 105
Query: 126 KHLGQLY-HPNLVKLIGYC----LEDDHRLLVYEFMPKGSL-------ENHLF--RRASY 171
+ + P++V+++ L+V E + G L + F R AS
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 228
I MK A + YLHS + +RD K N+L N KL+DFG AK
Sbjct: 166 I--------MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 288
+ + + ++T T Y APE + D++S GV++ +L G P
Sbjct: 213 ETTSHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF 263
Query: 289 REHNLIEWAKPYLQSKRRIFQVMDARI-EGQYSLGAALKTAV------LAIKCLSNEPKF 341
++ L + RI GQY + V L L EP
Sbjct: 264 -------YSNHGLAISPGMKT----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
Query: 342 RPTMDEVVK 350
R T+ E +
Sbjct: 313 RMTITEFMN 321
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 75/248 (30%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------------ 123
+G+G +G V + A+K L+++ L +
Sbjct: 21 IGKGSYGVVKLA---YNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 124 --------------EIKHLGQLYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSL------ 161
EI L +L HPN+VKL + +DH +V+E + +G +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 162 ----EN---HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
E+ F+ + G+ YLH K +I+RD K SN+L+
Sbjct: 132 KPLSEDQARFYFQ-----DLIK-------------GIEYLHYQK--IIHRDIKPSNLLVG 171
Query: 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT---AKSDVYSFGVV 271
+ + K++DFG++ + GS + +S V GT + APE ++ DV++ GV
Sbjct: 172 EDGHIKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 272 LLEMLSGR 279
L + G+
Sbjct: 230 LYCFVFGQ 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-----WLTEIKHLGQ 130
LGEG F V+K D++T ++A+K++ + L EIK L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVALGAA 188
L HPN++ L+ + LV++FM LE + + + P I+ M + L
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS--HIKAYMLMTL--- 122
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVMGT 245
+GL YLH +++RD K +N+LLD N KL+DFGLAK P + +H V TR
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---- 176
Query: 246 YGYAAPE--YMATGHLTAKSDVYSFGVVLLEMLSGR 279
Y APE + A + D+++ G +L E+L
Sbjct: 177 -WYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 66/286 (23%)
Query: 15 NGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDS 74
+ + + + + + P E E L ++
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES----------------QYQVGP 49
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------EIKHL 128
+LG GGFG V+ G + +A+K + ++ + E E+ L
Sbjct: 50 LLGSGGFGSVYSG---IRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 129 GQLYH--PNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
++ +++L+ + D +L+ E P L + + R ++ L
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----------ALQEEL 150
Query: 186 GAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLA---KDGPTGSQ 235
+ + + H+ V++RD K NIL+DLN KL DFG KD
Sbjct: 151 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----- 203
Query: 236 SHVSTRVMGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 279
+ GT Y+ PE++ H + V+S G++L +M+ G
Sbjct: 204 -VYTDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-LSWTIRMKVALGA 187
Q+ HPN++ L +L+ E + G L + L ++ S + + I+ +
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---- 125
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
G+ YLH+ K+ + D K NI+L + KL DFGLA + G + +
Sbjct: 126 -DGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT + APE + L ++D++S GV+ +LSG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 58/316 (18%), Positives = 108/316 (34%), Gaps = 67/316 (21%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G++ + + + + + S + + + + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYH 133
+G G +G V + D+ V+A+K++ + E L L EI L +L H
Sbjct: 61 IGTGSYGHVCEA-YDKLE--------KRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 134 PNLVKL----IGYCLEDDHRL-LVYEFMP---------KGSLENHLFRRASYIQPLSWTI 179
++VK+ I +E L +V E L + Y L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY-NLL---- 166
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA------------ 227
G+ Y+HS A +++RD K +N L++ + + K+ DFGLA
Sbjct: 167 ---------VGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 228 ---------KDGPTGSQSHVSTRVMGTYG----YAAPEYM-ATGHLTAKSDVYSFGVVLL 273
+ T + R + + Y APE + + T DV+S G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 274 EMLSGRRVIDKNRPSR 289
E+L+ + R
Sbjct: 276 ELLNMIKENVAYHADR 291
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 55/219 (25%), Positives = 82/219 (37%), Gaps = 45/219 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG A K + EI+ + L HP
Sbjct: 164 ELGTGAFGVVHRV---TER------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------------ASYIQPLSWTIRM 181
LV L +D+ +++YEFM G E LF + Y++ +
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVEYMRQVCK---- 266
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVS 239
GL ++H + ++ D K NI+ + KL DFGL V
Sbjct: 267 --------GLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT +AAPE + +D++S GV+ +LSG
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LGEG FG V H T +A+K L + + +E EI +L
Sbjct: 17 LGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVE--REISYLKL 65
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP+++KL Y + + +V E+ G L +++ + RM G
Sbjct: 66 LRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRR 112
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ Y H K +++RD K N+LLD N N K++DFGL+ G+ S
Sbjct: 113 FFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168
Query: 243 MGTYGYAAPEYMATGHL--TAKSDVYSFGVVLLEMLSGR 279
G+ YAAPE + G L + DV+S G+VL ML GR
Sbjct: 169 -GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K GTG A K + + L E+ L
Sbjct: 12 ELGSGQFAIVRKC---RQK------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
++ HPN++ L E+ + L+ E + G L + L + S + + +K L
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD- 119
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
G+ YLHS ++ + D K NI+L N KL DFG+A G++ +
Sbjct: 120 --GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT + APE + L ++D++S GV+ +LSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP-LSWTIRMKVALG 186
Q+ H N++ L E+ + L+ E + G L + L ++ S + + I+ +
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL--- 125
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ YLH+ K+ + D K NI+L + KL DFGLA + G +
Sbjct: 126 --DGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNI 178
Query: 243 MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT + APE + L ++D++S GV+ +LSG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 50/228 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+G+G FG VFK T G +A+K + E +L+ EIK
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALR-------EIK 68
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL--------LVYEFMP---KGSLENHLFR-RASYIQP 174
L L H N+V LI C LV++F G L N L + S I+
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPT 232
+ M++ L GL Y+H +K +++RD K +N+L+ + KL+DFGLA+
Sbjct: 129 V-----MQMLL---NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 233 GSQSHVSTRVMGTYGYAAPEY-MATGHLTAKSDVYSFGVVLLEMLSGR 279
SQ + T + T Y PE + D++ G ++ EM +
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLT--- 123
+R +LG+GGFG VF G + +A+K + + + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---HRL------TDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 124 -EIKHLGQL----YHPNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSW 177
E+ L ++ HP +++L+ + + +LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-------- 134
Query: 178 TIRMKVALGAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLA--- 227
+ + + HS V++RD K NIL+DL KL DFG
Sbjct: 135 --PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGR 279
D P + GT Y+ PE+++ + V+S G++L +M+ G
Sbjct: 191 HDEP------YTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/226 (26%), Positives = 87/226 (38%), Gaps = 52/226 (23%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWLTEIKH------ 127
V+G G FG V R T V A+K L++ + ++
Sbjct: 76 VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKF----EMIKRSDSAFFWEERD 121
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ P +V+L Y +DD L +V E+MP G L N + V
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY-------------DVPE 167
Query: 186 GAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
A+ L +HS I+RD K N+LLD + + KL+DFG
Sbjct: 168 KWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 238 VSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGR 279
T V GT Y +PE + G+ + D +S GV L EML G
Sbjct: 226 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 50/241 (20%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE----- 113
+GL A + + + +GEG +G VFK D G +A+K R+
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKA-RDLKN-------GGRFVALKRVRVQTGEEGMP 55
Query: 114 --SLQGHLEWLTEIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMP---KGS 160
+++ E+ L L HPN+V+L + + +L LV+E +
Sbjct: 56 LSTIR-------EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 161 LENH--LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218
L+ I+ + + + +GL +LHS + V++RD K NIL+ +
Sbjct: 109 LDKVPEPGVPTETIKDMMFQL--------LRGLDFLHSHR--VVHRDLKPQNILVTSSGQ 158
Query: 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
KL+DFGLA+ Q +++ V+ T Y APE + D++S G + EM
Sbjct: 159 IKLADFGLAR--IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
Query: 279 R 279
+
Sbjct: 216 K 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 18 ELGSGQFAVVKKC---REK------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
++ HPN++ L E+ + L+ E + G L + L + S + + +K L
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILNG 126
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
+ YLHS + + + D K NI+L K+ DFGLA + +
Sbjct: 127 ---VYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF 178
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
GT + APE + L ++D++S GV+ +LSG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ P + +G G +G V+K D H+ G +A+K + + G +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 124 EIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMP---KGSLENH--LFRRAS 170
E+ L +L HPN+V+L+ + + ++ LV+E + + L+ A
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230
I+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+
Sbjct: 121 TIKDLMRQF--------LRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR-- 168
Query: 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
Q ++ V+ T Y APE + D++S G + EM +
Sbjct: 169 IYSYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 62/261 (23%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
N+ ++G G +G V+ D++T +A+K++N+ E L L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
I L +L +++L L+ D +V E S LF+ L+
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP---IFLT-EE 129
Query: 180 RMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA----KDGP 231
+K L G ++H + +I+RD K +N LL+ + + K+ DFGLA +
Sbjct: 130 HIKTILYNLL---LGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 232 TGSQS---------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFG 269
T + HV TR Y APE + + T D++S G
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTG 239
Query: 270 VVLLEMLSGRRVIDKNRPSRE 290
+ E+L+ + + +R
Sbjct: 240 CIFAELLNMLQSHINDPTNRF 260
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 44/220 (20%), Positives = 79/220 (35%), Gaps = 48/220 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + T + K + + EI L H
Sbjct: 12 DLGRGEFGIVHRC---VET------SSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHR 61
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR-------------ASYIQPLSWTIR 180
N++ L E L +++EF+ + +F R SY+ +
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGL--D--IFERINTSAFELNEREIVSYVHQV----- 111
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHV 238
+ L +LHS + + D + NI+ ++ K+ +FG A+ G +
Sbjct: 112 -------CEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
+ Y APE ++ +D++S G ++ +LSG
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 50/220 (22%), Positives = 85/220 (38%), Gaps = 42/220 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
LG G F V + TG A K R Q+ E L EI L
Sbjct: 36 ELGRGKFAVVRQC---ISK------STGQEYAAKFLKKRRRGQDCRA---EILHEIAVLE 83
Query: 130 QLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--ASYIQPLS-----WTIRM 181
P ++ L +L+ E+ G E +F + +S I+
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQ 139
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHV 238
+ +G+ YLH + +++ D K NILL + K+ DFG+++ +
Sbjct: 140 IL-----EGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG 278
+MGT Y APE + +T +D+++ G++ +L+
Sbjct: 193 ---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 77/354 (21%), Positives = 132/354 (37%), Gaps = 81/354 (22%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
R + LG+G +G V+K ID T G V+AVK++ ++ E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 125 IKHLGQL-YHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
I L +L H N+V L+ D+ R LV+++M E L L +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDL-HAVIRANILE-PVHK 111
Query: 182 KV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + K + YLHS +++RD K SNILL+ + K++DFGL++ +
Sbjct: 112 QYVVYQLI---KVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 238 VSTRVMGTYG-------------------YAAPEYM-ATGHLTAKSDVYSFGVVLLEMLS 277
+ + Y APE + + T D++S G +L E+L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 278 GR-------------RVIDK-NRPSREH-NLI--EWAKPYLQS--------KRRIFQVMD 312
G+ R+I + PS E I +AK ++S + +
Sbjct: 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 313 ARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDEVVKA--LEQIQDTND 360
+ A+ K L P R + ++ +K + + N+
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 53/213 (24%), Positives = 75/213 (35%), Gaps = 48/213 (22%)
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
E Y L+ + + AKG+ +L S K I+RD NILL K+
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 234
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRR 280
DFGLA+D + APE + T +SDV+SFGV+L E+ S G
Sbjct: 235 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA- 293
Query: 281 VIDKNRP----SREHNLIEWAKPYLQSKRR----------IFQVMDARIEGQYSLGAALK 326
P + L+ R ++Q M
Sbjct: 294 -----SPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTM--------------- 329
Query: 327 TAVLAIKCLSNEPKFRPTMDEVVKALE-QIQDT 358
+ C EP RPT E+V+ L +Q
Sbjct: 330 -----LDCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LG G FG V + + + T +AVK L + + H ++E+K L +
Sbjct: 27 GKPLGRGAFGQVIEADA----FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 132 -YHPNLVKLIGYCLEDDHRLLV-YEFMPKGSLENHLFRRASYIQPL 175
+H N+V L+G C + L+V EF G+L +L + + P
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 27/214 (12%), Positives = 59/214 (27%), Gaps = 49/214 (22%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK 126
+R G ++ D R +A+ ++ + + E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQAL-DTAL---DRQ-----VALTFVDPQGVLPDDVLQETLSRTL 83
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L ++ P + +++ L+V E++ GSL+ S ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQS 137
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
A H +A V S + + ++ + L+
Sbjct: 138 LAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280
+ D+ G L +L R
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 67/305 (21%), Positives = 98/305 (32%), Gaps = 102/305 (33%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + + T A+K L E++ +
Sbjct: 25 VLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REVELHWRASQC 70
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSL-------ENHLF--RRASYIQPLSWTIR 180
P++V+++ L+V E + G L + F R AS I
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------- 122
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
MK A + YLHS + +RD K N+L N KL+DFG AK+
Sbjct: 123 MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------- 169
Query: 238 VSTRVMGT-YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
G Y + D++S GV++ +L G P +
Sbjct: 170 ----TTGEKYDKSC-------------DMWSLGVIMYILLCGY------PPF-------Y 199
Query: 297 AKPYLQSKRRIFQVMDARI-EGQY----------SLGAALKTAVLAIKCLSNEPKFRPTM 345
+ L + RI GQY S K L L EP R T+
Sbjct: 200 SNHGLAISPGMKT----RIRMGQYEFPNPEWSEVSEEV--KM--LIRNLLKTEPTQRMTI 251
Query: 346 DEVVK 350
E +
Sbjct: 252 TEFMN 256
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 40/228 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLRD--EYRTY 59
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + + + E H +LV + + SLE L + T+ M A
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQM 115
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQSHVS 239
+ +H ++YRD K N L+ + + DFG+ K D T H+
Sbjct: 116 LARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIP 171
Query: 240 TR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
R + GT Y + + T HL + + D+ + G V + L G
Sbjct: 172 YREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 38/226 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+R +G G FG ++ G D G +A+K ++ L E K
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIA--------AGEEVAIKLECVKTKHPQLHI--ESKIY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ + + E D+ ++V E + SLE LF S L T+ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHVSTR 241
+ Y+HS I+RD K N L+ L + DFGLAK D T H+ R
Sbjct: 115 ISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYR 170
Query: 242 ----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
+ GT YA+ + T HL + + D+ S G VL+ G
Sbjct: 171 ENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 40/228 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
NFR +G G FG + G ++ Y T +A+K +S L E +
Sbjct: 10 NFRVGKKIGCGNFGELRLG---KNLY------TNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
QL + ++ + + +V E + SLE LF L T+ M +A+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQSHVS 239
+ Y+HS +IYRD K N L+ N + DF LAK D T H+
Sbjct: 115 ISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--KHIP 170
Query: 240 TR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 171 YREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 31/175 (17%), Positives = 60/175 (34%), Gaps = 21/175 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK------RLNQES-----LQ 116
R ++ S G +++ T ++K RL E
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGY-CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPL 175
L+ K L + +G+ +D +R LV + + SL+ + L
Sbjct: 101 KPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPK-HVL 156
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAK 228
S ++VA L +LH + ++ + NI +D ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
S++G+G FG V K + D +A+K + N+++ Q E++ L
Sbjct: 60 SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAFLNQA----QIEVRLLEL 106
Query: 131 L--YHP----NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF---RRASYIQPLSWTIRM 181
+ + +V L + + +H LV+E L +L+ R ++ + +S +
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNF-RGVSLNLTR 160
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKDGPTGSQSHVS 239
K A L +L + + +I+ D K NILL K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+R Y +PE + D++S G +L+EM +G
Sbjct: 221 SRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
FR +G G FG ++ G T +A+K N ++ L + E K
Sbjct: 8 KFRLGRKIGSGSFGEIYLGT---------NIQTNEEVAIKLENVKTKHPQLLY--ESKIY 56
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + + + +E D+ +LV + + SLE LF S L T+ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHVSTR 241
+ ++HS ++RD K N L+ L A + DFGLAK D T H+ R
Sbjct: 113 INRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYR 168
Query: 242 ----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
+ GT YA+ + T HL + + D+ S G VL+ L G
Sbjct: 169 ENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 40/228 (17%), Positives = 85/228 (37%), Gaps = 42/228 (18%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQL- 131
LG G F V+ D +A+K + + EIK L ++
Sbjct: 25 RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVYTEAA--EDEIKLLQRVN 73
Query: 132 ----------YHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
+++KL+ + H ++V+E + + L + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHRGIPL 130
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL------NYNAKLSDFGLAKDGP 231
+++ GL Y+H + +I+ D K N+L+++ K++D G A
Sbjct: 131 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+ + TR Y +PE + +D++S ++ E+++G
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 39/238 (16%), Positives = 86/238 (36%), Gaps = 40/238 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----L 122
++ +G+GGFGC++ ++ G+ VK ++ E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 123 TEIKHLGQLYHPNLVKLIG----------YCLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
+ + + + +K +G +R ++ + L+ ++ +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANAKR 148
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAKD- 229
T+ ++L L Y+H + ++ D K SN+LL+ + L D+GLA
Sbjct: 149 FSRK-TVLQ-LSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 230 GPTGSQSHVSTR----VMGTYGYAAPEYMATGHL----TAKSDVYSFGVVLLEMLSGR 279
P G + GT + + + H + + D+ G +++ L+G
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 3e-08
Identities = 33/214 (15%), Positives = 51/214 (23%), Gaps = 49/214 (22%)
Query: 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYA--------PARPGTGMV 104
FS T + +GEG FG VF+ D A P
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-------------------- 144
+ + E + + L+ + + L
Sbjct: 65 KTFEEILPEII--ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 145 ----------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+DD +V EF G + + S + LA
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVA 177
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ +RD N+LL KL K
Sbjct: 178 E-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 56/229 (24%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLG 129
V+G+G FG V K + D +A+K + N++ Q EI+ L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRFHRQA----AEEIRILE 148
Query: 130 QL--YHP----NLVKLIGYCLEDDHR--------LL---VYEFMPKGSLENHLFRRASYI 172
L N++ ++ R LL +YE + K
Sbjct: 149 HLRKQDKDNTMNVIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKF----------- 194
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA-KLSDFGLAKDG 230
Q S + K A + L LH K ++I+ D K NILL + K+ DFG +
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR 279
+++ +R Y APE + D++S G +L E+L+G
Sbjct: 253 HQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 35/184 (19%), Positives = 57/184 (30%), Gaps = 60/184 (32%)
Query: 147 DHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
H +V+E + G L + S Q L K+ +GL YLH+ K ++I+ D
Sbjct: 118 THICMVFEVL--GHHL--LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTD 172
Query: 206 FKTSNILLDLN------------------------------------------------- 216
K NILL +N
Sbjct: 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEML 276
K++D G A + TR Y + E + +D++S + E+
Sbjct: 233 LKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELA 287
Query: 277 SGRR 280
+G
Sbjct: 288 TGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 43/239 (17%), Positives = 80/239 (33%), Gaps = 45/239 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------- 120
+ +G GGFG ++ + P VK QE+ E
Sbjct: 37 NQWVLGKKIGSGGFGLIYLA-FPTNK-----PEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 121 ----WLTEIKHLGQLYHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
+ + QL + + G +R +V E + L+ +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISG---QN 145
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAKD- 229
+ +++ + L Y+H + ++ D K +N+LL + L+D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 230 GPTGSQSHVSTRV----MGTYGYAAPEYMA-TGHL----TAKSDVYSFGVVLLEMLSGR 279
P G+ GT E+ + H + +SDV G +L L G+
Sbjct: 204 CPNGNHKQYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 44/293 (15%), Positives = 81/293 (27%), Gaps = 110/293 (37%)
Query: 51 LGSNIKSFSFNGLKTA-TRN-------FRPDS-----VLGEGGFGCVFKGWIDEHTYAPA 97
L + I+S S N L+ A R F P + +L + W D
Sbjct: 355 LTTIIES-SLNVLEPAEYRKMFDRLSVFPPSAHIPTILL------SLI--WFDVIKSDV- 404
Query: 98 RPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNLV----KLI 140
MV+ K L++ SL +LE ++++ L H ++V
Sbjct: 405 -----MVVVNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPK 457
Query: 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 200
+ +D + L+ + + S+I + H +
Sbjct: 458 TFDSDD---------LIPPYLDQYFY---SHI-------------------GH-HLKNIE 485
Query: 201 VIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL 259
R + LD + K+ A + + + + Y ++
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ--LKFYK---------PYI 534
Query: 260 TAKSDVYSFGVVLLEMLSGRRVID--KNRPSREHNLIEWAKPYLQSKRRIFQV 310
Y R V P E NLI Y + ++
Sbjct: 535 CDNDPKYE-----------RLVNAILDFLPKIEENLIC--SKYT----DLLRI 570
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 47/239 (19%), Positives = 76/239 (31%), Gaps = 62/239 (25%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
LGEG FG V + D +A+K + N EI L +
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKYREAA----RLEINVLKK 72
Query: 131 L--YHP----NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ V + + H + +E + K + L + + QP +A
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFL--KENNFQPYPLPHVRHMA 129
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-------------------KLSDFG 225
L +LH + ++ + D K NIL + +++DFG
Sbjct: 130 YQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 226 LAKDGPTGSQSHVSTRVMGTYGYAAPE------YMATGHLTAKSDVYSFGVVLLEMLSG 278
A + V+TR Y PE + DV+S G +L E G
Sbjct: 188 SATFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 58/253 (22%), Positives = 86/253 (33%), Gaps = 90/253 (35%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
LGEG FG V + D G +AVK + N + +EI+ L
Sbjct: 20 DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRYCEAA----RSEIQVLEH 67
Query: 131 L--YHP----NLVKLIGYCLEDDHR--------LL---VYEFMPKGSLENHLFRRASYIQ 173
L P V+++ + +H LL Y+F ++ + F
Sbjct: 68 LNTTDPNSTFRCVQMLEWF---EHHGHICIVFELLGLSTYDF-----IKENGFL------ 113
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-------------- 219
P K+A K + +LH K+ + D K NIL +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 220 -----KLSDFGLAKDGPTGSQSH---VSTRVMGTYGYAAPE------YMATGHLTAKSDV 265
K+ DFG A + H VSTR Y APE + + DV
Sbjct: 172 INPDIKVVDFGSATY---DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDV 217
Query: 266 YSFGVVLLEMLSG 278
+S G +L+E G
Sbjct: 218 WSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.2 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.62 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-60 Score=437.62 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=213.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
..|++.+.||+|+||+||+|... .+|+.||||++..........+.+|+.+|+.++|||||++++++.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEEC---------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56999999999999999999544 479999999998766555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|||||||+||+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999998753 4899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..+......+.
T Consensus 218 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------ 283 (346)
T 4fih_A 218 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------------ 283 (346)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------------
T ss_pred eecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------------
Confidence 8654322 23456789999999999999999999999999999999999999997654321111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.... .........+.++.+||.+||+.||++|||+.|+|+|=+.
T Consensus 284 -~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 284 -DNLP--PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp -HSSC--CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -cCCC--CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 0000 0111223456788999999999999999999999998554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-59 Score=432.85 Aligned_cols=268 Identities=27% Similarity=0.411 Sum_probs=213.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||+||+|.+... .+..++..||||++.........+|.+|+.+|++++|||||++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4678889999999999999987642 344578999999998776666678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
.+|||||||++|+|.+++..... ...++++..++.++.||+.||+|||+++ |+||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence 99999999999999999976432 1246999999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 295 (400)
+.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||........ +.
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~ 271 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID 271 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999999999987654444334455789999999999999999999999999999999999 8999976543211 11
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
. + ........+..++.++.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 272 ~----i----------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 C----I----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp H----H----------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H----H----------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 0 00111223445667899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=429.09 Aligned_cols=269 Identities=27% Similarity=0.409 Sum_probs=219.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||+||+|.+... ....++..||||++.........+|.+|+.+|++++|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5688899999999999999987532 234468899999998776666678999999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRA---------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.+|||||||++|+|.++|.... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 9999999999999999997642 22357999999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+..... +...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~- 242 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC- 242 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH-
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-
Confidence 99999999986544333223334578999999999999999999999999999999998 899997654321 1110
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
+........+..++.++.+|+.+||+.||++|||+.+|+..|+.+....
T Consensus 243 -------------i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 243 -------------ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp -------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0001112234456778999999999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=429.33 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=212.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.++||+|+||+||+|.. ..+|+.||+|++..... .....+.+|+++|++++|||||+++++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~---------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 5699999999999999999954 44799999999976533 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEc
Confidence 9999999999999999999998764 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++..............+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+.+......
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------------ 244 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------------ 244 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99987655444444566899999999999999999999999999999999999999997654211111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+... ...++...+.++.+||.+||+.||++|||+.|++.+
T Consensus 245 ----~i~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 245 ----KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ----HHHHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ----HHHcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 11111 112333456788999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=434.18 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|+. ..+|+.||||++..... .....+.+|+.+|++++|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKS---------TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEE---------TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 6899999999999999999954 44789999999976543 234568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++.+|||||||+||+|.++|..... ..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999999976543 46799999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+++..... .......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+........
T Consensus 171 la~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------------- 235 (350)
T 4b9d_A 171 IARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------------- 235 (350)
T ss_dssp EESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------------
T ss_pred cceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------------
Confidence 99865321 122345689999999999999999999999999999999999999997654211110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+..... ...+...+.++.+||.+||+.||++|||+.|+|+|=+
T Consensus 236 ---~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 236 ---KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp ---HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ---HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 1111111 1223445678899999999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=437.30 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=213.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.|++.+.||+|+||+||+|... .+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~---------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVR---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 56999999999999999999544 479999999998766555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|||||||+||+|.+++... .+++..+..++.||+.||+|||++| |+||||||+||||+.+|.+||+|||+|
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999998653 4899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+..+......+
T Consensus 295 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------------- 359 (423)
T 4fie_A 295 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------------- 359 (423)
T ss_dssp EECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------
T ss_pred eECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------
Confidence 8654322 2345678999999999999999999999999999999999999999765432211111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...... ........+.++.+||.+||+.||++|||+.|+|+|=+.
T Consensus 360 ~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 360 RDNLPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp HHSCCC--CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HcCCCC--CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 000000 111123456788999999999999999999999998543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-58 Score=423.85 Aligned_cols=257 Identities=24% Similarity=0.240 Sum_probs=211.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
..|++.+.||+|+||+||+|+. ..+|+.||||+++..... .+|+.+++.++|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~---------~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKD---------KQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEE---------CCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4578888999999999999954 447899999999765432 37999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEEeeccC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGL 226 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~ 226 (400)
.+|||||||+||+|.++|...+ ++++..+..++.||+.||+|||+++ |+||||||+||||+.+| .+||+|||+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999998763 5899999999999999999999998 99999999999999887 699999999
Q ss_pred CccCCCCCCc---ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQS---HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++........ ......+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.........+.. .
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~ 271 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------E 271 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------S
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------C
Confidence 9865433211 112346899999999999999999999999999999999999999987655433222210 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
. ......+..++..+.+||.+||+.||.+|||+.|++++|..+....
T Consensus 272 ~---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 272 P---------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp C---------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred C---------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0 0011233455678899999999999999999999999998876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-58 Score=421.80 Aligned_cols=266 Identities=25% Similarity=0.353 Sum_probs=215.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++++.+.||+|+||+||+|.+... ....+++.||||++..... ....+|.+|+.++++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3467788999999999999987531 2334678999999976433 2346789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
+.++||||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC
Confidence 999999999999999999975431 1246899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchh
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 293 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 293 (400)
.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.+..... +
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986544333333455689999999999999999999999999999999998 899998754321 1
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
... +........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+.
T Consensus 257 ~~~--------------i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 VEM--------------IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH--------------HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 110 1111112234556778999999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=415.61 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=205.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|.+.. .||||+++.... .....|.+|+.++++++|||||++++++.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 578889999999999999996532 489999875432 334578899999999999999999998765
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+.+|||||||++|+|.+++.... .++++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCS
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeecc
Confidence 56899999999999999997654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
+|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.......... ..
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------~~ 251 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------VG 251 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HH
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------Hh
Confidence 9987554443334556789999999999964 35899999999999999999999999765432111000 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.. ...+ .....+..++..+.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus 252 ~~-----~~~p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 252 RG-----YASP-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TT-----CCCC-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cC-----CCCC-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 00 0000 11123345667899999999999999999999999999988643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=412.56 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=201.8
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe--
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~-- 145 (400)
|++.+.||+|+||+||+|.+. .++..||+|++...... ....+.+|+.+|++++|||||++++++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 467788999999999999654 47899999999765432 34568899999999999999999999875
Q ss_pred --CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEe
Q 015781 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLS 222 (400)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~ 222 (400)
+..+|||||||+||+|.+++.+. .++++..+..++.||+.||+|||+++.+|+||||||+||||+. ++.+||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 35689999999999999999876 3689999999999999999999998777999999999999974 7999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+...... +.. ..
T Consensus 175 DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~----~i- 242 (290)
T 3fpq_A 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RV- 242 (290)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HH-
T ss_pred eCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH----HH-
Confidence 99999864322 3456789999999999865 699999999999999999999999975432111 000 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
........++...+.++.+||.+||+.||++|||+.++|+|=+
T Consensus 243 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 243 --------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp --------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred --------HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000000111223456889999999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=408.26 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=195.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|. +..+|+.||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEE---------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 579999999999999999994 4557999999999765432 2346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+||||| +|+|.+++.+. .++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeec
Confidence 999999999999 78999999775 36999999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|+|+...... .....+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+..... +..
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~-------- 222 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK-------- 222 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--------
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH--------
Confidence 9998654322 2345789999999999988876 579999999999999999999997643211 000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ...++...+.++.+|+.+||+.||++|||+.|+++|=+.
T Consensus 223 -----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 223 -----NISNG--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp -----HHHHT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred -----HHHcC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 00000 112233456788999999999999999999999997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=414.47 Aligned_cols=253 Identities=27% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|+.. ....+++.||+|++...... ....+.+|+.+|++++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKI------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEEC------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEc------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999653 23447899999999765432 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++.+|||||||+||+|.+++.+.. ++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999999999998763 6899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+|+...... ......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+........
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------------- 236 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------------- 236 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH-------------
Confidence 998643322 12445789999999999999999999999999999999999999997654321111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKAL 352 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L 352 (400)
.+... ...++...+.++.+||.+||+.||++||| ++|+++|=
T Consensus 237 ---~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 237 ---MILKA--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred ---HHHcC--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 11111 11233445678899999999999999998 46888763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=419.78 Aligned_cols=277 Identities=27% Similarity=0.358 Sum_probs=224.8
Q ss_pred hHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCC-Ccccc
Q 015781 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYH-PNLVK 138 (400)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-pniv~ 138 (400)
..+....++|++.+.||+|+||+||+|.+... .+..+++.||||.+...... ....+.+|+.+|.++.| ||||+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 33445567899999999999999999987642 23446789999999765443 34568899999999965 99999
Q ss_pred eeeEEEeC-CeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 015781 139 LIGYCLED-DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (400)
Q Consensus 139 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 205 (400)
++++|.+. +.+|||||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD 210 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 210 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence 99998764 578999999999999999976432 1245899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCC
Q 015781 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK 284 (400)
Q Consensus 206 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~ 284 (400)
|||+|||++.++.+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655444444556789999999999999999999999999999999998 9999987
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
....... . ..+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+.+.+
T Consensus 291 ~~~~~~~--~--------------~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEEF--C--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHHH--H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHH--H--------------HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 5432111 0 111111122334455678999999999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=399.18 Aligned_cols=274 Identities=25% Similarity=0.308 Sum_probs=201.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||+||+|.++ |+.||||++...... ......|+..+.+++||||+++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 56888899999999999999753 678999999765322 222345677778899999999999998654
Q ss_pred ----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCCEEEcCCC
Q 015781 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 148 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~ 217 (400)
.+|||||||++|+|.+++... ++++..++.++.|++.||+|||++ ..+|+||||||+||||+.++
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 579999999999999999764 589999999999999999999986 12499999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc--ceeeecccccCcccchhhccC------CCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||+||.+||.......
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~ 225 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence 9999999999865433221 122346899999999999754 36779999999999999999998876543321
Q ss_pred cchhHHhhhHHHhhhhhh-hhhccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 290 EHNLIEWAKPYLQSKRRI-FQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
..... +... ......+ .........+.. .......+.+|+.+||+.||++|||+.+|++.|+++.+..+
T Consensus 226 ~p~~~-~~~~-~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 226 LPYYD-LVPS-DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CTTTT-TSCS-SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccchh-cccc-cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 10000 0000 0000000 011111111222 23566788999999999999999999999999999877654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=396.76 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=189.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||+||+|... .+|+.||+|++...... ....+.+|+.+|++++|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET---------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 46899999999999999999544 47899999999765433 345688999999999999999999998765
Q ss_pred C------------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 147 D------------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 147 ~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
+ ++|+|||||.||+|.+++...... ...++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC
Confidence 4 479999999999999999865432 23567778999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCc----------ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCC
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQS----------HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 284 (400)
.++.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999999999865432211 12234689999999999999999999999999999999996 6643
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYS---LGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ... .+.... ...++ ...+..+.+|+.+||+.||++|||+.++++|
T Consensus 230 ~~~-----~~~----------~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QME-----RVR----------TLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-----HHH----------HHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccH-----HHH----------HHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 210 000 000000 11112 2234456789999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=404.81 Aligned_cols=271 Identities=24% Similarity=0.300 Sum_probs=205.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|+. ..+|+.||||++..... .....+.+|+.+|+.++|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARR---------RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 35799999999999999999954 44799999999976532 23456789999999999999999999876
Q ss_pred e------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 E------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
. .+.+|||||||+ |+|.+++... .++++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCC
Confidence 4 367899999995 6899999765 46999999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCC--CcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 219 AKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
+||+|||+++...... ........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.........+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~ 276 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999998653321 12234557999999999998775 56999999999999999999999998765433322221
Q ss_pred hhhHHHh-h------hhhhhhhcccc-ccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 296 WAKPYLQ-S------KRRIFQVMDAR-IEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 296 ~~~~~~~-~------~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
....... . ........... .....+ ...+.++.+||.+||+.||.+|||+.|+|+|=+
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 1000000 0 00000000000 000001 123567889999999999999999999999743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=392.69 Aligned_cols=272 Identities=23% Similarity=0.265 Sum_probs=203.0
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
+...++|++.+.||+|+||+||+|..+ .+..+++.||+|.+.... ....+.+|+++|+.+ +||||++++++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 345678999999999999999999754 233468899999987653 344677899999988 69999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceEE
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKL 221 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~kl 221 (400)
+.+.+++|+|||||+|++|.+++. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999883 4889999999999999999999998 9999999999999876 79999
Q ss_pred eeccCCccCCCCCC--------------------------cceeeecccccCcccchhhccC-CCCCccchhhHHHHHHH
Q 015781 222 SDFGLAKDGPTGSQ--------------------------SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLE 274 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~ 274 (400)
+|||+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999975433211 0112345799999999999765 58999999999999999
Q ss_pred HHhCCCccCCCCCCcc-chhHHhh---hHHHhhhh---------------hhhhhcc---------cc---------ccC
Q 015781 275 MLSGRRVIDKNRPSRE-HNLIEWA---KPYLQSKR---------------RIFQVMD---------AR---------IEG 317 (400)
Q Consensus 275 l~tg~~pf~~~~~~~~-~~~~~~~---~~~~~~~~---------------~~~~~~~---------~~---------~~~ 317 (400)
|++|+.||........ ...+... ........ ....... +. ...
T Consensus 240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 9999999965433211 1111000 00000000 0000000 00 000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 318 QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 318 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
......+.++.+|+.+||+.||++|||+.|+|+|=
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00112356788999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=413.13 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=213.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||+||+|.. ..+|+.||+|++..........+.+|+.+|+.++||||++++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~---------~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTE---------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 36899999999999999999954 447999999999877666667788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC--CceEEeec
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNAKLSDF 224 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~--~~~kl~Df 224 (400)
+.+|||||||.||+|.++|.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999999999996543 36899999999999999999999998 9999999999999754 89999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+. ...
T Consensus 302 G~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~~~ 372 (573)
T 3uto_A 302 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCD 372 (573)
T ss_dssp SSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTC
T ss_pred cceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------hCC
Confidence 9998765432 3455789999999999999999999999999999999999999998654321111110 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..+........+..+.+||.+||+.||.+|||+.|+|+|=+
T Consensus 373 --------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 373 --------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp --------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred --------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 00011111234567889999999999999999999999744
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=407.93 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=206.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHH---HHHHHHHHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHL---EWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~---~~~~e~~~l~~l~hpniv~~~ 140 (400)
.++|++.++||+|+||+||+|.. ..+|+.||+|++.+.... ... ....++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~---------~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 36799999999999999999954 457999999999764321 111 223457788888999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
++|.+.+.+|||||||.||+|.++|.+.+ .+++..+..++.||+.||+|||++| |+||||||+||||+.+|++|
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEE
Confidence 99999999999999999999999998764 5899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+|+...... ....+||+.|+|||++. +..|+.++|+|||||++|+|++|.+||.+........+..
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---- 404 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---- 404 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----
Confidence 99999998654322 34578999999999996 4579999999999999999999999997643322111111
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
.... ....++...+.++.+||.+||+.||.+|++ +.+|++|=+
T Consensus 405 ---------~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 405 ---------MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp ---------HHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ---------hhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 0011 112234456778899999999999999998 789988743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=374.81 Aligned_cols=281 Identities=41% Similarity=0.674 Sum_probs=238.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|.+. ++..||+|++..........+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4478999999999999999999642 478899999887766666778899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..++||||+++++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999998765544456899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|..... ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccc
Confidence 9986543333323344568999999999998899999999999999999999999998877766666666654322 222
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+....+...........+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 334445555556667888999999999999999999999999999999886543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=365.72 Aligned_cols=289 Identities=41% Similarity=0.732 Sum_probs=237.2
Q ss_pred CCcccccHhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC
Q 015781 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL 131 (400)
Q Consensus 53 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l 131 (400)
..+..++..++....++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.+++.+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 34567888889999999999999999999999998432 4788999998765432 223578999999999
Q ss_pred CCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCeeeccCCC
Q 015781 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD---KAKVIYRDFKT 208 (400)
Q Consensus 132 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~dlkp 208 (400)
+||||+++++++.+.+..++||||+.+++|.+++........++++..++.++.||+.||+|||++ + |+||||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp 162 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKA 162 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCch
Confidence 999999999999999999999999999999999988766556799999999999999999999998 7 99999999
Q ss_pred CCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCC--
Q 015781 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNR-- 286 (400)
Q Consensus 209 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~-- 286 (400)
+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 999999999999999999986543322 23444569999999999988899999999999999999999999996321
Q ss_pred CCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 287 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.........|..... ....+....+.......+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 242 NDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 112222333333222 22233445555566677888899999999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=358.64 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=212.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||+||+|.. ..++..||+|++..........+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMD---------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEB---------TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEE---------CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 36899999999999999999954 346899999999876656667788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+.+++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999764 4899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+......+ ..
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~---- 230 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------AT---- 230 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH----
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh----
Confidence 876543322 234567999999999999999999999999999999999999999765432111100 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 231 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 231 -----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp -----HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred -----CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence 0001111233456678899999999999999999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=369.22 Aligned_cols=271 Identities=24% Similarity=0.370 Sum_probs=219.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+.... .....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 367999999999999999999864311 02334678899999976543 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+.+.+|+||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 99999999999999999999987542 1235899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986544332222334567889999999999999999999999999999999 99999765432111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
. .+........+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 316 ~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 K-----------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H-----------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-----------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1111111223445567899999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=360.66 Aligned_cols=269 Identities=26% Similarity=0.377 Sum_probs=218.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|... .++..||+|.+..........+.+|+.++++++||||+++++++.+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 57899999999999999999654 368899999987766566677899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred eeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccc
Confidence 9999999999999999998754 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcc------------eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 228 KDGPTGSQSH------------VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 228 ~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 8653322111 1124579999999999999999999999999999999999999987654322111000
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 365 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 365 (400)
..... ....+..++..+.+++.+||+.||.+|||+.++++.|+.++.......+.
T Consensus 236 -----------~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~ 290 (310)
T 3s95_A 236 -----------VRGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290 (310)
T ss_dssp -----------HHHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCC
T ss_pred -----------hhccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccC
Confidence 00000 01112234456888999999999999999999999999998765544443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=358.93 Aligned_cols=272 Identities=26% Similarity=0.326 Sum_probs=210.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.+.||+|+||+||+|.+. +..||+|++.... ........|+.++++++||||+++++++.+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 67999999999999999999653 5789999997654 23344567899999999999999999998754
Q ss_pred ----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCeeeccCCCCCEEE
Q 015781 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD----------KAKVIYRDFKTSNILL 213 (400)
Q Consensus 148 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~~~ivH~dlkp~Nill 213 (400)
.+++||||+++++|.+++... .+++..++.++.||+.||+|||+. + |+||||||+||++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill 164 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL 164 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE
Confidence 469999999999999999763 489999999999999999999998 7 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-----CCCCccchhhHHHHHHHHHhCCCccCCCCCC
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 288 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 288 (400)
+.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999999765443332233446799999999999763 4566889999999999999999999876543
Q ss_pred ccchhHHhhhHHHhhhhhhhh-hccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 289 REHNLIEWAKPYLQSKRRIFQ-VMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
............. ....+.. .......... ....+..+.+|+.+||+.||++|||+.++++.|+.+++..
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 245 YMLPFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCTTHHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccchhhhhccCC-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 3322221100000 0000000 1111111111 2345677999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=360.68 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=209.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..+|++.+.||+|+||.||+|.. ..+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARH---------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36799999999999999999954 34789999999976533 23456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999998763 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCC-CccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++....... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+........
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------- 224 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE----------- 224 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH-----------
Confidence 9997654332 23456899999999999888775 78999999999999999999997654211100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ....+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 225 -----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 225 -----RVLRG--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp -----HHHHC--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred -----HHHhC--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 00000 112233456778899999999999999999999998554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=353.98 Aligned_cols=267 Identities=27% Similarity=0.409 Sum_probs=205.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..+|++.+.||+|+||+||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 367999999999999999999653 677999998765432 3356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||+++.+|+||||||+||+++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999999976431 12389999999999999999999997666999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 184 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------------ 249 (309)
T 3p86_A 184 GLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------------ 249 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred CCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 9997543321 12334679999999999999999999999999999999999999997654311110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~ 363 (400)
...........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....++.
T Consensus 250 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 250 ----AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp ----HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred ----HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 0000111123344556788999999999999999999999999999877655543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=356.27 Aligned_cols=265 Identities=24% Similarity=0.389 Sum_probs=213.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. ....+..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred hHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 579999999999999999997753 122456799999986533 3345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999997653 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+.......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------------- 264 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------------- 264 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------------
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-------------
Confidence 98654432211 1223456778999999998999999999999999999999 99999764321110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
..+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 265 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 265 ----SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1111111222334556788999999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=364.07 Aligned_cols=278 Identities=26% Similarity=0.342 Sum_probs=221.8
Q ss_pred HhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCccc
Q 015781 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLV 137 (400)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv 137 (400)
...+....++|++.+.||+|+||.||+|.+... .+..+++.||+|++...... ....+.+|+.++.++ +||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 334445567899999999999999999976431 35567899999999765433 345688999999999 799999
Q ss_pred ceeeEEEeCC-eeEEEEeecCCCCHHHHHhhhcCC---------------------------------------------
Q 015781 138 KLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASY--------------------------------------------- 171 (400)
Q Consensus 138 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------- 171 (400)
++++++.+.+ ..++||||+.+|+|.+++......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999998754 489999999999999999865421
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCC
Q 015781 172 -----------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234 (400)
Q Consensus 172 -----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 234 (400)
...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999998 9999999999999999999999999998654444
Q ss_pred CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccc
Q 015781 235 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDA 313 (400)
Q Consensus 235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (400)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+........ ..+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----------------~~~~~ 311 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----------------RRLKE 311 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH----------------HHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH----------------HHHHc
Confidence 3334455678999999999999999999999999999999998 999997654322110 00111
Q ss_pred cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 314 RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 314 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
......+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.+
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1112223345567889999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=356.15 Aligned_cols=251 Identities=28% Similarity=0.362 Sum_probs=208.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 57999999999999999999543 4789999999976432 23456788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||++|++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999875 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 150 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------ 215 (337)
T 1o6l_A 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------------ 215 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred cchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH------------
Confidence 9998533222 12345689999999999999999999999999999999999999997643211000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
.+... ...++...+..+.+||.+||+.||.+|| ++.++++|-+
T Consensus 216 ----~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 216 ----LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ----HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ----HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 00011 1123334567889999999999999999 9999998743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=364.81 Aligned_cols=269 Identities=25% Similarity=0.357 Sum_probs=213.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||+|.+... .+..++..||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 5799999999999999999986532 2445788999999975432 3345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---ceE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAK 220 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~k 220 (400)
...++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999987642 2245899999999999999999999998 99999999999998554 599
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-------- 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------- 296 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--------
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------
Confidence 999999974322121222334567899999999999999999999999999999998 99999765421111
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+....
T Consensus 297 ---------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 297 ---------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 001111111223345567889999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=347.30 Aligned_cols=265 Identities=24% Similarity=0.323 Sum_probs=209.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT---------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEEC---------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 468999999999999999999543 4688999999855432 2345678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++..|+||||+++++|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998763 6899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ......
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~ 227 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD 227 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc
Confidence 999986543221 1233457999999999999999999999999999999999999999765421100 000000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhchhcCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDTND 360 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~eil~~L~~~~~~~~ 360 (400)
. ............+..+.+++.+||+.||.+|| ++.++++.|+.+.....
T Consensus 228 ------~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 228 ------S-VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp ------C-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ------c-CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 0 00001112223456788999999999999998 99999999998765544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=360.95 Aligned_cols=255 Identities=25% Similarity=0.308 Sum_probs=208.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
.++|++.+.||+|+||.||+|... .+|..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~---------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC---------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 467999999999999999999543 47899999999765432 245788999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--- 217 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~--- 217 (400)
+++.+.+.+|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCc
Confidence 9999999999999999999999999764 46899999999999999999999998 99999999999998776
Q ss_pred -ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i-- 230 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-- 230 (361)
T ss_dssp CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--
T ss_pred cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 79999999998654432 234467999999999999889999999999999999999999999765321111000
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...... .... .....+..+.+||.+||..||.+|||+.++++|-+
T Consensus 231 ----~~~~~~----~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 231 ----TAVSYD----FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp ----HTTCCC----CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred ----HhcCCC----CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 000000 0000 00123567889999999999999999999998744
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.81 Aligned_cols=286 Identities=37% Similarity=0.618 Sum_probs=229.1
Q ss_pred CcccccHhHHHHHhcCCCCC------CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc----chhHHHHHH
Q 015781 54 NIKSFSFNGLKTATRNFRPD------SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----LQGHLEWLT 123 (400)
Q Consensus 54 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ 123 (400)
....+.+.++......|... +.||+|+||.||+|.. ++..||+|++.... ......+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~ 79 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQ 79 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHH
Confidence 34567888888888877766 8999999999999964 36789999987532 123456889
Q ss_pred HHHHHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 015781 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (400)
Q Consensus 124 e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 203 (400)
|+.+++.++||||+++++++.+.+..++||||+++++|.+++..... ..++++..++.++.||+.||+|||+++ |+|
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H 156 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH--HIH 156 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eec
Confidence 99999999999999999999999999999999999999999975432 256899999999999999999999988 999
Q ss_pred ccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccC
Q 015781 204 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 283 (400)
Q Consensus 204 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~ 283 (400)
+||||+||+++.++.++|+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986554333333444678999999999865 58999999999999999999999998
Q ss_pred CCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
..........+ ..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 236 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 236 EHREPQLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTBSSSBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cCcchHHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 76543322211 1111122222333333332 34566788899999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=352.71 Aligned_cols=279 Identities=26% Similarity=0.386 Sum_probs=214.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
.++|++.+.||+|+||+||+|.+.. .+..++..||+|++..........+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3679999999999999999997643 3555799999999987665556678899999999999999999999864
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccC
Confidence 356899999999999999998754 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH---
Q 015781 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--- 300 (400)
Q Consensus 225 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--- 300 (400)
|++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~ 234 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQG 234 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCT
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCcccc
Confidence 999865433211 1223345778899999999999999999999999999999999988643210 00000000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
...................+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00000111111122222334456778999999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=351.47 Aligned_cols=269 Identities=28% Similarity=0.378 Sum_probs=218.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 46799999999999999999976431 2234578999999976533 334568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASY--------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 205 (400)
.+..++||||+.+++|.+++...... ...+++..++.++.||+.||+|||+++ |+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccc
Confidence 99999999999999999999875421 134889999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCC
Q 015781 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK 284 (400)
Q Consensus 206 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~ 284 (400)
|||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986544333222334567889999999998899999999999999999999 9999976
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
......... +........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 256 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 256 IPPERLFNL-----------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCGGGHHHH-----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHHHHHH-----------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 543221111 111111223344567889999999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=351.74 Aligned_cols=257 Identities=18% Similarity=0.209 Sum_probs=209.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||+||+|... .++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEEC---------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 468999999999999999999544 478999999987553 3445678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC--CCceEEeec
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSDF 224 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~Df 224 (400)
+..++||||++|++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999999999996543 46899999999999999999999998 999999999999987 789999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ......
T Consensus 149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~~~ 219 (321)
T 1tki_A 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------NIMNAE 219 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC
T ss_pred CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHcCC
Confidence 9998765432 2345679999999999988889999999999999999999999997653211110 000000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
... .... ....+..+.+|+.+||+.||.+|||+.++++|-+--
T Consensus 220 ~~~----~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 220 YTF----DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp CCC----CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCC----Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 000 0000 012356788999999999999999999999986643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.90 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=211.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 3678899999999999999996643 5789999998754322 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCC
Confidence 999999999999999999998654 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~------------- 325 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR------------- 325 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------------
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------------
Confidence 9986433221111112235778999999998899999999999999999998 99999765321110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 326 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 326 ----EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01111111222334566888999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=358.11 Aligned_cols=275 Identities=25% Similarity=0.361 Sum_probs=221.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+.... ......+..||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 367999999999999999999864321 023345678999999765432 345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+++..++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEE
Confidence 99999999999999999999987542 1245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986554333333344567889999999999999999999999999999999 9999976542111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
...+........+..++..+.+|+.+||+.||.+|||+.+++++|+.+.......
T Consensus 303 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 303 ----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp ----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred ----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 1111111122223345678899999999999999999999999999997665443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=343.86 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=211.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hhceeeheecCCCccEEEEEEec----------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 57899999999999999999764 256799999986543 3456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccc
Confidence 9999999999999999997654 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~-------------- 218 (269)
T 4hcu_A 154 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-------------- 218 (269)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--------------
T ss_pred ccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH--------------
Confidence 7543321 111223456778999999999999999999999999999999 999997654211100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 219 ---DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0011111122333466788999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.98 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=211.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 367999999999999999999654 356799999976543 345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred CceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999999998764 35899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------ 217 (268)
T 3sxs_A 151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK------------ 217 (268)
T ss_dssp EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------------
T ss_pred ceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH------------
Confidence 9865443221 2233456778999999998899999999999999999999 9999975542111000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.........+...+..+.+++.+||+.||.+|||+.+++++|+.+++.
T Consensus 218 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 218 -----VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000111112223456788999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=357.08 Aligned_cols=260 Identities=25% Similarity=0.283 Sum_probs=208.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccCCCCcccceee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
.++|++.+.||+|+||+||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINR---------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 357999999999999999999544 4689999999865322 13456889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc---
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--- 218 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--- 218 (400)
++.+++.+|+||||+++++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCc
Confidence 999999999999999999999988776544456899999999999999999999998 999999999999976654
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~--- 242 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE--- 242 (351)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH---
T ss_pred EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH---
Confidence 99999999986544221 23446799999999999998999999999999999999999999976321 0000
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........ ...... ...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 243 ~i~~~~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 243 GIIKGKYK----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp HHHHTCCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHcCCCC----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 00000000 000000 1235678899999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=356.54 Aligned_cols=259 Identities=26% Similarity=0.289 Sum_probs=207.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|... .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 368999999999999999999554 36889999998754432 23457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999999988654 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++................||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+..
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~------ 223 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE------ 223 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT------
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc------
Confidence 9976543333333445689999999999987765 77899999999999999999999765432111 111110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
...........+..+.+|+.+||+.||.+|||+.+++++-+.-
T Consensus 224 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 224 --------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp --------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred --------ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 0000011123456778999999999999999999999986653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=358.91 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=203.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
.++|++.++||+|+||.||+|... .+++.||+|++..... .....+.+|..+++.+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 368999999999999999999554 4689999999976432 2334577899999887 79999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+.+.+|+||||+.|++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999998763 5899999999999999999999998 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........
T Consensus 167 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---------- 234 (353)
T 3txo_A 167 DFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---------- 234 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred cccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence 999998533222 23445689999999999998899999999999999999999999997654321110
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKAL 352 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~eil~~L 352 (400)
.+... ...++...+..+.+|+.+||+.||.+||++ .++++|-
T Consensus 235 ------~i~~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 235 ------AILND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp ------HHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred ------HHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 11111 112333456678899999999999999998 8888863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=359.70 Aligned_cols=257 Identities=22% Similarity=0.274 Sum_probs=211.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|... .++..+|+|++..........+.+|+.+++.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 367999999999999999999554 46889999999876555556788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC--CCceEEeec
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSDF 224 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~Df 224 (400)
...++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999987543 46899999999999999999999998 999999999999974 577999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ...
T Consensus 196 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~~~- 265 (387)
T 1kob_A 196 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC- 265 (387)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC-
T ss_pred ccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-
Confidence 9998754432 233457999999999999999999999999999999999999999765321110000 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
............+..+.+||.+||+.||.+|||+.++++|-+.
T Consensus 266 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 266 -------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp -------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 0001111222456688899999999999999999999998554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.32 Aligned_cols=272 Identities=26% Similarity=0.359 Sum_probs=215.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|..... ....++..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 457899999999999999999987531 12245789999999865433 3456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASY--------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
+++..++||||+++++|.+++...... ..++++..++.++.||+.||+|||+++ |+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 999999999999999999999874321 156899999999999999999999998 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccC
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 283 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~ 283 (400)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999875433222222334567899999999999999999999999999999999 999997
Q ss_pred CCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
....... .. .+.. ......+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+...
T Consensus 279 ~~~~~~~---~~-------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEV---IY-------------YVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHH---HH-------------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHH---HH-------------HHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 6432110 00 0000 00112233456688999999999999999999999999999866443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=347.89 Aligned_cols=271 Identities=27% Similarity=0.358 Sum_probs=220.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... .+..++..||+|++..... .....+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 36799999999999999999976321 2445789999999986543 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCC
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASY--------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~N 210 (400)
+.+..++||||+++++|.+++...... ..++++..++.++.||+.||+|||+++ |+|+||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccce
Confidence 999999999999999999999875421 235899999999999999999999998 9999999999
Q ss_pred EEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCc
Q 015781 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSR 289 (400)
Q Consensus 211 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~ 289 (400)
|+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987655443333444567889999999999999999999999999999999 999997654321
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
... ...........+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus 256 ~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 KFY----------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHH----------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH----------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 110 001111111223345668899999999999999999999999999886654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=358.73 Aligned_cols=258 Identities=25% Similarity=0.349 Sum_probs=206.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccC-CCCcccceeeE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
.++|++.++||+|+||.||+|... .+++.||+|++....... ...+..|..++.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 367999999999999999999554 478999999997654322 23467888888776 89999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+.+.+|+||||+.||+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998763 5899999999999999999999998 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc--hhHHhhhHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH--NLIEWAKPY 300 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~--~~~~~~~~~ 300 (400)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-- 271 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-- 271 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--
Confidence 999998533222 2345578999999999999999999999999999999999999999654321110 0000000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKAL 352 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~eil~~L 352 (400)
..+... ...++...+..+.+||.+||+.||.+||++ .+|++|-
T Consensus 272 -------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 272 -------QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp -------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred -------HHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 011111 112344456788999999999999999985 6888763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.05 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. ...++..||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 579999999999999999996542 223577899999976532 3345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999997654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~---------- 260 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---I---------- 260 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---H----------
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----------
Confidence 98654322111 1122345778999999999999999999999999999998 9999975432110 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+........+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus 261 ----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 261 ----KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111111122233445678899999999999999999999999999986643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=344.43 Aligned_cols=272 Identities=23% Similarity=0.276 Sum_probs=213.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 67999999999999999999654 3688999999976543 2345677999999999999999999999876
Q ss_pred C--eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE----cCCCceE
Q 015781 147 D--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAK 220 (400)
Q Consensus 147 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~k 220 (400)
. ..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEE
Confidence 5 789999999999999999875431 34899999999999999999999998 9999999999999 7788899
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhc--------cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
|+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 157 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 233 (319)
T 4euu_A 157 LTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (319)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred EccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence 99999998654432 223457999999999986 5788999999999999999999999997654332221
Q ss_pred hHHhhhHHHhhhhhhh---hhc--------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKPYLQSKRRIF---QVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+............+. ... .......++...+..+.+++.+||+.||++|||+.+++++...
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1111000000000000 000 0111224456788899999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=362.00 Aligned_cols=259 Identities=24% Similarity=0.261 Sum_probs=208.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||+||+|.. ..+|..+|+|++...... ....+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~---------~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 78 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVK---------VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEE---------TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEE---------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 3456899999999999999999954 447899999999765533 34568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---CCCce
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNA 219 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~ 219 (400)
+.+.+..|+||||+.|++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+
T Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 79 ISEEGHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EECSSEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCE
T ss_pred EEECCEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcE
Confidence 99999999999999999999999876 35899999999999999999999998 99999999999998 46789
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||+|||++........ ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+.
T Consensus 153 kL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~---- 226 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK---- 226 (444)
T ss_dssp EECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----
T ss_pred EEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----
Confidence 9999999986543322 2344689999999999999899999999999999999999999997643211110000
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... . ..........+..+.+|+.+||+.||.+|||+.++|+|-+.
T Consensus 227 --~~~------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 227 --AGA------Y--DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp --HTC------C--CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred --hCC------C--CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 000 0 00011112345678899999999999999999999997543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.82 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||+||+|.+... .......||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 5799999999999999999976431 112234578898865432 3446788999999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
. .++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcc
Confidence 4 788999999999999998754 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------------- 230 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------- 230 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------------
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-------------
Confidence 986544333333344567889999999999999999999999999999999 999997654322111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.+........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 231 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 231 ----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1111111223334566788999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.72 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=215.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||.||+|..... ....++..||+|++..... .....+.+|+.+++++ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 346899999999999999999976321 2344678999999975432 2345688999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASY-------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+++ |+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 9999999999999999999999765421 124789999999999999999999998 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccC
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVID 283 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~ 283 (400)
||||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544333333444567889999999999999999999999999999998 999997
Q ss_pred CCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
........ ...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 277 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPVDANF----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCCSHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCcHHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 75432111 0111111112223345678899999999999999999999999999875543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=347.62 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=207.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+|+.||+|++..... .....+.+|..+++.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 57999999999999999999543 4689999999976432 23456778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+...+|+||||+.|++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeec
Confidence 999999999999999999999865 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 151 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------- 212 (318)
T 1fot_A 151 GFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------- 212 (318)
T ss_dssp SSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------
T ss_pred CcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence 99986433 123468999999999999999999999999999999999999999764321100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
..+.... ..++...+..+.+++.+||+.||.+|| ++.++++|-+
T Consensus 213 ---~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 213 ---EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp ---HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---HHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 0111111 123334567889999999999999999 8999998743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=348.96 Aligned_cols=271 Identities=24% Similarity=0.346 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... ......||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 46899999999999999999965431 1122489999997653 234567889999999999999999999998
Q ss_pred eCCee------EEEEeecCCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 145 EDDHR------LLVYEFMPKGSLENHLFRRAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 145 ~~~~~------~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+.... ++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 77655 999999999999999976542 2235899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 295 (400)
+.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~- 252 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL- 252 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-
Confidence 9999999999986544333323334566789999999999999999999999999999999 99999865432211111
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.......
T Consensus 253 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 253 ----------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp ----------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred ----------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 001111223345568899999999999999999999999999986654443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=343.26 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=209.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 57999999999999999999654 366799999986543 3456889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999997644 35899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------------- 232 (283)
T 3gen_A 168 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------------- 232 (283)
T ss_dssp GGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--------------
T ss_pred cccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH--------------
Confidence 75433211 11223456788999999998999999999999999999998 999997654211110
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 233 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 233 ---HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ---HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 01111111223334567889999999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.68 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=207.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
.++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.+++.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 356999999999999999999544 46899999998765432 345788999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--- 217 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~--- 217 (400)
+++.+....++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCC
Confidence 9999999999999999999999999754 46899999999999999999999988 99999999999998877
Q ss_pred -ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-- 229 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-- 229 (326)
T ss_dssp CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--
T ss_pred CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--
Confidence 79999999998654332 223457999999999999889999999999999999999999999764321111000
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..... ..........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 230 ----~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 230 ----SAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp ----HHTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ----HhcCC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 00000 00000001234578899999999999999999999997554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=345.74 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=208.3
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCee
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 149 (400)
|...+.||+|+||.||+|... .+|+.||||++..........+.+|+.+++.++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 666779999999999999654 36889999999876655667788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 150 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++||||+++++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 118 ~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190 (321)
T ss_dssp EEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence 999999999999999864 35899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... +..
T Consensus 191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~----------~~~ 255 (321)
T 2c30_A 191 ISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKR----------LRD 255 (321)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH----------HHH
T ss_pred cccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----------Hhc
Confidence 543221 23446799999999999999999999999999999999999999976432111 000 000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..... .......+..+.+++.+||+.||++|||+.+++++-+..
T Consensus 256 ~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 256 SPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp SSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred CCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 00000 011223456788999999999999999999999986654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=348.75 Aligned_cols=268 Identities=19% Similarity=0.181 Sum_probs=213.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++..... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL---------YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET---------TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC---------CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 367999999999999999999543 4689999999875532 23567899999999 99999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc-----eE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AK 220 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-----~k 220 (400)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 999999998653 46899999999999999999999998 999999999999998887 99
Q ss_pred EeeccCCccCCCCCCcc-----eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 221 LSDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 99999998643322211 1245689999999999999999999999999999999999999998765433222221
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
.... ... ....... ....+ .+.+++.+||+.||.+||++.+|++.|+.+.......
T Consensus 231 ~i~~---~~~---~~~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 231 KIGD---TKR---ATPIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHHH---HHH---HSCHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHh---hhc---cCCHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1110 000 0000000 01123 7889999999999999999999999999887765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=354.92 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=207.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN---------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 57999999999999999999544 4689999999876432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+.+|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEecc
Confidence 999999999999999999999765 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||................
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--- 233 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--- 233 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---
Confidence 9998654332 2345689999999999863 468999999999999999999999997654432222111100
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~eil~~ 351 (400)
.....++...+..+.+||.+||+.||.+||+ +.++++|
T Consensus 234 ------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 234 ------------TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ------------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ------------hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0112233445678899999999999999998 7777764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=360.10 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=197.3
Q ss_pred hcCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHH-ccCCCCcccceeeEEE
Q 015781 67 TRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL-GQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~ 144 (400)
.++|.+. ++||+|+||+||+|... .++..||+|++... ..+.+|+.++ +..+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~---------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEEC---------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3567766 78999999999999544 47899999998642 3456777776 4458999999999987
Q ss_pred e----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CC
Q 015781 145 E----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 217 (400)
Q Consensus 145 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~ 217 (400)
. ...+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCc
Confidence 6 5678999999999999999986542 46899999999999999999999988 999999999999987 78
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..............
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~- 277 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT- 277 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH-
T ss_pred cEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH-
Confidence 99999999998654322 23456789999999999999999999999999999999999999976654321110000
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.+... ............+..+.+||.+||+.||.+|||+.++++|-+.....
T Consensus 278 --~i~~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 278 --RIRMG-------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp --HHHHT-------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred --HHHcC-------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 00000 00000001123456788999999999999999999999997765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=341.12 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|.... ....+..||+|++..... .....+.+|+.++++++||||+++++++. +
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred HHeEEEeEeeecCCeeEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 679999999999999999997653 223467899999876433 23456889999999999999999999985 5
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred CccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence 67899999999999999997654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----------- 230 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------- 230 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----------
Confidence 9865432211 2233456788999999998999999999999999999997 99999765432211100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 231 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 231 ------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00011123334567888999999999999999999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.06 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=206.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCccccee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~ 140 (400)
...++|++.++||+|+||.||+|... .+++.||+|++..... .....+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 34578999999999999999999554 4789999999976432 2334567888888876 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+++.+.+.+|+||||+.||+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEE
Confidence 99999999999999999999999998753 5899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||+++....... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 159 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------- 229 (345)
T 1xjd_A 159 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS------- 229 (345)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------
T ss_pred EeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------
Confidence 999999986432221 24457899999999999999999999999999999999999999976542111000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~ 351 (400)
+... ...++...+..+.+|+.+||+.||.+||++. ++++|
T Consensus 230 ---------i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 230 ---------IRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ---------HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---------HHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0000 1122334567888999999999999999998 88765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=353.21 Aligned_cols=257 Identities=25% Similarity=0.317 Sum_probs=208.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3467999999999999999999544 4689999999976543 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC---CceE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAK 220 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~~k 220 (400)
.+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999999998765 45899999999999999999999998 9999999999999765 4599
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 172 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------ 242 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI------ 242 (362)
T ss_dssp ECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred EeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------
Confidence 99999998655332 233467999999999999989999999999999999999999999764321110000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..... . .........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 243 ~~~~~---~-----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 243 KAGAY---D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp HHTCC---C-----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred HhCCC---C-----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 00000 0 0000012345678899999999999999999999998554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=350.90 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=207.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||+||+|.+... .......||+|.+..... .....+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 5799999999999999999976541 122234588888764432 22335668999999999999999999886 4
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred CccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCc
Confidence 56899999999999999997653 35888999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 231 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---------- 231 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH----------
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH----------
Confidence 987655444334455678889999999999999999999999999999999 999998754322111111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.......+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 232 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 232 -------KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111112223444677899999999999999999999999988543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=351.04 Aligned_cols=251 Identities=25% Similarity=0.309 Sum_probs=208.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATH---------YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 6799999999999999999954 347899999998754322 2346789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+ +|+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCS
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEe
Confidence 999999999999 789999987763 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+
T Consensus 153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------- 220 (336)
T 3h4j_B 153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------- 220 (336)
T ss_dssp SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------
T ss_pred ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------
Confidence 9998654432 2344679999999999987776 78999999999999999999999765432211100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ......+...+..+.+|+.+||+.||.+|||+.++++|-+.-
T Consensus 221 --------~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 221 --------N-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp --------C-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred --------H-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 0 001122334566788999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=345.84 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... ++..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 67999999999999999999653 3788999998765332 23567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 91 ERCLTLVFEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCc
Confidence 999999999996 58888887654 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH----
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY---- 300 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---- 300 (400)
++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 9986543221 2334578999999999876 56899999999999999999999999876554332221100000
Q ss_pred -Hhhhhhhhhhc-------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 301 -LQSKRRIFQVM-------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 301 -~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
......+.... ............+.++.+|+.+||+.||.+|||+.++++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 00000000000 00000001122346788999999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=350.32 Aligned_cols=248 Identities=24% Similarity=0.275 Sum_probs=208.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 57999999999999999999544 4689999999976432 23456788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+...+|+||||++|++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccc
Confidence 9999999999999999999998763 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------- 247 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------------- 247 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------------
Confidence 999865332 23467999999999999999999999999999999999999999764321110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L~ 353 (400)
..+... ...++...+..+.+||.+||+.||.+||+ +.+|++|-+
T Consensus 248 ---~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 248 ---EKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ---HHHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---HHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 011111 11223345678899999999999999998 999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=346.43 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+... .......||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 6799999999999999999976541 11223457888876443 23456788999999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
. .++||+++.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred C-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 5 788999999999999998754 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------------- 230 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------- 230 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------------
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------------
Confidence 986544333333334567889999999999999999999999999999999 999997654322111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 231 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ----ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111112222334566788999999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=351.93 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=198.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|... .+++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDK---------LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEET---------TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 67999999999999999999544 4689999999976542 3356789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--eEEeecc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDFG 225 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg 225 (400)
..++||||+.+++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+||+++.++. +||+|||
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999999997753 5899999999999999999999988 999999999999987765 9999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCc-cchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAK-SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--------- 231 (361)
T 3uc3_A 164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI--------- 231 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH---------
T ss_pred ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH---------
Confidence 987432221 2334579999999999988877665 899999999999999999998655432221110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
..+.............+..+.+|+.+||+.||.+|||+.++++|-+..+
T Consensus 232 ---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 232 ---QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp ---HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred ---HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 0111111111111134567889999999999999999999999866543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=348.85 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=206.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
++|++.+.||+|+||.||+|... .+++.||+|++...... ....+.+|..++.++ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 57999999999999999999554 46899999999765432 234577899999887 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998753 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc--hhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH--NLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~ 301 (400)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 154 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--- 228 (345)
T 3a8x_A 154 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--- 228 (345)
T ss_dssp GGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---
T ss_pred ccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---
Confidence 99998533222 1244568999999999999999999999999999999999999999653221110 0000000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM------DEVVKAL 352 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~eil~~L 352 (400)
..+... ...++...+..+.+|+.+||+.||.+||++ .++++|-
T Consensus 229 ------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 229 ------QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ------HHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 011111 112334456788999999999999999995 7888763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=341.01 Aligned_cols=267 Identities=23% Similarity=0.273 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... .+++.||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 57999999999999999999554 36889999999765432 23567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999965 6666665533 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCC-CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh--
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ-- 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-- 302 (400)
++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ..........
T Consensus 147 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~ 222 (292)
T 3o0g_A 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTP 222 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred cceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCC
Confidence 9986543221 234457899999999997765 89999999999999999998888543322111 1100000000
Q ss_pred hhhhh---hhhcc---------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRI---FQVMD---------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~---~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
....+ ....+ ...........+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 00000 00000 00001112235677889999999999999999999998743
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.29 Aligned_cols=255 Identities=28% Similarity=0.532 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-------HHHHHHHHHHHccCCCCccccee
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
++|++.+.||+|+||.||+|... .++..||+|++....... ...+.+|+.++++++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 57999999999999999999654 368899999986543321 15678999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-- 218 (400)
+++.+.. ++||||+.+++|.+++.... .++++..++.++.||+.||+|||+++.+|+|+||||+||+++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence 9987655 69999999999999887654 4789999999999999999999997656999999999999988776
Q ss_pred ---eEEeeccCCccCCCCCCcceeeecccccCcccchhh--ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 ---AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
+||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||...........
T Consensus 165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 239 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239 (287)
T ss_dssp SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence 99999999975332 23446799999999998 345678999999999999999999999976543221100
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
............+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 240 --------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 --------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011111222233445567899999999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=352.44 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=199.8
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 152 (400)
.+.||+|+||.||+|... .+|..||+|++..........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET---------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEc---------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 568999999999999554 36899999999877666667889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE--cCCCceEEeeccCCccC
Q 015781 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 153 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~ 230 (400)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999987654 35899999999999999999999998 9999999999999 56788999999999875
Q ss_pred CCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhh
Q 015781 231 PTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310 (400)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (400)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ ........
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~~~~---- 306 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NILACRWD---- 306 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTCCC----
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhccCC----
Confidence 44322 234579999999999998889999999999999999999999997654321110 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 311 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.........+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 307 ----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 307 ----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp ----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 000001234567889999999999999999999999644
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.64 Aligned_cols=279 Identities=18% Similarity=0.204 Sum_probs=212.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----------HHHHHHHHHHHccCCCCc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN 135 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn 135 (400)
.++|++.+.||+|+||.||+|.+... .....++.||+|++....... ...+..|+..+..++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 35799999999999999999987542 223357889999987654211 112445677788899999
Q ss_pred ccceeeEEEeC----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 136 LVKLIGYCLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 136 iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
|+++++++.+. ...|+||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Ni 183 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNL 183 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHE
Confidence 99999998765 5589999999 999999998753 46999999999999999999999998 99999999999
Q ss_pred EEc--CCCceEEeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCC
Q 015781 212 LLD--LNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284 (400)
Q Consensus 212 ll~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 284 (400)
|++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 8899999999999754322111 111335699999999999999999999999999999999999999986
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
...... ...+.... ....+..+.+..+. ....+..+.+++.+||+.||.+||++.+|++.|+.+.......
T Consensus 264 ~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 264 NLKDPK--YVRDSKIR--YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp GTTCHH--HHHHHHHH--HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccCHH--HHHHHHHH--hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 433211 11111110 11112222222111 1123567889999999999999999999999999987765544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=349.68 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=207.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
...+|++.++||+|+||.||+|... .+++.||+|++..... .....+..|..++..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 3468999999999999999999554 4689999999976532 2345577899999887 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
++.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEE
Confidence 9999999999999999999999998763 5899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~------- 230 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F------- 230 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---H-------
Confidence 9999998633222 124456899999999999999999999999999999999999999976432110 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKAL 352 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~L 352 (400)
..+... ...++...+..+.+|+.+||+.||.+||+ +.++++|-
T Consensus 231 ------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 231 ------QSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred ------HHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 011111 11233445678899999999999999995 68888873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=348.40 Aligned_cols=280 Identities=25% Similarity=0.333 Sum_probs=218.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE--e
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL--E 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~ 145 (400)
++|++.+.||+|+||.||+|.+.. .+..++..||+|++..........+.+|+.++++++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 679999999999999999997543 345578999999998776666667889999999999999999999886 4
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccc
Confidence 567899999999999999998754 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++.......... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||............ +. ......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~-~~~~~~ 250 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CE-RDVPAL 250 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cc-cccccH
Confidence 998654433211 223356788899999999989999999999999999999999998643211000000 00 000000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+............+...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111222222233344556778999999999999999999999999999985544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.56 Aligned_cols=274 Identities=22% Similarity=0.306 Sum_probs=194.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..+|++.+.||+|+||.||+|.. ..++..||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLN---------KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEEC---------SSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEE---------CCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 36799999999999999999954 447899999998765422 34567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
++..++||||+. ++|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECc
Confidence 999999999996 699999876542 2245899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH--
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-- 300 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-- 300 (400)
||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999986543221 2234578999999999976 46899999999999999999999999865432211111000000
Q ss_pred ---Hhhhhhhhhh---c--------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 301 ---LQSKRRIFQV---M--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 301 ---~~~~~~~~~~---~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.......... . ...+........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 0000000000 0 0000001111345678999999999999999999999997443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.06 Aligned_cols=262 Identities=21% Similarity=0.230 Sum_probs=208.6
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCccccee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
....++|++.++||+|+||+||+|... .+++.||+|++....... ...+.+|..++..++||||++++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 140 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344578999999999999999999654 368999999997543221 22377899999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+++.+.+.+|+||||+.||+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred EEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEE
Confidence 99999999999999999999999997643 46899999999999999999999988 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|..||...........+
T Consensus 216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i- 293 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI- 293 (437)
T ss_dssp ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-
T ss_pred EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh-
Confidence 999999976543222 2234468999999999986 457899999999999999999999999765432111111
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHH
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALE 353 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~ 353 (400)
..... .. .. .......+..+.+||.+||..+|++ ||++.++++|-+
T Consensus 294 -----~~~~~---~~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 294 -----MNHKE---RF---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp -----HTHHH---HC---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred -----hhccc---cc---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 00000 00 00 0111224667889999999988888 999999999744
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=340.03 Aligned_cols=268 Identities=17% Similarity=0.173 Sum_probs=214.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .++..||+|++.... ....+.+|+..++.+ +|+|++++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 467999999999999999999543 368999999986543 223567899999998 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc-----eE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AK 220 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-----~k 220 (400)
....++||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++. +|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEE
Confidence 99999999999 999999998654 46899999999999999999999988 999999999999987766 99
Q ss_pred EeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 221 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 9999999865433221 12344679999999999999999999999999999999999999998765433322221
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
....... ...... .....+..+.+++.+||+.||.+|||+.+|++.|+.+......
T Consensus 232 ~~~~~~~------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 232 RIGEKKQ------STPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHH------HSCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhhcc------CccHHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1110000 000000 0112356788999999999999999999999999998775543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=350.80 Aligned_cols=254 Identities=25% Similarity=0.304 Sum_probs=193.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+|+.++++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 3467999999999999999999654 367899999997653 33457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl~ 222 (400)
.+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEc
Confidence 99999999999999999999765 35899999999999999999999998 999999999999975 8899999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 194 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~-------- 260 (349)
T 2w4o_A 194 DFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF-------- 260 (349)
T ss_dssp CCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH--------
T ss_pred cCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH--------
Confidence 999998643321 23346789999999999998999999999999999999999999975432110 00
Q ss_pred hhhhhhhhcccc--ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 303 SKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 303 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+.... .........+..+.+|+.+||+.||++|||+.++++|-+-
T Consensus 261 -----~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 261 -----RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp -----HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred -----HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0000000 0111122346678899999999999999999999997544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=362.55 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=187.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .++..||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK---------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC---------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC---------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 368999999999999999999554 468999999986542 233456889999999999999999999985
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.. ..+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCE
Confidence 43 5789999998 67999998754 46899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCc-------------------------ceeeecccccCcccchhh-ccCCCCCccchhhHHHHHH
Q 015781 220 KLSDFGLAKDGPTGSQS-------------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLL 273 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~ 273 (400)
||+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999865422110 123446789999999976 5667999999999999999
Q ss_pred HHHh-----------CCCccCCCCCCccc-----------------hhHHhhhHHHhh--h-----------hhhhhhcc
Q 015781 274 EMLS-----------GRRVIDKNRPSREH-----------------NLIEWAKPYLQS--K-----------RRIFQVMD 312 (400)
Q Consensus 274 ~l~t-----------g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~--~-----------~~~~~~~~ 312 (400)
||++ |.++|.+....... ..+......+.. . ......+.
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 9999 66677654321100 000000000000 0 00000000
Q ss_pred cccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 313 ARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 313 ~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... .......+..+.+||.+||..||.+|||+.|+|+|-+
T Consensus 356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399 (458)
T ss_dssp CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence 0000 0001223667889999999999999999999999843
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=346.83 Aligned_cols=276 Identities=26% Similarity=0.346 Sum_probs=219.7
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccce
Q 015781 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKL 139 (400)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~ 139 (400)
.+....++|++.+.||+|+||+||+|.+... .+..+++.||+|++...... ....+.+|+.+++++ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3334557899999999999999999976431 24457899999999765433 345688999999999 79999999
Q ss_pred eeEEEeCC-eeEEEEeecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 015781 140 IGYCLEDD-HRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (400)
Q Consensus 140 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 206 (400)
++++.+.+ ..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+++ |+||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~di 174 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 174 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccC
Confidence 99987654 589999999999999999865421 123789999999999999999999998 999999
Q ss_pred CCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCC
Q 015781 207 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKN 285 (400)
Q Consensus 207 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~ 285 (400)
||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986554433333444667899999999999999999999999999999998 99999765
Q ss_pred CCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
...... .. .+........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.+
T Consensus 255 ~~~~~~--~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEEF--CR--------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHHH--HH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHHH--HH--------------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 432110 00 00000111223334567889999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=342.66 Aligned_cols=275 Identities=28% Similarity=0.392 Sum_probs=212.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|.+.. .+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 458899999999999999997643 3556799999999976542 2345688999999999999999999999876
Q ss_pred --CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcc
Confidence 67899999999999999997654 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH--H
Q 015781 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY--L 301 (400)
Q Consensus 225 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~ 301 (400)
|++......... .......+|..|+|||++.+..++.++|||||||++|+|++|..|+...... ......+. .
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~ 246 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQ 246 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGG
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccc
Confidence 999865443321 2233456788899999999999999999999999999999999987432100 00000000 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.....+............+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0001111111122222334456678999999999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.92 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=207.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
...++|++.++||+|+||+||+|... .++..||+|++...... ....+.+|+.+++.++||||+++++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34578999999999999999999554 46899999998753221 2234678999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
++.+...+|+||||++||+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL 209 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL 209 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEE
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEE
Confidence 999999999999999999999998653 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCC----CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH----LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+|||+++...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...........
T Consensus 210 ~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---- 284 (410)
T 3v8s_A 210 ADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---- 284 (410)
T ss_dssp CCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----
T ss_pred eccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH----
Confidence 9999998654332 11234578999999999997655 78999999999999999999999976543211111
Q ss_pred hHHHhhhhhhhhhccccccCCCC--HHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHh
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYS--LGAALKTAVLAIKCLSNEPKF--RPTMDEVVKALEQ 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~--Rps~~eil~~L~~ 354 (400)
++.......++ ...+..+.+||.+||+.+|.+ ||++.+|++|-+.
T Consensus 285 ------------i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 285 ------------IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp ------------HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ------------HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 11100001111 234567889999999999988 9999999998554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.69 Aligned_cols=273 Identities=24% Similarity=0.373 Sum_probs=216.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+.... .....++..||+|++..... .....+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 367999999999999999999875311 12334688999999976543 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+.+..++||||+.+++|.+++...... ...+++..++.++.||+.||+|||+++ |+|+||||+||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEE
Confidence 999999999999999999999865421 134899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999986554333222334567889999999988889999999999999999999 9999976532110
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
. ..+........+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 269 --~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 --F--------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp --H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --H--------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 0 0001111112233456688999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=341.28 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=217.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34679999999999999999996543 58899999997654 345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999999977543 56899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~------------ 223 (288)
T 3kfa_A 157 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------------ 223 (288)
T ss_dssp GGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------------
T ss_pred cceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------
Confidence 9986543322 22333556889999999999999999999999999999999 999997654321111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 224 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 224 -----LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111122233445678899999999999999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=348.24 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=200.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCC--CcccceeeE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYH--PNLVKLIGY 142 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--pniv~~~~~ 142 (400)
.++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++| |||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 367999999999999999999542 478899999876533 234568899999999976 999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.++...|+|||+ .+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEEC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEe
Confidence 9999999999995 588999999875 46899999999999999999999998 99999999999997 6789999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhcc-----------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 9999987654433333445689999999999865 67889999999999999999999999754321
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ..+....+.......+...+..+.+|+.+||+.||.+|||+.++++|.+.-
T Consensus 227 --~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 227 --I----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp --H----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --H----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 0 011112222222233334456788999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=344.24 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=197.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------------------------hHHHH
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------------------------GHLEW 121 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~ 121 (400)
++|++.+.||+|+||.||+|... .++..||+|++...... ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNE---------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEET---------TTTEEEEEEEEECC-------------------------------CHH
T ss_pred cceEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 67999999999999999999544 36899999998764321 12357
Q ss_pred HHHHHHHccCCCCcccceeeEEEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 015781 122 LTEIKHLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA 199 (400)
Q Consensus 122 ~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 199 (400)
.+|+.++++++||||+++++++.+ ....|+||||+++++|.+++.. .++++..++.++.||+.||+|||+++
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~- 157 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK- 157 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 899999999999999999999986 5789999999999999775432 46899999999999999999999998
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCC---CCCccchhhHHHHHHHHH
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEML 276 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~ 276 (400)
|+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 99999999999999999999999999986543221 234467999999999997654 377899999999999999
Q ss_pred hCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 277 SGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 277 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
+|..||....... .... +.............+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 235 ~g~~pf~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 235 FGQCPFMDERIMC------LHSK----------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HSSCSSCCSSHHH------HHHH----------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HCCCCCCCccHHH------HHHH----------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 9999997543210 0000 00001111111234567889999999999999999999998743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=341.80 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=203.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..++|.+.+.||+|+||.||+|.+.. ...++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34679999999999999999997653 334678999999876532 2345688999999999999999999999
Q ss_pred EeCC-----eeEEEEeecCCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 144 LEDD-----HRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 144 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
.+.+ ..++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence 8754 3599999999999999985432 22356899999999999999999999988 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 295 (400)
+.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 262 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL- 262 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-
Confidence 9999999999986544332222334567889999999999999999999999999999999 88999765432111100
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 263 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 263 ----------------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ----------------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00011122334556789999999999999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=344.60 Aligned_cols=279 Identities=30% Similarity=0.429 Sum_probs=216.5
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC--
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED-- 146 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-- 146 (400)
|++.+.||+|+||+||++.+.. .+..+++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4899999999999999987643 5666899999999986543 3345688999999999999999999999874
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..+++||||+++++|.+++... .+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccc
Confidence 6789999999999999999654 4899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... .......++..|+|||++.+..++.++|||||||++|+|++|..||....... .....+... .....
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~-~~~~~ 258 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQG-QMTVL 258 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCH-HHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhccccc-chhHH
Confidence 9876543321 12334567888999999999899999999999999999999999986432100 000000000 00011
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
.+............+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 112222222233344556778999999999999999999999999999987765444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.23 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|.+. +..+|+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 57999999999999999999753 67799999986543 334568899999999999999999999987
Q ss_pred C--CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 146 D--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 146 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
. ...++||||+++++|.+++..... .++++..++.++.||+.||+|||+++..++|+||||+||+++.++.++|.|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred CCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 7 788999999999999999976542 368999999999999999999999766699999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCC---ccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTA---KSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
||++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||........
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------- 219 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------- 219 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----------
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----------
Confidence 988764322 2246899999999998765554 79999999999999999999976432110
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.............+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 ------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011111112223344556789999999999999999999999999998864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.81 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
++|++.+.||+|+||.||+|... ....+++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 57999999999999999999754 2334789999999986532 2234567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+.+|+||||+.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEe
Confidence 99999999999999999999998753 5889999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------------ 230 (327)
T 3a62_A 165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------------ 230 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------------
T ss_pred CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------------
Confidence 99987533221 1234467999999999999889999999999999999999999999764321110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
..+... ...++...+..+.+|+.+||+.||.+|| ++.++++|-+
T Consensus 231 ----~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 231 ----DKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ----HHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ----HHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 001111 1122334567888999999999999999 8889998744
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=348.26 Aligned_cols=270 Identities=26% Similarity=0.346 Sum_probs=215.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 46799999999999999999976542 1223456899999976543 2345688999999999 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
+.+..++||||+++++|.+++..... ...++++..++.++.||+.||+|||+++ |+||||||+||+++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC
Confidence 99999999999999999999976431 1246899999999999999999999998 99999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchh
Q 015781 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNL 293 (400)
Q Consensus 215 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~ 293 (400)
.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~- 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY- 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence 999999999999986543333223344567889999999999999999999999999999998 999997654321110
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
...........+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 278 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 278 ---------------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ---------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 01111111122233456788999999999999999999999999987553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=364.68 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=214.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+|+.++++++||||+++++++.+.
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3568889999999999999997653 578999999976543 456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccc
Confidence 999999999999999999976432 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 365 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------------- 429 (495)
T 1opk_A 365 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------------- 429 (495)
T ss_dssp EECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--------------
T ss_pred ceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH--------------
Confidence 98654322 111223345778999999998899999999999999999999 99999765432111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
..+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 430 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 430 ---ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111112223344556788999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=345.69 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=198.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 467999999999999999999654 3688999999975443 245678899999999999999999999865
Q ss_pred CC---------------------------------------------------------eeEEEEeecCCCCHHHHHhhh
Q 015781 146 DD---------------------------------------------------------HRLLVYEFMPKGSLENHLFRR 168 (400)
Q Consensus 146 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~ 168 (400)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 389999999999999999875
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCc----------ce
Q 015781 169 ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS----------HV 238 (400)
Q Consensus 169 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~ 238 (400)
... ....+..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 156 ~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CSL-EDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CSG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cCc-cchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 432 34577788999999999999999998 999999999999999999999999999865443211 12
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCC
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQ 318 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (400)
.....||+.|+|||++.+..++.++|||||||++|+|++|..|+.... ... ...... ....
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------------~~~------~~~~~~-~~~~ 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------------RII------TDVRNL-KFPL 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------------HHH------HHHHTT-CCCH
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------------HHH------HHhhcc-CCCc
Confidence 234579999999999999999999999999999999999877652110 000 000000 0000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 319 YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 319 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 112344667889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=356.14 Aligned_cols=280 Identities=25% Similarity=0.325 Sum_probs=199.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCC-CCcccceee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIG 141 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-hpniv~~~~ 141 (400)
...++|++.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.+++.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDR---------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEET---------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEEC---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 45678999999999999999999544 468999999986542 234456778999999997 999999999
Q ss_pred EEEeCC--eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 142 YCLEDD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 142 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
++...+ .+|+||||+. ++|..++... .+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCE
Confidence 997554 7899999996 6999988753 5899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCC-------------------CcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCC
Q 015781 220 KLSDFGLAKDGPTGS-------------------QSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR 279 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~ 279 (400)
||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999997543211 1112344689999999999976 67899999999999999999999
Q ss_pred CccCCCCCCccchhHHhhhHHHhhhhhh---------------hhhc---ccccc------------CCCCHHHHHHHHH
Q 015781 280 RVIDKNRPSREHNLIEWAKPYLQSKRRI---------------FQVM---DARIE------------GQYSLGAALKTAV 329 (400)
Q Consensus 280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~---~~~~~------------~~~~~~~~~~l~~ 329 (400)
+||.+.........+...... .....+ .... ..... .......+..+.+
T Consensus 229 ~pf~~~~~~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 229 PIFPGSSTMNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp CSCCCSSHHHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 999876543222111100000 000000 0000 00000 0001123567889
Q ss_pred HHHhcccCCCCCCCCHHHHHHH--HHhchhcCCCC
Q 015781 330 LAIKCLSNEPKFRPTMDEVVKA--LEQIQDTNDAG 362 (400)
Q Consensus 330 li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~~~ 362 (400)
|+.+||+.||.+|||+.++++| +..+.+.+..+
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~ 342 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCC
T ss_pred HHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCC
Confidence 9999999999999999999998 55555444433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=343.57 Aligned_cols=264 Identities=24% Similarity=0.414 Sum_probs=206.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.+.||+|+||.||+|.+.. .....+..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHhhcccEEecCCCeEEEEEEEec-----CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 578888999999999999997754 1223456799999976533 2345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999997653 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 227 AKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 227 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~---------- 260 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VM---------- 260 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----------
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HH----------
Confidence 98654322111 1222346788999999998999999999999999999999 999996543211 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+........+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 261 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 261 ----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00001111122334567889999999999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.66 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=208.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||+|.+.. ...++..||+|.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred cceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 679999999999999999997653 233567899999986532 3455688999999999999999999998754
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred -CCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCC
Confidence 5789999999999999997754 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~----------- 227 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL----------- 227 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-----------
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-----------
Confidence 9865432211 1233456889999999998999999999999999999998 99999754432211110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 228 ------EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00011112233456788999999999999999999999999988653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=356.69 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=209.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.+. +..||||++.... ....+.+|+.++++++||||+++++++.+.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 467888999999999999999653 5689999998654 456788999999999999999999998766
Q ss_pred C-eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 147 D-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 147 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
. ..|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCC
Confidence 5 78999999999999999987643 34789999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++..... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 335 ~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------- 399 (450)
T 1k9a_A 335 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------- 399 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----------
T ss_pred Cccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 99854322 122356889999999999999999999999999999998 99999765432211111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
........+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 400 -------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 -------EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11111223445667899999999999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.39 Aligned_cols=272 Identities=19% Similarity=0.240 Sum_probs=205.9
Q ss_pred hcCCCCCCccccC--CCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 67 TRNFRPDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 67 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.++|++.+.||+| +||.||+|... .+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3679999999999 99999999654 3689999999976543 233557789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+++.+|+||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEEC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999999999987532 45899999999999999999999998 9999999999999999999999
Q ss_pred eccCCccCCCCCC-----cceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 223 DFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 223 Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 9998864322110 111223478999999999987 579999999999999999999999997755432211100
Q ss_pred -hhhHHHhhh-----h-------------hhhhhc---------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 015781 296 -WAKPYLQSK-----R-------------RIFQVM---------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347 (400)
Q Consensus 296 -~~~~~~~~~-----~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 347 (400)
...+..... . .+.... ............+..+.+|+.+||+.||.+|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 000000000 0 000000 000001122344667899999999999999999999
Q ss_pred HHHH
Q 015781 348 VVKA 351 (400)
Q Consensus 348 il~~ 351 (400)
+++|
T Consensus 331 ll~h 334 (389)
T 3gni_B 331 LLNH 334 (389)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=357.18 Aligned_cols=263 Identities=21% Similarity=0.207 Sum_probs=207.8
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccc
Q 015781 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~ 138 (400)
+.....++|++.++||+|+||.||+|... .+|+.||+|++...... ....+.+|..++..++||||++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~---------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMK---------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 33345678999999999999999999554 47899999999754321 2234678999999999999999
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
+++++.+.+.+|+||||+.||+|.+++.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCC
Confidence 9999999999999999999999999998754 46899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhc-------cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
+||+|||++........ ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999986543221 1223468999999999987 356899999999999999999999999765432111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHHHH
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR---PTMDEVVKALE 353 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~eil~~L~ 353 (400)
..+ .... .... ........+.++.+||.+||. +|.+| |++.++++|-+
T Consensus 280 ~~i------~~~~----~~~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 280 GKI------VHYK----EHLS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHH------HTHH----HHCC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHH------Hhcc----cCcC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 111 0000 0000 011112346788999999999 99998 69999999743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=340.11 Aligned_cols=269 Identities=23% Similarity=0.324 Sum_probs=204.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.+|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 56999999999999999999654 3688999999975332 33456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+.+++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEec
Confidence 999999999999999999999865444467899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 181 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~----- 249 (310)
T 2wqm_A 181 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK----- 249 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHH-----
T ss_pred cceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHH-----
Confidence 99876433221 2234578999999999998899999999999999999999999997543211 000000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~ 363 (400)
+.............+..+.+|+.+||+.||.+|||+.++++.|++++.....+.
T Consensus 250 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 250 -----IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp -----HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred -----hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 000001111123345678899999999999999999999999999988776654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=345.97 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=207.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|.+... .+..++..||+|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 5799999999999999999975421 1345788999999975432 3345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCceE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASY---IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAK 220 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~k 220 (400)
...|+||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. +..++
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999875421 234899999999999999999999998 999999999999984 45699
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---- 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE---- 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH----
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH----
Confidence 999999874332222222334567899999999999999999999999999999998 999997653211 010
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 257 ----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 257 ----------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ----------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00001111223345567889999999999999999999999999986644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.58 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=196.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch----hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.+|++.+.||+|+||.||+|.+. +..+|+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 57999999999999999999653 678999998764332 235678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeeccCCCCCEEEcC-------
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDL------- 215 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-ivH~dlkp~Nill~~------- 215 (400)
.+.+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+++.. ++||||||+||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~ 150 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred ecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence 999999999999999999999853 4689999999999999999999997632 889999999999986
Q ss_pred -CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 216 -NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
++.++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---- 222 (271)
T 3dtc_A 151 SNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---- 222 (271)
T ss_dssp SSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----
T ss_pred cCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 7789999999997644322 2235789999999999999999999999999999999999999976432110
Q ss_pred HhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.............+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 223 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ------------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111122233445567889999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.51 Aligned_cols=249 Identities=27% Similarity=0.317 Sum_probs=196.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHH-HccCCCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKH-LGQLYHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~hpniv~~~~~~ 143 (400)
++|++.++||+|+||.||+|... .++..||+|++...... ....+..|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 57999999999999999999554 46889999999765432 22345566666 5678999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+.+|+||||+.||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999998753 5889999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.........
T Consensus 183 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------------ 248 (373)
T 2r5t_A 183 FGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------------ 248 (373)
T ss_dssp CCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------------
T ss_pred CccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------------
Confidence 99997532211 1244568999999999999999999999999999999999999999764321100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH----HHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD----EVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----eil~~ 351 (400)
..+.... ..++...+..+.+||.+||+.||.+||++. ++++|
T Consensus 249 ----~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 249 ----DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp ----HHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred ----HHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 0111111 112334566788999999999999999975 55554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=336.90 Aligned_cols=268 Identities=24% Similarity=0.326 Sum_probs=214.7
Q ss_pred cCCCCCC-ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|.+.+ .||+|+||.||+|.+.. ..++..||+|++..... .....+.+|+.+++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566666 99999999999997642 23578899999987533 3455688999999999999999999999 5
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccc
Confidence 567899999999999999997543 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----------- 224 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------- 224 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-----------
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-----------
Confidence 99865433221 11223456889999999988889999999999999999998 999997654321110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCCCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGVSR 365 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 365 (400)
.+........+...+..+.+++.+||+.||.+|||+.+++++|+.+......+...
T Consensus 225 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 225 ------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred ------HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 00111112233455678999999999999999999999999999997776665444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.33 Aligned_cols=266 Identities=24% Similarity=0.302 Sum_probs=208.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe--
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-- 145 (400)
++|++.+.||+|+||.||+|... .+++.||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGL---------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEec---------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 57999999999999999999543 3688999999876655566678899999999999999999999873
Q ss_pred --CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
....++||||+.+++|.+++........++++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEe
Confidence 34789999999999999999875544467999999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcc-------eeeecccccCcccchhhccCC---CCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 224 FGLAKDGPTGSQSH-------VSTRVMGTYGYAAPEYMATGH---LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 224 fg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--- 254 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--- 254 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---
Confidence 99887543211100 012245799999999987544 68999999999999999999999853211000
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+................+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 255 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 255 ------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 000001111111222344668899999999999999999999999999986543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=342.13 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|....... .....+..||+|++..........+.+|+.++++++||||+++++++.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 679999999999999999997653110 000113579999998766666678899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--------e
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--------A 219 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~--------~ 219 (400)
..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999998754 34899999999999999999999998 999999999999988887 9
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCC-ccCCCCCCccchhHHhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRR-VIDKNRPSREHNLIEWA 297 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~-pf~~~~~~~~~~~~~~~ 297 (400)
+|+|||++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.. ||........ ..
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~-- 229 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQ-- 229 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH--
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HH--
Confidence 9999999875432 223468899999999987 678999999999999999999654 4443221100 00
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~ 363 (400)
.... ....+...+..+.+|+.+||+.||.+|||+.+++++|+.+....+...
T Consensus 230 --~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 230 --FYED------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp --HHHT------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred --Hhhc------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 0000 011112224567889999999999999999999999999977655543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=334.10 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=210.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 57899999999999999999764 366899999987653 3457889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred CeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccc
Confidence 9999999999999999997654 46899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----------- 216 (267)
T 3t9t_A 152 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VE----------- 216 (267)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH-----------
T ss_pred ccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HH-----------
Confidence 7643211 111223456788999999998899999999999999999999 8999976432110 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
. +........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 217 --~-i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 217 --D-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --H-HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --H-HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000011122233456788999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.77 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=207.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 67999999999999999999554 36889999998654322 2346788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+||
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSC
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEec
Confidence 9999999999999999999998763 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------- 219 (279)
T 3fdn_A 154 GWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------- 219 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------
T ss_pred cccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH----------
Confidence 998654332 223457899999999999999999999999999999999999999754321110000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
. ......+...+..+.+|+.+||+.||.+|||+.++++|-+--....
T Consensus 220 ---~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 220 ---S-----RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ---H-----HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ---H-----hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0 0111223345567889999999999999999999999876644433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=360.84 Aligned_cols=251 Identities=29% Similarity=0.365 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEc---------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 57999999999999999999543 4789999999976422 22345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999776 368999999999999999999998 88 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------- 361 (446)
T 4ejn_A 293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------- 361 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---------
Confidence 99997543222 1234578999999999999999999999999999999999999999765321111100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~ 353 (400)
... ...++...+..+.+||.+||+.||.+|| ++.++++|-+
T Consensus 362 -------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 362 -------LME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp -------HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -------HhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 000 1122334567888999999999999999 9999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.00 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=208.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|.+.+.||+|+||.||+|.. ..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKH---------ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5799999999999999999954 347899999999764322 2456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEec
Confidence 999999999999999999999754 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----------- 226 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----------- 226 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-----------
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-----------
Confidence 9998654432 2344679999999999988766 689999999999999999999997654311110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+.... ...+...+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 227 -----~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 227 -----KICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp -----HHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred -----HHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 000000 11222345678899999999999999999999997554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.69 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... ++..||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 57899999999999999999652 4788999998765432 23567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECc
Confidence 9999999999965 9999887643 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ....
T Consensus 146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 222 (288)
T 1ob3_A 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG-TPNS 222 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCT
T ss_pred cccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC-CCCh
Confidence 987543221 12234578999999999975 4589999999999999999999999976543211111100000 0000
Q ss_pred hhhhhh-----ccccc-------cCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 305 RRIFQV-----MDARI-------EGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~-----~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
..+... .+... ........+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000000 00000 00111234567889999999999999999999998743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.29 Aligned_cols=256 Identities=25% Similarity=0.304 Sum_probs=201.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 367999999999999999999654 3688999999876543 234678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~ 222 (400)
....++||||+.+++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEE
Confidence 99999999999999999999765433467999999999999999999999998 9999999999999 456889999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.............+
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 999997644322 234467899999999985 5789999999999999999999999976532111000000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
...... ......+..+.+|+.+||+.||.+|||+.+++++-
T Consensus 240 --------~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 240 --------KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp --------CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred --------CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000000 00011346788999999999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=350.50 Aligned_cols=271 Identities=22% Similarity=0.221 Sum_probs=206.1
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-----CCcc
Q 015781 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----HPNL 136 (400)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----hpni 136 (400)
......++|++.+.||+|+||+||+|... .++..||+|++.... .....+..|+.+++.+. ||||
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 33345578999999999999999999654 368899999997533 23345667888888886 9999
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL- 215 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~- 215 (400)
+++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccc
Confidence 99999999999999999999 9999999987643 45899999999999999999999998 999999999999975
Q ss_pred ------------------------CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHH
Q 015781 216 ------------------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVV 271 (400)
Q Consensus 216 ------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~i 271 (400)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999864332 234578999999999999999999999999999
Q ss_pred HHHHHhCCCccCCCCCCccchhHHhhhHHHhhh-------hhhhhhccc-ccc-----------------CCCC---HHH
Q 015781 272 LLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK-------RRIFQVMDA-RIE-----------------GQYS---LGA 323 (400)
Q Consensus 272 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~-----------------~~~~---~~~ 323 (400)
+|+|++|..||...........+.......... ......... ... ...+ ...
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 999999999997654332221111100000000 000000000 000 0000 011
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 324 ALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 324 ~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
+..+.+|+.+||+.||.+|||+.++|+|-
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 25677999999999999999999999763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.40 Aligned_cols=269 Identities=23% Similarity=0.388 Sum_probs=214.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 346799999999999999999976421 1223578899999976543 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
+.+..++||||+.+++|.+++..... ...++++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCe
Confidence 99999999999999999999976431 1245789999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~-- 251 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LR-- 251 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HH--
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HH--
Confidence 99999999975433222222233466889999999999999999999999999999999 8999976432110 00
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.+.. ......+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 252 -----------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 -----------FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -----------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0000 00112233456678899999999999999999999999988744
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=333.00 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=208.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|... .++..+|+|++..........+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQK---------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeC---------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467999999999999999999654 3678999999987665666788899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~ 222 (400)
....++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||++ +.++.++|+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999999998776 35899999999999999999999998 9999999999999 788999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------- 219 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------- 219 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------
Confidence 999998654332 2334579999999999865 4999999999999999999999999764321110000
Q ss_pred hhhhhhhhccccccCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 303 SKRRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... ....+. ..+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 220 --------~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 220 --------REG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp --------HHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred --------HhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 000 001111 235678899999999999999999999987554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=350.48 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCC--CCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY--HPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--hpniv~~~~~~ 143 (400)
++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++.++ ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 56999999999999999999532 378899999876533 33456889999999996 59999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
..++.+|+||| +.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECC
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEe
Confidence 99999999999 55889999998753 5889999999999999999999998 99999999999995 58999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhcc-----------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---- 273 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 273 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----
Confidence 999987654333323445689999999999865 36889999999999999999999999754321
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.. .+..+.+......++...+..+.+|+.+||+.||.+|||+.+++++-+.
T Consensus 274 -~~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 274 -IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp -HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -HH----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 00 0111122222222233335678899999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.03 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=211.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|.+.. +..||||++.... .....+.+|+.++++++||||+++++++.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred chHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 34678899999999999999997642 5679999998654 34567899999999999999999999986
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCC
Confidence 5678999999999999999976432 35788999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++....... .......+++.|+|||++....++.++|||||||++|+|++ |..||.+...... ..
T Consensus 330 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~--------- 396 (454)
T 1qcf_A 330 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IR--------- 396 (454)
T ss_dssp GGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH---------
T ss_pred CceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH---------
Confidence 9986433211 11222346778999999998999999999999999999999 9999976532111 10
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 397 -----~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 397 -----ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -----HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 00111111223445678899999999999999999999999999986543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=334.84 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=196.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|.+. ..+|+|++..... .....+.+|+.++++++||||++++++. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred cceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 67999999999999999999643 2499999876543 3345688999999999999999999965 5
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred CCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccce
Confidence 567899999999999999996544 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++................||+.|+|||++. +..++.++|||||||++|+|++|..||......... .. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~----~~~ 239 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IE----MVG 239 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HH----HHH
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HH----Hhc
Confidence 997654333333344567999999999986 567888999999999999999999999765432110 00 000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.. .... ........++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 240 ~~-----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 RG-----SLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HT-----SCCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cc-----ccCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 0000 0111223456788999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=343.62 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=198.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++....... ...+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL---------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC---------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 368999999999999999999543 468999999997654322 34678999999999999999999998
Q ss_pred EeCCe----eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 144 LEDDH----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 144 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
..... .|+||||+++++|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCE
Confidence 76543 499999999999999998763 5899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~ 229 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------Y 229 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------H
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------H
Confidence 99999999765432211 1223457899999999999999999999999999999999999999765431110 0
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-HHhchhc
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA-LEQIQDT 358 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~-L~~~~~~ 358 (400)
....... ..........+..+.+++.+||+.||.+||+..+++.+ +..+...
T Consensus 230 ~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 230 QHVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHCCC--------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHhcCCC--------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0000000 00000011245678899999999999999976666654 5444433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=345.31 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|... .+++.||+|++...... ..+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHK---------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 3467999999999999999999543 47899999999765432 23677777777 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC----CceE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNAK 220 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~----~~~k 220 (400)
+....|+||||+.|++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||++..+ +.+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEE
Confidence 999999999999999999999765 35899999999999999999999998 9999999999998443 3599
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+.....
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-- 236 (342)
T 2qr7_A 161 ICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-- 236 (342)
T ss_dssp ECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--
T ss_pred EEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--
Confidence 999999986543221 2345678999999999988889999999999999999999999997643322211111100
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.. ............+..+.+|+.+||+.||++|||+.++++|-+...
T Consensus 237 --~~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 237 --SG-------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp --HC-------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred --cC-------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 00 001111122345678889999999999999999999999877644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.93 Aligned_cols=272 Identities=24% Similarity=0.303 Sum_probs=201.7
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-----hhHHHHHHHHHHHccC---CCCccc
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQL---YHPNLV 137 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~hpniv 137 (400)
..++|++.+.||+|+||+||+|. +..+++.||+|++..... .....+.+|+.+++.+ +||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEE---------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 45789999999999999999994 445789999999874331 1123455666666655 599999
Q ss_pred ceeeEEEeCC-----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 138 KLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 138 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
++++++.... ..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 9999998765 5899999995 699999977543 34899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998654322 2344678999999999999999999999999999999999999997654322211
Q ss_pred hHHhhhHHHhhhhhhhhhc---cccccC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 293 LIEWAKPYLQSKRRIFQVM---DARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+..... ......+.... ...... ......+..+.+|+.+||+.||.+|||+.++|+|-+--
T Consensus 230 ~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~ 301 (308)
T 3g33_A 230 KIFDLIG-LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301 (308)
T ss_dssp HHHHHHC-CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred HHHHHhC-CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence 1100000 00000000000 000000 00113456788999999999999999999999975543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=337.79 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=201.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh---HHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .++..||+|++....... ...+.+|+.++++++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 368999999999999999999554 368899999997653322 35688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++..|+||||+++++|.+++... .++++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECS
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEec
Confidence 9999999999999999999999875 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .. ......
T Consensus 178 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~ 249 (309)
T 2h34_A 178 FGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQ 249 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHS
T ss_pred CccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhcc
Confidence 999876543221 1223457899999999999889999999999999999999999999764321 00 000000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhchhcCCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~eil~~L~~~~~~~~~ 361 (400)
. . ......+...+..+.+++.+||+.||++|| |+.++++.|+.+....+.
T Consensus 250 ~------~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 250 A------I--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp C------C--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred C------C--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0 0 001112233456788999999999999999 999999999987555443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=338.85 Aligned_cols=268 Identities=24% Similarity=0.260 Sum_probs=201.8
Q ss_pred cCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
+.|++. +.||+|+||.||+|. +..+++.||+|++..........+.+|+.++.++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 568884 789999999999994 4446889999999776555566788999999885 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc---eEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl~ 222 (400)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEE
Confidence 99999999999999999999876 35899999999999999999999998 999999999999988776 9999
Q ss_pred eccCCccCCCCCC-----cceeeecccccCcccchhhcc-----CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 223 DFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 223 Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 9999875432211 111223569999999999865 568899999999999999999999998765432110
Q ss_pred hHHhhhHHHhhhhhh-hhhccccccCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKPYLQSKRRI-FQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........ ....+ ..+.... ..++. ..+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 237 ~~~~~~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 237 DRGEACPA--CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp ----CCHH--HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred cccccchh--HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 00000000 00000 0000000 01111 235678899999999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.70 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..|++.+.||+|+||+||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc---------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 45889999999999999999543 3689999999875432 22346789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+. |+|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeec
Confidence 9999999999996 68888886544 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...
T Consensus 199 G~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~-- 264 (348)
T 1u5q_A 199 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-- 264 (348)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH--
T ss_pred cCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHH--
Confidence 99976432 22357999999999984 56789999999999999999999999976432110 000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
+.............+..+.+|+.+||+.||++|||+.+++++.+...
T Consensus 265 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 265 --------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp --------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------HHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 00000111112234567889999999999999999999999877654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=335.84 Aligned_cols=265 Identities=28% Similarity=0.403 Sum_probs=207.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE-e
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL-E 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~ 145 (400)
.+|++.+.||+|+||+||+|.+.. ...+...+|+|.+..... .....+.+|+.++++++||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 568899999999999999997643 223456799999876433 33456889999999999999999999854 5
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccc
Confidence 568899999999999999997643 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCc--ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 226 LAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 226 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++......... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------- 246 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------- 246 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-------
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------
Confidence 99865432211 12233567889999999999999999999999999999999 566676544322111110
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 247 ----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 247 ----------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000111122345678899999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=355.83 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=208.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.++++++||||+++++++.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34678899999999999999997653 45699999986543 35678899999999999999999999876
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..++||||+.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCc
Confidence 678999999999999999976432 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...... .
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~---------- 391 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---------- 391 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H----------
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----------
Confidence 9986543221 12223456788999999999999999999999999999999 9999976532110 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.....+.
T Consensus 392 ----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 392 ----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp ----HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred ----HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 001111112233456678899999999999999999999999999986554443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=340.24 Aligned_cols=249 Identities=26% Similarity=0.321 Sum_probs=195.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||+||+|.... +++.||||++..... ........|+..+.++ +||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3579999999999999999996543 688999999865432 2233455566555554 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..++||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999 779999987764 46999999999999999999999988 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... |.
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~------ 262 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ------ 262 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH------
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH------
Confidence 99987654322 2334568999999999875 799999999999999999999776643210 00
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+.........+...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 263 -----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 263 -----QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp -----HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -----HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 000000000111223567889999999999999999999998643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=341.53 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=209.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcE--EEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
++|++.+.||+|+||.||+|.... ++.. +|+|.+..... .....+.+|+.+++++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 579999999999999999996543 4554 49998865322 2344678999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
.+.+..|+||||+++++|.+++.... ....++++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence 99999999999999999999997653 22356899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~ 290 (400)
+++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 99999999999999987432211 1223456889999999988889999999999999999998 9999976532110
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus 251 -----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 251 -----------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -----------------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----------------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 000111111223334567889999999999999999999999999998776543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=336.38 Aligned_cols=260 Identities=27% Similarity=0.359 Sum_probs=207.4
Q ss_pred hcCCCCCC-ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..+|++.+ .||+|+||.||+|.+.. ..++..||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35788888 99999999999996532 235789999999765322 245688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
+.+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEcc
Confidence 567789999999999999999765 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHH
Q 015781 224 FGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 224 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~------- 230 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T------- 230 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H-------
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H-------
Confidence 99998654433211 1222346788999999988889999999999999999999 9999976542111 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+-.
T Consensus 231 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 231 -------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111111122334556789999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=362.78 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=211.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.++||+|+||.||+|... .+|..||+|++..... .....+.+|+.+|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 467999999999999999999554 4789999999976432 2334578899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+.+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999976542 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+..
T Consensus 330 FGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~------- 399 (576)
T 2acx_A 330 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER------- 399 (576)
T ss_dssp CTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-------
T ss_pred cccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-------
Confidence 99998754432 23446899999999999988999999999999999999999999987543222111110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKAL 352 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L 352 (400)
... .....++...+..+.+||.+||+.||.+|| ++.++++|-
T Consensus 400 ------~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 400 ------LVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ------HHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ------Hhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 000 011223344567889999999999999999 789999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=346.39 Aligned_cols=263 Identities=22% Similarity=0.226 Sum_probs=202.9
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-----chhHHHHHHHHHHHccCCCCcccc
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVK 138 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~ 138 (400)
....++|++.+.||+|+||.||+|... .++..||+|++.... ......+.+|+.+++.++||||++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 355678999999999999999999654 368899999987543 233457889999999999999999
Q ss_pred eeeEEEeCCeeEEEEeecCCCCHHHHHhhhcC------------------------------------CCCCCCHHHHHH
Q 015781 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS------------------------------------YIQPLSWTIRMK 182 (400)
Q Consensus 139 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~ 182 (400)
+++++.+.+..++||||+++++|.+++..... ....+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 99999999999999999999999999852111 011246778899
Q ss_pred HHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC--ceEEeeccCCccCCCCC--CcceeeecccccCcccchhhcc--
Q 015781 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGS--QSHVSTRVMGTYGYAAPEYMAT-- 256 (400)
Q Consensus 183 i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-- 256 (400)
++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 173 IMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 9999999999999998 99999999999998776 89999999997542211 1112344679999999999965
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhcccccc--CCCCHHHHHHHHHHHHhc
Q 015781 257 GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIE--GQYSLGAALKTAVLAIKC 334 (400)
Q Consensus 257 ~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~ 334 (400)
..++.++|||||||++|+|++|..||.......... ........ .......+..+.+|+.+|
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS----------------QVLNKKLCFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HHHHCCCCTTSGGGGGSCHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH----------------HHHhcccccCCcccccCCHHHHHHHHHH
Confidence 678999999999999999999999997654321110 01111100 001112456788999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 015781 335 LSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 335 l~~dP~~Rps~~eil~~L~ 353 (400)
|+.||.+|||+.++++|-+
T Consensus 315 l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHH
T ss_pred cCCChhHCCCHHHHhcChh
Confidence 9999999999999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=342.13 Aligned_cols=255 Identities=25% Similarity=0.299 Sum_probs=207.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
.++|++.+.||+|+||.||+|... .+|..||+|++...... ....+.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 467999999999999999999554 46889999998765432 245688999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--- 217 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~--- 217 (400)
+++.+.+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCc
Confidence 9999999999999999999999999764 46899999999999999999999998 99999999999999887
Q ss_pred -ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-- 230 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-- 230 (321)
T ss_dssp CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--
T ss_pred CCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--
Confidence 79999999998654432 123457899999999999899999999999999999999999999764321110000
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...... .... .....+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 231 ----~~~~~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 231 ----TSVSYD----FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp ----HTTCCC----CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ----Hhcccc----cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000000 0000 00123457889999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=337.73 Aligned_cols=268 Identities=24% Similarity=0.301 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... .+|..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 67999999999999999999654 36889999998665432 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999998887654 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH-----
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP----- 299 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----- 299 (400)
++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 148 FARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 9986543221 2334578999999999876 5789999999999999999999999987654322221111000
Q ss_pred ---HHhhhhhhhhhccccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 300 ---YLQSKRRIFQVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 300 ---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
....................+ ...+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000000000000000000000 13456788999999999999999999999973
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=334.46 Aligned_cols=258 Identities=26% Similarity=0.302 Sum_probs=207.4
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 3467999999999999999999554 3688999999875443 33456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeC
Confidence 999999999999999999988654 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++................|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----- 223 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----- 223 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-----
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-----
Confidence 99976433322222344678999999999987665 7789999999999999999999976543211 1111110
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. ..........+..+.+|+.+||+.||.+|||+.+++++-+
T Consensus 224 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 224 K---------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp T---------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred c---------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 0 0000111234567889999999999999999999998744
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=342.12 Aligned_cols=277 Identities=26% Similarity=0.389 Sum_probs=215.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+.. .+..++..||+|++..........+.+|+.++++++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 568999999999999999997543 345579999999998766556677889999999999999999999987643
Q ss_pred --eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 148 --HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 148 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCc
Confidence 7899999999999999998754 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH---H
Q 015781 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY---L 301 (400)
Q Consensus 226 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---~ 301 (400)
++.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... ........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~ 266 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ 266 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchh
Confidence 998754432211 122345677899999999888999999999999999999999988642100 00000000 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.....+...+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000011111111112223445667899999999999999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=334.07 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=206.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
....+|++.+.||+|+||.||+|... .+++.||+|++.... ..+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 44567999999999999999999654 368899999987653 24568999999999999999999886
Q ss_pred e----------------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCC
Q 015781 145 E----------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 208 (400)
Q Consensus 145 ~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp 208 (400)
. ...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp 150 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKP 150 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCH
Confidence 4 4558999999999999999976543 46899999999999999999999998 99999999
Q ss_pred CCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCC
Q 015781 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPS 288 (400)
Q Consensus 209 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~ 288 (400)
+||+++.++.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 225 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-- 225 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--
T ss_pred HHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--
Confidence 99999999999999999988654432 1234568999999999999899999999999999999999998873210
Q ss_pred ccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 289 REHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
.. . ..... ...+...+..+.+++.+||+.||.+|||+.+++++|+.++....
T Consensus 226 ------~~----~------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 ------KF----F------TDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ------HH----H------HHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ------HH----H------HHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00 0 01111 11222345578899999999999999999999999999865543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.14 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc--CCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|.+ ++..||+|++.... ...+..|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 46899999999999999999965 36789999987543 2334455555544 79999999999865
Q ss_pred eC----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeeeccCCCCCEE
Q 015781 145 ED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~ivH~dlkp~Nil 212 (400)
+. ...++||||+++++|.+++.. ..+++..++.++.||+.||+||| +++ |+||||||+||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nil 145 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNIL 145 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEE
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEE
Confidence 43 568999999999999999954 35899999999999999999999 877 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcc--eeeecccccCcccchhhccC------CCCCccchhhHHHHHHHHHhC------
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG------HLTAKSDVYSFGVVLLEMLSG------ 278 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDiwslG~il~~l~tg------ 278 (400)
++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999999997543322111 12234799999999999776 455789999999999999999
Q ss_pred ----CCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 279 ----RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 279 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..||....+........ ....... ...............+..+.+|+.+||+.||.+|||+.++++.|++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDM--RKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHH--HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccccccCCCCcchhhh--hHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 77876544332211110 0000000 0000001111234577889999999999999999999999999987
Q ss_pred c
Q 015781 355 I 355 (400)
Q Consensus 355 ~ 355 (400)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=359.45 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=211.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.++||+|+||.||+|... .+|+.||+|++...... ....+.+|+.++++++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK---------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 367899999999999999999554 47899999999765332 235678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+.+|+||||++||+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEee
Confidence 9999999999999999999999876543457999999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+ ..
T Consensus 333 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~----- 403 (543)
T 3c4z_A 333 LGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ----- 403 (543)
T ss_dssp CTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HH-----
T ss_pred cceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HH-----
Confidence 999986544322 233468999999999999999999999999999999999999999875432211111 00
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
.+... ...++...+..+.+|+.+||+.||.+||++ .+|++|
T Consensus 404 -----~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 404 -----RVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -----HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -----HHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01111 112334556788999999999999999964 778775
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=335.48 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=203.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc--CCCCcccceeeE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGY 142 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~~~ 142 (400)
...++|++.+.||+|+||.||+|... +..||+|++.... ...+..|.+++.. ++||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 44578999999999999999999653 6789999986543 2334455555544 489999999999
Q ss_pred EEeC----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCeeeccCCCCC
Q 015781 143 CLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTSN 210 (400)
Q Consensus 143 ~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~ivH~dlkp~N 210 (400)
+.+. ...++||||+++++|.+++... .+++..++.++.|++.||+|||++ + |+||||||+|
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~N 172 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKN 172 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGG
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHH
Confidence 9887 7899999999999999999653 589999999999999999999998 6 9999999999
Q ss_pred EEEcCCCceEEeeccCCccCCCCCCcc--eeeecccccCcccchhhccCCCCCc------cchhhHHHHHHHHHhC----
Q 015781 211 ILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATGHLTAK------SDVYSFGVVLLEMLSG---- 278 (400)
Q Consensus 211 ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDiwslG~il~~l~tg---- 278 (400)
|+++.++.+||+|||++.......... ......||+.|+|||++.+..+... +|||||||++|+|++|
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999999997543322111 1124579999999999987766665 9999999999999999
Q ss_pred ------CCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 015781 279 ------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDE 347 (400)
Q Consensus 279 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~e 347 (400)
..||............ . .. ........... ...++..+.+|+.+||+.||.+|||+.+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~-~-~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYED-M-RE---------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHH-H-HH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccccccccHhhhcCCCCchhh-h-HH---------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 5555443322211100 0 00 00011111122 2367888999999999999999999999
Q ss_pred HHHHHHhchhcCCC
Q 015781 348 VVKALEQIQDTNDA 361 (400)
Q Consensus 348 il~~L~~~~~~~~~ 361 (400)
++++|+.+.+..+.
T Consensus 322 ll~~L~~l~~~~~~ 335 (337)
T 3mdy_A 322 VKKTLAKMSESQDI 335 (337)
T ss_dssp HHHHHHHHHHTTTC
T ss_pred HHHHHHHHHhhccc
Confidence 99999999887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.59 Aligned_cols=264 Identities=26% Similarity=0.343 Sum_probs=208.6
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.|.+.++||+|+||+||+|.+.. ...++..+|+|++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 46667899999999999997643 223456899999876443 33456889999999999999999999998766
Q ss_pred ee-EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 148 HR-LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 148 ~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
.. ++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 55 99999999999999997643 56899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCC--cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc-cCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+........ ........+++.|+|||.+.+..++.++|||||||++|+|++|..| |..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~----------- 239 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH----------- 239 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-----------
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-----------
Confidence 975433221 1122335678899999999999999999999999999999995555 54433211111
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
..........+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 240 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 240 ------FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ------HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011111112233445678899999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=341.74 Aligned_cols=254 Identities=24% Similarity=0.262 Sum_probs=182.4
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEeCCeeEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 151 (400)
.+.||+|+||.||+|... .+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 378999999999999554 46899999999654 2345678999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---ceEEeeccCCc
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAK 228 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~ 228 (400)
||||+++++|.+++... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999875 46899999999999999999999998 99999999999997665 89999999998
Q ss_pred cCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 158 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------~ 226 (325)
T 3kn6_A 158 LKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM---------K 226 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH---------H
T ss_pred ecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH---------H
Confidence 6543222 2344678999999999999999999999999999999999999997654321111110000 0
Q ss_pred hhccccccCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 309 QVMDARIEGQ--YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 309 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+........ .....+..+.+|+.+||+.||.+|||+.++++|-+--
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 0111000000 0012467889999999999999999999999886653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.62 Aligned_cols=267 Identities=21% Similarity=0.238 Sum_probs=198.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .+++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 478999999999999999999544 468999999997642 233456789999999999999999999996
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.. ..+|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSC
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCC
Confidence 54 457999999965 5766663 24889999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA- 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~- 297 (400)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+...
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 203 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp EEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998654322 234568999999999999999999999999999999999999999876532221111000
Q ss_pred ---------------hHHHhhh-----hhhhhhccccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 298 ---------------KPYLQSK-----RRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 298 ---------------~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+.... ..+........... .....+..+.+|+.+||+.||++|||+.|+|+|-+.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 0000000 00000000000000 011236678999999999999999999999998543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=334.30 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=210.2
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 3467999999999999999999754 356899999976542 35578899999999999999999999864
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+..++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred -CCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCc
Confidence 568999999999999999975432 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~--------- 221 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------- 221 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH---------
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH---------
Confidence 9986543221 11223456788999999988889999999999999999999 999997643211 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
.+........+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 222 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 222 -----NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -----HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 000111112233456788999999999999999999999999999865543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.76 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=207.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 468999999999999999999554 3688999999876543 23456788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc---eEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKL 221 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~---~kl 221 (400)
+.+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++|
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999999999998776 35899999999999999999999998 999999999999976655 999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 150 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------ 220 (284)
T 3kk8_A 150 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------ 220 (284)
T ss_dssp CCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred eeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------
Confidence 9999997654332 2234578999999999999999999999999999999999999997643211110000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... . ..........+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 221 ~~~------~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 221 AGA------Y--DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp HTC------C--CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred hcc------c--cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence 000 0 00001112345678899999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=332.39 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=187.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESI---------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEc---------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 57999999999999999999553 36889999998754321 2356789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+++++|.+++.... .++++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEee
Confidence 9999999999999999999997653 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------ 222 (278)
T 3cok_A 157 GLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------------ 222 (278)
T ss_dssp TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred cceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------------
Confidence 99986543221 1234578999999999998889999999999999999999999997654321110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..... ....+...+..+.+++.+||+.||.+|||+.++++|-+.
T Consensus 223 ----~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 223 ----KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp -----CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred ----HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 00000 011233345678899999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.28 Aligned_cols=270 Identities=22% Similarity=0.302 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||+|... .++..||+|++....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 57899999999999999999654 368899999987654221 11345799999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99999999996 59999887754 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... .....
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~ 223 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG-TPTEE 223 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTT
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChH
Confidence 97543322 12334578999999999876 5689999999999999999999999987543222111110000 00000
Q ss_pred hhhhhcc---------ccccC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 306 RIFQVMD---------ARIEG----QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 306 ~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+..... ..... ......+..+.+|+.+||+.||.+|||+.++++|-+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0000000 00000 00112356788999999999999999999999986554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.67 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=209.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 367999999999999999999554 3688999999976543 23456889999999999999999999875
Q ss_pred e--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeeccCCCCCEEEcCCCce
Q 015781 145 E--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~dlkp~Nill~~~~~~ 219 (400)
+ ....++||||+++++|.+++.........+++..++.++.||+.||+|||+.+ .+++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 57899999999999999999876554466999999999999999999999865 239999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~--- 227 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK--- 227 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH---
Confidence 9999999876543221 1234578999999999998899999999999999999999999997653211 0000
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
. ........+...+..+.+++.+||+.||.+|||+.+++++++....
T Consensus 228 -i----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 228 -I----------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -H----------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -H----------hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 0 0000112233456788999999999999999999999998876544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=346.08 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=200.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE-eC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL-ED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~ 146 (400)
.|++.+.||+|+||+||+|.+.. ....+..||+|.+..... .....+.+|+.++++++||||+++++++. .+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred eeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 46778899999999999997642 122356789999875432 34567889999999999999999999865 45
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccc
Confidence 67899999999999999997654 45789999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCc--ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 227 AKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 227 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...........+. .
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~ 311 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------Q 311 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------T
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------c
Confidence 9864332211 11233457788999999999999999999999999999999 778887654432111110 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
. .....+..++..+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 312 ~----------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 312 G----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 0111223345678899999999999999999999999999876544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=331.08 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=201.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+.|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 45888899999999999999554 3688999999876543 234568899999999999999999999875
Q ss_pred ----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-CCCceE
Q 015781 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAK 220 (400)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~k 220 (400)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++.+|+|+||||+||+++ .++.++
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEE
Confidence 45689999999999999999875 358999999999999999999999766699999999999997 789999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||......... . .
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~---~-- 240 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y---R-- 240 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H---H--
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H---H--
Confidence 9999999754332 233457899999999886 45899999999999999999999999764331110 0 0
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...........+...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 241 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 241 --------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp --------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred --------HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 000000000111122356889999999999999999999998743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=343.61 Aligned_cols=269 Identities=20% Similarity=0.234 Sum_probs=196.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .++..||+|++....... ...+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDT---------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEEC---------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 367999999999999999999543 468999999997654322 345678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-----CCCce
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-----LNYNA 219 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-----~~~~~ 219 (400)
+++..++||||+. ++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceE
Confidence 9999999999996 59999997753 5899999999999999999999998 99999999999994 45569
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....
T Consensus 177 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 254 (329)
T 3gbz_A 177 KIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254 (329)
T ss_dssp EECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence 999999997543221 123345789999999999764 58999999999999999999999997654322111110000
Q ss_pred HHHhhhhhhh------hh-------ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 299 PYLQSKRRIF------QV-------MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 299 ~~~~~~~~~~------~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
. ......+. .+ ....+........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 255 G-LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp C-CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred C-CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 0 00000000 00 00000000111245678899999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=342.11 Aligned_cols=247 Identities=22% Similarity=0.274 Sum_probs=205.1
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------hHHHHHHHHHHHccCCCCccc
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLV 137 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv 137 (400)
..++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.++++++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK---------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET---------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEEC---------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 4568999999999999999999543 46899999998765321 222456799999999999999
Q ss_pred ceeeEEEeCCeeEEEEeecCCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 138 KLIGYCLEDDHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
++++++.+.+..++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED 166 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC
Confidence 9999999999999999998666 999998765 35899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
+.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 999999999998654432 2334679999999999988777 78999999999999999999999642110
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.... ...+...+..+.+|+.+||+.||.+|||+.+++++-+-
T Consensus 237 ---------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 237 ---------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp ---------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred ---------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0000 01122245678899999999999999999999998553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=341.33 Aligned_cols=264 Identities=16% Similarity=0.158 Sum_probs=207.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC---CCcccceeeE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGY 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~ 142 (400)
..++|++.+.||+|+||+||+|.+... .+..+++.||+|++...... ++..|+.+++.+. |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 346799999999999999999965331 23457889999999865433 4555666665554 9999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC------
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL------ 215 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~------ 215 (400)
+...+..|+||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC-
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999986433 2356999999999999999999999988 999999999999998
Q ss_pred -----CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 216 -----NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 216 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|+||+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999754332333345567899999999999999999999999999999999999999854322110
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHHhchhcCC
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR-PTMDEVVKALEQIQDTND 360 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~eil~~L~~~~~~~~ 360 (400)
. ...... .. .....+.+++..||+.+|.+| |++.++.+.|+.+.....
T Consensus 294 ---------------~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 ---------------K----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ---------------E----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---------------e----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 000011 01 124567789999999999999 688899988988766543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.56 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=208.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|.+.+.||+|+||.||++... .++..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 367999999999999999999654 3688999999876532 2345678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D 184 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGD 184 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECC
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEee
Confidence 9999999999999999999998775 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 185 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~----- 251 (335)
T 2owb_A 185 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------L----- 251 (335)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H-----
T ss_pred ccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------H-----
Confidence 999986543221 233467899999999999989999999999999999999999999754321100 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ....+...+..+.+|+.+||+.||.+|||+.+++++-+.
T Consensus 252 -----~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 252 -----RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp -----HHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -----HHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 00000 111223345678899999999999999999999997554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=331.50 Aligned_cols=272 Identities=19% Similarity=0.207 Sum_probs=209.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE-
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC- 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~- 143 (400)
...++|++.+.||+|+||.||+|... .++..||+|++...... ..+.+|+.+++.++|++++..+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEc---------CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 34578999999999999999999543 36889999987654322 2467899999999988877766655
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAK 220 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~k 220 (400)
.+.+..++||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+|
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEE
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEE
Confidence 6778889999999 999999997644 46899999999999999999999998 9999999999999 7899999
Q ss_pred EeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 221 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999865433221 12234678999999999999999999999999999999999999998765544333222
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAGV 363 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~~ 363 (400)
...... . ....... ....+..+.+|+.+||+.||++|||+.++++.|+.+........
T Consensus 229 ~~~~~~-----~-~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 229 RISEKK-----M-STPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHH-----H-HSCHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhhccc-----c-cchhhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 111000 0 0000000 01224678899999999999999999999999999987766543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=331.77 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 146 (400)
++|++.+.||+|+||.||+|... +..||+|++.... ....+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred hhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 67999999999999999999643 6789999997653 445688999999999999999999987554
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccc
Confidence 578999999999999999976542 24789999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----------- 224 (278)
T 1byg_A 164 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----------- 224 (278)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H-----------
T ss_pred ccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-----------
Confidence 8754332 123357889999999999999999999999999999998 9999976532111 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 225 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 ---PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 001111112233445678899999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=333.88 Aligned_cols=256 Identities=31% Similarity=0.489 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||.||+|.+. +..||+|++.... ....+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN-- 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 57899999999999999999653 5679999987543 44578899999999999999999998873
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc---CCCCeeeccCCCCCEEEcCCCc-eEEee
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYN-AKLSD 223 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~dlkp~Nill~~~~~-~kl~D 223 (400)
..++||||+++++|.+++..... ...++...++.++.||+.||+|||+ ++ |+||||||+||+++.++. +||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcc
Confidence 47999999999999999976532 1247889999999999999999999 66 999999999999988886 79999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.+..
T Consensus 150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----- 217 (307)
T 2eva_A 150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAV----- 217 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHH-----
T ss_pred cccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHH-----
Confidence 9999754321 2234689999999999999999999999999999999999999975432111 010100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
............+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 218 --------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 218 --------HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp --------HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred --------hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00011112223456788999999999999999999999999998765543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=347.62 Aligned_cols=277 Identities=23% Similarity=0.275 Sum_probs=214.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|.+. .++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 367999999999999999999654 3688999999976543 234567799999999999999999999987
Q ss_pred CC--eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE----cCCCce
Q 015781 146 DD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNA 219 (400)
Q Consensus 146 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill----~~~~~~ 219 (400)
.+ ..++||||+.+++|.+++...... ..+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeE
Confidence 65 789999999999999999765431 34899999999999999999999998 9999999999999 777889
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhcc--------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998654322 2334679999999999865 56788999999999999999999999755432222
Q ss_pred hhHHhhhHHHhhhhhh---hhhc--------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 292 NLIEWAKPYLQSKRRI---FQVM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+............+ .... .......+....+..+.+++.+||+.||++|||+.++++.++.+...
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111000000000000 0000 00112234567888999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=335.79 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|... .+|+.||+|++..........+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 3467999999999999999999543 3688999999986654445568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~ 222 (400)
.+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ ++|+||||+||++ +.++.++|+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEc
Confidence 999999999999999999997763 5899999999999999999999998 9999999999999 788999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||++...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+ ..
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~~ 221 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------KE 221 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hc
Confidence 99998754322 123356899999999999989999999999999999999999999764321110000 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.. ...........+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 222 ~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 222 GY--------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp CC--------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CC--------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 00 001111223445688899999999999999999999997653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=329.90 Aligned_cols=269 Identities=20% Similarity=0.217 Sum_probs=212.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE-Ee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC-LE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~ 145 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++..... ...+.+|+.+++.++|++++..+.++ .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc---------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 468999999999999999999543 3689999999876542 23577899999999988877666555 66
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~ 222 (400)
....++||||+ +++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEe
Confidence 78889999999 999999997543 46899999999999999999999998 9999999999999 488999999
Q ss_pred eccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 223 Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 99999865443221 1124467999999999999999999999999999999999999999876544333222111
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
.... . ....... ....+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 231 ~~~~-----~-~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 231 SEKK-----M-STPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHH-----H-HSCHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccc-----c-CCchHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 1000 0 0000000 1123467889999999999999999999999999998777654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=341.43 Aligned_cols=264 Identities=25% Similarity=0.315 Sum_probs=193.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEE--
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL-- 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~-- 144 (400)
.+|++.+.||+|+||.||+|.+. .++..||+|++..........+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 57999999999999999999654 368899999987665555667889999999996 999999999984
Q ss_pred ------eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 ------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
....+++||||+ +|+|.+++..... ..++++..++.++.||+.||+|||+++.+|+|+||||+||+++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 344589999999 4799999876332 14689999999999999999999997666999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcc----------eeeecccccCcccchhh---ccCCCCCccchhhHHHHHHHHHhCCCccCCC
Q 015781 219 AKLSDFGLAKDGPTGSQSH----------VSTRVMGTYGYAAPEYM---ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 285 (400)
+||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998654322111 11235689999999998 5667889999999999999999999999654
Q ss_pred CCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
..... .............+..+.+|+.+||+.||.+|||+.+++++|+.+.......
T Consensus 257 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 257 AKLRI--------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred hHHHh--------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 32110 0000011111122335778999999999999999999999999998765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=330.30 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=207.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK---------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc---------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 57999999999999999999654 36889999998654321 2356789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecc
Confidence 9999999999999999999998763 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||......... .
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~------ 222 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------R------ 222 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H------
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------H------
Confidence 9987543321 23457899999999999999999999999999999999999999754321100 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ...++...+..+.+++.+||+.||.+|||+.++++|-+-
T Consensus 223 ----~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 223 ----RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp ----HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred ----HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 00110 112233456678899999999999999999999997554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=332.65 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=203.3
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
...+|++.+.||+|+||+||+|... .++..||+|++..... .....+.+|+..+..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 3467999999999999999999654 3688999999876432 3445678899999988 89999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC------
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------ 216 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~------ 216 (400)
+.+.+..++||||+++++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccc
Confidence 99999999999999999999999876443456899999999999999999999998 9999999999999844
Q ss_pred -------------CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCcc
Q 015781 217 -------------YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVI 282 (400)
Q Consensus 217 -------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf 282 (400)
..++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 479999999998654322 23589999999999765 5668999999999999999999876
Q ss_pred CCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 283 DKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..... +. .+.. ......+...+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 232 ~~~~~--------~~-----------~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 232 RNGDQ--------WH-----------EIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp SSSHH--------HH-----------HHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred cchhH--------HH-----------HHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 43210 00 0000 01112233456688999999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=333.06 Aligned_cols=258 Identities=24% Similarity=0.275 Sum_probs=192.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .+++.||+|++....... ...+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV---------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec---------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 367999999999999999999553 368999999997653322 223445556688889999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEee
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
+.+..++||||++ ++|.+++.........+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEee
Confidence 9999999999996 599888876444446799999999999999999999997 8 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhh----ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------- 221 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--------- 221 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---------
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---------
Confidence 99997654322 22334789999999996 456789999999999999999999999975322100
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+................+..+.+++.+||+.||++|||+.++++|-+.
T Consensus 222 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 222 ------QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp ------HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ------HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 0001111111111222346678899999999999999999999997554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=362.47 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=207.2
Q ss_pred CCCCC-ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 70 FRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 70 y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.+.+ .||+|+||.||+|.+.. ..++..||||++..... .....+.+|+.+|++++||||+++++++.+ +
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 34444 79999999999997753 12467899999986533 345678999999999999999999999976 5
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 6899999999999999997543 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 228 KDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 228 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------------- 550 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------------- 550 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-------------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------------
Confidence 865432211 11222345688999999999999999999999999999998 999998754321111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
.+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+.......
T Consensus 551 ----~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 551 ----FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred ----HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 01111112234456678999999999999999999999999999876554443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.71 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|.+... .+.+..||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccC------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 5799999999999999999976431 12345799999876432 33456889999999999999999999998
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.. .++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccc
Confidence 765 899999999999999998754 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcc-eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 225 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-------- 234 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L-------- 234 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---H--------
Confidence 9998654433211 1233467788999999988889999999999999999999 9999976542110 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+.........+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 235 -----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 001111111122334567889999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=351.89 Aligned_cols=200 Identities=25% Similarity=0.356 Sum_probs=166.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK---------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 468999999999999999999654 468999999997642 233457889999999999999999999997
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCE
Confidence 76 57899999995 6999999764 46899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCc--------------------ceeeecccccCcccchhh-ccCCCCCccchhhHHHHHHHHHhC
Q 015781 220 KLSDFGLAKDGPTGSQS--------------------HVSTRVMGTYGYAAPEYM-ATGHLTAKSDVYSFGVVLLEMLSG 278 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~tg 278 (400)
||+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++|+|++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999865432211 123557899999999986 566799999999999999999985
Q ss_pred CCcc
Q 015781 279 RRVI 282 (400)
Q Consensus 279 ~~pf 282 (400)
..||
T Consensus 249 ~~p~ 252 (432)
T 3n9x_A 249 LQSH 252 (432)
T ss_dssp CTTT
T ss_pred cccc
Confidence 4444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=344.18 Aligned_cols=269 Identities=26% Similarity=0.331 Sum_probs=207.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 357999999999999999999654 3689999999976532 234568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++..++||||+++++|.+++.... .+++..+..++.||+.||+|||+. + |+|+||||+||+++.++.++|+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999999999998763 589999999999999999999985 7 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh--------
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-------- 296 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-------- 296 (400)
|++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 998643211 22345789999999999999999999999999999999999999976542211100000
Q ss_pred --------------hhHHHhhhhhh----hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 297 --------------AKPYLQSKRRI----FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 297 --------------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........... ................+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 00000000000 00111111111122346678999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=342.04 Aligned_cols=270 Identities=26% Similarity=0.356 Sum_probs=202.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.++++++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 67999999999999999999654 36889999998654432 23457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCC
Confidence 99999999999998888876544 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-------
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA------- 297 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~------- 297 (400)
++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...
T Consensus 170 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 170 FARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 9976433221 23345789999999999775 7899999999999999999999999776532221111000
Q ss_pred -hHHHhhhhhhhhhccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 298 -KPYLQSKRRIFQVMDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 298 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...................... ....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000000000000000011111 11346788999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=329.46 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=203.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccCCCCcccceeeE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
.++|++.+.||+|+||.||+|.. ..++..+|+|++..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLD---------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEB---------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEE---------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 47899999999999999999954 34688999999976532 234568899999999999999999999
Q ss_pred EE--eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 143 CL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 143 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+. +....++||||+.++ |.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEE
Confidence 84 456889999999765 7777766433 56899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCC--CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|+|||++................|++.|+|||++.+.. ++.++|||||||++|+|++|..||........ . .
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~ 223 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---F---E 223 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---H
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---H---H
Confidence 99999998655433333344567899999999997643 37799999999999999999999976432110 0 0
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ....+...+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 224 ----------~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 224 ----------NIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ----------HHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ----------HHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 00000 112233445678899999999999999999999998554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.83 Aligned_cols=257 Identities=26% Similarity=0.312 Sum_probs=205.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
..++|++.+.||+|+||+||+|... .++..||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 90 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET---------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3467999999999999999999544 468899999986532 22355788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---CCCceE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAK 220 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~k 220 (400)
.+....|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999999999987763 5899999999999999999999998 99999999999994 456799
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.........+.
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----- 235 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE----- 235 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 99999997654322 2344679999999999975 59999999999999999999999997654321111110
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.... ..........+..+.+||.+||+.||.+|||+.++|+|-+.-
T Consensus 236 -~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 281 (486)
T 3mwu_A 236 -TGKY--------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (486)
T ss_dssp -HTCC--------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred -hCCC--------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence 0000 000000123456788999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.42 Aligned_cols=255 Identities=29% Similarity=0.396 Sum_probs=210.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
+.|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEEC---------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 56899999999999999999543 3688999999976543 3346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
...++||||+++++|.+++.. .++++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeeccc
Confidence 999999999999999999864 35899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------- 230 (303)
T 3a7i_A 166 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------------- 230 (303)
T ss_dssp CEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------
T ss_pred ceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------------
Confidence 976543221 23345789999999999999999999999999999999999999976432111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.........+...+..+.+|+.+||+.||.+|||+.+++++.+....
T Consensus 231 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 231 ----IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----HHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----hhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 00001112233445678899999999999999999999998776543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=329.09 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=202.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCCe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 148 (400)
.|....+||+|+||.||+|... .++..||+|.+..........+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3555569999999999999654 3688999999987655556678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CCceEEeeccCC
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLA 227 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~ 227 (400)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ ++|+||||+||+++. ++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999999976532 235678999999999999999999998 999999999999987 899999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCC--CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........ ..+
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~--------- 236 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMF--------- 236 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHH---------
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHH---------
Confidence 76543221 233457899999999997643 78999999999999999999999964322110 000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
...........+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 237 ---KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp ---HHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred ---hhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000001122334455678889999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.36 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=204.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~ 140 (400)
.++|++.+.||+|+||.||+|... .++..+|+|++...... ....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 357999999999999999999654 36889999998765332 346788999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC---
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--- 217 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~--- 217 (400)
+++.+....++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCC
Confidence 9999999999999999999999999765 35899999999999999999999988 99999999999998877
Q ss_pred -ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 149 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-- 223 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-- 223 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred CceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--
Confidence 89999999998654322 123456899999999999889999999999999999999999999764321110000
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhch
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQ 356 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~ 356 (400)
.... ...........+..+.+++.+||+.||.+|||+.+++++ ++.+.
T Consensus 224 ----~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 224 ----SAVN--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp ----HTTC--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred ----Hhcc--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000 000000001234578899999999999999999999996 44443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=341.49 Aligned_cols=270 Identities=18% Similarity=0.191 Sum_probs=200.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----------HHHHHHHHHHHccCCCCcc
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPNL 136 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpni 136 (400)
++|++.+.||+|+||.||+|.... ...++..+|+|++....... ...+.+|+..++.++||||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 679999999999999999997653 12257789999987653211 1235678889999999999
Q ss_pred cceeeEEEe----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 137 VKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 137 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+++++++.+ ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 183 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLL 183 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEE
Confidence 999999988 78899999999 999999997654 5899999999999999999999998 999999999999
Q ss_pred EcCCC--ceEEeeccCCccCCCCCC-----cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCC
Q 015781 213 LDLNY--NAKLSDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285 (400)
Q Consensus 213 l~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 285 (400)
++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98877 999999999975432211 11123457999999999999989999999999999999999999999653
Q ss_pred CCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
....... ........ ..+....... ......+..+.+++.+||+.||++|||+.+|++.|+.+.-
T Consensus 264 ~~~~~~~-~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 264 LKDPVAV-QTAKTNLL---DELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TTCHHHH-HHHHHHHH---HTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccccHHH-HHHHHhhc---ccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2211110 00000000 0000000000 0011345678899999999999999999999999988643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=346.71 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=200.8
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
....++|++.+.||+|+||+||+|... .+|+.||+|++...... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI---------ESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET---------TTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 345678999999999999999999554 46899999998654322 23799999999999999999998
Q ss_pred Ee--------------------------------------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHH
Q 015781 144 LE--------------------------------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185 (400)
Q Consensus 144 ~~--------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 185 (400)
.. ...+++||||++ ++|.+.+.........+++..++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 43 345889999996 588888876444446799999999999
Q ss_pred HHHHHHHHhhcCCCCeeeccCCCCCEEEc-CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCcc
Q 015781 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKS 263 (400)
Q Consensus 186 qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s 263 (400)
||+.||+|||++| |+||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++
T Consensus 149 qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 149 QLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 9999999999988 99999999999997 68899999999998654332 22345789999999998764 589999
Q ss_pred chhhHHHHHHHHHhCCCccCCCCCCccchhHHhh-hH-H---H-hhhh-----hhhhhccccccCCCCHHHHHHHHHHHH
Q 015781 264 DVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA-KP-Y---L-QSKR-----RIFQVMDARIEGQYSLGAALKTAVLAI 332 (400)
Q Consensus 264 DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~~-~---~-~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~ 332 (400)
|||||||++|+|++|+.||.+.........+... .. . . .... .+...........++...+..+.+|+.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999999999875432221111000 00 0 0 0000 000000011111123345667899999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 015781 333 KCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 333 ~~l~~dP~~Rps~~eil~~ 351 (400)
+||+.||.+|||+.++++|
T Consensus 304 ~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=330.04 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=208.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 367999999999999999999654 3688999999876532 2345678899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEe
Confidence 9999999999999999999998775 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... .
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~----- 225 (294)
T 2rku_A 159 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------L----- 225 (294)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H-----
T ss_pred ccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-----
Confidence 999986543221 233457899999999999888999999999999999999999999764321100 0
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+... ....+...+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 226 -----~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 226 -----RIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp -----HHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred -----HHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 00000 112233445678899999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=332.07 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=203.7
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
...++|++.+.||+|+||.||+|... .+|..||+|++.... ....+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 34568999999999999999999654 368899999997653 3456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997543 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... .
T Consensus 170 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~--- 237 (314)
T 3com_A 170 GVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------I--- 237 (314)
T ss_dssp TTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------H---
T ss_pred ccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------H---
Confidence 99976433211 23345789999999999988999999999999999999999999976432110000 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... .......+...+..+.+|+.+||+.||.+|||+.+++++-+-
T Consensus 238 ---~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 238 ---PTN--PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp ---HHS--CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ---hcC--CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 000 000011122345678899999999999999999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.87 Aligned_cols=273 Identities=25% Similarity=0.264 Sum_probs=200.8
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----HHHHHHHHHHHccCCCCcccce
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKL 139 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~hpniv~~ 139 (400)
...++|++.+.||+|+||.||+|.. ..+|..||+|++....... ...+.+|+.+++.++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARD---------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEEC---------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 4457899999999999999999954 4478999999987543221 2357789999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
++++.+.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCE
Confidence 9999999999999999965 8988887643 46888999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+....
T Consensus 152 kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~ 229 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229 (346)
T ss_dssp EECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999986543221 23446789999999998654 58999999999999999999999997654322111110000
Q ss_pred HHHhhhhhhh------hhccccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 299 PYLQSKRRIF------QVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 299 ~~~~~~~~~~------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.......+. ...........+ ...+..+.+||.+||+.||.+|||+.++++|-+--
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 230 -GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp -CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred -CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 000000000 000000000001 23357889999999999999999999999986653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=337.92 Aligned_cols=275 Identities=20% Similarity=0.284 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe--
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-- 145 (400)
++|++.+.||+|+||.||+|.. ++..||+|++....... .....++..+..++||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccc
Confidence 6799999999999999999954 36789999997543221 122344445556899999999986542
Q ss_pred ---CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCeeeccCCCCCEEE
Q 015781 146 ---DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD---------KAKVIYRDFKTSNILL 213 (400)
Q Consensus 146 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~~~ivH~dlkp~Nill 213 (400)
...+++||||+++++|.+++.... .++..++.++.||+.||+|||+. + |+||||||+|||+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill 153 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV 153 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE
Confidence 236789999999999999997643 58899999999999999999998 7 9999999999999
Q ss_pred cCCCceEEeeccCCccCCCCCC------cceeeecccccCcccchhhcc-------CCCCCccchhhHHHHHHHHHhCCC
Q 015781 214 DLNYNAKLSDFGLAKDGPTGSQ------SHVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 214 ~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~tg~~ 280 (400)
+.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999976543211 112234579999999999976 356678999999999999999977
Q ss_pred ccCCCCCCccc-hhHHhhhHHHhhhhhhhhh-ccccccCC------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 281 VIDKNRPSREH-NLIEWAKPYLQSKRRIFQV-MDARIEGQ------YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 281 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
||......... ...............+... ........ .....+..+.+|+.+||+.||++|||+.++++.|
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 76443322211 1110000000000000000 00111111 1234677899999999999999999999999999
Q ss_pred HhchhcCCC
Q 015781 353 EQIQDTNDA 361 (400)
Q Consensus 353 ~~~~~~~~~ 361 (400)
+.+......
T Consensus 314 ~~ll~~~~~ 322 (336)
T 3g2f_A 314 AELMMIWER 322 (336)
T ss_dssp HHHHHCCCC
T ss_pred HHHHHHHHh
Confidence 998754443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=353.08 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=200.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .++..+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK---------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET---------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 357999999999999999999554 4688999999876542 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCceEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKL 221 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~~kl 221 (400)
+....|+|||||.+++|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEE
Confidence 9999999999999999999987763 5899999999999999999999998 999999999999976 455999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||++....... ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.........+.
T Consensus 181 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------ 250 (494)
T 3lij_A 181 VDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------ 250 (494)
T ss_dssp CCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------
T ss_pred EECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------
Confidence 9999998654322 234467999999999986 569999999999999999999999997654321111110
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... . .... .....+..+.+|+.+||+.||.+|||+.++|+|-+
T Consensus 251 ~~~~---~-~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 251 KGKY---T-FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp HTCC---C-CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred hCCC---C-CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 0000 0 0000 00124567889999999999999999999998744
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=365.07 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=208.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccC-CCCcccceee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~~~~ 141 (400)
...+|++.++||+|+||.||+|... .+++.||+|++..... .....+..|..++..+ +||+|+++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 4568999999999999999999554 4689999999976432 2344577899999887 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
++.+.+.+||||||+.||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEE
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEE
Confidence 9999999999999999999999998764 5899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.......
T Consensus 484 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---------- 551 (674)
T 3pfq_A 484 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---------- 551 (674)
T ss_dssp CCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------
T ss_pred eecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH----------
Confidence 99999985432221 245578999999999999999999999999999999999999999765421110
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM-----DEVVKA 351 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~eil~~ 351 (400)
..++.. ...++...+.++.+||.+||+.||.+||++ .+|++|
T Consensus 552 ------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 552 ------QSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------HHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------HHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111111 122344567789999999999999999998 888876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.52 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=211.0
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ....+.+|+.+|++++||||+++++++.+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4568888999999999999997653 45799999986543 35678899999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..||||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccccc
Confidence 678999999999999999976432 45899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... ...
T Consensus 410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~---------- 475 (535)
T 2h8h_A 410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---------- 475 (535)
T ss_dssp TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH----------
T ss_pred ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence 98654321 111222356788999999999999999999999999999999 999997653211 010
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+......
T Consensus 476 ----~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 476 ----QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 0111111122345567889999999999999999999999999998654443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=353.14 Aligned_cols=253 Identities=25% Similarity=0.300 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-------------hhHHHHHHHHHHHccCC
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLY 132 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~ 132 (400)
..++|++.+.||+|+||+||+|... .++..+|+|++..... .....+.+|+.++++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK---------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEEC---------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 4478999999999999999999544 4688999999876432 12456889999999999
Q ss_pred CCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 133 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
||||+++++++.+...+|+|||||.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 178 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENIL 178 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEE
Confidence 9999999999999999999999999999999997763 5899999999999999999999998 999999999999
Q ss_pred EcCCC---ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 213 LDLNY---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 213 l~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.....
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 98776 69999999998654432 234467999999999986 569999999999999999999999998654321
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
....+. ... ..++ ...+..+.+|+.+||+.||.+|||+.++|+|-+--
T Consensus 255 ~~~~i~----------------~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 255 IIKKVE----------------KGK--YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp HHHHHH----------------HCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHH----------------cCC--CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 111110 000 0001 12356788999999999999999999999986653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.17 Aligned_cols=245 Identities=17% Similarity=0.151 Sum_probs=191.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccc---cchhHHHHHHHH---HHHccCCCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI---KHLGQLYHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~hpniv~~~ 140 (400)
.++|++.+.||+|+||+||+|.. ..+|+.||||++... .......+.+|+ ..++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 36788899999999999999954 346889999998743 223445678899 556666899999998
Q ss_pred -------eEEEeCC-----------------eeEEEEeecCCCCHHHHHhhhcCCCC---CCCHHHHHHHHHHHHHHHHH
Q 015781 141 -------GYCLEDD-----------------HRLLVYEFMPKGSLENHLFRRASYIQ---PLSWTIRMKVALGAAKGLAY 193 (400)
Q Consensus 141 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~i~~qi~~~l~~ 193 (400)
+++.+.+ ..|+||||+ +|+|.+++........ ++++..++.++.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666553 278999999 6899999987543111 23458888999999999999
Q ss_pred hhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-----------CCCCc
Q 015781 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----------HLTAK 262 (400)
Q Consensus 194 LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 262 (400)
||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 222 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99998 99999999999999999999999999985322 2345567 999999999877 89999
Q ss_pred cchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCC
Q 015781 263 SDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342 (400)
Q Consensus 263 sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 342 (400)
+|||||||++|+|++|+.||...........+ .. .....+..+.+|+.+||+.||.+|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR------SCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS------SCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh------hccCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999999999765432211100 00 001234678899999999999999
Q ss_pred CCHHHHHHH
Q 015781 343 PTMDEVVKA 351 (400)
Q Consensus 343 ps~~eil~~ 351 (400)
||+.+++++
T Consensus 352 pt~~e~l~h 360 (377)
T 3byv_A 352 LLPLQAMET 360 (377)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhhC
Confidence 999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.60 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=207.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK---------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 467999999999999999999543 4689999999865432 3456788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAK 220 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~k 220 (400)
.+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||++ +.++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 169 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIR 169 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999999998765 35899999999999999999999998 9999999999999 5678999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.........+
T Consensus 170 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------ 239 (484)
T 3nyv_A 170 IIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV------ 239 (484)
T ss_dssp ECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred EEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------
Confidence 99999997654332 2334579999999999965 6999999999999999999999999765432111111
Q ss_pred HhhhhhhhhhccccccC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 301 LQSKRRIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
....... ......+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 240 ----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 240 ----------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp ----------HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred ----------HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 0000000 0012345678899999999999999999999998664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=341.72 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=197.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .+|..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 367999999999999999999553 4689999999865432 23456789999999999999999999997
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
... .+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCC
Confidence 653 469999999 8899999875 35899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 167 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 241 (367)
T 1cm8_A 167 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241 (367)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999864332 234578999999999877 67999999999999999999999999876532221111000
Q ss_pred hH-----HHhh-----hhhh-hh---hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 298 KP-----YLQS-----KRRI-FQ---VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 298 ~~-----~~~~-----~~~~-~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.. .... .... .. .....+ .......+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 00 0000 0000 00 000000 111223466788999999999999999999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.41 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=200.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||.||+|... .++..+|+|++..........+.+|+.+++.++||||+++++++.++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 468999999999999999999654 36889999999876655667888999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999999987654 46899999999999999999999998 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeecccccCcccchhh-----ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYM-----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
+...... ........|++.|+|||++ .+..++.++|||||||++|+|++|..||......... ....
T Consensus 164 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~ 235 (302)
T 2j7t_A 164 SAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIA 235 (302)
T ss_dssp HHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH
T ss_pred Ccccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHh
Confidence 7531110 0112335689999999998 3567899999999999999999999999765421110 0000
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.. .......+...+..+.+++.+||+.||.+|||+.++++|-
T Consensus 236 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 236 KS---------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp HS---------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred cc---------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00 0000111233456788999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=342.21 Aligned_cols=267 Identities=20% Similarity=0.234 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC--------CCcccc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--------HPNLVK 138 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~ 138 (400)
.++|++.+.||+|+||+||+|... .+++.||+|++.... .....+.+|+.+++.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI---------QGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEec---------CCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 368999999999999999999543 368999999997543 33456778999998885 788999
Q ss_pred eeeEEE----eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEE
Q 015781 139 LIGYCL----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILL 213 (400)
Q Consensus 139 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill 213 (400)
+++++. +....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE
Confidence 999987 556899999999 6677777765432 4689999999999999999999998 8 9999999999999
Q ss_pred cCCC-------------------------------------------------ceEEeeccCCccCCCCCCcceeeeccc
Q 015781 214 DLNY-------------------------------------------------NAKLSDFGLAKDGPTGSQSHVSTRVMG 244 (400)
Q Consensus 214 ~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g 244 (400)
+.++ .+||+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 8775 7999999999865432 233578
Q ss_pred ccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh-----------hhhccc
Q 015781 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI-----------FQVMDA 313 (400)
Q Consensus 245 t~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~ 313 (400)
|+.|+|||++.+..++.++|||||||++|+|++|..||......................... ......
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 999999999999999999999999999999999999998765443221111111000000000 000000
Q ss_pred -------------------cccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 314 -------------------RIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 314 -------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
......+...+..+.+|+.+||+.||.+|||+.++|+|-+
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0011235677888999999999999999999999998743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=341.24 Aligned_cols=260 Identities=27% Similarity=0.330 Sum_probs=207.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccC-CCCcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~~~~~ 142 (400)
++|++.+.||+|+||.||+|.... ...+++.||+|++..... .....+.+|+.+++.+ +||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 679999999999999999997632 234689999999876432 2233456789999998 69999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEES
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEe
Confidence 999999999999999999999998763 5899999999999999999999998 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+. ..
T Consensus 202 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~- 277 (355)
T 1vzo_A 202 DFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RR- 277 (355)
T ss_dssp CSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HH-
T ss_pred eCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HH-
Confidence 999997643322 112334679999999999975 347899999999999999999999997654332211110 00
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHh
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKALEQ 354 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~L~~ 354 (400)
... ....++...+..+.+|+.+||+.||.+|| |+.+++++.+.
T Consensus 278 ---------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 278 ---------ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ---------HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ---------Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 000 11223344566788999999999999999 99999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.28 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=206.3
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--------hhHHHHHHHHHHHccC-C
Q 015781 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQL-Y 132 (400)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~ 132 (400)
......++|++.+.||+|+||.||+|... .+|..||||++..... .....+.+|+.+++++ +
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34555678999999999999999999654 3688999999875431 1133567899999998 7
Q ss_pred CCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 133 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
||||+++++++......|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| ++|+||||+||+
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl 232 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENIL 232 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 999999999999999999999999999999999865 35899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc------CCCCCccchhhHHHHHHHHHhCCCccCCCC
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNR 286 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~ 286 (400)
++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999998654432 2344679999999999863 358899999999999999999999997643
Q ss_pred CCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 287 PSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.......+ ...... .... .. ...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 310 ~~~~~~~i------~~~~~~---~~~~-~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 310 QILMLRMI------MEGQYQ---FSSP-EW----DDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp HHHHHHHH------HHTCCC---CCHH-HH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHH------HhCCCC---CCCc-cc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 21110000 000000 0000 00 012456889999999999999999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=345.35 Aligned_cols=270 Identities=20% Similarity=0.250 Sum_probs=204.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC------CCCccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL------YHPNLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~ 140 (400)
..+|++.+.||+|+||+||+|... .++..||+|++.... .....+.+|+.+++.+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~---------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH---------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEEC---------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 357999999999999999999554 368999999997653 2234455666666665 678999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-- 218 (400)
+++......++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcc
Confidence 9999999999999999 5699999987543 45899999999999999999999998 999999999999999887
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+....
T Consensus 241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 999999999754332 234578999999999999999999999999999999999999998765432211111000
Q ss_pred -----HHHhhhhhhhhhcccc------------------------------------ccCCCCHHHHHHHHHHHHhcccC
Q 015781 299 -----PYLQSKRRIFQVMDAR------------------------------------IEGQYSLGAALKTAVLAIKCLSN 337 (400)
Q Consensus 299 -----~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~li~~~l~~ 337 (400)
............++.. ....+....+..+.+||.+||+.
T Consensus 316 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 316 GMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 0000000000000000 00000111256788999999999
Q ss_pred CCCCCCCHHHHHHHHHhch
Q 015781 338 EPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 338 dP~~Rps~~eil~~L~~~~ 356 (400)
||.+|||+.++|+|-+--.
T Consensus 396 dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp STTTSCCHHHHHTSTTTC-
T ss_pred ChhhCCCHHHHhCChhhcc
Confidence 9999999999999866543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.44 Aligned_cols=256 Identities=27% Similarity=0.346 Sum_probs=198.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|... .++..||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3468999999999999999999654 368899999987543 3345788999999998 7999999999998
Q ss_pred e------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 E------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
. .+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+|+||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCC
Confidence 7 5688999999999999999986532 46899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~ 293 (400)
++|+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF- 244 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-
Confidence 9999999987643321 1233457899999999986 5678999999999999999999999997544211100
Q ss_pred HHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+.............+..+.+|+.+||..||.+|||+.++++|-+
T Consensus 245 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 245 ---------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp ---------------HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred ---------------HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 000000011112234567889999999999999999999999743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.46 Aligned_cols=267 Identities=20% Similarity=0.263 Sum_probs=209.4
Q ss_pred ccHhHHHHHhcCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccC-CC
Q 015781 58 FSFNGLKTATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YH 133 (400)
Q Consensus 58 ~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h 133 (400)
..+.......++|.+. +.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++.+ .|
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISK---------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC
Confidence 3344455667788887 89999999999999554 3688999999876433 2345788999999998 46
Q ss_pred CcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE
Q 015781 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (400)
Q Consensus 134 pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill 213 (400)
|||+++++++.+....++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||++
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~ 164 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILL 164 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEE
Confidence 9999999999999999999999999999998854322 56899999999999999999999998 9999999999999
Q ss_pred cC---CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 214 DL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 214 ~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
+. ++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 87 7899999999998654322 22345799999999999999999999999999999999999999976542111
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...+ .. .............+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 242 ~~~i-------------~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 242 YLNI-------------SQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp HHHH-------------HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred HHHH-------------Hh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 1000 00 00111111223445678899999999999999999999998553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=336.53 Aligned_cols=272 Identities=24% Similarity=0.302 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+|++.+.||+|+||.||+|... .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 57999999999999999999654 36889999998665432 24467799999999999999999999987
Q ss_pred --------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 146 --------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
.+..|+||||+. ++|.+.+.... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDG 161 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTS
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCC
Confidence 456899999996 48877776543 45899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCC--cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 218 NAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999976542221 112344678999999999876 46899999999999999999999999875532222111
Q ss_pred HhhhHHHh-----hh--hhhhhhccccccCCCCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 295 EWAKPYLQ-----SK--RRIFQVMDARIEGQYSL-------GAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 295 ~~~~~~~~-----~~--~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
........ .. ................. ..+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 11000000 00 00000000000000000 114568899999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.36 Aligned_cols=267 Identities=25% Similarity=0.356 Sum_probs=188.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|.. ..++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYC---------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred hhhhhhhheeccccceEEEEEEE---------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 46899999999999999999954 33688999999876532 234567789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.+..++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999975211 1245899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCC---cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 222 SDFGLAKDGPTGSQ---SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--- 239 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--- 239 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH---
Confidence 99999875433211 112234578999999999865 56899999999999999999999999765432211100
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
... ..................+..+.+++.+||+.||.+|||+.++++|-
T Consensus 240 ---~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 240 ---LQN--DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp ---HTS--SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ---hcc--CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 000 00000000001111223456788999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.51 Aligned_cols=268 Identities=21% Similarity=0.234 Sum_probs=210.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC-CcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|.+. .++..||||++...... ..+..|+.+++.++| ++|..+..++.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI---------QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET---------TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 468999999999999999999653 36889999988755432 246789999999987 556666667778
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE---cCCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill---~~~~~~kl~ 222 (400)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEE
Confidence 88999999999 999999997643 46999999999999999999999998 9999999999999 688999999
Q ss_pred eccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 223 Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 99999865443221 1123568999999999999999999999999999999999999999876554332222211
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
... .+..... .+. ..++.++.+|+.+||+.+|++||++.+|++.|+.+......
T Consensus 229 ~~~-----~~~~~~~-~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 229 SEK-----KVATSIE-ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HHH-----HHHSCHH-HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhc-----cccccHH-HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 100 0000000 000 12346788999999999999999999999999998665443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=333.08 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEe-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~- 145 (400)
++|++.+.||+|+||+||+|... .+++.||+|++.... ...+.+|+.+++.++ ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEEC---------CCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 67999999999999999999543 368899999997543 456789999999997 9999999999987
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEEee
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~D 223 (400)
....++||||+.+++|.+++. .+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~D 174 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 174 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEe
Confidence 678899999999999998873 3788999999999999999999998 99999999999999776 899999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||++........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... +.... ....
T Consensus 175 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~-~~~~ 249 (330)
T 3nsz_A 175 WGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIA-KVLG 249 (330)
T ss_dssp CTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHH-HHHC
T ss_pred CCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHH-HhcC
Confidence 999986543322 234578999999999876 67899999999999999999999999544322111 00000 0000
Q ss_pred hhhhhhh---------------hc--------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 303 SKRRIFQ---------------VM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 303 ~~~~~~~---------------~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. ..+.. .. ............+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 250 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 250 T-EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp H-HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred C-chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0 00000 00 000011112224678899999999999999999999999744
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=346.07 Aligned_cols=259 Identities=25% Similarity=0.316 Sum_probs=195.9
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------hHHHHHHHHHHHccCCCCc
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPN 135 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpn 135 (400)
....++|.+.+.||+|+||+||+|... .++..||+|++...... ....+.+|+.+|++++|||
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 201 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC
Confidence 345689999999999999999999654 36889999998764321 1124778999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 136 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
|+++++++. .+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 202 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSS 274 (419)
T ss_dssp BCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESS
T ss_pred EeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEec
Confidence 999999975 45689999999999998887654 46899999999999999999999998 999999999999965
Q ss_pred CC---ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 216 NY---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 216 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 44 59999999998654322 2345679999999999853 578889999999999999999999997654322
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..... . .... .... ... ....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 352 ~~~~~--i----~~~~--~~~~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 352 SLKDQ--I----TSGK--YNFI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp CHHHH--H----HTTC--CCCC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHH--H----hcCC--CCCC-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 21100 0 0000 0000 000 01235678899999999999999999999997543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=359.95 Aligned_cols=253 Identities=27% Similarity=0.358 Sum_probs=202.3
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 151 (400)
+.||+|+||.||+|.+.. ..++..||||++..... .....+.+|+.++++++||||+++++++.+ +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 479999999999997643 23578999999976533 234678899999999999999999999864 56899
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 447 v~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999999999999764 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCC-cceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 232 TGSQ-SHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 232 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...... ..
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~~ 583 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TA 583 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HH
Confidence 3322 112233456788999999999999999999999999999998 9999976543111 11
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 584 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 584 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111111223344566789999999999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.17 Aligned_cols=266 Identities=27% Similarity=0.362 Sum_probs=208.2
Q ss_pred HHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc--CCCCccccee
Q 015781 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLI 140 (400)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~hpniv~~~ 140 (400)
.....++|++.+.||+|+||.||+|.. +++.||+|++.... ...+.+|.+++.. ++||||++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 345667899999999999999999965 36789999997543 3456677777766 7899999999
Q ss_pred eEEEeCC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeeeccCCC
Q 015781 141 GYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFKT 208 (400)
Q Consensus 141 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~ivH~dlkp 208 (400)
+++.... ..++||||+.+++|.+++... .+++..++.++.||+.||+||| +++ |+||||||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp 175 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKS 175 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSG
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCH
Confidence 9998876 789999999999999999753 4899999999999999999999 777 99999999
Q ss_pred CCEEEcCCCceEEeeccCCccCCCCCCcc--eeeecccccCcccchhhccCC------CCCccchhhHHHHHHHHHhC--
Q 015781 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATGH------LTAKSDVYSFGVVLLEMLSG-- 278 (400)
Q Consensus 209 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwslG~il~~l~tg-- 278 (400)
+||+++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999997543332211 123457899999999997652 33689999999999999999
Q ss_pred --------CCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCC-----CCHHHHHHHHHHHHhcccCCCCCCCCH
Q 015781 279 --------RRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQ-----YSLGAALKTAVLAIKCLSNEPKFRPTM 345 (400)
Q Consensus 279 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~ 345 (400)
..||.......... ..+.. .+........ ........+.+|+.+||+.||.+|||+
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 324 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDPSV-EEMRK----------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCH-HHHHH----------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred cCCcccccccCccccCcCcccH-HHHHH----------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCH
Confidence 67776543322111 11110 0011111111 123667789999999999999999999
Q ss_pred HHHHHHHHhchhcCC
Q 015781 346 DEVVKALEQIQDTND 360 (400)
Q Consensus 346 ~eil~~L~~~~~~~~ 360 (400)
.+++++|+.+.+...
T Consensus 325 ~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 325 LRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhc
Confidence 999999999977654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.99 Aligned_cols=277 Identities=15% Similarity=0.171 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccc---------
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVK--------- 138 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~--------- 138 (400)
++|++.+.||+|+||.||+|...... .......+..||+|++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~-~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTL-TCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCc-cccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 67999999999999999999765310 0001113788999998754 25678999999999999987
Q ss_pred ------eeeEEEe-CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 139 ------LIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 139 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
+++++.. +...|+||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHE
Confidence 5677766 68899999999 9999999987532 46899999999999999999999998 99999999999
Q ss_pred EEcCCC--ceEEeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCC
Q 015781 212 LLDLNY--NAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDK 284 (400)
Q Consensus 212 ll~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~ 284 (400)
+++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999764332111 112335799999999999998999999999999999999999999976
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
...... ............. ...... .......+..+.+|+.+||+.||.+|||+.++++.|+.+.......
T Consensus 271 ~~~~~~-~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDKP---GPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHSC---CCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcCHH-HHHHHHHhccCCh---hhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 542211 1111111000000 000000 0000123567889999999999999999999999999987766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.34 Aligned_cols=267 Identities=21% Similarity=0.235 Sum_probs=195.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA---------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEEC---------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 368999999999999999999543 3688999999875432 23456789999999999999999999997
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
... ..|+||||+. ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSC
T ss_pred cccccccccceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCC
Confidence 654 7899999996 57888874 24789999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh--
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-- 296 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-- 296 (400)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 166 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred EEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998643321 23346789999999999999999999999999999999999999987543211111000
Q ss_pred --------------hhHHHhhh-----hhhhhhccccccCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 297 --------------AKPYLQSK-----RRIFQVMDARIEGQ---YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 297 --------------~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
...+.... ..+........... .....+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00000000 00000000000000 012346788999999999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=325.27 Aligned_cols=255 Identities=25% Similarity=0.290 Sum_probs=204.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---------hhHHHHHHHHHHHccCC-CCcc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------QGHLEWLTEIKHLGQLY-HPNL 136 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-hpni 136 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEc---------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999554 4689999999875431 12345778999999995 9999
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+++++++.++...++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD 160 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC
Confidence 99999999999999999999999999999875 35899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhc------cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
+.++|+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 999999999998654332 233457899999999985 45688999999999999999999999975432110
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. ....... ...........+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 238 ~------~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 238 L------RMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp H------HHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred H------HHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 0 0000000 00000111234667889999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=324.25 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 367999999999999999999554 3688999999875432 2245678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEee
Confidence 99999999999999999999998763 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
||++....... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||....... ... ...
T Consensus 155 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~ 224 (276)
T 2h6d_A 155 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFK----KIR 224 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHH
T ss_pred cccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHH----Hhh
Confidence 99998654322 2234578999999999987765 689999999999999999999997543211 000 000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.. ....+...+..+.+++.+||+.||.+|||+.++++|-+.
T Consensus 225 ---------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 225 ---------GG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp ---------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred ---------cC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 00 011223345678899999999999999999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.39 Aligned_cols=266 Identities=24% Similarity=0.276 Sum_probs=197.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~- 146 (400)
.+|++.++||+|+||.||+|.+. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 46899999999999999999654 3688999999865432 223799999999999999999988542
Q ss_pred -----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-CceE
Q 015781 147 -----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 220 (400)
Q Consensus 147 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~-~~~k 220 (400)
..+++||||+. ++|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 121 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEE
Confidence 24679999996 4777777654333467999999999999999999999988 9999999999999965 5689
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++....... .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........+.....
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp ECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999986543322 2345789999999998764 789999999999999999999999987543221111100000
Q ss_pred HHhhhhhhhhhc------------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 300 YLQSKRRIFQVM------------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
......+.... .......++...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 275 -~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 275 -TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp -SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00000000000 000000112234578899999999999999999999998744
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=337.26 Aligned_cols=270 Identities=25% Similarity=0.280 Sum_probs=204.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..+|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN---------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC---------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 358999999999999999999544 36889999999754332 33568899999999999999999999975
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
. ...|+||||+. ++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+|
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEE
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEE
Confidence 5 46899999995 6999988653 5899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCc-ceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh
Confidence 9999999865432211 11234579999999998654 558999999999999999999999998765443322221000
Q ss_pred HHHhhhhhhh--------hh-ccccccCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 299 PYLQSKRRIF--------QV-MDARIEGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 299 ~~~~~~~~~~--------~~-~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
... ....+. .. ......... ....+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 249 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 249 GSP-SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp CSC-CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CCC-CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 000 000000 00 000000000 12235678899999999999999999999997543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.39 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=209.0
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||.||+|.+.. ....+..||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34679999999999999999997753 123467899999876433 23456889999999999999999999985
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++..|+||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEec
Confidence 456899999999999999997654 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
|++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~------- 604 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR------- 604 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH-------
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-------
Confidence 999865433221 2233456789999999998999999999999999999997 9999976542111 100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
+........+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus 605 -------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 605 -------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000011123344567889999999999999999999999999988643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=332.45 Aligned_cols=255 Identities=26% Similarity=0.334 Sum_probs=198.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--------hhHHHHHHHHHHHccCCCCcc
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNL 136 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~hpni 136 (400)
...++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.++++++||||
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 77 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC
Confidence 34568999999999999999999554 3689999999876432 112347789999999999999
Q ss_pred cceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 137 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
+++++++..+. .|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+
T Consensus 78 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CCEEEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSS
T ss_pred ceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecC
Confidence 99999987655 89999999999999998754 46899999999999999999999998 9999999999999876
Q ss_pred Cc---eEEeeccCCccCCCCCCcceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCcc
Q 015781 217 YN---AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE 290 (400)
Q Consensus 217 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~ 290 (400)
+. +||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 54 9999999998654321 223457899999999974 46789999999999999999999999976543322
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. .... ...... .... ....+..+.+|+.+||+.||.+|||+.++++|
T Consensus 228 ~~--~~~~---~~~~~~----~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 228 LK--DQIT---SGKYNF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HH--HHHH---HTCCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH--HHHH---hCcccc----Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11 0000 000000 0000 01235678899999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=329.84 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCC------ccccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP------NLVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp------niv~~~ 140 (400)
.++|++.+.||+|+||.||+|.... .++..||+|++.... .....+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3689999999999999999996532 358899999997543 3345677888888888655 499999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-----
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----- 215 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~----- 215 (400)
+++.+.+..++||||+ +++|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecccccc
Confidence 9999999999999999 8999999977643 46899999999999999999999998 999999999999987
Q ss_pred --------------CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc
Q 015781 216 --------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281 (400)
Q Consensus 216 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 281 (400)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 668999999999864332 2345789999999999998999999999999999999999999
Q ss_pred cCCCCCCccchhHHhhhHHH-----hhhh--------------------hhhhhccc-cccCCCCHHHHHHHHHHHHhcc
Q 015781 282 IDKNRPSREHNLIEWAKPYL-----QSKR--------------------RIFQVMDA-RIEGQYSLGAALKTAVLAIKCL 335 (400)
Q Consensus 282 f~~~~~~~~~~~~~~~~~~~-----~~~~--------------------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 335 (400)
|...........+....... .... ........ ..........+..+.+|+.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 98654322211111000000 0000 00000000 0001123456788999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 015781 336 SNEPKFRPTMDEVVKA 351 (400)
Q Consensus 336 ~~dP~~Rps~~eil~~ 351 (400)
+.||.+|||+.++++|
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=339.90 Aligned_cols=255 Identities=12% Similarity=-0.003 Sum_probs=184.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHH---HHHHccCCCCccccee-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE---IKHLGQLYHPNLVKLI- 140 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e---~~~l~~l~hpniv~~~- 140 (400)
.+|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+| +..|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV---------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEEC---------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 45889999999999999999654 3689999999987553 223446667 455555 799988755
Q ss_pred ------eEEEeC-----------------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHH------HHHHHHHHHHH
Q 015781 141 ------GYCLED-----------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR------MKVALGAAKGL 191 (400)
Q Consensus 141 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~qi~~~l 191 (400)
+++... ..+|+||||++ ++|.+++..... .+.+..+ +.++.||+.||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHH
Confidence 454433 33799999997 899999987542 3444555 67789999999
Q ss_pred HHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc--CCCCCccchhhHH
Q 015781 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFG 269 (400)
Q Consensus 192 ~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG 269 (400)
+|||+++ |+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 208 ~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 208 ANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp HHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred HHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 9999998 99999999999999999999999999986532 1224567799999999977 6799999999999
Q ss_pred HHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 015781 270 VVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV 349 (400)
Q Consensus 270 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 349 (400)
|++|+|++|+.||....+....... . ...................+..+.+|+.+||+.||++|||+.+++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGSWK---R------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTCCC---B------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHHhCCCCCCCcCcccccchh---h------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999999999999876442211100 0 000000001111111124567889999999999999999999999
Q ss_pred HHH
Q 015781 350 KAL 352 (400)
Q Consensus 350 ~~L 352 (400)
+|-
T Consensus 352 ~hp 354 (371)
T 3q60_A 352 ETP 354 (371)
T ss_dssp TSH
T ss_pred cCH
Confidence 863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=339.77 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=186.4
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc--chhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .+|..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET---------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEEC---------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 368999999999999999999543 478999999987543 233456789999999999999999999986
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.. ...|+|||++ +++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCC
Confidence 54 5679999999 7899988864 35899999999999999999999988 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 171 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 171 LKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp EEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999864321 334678999999999876 67899999999999999999999999876542222111100
Q ss_pred hH-----HHhh--hhhhhhhccccc-cCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 298 KP-----YLQS--KRRIFQVMDARI-EGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 298 ~~-----~~~~--~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. .... ............ ..... ...+..+.+|+.+||+.||.+|||+.++|+|-+
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 00 0000 000000000000 00001 123467889999999999999999999999743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.75 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=198.6
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCC--CCccccee
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY--HPNLVKLI 140 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--hpniv~~~ 140 (400)
...++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++ ||||++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 34467999999999999999999542 378899999875432 23456889999999997 59999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
+++.+.+..++|||+ .+++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ ++.+|
T Consensus 95 ~~~~~~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~k 166 (313)
T 3cek_A 95 DYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLK 166 (313)
T ss_dssp EEEECSSEEEEEECC-CSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEE
T ss_pred EEeecCCEEEEEEec-CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-CCeEE
Confidence 999999999999994 588999999875 36899999999999999999999998 99999999999996 48999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhcc-----------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
|+|||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 999999986544333223344678999999999865 468889999999999999999999997543210
Q ss_pred cchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
. .+....+.......+...+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 247 -----~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 247 -----S----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp -----H----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -----H----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 0 0111112222222233335678899999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=331.83 Aligned_cols=273 Identities=23% Similarity=0.288 Sum_probs=192.8
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
....++|++.+.||+|+||.||+|... .++..||+|++..... ......+++..+..++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 455688999999999999999999554 3688999998865432 233456788888889999999999999
Q ss_pred EeCCe-------eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCeeeccCCCCCEEEc
Q 015781 144 LEDDH-------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--SDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 144 ~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~dlkp~Nill~ 214 (400)
..... .++||||+.+ +|...+.........+++..++.++.||+.||.||| +++ |+||||||+||+++
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVN 165 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEE
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEe
Confidence 76433 7899999965 666665543333467899999999999999999999 777 99999999999999
Q ss_pred C-CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 215 L-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 215 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
. ++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 6 8999999999998654432 22345789999999998654 48999999999999999999999998754322111
Q ss_pred hHHhhhHHHhhhhhhhhhcc----------------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 293 LIEWAKPYLQSKRRIFQVMD----------------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
.+. ............... ...........+..+.+|+.+||+.||.+|||+.++++|-+.
T Consensus 243 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 243 EIV--RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HHH--HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred HHH--HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 110 000000000000000 000011122356789999999999999999999999998443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=323.28 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=195.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
..++|++.+.||+|+||.||+|... .++..||+|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNA---------LDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEc---------CCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 3467999999999999999999543 368899999986532 344568899999999999999999998865
Q ss_pred -------------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 146 -------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 146 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
....|+||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil 148 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIF 148 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEE
Confidence 457899999999999999997643 35788999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCC------------cceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCC
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQ------------SHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGR 279 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~ 279 (400)
++.++.++|+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999986532210 1122345789999999999764 68999999999999999998
Q ss_pred CccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 280 RVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 280 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
||.... ..... ... +. .........++...+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 227 -p~~~~~-----~~~~~----~~~---~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 227 -PFSTGM-----ERVNI----LKK---LR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp -CCSSHH-----HHHHH----HHH---HH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred -ccCCch-----hHHHH----HHh---cc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 443210 00000 000 00 011112223344556678899999999999999999999997443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=335.00 Aligned_cols=276 Identities=22% Similarity=0.261 Sum_probs=200.0
Q ss_pred cHhHHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-----------hHHHHHHHHHH
Q 015781 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----------GHLEWLTEIKH 127 (400)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~ 127 (400)
....+....++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 34556777899999999999999999999542 3789999998653321 12568899999
Q ss_pred HccCCCCcccceeeEEEe-----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 015781 128 LGQLYHPNLVKLIGYCLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (400)
Q Consensus 128 l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 202 (400)
+++++||||+++++++.. ....|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ |+
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iv 156 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG--VV 156 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc--CE
Confidence 999999999999999854 346899999996 68888887543 46899999999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCc
Q 015781 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRV 281 (400)
Q Consensus 203 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~p 281 (400)
|+||||+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999997543322 2334578999999999876 6789999999999999999999999
Q ss_pred cCCCCCCccchhHHh-hhH-HHh-----hhhhhhhhccccccC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 015781 282 IDKNRPSREHNLIEW-AKP-YLQ-----SKRRIFQVMDARIEG-------QYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347 (400)
Q Consensus 282 f~~~~~~~~~~~~~~-~~~-~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 347 (400)
|...........+.. ... ... ............... ......+..+.+|+.+||+.||.+|||+.+
T Consensus 234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 976543221111100 000 000 000000000000000 011223567889999999999999999999
Q ss_pred HHHHHH
Q 015781 348 VVKALE 353 (400)
Q Consensus 348 il~~L~ 353 (400)
+++|-+
T Consensus 314 ll~hp~ 319 (362)
T 3pg1_A 314 ALRHPY 319 (362)
T ss_dssp HHTSGG
T ss_pred HHcCch
Confidence 999744
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=331.47 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=198.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 3689999999999999999997542 389999875432 22334668999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+....++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++ ++.++|+||
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCC
T ss_pred cCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeec
Confidence 9999999999999999999997643 46899999999999999999999998 99999999999998 679999999
Q ss_pred cCCccCCCCC---CcceeeecccccCcccchhhcc---------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 225 GLAKDGPTGS---QSHVSTRVMGTYGYAAPEYMAT---------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 225 g~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
|++....... .........|++.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987542211 1112233568999999999864 357889999999999999999999997654211100
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
.+.............+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 254 ----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 254 ----------------QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ----------------HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ----------------HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 000000001111123456889999999999999999999999999987664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=336.18 Aligned_cols=277 Identities=20% Similarity=0.283 Sum_probs=188.9
Q ss_pred cCCCC-CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 68 RNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 68 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
+.|.+ .++||+|+||+||+|.... ..++..||+|++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 45666 4589999999999997642 23578899999976543 3467799999999999999999999954
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE----cC
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DL 215 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill----~~ 215 (400)
+..+|+||||+. ++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCC
Confidence 678999999995 588888764321 1134899999999999999999999998 9999999999999 67
Q ss_pred CCceEEeeccCCccCCCCCC-cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc--
Q 015781 216 NYNAKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-- 291 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-- 291 (400)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 78999999999986543211 122344688999999999977 45899999999999999999999999765432100
Q ss_pred ----hhHHhhhHHHh--hhh------------hhhhhccccccCCC---------CHHHHHHHHHHHHhcccCCCCCCCC
Q 015781 292 ----NLIEWAKPYLQ--SKR------------RIFQVMDARIEGQY---------SLGAALKTAVLAIKCLSNEPKFRPT 344 (400)
Q Consensus 292 ----~~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps 344 (400)
..+......+. ... .+............ ....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 00000000000 000 00000000000000 0011456789999999999999999
Q ss_pred HHHHHHHHHhch
Q 015781 345 MDEVVKALEQIQ 356 (400)
Q Consensus 345 ~~eil~~L~~~~ 356 (400)
+.++|+|-+...
T Consensus 328 a~e~L~hp~f~~ 339 (405)
T 3rgf_A 328 SEQAMQDPYFLE 339 (405)
T ss_dssp HHHHHTSGGGTS
T ss_pred HHHHhcChhhcc
Confidence 999999876643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=331.38 Aligned_cols=267 Identities=17% Similarity=0.196 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-----------CCcc
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPNL 136 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpni 136 (400)
.+|++.+.||+|+||+||+|... .+++.||+|++.... .....+.+|+.+++++. ||||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CeEEEEEeeeecCCeEEEEEEec---------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 67999999999999999999543 368999999997543 23445778888888876 8999
Q ss_pred cceeeEEEeCC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCE
Q 015781 137 VKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNI 211 (400)
Q Consensus 137 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Ni 211 (400)
+++++++...+ ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NI 163 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENV 163 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHe
Confidence 99999998654 789999999 8999999987543 4589999999999999999999997 8 99999999999
Q ss_pred EEc------CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCC
Q 015781 212 LLD------LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKN 285 (400)
Q Consensus 212 ll~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~ 285 (400)
|++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 3447999999999765432 23357899999999999999999999999999999999999999865
Q ss_pred CCCccchhHHhhhHHHh-----------hhhhhhhhcc-------------------ccccCCCCHHHHHHHHHHHHhcc
Q 015781 286 RPSREHNLIEWAKPYLQ-----------SKRRIFQVMD-------------------ARIEGQYSLGAALKTAVLAIKCL 335 (400)
Q Consensus 286 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~l 335 (400)
................. .......... ......++...+..+.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 43221111100000000 0000000000 00112345678889999999999
Q ss_pred cCCCCCCCCHHHHHHHHHh
Q 015781 336 SNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 336 ~~dP~~Rps~~eil~~L~~ 354 (400)
+.||.+|||+.++++|-+.
T Consensus 319 ~~dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWL 337 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGG
T ss_pred ccCccccCCHHHHhhChhh
Confidence 9999999999999997554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.23 Aligned_cols=269 Identities=24% Similarity=0.304 Sum_probs=196.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
.+|++.++||+|+||+||+|.... ++. +|+|++...... ..+|+.+++.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE---------SDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC---------CCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 579999999999999999996643 344 788876543321 236999999999999999999986543
Q ss_pred ------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-CCCceE
Q 015781 148 ------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAK 220 (400)
Q Consensus 148 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~k 220 (400)
.+++||||+.+ ++...+.........+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence 37899999965 555554433333367999999999999999999999998 99999999999998 799999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999986543322 2345789999999998664 589999999999999999999999987653222111100000
Q ss_pred HHhhhhhhhh----hc--------cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchh
Q 015781 300 YLQSKRRIFQ----VM--------DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 357 (400)
Q Consensus 300 ~~~~~~~~~~----~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~ 357 (400)
......+.. .. .......++...+..+.+|+.+||+.||.+|||+.++++| +..+..
T Consensus 260 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 260 -TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp -CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred -CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000000000 00 0000111122345688999999999999999999999997 444433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.05 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=197.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEE--
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-- 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-- 144 (400)
..+|++.+.||+|+||.||+|... .+++.||+|++..........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 468999999999999999999654 368999999998766556677889999999999999999999873
Q ss_pred ------------eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 ------------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+....|+||||+. ++|.+++.. .++++..++.++.||+.||+|||+++ |+||||||+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence 4468899999996 699999864 35899999999999999999999998 999999999999
Q ss_pred Ec-CCCceEEeeccCCccCCCCCC-cceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 213 LD-LNYNAKLSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 213 l~-~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
++ .++.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 567999999999986533211 112233567899999998865 678999999999999999999999998765322
Q ss_pred cchhHHhhhHHH--hhhhhhhh----hcccccc-CC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 290 EHNLIEWAKPYL--QSKRRIFQ----VMDARIE-GQ-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 290 ~~~~~~~~~~~~--~~~~~~~~----~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
....+....+.. .....+.. ....... .. .....+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 111110000000 00000000 0000000 00 01234667899999999999999999999999744
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=333.10 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----------------HHHHHHHHHHHc
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------------HLEWLTEIKHLG 129 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~ 129 (400)
.++|++.+.||+|+||.||+|.. ++..||+|++....... ...+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 36899999999999999999964 47899999987643221 167889999999
Q ss_pred cCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHH------HhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCee
Q 015781 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH------LFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVI 202 (400)
Q Consensus 130 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~iv 202 (400)
+++||||+++++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||+|||+ ++ ++
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~ 174 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--IC 174 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC--Ee
Confidence 99999999999999999999999999999999988 4332 12579999999999999999999999 88 99
Q ss_pred eccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCC-ccchhhHHHHHHHHHhCCC
Q 015781 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTA-KSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 203 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDiwslG~il~~l~tg~~ 280 (400)
|+||||+||+++.++.++|+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865332 23446789999999999877 6666 9999999999999999999
Q ss_pred ccCCCCCCccchhHHhhhHHHhhhhhhhh-------hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQ-------VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
||....... ....... .....+.. ..............+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 251 pf~~~~~~~--~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 251 PFSLKISLV--ELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp SSCCSSCSH--HHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCCcHH--HHHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 998654321 1111000 00000000 00000000011335678899999999999999999999999643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=332.46 Aligned_cols=270 Identities=21% Similarity=0.236 Sum_probs=202.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CC-----cccce
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP-----NLVKL 139 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~~ 139 (400)
..++|++.+.||+|+||+||+|... .+++.||+|++.... .....+..|+.+++.+. |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDR---------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEc---------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 3578999999999999999999554 368899999997543 22345667777777764 44 49999
Q ss_pred eeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc--CCC
Q 015781 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNY 217 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~ 217 (400)
++++...+..++||||+. ++|.+++..... ..+++..++.++.||+.||.|||.+..+|+||||||+|||++ .++
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999995 599999987542 458999999999999999999996434499999999999994 478
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 8999999999865432 23457899999999999999999999999999999999999999876543222111100
Q ss_pred hH-----HHhhhhhhhhhcccc-----------------------------------------ccCCCCHHHHHHHHHHH
Q 015781 298 KP-----YLQSKRRIFQVMDAR-----------------------------------------IEGQYSLGAALKTAVLA 331 (400)
Q Consensus 298 ~~-----~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li 331 (400)
.. ...........+... ............+.+||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 00 000000000000000 00011223456789999
Q ss_pred HhcccCCCCCCCCHHHHHHHHH
Q 015781 332 IKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 332 ~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+||+.||++|||+.++|+|-+
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSF 375 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGG
T ss_pred HHhcCCChhhCCCHHHHhcCcc
Confidence 9999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.13 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=204.8
Q ss_pred HHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceee
Q 015781 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
....++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence 355678999999999999999999654 3688999999865432 34567889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC---Cc
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YN 218 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~---~~ 218 (400)
++.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 89 ILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred EEeCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCccc
Confidence 9999999999999999999999987653 5899999999999999999999998 9999999999999654 46
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+||+|||++....... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||........ ..
T Consensus 163 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~--- 232 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK--- 232 (287)
T ss_dssp EEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---
T ss_pred EEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH---
Confidence 9999999987644322 1233468999999999865 589999999999999999999999976532111 00
Q ss_pred HHHhhhhhhhhhccccccCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 299 PYLQSKRRIFQVMDARIEGQY--SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
. . ......... ....+..+.+++.+||+.||.+|||+.+++++-+
T Consensus 233 ~-~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 233 R-V---------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp H-H---------HHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred H-H---------HcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 0 0 000000000 0123567889999999999999999999999643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=329.16 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|... .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 468999999999999999999544 46899999999764332 2456789999999999999999999998
Q ss_pred eCCee------EEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
..+.. |+||||+. ++|.+++. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCC
Confidence 77654 99999995 68887763 34899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 183 ~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 183 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999754322 334578999999999977 68899999999999999999999999765432211111000
Q ss_pred hH-----HHh-----hhhhhhhhccccccC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 298 KP-----YLQ-----SKRRIFQVMDARIEG---QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 298 ~~-----~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. ... ............... ......+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 00 000 000000000000000 001123568899999999999999999999999854
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=327.69 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=177.6
Q ss_pred hcCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++. ++||+|+||+||+|... .+++.||+|++..... ...+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3578885 47999999999999654 3688999999865321 11222334566789999999999976
Q ss_pred ----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCc
Q 015781 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (400)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~ 218 (400)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCce
Confidence 4568999999999999999987543 56899999999999999999999998 999999999999976 455
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 999999999764432 22345789999999999888899999999999999999999999976543211100000
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
.+ ...............+..+.+|+.+||+.||.+|||+.++++|-+.-..
T Consensus 244 -------~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 244 -------RI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -------hh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 0000000111112346678899999999999999999999998765433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=330.03 Aligned_cols=271 Identities=25% Similarity=0.285 Sum_probs=201.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|... .+|..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 368999999999999999999554 3689999999975432 234467799999999999999999998875
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
. ...++||||+. ++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEE
Confidence 4 67899999995 6999988753 5899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcc--------eeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 221 LSDFGLAKDGPTGSQSH--------VSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999998654322110 1223578999999998754 67899999999999999999999999875422111
Q ss_pred hhHHhhhHHHhhh--------hhhhhhcccccc------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 292 NLIEWAKPYLQSK--------RRIFQVMDARIE------GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 292 ~~~~~~~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+.......... ............ .......+..+.+|+.+||+.||.+|||+.++++|-+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 1110000000000 000000000000 00012345678899999999999999999999997443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.37 Aligned_cols=268 Identities=19% Similarity=0.215 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc------cccee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN------LVKLI 140 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~~~ 140 (400)
.++|++.+.||+|+||+||+|..... .+..||+|++.... .....+.+|+.+++.++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999965431 24789999997543 33456778888888887655 89999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEE-------
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL------- 213 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill------- 213 (400)
+++...+..++||||+ +++|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccc
Confidence 9999999999999999 6788777766532 46899999999999999999999988 9999999999999
Q ss_pred ------------cCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc
Q 015781 214 ------------DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281 (400)
Q Consensus 214 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p 281 (400)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 56789999999999864332 2345789999999999999999999999999999999999999
Q ss_pred cCCCCCCccchhHHhhhHH-----Hhhhhh--------------------hhhhc-cccccCCCCHHHHHHHHHHHHhcc
Q 015781 282 IDKNRPSREHNLIEWAKPY-----LQSKRR--------------------IFQVM-DARIEGQYSLGAALKTAVLAIKCL 335 (400)
Q Consensus 282 f~~~~~~~~~~~~~~~~~~-----~~~~~~--------------------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l 335 (400)
|...........+...... ...... ..... ............+..+.+|+.+||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 9865432211111100000 000000 00000 000001123345678999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 015781 336 SNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 336 ~~dP~~Rps~~eil~~L~ 353 (400)
+.||.+|||+.++++|-+
T Consensus 319 ~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 319 EFDPAQRITLAEALLHPF 336 (355)
T ss_dssp CSSTTTSCCHHHHTTSGG
T ss_pred cCChhhCcCHHHHhcChh
Confidence 999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.38 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=182.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHH-HHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIK-HLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|... .+++.||+|++...... ....+..|+. +++.++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 67999999999999999999654 36899999999765332 2334555555 7788899999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEee
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRA-SYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+..++||||+. ++|.+++.... .....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence 999999999996 48888876421 1235789999999999999999999998 7 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhh----ccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 170 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------- 238 (327)
T 3aln_A 170 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------- 238 (327)
T ss_dssp CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------
T ss_pred CCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--------
Confidence 99997654322 12334789999999998 4567899999999999999999999999764321000
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
. ..........+........+..+.+|+.+||+.||.+|||+.+++++-+..
T Consensus 239 -~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 290 (327)
T 3aln_A 239 -L---TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290 (327)
T ss_dssp -----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred -H---HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence 0 000000000111111123456788999999999999999999999975543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.01 Aligned_cols=271 Identities=25% Similarity=0.332 Sum_probs=201.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccC---CCCccccee
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLI 140 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~hpniv~~~ 140 (400)
..++|++.+.||+|+||.||+|.... .++..||+|++...... ....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 34789999999999999999996532 25789999998654321 122345666665555 899999999
Q ss_pred eEEE-----eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC
Q 015781 141 GYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (400)
Q Consensus 141 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~ 215 (400)
+++. .....++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++| |+|+||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~ 155 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcC
Confidence 9987 5567899999996 699999977543 45899999999999999999999998 999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
++.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999999997643221 2334678999999999998899999999999999999999999998654322111110
Q ss_pred hhhHHHhhhhhhhh-------hc---cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 296 WAKPYLQSKRRIFQ-------VM---DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 296 ~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... ......+.. .. ............+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 233 DVIG-LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp HHHC-CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHcC-CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000 000000000 00 000001122335667889999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=323.63 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=194.8
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh------HHHHHHHHHHHccC----CCCc
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------HLEWLTEIKHLGQL----YHPN 135 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l----~hpn 135 (400)
..++|++.+.||+|+||.||+|.. ..++..||+|++....... ...+.+|+.++.++ +|||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHR---------LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEEC---------TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred hhhceEEeeEEEcCCCEEEEEEEE---------ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 446899999999999999999943 4468899999997654321 12345688888887 8999
Q ss_pred ccceeeEEEeCCeeEEEEee-cCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc
Q 015781 136 LVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (400)
Q Consensus 136 iv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~ 214 (400)
|+++++++.+.+..++|||+ +.+++|.+++.... ++++..++.++.||+.||+|||+++ |+|+||||+||+++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILID 173 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEe
Confidence 99999999999999999999 78999999998753 5899999999999999999999998 99999999999999
Q ss_pred -CCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCC-CccchhhHHHHHHHHHhCCCccCCCCCCccch
Q 015781 215 -LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLT-AKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292 (400)
Q Consensus 215 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~ 292 (400)
.++.++|+|||++....... .....|++.|+|||++.+..+. .++|||||||++|+|++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----- 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence 88999999999998654322 2345689999999999877664 589999999999999999999964210
Q ss_pred hHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
... . ...++...+..+.+++.+||+.||++|||+.+++++-+.-
T Consensus 245 -------~~~----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 245 -------ILE----------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp -------HHH----------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred -------Hhh----------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 000 0 1112234456788999999999999999999999975543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.18 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=200.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCC--CCccc
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNLV 137 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv 137 (400)
..++|++.+.||+|+||.||+|... .++..||+|++...... ....+.+|+.+++++. ||||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEET---------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 4468999999999999999999543 36899999998765332 1234567888998885 59999
Q ss_pred ceeeEEEeCCeeEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-C
Q 015781 138 KLIGYCLEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-L 215 (400)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~ 215 (400)
++++++.+.+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ .
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCC
Confidence 999999999999999999976 8999999875 35899999999999999999999988 99999999999998 7
Q ss_pred CCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 216 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 8999999999998654322 234578999999999987766 6789999999999999999999964210
Q ss_pred HhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... ....+...+..+.+|+.+||+.||.+|||+.+++++-+
T Consensus 255 -----~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 255 -----IIRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp -----HHHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -----hhcc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 0000 00112234567889999999999999999999998644
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.65 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|.+.+.||+|+||.||+|... .+|..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 367999999999999999999543 46899999999764322 2456789999999999999999999998
Q ss_pred eCCe------eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDDH------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
.... .|+||||+. ++|.+++. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCc
Confidence 7654 499999996 68876653 34899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 165 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 165 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred EEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999764321 234578999999999876 67899999999999999999999999875532211111000
Q ss_pred hH-----HHhh-----hhhhhhhcccccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 298 KP-----YLQS-----KRRIFQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 298 ~~-----~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.. .... .......+..... .......+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00 0000 0000000000000 1122345678999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=317.12 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=182.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HH-HHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HL-EWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~-~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||.||+|... .+|..||+|++....... .. .+.++..+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 57899999999999999999654 368899999997654322 22 23445567788899999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
.+..++||||+ ++.+..+..... ..+++..++.++.||+.||.|||+. + ++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999 666666665433 4689999999999999999999984 8 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
|++....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||....... ... ..
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~ 241 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVL---TK 241 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH---HH
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHH---HH
Confidence 9997543322 223457899999999984 4578899999999999999999999997543210 000 00
Q ss_pred HHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.... ..... ......+..+.+|+.+||+.||.+|||+.+++++-+
T Consensus 242 ~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 242 VLQE-------EPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp HHHS-------CCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred Hhcc-------CCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 0000 00000 011134567889999999999999999999999744
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.51 Aligned_cols=256 Identities=25% Similarity=0.288 Sum_probs=187.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 146 (400)
+.|.+.++||+|+||+||.+.. .+|+.||||++.... ...+.+|+.+++++ +||||+++++++.++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 3466678999999999986532 247899999986543 34567899999876 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC-------
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------- 216 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~------- 216 (400)
+..|+||||+. ++|.+++......... ..+..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 99999999995 6999999865432111 123346789999999999999998 9999999999999654
Q ss_pred ------CceEEeeccCCccCCCCCCc--ceeeecccccCcccchhhcc-------CCCCCccchhhHHHHHHHHHh-CCC
Q 015781 217 ------YNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-------GHLTAKSDVYSFGVVLLEMLS-GRR 280 (400)
Q Consensus 217 ------~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t-g~~ 280 (400)
+.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999875443221 11234579999999999965 578999999999999999999 999
Q ss_pred ccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 281 VIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 281 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
||....... .. ....... ............+..+.+|+.+||+.||.+|||+.++++|-
T Consensus 239 Pf~~~~~~~-~~-------i~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 239 PFGDKYSRE-SN-------IIRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp TTCSTTTHH-HH-------HHHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCCCchhhH-HH-------HhcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 996543211 00 0000000 00111122456778899999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.56 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=185.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~ 146 (400)
.+|.+.++||+|+||+||.... .+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~----------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM----------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE----------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEE----------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4588889999999999654322 24788999999765433 245799999998 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-----CCceEE
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAKL 221 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-----~~~~kl 221 (400)
...|+||||+. ++|.+++.... ..+....++.++.||+.||+|||+++ |+||||||+||+++. ...++|
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred CEEEEEEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999999995 69999997654 23444556789999999999999998 999999999999943 235889
Q ss_pred eeccCCccCCCCCCc-ceeeecccccCcccchhhc---cCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHh
Q 015781 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMA---TGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 296 (400)
+|||++......... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||........
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------ 238 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------ 238 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------
Confidence 999999865433211 2234467999999999997 4567889999999999999999 9999965422100
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. ...... . ..........+..+.+|+.+||+.||.+|||+.++++|
T Consensus 239 -~-~~~~~~------~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 239 -N-ILLGAC------S-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -H-HHTTCC------C-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -H-HHhccC------C-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 000000 0 00011123456678899999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.27 Aligned_cols=270 Identities=27% Similarity=0.339 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~- 145 (400)
++|++.+.||+|+||.||+| .+..+|..||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 68999999999999999998 4556789999999876432 334568899999999999999999998765
Q ss_pred -----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc--
Q 015781 146 -----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (400)
Q Consensus 146 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~-- 218 (400)
++..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCce
Confidence 6778999999999999999986542 235888999999999999999999988 999999999999987665
Q ss_pred -eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|.
T Consensus 162 ~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~ 233 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWH 233 (676)
T ss_dssp EEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSS
T ss_pred eEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhh
Confidence 9999999998754432 234467899999999999999999999999999999999999999654211 1111
Q ss_pred hHHHhhhh----------hhhhhc-cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH-----HHHHHhchh
Q 015781 298 KPYLQSKR----------RIFQVM-DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEV-----VKALEQIQD 357 (400)
Q Consensus 298 ~~~~~~~~----------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei-----l~~L~~~~~ 357 (400)
........ ...... ............+..+.+|+.+||..||.+|||+.++ ++.++.+..
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 10000000 000000 0011122345578899999999999999999999884 445555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=306.09 Aligned_cols=235 Identities=13% Similarity=0.106 Sum_probs=185.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+..+.+++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 57999999999999999999654 36899999999875432 2356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..|+||||++|++|.+++... .....+..++.||+.||+|||++| |+||||||+||+++.++.++|+++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSC
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999999999998532 355578889999999999999998 999999999999999999999854
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+ |++ .++.++|||||||++|+|++|+.||.............
T Consensus 174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------- 215 (286)
T 3uqc_A 174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------- 215 (286)
T ss_dssp C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------
T ss_pred c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------
Confidence 3 333 36889999999999999999999998765432110000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCC
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~ 360 (400)
....... ..........+..+.+|+.+||+.||.+| |+.++++.|+.+.....
T Consensus 216 ~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 216 RDTAGQP--IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCTTSCB--CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHhccCC--CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000 00000112345678899999999999999 99999999999865543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=302.15 Aligned_cols=239 Identities=22% Similarity=0.264 Sum_probs=184.8
Q ss_pred cCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHH-ccCCCCcccceeeEEEe
Q 015781 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL-GQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~hpniv~~~~~~~~ 145 (400)
.+|.+. ++||+|+||.||+|... .+++.||+|++... ..+.+|+.++ +.++||||+++++++.+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEc---------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 78999999999999554 36889999998643 3456788777 55689999999999987
Q ss_pred ----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CCc
Q 015781 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (400)
Q Consensus 146 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~~ 218 (400)
....++||||+++++|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+||+++. ++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCc
Confidence 6788999999999999999987543 46899999999999999999999998 999999999999988 788
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
++|+|||++.... +..++.++|||||||++|+|++|..||...........
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----- 209 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----- 209 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----
Confidence 9999999886432 24567899999999999999999999976532111000
Q ss_pred HHHhhhhhhhhhccccccCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCCC
Q 015781 299 PYLQSKRRIFQVMDARIEGQYS----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDAG 362 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~~ 362 (400)
....... .....+ ...+..+.+|+.+||+.||.+|||+.++++|-+-........
T Consensus 210 --------~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 210 --------MKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp --------SCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred --------HHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 0000000 000111 124567889999999999999999999999876654444333
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=335.79 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=192.2
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||.||+|.+... +++.||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 36899999999999999999976431 478999999875432 334467899999999999999999999987
Q ss_pred CCe-----eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceE
Q 015781 146 DDH-----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~k 220 (400)
.+. .||||||++|++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEE
Confidence 665 7999999999999887643 5899999999999999999999998 9999999999999875 899
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.........
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------- 285 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------- 285 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---------
Confidence 9999999865432 345799999999999765 488999999999999999999988653211000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHhc
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-MDEVVKALEQI 355 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~eil~~L~~~ 355 (400)
........+..+.+||.+||+.||.+||+ +.++...|..+
T Consensus 286 ---------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ---------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001123457888999999999999995 55566556554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.23 Aligned_cols=244 Identities=16% Similarity=0.132 Sum_probs=182.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCC-Ccccc-----
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYH-PNLVK----- 138 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-pniv~----- 138 (400)
+.|+..++||+|+||+||+|.+. .+|+.||||++...... ....+.+|+.+++.+.| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEec---------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 45778889999999999999654 36889999998844332 24568899999999977 32211
Q ss_pred ----ee------------eEEEe-----CCeeEEEEeecCCCCHHHHHhhh---cCCCCCCCHHHHHHHHHHHHHHHHHh
Q 015781 139 ----LI------------GYCLE-----DDHRLLVYEFMPKGSLENHLFRR---ASYIQPLSWTIRMKVALGAAKGLAYL 194 (400)
Q Consensus 139 ----~~------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~qi~~~l~~L 194 (400)
.. .++.. ...++++|+++ +++|.+++... .....++++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 11 11111 22457788876 78999998532 11224578889999999999999999
Q ss_pred hcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhh----------ccCCCCCccc
Q 015781 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----------ATGHLTAKSD 264 (400)
Q Consensus 195 H~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sD 264 (400)
|+++ |+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ .+..++.++|
T Consensus 228 H~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 HHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred HhCC--cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 9998 99999999999999999999999999876432 1344577 999999999 5556888999
Q ss_pred hhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 015781 265 VYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT 344 (400)
Q Consensus 265 iwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 344 (400)
||||||++|+|++|+.||.......... ..+.. .. ..+..+.+|+.+||+.||++|||
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~----~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--CK----NIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--CC----CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--cc----cCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999997654321111 01110 01 22467889999999999999999
Q ss_pred HHHHHHH
Q 015781 345 MDEVVKA 351 (400)
Q Consensus 345 ~~eil~~ 351 (400)
+.+++++
T Consensus 358 ~~~~l~~ 364 (413)
T 3dzo_A 358 PLQAMET 364 (413)
T ss_dssp HHHHTTS
T ss_pred HHHHHhC
Confidence 9888775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.21 Aligned_cols=243 Identities=17% Similarity=0.133 Sum_probs=181.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--------hhHHHHHHHHHHHccCC------
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLY------ 132 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~------ 132 (400)
.++|++.+.||+|+||+||+|.. +|+.||+|++..... .....+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 36799999999999999999964 368999999976532 12356778888887775
Q ss_pred ---CCcccceeeE-----------------EEe-------------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHH
Q 015781 133 ---HPNLVKLIGY-----------------CLE-------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179 (400)
Q Consensus 133 ---hpniv~~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 179 (400)
||||+++.++ +.+ .+.+|+||||+.+|++.+.+.+ ..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence 6666665554 333 6889999999999977666633 3579999
Q ss_pred HHHHHHHHHHHHHHhh-cCCCCeeeccCCCCCEEEcCCC--------------------ceEEeeccCCccCCCCCCcce
Q 015781 180 RMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY--------------------NAKLSDFGLAKDGPTGSQSHV 238 (400)
Q Consensus 180 ~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~ 238 (400)
++.++.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------ 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred HHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence 9999999999999999 888 99999999999999887 899999999986432
Q ss_pred eeecccccCcccchhhccCCCCCccchhhHHHH-HHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhhh-hcccccc
Q 015781 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVV-LLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ-VMDARIE 316 (400)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~i-l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 316 (400)
....||+.|+|||++.+.. +.++||||||++ .+++++|..||... .|........ ... .......
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~--~~~~~~~~~~~ 301 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKM--LKQMTFKTKCN 301 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHH--HHTCCCSSCCC
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhh--hhhhccCcccc
Confidence 1347999999999998665 899999998777 77888899988421 1111110000 000 0000111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HH
Q 015781 317 GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVV-KA 351 (400)
Q Consensus 317 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil-~~ 351 (400)
.......+.++.+||.+||+.| |+.++| +|
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 1122357889999999999976 999999 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-33 Score=279.46 Aligned_cols=173 Identities=19% Similarity=0.125 Sum_probs=129.6
Q ss_pred CCCCCcEEEEEEeccccc----------hhHHHHHHHHHHHccC-CCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHh
Q 015781 98 RPGTGMVIAVKRLNQESL----------QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF 166 (400)
Q Consensus 98 ~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 166 (400)
+...|+.+++|++..... ....++.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.
T Consensus 255 r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~ 334 (569)
T 4azs_A 255 RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA 334 (569)
T ss_dssp EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH
T ss_pred cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 334688899999875421 2234688999999999 79999999999999999999999999999999998
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeeccccc
Q 015781 167 RRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246 (400)
Q Consensus 167 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 246 (400)
..+ +++.. .|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+++...... ......+||+
T Consensus 335 ~~~----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp 403 (569)
T 4azs_A 335 AGE----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSF 403 (569)
T ss_dssp TTC----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHH
T ss_pred hCC----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceech
Confidence 763 56654 47899999999999999 9999999999999999999999999998654322 2344578999
Q ss_pred CcccchhhccCCCCCccchhhHHHHHHHHHhCCCcc
Q 015781 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282 (400)
Q Consensus 247 ~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf 282 (400)
.|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus 404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHC------------------CCCCTTHHHH
T ss_pred hhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9999999965 4678899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=243.53 Aligned_cols=185 Identities=15% Similarity=0.184 Sum_probs=142.5
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------hHHHHHHHHHHHccCCCCcccceeeE
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~~~~~ 142 (400)
...++||+|+||.||+|... +..+++|........ ....+.+|+.++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 44679999999999999432 567888876543221 12347899999999999999966666
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+.+..|+||||+++++|.+++.. +..++.||+.||+|||+++ |+||||||+|||++. .+||+
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEEC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEE
Confidence 6677788999999999999998864 4688999999999999998 999999999999998 99999
Q ss_pred eccCCccCCCCCCcc-----eeeecccccCcccchhhcc--CCCCCccchhhHHHHHHHHHhCCCcc
Q 015781 223 DFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMAT--GHLTAKSDVYSFGVVLLEMLSGRRVI 282 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~tg~~pf 282 (400)
|||+++......... ......||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999998764432111 1235689999999999976 56888899999998888877766555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=197.51 Aligned_cols=147 Identities=14% Similarity=0.049 Sum_probs=116.6
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc------------------hhHHHHHHHHHH
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------QGHLEWLTEIKH 127 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~ 127 (400)
....|.+.+.||+|+||.||+|.+ .+|..||+|++..... .....+.+|+.+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 345566779999999999999965 2588999999965322 123457899999
Q ss_pred HccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCC
Q 015781 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (400)
Q Consensus 128 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlk 207 (400)
+++++ | +++.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| |+|||||
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g--iiHrDlk 220 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG--IVHGDLS 220 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC--CEeCCCC
Confidence 99998 4 666665544 55699999999999987 311 224579999999999999988 9999999
Q ss_pred CCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhc
Q 015781 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255 (400)
Q Consensus 208 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 255 (400)
|+|||++ ++.++|+|||+++. +..+.|||.+.
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999 99999999999863 34478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-21 Score=170.64 Aligned_cols=138 Identities=17% Similarity=0.082 Sum_probs=104.7
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcE--EEEEEeccccch------------------------hHHHHH
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESLQ------------------------GHLEWL 122 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~ 122 (400)
-|.+.+.||+|+||.||+|.... +|.. ||||++...... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 36788999999999999996622 4778 999987543211 012567
Q ss_pred HHHHHHccCCCCcc--cceeeEEEeCCeeEEEEeecCC-C----CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 015781 123 TEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPK-G----SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195 (400)
Q Consensus 123 ~e~~~l~~l~hpni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 195 (400)
+|+..|..+.|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.||+.+|.|||
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHH
Confidence 89999999988764 333332 356899999942 3 77766432 123456789999999999999
Q ss_pred -cCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 196 -SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 196 -~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
.+| |+||||||+|||++. .++|+|||++...
T Consensus 188 ~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 888 999999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-18 Score=162.00 Aligned_cols=137 Identities=12% Similarity=0.058 Sum_probs=96.4
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--------------hHHH--------HHHHHH
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------------GHLE--------WLTEIK 126 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~ 126 (400)
-|++.+.||+|+||.||+|... +|+.||||+++..... .... ...|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 3899999999999999999543 4889999997643110 0111 234566
Q ss_pred HHccCCCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccC
Q 015781 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (400)
Q Consensus 127 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dl 206 (400)
.|.++.+.++.-. ..+... ..+|||||++|++|..+.. ......++.||+.+|.+||.+| ||||||
T Consensus 166 nL~rL~~~gv~vp-~p~~~~-~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~g--IVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVP-EPIAQS-RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKHG--LIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCC-CEEEEE-TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred HHHHHHhcCCCCC-eeeecc-CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHCC--CcCCCC
Confidence 6666644433221 112111 2379999999988854321 1223567899999999999988 999999
Q ss_pred CCCCEEEcCCC----------ceEEeeccCCcc
Q 015781 207 KTSNILLDLNY----------NAKLSDFGLAKD 229 (400)
Q Consensus 207 kp~Nill~~~~----------~~kl~Dfg~~~~ 229 (400)
||.|||+++++ .+.|+||+.+..
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999998776 389999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.5e-13 Score=119.67 Aligned_cols=144 Identities=13% Similarity=-0.027 Sum_probs=109.5
Q ss_pred HHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEE
Q 015781 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (400)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~ 143 (400)
.....|++...++.|+.+.||++.. .+..+++|+...........+.+|+.+++.+. +..+.++++++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3446788888999999999999842 25679999987532222335678888888874 67788999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK------------------------- 198 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------- 198 (400)
.+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred ecCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 99899999999999999977531 11123467788888999999810
Q ss_pred --------------------------------CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 --------------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 --------------------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-11 Score=108.79 Aligned_cols=135 Identities=17% Similarity=0.039 Sum_probs=94.3
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc--ccceeeEEEeC
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIGYCLED 146 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~~~~~~~~~ 146 (400)
.|.+..+.+.|..+.||++... +|..+++|+..... ...+..|+.+++.+.+.+ +.+++.+..++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444444456667999997432 35679999976542 234567888888775434 56688888887
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---------------------------- 198 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------- 198 (400)
+..++||||++|.+|. .. .... ..++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~-------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SS-------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp SCEEEEEECCSSEETT--TS-------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCCEEEEEecCCcccC--cC-------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 8899999999998883 11 1111 245666777777777642
Q ss_pred ----------------------------CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 ----------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 ----------------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877666799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.1e-10 Score=107.67 Aligned_cols=140 Identities=14% Similarity=0.190 Sum_probs=101.8
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEec--cccc-hhHHHHHHHHHHHccCC--CCcccceeeEEEeC-
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESL-QGHLEWLTEIKHLGQLY--HPNLVKLIGYCLED- 146 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~- 146 (400)
.+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.+. +..+.+++.++.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred EEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 457899999999997532 3568888876 3221 22345678888888886 45578888888766
Q ss_pred --CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 015781 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--------------------------- 197 (400)
Q Consensus 147 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------- 197 (400)
+..|+||||++|..+.+.. ...++......++.+++..|..||..
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred ccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 4589999999988774311 13467788888999999999999972
Q ss_pred -----------------------------CCCeeeccCCCCCEEEcCCCc--eEEeeccCCcc
Q 015781 198 -----------------------------KAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKD 229 (400)
Q Consensus 198 -----------------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 229 (400)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=4.3e-11 Score=109.71 Aligned_cols=182 Identities=18% Similarity=0.181 Sum_probs=117.8
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccC-CCCc--ccceeeEEEeCC--
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPN--LVKLIGYCLEDD-- 147 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~hpn--iv~~~~~~~~~~-- 147 (400)
.+.++.|....||++ +..+++|+.... .....+.+|...|+.+ .+.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999985 245889986543 2345677899888777 3333 344444433332
Q ss_pred -eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q 015781 148 -HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---------------------------- 198 (400)
Q Consensus 148 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------- 198 (400)
..|+||++++|.+|.+.... .++......++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 34899999999888653321 2566667777777777777777511
Q ss_pred ----------------------------CCeeeccCCCCCEEEcC--CCceEEeeccCCccCCCCCCcceeeecccccCc
Q 015781 199 ----------------------------AKVIYRDFKTSNILLDL--NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248 (400)
Q Consensus 199 ----------------------------~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 248 (400)
..++|+|++|.||+++. +..+.|+||+.+......... .....+
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~ 236 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMED 236 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCT
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhh
Confidence 23799999999999988 456789999988653221100 001111
Q ss_pred ---ccchhhcc-----CCC---------CCccchhhHHHHHHHHHhCCCcc
Q 015781 249 ---AAPEYMAT-----GHL---------TAKSDVYSFGVVLLEMLSGRRVI 282 (400)
Q Consensus 249 ---~aPE~~~~-----~~~---------~~~sDiwslG~il~~l~tg~~pf 282 (400)
..|+.... +.. ....+.|++|.++|.+.+|..+|
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22222110 111 12368999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.9e-07 Score=82.40 Aligned_cols=133 Identities=17% Similarity=0.089 Sum_probs=92.8
Q ss_pred cccCCCc-eEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEeCCeeEEEE
Q 015781 76 LGEGGFG-CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (400)
Q Consensus 76 lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 153 (400)
+..|..| .||+.... ..+..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..|+||
T Consensus 32 ~~~G~S~~~v~rl~~~---------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK---------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEECC---------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEec---------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445555 68886332 23567889986543 3345677888887774 333678889999999999999
Q ss_pred eecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 015781 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK----------------------------------- 198 (400)
Q Consensus 154 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------- 198 (400)
|+++|.++.+...... .....+..++...|..||...
T Consensus 100 e~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp ECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 9999998887654321 122345556666666666431
Q ss_pred ---------------------CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 ---------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 ---------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 127899999999999987777799998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5e-07 Score=82.57 Aligned_cols=135 Identities=21% Similarity=0.136 Sum_probs=88.0
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCC---cccceeeEEE-eCCe
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP---NLVKLIGYCL-EDDH 148 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~-~~~~ 148 (400)
.+.++.|....||+. +..+++|+.... .....+..|..+|+.+.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 346788888899986 345888885322 2345677899999888642 3556666664 3456
Q ss_pred eEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 015781 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------------- 197 (400)
Q Consensus 149 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------- 197 (400)
.|+|||+++|.+|.+.... .++......++.++...|..||+.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~ 161 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF 161 (306)
T ss_dssp EEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred eEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence 7899999999888763211 123333333333444433333322
Q ss_pred ---------------------------CCCeeeccCCCCCEEEcC---CCce-EEeeccCCcc
Q 015781 198 ---------------------------KAKVIYRDFKTSNILLDL---NYNA-KLSDFGLAKD 229 (400)
Q Consensus 198 ---------------------------~~~ivH~dlkp~Nill~~---~~~~-kl~Dfg~~~~ 229 (400)
...++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124799999999999987 4554 8999997764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.3e-06 Score=79.82 Aligned_cols=86 Identities=2% Similarity=-0.124 Sum_probs=51.7
Q ss_pred Ccc-ccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc---chhHHHHHHHHHHHccCC-C--CcccceeeEEEeC
Q 015781 74 SVL-GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLY-H--PNLVKLIGYCLED 146 (400)
Q Consensus 74 ~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--pniv~~~~~~~~~ 146 (400)
+.| +.|....+|+....... .....+..+++|+..... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456 78888999987532000 000014578899876533 111234557777777663 2 3466777776654
Q ss_pred ---CeeEEEEeecCCCCHH
Q 015781 147 ---DHRLLVYEFMPKGSLE 162 (400)
Q Consensus 147 ---~~~~lv~e~~~~~~L~ 162 (400)
+..|+|||+++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=75.97 Aligned_cols=76 Identities=14% Similarity=0.108 Sum_probs=46.7
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-------hhHHHHHHHHHHHccCCC--Cc-ccceeeE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLYH--PN-LVKLIGY 142 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--pn-iv~~~~~ 142 (400)
.+.||.|.++.||++.... .+..+++|....... .....+..|..+++.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4578999999999985432 356799997653211 112345667777776632 33 3455543
Q ss_pred EEeCCeeEEEEeecCCC
Q 015781 143 CLEDDHRLLVYEFMPKG 159 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~ 159 (400)
+.+..++|||++.+.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 445568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=0.0001 Score=67.87 Aligned_cols=30 Identities=23% Similarity=0.273 Sum_probs=26.8
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 449999999999999888899999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=7.1e-05 Score=67.42 Aligned_cols=79 Identities=15% Similarity=0.147 Sum_probs=52.8
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCC---cccceeeEEEe
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP---NLVKLIGYCLE 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp---niv~~~~~~~~ 145 (400)
...-.+.+|.|..+.||+.... +|+.+++|+...........+..|...|+.|.-. -+.+++.+ +
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~ 83 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D 83 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred CeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence 3444567899999999998765 3778999987655433334566788877776321 24444443 2
Q ss_pred CCeeEEEEeecCCCCH
Q 015781 146 DDHRLLVYEFMPKGSL 161 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L 161 (400)
.-++||||+.++..
T Consensus 84 --~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 --DRTLAMEWVDERPP 97 (288)
T ss_dssp --TTEEEEECCCCCCC
T ss_pred --CceEEEEeecccCC
Confidence 23789999977653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00025 Score=64.52 Aligned_cols=74 Identities=18% Similarity=0.091 Sum_probs=56.0
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC---CCcccceeeEEEeCCeeE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGYCLEDDHRL 150 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---hpniv~~~~~~~~~~~~~ 150 (400)
+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|. ...+.+++.+....+..|
T Consensus 42 ~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~ 107 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSF 107 (312)
T ss_dssp EEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEE
T ss_pred EEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceE
Confidence 5689999999999743 2457889987643 2445677888777773 356888888888788899
Q ss_pred EEEeecCCCCH
Q 015781 151 LVYEFMPKGSL 161 (400)
Q Consensus 151 lv~e~~~~~~L 161 (400)
+||||++|..+
T Consensus 108 lvme~l~G~~~ 118 (312)
T 3jr1_A 108 LLLEALNKSKN 118 (312)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeccCCCC
Confidence 99999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00025 Score=60.00 Aligned_cols=101 Identities=16% Similarity=0.042 Sum_probs=67.0
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcc
Q 015781 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237 (400)
Q Consensus 159 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 237 (400)
.+|.++|...+ .|+++.++|.++.|.+.+|.-+- ... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 48999998877 79999999999999999987762 111 11233456889999999988864 1110
Q ss_pred eeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCC
Q 015781 238 VSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRR 280 (400)
Q Consensus 238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~ 280 (400)
.....+.|||.+. ...+.+.=|||||+++|.-+--..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122366888763 344677889999999998876443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0005 Score=65.48 Aligned_cols=77 Identities=17% Similarity=0.190 Sum_probs=45.9
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeeccc--ccCcccchhhccC---CCCCccchhhHHHHHH
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG--TYGYAAPEYMATG---HLTAKSDVYSFGVVLL 273 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDiwslG~il~ 273 (400)
..++|+|+++.||+++.++ +.|+||+.+......... ..... ...|++|+..... .-....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998776 999999988753321110 00010 1335565544211 1112345557777778
Q ss_pred HHHhCC
Q 015781 274 EMLSGR 279 (400)
Q Consensus 274 ~l~tg~ 279 (400)
..+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00033 Score=63.40 Aligned_cols=71 Identities=7% Similarity=0.071 Sum_probs=42.1
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLL 151 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~l 151 (400)
.+.|+.|....+|+. ..+++|+....... .....+|+..++.+...++ .+++.+ +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 567889999999986 13888887653211 1112356666665532223 345543 3444578
Q ss_pred EEeec-CCCCH
Q 015781 152 VYEFM-PKGSL 161 (400)
Q Consensus 152 v~e~~-~~~~L 161 (400)
|+||+ +|.+|
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 66555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0036 Score=56.97 Aligned_cols=29 Identities=28% Similarity=0.207 Sum_probs=25.0
Q ss_pred CeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 200 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 48999999999999877666899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0025 Score=58.40 Aligned_cols=32 Identities=31% Similarity=0.344 Sum_probs=27.3
Q ss_pred CCeeeccCCCCCEEEcCC----CceEEeeccCCccC
Q 015781 199 AKVIYRDFKTSNILLDLN----YNAKLSDFGLAKDG 230 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 230 (400)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 349999999999999874 67999999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0037 Score=57.09 Aligned_cols=141 Identities=13% Similarity=0.062 Sum_probs=75.1
Q ss_pred ccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCC--cccceeeE-----EEeCC
Q 015781 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIGY-----CLEDD 147 (400)
Q Consensus 75 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hp--niv~~~~~-----~~~~~ 147 (400)
.|+ |....||+.... .|..+++|+...... ....+..|...++.+... .+.+++.. ...++
T Consensus 33 ~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred eec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 466 778899986321 355799999864321 233445566666555311 13333332 23356
Q ss_pred eeEEEEeecCCCCHH-----HH------H---hhhc-CC----CCCCCHHH----------------------HHHHHHH
Q 015781 148 HRLLVYEFMPKGSLE-----NH------L---FRRA-SY----IQPLSWTI----------------------RMKVALG 186 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~-----~~------l---~~~~-~~----~~~~~~~~----------------------~~~i~~q 186 (400)
..+++|++++|.++. .+ + .... .. ....+... ....+.+
T Consensus 101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 180 (328)
T 1zyl_A 101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 180 (328)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence 678899999875431 11 1 1100 00 00112111 0112222
Q ss_pred HHHHHHHhhc--CCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 187 AAKGLAYLHS--DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 187 i~~~l~~LH~--~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
++..+..+-. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2222322211 223489999999999999 4 899999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00082 Score=62.86 Aligned_cols=148 Identities=16% Similarity=0.158 Sum_probs=79.7
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv 152 (400)
+.|..|-...+|++...... ......+..+++|+.... ........+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888899998653210 011123568999986432 223445568888887774 2223556655543 289
Q ss_pred EeecCCCCHHH-----------H---Hhh-hc---CCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 015781 153 YEFMPKGSLEN-----------H---LFR-RA---SYIQPLS--WTIRMKVALGAAK-------------------GLAY 193 (400)
Q Consensus 153 ~e~~~~~~L~~-----------~---l~~-~~---~~~~~~~--~~~~~~i~~qi~~-------------------~l~~ 193 (400)
|||++|.+|.. + |.+ +. ....+.. +.++..++.++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998765421 1 111 00 0112222 3445545444321 1222
Q ss_pred ----hhc--CCCCeeeccCCCCCEEEcCC----CceEEeeccCCc
Q 015781 194 ----LHS--DKAKVIYRDFKTSNILLDLN----YNAKLSDFGLAK 228 (400)
Q Consensus 194 ----LH~--~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~ 228 (400)
|.. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 12348999999999999876 789999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00087 Score=63.94 Aligned_cols=80 Identities=16% Similarity=0.098 Sum_probs=47.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv 152 (400)
+.|+.|-...+|++....... .....+..+++|+...... ...+..|+.+++.+...++ .++++.+. + .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 457888889999986542100 0011356799998854211 1345578888777743333 55665543 2 389
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999976443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0073 Score=55.54 Aligned_cols=31 Identities=13% Similarity=0.101 Sum_probs=27.2
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0039 Score=59.81 Aligned_cols=74 Identities=16% Similarity=0.103 Sum_probs=43.1
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv 152 (400)
+.|+.|-...+|++.... .+..+++|+....... ......|+.+++.|...++ .++++.+. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 356777788899885432 2467889987543211 1112367777777754444 45666552 2 259
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0047 Score=57.52 Aligned_cols=82 Identities=10% Similarity=0.039 Sum_probs=41.4
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc-ccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 152 (400)
+.|+.|....+|+........ ......+..+++|+....... ......|..+++.+...+ +.++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 457778888999986432000 000012357889987643211 112245666666664223 34565443 2 3689
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.15 Score=48.28 Aligned_cols=81 Identities=14% Similarity=0.027 Sum_probs=44.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc-ccceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 152 (400)
+.|..|-...+|+........ .....+..+++++..... .......+|..+++.+.-.+ ..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 456777788899986542110 001125778999875432 11112236777666663222 34555433 2 2689
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988663
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.36 E-value=0.21 Score=42.17 Aligned_cols=122 Identities=8% Similarity=0.069 Sum_probs=81.8
Q ss_pred HHHHHccCCCCcccceeeEEEeCCeeEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 015781 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (400)
Q Consensus 124 e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 202 (400)
|+..|.. .||+++.. .+-.+++.+.+.++.-+. -++.. + ..++....+.++.+|+....+++. -+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~----r~ 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT----RY 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS----SE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC----ce
Confidence 4444432 58888877 566777776666665432 22222 2 346788899999999887766554 46
Q ss_pred eccCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCcc
Q 015781 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVI 282 (400)
Q Consensus 203 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf 282 (400)
|--|.|+||+++.++.++++-.|+-....+. .++...-+-.+=|++..+++++..|
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~------------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVVDPL------------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTBSCC------------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCCCCC------------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 8889999999999999999988764432211 1122223345678889999998877
Q ss_pred C
Q 015781 283 D 283 (400)
Q Consensus 283 ~ 283 (400)
.
T Consensus 158 e 158 (215)
T 4ann_A 158 D 158 (215)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.42 Score=40.43 Aligned_cols=115 Identities=10% Similarity=0.071 Sum_probs=78.0
Q ss_pred CCCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeeeccCCCCC
Q 015781 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA-YLHSDKAKVIYRDFKTSN 210 (400)
Q Consensus 132 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~ivH~dlkp~N 210 (400)
.||++ -..+-.+++.+.+.++.-+++.=...+. .++....+.++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCce
Confidence 57888 4455577788777777653433333332 3678889999999987766 5554 5788899999
Q ss_pred EEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccC
Q 015781 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID 283 (400)
Q Consensus 211 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~ 283 (400)
|+++.++.+++.-.|+-... +|.- ++...=+-.+=|++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988865432 2211 1111223456688888888877663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.62 E-value=0.5 Score=44.23 Aligned_cols=28 Identities=29% Similarity=0.333 Sum_probs=24.2
Q ss_pred eeeccCCCCCEEE------cCCCceEEeeccCCc
Q 015781 201 VIYRDFKTSNILL------DLNYNAKLSDFGLAK 228 (400)
Q Consensus 201 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~ 228 (400)
++|+|+.+.||++ +++..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 400 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 3e-72
Identities = 61/291 (20%), Positives = 117/291 (40%), Gaps = 31/291 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V+KG + + + + + + Q + E+ L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ H N++ +GY +V ++ SL +HL + + +A A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTA 114
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+ YLH +I+RD K++NI L + K+ DFGLA S SH ++ G+ +
Sbjct: 115 QGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 249 AAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
APE + + +SDVY+FG+VL E+++G+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
++ ++ L +CL + RP +++ ++E +
Sbjct: 233 KVRSNCPKAMKR------------LMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-66
Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 45/315 (14%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-W 121
++ +F S LG G G VFK +G+V+A K ++ E
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ E++ L + P +V G D + E M GSL+ L + + I
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILG 107
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
KV++ KGL YL K K+++RD K SNIL++ KL DFG++ ++
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 162
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVID------------------ 283
+GT Y +PE + H + +SD++S G+ L+EM GR I
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 284 -KNRPSREHNLIEWAKPYLQSKR---RIFQVMDARIEGQYSLGAALKTAVLAI----KCL 335
P R Y R IF+++D + + ++ KCL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 336 SNEPKFRPTMDEVVK 350
P R + +++
Sbjct: 283 IKNPAERADLKQLMV 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-65
Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 33/295 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F + V+G G FGCV+ G + ++ G + AVK LN+ + G + +LTE
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 128 LGQLYHPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ HPN++ L+G CL + L+V +M G L N + + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQ 138
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRVMG 244
AKG+ +L K ++RD N +LD + K++DFGLA+D H T
Sbjct: 139 VAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
+ A E + T T KSDV+SFGV+L E+++ P + N + LQ +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR 251
Query: 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359
R + +Y + + +KC + + RP+ E+V + I T
Sbjct: 252 RLLQ--------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-65
Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 35/288 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V+ G+ + +AVK L Q S+ +L E +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSMSPD-AFLAEANLM 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
QL H LV+L + ++ E+M GSL + L + L+ + +A A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIA 119
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+A++ I+RD + +NIL+ + K++DFGLA+ ++ +
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRRI 307
APE + G T KSDV+SFG++L E+++ R+ + E +E ++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++ L C P+ RPT D + LE
Sbjct: 237 EELYQ-----------------LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-65
Identities = 76/309 (24%), Positives = 116/309 (37%), Gaps = 39/309 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
LG G FG V + Y + M +AVK L + E ++E+K
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-------------- 172
L L H N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
L + + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 233 GSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292
S V + APE + T +SDV+S+G+ L E+ S P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352
++++ A + + C +P RPT ++V+ +
Sbjct: 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 353 EQI--QDTN 359
E+ + TN
Sbjct: 303 EKQISESTN 311
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 6e-65
Identities = 70/314 (22%), Positives = 127/314 (40%), Gaps = 40/314 (12%)
Query: 55 IKSFSFNGLKTATRNF---------RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVI 105
I F+F A R F + + V+G G FG V G + + +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFV 57
Query: 106 AVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
A+K L + + ++L+E +GQ HPN++ L G + +++ EFM GSL++
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 165 LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
L + + + + G A G+ YL ++RD NIL++ N K+SDF
Sbjct: 118 LRQN---DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDF 172
Query: 225 GLAKDGPTGSQSHVSTRV---MGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV 281
GL++ + T + APE + T+ SDV+S+G+V+ E++S
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE- 231
Query: 282 IDKNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKF 341
RP + + + ++ + L + C +
Sbjct: 232 ----RPYWDMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 342 RPTMDEVVKALEQI 355
RP ++V L+++
Sbjct: 277 RPKFGQIVNTLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-64
Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R +G+G FG V++G G +AVK + + EI
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREERSWFR-EAEIYQ 50
Query: 128 LGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
L H N++ I +D+ LV ++ GSL ++L R ++ +K+
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKL 105
Query: 184 ALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ 235
AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 236 SHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVI----DKN 285
+GT Y APE + ++D+Y+ G+V E+ + D
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 286 RPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPT 344
P + + + ++ K Q + I ++ AL+ + +C R T
Sbjct: 226 LPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 345 MDEVVKALEQIQD 357
+ K L Q+
Sbjct: 285 ALRIKKTLSQLSQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 2e-64
Identities = 73/310 (23%), Positives = 120/310 (38%), Gaps = 43/310 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N +GEG FG VF+ ++AVK L +E+ ++ E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAP----GLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI--------------- 172
+ + +PN+VKL+G C L++E+M G L L + +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 173 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287
++ + + PE + T +SDV+++GVVL E+ S
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
E I+ V D I L+ L C S P RP+
Sbjct: 248 HEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 348 VVKALEQIQD 357
+ + L+++ +
Sbjct: 292 IHRILQRMCE 301
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 42/306 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
N VLG G FG V Y ++ G + +AVK L +++ E ++E+K
Sbjct: 38 NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------------ 168
+ QL H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 169 -ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ L++ + A AKG+ +L ++RD N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287
+D + S V + APE + G T KSDV+S+G++L E+ S P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 288 SREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDE 347
+ ++++ + A + ++ C + + + RP+
Sbjct: 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 348 VVKALE 353
+ L
Sbjct: 317 LTSFLG 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-64
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ + +G+G FG V G G +AVK + ++ +L E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATAQ--AFLAEASV 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLD 111
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ + YL + ++RD N+L+ + AK+SDFGL K+ S
Sbjct: 112 VCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPV 164
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE + + KSDV+SFG++L E+ S R P L + R
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PR 212
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
+ + + C + RP+ ++ + LE I+
Sbjct: 213 VEKGYKMDAPDGCPPAVYE----VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-64
Identities = 57/288 (19%), Positives = 111/288 (38%), Gaps = 33/288 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ LG G FG V G +A+K + + S E++ E K
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ L H LV+L G C + ++ E+M G L N+L +++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDV 109
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+ + YL S + ++RD N L++ K+SDFGL++ + S
Sbjct: 110 CEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
++ PE + ++KSD+++FGV++ E+ S ++ + + E
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------T 210
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ + + A+ K + C + RPT ++ + +
Sbjct: 211 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 1e-63
Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 31/287 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G +G V++G + +AVK L +++++ E+L E +
Sbjct: 18 DITMKHKLGGGQYGEVYEGV---------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
++ HPNLV+L+G C + ++ EFM G+L ++L Q +S + + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 125
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ YL I+RD N L+ N+ K++DFGL++ G +
Sbjct: 126 SAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 182
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308
APE +A + KSDV++FGV+L E+ + + ++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VY 226
Query: 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++++ + G K L C P RP+ E+ +A E +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-63
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 35/291 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V G+ +A+K + E +++ E + +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVM 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L HP LV+L G CLE LV+EFM G L ++L + + + + L
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+AYL VI+RD N L+ N K+SDFG+ + Q ST +
Sbjct: 112 EGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 168
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE-HNLIEWAKPYLQSKRRI 307
A+PE + ++KSDV+SFGV++ E+ S ++ +NR + E I + +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358
V + C P+ RP +++ L +I ++
Sbjct: 229 THVYQ-----------------IMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-61
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 31/285 (10%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQL 131
D LG G FG V +G + +A+K L Q + + E + E + + QL
Sbjct: 14 DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + + +LV E G L L + + + + ++ + G+
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGM 122
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTYGYAA 250
YL + ++RD N+LL + AK+SDFGL+K G S + + A
Sbjct: 123 KYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 251 PEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQV 310
PE + +++SDV+S+GV + E LS + +P ++ E Q K
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGK------ 229
Query: 311 MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
R+E L L C + + RP V + +
Sbjct: 230 ---RMECPPECPPELYA--LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-61
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 31/293 (10%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
++ R LG+G FG V +G D + G + +AVK L + L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ + L H NL++L G L ++ V E P GSL + L + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV-STRVM 243
+ A+G+ YL S + I+RD N+LL K+ DFGL + P +V
Sbjct: 118 VQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 244 GTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
+ + APE + T + SD + FGV L EM + + P N + +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKE 230
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356
R+ + D + + ++C +++P+ RPT + L + Q
Sbjct: 231 GERLPRPED--------CPQDIYN--VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-61
Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 35/289 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIK 126
++ +G G +G K R G ++ K L+ S+ ++E+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L +L HPN+V+ ++ + +V E+ G L + + + Q L ++V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 185 LGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L H V++RD K +N+ LD N KL DFGLA+ + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
+GT Y +PE M KSD++S G +L E+ + P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ K R RI +YS L + + L+ + RP+++E+++
Sbjct: 228 EGKFR-------RIPYRYS--DELNE--IITRMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 69/284 (24%), Positives = 108/284 (38%), Gaps = 32/284 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
++ LGEG +G V T +AVK ++ + E EI
Sbjct: 6 DWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L H N+VK G+ E + + L E+ G L + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQL 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 248 YAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
Y APE + DV+S G+VL ML+G D+ S + K + +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ +A L K L P R T+ ++ K
Sbjct: 231 -------------KIDSAPLA--LLHKILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-61
Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 42/301 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
+ + V+GEG FG V K I + G M A+KR+ + S H ++ E++
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQP 174
L +L HPN++ L+G C + L E+ P G+L + L + S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
LS + A A+G+ YL + I+RD NIL+ NY AK++DFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 235 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
+ T + A E + T SDV+S+GV+L E++S P
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCA 233
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
E + Q R + L + L +C +P RP+ +++ +L +
Sbjct: 234 ELYEKLPQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 355 I 355
+
Sbjct: 283 M 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 64/292 (21%), Positives = 110/292 (37%), Gaps = 44/292 (15%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
R + D +G G F V+KG T + +A L L + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 126 KHLGQLYHPNLVKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ L L HPN+V+ +LV E M G+L+ +L R + + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLR 115
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSDFGLAKDGPTGSQSHVST 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSRE--HNLIEWAK 298
V+GT + APE DVY+FG+ +LEM + + + + + + K
Sbjct: 172 AVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
P K I +V + + C+ R ++ +++
Sbjct: 231 PASFDKVAIPEVKE-----------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-61
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 28/294 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
V+G G FG V+KG + + P +A+K L + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+GQ H N+++L G + +++ E+M G+L+ L + S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGI 119
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTY 246
A G+ YL + ++RD NIL++ N K+SDFGL++ ++ ++
Sbjct: 120 AAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE ++ T+ SDV+SFG+V+ E+++ + E
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------- 221
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTND 360
+ + ++ + L ++C E RP ++V L+++ D
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 72/286 (25%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L +P +V++IG C E + +LV E G L +L + + + +++ + G
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMG 119
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG-SQSHVSTRVMGTYGYA 249
+ YL ++ ++RD N+LL + AK+SDFGL+K + T +
Sbjct: 120 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 250 APEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309
APE + ++KSDV+SFGV++ E S + +P R E + +R
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGERM--- 229
Query: 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
L C + + + RP V L
Sbjct: 230 ----GCPAGCPREMYD----LMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 68/287 (23%), Positives = 116/287 (40%), Gaps = 36/287 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG+G FG V+K T ++ A K ++ +S + +++ EI L
Sbjct: 13 FWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HPN+VKL+ +++ ++ EF G+++ + +PL+ + V
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTL 120
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L YLH K+I+RD K NIL L+ + KL+DFG++ Q +GT +
Sbjct: 121 DALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYW 176
Query: 249 AAPEYMAT-----GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
APE + K+DV+S G+ L+EM P E N + +S
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKS 230
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ + K KCL R T ++++
Sbjct: 231 EPPTLAQPS-------RWSSNFKD--FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 7e-60
Identities = 74/291 (25%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ V+A+K+++ Q + +W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E++ L +L HPN ++ G L + LV E+ + + + +PL V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAV 120
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
GA +GLAYLHS +I+RD K NILL KL DFG A + +
Sbjct: 121 THGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFV 172
Query: 244 GTYGYAAPEY---MATGHLTAKSDVYSFGVVLLEMLSGRRVI-DKNRPSREHNLIEWAKP 299
GT + APE M G K DV+S G+ +E+ + + + N S +++ + P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
LQS + CL P+ RPT + ++K
Sbjct: 233 ALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 40/285 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEI 125
+F LG+G FG V+ + ++A+K L + L + E+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYIT 113
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
A L+Y HS +VI+RD K N+LL K++DFG + P S T + GT
Sbjct: 114 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
Y PE + K D++S GV+ E L G+ + N + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF- 226
Query: 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ + L + L + P RP + EV++
Sbjct: 227 ---------------VTEGARD--LISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-59
Identities = 68/320 (21%), Positives = 131/320 (40%), Gaps = 32/320 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHL 128
F+ VLG G FG V+KG + P + +A+K L + S + + E L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ +P++ +L+G CL +L + + MP G L +++ I + + A
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIA 121
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
KG+ YL ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 122 KGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308
A E + T +SDV+S+GV + E+++ P+ E I
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------IS 223
Query: 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI----QDTNDAGVS 364
+++ + ++ +KC + RP E++ ++ Q
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
Query: 365 RDESLQNSDRSTYKRKGLNE 384
L + S + R ++E
Sbjct: 284 ERMHLPSPTDSNFYRALMDE 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-59
Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ R + LG+G FG V+ G + +A+K L + +L E + +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVM 66
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L H LV+L ++ +V E+M KGSL + L + L + +A A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIA 123
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+AY+ + ++RD + +NIL+ N K++DFGLA+ ++ +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180
Query: 249 AAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308
APE G T KSDV+SFG++L E+ + RV +RE +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VL 224
Query: 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
++ L +C EP+ RPT + + LE
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-58
Identities = 66/310 (21%), Positives = 133/310 (42%), Gaps = 29/310 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LG+G FG V++G + +A+K +N+ S++ +E+L E
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYIQPLSWTIRM 181
+ + ++V+L+G + L++ E M +G L+++L + P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
++A A G+AYL+++K ++RD N ++ ++ K+ DFG+ +D +
Sbjct: 137 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
+ + +PE + G T SDV+SFGVVL E+ + +P + + + + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFVM 249
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361
+ L C PK RP+ E++ ++++ +
Sbjct: 250 EGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
Query: 362 GVSRDESLQN 371
VS S +N
Sbjct: 299 EVSFYYSEEN 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-57
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ TG +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE 124
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS +VI+RD K+ NILL ++ + KL+DFG + + ++GT
Sbjct: 125 CLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 180
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+ APE + K D++S G++ +EM+ G P R LI
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------ 234
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
++ L A + +CL + + R + E+++
Sbjct: 235 -------ELQNPEKLSAIFRD--FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-56
Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 30/290 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+GEG FG V +G + +A+K + E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ Q HP++VKLIG ++ ++ E G L + L R L + A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQL 117
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+ LAYL S + ++RD N+L+ N KL DFGL++ S + +++
Sbjct: 118 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIK 174
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307
+ APE + T+ SDV+ FGV + E+L +P + + +R
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLP 229
Query: 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357
+ L + L KC + +P RP E+ L I +
Sbjct: 230 M---------PPNCPPTLYS--LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-56
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 34/301 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
LGEG FG V +P +AVK L ++ + L + ++E++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQP 174
+ + H N++ L+G C +D ++ E+ KG+L +L R + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
LS + A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 235 QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294
+T + APE + T +SDV+SFGV+L E+ + P E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 295 EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354
+F+++ + ++ C P RPT ++V+ L++
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 355 I 355
I
Sbjct: 294 I 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-55
Identities = 78/306 (25%), Positives = 121/306 (39%), Gaps = 36/306 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKH 127
+ LG G FG V + + + T +AVK L + + H ++E+K
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 128 LGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP----------- 174
L +H N+V L+G C + L ++ EF G+L +L + + P
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 175 -LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
L+ + + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 234 SQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL 293
+ APE + T +SDV+SFGV+L E+ S P +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKI 242
Query: 294 IEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
E L+ R+ Y+ + + C EP RPT E+V+ L
Sbjct: 243 DEEFCRRLKEGTRMRAP-------DYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLG 292
Query: 354 QIQDTN 359
+ N
Sbjct: 293 NLLQAN 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-54
Identities = 58/293 (19%), Positives = 102/293 (34%), Gaps = 36/293 (12%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLE 120
K +F+ +LGEG F V T A+K L + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + +L HP VKL +D+ + G L ++ + T
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCT 110
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
L YLH +I+RD K NILL+ + + +++DFG AK S+ +
Sbjct: 111 RFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
+GT Y +PE + SD+++ G ++ ++++G P R N
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYL----- 217
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353
+++ + + L K L + R +E+
Sbjct: 218 -----IFQKIIKLEYDFPEKFFPKARD--LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 1e-51
Identities = 60/284 (21%), Positives = 97/284 (34%), Gaps = 33/284 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ LG G FG V + TG A K + EI+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP LV L +D+ +++YEFM G L + +S ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
KGL ++H ++ D K NI+ + KL DFGL V GT
Sbjct: 135 KGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 189
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+AAPE + +D++S GV+ +LSG ++ +
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ K K L +P R T+ + ++
Sbjct: 250 ------------SGISEDGKD--FIRKLLLADPNTRMTIHQALE 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 4e-51
Identities = 69/297 (23%), Positives = 117/297 (39%), Gaps = 38/297 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIK 126
+ +LG GG V +AVK L + + +L + E +
Sbjct: 9 YELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP +V + + +V E++ +L + + P++ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIE 115
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTR 241
V A + L + H +I+RD K +NI++ K+ DFG+A+ +G+ +
Sbjct: 116 VIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
V+GT Y +PE + A+SDVYS G VL E+L+G + P P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQD 357
S R L A L VL K L+ P+ R T E+ L ++ +
Sbjct: 234 PSARH------------EGLSADLDAVVL--KALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 1e-50
Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 33/284 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + TG V K +N EI +
Sbjct: 30 YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
QL+HP L+ L + +L+ EF+ G L + + +S + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+GL ++H +++ D K NI+ + + K+ DFGLA T
Sbjct: 138 EGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATA 192
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
+AAPE + + +D+++ GV+ +LSG ++
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
S+ K L EP+ R T+ + ++
Sbjct: 253 ------------SSVSPEAKD--FIKNLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 1e-48
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 41/284 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH------LEWL 122
+F ++G GGFG V+ + TG + A+K L+++ ++ L
Sbjct: 5 DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ + P +V + D + + M G L HL + + + +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ L GL ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 116 IIL----GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHAS 165
Query: 243 MGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301
+GT+GY APE + G + +D +S G +L ++L G +++ +H +
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------- 218
Query: 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 345
R+ M + +S L L + R
Sbjct: 219 ----RMTLTMAVELPDSFSPEL----RSLLEGLLQRDVNRRLGC 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 5e-48
Identities = 65/298 (21%), Positives = 107/298 (35%), Gaps = 48/298 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
N+ P +LG G V + T AVK ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 121 -WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L E+ L ++ HPN+++L + LV++ M KG L ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEK 110
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
K+ + + LH +++RD K NILLD + N KL+DFG +
Sbjct: 111 ETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEK 165
Query: 239 STRVMGTYGYAAPEYMATGHL------TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHN 292
V GT Y APE + + D++S GV++ +L+G +
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225
Query: 293 LIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+I S +K L + L +P+ R T +E +
Sbjct: 226 MIMSGNYQFGSPEWD------------DYSDTVKD--LVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 8e-48
Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 40/318 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ VLG G F V T ++A+K + +++L+G EI L
Sbjct: 11 YDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
++ HPN+V L H L+ + + G L + + + + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVL 117
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ YLH +++RD K N+L + +SDFGL+K V + GT
Sbjct: 118 DAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGT 172
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305
GY APE +A + D +S GV+ +L G ++ I A+ S
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK----ALEQIQDTNDA 361
+ + K + + +P+ R T ++ ++ A + D N
Sbjct: 233 WD------------DISDSAKDFIR--HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
Query: 362 GVSRDESLQNSDRSTYKR 379
++ +N +S +K+
Sbjct: 279 QSVSEQIKKNFAKSKWKQ 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-47
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 39/295 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG VF T A+K L ++ + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 126 KHLG-QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L HP L + ++ V E++ G L H+ + A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYA 109
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
GL +LH ++YRD K NILLD + + K++DFG+ K+ G G
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 165
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
T Y APE + D +SFGV+L EML G+ + I P+
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR- 224
Query: 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359
L K L +K EP+ R + ++ ++ N
Sbjct: 225 ---------------WLEKEAKD--LLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-46
Identities = 47/284 (16%), Positives = 93/284 (32%), Gaps = 34/284 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + + K + + + EI L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
H N++ L + ++++EF+ + + A L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS + + D + NI+ ++ K+ +FG A+ G + +
Sbjct: 113 EALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
Y APE ++ +D++S G ++ +LSG + I A+ +
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ + L E K R T E ++
Sbjct: 228 ------------KEISIEAMD--FVDRLLVKERKSRMTASEALQ 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-45
Identities = 77/341 (22%), Positives = 127/341 (37%), Gaps = 35/341 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEI 125
+ S +GEG +G V + + +A+K+++ Q + + L EI
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
K L + H N++ + + ++ + L++ Q LS
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLY 116
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMG 244
+GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+ P + T +
Sbjct: 117 QILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 245 TYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303
T Y APE M T D++S G +L EMLS R + + N I
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAV-------------LAIKCLSNEPKFRPTMDEVVK 350
+ + SL K L K L+ P R +++ +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
Query: 351 A--LEQIQDTNDAGVSR-----DESLQNSDRSTYKRKGLNE 384
LEQ D +D ++ D L + + K E
Sbjct: 295 HPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 69/292 (23%), Positives = 106/292 (36%), Gaps = 33/292 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLG 129
LGEG F V+K T ++A+K++ + L EIK L
Sbjct: 5 FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
+L HPN++ L+ + LV++FM L+ + L +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQ 111
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
GL YLH +++RD K +N+LLD N KL+DFGLAK GS + T + T Y
Sbjct: 112 GLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167
Query: 250 APE-YMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------EWAK 298
APE D+++ G +L E+L + + + I +W
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
F+ A L P R T + +K
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-45
Identities = 67/308 (21%), Positives = 117/308 (37%), Gaps = 35/308 (11%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL A + + + +GEG +G VFK G +A+KR+ ++ + +
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPL 52
Query: 122 -----LTEIKHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASY 171
+ ++HL HPN+V+L C + LV+E + +
Sbjct: 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-- 110
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + +GL +LHS +V++RD K NIL+ + KL+DFGLA+
Sbjct: 111 -PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR--- 164
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291
S T V+ T Y APE + D++S G + EM + + + +
Sbjct: 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
Query: 292 NLIEWAKPY---------LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFR 342
I + R+ F A+ ++ L +KCL+ P R
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284
Query: 343 PTMDEVVK 350
+ +
Sbjct: 285 ISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 28/295 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K++ ++ + EI
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L HPN+VKL+ ++ LV+EF+ + + F AS + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+GLA+ HS + V++RD K N+L++ KL+DFGLA+ + + V+ +
Sbjct: 111 LLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLW 167
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------EW 296
A + + + D++S G + EM++ R + + + I W
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVVK 350
+ AR + + + L + L +P R + +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 2e-44
Identities = 51/295 (17%), Positives = 92/295 (31%), Gaps = 36/295 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+R +G G FG ++ G G +A+K ++ L E K
Sbjct: 9 YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTKHPQLH--IESKIYK 57
Query: 130 QLYHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ + I +C + D+ ++V E + + F + S + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMI 113
Query: 189 KGLAYLHSDKAKVIYRDFKTSNIL---LDLNYNAKLSDFGLAK-----DGPTGSQSHVST 240
+ Y+HS I+RD K N L + DFGLAK +
Sbjct: 114 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 241 RVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300
+ GT YA+ + + D+ S G VL+ G + + + E
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----- 226
Query: 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
+ + + Y A C S +P + + +
Sbjct: 227 -RISEKKMSTPIEVLCKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-44
Identities = 59/291 (20%), Positives = 105/291 (36%), Gaps = 42/291 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LT 123
+ LG G F V K TG+ A K + + +
Sbjct: 12 YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E+ L ++ HPN++ L +L+ E + G L + L + + L+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEF 118
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLD----LNYNAKLSDFGLAKDGPTGSQSHVS 239
G+ YLHS ++ + D K NI+L K+ DFGLA G++
Sbjct: 119 LKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299
+ GT + APE + L ++D++S GV+ +LSG + +
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
Query: 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ + + A K + L +PK R T+ + ++
Sbjct: 234 EFEDEYFS------------NTSALAKD--FIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 5e-44
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 30/295 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G V+K A+ G A+K++ E + EI
Sbjct: 3 KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+VKL +LV+E + + + L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQ 108
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
G+AY H +V++RD K N+L++ K++DFGLA+ + + ++ +
Sbjct: 109 LLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLW 165
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI----------EW 296
A M + + D++S G + EM++G + + + I W
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVVK 350
K + + + L ++ + L K L +P R T + ++
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-42
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 52/291 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLT 123
++ +LG GGFG V+ G R + +A+K + ++ + E
Sbjct: 6 YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 124 EIKHLGQL--YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E+ L ++ +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 240
+ + + H V++RD K NIL+DLN KL DFG + V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 241 RVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299
GT Y+ PE++ + + V+S G++L +M+ G P I +
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQV 221
Query: 300 YLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ + + + + + L CL+ P RPT +E+
Sbjct: 222 FFRQR----------------VSSECQH--LIRWCLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 2e-42
Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 23/240 (9%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTE 124
++F+ LG G FG V G A+K L +E L+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L + HP ++++ G + ++ +++ LF Q + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L YLHS +IYRD K NILLD N + K++DFG AK P V+ + G
Sbjct: 111 AEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
T Y APE ++T D +SFG+++ EML+G + + + I A+
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 63/300 (21%), Positives = 111/300 (37%), Gaps = 36/300 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ V+G G FG V++ +G ++A+K++ Q+ + E++ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQDKRFKN----RELQIM 67
Query: 129 GQLYHPNLVKLIGYCLEDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+L H N+V+L + + LV +++P+ + Q L
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKL 126
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVSTR 241
+ LAY+HS + +RD K N+LLD + KL DFG AK G + +
Sbjct: 127 YMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 242 VMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI------- 294
+ Y A T+ DV+S G VL E+L G+ + + + I
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 295 ---EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKFRPTMDEVVK 350
+ + F + A + A+ L + L P R T E
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 39/284 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK-HLGQLYH 133
VLG G G V + + T A+K L + E++ H
Sbjct: 19 VLGLGINGKVLQIF---------NKRTQEKFALKMLQDCP-----KARREVELHWRASQC 64
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
P++V+++ L+V E + G L + + R Q + ++ +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ YLHS + +RD K N+L KL+DFG AK+ + + T
Sbjct: 123 AIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRR 306
Y APE + D++S GV++ +L G P ++ + + R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRM 231
Query: 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
+ S + L L EP R T+ E +
Sbjct: 232 GQYEFPNPEWSEVSEEVKM----LIRNLLKTEPTQRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 2e-41
Identities = 45/297 (15%), Positives = 85/297 (28%), Gaps = 36/297 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLR--DEYRTY 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L + + Y ++ ++ + SLE+ L + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQML 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AKLSDFGLAK-----DGPTGSQSHV 238
+ +H ++YRD K N L+ + + DFG+ K
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 239 STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298
+ GT Y + + + D+ + G V + L G + + E
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355
QS E + P D + ++
Sbjct: 230 EKKQS--------TPLRELCAGFPEEFYK--YMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-41
Identities = 67/309 (21%), Positives = 116/309 (37%), Gaps = 42/309 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIK 126
+ + +G+G FG VFK TG +A+K++ E+ + + L EIK
Sbjct: 11 KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 127 HLGQLYHPNLVKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L L H N+V LI C LV++F + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLS 117
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+V GL Y+H +K +++RD K +N+L+ + KL+DFGLA+ S
Sbjct: 118 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 239 S--TRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI- 294
+ T + T Y PE + D++ G ++ EM + ++ N + LI
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 295 ------------EWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV-LAIKCLSNEPKF 341
L K + + +++ + A+ L K L +P
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 342 RPTMDEVVK 350
R D+ +
Sbjct: 296 RIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-40
Identities = 66/336 (19%), Positives = 128/336 (38%), Gaps = 36/336 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+R +G G +G V TG +A+K+L + E++
Sbjct: 20 YRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + H N++ L+ D+ +F + + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ + S ++ V+ +
Sbjct: 131 LKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYVVTRWY 184
Query: 248 YAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI---------EWAK 298
A + T D++S G ++ EM++G+ + + + I E+ +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAI----KCLSNEPKFRPTMDEVVKA--L 352
+ + + +E + + LA+ K L + + R T E +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 353 EQIQDTNDAGVSR--DESLQNSDRS--TYKRKGLNE 384
E + DT D + D+S + DR+ +KR E
Sbjct: 305 ESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKE 340
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-39
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 30/296 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G VFK T ++A+KR+ + L EI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+V+L D LV+EF + + I
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQ 109
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
KGL + H V++RD K N+L++ N KL++FGLA+ + + S V+ +
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLW 166
Query: 247 GYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH---NLIEWAKPYLQS 303
+ D++S G + E+ + R + + P +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 304 KRRIFQVMDARIEGQYSLGAALKTAV---------LAIKCLSNEPKFRPTMDEVVK 350
+ ++ D + Y +L V L L P R + +E ++
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-38
Identities = 66/239 (27%), Positives = 92/239 (38%), Gaps = 20/239 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG V TG A+K L +E + E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L HP L L D V E+ G L HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGA 112
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
L YLHS V+YRD K N++LD + + K++DFGL K+G + + GT
Sbjct: 113 EIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
Y APE + D + GVV+ EM+ GR R LI +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 2e-36
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 23/239 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
F LG G FG V +G A+K L+++ + + L E
Sbjct: 42 QFDRIKTLGTGSFGRVMLVK---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P LVKL ++ + +V E++ G + +HL R S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAA 148
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
YLHS +IYRD K N+L+D +++DFG AK + + GT
Sbjct: 149 QIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 246 YGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304
APE + + D ++ GV++ EM +G ++P + + I K S
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-35
Identities = 54/307 (17%), Positives = 103/307 (33%), Gaps = 49/307 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ LG G + VF+ + VK L + + EIK L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKKK---KIKREIKIL 83
Query: 129 GQL-YHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L PN++ L + R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMY 136
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
K L Y H +++RD K N+++D + +L D+GLA+ G + +
Sbjct: 137 EILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVA 191
Query: 245 TYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGR--------------RVIDKNRPSR 289
+ + PE + D++S G +L M+ + R+
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV------LAIKCLSNEPKFRP 343
++ I+ L + +R + + + + V K L + + R
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
Query: 344 TMDEVVK 350
T E ++
Sbjct: 312 TAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-34
Identities = 73/296 (24%), Positives = 118/296 (39%), Gaps = 34/296 (11%)
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL- 115
+ + + K NF VLG G +G VF + TG + A+K L + ++
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLV------RKISGHDTGKLYAMKVLKKATIV 66
Query: 116 ---QGHLEWLTEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
+ TE + L + P LV L + L+ +++ G L HL +R
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--- 123
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + L +LH K +IYRD K NILLD N + L+DFGL+K+
Sbjct: 124 -ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-F 179
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATGH--LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289
++ + GT Y AP+ + G D +S GV++ E+L+G +
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
Query: 290 EHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTM 345
I ++ L+S+ Q M A + L + L +PK R
Sbjct: 240 SQAEI--SRRILKSEPPYPQEMSALAKD------------LIQRLLMKDPKKRLGC 281
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-32
Identities = 57/299 (19%), Positives = 109/299 (36%), Gaps = 30/299 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTE 124
++ S +G G +G V + TG+ +AVK+L++ S+ E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
++ L + H N++ L+ + L Q L+ +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
+GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+ + ++ V
Sbjct: 128 YQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVAT 181
Query: 245 TYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-------------RVIDKNRPSREH 291
+ A + H D++S G ++ E+L+GR ++
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVK 350
L + + ++ + M +GA L K L + R T + +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-31
Identities = 56/315 (17%), Positives = 109/315 (34%), Gaps = 53/315 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
+ ++ +G G G V + +A+K+L++ E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 126 KHLGQLYHPNLVKLIGYCL------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G+ +LHS +I+RD K SNI++ + K+ DFGLA+ T S +
Sbjct: 121 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 240 TRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR----------------RVID 283
T + T Y APE + D++S G ++ EM+ + +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAV--------LAIKCL 335
P L + Y++++ + + ++ A + L K L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 336 SNEPKFRPTMDEVVK 350
+P R ++D+ ++
Sbjct: 296 VIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 1e-26
Identities = 36/240 (15%), Positives = 79/240 (32%), Gaps = 24/240 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G F V+ +A+K + + + EIK L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQ 64
Query: 130 QLYHPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMK------ 182
++ + K +LL + + + L+ + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQS 236
++ GL Y+H + +I+ D K N+L+++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 237 HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296
T + T Y +PE + +D++S ++ E+++G + + + +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 2e-14
Identities = 21/170 (12%), Positives = 43/170 (25%), Gaps = 38/170 (22%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------QGHLEWLT 123
++GEG VF VK G L +
Sbjct: 6 KLMGEGKESAVFN----------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 124 EIKHLGQLYHPNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
+ L KL G + ++ E + + +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVEN 104
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+V + +A + +++ D N+L+ + DF + +
Sbjct: 105 PDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 400 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.67 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-57 Score=409.75 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=212.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|. +..+|+.||+|++..........+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 579999999999999999995 44478999999998766566677899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|+|||||+||+|.+++.+. ++++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhh
Confidence 999999999999999987653 5899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+ ..
T Consensus 164 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~----- 230 (293)
T d1yhwa1 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------AT----- 230 (293)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH-----
T ss_pred eeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------Hh-----
Confidence 87543322 244568999999999999999999999999999999999999999765431111000 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
........+...+..+.+||.+||+.||++|||+.|+++|=
T Consensus 231 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 231 ----NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp ----HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred ----CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 00111122334567889999999999999999999999873
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=410.94 Aligned_cols=256 Identities=26% Similarity=0.288 Sum_probs=207.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||+||+|.. ..+|+.||+|++...... ....+.+|+.++++++||||+++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 5799999999999999999954 347899999999765432 234588999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchh
Confidence 9999999999999999998654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............ +
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~--------- 219 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W--------- 219 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-H---------
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-H---------
Confidence 987654443334456789999999999988776 57899999999999999999999765432211100 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.............+.++.+|+.+||+.||++|||+.|+++|=+
T Consensus 220 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 220 -----KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp -----HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred -----hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0000001111234567889999999999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=402.47 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=210.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEEC---------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 56999999999999999999543 4789999999875432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..|+|||||++|+|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeeccc
Confidence 9999999999999999999998763 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+........
T Consensus 151 G~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------------ 214 (263)
T d2j4za1 151 GWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------------ 214 (263)
T ss_dssp CSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------
T ss_pred ceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH------------
Confidence 999865432 2345689999999999999999999999999999999999999997654211110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+.. ....++...+.++.+|+.+||+.||++|||+.|+++|=+
T Consensus 215 ----~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 215 ----RISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp ----HHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ----HHHc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 0001 111233445678899999999999999999999998744
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=404.84 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=198.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|.. ..+|+.||+|.+...... ....+.+|+.++++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 5799999999999999999954 447899999999776432 34568899999999999999999999865
Q ss_pred --CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeeccCCCCCEEEcCCCceE
Q 015781 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYNAK 220 (400)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---~~ivH~dlkp~Nill~~~~~~k 220 (400)
++.+|+|||||++|+|.+++.+.......+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 45689999999999999999765444467999999999999999999999853 2499999999999999999999
Q ss_pred EeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|+||+.||........ ..
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~----- 224 (269)
T d2java1 155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG----- 224 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH-----
T ss_pred EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH-----
Confidence 99999998754322 123457899999999999999999999999999999999999999976432111 00
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.+.... ....+...+.++.+|+.+||+.||++|||+.|+++|
T Consensus 225 --------~i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 225 --------KIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------HHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------HHHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 001111 112334456789999999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=398.30 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|.++ ..||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 467999999999999999999643 2499999875432 34567889999999999999999999875
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+ +.+++|||||++|+|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 75 ~-~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 75 A-PQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp S-SSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCC
T ss_pred c-cEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccc
Confidence 4 56899999999999999997654 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|+++...............||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.......... .
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~ 222 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------V 222 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------H
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------H
Confidence 99987654444334556789999999999864 35889999999999999999999999865432211100 0
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
... ...+ .....+..++..+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus 223 ~~~-----~~~p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 223 GRG-----YLSP-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHT-----SCCC-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcC-----CCCC-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 000 0000 01122334567889999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=404.53 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=210.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+.|++.+.||+|+||+||+|... .++..||+|++..........+.+|+++|++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK---------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC---------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 46899999999999999999554 478999999998766666677889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|+|||||++|+|.+++.+.. .++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999999987654 46999999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhc-----cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
...... ........||+.|+|||++. +..|+.++|||||||++|+|+||+.||.+..+......+. .
T Consensus 158 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~------~ 229 (288)
T d2jfla1 158 AKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------K 229 (288)
T ss_dssp EECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH------H
T ss_pred hccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH------c
Confidence 753221 11233568999999999984 4568999999999999999999999997765422111110 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
. .......+...+.++.+|+.+||+.||++|||+.|+++|=
T Consensus 230 ~---------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 230 S---------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp S---------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred C---------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0 0001112234567889999999999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=405.12 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=207.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|.. ..+|+.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 5799999999999999999954 34789999999976432 23356889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccc
Confidence 9999999999999999999988764 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+........
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------------ 220 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------------ 220 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------------
Confidence 99987654443334455789999999999999999999999999999999999999997653211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.+... ...++...+.++.+||.+||+.||.+|||++|++.+-+
T Consensus 221 ----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 221 ----KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ----HHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ----HHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 01111 11233345678899999999999999999999876543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-56 Score=402.37 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=215.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|.+.. +++.||||++.... ....++.+|+.+|++++||||+++++++.+++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 578889999999999999996643 68899999997654 34567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..|+|||||++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccce
Confidence 99999999999999999976543 57899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+....... .......|++.|+|||++.+..|+.++|||||||++|||++|..||....... .+
T Consensus 163 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----------------~~ 225 (287)
T d1opja_ 163 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QV 225 (287)
T ss_dssp TTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HH
T ss_pred eecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----------------HH
Confidence 87544322 22334568899999999999999999999999999999999776654322211 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
...+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 226 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111122223334445677899999999999999999999999999887543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=395.84 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=202.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|.+. ++..||||++..... ...++.+|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57889999999999999999764 356799999986543 4567899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999987654 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhC-CCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||....... ...
T Consensus 149 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~----------- 213 (263)
T d1sm2a_ 149 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE----------- 213 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH-----------
T ss_pred eeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH-----------
Confidence 865443222 23345789999999999999999999999999999999995 55554432111 110
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.+........+..++..+.+|+.+||+.||++|||+.+|+++|+++.+.
T Consensus 214 ---~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 214 ---DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0011111222334567889999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=394.04 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=200.0
Q ss_pred CCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe--
Q 015781 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (400)
Q Consensus 70 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-- 145 (400)
|++.+.||+|+||+||+|... .++..||+|.+..... .....+.+|+++|++++||||+++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 467788999999999999554 4688999999876543 234568899999999999999999999875
Q ss_pred --CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc-CCCceEEe
Q 015781 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLS 222 (400)
Q Consensus 146 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~-~~~~~kl~ 222 (400)
+..+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++.+|+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 35689999999999999999876 358999999999999999999999877799999999999996 57899999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||......... .. ..
T Consensus 158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~----~i- 225 (270)
T d1t4ha_ 158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----RV- 225 (270)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----HH-
T ss_pred ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HH----HH-
Confidence 99999864332 2345789999999999865 6999999999999999999999999754321110 00 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
........++...+.++.+|+.+||+.||++|||+.|+|+|
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 --------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00000011112234568899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-55 Score=398.39 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.++||+|+||+||+|.+... ......||||.+...... ....+.+|+.+|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 5688889999999999999976531 123457899998765433 345689999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCccc
Confidence 99999999999999999887654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcce---eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 227 AKDGPTGSQSHV---STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 227 ~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+...... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~-------- 243 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---I-------- 243 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---H--------
Confidence 986543322111 122457899999999999999999999999999999998 8999976543211 1
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 244 ------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 244 ------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111112223445677899999999999999999999999999987553
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=408.30 Aligned_cols=266 Identities=27% Similarity=0.380 Sum_probs=206.9
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|... .+|+.||+|++..... .....+.+|+.+|+.++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET---------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 367999999999999999999543 4789999999976533 234568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
++.+|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeC
Confidence 999999999999999999998764 58999999999999999999997 57 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh-hh-----
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW-AK----- 298 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-~~----- 298 (400)
|+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. ..
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 999854221 23456899999999999999999999999999999999999999976543211100000 00
Q ss_pred -------------HHH---hhhhhhhhh----ccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 299 -------------PYL---QSKRRIFQV----MDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 299 -------------~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ......... .............+.++.+|+.+||+.||++|||+.|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 000000000 00000001111235678899999999999999999999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-55 Score=401.90 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=193.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.+.|++.+.||+|+||+||+|... .+++.||+|++....... ...+.+|+.+|++++||||+++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK---------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET---------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 356999999999999999999543 478999999997654332 3457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---CCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~ 222 (400)
++.+|+|||||+||+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||++. .++.+||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEe
Confidence 99999999999999999999765 46999999999999999999999998 99999999999994 57899999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHh
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+ ..
T Consensus 153 DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~ 223 (307)
T d1a06a_ 153 DFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------LK 223 (307)
T ss_dssp CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HT
T ss_pred ccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------hc
Confidence 999998654322 234568999999999999999999999999999999999999999764321110000 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
. ............+.++.+|+.+||+.||++|||+.|+++|-
T Consensus 224 ~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 265 (307)
T d1a06a_ 224 A--------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265 (307)
T ss_dssp T--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred c--------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 0 01111122234567889999999999999999999999973
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=385.73 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=213.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|.++ ++..||||+++.... ...++.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 68999999999999999999764 367899999987654 3467899999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999999987655 46899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRR 306 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 306 (400)
+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.........
T Consensus 148 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~------------- 213 (258)
T d1k2pa_ 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------------- 213 (258)
T ss_dssp CBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------------
T ss_pred eeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-------------
Confidence 865443222 2334678999999999999999999999999999999998 8999976543211100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 307 IFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
+........+...+..+.+|+.+||+.||++|||+.+|+++|.++
T Consensus 214 ----i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 ----IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----HHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111112223344567889999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-55 Score=406.79 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=211.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|... .+|..||+|++..........+.+|+.+|++++||||+++++++.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~---------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTER---------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 58999999999999999999543 478999999998776666677889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc--CCCceEEeecc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDFG 225 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg 225 (400)
.+|||||||+||+|.+++.... .++++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecc
Confidence 9999999999999999996543 46899999999999999999999998 99999999999995 46889999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+ ....
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~- 241 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCD- 241 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTC-
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-
Confidence 998754432 344578999999999999999999999999999999999999999765432111111 0000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
...........+..+.+||.+||+.||++|||+.|+|+|
T Consensus 242 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 -------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111112345678899999999999999999999997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.4e-55 Score=407.00 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=212.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|.. ..+|+.||+|++..........+.+|+.+|++++||||+++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVE---------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5799999999999999999954 4478999999998776566667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc--CCCceEEeecc
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDFG 225 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg 225 (400)
.+|||||||+||+|.+++.... .++++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecc
Confidence 9999999999999998876543 46999999999999999999999998 99999999999997 67899999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++....... ......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.........+.
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~---------- 241 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---------- 241 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----------
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 998765432 3455689999999999999999999999999999999999999997654321110000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
. .............+.++.+||.+||+.||.+|||+.|+|+|
T Consensus 242 ---~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 ---R-CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---H-CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---h-CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111122233456788999999999999999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=402.48 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=213.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.++||+|+||+||+|.+... ........||+|.+..... .....+.+|+.++.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 36799999999999999999987542 1223456799999865432 3345688999999988 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS-------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~d 205 (400)
+.+.+|+|||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 99999999999999999999976432 1235899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCC
Q 015781 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDK 284 (400)
Q Consensus 206 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~ 284 (400)
|||+||+++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986555444434455678999999999999999999999999999999998 8999986
Q ss_pred CCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 285 NRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
....... ...+........+...+..+.+|+.+||+.||++|||+.+|+++|.
T Consensus 270 ~~~~~~~----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDANF----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHH----------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 5432211 1111111222334456678999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=396.99 Aligned_cols=250 Identities=27% Similarity=0.362 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
+.|+..+.||+|+||+||+|... .+++.||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC---------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 35899999999999999999543 47899999999765432 2346889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++..|+|||||.+|+|..++... .++++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeec
Confidence 999999999999999997766554 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhcc---CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHH
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYL 301 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 301 (400)
|++..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.......
T Consensus 160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---------- 223 (309)
T d1u5ra_ 160 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------- 223 (309)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----------
T ss_pred ccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH----------
Confidence 99986433 234579999999999864 45899999999999999999999999764321110
Q ss_pred hhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 302 QSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+.........+...+..+.+|+.+||+.||.+|||+.++|+|-+-
T Consensus 224 ------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 224 ------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp ------HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ------HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 01111111111223446788999999999999999999999987443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=389.25 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=209.8
Q ss_pred cCCCCCCc-cccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSV-LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|.+.+. ||+|+||+||+|.+.. ..++..||||++...... ....+.+|+++|++++||||+++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEec-------CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666674 9999999999997643 224678999999765433 34678899999999999999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccch
Confidence 46899999999999999986543 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---------- 224 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------- 224 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----------
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 99875543322 12234568999999999999999999999999999999998 8999986543211111
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 225 -------i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 225 -------IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111123344566789999999999999999999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=389.05 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=207.6
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||+||+|.++ ++..||||++.... .....+.+|+.++++++||||+++++++.+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 367899999999999999999764 36789999997654 345678999999999999999999998765
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..|+||||+++|+|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccc
Confidence 567999999999999998765443 45899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCc-cCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRV-IDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++....... .......||+.|+|||++.+..++.++|||||||++|||+||..| |...... ....
T Consensus 156 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~---------- 221 (272)
T d1qpca_ 156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ---------- 221 (272)
T ss_dssp CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----------
T ss_pred eEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHH----------
Confidence 987654322 223345789999999999989999999999999999999996555 4433211 1110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
.+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 222 ----~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 222 ----NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 01111122233455678899999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=387.58 Aligned_cols=265 Identities=23% Similarity=0.395 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
..|++.++||+|+||+||+|.+... .......||||++...... ....+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4688889999999999999987642 2223467999999765433 344688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999887654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++........ .......||+.|+|||++.++.++.++|||||||++|||++|..||...... ...
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~------------ 222 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV------------ 222 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH------------
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHH------------
Confidence 9865433221 1223456899999999999999999999999999999999976655432211 011
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
...+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 223 --~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 223 --MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111112222334445667899999999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=392.98 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCCCCcccceee
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~hpniv~~~~ 141 (400)
++|++.+.||+|+||+||+|... .+|+.||+|++...... ....+.+|+.+|++++||||+++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 57999999999999999999543 47899999998754332 2457889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC----
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---- 217 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~---- 217 (400)
++.+.+.+|||||||+||+|.+++.... ++++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSC
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCccc
Confidence 9999999999999999999999998763 6899999999999999999999998 99999999999998776
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--- 228 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--- 228 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH---
Confidence 59999999998754432 234567899999999999999999999999999999999999999765432111100
Q ss_pred hHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 298 KPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
.... ...........+..+.+||++||+.||.+|||+.++++|=
T Consensus 229 ---~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 229 ---SAVN--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp ---HTTC--------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ---HhcC--------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0000 0000000112356788999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=385.41 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=201.6
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEeCCeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 151 (400)
+.||+|+||+||+|.+.. ..+++.||||++..... .....+.+|+.+|++++||||+++++++.+ +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 469999999999997643 23578899999975432 234568899999999999999999999865 46789
Q ss_pred EEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccCC
Q 015781 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (400)
Q Consensus 152 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 231 (400)
||||+++|+|.+++... .++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 vmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999765 46899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCc-ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhhhhhh
Q 015781 232 TGSQS-HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKRRIFQ 309 (400)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (400)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...... . .
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~--------------~ 221 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---T--------------A 221 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------H
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---H--------------H
Confidence 43322 12234578999999999999999999999999999999998 8999986542111 1 1
Q ss_pred hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 310 VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 310 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
.+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 222 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1111112233445667899999999999999999999999888764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=395.85 Aligned_cols=249 Identities=29% Similarity=0.374 Sum_probs=210.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|+. ..+|+.||+|++..... .....+.+|+.+|++++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 5799999999999999999954 44789999999976532 23456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeec
Confidence 9999999999999999999998764 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........
T Consensus 150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----------- 216 (337)
T d1o6la_ 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------
T ss_pred ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH-----------
Confidence 9998654322 234557899999999999999999999999999999999999999987543211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~ 351 (400)
+... ...++...+.++.+||.+||+.||.+||+ +.++++|
T Consensus 217 -----i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 -----ILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HhcC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 0011 11234455678899999999999999995 8999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=389.58 Aligned_cols=271 Identities=27% Similarity=0.356 Sum_probs=207.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|.+... .+..+++.||+|++...... ....+.+|...+.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 46799999999999999999987542 34457889999999764433 344577788877776 6899999999876
Q ss_pred eC-CeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 145 ED-DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 145 ~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
+. ..+++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NI 165 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 165 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccce
Confidence 54 568999999999999999976432 1245899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhC-CCccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSG-RRVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg-~~pf~~~~~~~~ 290 (400)
||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|| .+||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999865544443344556899999999999999999999999999999999987 467765443211
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
. . ..+........+...+.++.+|+.+||+.||++|||+.+|+++|+.+.+.+
T Consensus 246 ~--~--------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 246 F--C--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp H--H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H--H--------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 1 0 011111122233445668899999999999999999999999999886654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=382.36 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
++|++.+.||+|+||.||+|.+.. ....+..||+|.+...... ....+.+|+.++++++||||+++++++. +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 579999999999999999997653 2335678999998754433 3456889999999999999999999986 4
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+|+||||+.+|+|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchh
Confidence 67899999999999999887654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++....... .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...........+.
T Consensus 155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~---------- 223 (273)
T d1mp8a_ 155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---------- 223 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----------
T ss_pred heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH----------
Confidence 986543222 23344678999999999999999999999999999999998 899998765432111110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
.......+..++..+.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 224 -------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 224 -------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111123445667899999999999999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-53 Score=388.55 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=207.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|.. ..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 5699999999999999999954 34789999999975432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+++.+|+|||||.||+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecC
Confidence 9999999999999999999988764 5788999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------------- 210 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------------- 210 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-------------
Confidence 999875432 33468999999999999999999999999999999999999999765321110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
..+... ...++...+.++.+++.+||+.||.+|+ |+.++++|
T Consensus 211 ---~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 211 ---EKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHcC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 011111 1123344567788999999999999996 99999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=388.56 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=207.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-chhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.+|++.++||+|+||+||+|.+.. ........||+|.+.... ......+.+|+.++++++||||+++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIP-----EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcC-----CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 469999999999999999997654 122234579999886543 23456789999999999999999999999875
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
..+++||++.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred -CeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccc
Confidence 5678889999999999887754 57899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++...............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+.........
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~------------ 225 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI------------ 225 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH------------
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH------------
Confidence 987655444434445678999999999999999999999999999999998 7889876543221111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
+........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 226 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 226 -----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11111122334556788999999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=387.25 Aligned_cols=250 Identities=19% Similarity=0.231 Sum_probs=208.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeC
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 146 (400)
.++|++.+.||+|+||+||+|.. ..+++.||+|++..... ....+.+|+.+|+.++||||+++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~---------~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 46899999999999999999954 44789999999987643 344678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC--CCceEEeec
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSDF 224 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~--~~~~kl~Df 224 (400)
+.+|||||||+|++|.+++.... .++++..++.++.||+.||+|||++| |+||||||+|||++. ...+||+||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEccc
Confidence 99999999999999999997654 46899999999999999999999998 999999999999975 458999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|++....... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...........
T Consensus 149 G~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----------- 214 (321)
T d1tkia_ 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----------- 214 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------
T ss_pred chhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence 9998754432 34456899999999999999999999999999999999999999976543211111
Q ss_pred hhhhhhccccccCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSL----GAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
+.... ..++. ..+.++.+|+.+||+.||++|||+.|+++|=
T Consensus 215 -----i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 215 -----IMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -----HHHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -----HHhCC--CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 11100 01111 2356788999999999999999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-52 Score=380.95 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHHHHHHHHHHccCCCCcccceeeEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~ 143 (400)
.++|++.+.||+|+||+||+|.. ..+|+.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARD---------LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 36799999999999999999954 347899999999765432 234688999999999999999999999
Q ss_pred EeCC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 144 LEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 144 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.+.+ .+|+||||++|++|.+++.... ++++..++.++.||+.||+|||++| |+||||||+||+++.++.+
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccc
Confidence 8654 4799999999999999987763 6899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCC-CcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGS-QSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
+|+|||.+....... ........+||+.|+|||++.+..++.++|||||||++|+|+||++||.+..+.....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------ 224 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------ 224 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------
Confidence 999999887543322 2223445689999999999999999999999999999999999999997654321100
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHhch
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-TMDEVVKALEQIQ 356 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~eil~~L~~~~ 356 (400)
...... ...........+.++.++|.+||+.||.+|| |+.++++.|.+++
T Consensus 225 ~~~~~~--------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 225 QHVRED--------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHCC--------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcC--------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000000 0001111223456888999999999999999 8999999998875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-52 Score=391.72 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=204.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---hHHH---HHHHHHHHccCCCCcccceee
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLE---WLTEIKHLGQLYHPNLVKLIG 141 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~---~~~e~~~l~~l~hpniv~~~~ 141 (400)
++|++.++||+|+||.||+|.. ..+|+.||+|++...... .... ...++.+++.++||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 5799999999999999999954 447899999998654321 1122 234578888889999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 142 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
++.+.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEE
Confidence 9999999999999999999999998763 5889999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
+|||+++...... .....||+.|+|||++.. ..|+.++|||||||++|+|+||+.||..........+..
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----- 219 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----- 219 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 9999998654332 344679999999999964 568999999999999999999999998754432211111
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPT-----MDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~eil~~ 351 (400)
... ......+...+.++.+||.+||+.||.+||| +.++++|
T Consensus 220 --------~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 --------MTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------HSS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------hcc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000 1111223345678899999999999999999 7999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=378.77 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|++.+.||+|+||+||+|+++. +..||||++.... .....+.+|+.++++++||||+++++++.+ +
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 579999999999999999997653 4569999997654 345678999999999999999999999865 5
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence 67999999999999999876543 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhh
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRI 307 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (400)
+....... .......||+.|+|||++..+.++.++|||||||++|||++|..||...... ....
T Consensus 161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~------------- 224 (285)
T d1fmka3 161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL------------- 224 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH-------------
T ss_pred hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH-------------
Confidence 86543322 2234467899999999999999999999999999999999976555332211 0001
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 308 FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+-...
T Consensus 225 -~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 -DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -HHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111111222344456678999999999999999999999999998865443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=385.41 Aligned_cols=268 Identities=26% Similarity=0.347 Sum_probs=215.9
Q ss_pred HhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-HHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
..++|++.+.||+|+||+||+|.+... .+..++..||||++....... ..++.+|+.+|++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 346799999999999999999987531 234467899999997654433 456899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS--------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 204 (400)
+.+..++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 99999999999999999999975321 1235889999999999999999999988 9999
Q ss_pred cCCCCCEEEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCC-CccC
Q 015781 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVID 283 (400)
Q Consensus 205 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~-~pf~ 283 (400)
||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999997554433333344567899999999999999999999999999999999995 5776
Q ss_pred CCCCCccchhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhch
Q 015781 284 KNRPSREHNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQ 356 (400)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~ 356 (400)
...+...... +.+. .....+..++.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 245 ~~~~~e~~~~----------------v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYY----------------VRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHH----------------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHH----------------HHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5433211110 0111 111233445668899999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-52 Score=390.08 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=208.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||.||+|.. ..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~---------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 5799999999999999999954 34789999999875432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+....++||||+.+|+|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeec
Confidence 9999999999999999999998764 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 225 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
|+++..... .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+........
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------------ 248 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------------ 248 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH------------
Confidence 999875432 334689999999999999999999999999999999999999997653211110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 305 RRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
.+... ....+...+.++.+||.+||+.||.+|+ |+.++++|
T Consensus 249 ----~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 249 ----KIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----HHHHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----HHhcC--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 01111 1122334567889999999999999994 99999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=375.70 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe-C
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-D 146 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~ 146 (400)
++|++.+.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56888999999999999999763 5679999997653 34578899999999999999999999854 4
Q ss_pred CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccC
Q 015781 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (400)
Q Consensus 147 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 226 (400)
+.+|+||||+++|+|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccc
Confidence 668999999999999999976542 35899999999999999999999988 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHhhhh
Q 015781 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQSKR 305 (400)
Q Consensus 227 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 305 (400)
++..... .....+++.|+|||++.+..++.++|||||||++|||+| |++||........ ..+
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~--------- 212 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR--------- 212 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH---------
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHH---------
Confidence 9864332 233467899999999999999999999999999999998 6888866433211 111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 306 RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
+........+...+..+.+|+.+||+.||.+|||+.+++++|+.++.-
T Consensus 213 -----i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 -----VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111122334445567889999999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-52 Score=376.42 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch---------hHHHHHHHHHHHccCC-CCccc
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------GHLEWLTEIKHLGQLY-HPNLV 137 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-hpniv 137 (400)
++|++.+.||+|+||+||+|+.. .+|+.||||++...... ....+.+|+.++++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEEC---------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 68999999999999999999543 47899999998765321 1234778999999997 99999
Q ss_pred ceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 138 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
++++++.+++..|||||||++|+|.+++.... ++++..++.++.||+.||+|||++| |+||||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM 147 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTC
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCC
Confidence 99999999999999999999999999998764 6899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhcc------CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccc
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH 291 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~ 291 (400)
.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+..+....
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~ 224 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence 99999999998755432 2344689999999999853 35788999999999999999999999865431111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
..+ ... ............+.++.+|+.+||+.||++|||+.|+++|
T Consensus 225 ~~i------~~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMI------MSG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHH------HHT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHH------HhC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 100 000 0011111223466789999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=377.42 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
++|++.+.||+|+||+||+|.+.. ..+....||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 579999999999999999998753 223455799999876432 23456889999999999999999999997
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeec
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Df 224 (400)
+ ...++||||+++++|.+++.... .++++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred e-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccc
Confidence 6 46789999999999999887765 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCccCCCCCCcce-eeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccchhHHhhhHHHh
Q 015781 225 GLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREHNLIEWAKPYLQ 302 (400)
Q Consensus 225 g~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 302 (400)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||.+.......
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----------- 224 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----------- 224 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-----------
Confidence 99997654433222 233567889999999999999999999999999999998 89999765432111
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhc
Q 015781 303 SKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQI 355 (400)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~ 355 (400)
..+.........+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 225 -----~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 225 -----HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111112223344567899999999999999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=381.11 Aligned_cols=269 Identities=27% Similarity=0.366 Sum_probs=220.7
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~~ 145 (400)
++|++.++||+|+||.||+|.+... .+..++..||||++...... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 6788999999999999999987532 34457899999999865433 345688999999998 69999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRAS--------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
....++|||||++|+|.+++..... ....+++..+..++.||+.||+|||+++ ++||||||+||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NI 176 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccc
Confidence 9999999999999999999976432 2236899999999999999999999998 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~ 290 (400)
+++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987665554444556789999999999999999999999999999999999 5666655443211
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhc
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDT 358 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~ 358 (400)
+..++........+...+..+.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 257 ----------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 ----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1111222222333444567899999999999999999999999999876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=384.71 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc---hhHHHHHHHHHHHc-cCCCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLG-QLYHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~-~l~hpniv~~~~~~ 143 (400)
++|++.+.||+|+||+||+|.. ..+++.||||++..... .....+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~---------~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEF---------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEE---------CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 5799999999999999999954 45799999999975432 22344566666654 68999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEee
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~D 223 (400)
.+++.+||||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccc
Confidence 99999999999999999999998764 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhh
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQS 303 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 303 (400)
||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..+......+
T Consensus 147 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------- 215 (320)
T d1xjda_ 147 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------- 215 (320)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------
T ss_pred cchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence 999986543322 344568999999999999999999999999999999999999999765432111100
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHH
Q 015781 304 KRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMD-EVVKA 351 (400)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~ 351 (400)
... ...++...+.++.+||.+||+.||.+|||+. ++++|
T Consensus 216 -------~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 216 -------RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -------HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -------HcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 000 1123334567889999999999999999996 78764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=378.40 Aligned_cols=270 Identities=26% Similarity=0.368 Sum_probs=213.3
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccC-CCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||.||+|+...... ....++..||||++...... ...++.+|+..+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCc--ccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3679999999999999999998654210 12234678999999776543 345678898888888 7999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 145 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
+++..++||||+.+|+|.++|..... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccccee
Confidence 99999999999999999999976542 1245899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHh-CCCccCCCCCCccc
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLS-GRRVIDKNRPSREH 291 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t-g~~pf~~~~~~~~~ 291 (400)
++.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |.+||........
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~- 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-
Confidence 99999999999999986554444334455678999999999999999999999999999999998 6888875443111
Q ss_pred hhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 292 NLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
...+........+...+..+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 247 ----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 ----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11111122223344556789999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=385.16 Aligned_cols=255 Identities=23% Similarity=0.250 Sum_probs=201.7
Q ss_pred hcCCCCC-CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHcc-CCCCcccceeeEEE
Q 015781 67 TRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ-LYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~hpniv~~~~~~~ 144 (400)
.++|.+. ++||+|+||+||+|.. ..+++.||||++... ..+.+|+.++.+ ++||||++++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEE---------CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3578876 4699999999999954 347899999998643 356688888655 48999999999987
Q ss_pred e----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC---CC
Q 015781 145 E----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NY 217 (400)
Q Consensus 145 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~---~~ 217 (400)
+ +..+|+|||||+||+|.++|..... .++++..++.++.||+.||+|||++| |+||||||+|||++. ++
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccc
Confidence 6 4678999999999999999986543 56999999999999999999999998 999999999999975 56
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.........+.
T Consensus 152 ~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-- 226 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 226 (335)
T ss_dssp CEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred cccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--
Confidence 79999999998654433 2345689999999999999999999999999999999999999997665432211110
Q ss_pred hHHHhhhhhhhhhccccccC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHh
Q 015781 298 KPYLQSKRRIFQVMDARIEG--QYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQ 354 (400)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~ 354 (400)
..+....... ......+.++.+||.+||+.||++|||+.++++|=+-
T Consensus 227 ----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 227 ----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred ----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 0000000000 1112456789999999999999999999999997443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=376.33 Aligned_cols=261 Identities=27% Similarity=0.413 Sum_probs=207.9
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCc--EEEEEEeccccc-hhHHHHHHHHHHHccC-CCCcccceeeEE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM--VIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~~~~~~ 143 (400)
++|++.++||+|+||+||+|.+.. ++. .||||.+..... .....+.+|+++|+++ +||||+++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578899999999999999997653 344 577888754322 2345688999999998 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCE
Q 015781 144 LEDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Ni 211 (400)
.+++.+++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence 99999999999999999999997541 23357899999999999999999999988 99999999999
Q ss_pred EEcCCCceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCC-CccCCCCCCcc
Q 015781 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSRE 290 (400)
Q Consensus 212 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~ 290 (400)
|++.++.+||+|||+++...... ......||..|+|||.+.+..|+.++|||||||++|||++|. +||........
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999997543322 123456899999999999999999999999999999999975 56755432110
Q ss_pred chhHHhhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 291 HNLIEWAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
. ..+........+...+..+.+||.+||+.||++|||+.+|+++|+++.+..
T Consensus 236 ---~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 ---Y--------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---H--------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---H--------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 111111122334456678999999999999999999999999999987643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=380.26 Aligned_cols=263 Identities=25% Similarity=0.242 Sum_probs=195.6
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh-----HHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
+++||+|+||+||+|. +..+|+.||||++....... ...+.+|+.++++++||||+++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEE---------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 4689999999999994 44578999999987654322 235789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCC
Q 015781 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (400)
Q Consensus 148 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 227 (400)
.+|+||||+.++++..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccc
Confidence 999999999887666554332 46888999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH-----H
Q 015781 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY-----L 301 (400)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----~ 301 (400)
+....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+..+.+....+.-.... .
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 86544322 2334679999999999864 46799999999999999999999999776543222111100000 0
Q ss_pred hhhhhhhhhccccccCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 302 QSKRRIFQVMDARIEGQYS-----LGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
..................+ ...+..+.+|+.+||+.||++|||+.|+|+|=
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 0000000000000000011 12356789999999999999999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=370.67 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=205.6
Q ss_pred CCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccc-cchhHHHHHHHHHHHccCCCCcccceeeEEEe-CCeeE
Q 015781 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-DDHRL 150 (400)
Q Consensus 73 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~ 150 (400)
.++||+|+||+||+|.+.. ..++...||||+++.. ......++.+|+++|++++||||+++++++.+ +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEEC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 5789999999999998753 2224567999999754 33345679999999999999999999999876 46889
Q ss_pred EEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeeccCCccC
Q 015781 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (400)
Q Consensus 151 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 230 (400)
+|||||++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999999987654 46788899999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCc--ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhhhhhh
Q 015781 231 PTGSQS--HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSKRRIF 308 (400)
Q Consensus 231 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (400)
...... .......||+.|+|||.+.+..++.++||||||+++|||+||..||........ ...+. . .
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i---~-~----- 249 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---L-Q----- 249 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-T-----
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH---H-c-----
Confidence 443221 122335789999999999999999999999999999999998887754332111 11110 0 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcC
Q 015781 309 QVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTN 359 (400)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~ 359 (400)
......+...+..+.+|+.+||+.||++|||+.||+++|+.+....
T Consensus 250 -----g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 250 -----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 0111223345668899999999999999999999999999997653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=374.11 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... .+|+.||+|++...... ....+.+|+++|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 57999999999999999999543 47899999999765432 24578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
.+.+|+||||+.+ .+.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCC
Confidence 9999999999955 55555544332 56999999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCC-CCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHHHhhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPYLQSK 304 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 304 (400)
+++...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+.-.. .....
T Consensus 148 ~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~-~~~~~ 224 (298)
T d1gz8a_ 148 LARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL-GTPDE 224 (298)
T ss_dssp HHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCT
T ss_pred cceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc-CCCch
Confidence 997644322 1234457999999999887655 4789999999999999999999997654322111100000 00000
Q ss_pred hh---hhhhccc--cccC--C-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 305 RR---IFQVMDA--RIEG--Q-----YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 305 ~~---~~~~~~~--~~~~--~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.. .....+. .... . .....+.++.+|+.+||+.||++|||+.|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000000 0000 0 011335678899999999999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=371.17 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=198.4
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------hHHHHHHHHHHHccCC--CCcccce
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNLVKL 139 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--hpniv~~ 139 (400)
++|++.++||+|+||+||+|... .+|+.||||++...... ...++.+|+.++++++ ||||+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 57999999999999999999543 47899999998754322 1223568999999886 8999999
Q ss_pred eeEEEeCCeeEEEEeecCC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-CC
Q 015781 140 IGYCLEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NY 217 (400)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-~~ 217 (400)
++++.+.+..|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTT
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCC
Confidence 9999999999999999976 5788888765 35899999999999999999999998 999999999999985 47
Q ss_pred ceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCC-CCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHL-TAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------- 215 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------- 215 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------
Confidence 9999999999864432 2345689999999999987765 5678999999999999999999964210
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... ...++...+.++.+|+.+||+.||++|||+.|+++|
T Consensus 216 ---i~~~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ---IIRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HHHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---Hhhc------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 011222345688999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=371.21 Aligned_cols=268 Identities=23% Similarity=0.370 Sum_probs=214.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc-hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|.++.. .+..++..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 36789999999999999999977431 1223467899999976533 334468899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRA------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
++..++||||+.+|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceE
Confidence 999999999999999999986532 12245789999999999999999999988 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCC-CccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGR-RVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~ 298 (400)
||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||.+.......
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------- 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------- 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence 999999998654433333344457899999999999999999999999999999999985 677654321110
Q ss_pred HHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 299 PYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
..+.+. .....+..++..+.+|+.+||+.||++|||+.+|+++|++..+
T Consensus 246 ---------~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ---------RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---------HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------HHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 011111 1122234456789999999999999999999999999988644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=368.85 Aligned_cols=276 Identities=25% Similarity=0.290 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEeCC
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 147 (400)
++|.+.+.||+|+||.||+|.+ +|..||||++...... ......|+..+.+++||||+++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 5688889999999999999965 3678999999755322 222334666667789999999999998654
Q ss_pred ----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeeccCCCCCEEEcCCC
Q 015781 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 148 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~~ivH~dlkp~Nill~~~~ 217 (400)
.+|+||||+++|+|.+++.+. ++++..++.++.|++.||+|||+. ..+|+||||||+||||+.++
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 679999999999999999764 489999999999999999999973 12399999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc--ceeeecccccCcccchhhccCC------CCCccchhhHHHHHHHHHhCCCccCCCCCCc
Q 015781 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGH------LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSR 289 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDiwslG~il~~l~tg~~pf~~~~~~~ 289 (400)
.+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 9999999999865433221 1234568999999999987543 5678999999999999999998886544322
Q ss_pred cchhH--H--hhhHHHhhhhhhhhhccccccCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 290 EHNLI--E--WAKPYLQSKRRIFQVMDARIEGQ-YSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 290 ~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
..... . ........ ........+.+... .+......+.+|+.+||+.||++|||+.||++.|+++.+..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred cchhhcccccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 11100 0 00000000 00000111111111 1234566789999999999999999999999999999876554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=369.66 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=198.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchh--HHHHHHHHHHHccC---CCCcccceee
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQL---YHPNLVKLIG 141 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~hpniv~~~~ 141 (400)
.++|++.+.||+|+||+||+|.... .+++.||||++....... ...+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 4789999999999999999996532 136789999986543221 22345666665554 7999999999
Q ss_pred EEEe-----CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCC
Q 015781 142 YCLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (400)
Q Consensus 142 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~ 216 (400)
++.. ....+++|||+.++.+........ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC
Confidence 9853 357899999998776654443332 56899999999999999999999998 9999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh
Q 015781 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW 296 (400)
Q Consensus 217 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 296 (400)
+.+||+|||++...... .......||+.|+|||++.+..|+.++|||||||++|+|++|++||.+..+......+..
T Consensus 153 ~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99999999998754322 234557899999999999999999999999999999999999999987654322211111
Q ss_pred hhHHHhhhhhh----------hhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 297 AKPYLQSKRRI----------FQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 297 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
.... .....+ ...........+....+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCC-CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhCC-CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000 00000000111223345678899999999999999999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-49 Score=363.37 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=200.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|... +|+.||||++...... ....+.+|+.+|++++||||+++++++.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999999653 4789999999765432 24578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
++..+++||++.++.+..+.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999776666555433 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH----
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY---- 300 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---- 300 (400)
.+........ ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 9976433221 23345789999999998654 5689999999999999999999999765432211111000000
Q ss_pred -Hhhhhhhhh------hccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 301 -LQSKRRIFQ------VMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 301 -~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
......... ..............+..+.+|+.+||+.||++|||+.|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000000111223345678899999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=367.21 Aligned_cols=272 Identities=24% Similarity=0.321 Sum_probs=199.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|... .+|+.||||++..... .....+.+|+.+|+.++||||++++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET---------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 468999999999999999999543 4789999999976433 23456789999999999999999999997
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCc
Q 015781 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (400)
Q Consensus 145 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~ 218 (400)
..+ .+|+||||+ +.+|..++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccc
Confidence 654 579999999 7788877754 35899999999999999999999998 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhh
Q 015781 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWA 297 (400)
Q Consensus 219 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~ 297 (400)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.............
T Consensus 160 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 999999999865432 344679999999999876 45689999999999999999999999876432221111100
Q ss_pred hH-----HHhh-----hhhhhhhc---cccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchhcCC
Q 015781 298 KP-----YLQS-----KRRIFQVM---DARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQDTND 360 (400)
Q Consensus 298 ~~-----~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~~~~ 360 (400)
.. .... ........ ............+..+.+||.+||..||.+|||+.|+|+| ++.+.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 00 0000 00000000 0000011122345678899999999999999999999998 655554433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=367.64 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=199.1
Q ss_pred CCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcccceeeEEEe---
Q 015781 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--- 145 (400)
Q Consensus 69 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--- 145 (400)
+|+..++||+|+||+||+|... .+|+.||||++...... ..+|+.+|++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEEC---------CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 5888899999999999999554 47899999999765422 2379999999999999999999854
Q ss_pred ---CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEE
Q 015781 146 ---DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKL 221 (400)
Q Consensus 146 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl 221 (400)
..++|||||||+++ +.+.+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeE
Confidence 23578999999654 44444433223357999999999999999999999988 99999999999999775 8999
Q ss_pred eeccCCccCCCCCCcceeeecccccCcccchhhcc-CCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh--
Q 015781 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK-- 298 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-- 298 (400)
+|||++....... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||......+....+....
T Consensus 165 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998654432 2344679999999998765 578999999999999999999999997655322211111000
Q ss_pred ---HHHhh-hh-----hhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchh
Q 015781 299 ---PYLQS-KR-----RIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 357 (400)
Q Consensus 299 ---~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~ 357 (400)
..... .. .+................+.++.+|+.+||+.||++|||+.|+|+| ++.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000 00 0000000001111123356678999999999999999999999987 555543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=365.34 Aligned_cols=275 Identities=25% Similarity=0.286 Sum_probs=199.7
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch-hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
+.+|++.+.||+|+||+||+|.. ..+|+.||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYD---------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEE---------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEE---------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 35799999999999999999954 347899999999765432 34567899999999999999999999876
Q ss_pred CC----eeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEE
Q 015781 146 DD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (400)
Q Consensus 146 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl 221 (400)
.. ..+++++++.+++|.+++... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred ccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEE
Confidence 53 234444556699999999653 5899999999999999999999998 999999999999999999999
Q ss_pred eeccCCccCCCCCCc-ceeeecccccCcccchhhc-cCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhH
Q 015781 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMA-TGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKP 299 (400)
Q Consensus 222 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~ 299 (400)
+|||++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......+..........
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 999999764332211 1234467999999999984 45678999999999999999999999976653222111110000
Q ss_pred HH-----------hhhhhhhhhcccc--ccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchh
Q 015781 300 YL-----------QSKRRIFQVMDAR--IEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 357 (400)
Q Consensus 300 ~~-----------~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~ 357 (400)
.. ............. .........+.++.+|+.+||+.||.+|||+.++|+| |+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 0000000000000 0000011234578899999999999999999999998 544433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-47 Score=350.58 Aligned_cols=268 Identities=17% Similarity=0.170 Sum_probs=210.5
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCC-CcccceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|.+. .+|+.||+|++..... ...+.+|++.++.++| +|++.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL---------LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET---------TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 468999999999999999999544 4689999999865432 2345678888888865 899999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcC-----CCceE
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAK 220 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~-----~~~~k 220 (400)
+...++||||+ +++|.+++.... ..++...+..++.|++.||+|||++| |+||||||+||+++. ++.+|
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceE
Confidence 99999999999 789999987654 46899999999999999999999998 999999999999964 57899
Q ss_pred EeeccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH
Q 015781 221 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE 295 (400)
Q Consensus 221 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 295 (400)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 9999999865432211 12344689999999999999999999999999999999999999998765543332221
Q ss_pred hhhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchhcCCC
Q 015781 296 WAKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQDTNDA 361 (400)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~~~~~ 361 (400)
....... ......+ ....+.++.+++..|+..+|++||+++.+.+.|+++.+....
T Consensus 227 ~i~~~~~------~~~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 227 RIGEKKQ------STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHHHHH------HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhccC------CCChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 1110000 0000001 112345788899999999999999999999988887654433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=351.81 Aligned_cols=263 Identities=20% Similarity=0.198 Sum_probs=200.8
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCccc-ceeeEEEe
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLE 145 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~ 145 (400)
.++|++.+.||+|+||+||+|.+. .+|+.||||++..... ..++..|+++++.++|+|++ .+.+++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEEC---------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 357999999999999999999654 3689999999876532 23567899999999877655 45566678
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEc---CCCceEEe
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLS 222 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~---~~~~~kl~ 222 (400)
++..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++| |+||||||+|||++ .+..++|+
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeee
Confidence 88999999999 667777766544 56899999999999999999999998 99999999999985 45679999
Q ss_pred eccCCccCCCCCCc-----ceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHH-h
Q 015781 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIE-W 296 (400)
Q Consensus 223 Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~ 296 (400)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||..||............. +
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999865433221 12345689999999999999999999999999999999999999998765433322221 1
Q ss_pred hhHHHhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHhchh
Q 015781 297 AKPYLQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKALEQIQD 357 (400)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~~~~~ 357 (400)
...... .... .....++.++.+++.+||+.||++||++.++.+.|+.+..
T Consensus 229 ~~~~~~-------~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 229 SEKKMS-------TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHH-------SCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hcccCC-------CChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 110000 0000 0111334678899999999999999999999888887644
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=359.43 Aligned_cols=257 Identities=27% Similarity=0.337 Sum_probs=208.2
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc----hhHHHHHHHHHHHccCCC-CcccceeeE
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYH-PNLVKLIGY 142 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h-pniv~~~~~ 142 (400)
++|++.+.||+|+||+||+|... .+..+|+.||+|++..... .....+.+|+.++++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 56999999999999999999653 3455799999999876432 223457789999999976 899999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEe
Q 015781 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (400)
Q Consensus 143 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~ 222 (400)
+.+....+++|||+.+++|.+++.... .+.+..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEES
T ss_pred eccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEe
Confidence 999999999999999999999998774 4788999999999999999999998 9999999999999999999999
Q ss_pred eccCCccCCCCCCcceeeecccccCcccchhhccC--CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhhHH
Q 015781 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAKPY 300 (400)
Q Consensus 223 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 300 (400)
|||+++........ ......|++.|++||.+.+. .++.++|||||||++|+|++|..||...........+.-..
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-- 248 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-- 248 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--
Confidence 99999865433222 23456799999999999654 46889999999999999999999998765543322221000
Q ss_pred HhhhhhhhhhccccccCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 015781 301 LQSKRRIFQVMDARIEGQYSLGAALKTAVLAIKCLSNEPKFRP-----TMDEVVKA 351 (400)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~ 351 (400)
. ......+...+.++.+|+.+||+.||++|| |++|+++|
T Consensus 249 ----------~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 ----------L--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------H--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------c--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 011123345677899999999999999999 48999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=358.31 Aligned_cols=271 Identities=24% Similarity=0.288 Sum_probs=196.0
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch--hHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|+.. .+|+.||||++...... ....+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 68999999999999999999654 46899999998665332 34567899999999999999999998854
Q ss_pred --------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC
Q 015781 146 --------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (400)
Q Consensus 146 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~ 217 (400)
.+..|+||||+.++.+..+.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDG 154 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTS
T ss_pred ccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCC
Confidence 35689999999766554433222 46899999999999999999999998 99999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc--ceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhH
Q 015781 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLI 294 (400)
Q Consensus 218 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~ 294 (400)
.+||+|||++......... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+..+......+
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i 234 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence 9999999999765432211 122345799999999998765 6899999999999999999999999765432222111
Q ss_pred HhhhHHHhhh-------hhhhhhccccccCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 015781 295 EWAKPYLQSK-------RRIFQVMDARIEGQYS-------LGAALKTAVLAIKCLSNEPKFRPTMDEVVKALE 353 (400)
Q Consensus 295 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L~ 353 (400)
.......... ................ ...+..+.+|+.+||+.||++|||+.|+|+|=+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 1100000000 0000000000000000 112456778999999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.1e-48 Score=357.63 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=198.8
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCcccceeeEEEe-
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~- 145 (400)
++|++.+.||+|+||+||+|+. ..+|+.||+|++.... ...+.+|+.+|+.+. ||||+++++++..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 5799999999999999999954 3478999999997643 346789999999995 9999999999974
Q ss_pred -CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCC-ceEEee
Q 015781 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (400)
Q Consensus 146 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~-~~kl~D 223 (400)
...+++|||||.+++|..+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecc
Confidence 45689999999999986542 46899999999999999999999998 99999999999998655 699999
Q ss_pred ccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchh-H-Hhh---
Q 015781 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNL-I-EWA--- 297 (400)
Q Consensus 224 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~-~-~~~--- 297 (400)
||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||........... + ...
T Consensus 174 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 174 WGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp GGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred cccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99998654432 23446789999999998765 579999999999999999999999976554221110 0 000
Q ss_pred --hHHHhh-----hhhhhhhcc--------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 298 --KPYLQS-----KRRIFQVMD--------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 298 --~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
...... ......... ...........+.++.+||.+||+.||++|||++|+|+|=
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000000 000000000 0001111223456788999999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=349.45 Aligned_cols=266 Identities=23% Similarity=0.259 Sum_probs=204.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|++. .+++.||||+++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEEC---------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 57999999999999999999544 4789999999865543 234678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCceEEeecc
Q 015781 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (400)
Q Consensus 146 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 225 (400)
....++||+++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecc
Confidence 99999999999998888877655 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeecccccCcccchhhccCC-CCCccchhhHHHHHHHHHhCCCccCCCCCCccc-hhHHhhhHHHhh
Q 015781 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGH-LTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREH-NLIEWAKPYLQS 303 (400)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~ 303 (400)
.++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||......... ..+..... ...
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~ 223 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPT 223 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCC
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC-CCC
Confidence 9987544332 233346788999999987654 689999999999999999999997543322111 11100000 000
Q ss_pred hhh---hhhhcc---------ccccCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 015781 304 KRR---IFQVMD---------ARIEGQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA 351 (400)
Q Consensus 304 ~~~---~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 351 (400)
... ...... ...........+..+.+|+.+||+.||++|||++|+|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000 000111223445678899999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=357.66 Aligned_cols=264 Identities=21% Similarity=0.245 Sum_probs=192.5
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEEe
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~~ 145 (400)
++|++.+.||+|+||+||+|++. .+|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~---------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA---------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET---------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEEC---------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 67999999999999999999544 4799999999976533 233467899999999999999999999963
Q ss_pred ------CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 146 ------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 146 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
..++|+|||||.++ +.+.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCE
T ss_pred ccccccCceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccce
Confidence 36889999999654 444442 35899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHh---
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEW--- 296 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~--- 296 (400)
+++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|+|++|++||.+.........+..
T Consensus 159 kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999987654322 33456789999999999999999999999999999999999999976643222111100
Q ss_pred ------h-------hHHHhhh-----hhhhhhcccccc---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 015781 297 ------A-------KPYLQSK-----RRIFQVMDARIE---GQYSLGAALKTAVLAIKCLSNEPKFRPTMDEVVKAL 352 (400)
Q Consensus 297 ------~-------~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~L 352 (400)
. ....... ............ .......+.++.+|+.+||..||++|||++|+|+|=
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0 0000000 000000000000 011234577899999999999999999999999983
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=355.47 Aligned_cols=270 Identities=23% Similarity=0.298 Sum_probs=199.1
Q ss_pred hcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccc--hhHHHHHHHHHHHccCCCCcccceeeEEE
Q 015781 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (400)
Q Consensus 67 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 144 (400)
.++|++.+.||+|+||+||+|+.. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET---------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 468999999999999999999543 4789999999976543 23456789999999999999999999986
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEEEcCCCce
Q 015781 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (400)
Q Consensus 145 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nill~~~~~~ 219 (400)
.. ...+++|+++.+++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccc
Confidence 32 344666777789999999854 35899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCccCCCCCCcceeeecccccCcccchhhccC-CCCCccchhhHHHHHHHHHhCCCccCCCCCCccchhHHhhh
Q 015781 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-HLTAKSDVYSFGVVLLEMLSGRRVIDKNRPSREHNLIEWAK 298 (400)
Q Consensus 220 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~ 298 (400)
|++|||++..... ......|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 161 kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 161 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp EECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999875432 23446789999999987665 46889999999999999999999998765332222111000
Q ss_pred HHHh----h---hhhhhhhccccc-cCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HHhchh
Q 015781 299 PYLQ----S---KRRIFQVMDARI-EGQY-----SLGAALKTAVLAIKCLSNEPKFRPTMDEVVKA--LEQIQD 357 (400)
Q Consensus 299 ~~~~----~---~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~--L~~~~~ 357 (400)
.... . ............ .... ....+..+.+||.+||+.||.+|||+.|+|+| +.++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0000 0 000000000000 0000 11235678899999999999999999999997 444433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-42 Score=321.90 Aligned_cols=284 Identities=17% Similarity=0.186 Sum_probs=199.6
Q ss_pred cCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-----------CCcc
Q 015781 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPNL 136 (400)
Q Consensus 68 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpni 136 (400)
.+|++.++||+|+||+||+|+.. .+|+.||||+++.... ....+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~---------~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 46999999999999999999543 4789999999987643 2345667888887765 5789
Q ss_pred cceeeEEEe--CCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeeeccCCCCCEEE
Q 015781 137 VKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILL 213 (400)
Q Consensus 137 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~dlkp~Nill 213 (400)
+++++++.. ....+++|+++..+.......... ....+++..+..++.||+.||+|||+ .| |+||||||+|||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeee
Confidence 999988764 356667777665554433332222 22568999999999999999999997 77 9999999999999
Q ss_pred cCCCc------eEEeeccCCccCCCCCCcceeeecccccCcccchhhccCCCCCccchhhHHHHHHHHHhCCCccCCCCC
Q 015781 214 DLNYN------AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGHLTAKSDVYSFGVVLLEMLSGRRVIDKNRP 287 (400)
Q Consensus 214 ~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDiwslG~il~~l~tg~~pf~~~~~ 287 (400)
+.++. ++++|||.+...... .....||+.|+|||++.+..|+.++|||||||++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 76553 999999998754322 2345799999999999999999999999999999999999999976543
Q ss_pred CccchhHHhhhHHH-----------hhhhhhhhhcc-------------------ccccCCCCHHHHHHHHHHHHhcccC
Q 015781 288 SREHNLIEWAKPYL-----------QSKRRIFQVMD-------------------ARIEGQYSLGAALKTAVLAIKCLSN 337 (400)
Q Consensus 288 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~l~~ 337 (400)
.............. ..........+ ...........+..+.+|+.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22111100000000 00000000000 0011233456788999999999999
Q ss_pred CCCCCCCHHHHHHH--HHhchhcCCCCCCCcccc
Q 015781 338 EPKFRPTMDEVVKA--LEQIQDTNDAGVSRDESL 369 (400)
Q Consensus 338 dP~~Rps~~eil~~--L~~~~~~~~~~~~~~~~~ 369 (400)
||.+|||++|+|+| ++..........|..+-.
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred ChhHCcCHHHHhcCcccCCCCCcccCCCCCcccC
Confidence 99999999999997 555555555555544433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=4.9e-25 Score=187.02 Aligned_cols=163 Identities=14% Similarity=0.085 Sum_probs=117.6
Q ss_pred CCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccch------------------hHHHHHHHHHHHccCC
Q 015781 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------GHLEWLTEIKHLGQLY 132 (400)
Q Consensus 71 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~ 132 (400)
.+.+.||+|+||+||+|... +|+.||||+++..... .......|...+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 35678999999999999653 4789999987542110 0122456888899999
Q ss_pred CCcccceeeEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeeccCCCCCEE
Q 015781 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (400)
Q Consensus 133 hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~dlkp~Nil 212 (400)
|++++..+++.. .+++|||+++..+.+ ++......++.|++.+|+|||++| |+||||||+|||
T Consensus 73 ~~~v~~~~~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NIL 135 (191)
T d1zara2 73 GLAVPKVYAWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVL 135 (191)
T ss_dssp TSSSCCEEEEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred CCCcceEEEecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhhee
Confidence 999998876532 379999998765422 344456778999999999999998 999999999999
Q ss_pred EcCCCceEEeeccCCccCCCCCCcceeeecccccCcccc------hhhccCCCCCccchhhHHHHH
Q 015781 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP------EYMATGHLTAKSDVYSFGVVL 272 (400)
Q Consensus 213 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDiwslG~il 272 (400)
++++ .++|+|||.+......... .|... +.+ ...|+.++|+||+.--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9865 5899999999765432211 11111 112 35688999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=2.4e-08 Score=86.89 Aligned_cols=147 Identities=15% Similarity=0.003 Sum_probs=98.3
Q ss_pred HHHHHhcCCCCCCccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC-CCccccee
Q 015781 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLI 140 (400)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~ 140 (400)
++......|++.+..+.++.+.||+... .+..+++|+...........+.+|...++.+. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 3455567788777766666678998743 24567889876654433434567777766553 33367788
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------
Q 015781 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---------------------- 198 (400)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------- 198 (400)
.+..+++..++||++++|.++.+..... .. ...++.++...+..||+..
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 8888889999999999998886543211 11 1223444445555555321
Q ss_pred -----------------------------------CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 -----------------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 -----------------------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999977666799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=3.7e-06 Score=72.17 Aligned_cols=73 Identities=21% Similarity=0.117 Sum_probs=48.3
Q ss_pred cccCC-CceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCC--CCcccceeeEEEeCCeeEEE
Q 015781 76 LGEGG-FGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLV 152 (400)
Q Consensus 76 lg~G~-~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~lv 152 (400)
+..|. -+.||+.... .+..+++|........ .+..|...++.+. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 34444 3678987543 3566889987655432 3445666665553 23366778888888889999
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=3.9e-05 Score=70.21 Aligned_cols=77 Identities=14% Similarity=0.119 Sum_probs=45.2
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEecccc-------chhHHHHHHHHHHHccCC-C-C-cccceeeEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-------LQGHLEWLTEIKHLGQLY-H-P-NLVKLIGYC 143 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h-p-niv~~~~~~ 143 (400)
+.||.|....||++... .+++.+++|.-.... .....+...|...|+.+. + | .+.+++.+
T Consensus 32 ~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence 46899999999998533 246778999654311 011223445666666552 2 2 34455543
Q ss_pred EeCCeeEEEEeecCCCCH
Q 015781 144 LEDDHRLLVYEFMPKGSL 161 (400)
Q Consensus 144 ~~~~~~~lv~e~~~~~~L 161 (400)
+.+..++|||++.+..+
T Consensus 102 -d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 -DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp -ETTTTEEEECCCTTSEE
T ss_pred -cCCCCEEEEeccCCccc
Confidence 45566899999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.00084 Score=59.29 Aligned_cols=136 Identities=14% Similarity=0.003 Sum_probs=74.1
Q ss_pred CceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCc-----ccce--eeEEEeCCeeEEEE
Q 015781 81 FGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-----LVKL--IGYCLEDDHRLLVY 153 (400)
Q Consensus 81 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpn-----iv~~--~~~~~~~~~~~lv~ 153 (400)
--.||++... +|..+++|+.+... ....++..|...+..|...+ .+.. -..+..++..+.++
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 3579987443 47789999987653 23445666776666653211 1111 12334567788999
Q ss_pred eecCCCCHH-----HHHh---------hh-cC--------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 015781 154 EFMPKGSLE-----NHLF---------RR-AS--------------------------YIQPLSWTIRMKVALGAAKGLA 192 (400)
Q Consensus 154 e~~~~~~L~-----~~l~---------~~-~~--------------------------~~~~~~~~~~~~i~~qi~~~l~ 192 (400)
+++.|..+. .+.. .. .. ...+-........+.+++..+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 998764321 1110 00 00 0001111223333444444433
Q ss_pred Hhh--cCCCCeeeccCCCCCEEEcCCCceEEeeccCCcc
Q 015781 193 YLH--SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (400)
Q Consensus 193 ~LH--~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 229 (400)
-+- ....+++|+|+.+.|||++++ ..++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 321 112348999999999999743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0014 Score=59.60 Aligned_cols=80 Identities=16% Similarity=0.096 Sum_probs=49.8
Q ss_pred CccccCCCceEEEEEecCCCcCCCCCCCCcEEEEEEeccccchhHHHHHHHHHHHccCCCCcc-cceeeEEEeCCeeEEE
Q 015781 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (400)
Q Consensus 74 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~hpni-v~~~~~~~~~~~~~lv 152 (400)
+.|+.|-.-.+|++...+..+ ........|++++..... ......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 467888888999987765322 112234567788776332 22345578888877743344 466666542 589
Q ss_pred EeecCCCCH
Q 015781 153 YEFMPKGSL 161 (400)
Q Consensus 153 ~e~~~~~~L 161 (400)
|||++|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.67 E-value=0.018 Score=49.93 Aligned_cols=30 Identities=30% Similarity=0.227 Sum_probs=26.5
Q ss_pred CCeeeccCCCCCEEEcCCCceEEeeccCCc
Q 015781 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (400)
Q Consensus 199 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 228 (400)
.++||+|+.++|++++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 349999999999999988777899999775
|